0001171843-15-001673.txt : 20150326 0001171843-15-001673.hdr.sgml : 20150326 20150326153508 ACCESSION NUMBER: 0001171843-15-001673 CONFORMED SUBMISSION TYPE: 10-K PUBLIC DOCUMENT COUNT: 10 CONFORMED PERIOD OF REPORT: 20141231 FILED AS OF DATE: 20150326 DATE AS OF CHANGE: 20150326 FILER: COMPANY DATA: COMPANY CONFORMED NAME: UNITED GUARDIAN INC CENTRAL INDEX KEY: 0000101295 STANDARD INDUSTRIAL CLASSIFICATION: PERFUMES, COSMETICS & OTHER TOILET PREPARATIONS [2844] IRS NUMBER: 111719724 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-10526 FILM NUMBER: 15727513 BUSINESS ADDRESS: STREET 1: 230 MARCUS BLVD CITY: HAUPPAUGE STATE: NY ZIP: 11788 BUSINESS PHONE: 631-273-0900 MAIL ADDRESS: STREET 1: P.O. BOX 18050 STREET 2: 230 MARCUS BLVD. CITY: HAUPPAUGE STATE: NY ZIP: 11788 FORMER COMPANY: FORMER CONFORMED NAME: UNITED INTERNATIONAL RESEARCH INC DATE OF NAME CHANGE: 19820422 10-K 1 f10k_032415.htm FORM 10-K f10k_032415.htm
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D. C. 20549

FORM 10-K

(Mark One)
 
þ
ANNUAL REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
      
For the fiscal year ended December 31, 2014
 
OR
 
¨
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
 
For the transition period from __________ to ____________
 
Commission file number 1-10526
 

UNITED-GUARDIAN, INC.
(Exact name of Registrant as specified in its charter)
 
 
  Delaware   11-1719724  
 
(State or other jurisdiction
of incorporation or organization)
 
(I.R.S. Employer
Identification No.)
  
         
         
  230 Marcus Blvd., Hauppauge, NY   11788  
  (Address of principal executive offices)   (Zip Code)  
 
 
Registrant's telephone number, including area code: (631) 273-0900


Securities registered pursuant to Section l2(b) of the Act:
 
Title of each class Name of each exchange on which registered
Common Stock, $.10 par value The NASDAQ Global Market
 
 
Securities registered pursuant to Section 12(g) of the Act:

 None
 
 
Cover Page 1 of 2
 
Indicate by check mark if the Registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.     Yes o         No þ

Indicate by check mark if the Registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.    Yes o        No þ

Indicate by check mark whether the Registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. 
Yes þ        No o

Indicate by check mark whether the Registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data file required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the Registrant was required to submit and post such files). Yes þ        No o   

Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K is not contained herein,  and will not be contained, to the best of Registrant's knowledge, in definitive  proxy or information statements  incorporated  by  reference  in Part III of this Form 10-K or any amendment to this Form 10-K.       þ

Indicate by check mark whether the Registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.
 
Large accelerated filer  ¨
  
Accelerated filer  ¨
  
Non-accelerated filer  ¨
  
Smaller reporting company  þ
       
 (Do not check if a smaller
reporting company)
    

Indicate by check mark whether the Registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act.)Yes  ¨       No  þ

As of June 30, 2014, the last business day of the Registrant’s most recently completed second fiscal quarter, the aggregate  market value of the Registrant's common stock held by non-affiliates (based on the closing sales price of such shares on The NASDAQ Global Market (“NASDAQ”) on such date) was approximately $74,690,668.  (For the purpose of this report it has been assumed that all officers and directors of the Registrant, as well as all stockholders holding 10% or more of Registrant's stock, are affiliates of the Registrant).

As of March 1, 2015, the Registrant had issued and outstanding 4,596,439 shares of Common Stock, $.10 par value per share ("Common Stock").
 
 
DOCUMENTS INCORPORATED BY REFERENCE:

Certain  information  required by Part III  (portions of Item 10, as well as Items  11,  12,  and  13) is  incorporated  by  reference to the Registrant's definitive  proxy statement for the 2015 annual meeting of  stockholders  ("2015 Proxy Statement"), which, pursuant to Regulation 14A of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), is to be filed  with the Securities and  Exchange Commission (the “SEC”) no later than 120 days after Registrant's fiscal year end.

 
Cover Page 2 of 2
 
This Annual Report on Form 10-K contains both historical and "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, which provides a safe harbor for forward-looking statements by the Registrant about its expectations or beliefs concerning future events, such as financial performance, business prospects, and similar matters. The Registrant desires to take advantage of such "safe harbor" provisions and is including this statement for that express purpose. Words such as "anticipates", "believes", "expects", "intends", "future", and similar expressions identify forward-looking statements. Any such "forward-looking" statements in this report reflect the Registrant's views as of the date of filing of this report with the United States Securities and Exchange Commission (the “SEC”) with respect to future events and financial performance, and are subject to a variety of factors that could cause the Registrant's actual results or performance to differ materially from historical results or from the anticipated results or performance expressed or implied by such forward-looking statements. Because of such factors, there can be no assurance that the actual results or developments anticipated by the Registrant will be realized or, even if substantially realized, that they will have the anticipated results. The risks and uncertainties that may affect the Registrant's business include, but are not limited to: economic conditions, governmental regulations, technological advances, pricing and competition, acceptance by the marketplace of new products, retention of key personnel, the sufficiency of financial resources to sustain and expand the Registrant's operations, and other factors described in this report and in prior filings with the SEC.  Readers should not place undue reliance on such forward-looking statements, which speak only as of the date hereof, and should be aware that except as may be otherwise legally required of the Registrant, the Registrant undertakes no obligation to publicly revise any such forward-looking statements to reflect events or circumstances that may arise after the date hereof.
 
PART  I
 
Item 1.
Business.
 
(a)  Introduction    
 
United-Guardian, Inc. ("United", the "Registrant", or the “Company”) is a Delaware corporation that, through its Guardian Laboratories Division ("Guardian"), manufactures and markets cosmetic ingredients, personal care products, pharmaceuticals, medical lubricants, health care products, and specialty industrial products. It also conducts research and product development, primarily related to the development of new and unique cosmetic and personal care products. The Company’s research and development department also modifies, refines, and expands the uses for existing products, with the goal of further developing the market for the Company's products.
 
United's predecessor, United International Research, Inc. ("UIR"), was founded and incorporated in New York in 1942 by Dr. Alfred R. Globus, United's Chairman and Director of Research until his death on April 9, 2009. On February 10, 1982, a merger took place between UIR and Guardian Chemical Corp. ("GCC"), an affiliate of UIR, whereby GCC was merged into UIR and the name was changed to United-Guardian, Inc., a New York corporation. On September 14, 1987, United-Guardian, Inc. (New York) was merged with and into a newly-formed Delaware corporation by the same name, United-Guardian, Inc., for the purpose of changing the domicile of the Company to Delaware.
 
The Company has a broad range of products, some of which are currently marketed, some of which are marketable but are not currently marketed by the Company, and some of which are still in the developmental stage. Of the products being actively marketed, the two largest product lines are the LUBRAJEL™ line of cosmetic ingredients and medical lubricants, which accounted for approximately 86% of the Company's sales in 2014, and RENACIDIN® IRRIGATION ("RENACIDIN"), a pharmaceutical product that accounted for approximately 9% of the Company's sales in 2014.
 
 
1
 
 (b)  Narrative Description of Business
 
The Company manufactures and markets cosmetic ingredients, personal and health care products, medical lubricants, pharmaceuticals, and specialty industrial products. It also conducts research and development, primarily related to the development of new and unique cosmetic and personal care products. The Company endeavors to develop products that fill unmet market needs, have unique properties, and use proprietary technology that it sometimes protects with patents. Many of the Company's products are marketed through collaborative agreements with larger companies. The personal care products manufactured by the Company, including the cosmetic ingredients, are marketed to end users through the Company's worldwide network of marketing partners and distributors, and are currently used by many of the major manufacturers of cosmetic and personal care products. The Company sells product outright to its marketing partners, Free On Board (“FOB”) the Company’s plant in Hauppauge, New York, and those marketing partners in turn resell those products to their customers, who are typically the end users of the products. The products are not sold on a consignment basis, so unless a product is determined to be defective it is not returnable except at the discretion of the Company.
 
The Company operates in one business segment. The Company’s products are separated into four distinct product categories: personal care products (including cosmetic ingredients), pharmaceuticals, medical products, and industrial products. Each product category is marketed differently.  
 
The Company’s personal care products, including cosmetic ingredients, are marketed globally by six marketing partners, of which Ashland Specialty Ingredients (“ASI”), a business segment of Ashland, Inc., is the largest. The products are sold directly to those marketing partners, which in turn resell those products to its customers for use in the manufacture or compounding of the customers’ personal care and cosmetic products. The Company’s non-pharmaceutical medical products (referred to hereinafter as “medical products”) and the specialty industrial products are sold directly by the Company to the end users or to contract manufacturers utilized by the end users. The Company’s pharmaceutical products are marketed by direct advertising, mailings, and trade exhibitions, and are sold to end users primarily through full-line drug wholesalers, which purchase the Company’s products outright for resale to their customers. The Company also sells a small quantity of pharmaceutical products directly to hospitals and pharmacies. The Company's products are sold under trademarks or trade names owned by the Company, some of which are registered with the United States Patent and Trademark Office as well as comparable regulatory agencies in some foreign countries.
 
PRODUCTS
 
The Company operates in one business segment, and its product lines are separated into four distinct product categories:
 
PERSONAL CARE
 
LUBRAJEL™ is an extensive line of water-based moisturizing and lubricating gel formulations that are used as ingredients in personal care (primarily cosmetic/skincare) products. In the personal care industry, they are used primarily as moisturizers and as bases for other cosmetic ingredients, and can be found as an ingredient in skin creams, moisturizers, makeup, and body lotions. The largest-selling product in the LUBRAJEL personal care line in 2014 was LUBRAJEL OIL, followed by LUBRAJEL CG. Some of the other varieties of LUBRAJEL sold for cosmetic use (all using the LUBRAJEL name), in descending order of sales, are PF (including Norgel (see LUBRAJEL PF below)), MS, DV, and NP. In addition, many of these products are available in comparable formulations that do not contain parabens as the preservative, and instead use a different preservative system that is preferred by some customers. Those equivalent products are differentiated by adding the word “Free” after the name (for example, LUBRAJEL MS Free, DV Free, etc.), indicating that those formulations do not contain parabens.
 
 
2
 
LUBRAJEL PF is different from the other products in the LUBRAJEL line in that it is a completely preservative-free form of LUBRAJEL. It is marketed under the LUBRAJEL PF tradename in all geographic markets other than France, where it is marketed under the tradename “Norgel” by Societe D'Etudes Dermatologiques ("Sederma"), a subsidiary of Croda International Plc (“Croda”). Sederma is the Company's exclusive marketing partner and distributor of the Company’s cosmetic ingredients in France and, along with its parent company, Croda, is a major supplier of specialty cosmetic ingredients to the personal care products industry. Tests have shown that this product self-preserves, and that it aids in the preservation of other cosmetic ingredients with which it is formulated.
 
LUBRAJEL NATURAL and LUBRAJEL NATURAL MARINE are two new natural forms of LUBRAJEL for cosmetic use. They are based on natural polysaccharides, which contribute moisturization, emulsion stabilization, and emolliency to personal care creams and lotions. LUBRAJEL NATURAL MARINE uses some components derived from marine sources. Both products are certified as natural by Ecocert, a leading industry certification organization for natural and organic products. The Company believes that there is a growing demand, especially in personal care products, for natural products. The Company expects to produce at least one additional formulation of these natural, water-based gels, which will be similar to the Company’s LUBRAJEL OIL product, but will contain all-natural components. This product will be marketed under the LUBRAJEL tradename as well. The Company hopes to begin to see sales of this product line in 2015.
 
Each of the following products accounted for less than 3% of the Company’s sales in 2014, listed in descending order of sales:
 
KLENSOFT™ is a surfactant (a surface active agent, such as a soap or detergent) that can be used in shampoos, shower gels, makeup removers, and other cosmetic formulations. KLENSOFT sales have been very variable due to the ordering patterns of the customers for the product. In 2014 sales of KLENSOFT increased by 87% over 2013, from $126,697 to $237,248. The Company expects the variability in sales of this product to continue.
 
LUBRAJEL II XD is a version of LUBRAJEL that was developed to be a direct replacement for one of the competitive products to LUBRAJEL.
 
UNITWIX™ is a cosmetic additive used as a thickener for oils and oil-based liquids. It is a proprietary, unpatented product. In 2011 the Company developed a new formula for UNITWIX that it now markets under the name UNITWIX II.  It was developed as a result of the escalation in the cost, and limited availability, of the raw materials used in the manufacturing of UNITWIX, and was intended to be a direct replacement for the original UNITWIX. The new formula is less expensive to manufacture, and therefore can be marketed at a lower price. Some of the Company's customers for this product have already switched to the new formula. The Company is hopeful that this lower-cost formulation will bring in new customers for which the original product was not cost effective. However, even with the new formulation there are still issues regarding cost and availability of the raw materials needed to manufacture this product, so the Company does not expect to see significant future sales from this product line.
 
LUBRASIL™ is a special form of LUBRAJEL in which silicone oil is incorporated into a LUBRAJEL base by micro-emulsification, thereby maintaining clarity similar to the other LUBRAJEL products. The product has a silky feel, and is water resistant while moisturizing the skin. In addition to the original LUBRASIL formulation, the Company added an additional LUBRASIL formulation marketed under the tradename, LUBRASIL SB, which has a higher level of silicone than the original LUBRASIL, and is intended to be an addition to, not a replacement for, the original LUBRASIL.
 
 
3
 
ORCHID COMPLEX™ is a successor product to the Company's previous OIL OF ORCHIDS product, and is a base for skin creams, lotions, cleansers, and other cosmetics. It is an extract of fresh orchids modified by stabilizers and preservatives, and is characterized by its excellent lubricity, spreadability, light feel, and emolliency. Because of its alcohol solubility, it may also be used in fragrance products such as perfumes and toiletries. Its emolliency makes it an excellent additive to shampoos, bath products and facial cleansers. It is also a superior emollient for sunscreens, vitamin creams, toners and skin serums. It is sold in two forms, water-soluble and oil-soluble.
 
LUBRASLIDE™ and a related product, B-122™, are powdered lubricants used in the manufacture of cosmetics such as pressed powders, eyeliners, and rouges. They are used as binders for these products, increasing water-repellency and drop strength and lowering the coefficient of friction.
 
The Company believes that its ability to increase sales of its cosmetic and other personal care products will depend on (a) the ability and determination of its marketing partners, especially its largest marketing partner, ASI, to continue to aggressively promote the Company’s products, particularly to new customers; (b) the Company's success in developing new forms of LUBRAJEL that expand its uses to new applications; and (c) the ability of the Company to continue to develop additional new products to expand its line of personal care products. The Company is continuing to develop new varieties of LUBRAJEL to extend that line even further, and is working with its marketing partners to find new marketing opportunities, including products previously developed by the Company that are not being actively marketed at the present time, but for which there may be new marketing opportunities.
 
The Company believes that there is still significant potential to expand the sales of its LUBRAJEL line of products through product modifications, additional claim substantiation, and geographic expansion, especially in such developing markets as mainland China, India, and Eastern Europe.
 
Any future increases in sales of the LUBRAJEL line of products may be negatively impacted by sales of competitive products, including new products being produced in China.  However, the Company believes that because of the strong brand identity, the cost to the end user of reformulation, the Company’s long history of supplying quality products, the extensive line of LUBRAJEL formulations, and the Company’s continuing product development programs, it will continue to be able to compete effectively in the marketplace and expand the market for its LUBRAJEL product line (see “Competition” below).
 
MEDICAL
 
LUBRAJEL RR and RC are both gels used primarily as lubricants for urinary catheters. Both are special grades of LUBRAJEL that can withstand sterilization by gamma radiation, which is one of the methods of terminally sterilizing medical and hospital products. LUBRAJEL RR was the original radiation-resistant LUBRAJEL product. LUBRAJEL RC was developed specifically for one customer that packages the product in unit doses as a catheter lubricant for many manufacturers. Combined sales of these two products in 2014 increased by 5.9% compared with 2013, with LUBRAJEL RC accounting for the largest portion of that increase. The combined sales of both products accounted for approximately 12.7% of the Company’s sales in 2014. Sales of both of these products are subject to year-to-year variations based on the ordering patterns of the customers for these two products.
 
LUBRAJEL LC was developed for a specific customer who required a product suitable for oral use, to be used in a line of mouth moisturizers that it markets. The inclusion of LUBRAJEL LC in that customer’s product line was discontinued in 2013. As a result, sales decreased by approximately 92% in 2014 compared with 2013. However, another customer began purchasing LUBRAJEL LC in the fourth quarter of 2014, so it is possible that the Company will be able to recover some of the sales that it lost.
 
 
4
 
 
LUBRAJEL MG is the original form of LUBRAJEL, developed as a medical lubricant in the 1970s. It is used by many medical device manufacturers for lubricating urinary catheters, pre-lubricated enema tips, and other medical devices. Sales decreased by 12% in 2014 compared with 2013, which the Company believes was the result of fluctuations in the buying patterns of customers for this product. Sales of this product represented 4.7% of the Company’s sales in both 2014 and in 2013 because overall Company sales in 2014 declined by about the same percentage as the sales decline in this product.
 
LUBRAJEL FLUID is a very low viscosity form of LUBRAJEL that was developed to provide superior lubrication in water-soluble products. It was specifically developed, and is currently being used, as a replacement for silicone oils in pre-lubricated condoms. Sales have decreased in each of the past two years due to a lessening of the concerns about the use of silicone-based products.
 
LUBRAJEL BA is a new LUBRAJEL formulation that was specifically developed for ASI and is intended for oral care uses. ASI actively promoted this product during 2013, and the Company received its first orders for this product from ASI in February 2014. Sales of this product are not yet a significant contributor to the Company’s revenue, and it is too early to project whether or not it will become a significant product for the Company.
 
LUBRAJEL TF is a medical lubricant specifically developed for a global medical products company.  Initial sales of this product began at the end of 2012. Although the Company is still hopeful that sales of this product will increase, sales of this product to date have been very low. The Company has not been made privy to the customer’s marketing plans for this product, so it is impossible to predict future sales to this customer at the present time.
 
Sales of all of the medical grades of LUBRAJEL decreased by 16.2% in 2014 compared with 2013. Sales of these products accounted for 18.2% of the Company’s sales in 2014 compared with approximately 19.0% in 2013, due to lower total Company sales in 2014. Approximately 83% of the decrease in sales in 2014 was the result of the loss of sales of Lubrajel LC in 2014 (as discussed above), with the remainder of the decrease caused by fluctuations in the purchasing patterns of its customers.
 
PHARMACEUTICAL
 
RENACIDIN® is a prescription drug product that is used primarily to prevent and to dissolve calcifications in urethral catheters and the urinary bladder. It is marketed as a ready-to-use sterile solution. It currently has regulatory approval only in the United States. Prior to 2010, RENACIDIN typically accounted for between16% and 20% of the Company's annual sales. This product has been manufactured for the Company under a long-term contract with a major U.S. drug company. Since November 2010, that supplier has experienced production issues at the facility that manufactures RENACIDIN. Those production issues were unrelated to the RENACIDIN product itself, but nevertheless resulted in two production curtailments, the second of which occurred in May 2012.  Since the Company did not receive any shipments of RENACIDIN in the first ten months of 2013, and was only able to resume sales in late October 2013, RENACIDIN sales in 2013 were only $451,565. The Company had product to sell during all of 2014, and as a result, sales of RENACIDIN increased to $1,182,402, which was still significantly below the Company’s typical yearly sales revenue from RENACIDIN prior to the production curtailments.
 
To reimburse the Company for profits it lost as a result of the most recent production curtailment, the Company and its supplier entered into a settlement agreement whereby the supplier paid the Company $518,050 for the profits it lost in 2012, and continued to pay the Company $97,610 per month for each month during 2013 that the product was not available. Once production resumed, the agreement provided that the Company was to be paid $48,805 for each of the first two months after the resumption of shipments, and a final payment of $24,403 for the third month. The total amount of the reimbursement in 2014 was $24,403, compared with $1,070,561 that it received as result of this settlement agreement in 2013.
 
 
5
 
The Company’s supply contract with its current RENACIDIN supplier was scheduled to expire in January 2014, but the Company and its supplier reached an agreement to extend the supply agreement into the first quarter of 2015. Separately, the Company has already located a replacement supplier, which will be supplying the product in a new 30 mL single-dose plastic bottle. Currently the product is available only in a 500 mL glass bottle, which is difficult for the patient or care-giver to use. The Company expects that this new single-dose unit will result in wider acceptance and use of the product, and has the potential to significantly increase RENACIDIN sales. The change to the new supplier required a new submission to, and approval by, the U.S. Food and Drug Administration (“FDA”). The Company submitted its application to the FDA in August 2014 in the form of a supplement to its previous NDA for RENACIDIN, and is hoping to receive approval by the end of the first quarter of 2015. Until then, the Company plans to continue selling the current form of the product, and will bring in sufficient inventory to last until the new supplier is approved and the Company can begin to sell the new single-dose unit. The Company expects to be selling both package sizes until the supply of the 500 mL bottle is exhausted.
 
CLORPACTIN® WCS-90 is an antimicrobial product used primarily in urology to treat infections in the urinary bladder. It is also used in surgery for treating a wide range of localized infections in the peritoneum (the lining of the abdominal cavity), as well as the eye, ear, nose and throat, and sinuses. The product is a powder that is mixed with water by the end user and used as a solution. It is also a powerful disinfectant, fungicide, and deodorizer. Sales of CLORPACTIN have been very consistent from year-to-year, although in 2014 sales increased by 8.5% and represented approximately 4% of the Company’s sales.
 
The Company’s pharmaceutical products are returnable only at the discretion of the Company unless (a) they are found to be defective, or (b) they are outdated (but not more than one year after their expiration date, a return policy that conforms to standard pharmaceutical industry practice).
 
INDUSTRIAL
 
DESELEX™ Liquid is a sequestering and chelating agent that is used primarily as a replacement for phosphates in the manufacture of detergents. It also has some use in personal care products as a chelating agent in shampoos and body washes.

THOROCLENS is a chlorine-based cleanser manufactured and packaged by the Company for a small company in New England who resells the product to its customers. Sales of this product increased by 15.0% in 2014.
 
DEVELOPMENT ACTIVITIES
 
The Company's research and development department has developed, in coordination with, and with  input from, its marketing partners, a large number of products that can be used in many different industries, including the personal care (including cosmetic), pharmaceutical, medical, health care, and specialty chemical industries. These products are in various stages of development, some currently marketable and some in the very early stages of development requiring a substantial amount of development work to bring them to market. Research is also being done on new uses for currently marketed products.
 
Prior to initiating research and development work on a product, market research is done to determine the marketability of the product, including the potential market size and the most effective method of marketing the product. After that, the research and development department will determine whether the product can be successfully developed, including (a) laboratory refinements and adjustments to suit the intended uses of the product; (b) stability studies to determine the effective shelf life of the product and suitable storage and transportation conditions; and (c) laboratory efficacy tests to determine the effectiveness of the product under different conditions. If development proves feasible, the Company will then determine whether production and sales costs make it feasible to bring the product to market.
 
 
6
 
 
If the initial development work is successful and the estimated costs of further development are acceptable to the Company, further development work to bring the product to market will continue, including scaling up from laboratory production batches to pilot batches to full-scale production batches. In the case of drug products or medical devices, significant additional work would have to be done, including studies to determine safety and effectiveness, preparation of an Investigational New Drug (IND) application, and finally the filing of a New Drug Application (NDA). The Company does not currently have plans to develop any new drugs or medical devices.
 
While there can be no assurance that any particular project will result in a new marketable product or a commercially successful product, the Company believes that a number of its development projects, including those discussed below, may have commercial potential if the Company's development efforts are successful.
 
The Company's major research focus is on the development of new and unique ingredients for cosmetic and other personal care products. The following are some of the projects that the Company is either working on or intends to work on in the near future:
 
LUBRAJEL OIL NATURAL:  This is intended to be the third product in the LUBRAJEL NATURAL line. It will be a new natural form of LUBRAJEL OIL that has similar lubricating properties to that of the Company’s regular LUBRAJEL OIL, but will utilize all-natural components. The polymer network in this product is based on fermented vegetable feed stock. Since development work on this product has not yet been completed, the Company has not yet applied for Ecocert certification for this product, but the Company believes that this product will be eligible for Ecocert certification, and plans to apply for it as soon as the formulation is finalized. The Company hopes to begin sampling this product to its marketing partners in the second quarter of 2015.
 
CONDOM LUBRICANT: In February 2014, the Company signed a product development agreement with an Australian company interested in having the Company develop a new water-based condom lubricant into which the Australian company’s patented anti-viral agent can be incorporated. The Company has completed the Phase I work, and is currently in discussions with the customer to continue on to Phase II, with the goal of supplying the product to the customer if the development work is successful.
 
It should be emphasized that some of the projects listed above are in the very early stages of research and development, and there can be no guarantee that any particular development project will result in a marketable product or in significant sales if it is marketed.     
 
The Company’s research and development costs in 2014 were approximately $730,000, as compared with approximately $717,000 in 2013. It expects its research and development costs in 2015 to be comparable to those of 2014. Any additional increase in development and/or production costs will depend on whether capital investments are required in order to continue development work on, or to manufacture, any of the new products under development.
 
The Company requires all employees and consultants who may receive confidential and proprietary information to agree in writing to keep such information confidential.
 
 
7
 
TRADEMARKS AND PATENTS
 
The Company strongly believes in protecting its intellectual property and intends, whenever reasonably possible and economically practical, to obtain patents in connection with its product development program. The Company currently holds a number of United States patents and trademarks relating to its products, and regularly has patent and/or trademark applications pending with respect to a number of its research and development products. Some patents previously issued to the Company on certain products have expired. There can be no assurance that any patents held by the Company will be valid or otherwise of value to the Company, or that any patent applied for will be granted. However, the Company believes that its proprietary manufacturing techniques and procedures with respect to certain products offer it some protection from duplication by competitors regardless of the patent status of the products. While in recent years the Company has relied more on trade secrets, proprietary formulations, and manufacturing methods than patents to protect its intellectual property, it intends to continue to file patent applications in situations where it believes that relying on trade secrets would be insufficient protection.
 
The various trademarks and trade names owned or used by the Company in its business are of varying importance to the Company. The most significant trademarks are LUBRAJEL™ and RENACIDIN®.
 
Set forth below is a table listing certain information with respect to all unexpired U.S. patents held by the Company.

PATENT NAME
  
PATENT #
  
FILING
DATE
  
ISSUE
DATE
  
EXPIRATION
DATE
                 
Delivery system for oil-soluble actives in cosmetic and personal care products
 
6,117,419
 
9/1996
 
9/2000
 
12/2016
 
               
Microemulsion of silicone in a water-based gel that forms a clear, transparent, highly stable moisturizer and lubricant for cosmetic and medical use
  
6,348,199
 
1/1994
 
2/2002
 
2/2019
 
There was one Company patent that expired in December 2013. It was patent #5,405,622, for a radiation-resistant lubricating gel. The Company is not aware of any impact on sales of any products that were based on that patent due to competitive products using that patent technology coming on to the market.
 
DOMESTIC SALES
 
In the United States the Company's cosmetic ingredient products are marketed and distributed exclusively by ASI in accordance with a marketing agreement entered into in 1996 with International Specialty Products (“ISP”), the predecessor company of ASI. That agreement was amended and expanded in 2000, 2002, 2005, and 2010 (see "Marketing Agreements" below). ASI also has certain non-exclusive rights to sell some of the Company's other industrial and medical products. It was also granted the exclusive right to market a new oral care product, LUBRAJEL BA, which was specifically developed for it in 2012. The Company received its first order for that product in February 2014.
 
The Company's domestic sales of pharmaceutical products are handled primarily through the major full-line drug wholesalers and accounted for approximately 12.5% of the Company's sales in 2014, and 6.0% in 2013. The Company's other products, such as its medical and specialty industrial products, are sold directly to customers or their contract manufacturers, who incorporate these products into their finished products.
 
 
8
 
 
FOREIGN SALES
 
In 2014, approximately 65% of the Company’s sales were to customers in foreign countries, compared with approximately 70% in 2013. These foreign sales consisted primarily of sales of its cosmetic ingredients to customers in Canada, Europe and Asia. In Asia the growth in sales has come almost exclusively from sales into China. The Company currently has six distributors for its personal care products outside the United States, with ASI being the largest. The Company has a written marketing agreement only with ASI; all other marketing arrangements are subject to cancellation at any time by either the Company or the distributor. The marketing agreement with ASI gives it exclusive foreign marketing rights with the exception of the following territories, where the Company's other marketing partners have exclusive marketing rights: the United Kingdom (by The Azelis Group); France (by Sederma SAS, a subsidiary of Croda International Plc.); Italy (by Luigi & Felice Castelli S.R.L.); Switzerland (by Azelis Cosmetics GmbH.); and South Korea (by C&M International). The Company also has significant direct sales to a company in Ireland for one of the Company’s LUBRAJEL products for a medical use.
 
Since the company’s sales are all in U.S. Dollars, the company does not have any issues with fluctuations in foreign currency exchange rates.
 
MARKETING
 
The Company markets its products through marketing partners and distributors, advertising in medical and trade journals, mailings to physicians and to the trade, and exhibitions at medical meetings. The pharmaceutical products are sold in the United States primarily to drug wholesalers, which in turn distribute and resell those products to drug stores, hospitals, physicians, long-term care facilities, the U.S. Department of Veterans Affairs, and other government agencies. The proprietary cosmetic ingredients and other personal care products are sold outright (not on consignment) to the Company’s marketing partners, which in turn market and resell the products to cosmetic and other personal care manufacturers for use in the manufacture or compounding of their products. The medical and specialty industrial products are sold by the Company directly to the end users. The industrial products are older products that have limited marketability but are still being sold to some long-time customers. They are not actively marketed, but are available for sale to any new customers.
 
MARKETING AGREEMENTS
 
In 1994, the Company entered into a marketing agreement with ISP, the predecessor of ASI, whereby it would market and distribute the Company's personal care products, as well as some medical and specialty industrial products, in certain parts of Europe, Asia, Australia, and Africa. ISP manufactured and marketed globally (and continues to do so as ASI) an extensive line of personal care and pharmaceutical additives and various other industrial products. In 1996, the parties entered into another agreement, extending ISP’s distribution rights to the United States, Canada, Mexico, and Central and South America. In July 2000, the parties entered into an Exclusive Marketing Agreement (the "2000 Agreement"), which modified, extended, and consolidated the 1994 and 1996 agreements. In December 2002, December 2005, and May 2010 the parties entered into letter agreements that further modified and extended the 2000 Agreement until December 31, 2011. The May 2010 agreement also provided for automatic two-year renewals after December 31, 2011 unless either party terminated the arrangement upon 60 days’ notice.  Since neither party provided notice to the other with respect to termination of the contract as of December 31, 2013, the agreement between the Company and ISP (now ASI) was automatically extended until December 31, 2015.
 
The Company believes that in the event ASI were to cease marketing the Company's products alternative arrangements could be made with one of the other global marketers of personal care products to continue to supply products to customers currently using the Company's products, without any significant interruption of sales.
 
 
9
 
 
The Company has other marketing arrangements with marketing partners in the U.K., France, Switzerland, South Korea, and Italy (see “Foreign Sales’” above), but all of these other arrangements are operating under either verbal agreements or expired written agreements, and are subject to termination at any time by either party.
 
RAW MATERIALS
 
The principal raw materials used by the Company consist of common industrial organic and inorganic chemicals. Most of these materials are available in ample supply from numerous sources. The Company has five major raw material vendors that together accounted for approximately 84% of the raw material purchases by the Company in 2014, and 67% in 2013. The names of the suppliers and the specific raw materials are considered by the Company to be confidential and proprietary.
 
INVENTORIES, RETURNS, and ALLOWANCES
 
The Company's business requires that it maintain moderate inventories of certain of its finished goods. Historically, sufficient inventory levels, returns and allowances have not been a significant factor in the Company's business. However, between November 2010 and May 2011, and again from May 2012 until October 31, 2013, the Company exhausted its inventory of RENACIDIN and was not able to fill all of its orders for RENACIDIN due to vendor supply problems (see Part I, Item 1(b) above).
 
BACKLOG
 
The Company currently does not have any significant backlog of orders.
 
SEASONALITY
 
Due to the nature of the Company's business and the types of products it markets it is not subject to any significant seasonal fluctuations in sales.
 
CUSTOMERS
 
The Company’s personal care/cosmetic ingredients are marketed and sold globally by six marketing partners. Those marketing partners in turn market and distribute those products to hundreds of end users world-wide. Although the Company depends on those marketing partners for the marketing and distribution of its personal care products, it is confident that if any of its marketing partners were to decide not to sell the Company’s products, or if the Company chose to replace one or more of those marketing partners, it would be able to put in place new marketing agreements to service its customers in any of the geographic areas affected. If necessary, the Company would also be able to sell directly to the end users of its products until such time as a new marketing partner is put in place.
 
The Company’s pharmaceutical products are sold to, and distributed by, full-line drug wholesalers throughout the United States. It’s medical and specialty industrial products are sold directly by the Company to the end users of those products or, in some cases, to contract manufacturers used by some of those end users.
 
 
10
 
 
COMPETITION
 
The Company has many products or processes that are either proprietary or have some unique characteristics, and therefore the Company believes it has been able, and will continue to be able, to compete effectively with other pharmaceutical, personal care, specialty chemical, or health care companies as to products deemed competitive with those of the Company. The pharmaceutical, health care, and cosmetic industries are all highly competitive, and the Company expects competition to intensify as advances in the field are made and become widely known. There are other domestic and foreign companies that are engaged in the same or similar areas of research as those in which the Company is engaged, some of which have substantially greater financial, research, manpower, marketing and distribution resources than the Company. In addition, there are many large, integrated and established pharmaceutical, specialty chemical, personal care and health care companies that have greater capacity than the Company to develop and to commercialize types of products upon which the Company's research and development programs are based. However, the Company believes that the expense of testing and evaluating possible substitutes for the Company's products that are already in customers' formulations, as well as the expense to the customer in relabeling its products, is a significant barrier to displacing the Company's products in current customer formulations. These cost factors make it less likely that a customer would choose a competitive product, unless there was a significant cost savings in doing so. The Company believes that manufacturing, regulatory, distribution and marketing expertise will be increasingly important competitive factors in favor of the Company. In this regard, the Company believes that its marketing arrangements with its global marketing partners will be important in the commercialization of many of the products it is currently developing.
 
ISO 9001:2008 REGISTRATION
 
In October 2009 the Company was certified by Underwriters Laboratories, Inc. to be in compliance with the current ISO 9001:2008 standard, indicating that the Company's documented procedures and overall operations had attained the high level of quality needed to comply with this ISO certification level.  Prior to that, since December 2003 the Company had been registered under the previous ISO 9001:2000 standard, also by Underwriters Laboratories, Inc. The Company had first earned ISO registration in November 1998, when it earned ISO 9002 registration, and has been in continuous compliance with each of these standards from the time of its approval under each standard.
 
GOVERNMENT REGULATION
 
Regulation by governmental authorities in the United States and other countries is a significant factor in the manufacturing and marketing of many of the Company's products. The Company and many of the Company's products are subject to certain government regulations. Products that may be developed and sold by the Company in the United States may require approval from federal regulatory agencies, such as the FDA, as well as state regulatory agencies. Products that may be developed and sold by the Company outside the United States may require approval from foreign regulatory agencies. Any medical device products developed by the Company will be subject to FDA regulation, and will usually require a 510(k) pre-market notification to the FDA to demonstrate that the device is at least as safe and effective as a legally marketed device. The Company would then need to receive clearance from the FDA prior to marketing the device. Most new pharmaceutical products will require clinical evaluation under an Investigational New Drug Application prior to submission of a New Drug Application for approval of a new drug product.
 
The Company is required to comply with all pertinent current Good Manufacturing Practices of the FDA for medical devices and drugs. Accordingly, the regulations to which the Company and certain of its products may be subject, and any changes with respect thereto, may materially affect the Company's ability to produce and market new products developed by the Company.
 
 
11
 
 
The Company's present and future activities are, and will likely continue to be, subject to varying degrees of additional regulation under the Occupational Safety and Health Act, Environmental Protection Act, import, export and customs regulations, and other present and possible future foreign, federal, state and local regulations.
 
Portions of the Company's operating expenses are directly attributable to complying with federal, state, and local environmental statutes and regulations. In 2014 and 2013 the Company incurred $42,000 and $33,000, respectively, in federal, state, and local environmental law compliance costs. There was no material financial or other impact on the Company as a result of compliance with environmental laws.
 
EMPLOYEES
 
The Company presently has 36 employees, 4 of whom serve in an executive capacity, 19 in research, quality control and manufacturing, 7 in maintenance and construction, and 6 in office and administrative support services. Of the total number of employees, 32 work full time.
 
Item 1A.
Risk Factors.
 
The information to be reported under this item is not required of smaller reporting companies.
 
Item 1B.
Unresolved Staff Comments.
 
The information to be reported under this item is not required of smaller reporting companies.
 
Item 2.
Properties.
 
The Company maintains its principal office and factory, and conducts its research, at a 50,000 square foot facility on a 2.7 acre parcel at 230 Marcus Boulevard, Hauppauge, New York 11788, which the Company owns. Of the 50,000 square feet, approximately 30,000 square feet is manufacturing space, 15,000 square feet is warehouse space, and 5,000 square feet is office and laboratory space. The Company has fully developed the 2.7 acres, and fully utilizes the building occupying the land. The Company believes that the aforementioned property is adequate for its immediately foreseeable needs. The property is presently unencumbered and, in the Company’s opinion, is adequately insured.
 
Item 3. 
Legal Proceedings.
 
None.
 
Item 4. 
Mine Safety Disclosures.
 
Not applicable.
 
 
12
 
 
PART II
 
Item 5.
Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities.
 
Market Information
 
The Common Stock of the Company has traded on the NASDAQ Global Market since March 16, 2009, under the symbol "UG". From December 1, 2008 through March 13, 2009, following the merger of the American Stock Exchange with the New York Stock Exchange, the Company's Common Stock was traded on the NYSE Amex Stock Exchange under the same symbol. Prior to December 1, 2008 its stock traded on the American Stock Exchange under the same symbol.
 
The following table sets forth the high and low closing sale prices of the shares of Common Stock, as reported by NASDAQ, for the period January 1, 2013 to December 31, 2014. The quotations represent prices between dealers and do not include retail markup, markdown or commission:
 
Quarters
    
Year Ended
December 31, 2014
    
Year Ended
 December 31, 2013
  
     
High
    
Low
    
High
    
Low
  
First 
(1/1 - 3/31) 
   $ 29.25     $ 26.95     $ 22.69     $ 18.84  
Second 
(4/1 - 6/30) 
     34.43       26.66       26.55       19.95  
Third 
(7/1 - 9/30) 
     30.60       20.99       28.33       23.80  
Fourth 
(10/1 - 12/31) 
     22.89       19.00       28.80       24.28  
 
Holders of Record
 
As of March 3, 2015, there were 832 holders of record of Common Stock.
 
Cash Dividends
 
On May 14, 2014, the Company’s Board of Directors declared a semi-annual cash dividend of $0.48 per share, which was paid on June 13, 2014 to all stockholders of record as of May 30, 2014. On November 20, 2014, the Company’s Board of Directors declared a semi-annual cash dividend of $0.32 per share, which was paid on December 22, 2014 to all stockholders of record as of December 8, 2014.
 
On May 15, 2013, the Company’s Board of Directors declared a semi-annual cash dividend of $0.47 per share, which was paid on June 14, 2013 to all stockholders of record as of May 30, 2013. On November 22, 2013, the Company’s Board of Directors declared a semi-annual cash dividend of $0.50 per share, which was paid on December 20, 2013 to all stockholders of record as of December 6, 2013.
 
Item 6. 
Selected Financial Data.
 
The information to be reported under this item is not required of smaller reporting companies.
 
 
13
 
 
Item 7. 
Management's Discussion and Analysis of Financial Condition and Results of Operations.
 
Critical Accounting Policies
 
The Company’s financial statements have been prepared in accordance with U.S. generally accepted accounting principles. Preparation of financial statements requires the Company to make estimates and assumptions affecting the reported amounts of assets, liabilities, revenues, and expenses and the disclosure of contingent assets and liabilities. The Company uses its historical experience and other relevant factors when developing its estimates and assumptions, which are continually evaluated.  Note A, Nature of Business and Summary of Significant Accounting Policies, of the Notes to Financial Statements, included in Item 8, Financial Statements and Supplementary Data, of this Annual Report on Form 10-K includes a discussion of the Company’s significant accounting policies. The following accounting policies are those that the Company considers critical to an understanding of the financial statements because their application places the most significant demands on the Company’s judgment. The Company’s financial results might have been different if other assumptions had been used or other conditions had prevailed.
 
Marketable Securities
 
The Company classifies its marketable securities as available-for-sale at the time of purchase and re-evaluates such designation as of each balance sheet date. The Company’s marketable securities include investments in equity and fixed income mutual funds, and government securities. The Company’s marketable securities are reported at fair value with the related unrealized gains and losses included in accumulated other comprehensive income (loss), a component of stockholders’ equity.  Realized gains or losses on mutual funds are determined using the average cost method, while realized gains or losses on government securities and bonds are determined using the specific-identification method.  Realized gains or losses on the Company's marketable securities are insignificant for the years ended December 31, 2014 and 2013. The Company evaluates its investments periodically for possible other-than-temporary impairment by reviewing factors such as the length of time and extent to which fair value had been below cost basis, the financial condition of the issuer and the Company’s ability and intent to hold the investment for a period of time which may be sufficient for anticipated recovery of market value. The Company would record an impairment charge to the extent that the cost of the available-for-sale securities exceeds the estimated fair value of the securities and the decline in value is determined to be other-than-temporary. During 2014 and 2013 the Company did not record an impairment charge regarding its investment in marketable securities because management believes, based on its evaluation of the circumstances, that the decline in fair value below the cost of certain of the Company’s marketable securities is temporary.
 
Revenue Recognition
 
The Company recognizes revenue when products are shipped, title and risk of loss pass to customers, persuasive evidence of a sales arrangement exists, and collections are reasonably assured.  Any allowances for returns are taken as a reduction in sales within the same period the revenue is recognized. Such allowances are based on historical experience as well as other factors that, in the Company’s judgment, could reasonably be expected to cause sales returns or doubtful accounts to differ from historical experience.
 
Accounts Receivable Allowance
 
The Company performs ongoing credit evaluations of the Company’s customers and adjusts credit limits, as determined by a review of current credit information. The Company continuously monitors collection and payments from customers and maintains an allowance for doubtful accounts based upon historical experience, the Company’s anticipation of uncollectible accounts receivable and any specific customer collection issues that have been identified. While the Company’s credit losses have historically been low and within expectations, the Company may not continue to experience the same credit loss rates that have historically been attained. The receivables are highly concentrated in a relatively small number of customers. Therefore, a significant change in the liquidity, financial position, or willingness to pay timely, or at all, of any one of the Company’s significant customers would have a significant impact on the Company’s results of operations and cash flows.
 
 
14
 
Inventory Valuation Allowance
 
In conjunction with the Company’s ongoing analysis of inventory valuation, management constantly monitors projected demand on a product-by-product basis. Based on these projections, management evaluates the levels of write-downs required for inventory on hand and inventory on order from contract manufacturers.  Although the Company believes that it has been reasonably successful in identifying write-downs in a timely manner, sudden changes in buying patterns from customers, either due to a shift in product interest and/or a complete pull back from their expected order levels, may result in the recognition of larger-than-anticipated write-downs.
 
 
Results of Operations
 
Year ended December 31, 2014 compared with the year ended December 31, 2013:
 
Net Sales
 
Net sales in 2014 decreased by $1,967,214 (12.8%) compared with 2013. The net decrease was the result of the following changes in sales in the different product categories:
 
(a)
Personal care products:

Sales of the Company's personal care products, including cosmetic ingredients, decreased by $2,038,440 (17.8%) for the year ended December 31, 2014 when compared with 2013. The decrease was attributable primarily to a decrease in sales to ASI, the Company’s largest marketing partner. Sales to ASI in 2014 decreased by $1,753,174 (18.1%) compared with 2013. Sales to three of the Company’s marketing partners in Europe, decreased by $422,921 (25.1%) in 2014 compared with 2013, while sales to the Company’s distributor in Korea increased slightly.

There were two principal reasons for the decline in the Company’s sales to ASI in 2014. The most significant was a reduction in sales in the third quarter of 2014 to ASI’s single largest customer for one of the Company’s products. The Company was informed by ASI that the customer had new management in place, and it has been mandated that there be a second supplier for all of that company’s products. As a result, a significant volume of business went to this second supplier in the third quarter of 2014, resulting in the loss of a significant amount of business for ASI and the Company. This also left ASI with excess inventory that it had brought in for this customer, which then had to be worked off. As a result of discussions between the Company, ASI, and this customer, the Company believes that in 2015 it will regain some of the business that it lost to the second source supplier. However, for the near future the Company anticipates that sales to this customer will be down compared with previous years, and the Company is working closely with ASI to expand its customer base to make up for some of this lost business.

The other significant reason for the decline in sales to ASI during 2014 was the purchase by ASI of unusually large quantities of product at the end of 2013 and first quarter of 2014 to fill orders placed by its customers in China. As a result, ASI did not purchase similar quantities of product for those customers in the second and third quarters of 2014.  ASI has informed the Company, however, that sales to those customers in China are expected to remain strong, and that these fluctuations in purchases are more an issue of the timing of orders rather than any loss of business. In the fourth quarter of 2014 and the first quarter of 2015 the Company received substantial new orders from ASI intended for those customers in China.
 
 
15
 
 
In addition to the lower sales to ASI, sales to the Company’s other marketing partners in Europe were down due to the continuing economic problems in Europe. Although there has also been additional competition in the marketplace for the Company’s products, the Company’s marketing partners in Europe have indicated that they have not yet experienced any significant loss of customers due to competitive products.
 
Total sales of all of the Company's LUBRAJEL products for both personal care and medical uses decreased by $2,547,184 (18.1%) in 2014 compared with 2013. The unit volume of all LUBRAJEL products sold, both for personal care and medical uses, decreased by approximately 17.9% in 2014 compared with 2013. Revenue from the Company’s personal care products was also negatively impacted in 2014 due to discounts offered by the Company from time to time to retain or increase the sales to some of its large-volume customers, and to bring in new customers that may be evaluating competitive products. In 2014 those sales discounts totaled $119,965, compared with $11,000 in 2013. Of the $119,965 in sales discounts in 2014, $23,965 had been paid, and $96,000 accrued, as of December 31, 2014. The $96,000 of accrued sales discounts consisted of rebates given to one of the Company’s largest customers in order to retain and increase its business with that customer. The Company anticipates that the rebates to be given in 2015 will be less than in 2014 due to the Company discounting the price of some of its products for some of its large volume customers rather than offering rebates.
 
(b)
Pharmaceuticals:
 
Sales of the Company’s two pharmaceutical products, RENACIDIN and CLORPACTIN, together increased by $769,636 (83.9%) for the year ended December 31, 2014 compared with 2013, with RENACIDIN accounting for almost the entire increase. RENACIDIN accounted for 8.8% of the Company's sales in 2014, and 3.0% of sales in 2013. RENACIDIN had been off the market from August 2012 until the end of October 2013 due to production and regulatory problems experienced by the Company’s sole supplier. RENACIDIN sales are still significantly lower than they were prior to the production curtailment. Towards the end of 2014 the Company worked with a pharmaceutical consultant to better understand why sales have not attained previous levels, and is continuing its efforts to ensure that previous prescribers of the product are aware that the product is available again.
 
The Company is also working with a new supplier that will be producing RENACIDIN in a new single-dose container, which the Company hopes will increase its sales of this product in future years. In August 2014 the Company filed an application with the FDA to market the new product, is hoping to receive FDA approval by the end of the first quarter of 2015, and hopes to have the new product on the market in the third quarter of 2015. However, any delays in FDA approval could change that timetable.  Meanwhile, the Company is continuing to receive new shipments of the current dosage form of RENACIDIN, and expects to have adequate inventory to last until the new single-dose form is approved.
 
The increase in sales of the Company’s pharmaceutical products was reduced by an increase of $49,462 in allowances for distribution fees, product returns, and chargebacks paid to the U.S. Department of Veterans Affairs.
 
 
16
 
 
(c)
Medical (non-pharmaceutical) products:

Sales of the Company’s medical products decreased by $534,454 (17.6%) in 2014 compared with 2013. Approximately 83% of the decrease for 2014 was attributable to the discontinuation of sales to a customer that had eliminated the Company’s product as an ingredient in one of its products at the end of 2013. The balance of the decrease is believed to be due to the timing of orders from certain customers.

(d)
Industrial and other products:

Sales of the Company's industrial products, as well as other miscellaneous products, increased by $5,471 (3.3%) in 2014 when compared with 2013.
 
 
Cost of Sales
 
Cost of sales as a percentage of net sales in 2014 increased to 39.5% from 36.4% in the prior year. The increase was primarily the result of the Company’s fixed overhead costs being allocated over a smaller number of production units, due to the decrease in demand for the Company’s products during the third quarter of 2014 (see “Net Sales” above).  Due to a reduction in the number of units produced some of the fixed overhead costs, which are usually absorbed as production costs, were included in cost of sales as period costs during the third quarter of 2014. Changes in the Company’s product sales mix and additional sales discounts provided to customers also contributed to the increase.
 
Operating Expenses
 
Operating expenses increased by $136,471 (5.4%) in 2014 compared with the prior year. The increase was mainly attributed to increases in freight expense, insurance, payroll and payroll-related expenses. The increase in freight expense was a result of an increase in shipments of RENACIDIN in 2014 compared with 2013.
 
Portions of the Company's operating expenses are directly attributable to the research and development that the Company performs. In 2014 and 2013, the Company incurred approximately $730,000 and $717,000 respectively, in research and development expenses, which are included in operating expenses. The increase in R&D costs incurred in 2014 was primarily attributable to increases in payroll costs. In 2014 approximately $20,000 was received from two customers for R&D work on the development of new products.  The payment was mainly for salary expense and is included in the 2014 R&D expense above.
 
Other Income (Expense)
 
Other income (net) decreased by $1,066,313 (80.2%) for the year ended December 31, 2014 when compared with 2013. The decreases were mainly attributable to the cessation of the RENACIDIN settlement payments in 2014.  As a result, income from those payments decreased $1,046,158 for the year ended 2014 as compared to 2013.
 
The Company earns interest income from money market funds and bonds, and dividend income from both stock and bond mutual funds.  Other income was reduced in 2014 by a decrease in investment income of $20,155 (7.8%), which primarily resulted from the loss on the sale of mutual funds.
 
 
17
 
 
Provision for Income Taxes
 
The provision for income taxes decreased by $1,023,999 (37.5%) in 2014 compared with 2013. This decrease was mainly due to a decrease in income from operations and from the cessation of the RENACIDIN damage settlement. The Company’s effective income tax rate was approximately 30% in 2014 and 32% in 2013, and is lower than the federal statutory rate of 34% primarily due to the additional tax deduction for domestic production activities as well as the utilization of research and development tax credits.
 
Liquidity and Capital Resources
 
Working capital increased from $13,061,866 at December 31, 2013 to $13,688,101 at December 31, 2014, an increase of $626,235 (4.8%). The current ratio increased from 11.5 to 1 at December 31, 2013 to 15.0 to 1 at December 31, 2014. The increases in working capital and the current ratio were mainly due to additional purchases of marketable securities, increases in cash, and decreases in accounts payable and income taxes payable, partially offset by a decrease in inventories.
 
 Accounts receivable (net of allowance for doubtful accounts) as of December 31, 2014 decreased by $197,487 as compared with 2013. The average period of time that an account receivable was outstanding was approximately 46 and 33 days in 2014 and in 2013, respectively. The increase was the result of extending some foreign customer payment terms from 45 days to 60 days. The Company has bad debt reserves of $30,000 and $18,000 for 2014 and 2013, respectively, and believes that the net balance of its accounts receivable is fully collectable as of December 31, 2014.
 
The Company does not maintain a line of credit with a financial institution because the Company has no foreseeable need for a line of credit, and therefore management believes that the cost of maintaining a line of credit is not justified, especially considering the strong financial condition of the Company.
 
The Company generated cash from operations of $4,480,752 in 2014 compared with $5,805,086 in 2013. The decrease in 2014 was primarily due to decreases in net income and accounts payable.
 
Net cash used in investing activities was $414,480 for the year ended December 31, 2014, compared with $1,460,662 for the year ended December 31, 2013. This decrease was mainly due to a decrease in purchases of marketable securities in 2014 compared with 2013.
 
Cash used in financing activities was $3,677,151 and $4,458,544 during the years ended December 31, 2014 and 2013, respectively. The decrease was mainly due to a lower dividend being paid out in December 2014 than was paid in December 2013.
 
 The Company believes that its working capital is sufficient to support its operating requirements for the next fiscal year. The Company's long-term liquidity position will be dependent upon its ability to generate sufficient cash flow from profitable operations. The Company has no material commitments for future capital expenditures.
 
Off Balance-Sheet Arrangements
 
The Company has no off balance-sheet transactions that have, or are reasonably likely to have, a current or future effect on the Company’s financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources.
 
 
18
 
 
Contractual Obligations and Commitments
 
The information to be reported under this item is not required of smaller reporting companies.
 
New Accounting Pronouncements
 
See Note "A" to the financial statements regarding new accounting pronouncements.
 
Item 7A. 
Quantitative and Qualitative Disclosures about Market Risk.
 
The information to be reported under this item is not required of smaller reporting companies.
 
Item 8.
Financial Statements and Supplementary Data.
 
Annexed hereto starting on page F-1.
 
Item 9.
Changes in and Disagreements with Accountants on Accounting and Financial Disclosure.
 
None.
 
Item 9A.
Controls and Procedures.
 
(a)  Evaluation of Disclosure Controls and Procedures

The Company’s management, with the participation of the Company’s Principal Executive Officer and Principal Financial Officer, has evaluated the design, operation, and effectiveness of the Company’s disclosure controls and procedures, as defined in Rules 13a-15(e) and 15d-15(e) of the Exchange Act as of December 31, 2014. On the basis of that evaluation, management concluded that the Company’s disclosure controls and procedures are designed to be, and are, effective at providing reasonable assurance that the information required to be disclosed in reports filed or submitted pursuant to the Exchange Act is recorded, processed, summarized, and reported within the time periods specified in the rules and forms of the SEC, and that such information is accumulated and communicated to management, including its Principal Executive Officer and Principal Financial Officer as appropriate, to allow timely decisions regarding required disclosure.

(b) Management’s Report on Internal Control over Financial Reporting

Management is responsible for establishing and maintaining adequate internal control over financial reporting, as such term is defined in Exchange Act Rule 13a-15(f).  The Company’s internal control system is designed to provide reasonable assurance to management and to the Company’s Board of Directors regarding the preparation and fair presentation of published financial statements. Under the supervision and with the participation of management, including the Company’s Principal Executive Officer and Principal Financial Officer, management conducted an evaluation of the effectiveness of the Company’s internal control over financial reporting based on the framework in Internal Control—Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission. Based on management’s evaluation under the framework in Internal Control—Integrated Framework, management concluded that the Company’s internal control over financial reporting was effective as of December 31, 2014. At the present time the Company is still utilizing the COSCO 2009 regulations until it converts to COSCO 2013.
 
 
19
 
 
This Annual Report does not include an attestation report of the Company’s registered public accounting firm regarding internal control over financial reporting.  Since the Company is a non-accelerated filer, management’s report is not subject to attestation by the Company's registered public accounting firm pursuant to Section 404(b) of the Sarbanes-Oxley Act of 2002. As a result, this Annual Report contains only management’s report on internal controls.

(c)  Changes in Internal Control over Financial Reporting

There were no changes in the Company’s internal control over financial reporting that occurred in the fourth quarter of 2014 that materially affected, or would be reasonably likely to materially affect, the Company’s internal control over financial reporting.
 
(d)  Limitations of the Effectiveness of Internal Controls

The effectiveness of the Company’s system of disclosure controls and procedures and internal control over financial reporting is subject to certain limitations, including the exercise of judgment in designing, implementing and evaluating the control system, the assumptions used in identifying the likelihood of future events, and the inability to eliminate fraud and misconduct completely. As a result, there can be no assurance that the Company’s disclosure controls and procedures and internal control over financial reporting will detect all errors or fraud. However, the Company’s control systems have been designed to provide reasonable assurance of achieving their objectives, and the Company’s Principal Executive Officer and Principal Financial Officer have concluded that the Company’s disclosure controls and procedures and internal control over financial reporting are effective at the reasonable assurance level.
 
Item 9B.
Other Information.
 
None.
 
PART III
 
 
Item 10.
Directors, Executive Officers and Corporate Governance.
 
The information required by this item is incorporated by reference to the section entitled “Directors and Executive Officers” to be contained in the Company’s 2015 Proxy Statement.
 
Code of Ethics
 
The Company has adopted a Code of Business Conduct and Ethics that applies to all officers, directors, and employees serving in any capacity to the Company, including the Chief Executive Officer and/or President, Chief Financial Officer, and Principal Accounting Officer. A copy of the Company's Code of Business Conduct and Ethics is available on the Company's web site at http://www.u-g.com/corporate. The Company intends to satisfy the disclosure requirement under Item 5.05 of Form 8-K relating to amendments to or waivers from any provision of its Code of Business Conduct and Ethics applicable to the Chief Executive Officer, Chief Financial Officer and Principal Accounting Officer by posting this information on the Company's web site.
 
 
20
 
 
Item 11.
Executive Compensation.
 
The information required by this item is incorporated herein by reference to the section entitled "Compensation of Directors and Executive Officers" to be contained in the Company's 2015 Proxy Statement.
 
Item 12.
Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters.
 
The information required by this item is incorporated by reference to the section entitled "Voting Securities and Principal Stockholders" to be contained in the Company's 2015 Proxy Statement.
 
Item 13. 
Certain Relationships and Related Transactions, and Director Independence.
 
The information required by this item is incorporated by reference to the section entitled “Directors and Executive Officers" to be contained in the Company's 2015 Proxy Statement.
 
Item 14. 
Principal Accounting Fees and Services.
 
Audit Fees
 
The aggregate fees that have been, or are expected to be, billed by Baker Tilly Virchow Krause, LLP (“Baker Tilly”), the Company’s principal accountants, to the Company for the quarterly reviews and year-end audit of the Company's financial statements for 2014 and 2013, were approximately $83,000 for each of those fiscal years ($7,000 for each of the first three fiscal quarters and $61,000 for the year-end audit). In addition, Baker Tilly was reimbursed up to $1,000 for out-of-pocket expenses each fiscal year.
 
Audit-Related Fees
 
During 2014 and 2013 there were no fees paid to Baker Tilly in connection with the Company's compliance with Section 404 of the Sarbanes-Oxley Act of 2002.
 
No other fees were billed by Baker Tilly for the last two fiscal years that were reasonably related to the performance of the audit or review of the Company's financial statements and not reported under "Audit Fees" above.
 
Tax Fees
 
There were no fees billed by Baker Tilly during the last two fiscal years for professional services rendered for tax compliance, tax advice, or tax planning. Accordingly, none of such services were approved pursuant to pre-approval procedures or permitted waivers thereof.
 
All Other Fees
 
There were no other non-audit-related fees billed to the Company by Baker Tilly in 2014 or 2013.
 
 
21
 
 
Pre-Approval Policies and Procedures
 
Engagement of accounting services by the Company is not made pursuant to any pre-approval policies and procedures. Rather, the Company believes that its accounting firm is independent because all of its engagements by the Company are approved by the Company's Audit Committee prior to any such engagement.
 
The Audit Committee of the Company's Board of Directors meets periodically to review and approve the scope of the services to be provided to the Company by its Independent Registered Public Accounting Firm, as well as to review and discuss any issues that may arise during an engagement. The Audit Committee is responsible for the prior approval of every engagement of the Company's Independent Registered Public Accounting Firm to perform audit and permissible non-audit services for the Company, such as quarterly financial reviews, tax matters, and consultation on new accounting and disclosure standards.
 
Before the auditors are engaged to provide those services, the Chief Financial Officer and Controller will make a recommendation to the Audit Committee regarding each of the services to be performed, including the fees to be charged for such services. At the request of the Audit Committee, the Independent Registered Public Accounting Firm and/or management shall periodically report to the Audit Committee regarding the extent of services being provided by the Independent Registered Public Accounting Firm, and the fees for the services performed to date.
 
Item 15.
Exhibits, Financial Statement Schedules.

(a)
Documents filed as part of this report.
     
 
(i)
Financial Statements - see Item 8. Financial Statements and Supplementary Data.
     
 
(ii)
Financial Statement Schedules – None.
     
   
(Financial statement schedules have been omitted either because they are not applicable, not required, or the information required to be set forth therein is included in the financial statements or notes thereto.)
   
 
(iii)
Report of Independent Registered Public Accounting Firm.
   
 
(iv)
Notes to Financial Statements.
   
(b)
Exhibits
   
 
The exhibits listed on the accompanying Exhibit Index are filed as part of this Annual Report.
 
 
 
22
 
SIGNATURES
 
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
 
 
  UNITED-GUARDIAN, INC.  
       
       
  By: /s/ Kenneth H. Globus  
    Kenneth H. Globus  
Date: March 20, 2015   President and Director  
 
 
 
 
Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the Registrant and in the capacities and on the dates indicated.
 
Signature
 
 
Title
 
Date
           
By:
/s/ Kenneth H. Globus
  
President, General Counsel, Chairman
  
March 20, 2015
 
Kenneth H. Globus
  
of the Board of Directors (Principal
Executive Officer)
    
           
By:
/s/ Robert S. Rubinger
  
Executive Vice President, Secretary,
 
March 20, 2015
 
Robert S. Rubinger
 
Chief Financial Officer, Director
(Principal Financial Officer and
Principal Accounting Officer)
   
           
By:
/s/ Lawrence F. Maietta
  
Director
 
March 20, 2015
 
Lawrence F. Maietta
        
           
By:
/s/ Arthur M. Dresner
  
Director
 
March 20, 2015
 
Arthur M. Dresner
 
 
   
           
By:
/s/ Andrew A. Boccone
  
Director
 
March 20, 2015
 
Andrew A. Boccone
       
           
By:
/s/ Christopher W. Nolan, Sr.
  
Director
 
March 20, 2015
 
Christopher W. Nolan, Sr.
       

 
 
23
 
EXHIBIT INDEX
 
 
Exhibit # Description  
     
2
  
Certificate of Merger of United-Guardian, Inc. (New York) with and into United-Guardian, Inc.  (Delaware) as filed with the Secretary of State of the State of Delaware on September 10, 1987. Incorporated by reference to Exhibit 3(b) of the Registrant's Annual Report on Form 10-K for the fiscal year ended February 29, 1988 (the "1988 10-K"). 
       
3
(a) 
Certificate of Incorporation of the Company as filed April 22, 1987. Incorporated by reference to Exhibit 4.1 of the Registrant's Current Report on Form 8-K, dated September 21, 1987 (the "1987 8-K").
       
3
(b) 
By-laws of the Company. Incorporated by reference to Exhibit 4.2 to the 1987 8-K.
       
4
(a)
Specimen Certificate for shares of Common Stock of the Company. Incorporated by reference to Exhibit 4(a) to the 1988 10-K.
       
10
(a)
Qualified Retirement Income Plan for Employees of the Company, as restated April 1, 1976. Incorporated by reference to Exhibit 11(c) of the Registrant's Registration Statement on Form S-1 (Registration No. 2-63114) declared effective February 9, 1979.
       
10
(b)
Exclusive Distributor Agreement between the Company and ISP Technologies Inc., dated July 5, 2000. Incorporated by reference to Exhibit 10(d) of the Registrant's Annual Report on Form 10-KSB for the fiscal year ended December 31, 2000.
       
10
(c)
Letter Amendment between the Company and ISP Technologies Inc. dated December 16, 2002 amending the Exclusive Distributor Agreement between the Registrant and ISP Technologies Inc. dated July 5, 2000. Incorporated by reference to Exhibit 10(d) to the Registrant's Annual Report on Form 10-KSB for the fiscal year ended December 31, 2002.
       
10
(d)
Letter Amendment between the Company and ISP Technologies Inc. dated December 20, 2005 amending the Exclusive Distributor Agreement between the Registrant and ISP Technologies Inc. dated July 5, 2000 and amended on December 31, 2002. Incorporated by reference to Exhibit 10(d) of the Registrant's Annual Report on Form 10-KSB for the fiscal year ended December 31, 2005.
       
10
(e)
Letter Amendment between the Company and ISP Technologies Inc. dated May 5, 2010 amending the Exclusive Distributor Agreement between the Company and ISP Technologies Inc. dated July 5, 2000 and amended on December 16, 2002 and December 20, 2005. Incorporated by reference to Exhibit 10.1 of the Registrant's Quarterly Report on Form 10-Q for the fiscal quarter ended June 30, 2010.
       
10
(f)
Manufacturing and Supply Agreement between the Company and Smiths Medical ASD, Inc. signed November 12, 2013 and effective as of November 1, 2013. Incorporated by reference to Exhibit 10.1 of the Registrant’s Current Report on Form 8-K dated and filed November 18, 2013.
       
21
  
Subsidiaries of the Company:
  
   
Name
 Jurisdiction of
Incorporation
Name Under Which
it does Business
  
           
   
 Dieselite Corporation (Inactive)
Delaware
N/A
  
       
31.1
  
Certification of Kenneth H. Globus, President and Principal Executive Officer of the Company, pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
       
31.2
  
Certification of Robert S. Rubinger, Chief Financial Officer of the Company, pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
       
32
  
Certifications of Kenneth H. Globus, President and Principal Executive Officer of the Company, and Robert S. Rubinger, Chief Financial Officer of the Company, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
 
 
 
24
 
 
INDEX TO FINANCIAL STATEMENTS
(For the years ended
December 31, 2014 and 2013)

 
 
 
 
F-1
 
 


Board of Directors and Stockholders
United-Guardian, Inc.
Hauppauge, New York

We have audited the accompanying balance sheets of United-Guardian, Inc. (the "Company") as of December 31, 2014 and 2013, and the related statements of income, comprehensive income, stockholders' equity, and cash flows for the years then ended. These financial statements are the responsibility of the Company's management. Our responsibility is to express an opinion on these financial statements based on our audits.

We conducted our audits in accordance with the standards of the Public Company Accounting Oversight Board (United States). Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. Our audits included consideration of internal control over financial reporting as a basis for designing audit procedures that are appropriate in the circumstances, but not for the purpose of expressing an opinion on the effectiveness of the Company's internal control over financial reporting. Accordingly, we express no such opinion. An audit also includes examining, on a test basis, evidence supporting the amounts and disclosures in the financial statements. An audit also includes assessing the accounting principles used and significant estimates made by management, as well as, evaluating the overall financial statement presentation. We believe that our audits provide a reasonable basis for our opinion.

In our opinion, the financial statements referred to above present fairly, in all material respects, the financial position of United-Guardian, Inc. as of December 31, 2014 and 2013, and the results of its operations and its cash flows for the years then ended in conformity with accounting principles generally accepted in the United States of America.



/s/ Baker Tilly Virchow Krause, LLP
Melville, New York
March 20, 2015
 

 
 
F-2
 
 
 
   
Years ended December 31,
  
   
2014
    
2013
  
             
Net sales
  $ 13,449,679     $ 15,416,893  
                 
Costs and expenses:
                
Cost of sales
    5,317,707       5,610,813  
Operating expenses
    2,640,997       2,504,526  
Total costs and expenses
     7,958,704       8,115,339  
Income from operations
    5,490,975       7,301,554  
                 
Other income:
                
Investment income
    239,592       259,747  
Income from damage settlement
     24,403       1,070,561  
Total other income
     263,995       1,330,308  
Income from operations before income taxes
     5,754,970       8,631,862  
                 
Provision for income taxes
    1,704,554       2,728,553  
Net income
   $ 4,050,416     $ 5,903,309  
                 
Earnings per common share (basic and diluted)
  $ .88     $ 1.28  
                 
Weighted average shares (basic and diluted)
    4,596,439       4,596,439  

 
 
   
Years ended December 31,
  
 
 
2014
    
2013
  
             
Net income
  $ 4,050,416     $ 5,903,309  
                 
Other comprehensive income (loss):
                
                 
Unrealized gain (loss) on marketable securities
    191,533       (71,711 )
                 
Income tax (expense) benefit
     (63,787 )     24,855  
Other comprehensive income (loss), net of tax
    127,746       (46,856 )
                 
Comprehensive income
  $ 4,178,162     $ 5,856,453  

See Notes to Financial Statements
 
 
F-3
 
 

ASSETS

   
December 31,
  
   
2014
    
2013
  
Current assets:
            
Cash and cash equivalents
  $ 2,023,383     $ 1,634,262  
Marketable securities
    9,389,501       8,863,205  
Accounts receivable, net of allowance for doubtful accounts of $30,000 in 2014 and $18,000 in 2013
     1,593,260       1,790,747  
Receivable in connection with damage settlement
     ---       48,805  
Inventories (net)
     1,237,154       1,610,747  
Prepaid expenses and other current assets
    165,691       130,001  
Prepaid income taxes
     30,643       ---  
Deferred income taxes
    223,439       229,451  
Total current assets
    14,663,071       14,307,218  
                 
                 
Property, plant, and equipment:
                
Land
    69,000       69,000  
Factory equipment and fixtures
    4,138,875       4,090,968  
Building and improvements
    2,773,002       2,766,319  
Waste disposal system
    ---       133,532  
Total property, plant and equipment
     6,980,877       7,059,819  
                 
Less accumulated depreciation
    5,772,974       5,725,318  
Net property, plant, and equipment
     1,207,903       1,334,501  
                 
Other assets:
     68,042       9,147  
Total assets
   $ 15,939,016     $ 15,650,866  
 
See Notes to Financial Statements
 
 
F-4
 
 
BALANCE SHEETS

LIABILITIES AND STOCKHOLDERS' EQUITY
 
   
December 31,
  
   
2014
    
2013
  
Current liabilities:
            
Accounts payable
  $ 141,111     $ 385,699  
Accrued expenses
     833,859       728,015  
Income taxes payable
     ---       131,638  
Total current liabilities
     974,970       1,245,352  
                 
Deferred income taxes
    227,108       169,587  
                 
Commitments and contingencies
                
                 
Stockholders’ equity:
               
Common stock, $.10 par value; 10,000,000 shares authorized; 4,596,439 shares issued and outstanding at December 31, 2014 and 2013, respectively
     459,644       459,644  
Accumulated other comprehensive income
    259,869       132,123  
Retained earnings
    14,017,425       13,644,160  
Total stockholders’ equity
     14,736,938       14,235,927  
Total liabilities and stockholders’ equity
   $ 15,939,016     $ 15,650,866  
 
See Notes to Financial Statements
 
 
F-5
 

Years ended December 31, 2014 and 2013
 
    Common stock    
Accumulated
other
comprehensive
    
Retained
        
    Shares     Amount    
income
     earnings     Total  
                               
Balance, January 1, 2013
     4,596,439     $ 459,644     $ 178,979     $ 12,199,395     $ 12,838,018  
                                         
Change in unrealized gains on marketable securities, net of deferred income tax benefit of $24,855
                     (46,856 )             (46,856 )
                                         
Net income
                            5,903,309       5,903,309  
                                         
Dividends declared
                            (4,458,544 )     (4,458,544 )
                                         
Balance, December 31, 2013
     4,596,439       459,644       132,123       13,644,160       14,235,927  
                                         
Change in unrealized gains on marketable securities, net of deferred income tax expense of $63,787
                     127,746               127,746  
 
                                       
Net income
                            4,050,416       4,050,416  
                                         
Dividends declared and paid
                             (3,677,151 )     (3,677,151 )
                                         
Balance, December 31, 2014
    4,596,439     $ 459,644     $ 259,869     $ 14,017,425     $ 14,736,938  
 
See Notes to Financial Statements
 
 
F-6
 
 
 
   
Years ended December 31,
  
   
2014
    
2013
  
Cash flows from operating activities:
            
Net income
   $ 4,050,416     $ 5,903,309  
Adjustments to reconcile net income to net cash provided by operating activities:
                
Depreciation and amortization
    181,188       189,729  
Realized loss (gain) on sales of marketable securities
     25,127       (18,675 )
Increase (decrease) in allowance for bad debts
    12,325       (11,089 )
Deferred income taxes
    (254 )     (12,161 )
Increase (decrease) in cash resulting from changes in operating assets and liabilities:
               
Accounts receivable
    185,162       (762,031 )
Receivable from damage settlement
     48,805       469,245  
Inventories
    373,593       (367,997 )
Prepaid expenses and other current and non-current assets
    (94,585 )     (6,690 )
Prepaid income taxes
     (30,643 )     3,602  
Accounts payable
    (244,588 )     234,314  
Accrued expenses and taxes payable
    (25,794 )     183,530  
Net cash provided by operating activities
    4,480,752       5,805,086  
                 
Cash flows from investing activities:
                
Acquisitions of plant and equipment
    (54,590 )     (288,367 )
Purchases of marketable securities
    (3,437,478 )     (5,311,313 )
Proceeds from sales of marketable securities
    3,077,588       4,139,018  
Net cash used in investing activities
    (414,480 )     (1,460,662 )
                 
Cash flows from financing activities:
                
Dividends paid
    (3,677,151 )     (4,458,544 )
Net cash used in financing activities
    (3,677,151 )     (4,458,544 )
                 
Net increase (decrease) in cash and cash equivalents
    389,121       (114,120 )
Cash and cash equivalents, beginning of year
    1,634,262       1,748,382  
Cash and cash equivalents, end of year
  $ 2,023,383     $ 1,634,262  
 
See Notes to Financial Statements
 
 
F-7
 
 
 
NOTE A - NATURE OF BUSINESS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
 
Nature of Business
 
United-Guardian, Inc. (the "Company") is a Delaware corporation that, through its Guardian Laboratories Division, manufactures and markets cosmetic ingredients, personal care products, pharmaceuticals, medical lubricants, health care products, and specialty industrial products. It also conducts research and product development, primarily related to the development of new and unique cosmetic and personal care products. The Company’s research and development department also modifies, refines, and expands the uses for existing products, with the goal of further developing the market for the Company's products. Two major product lines, LUBRAJEL™ and RENACIDIN® IRRIGATION (“RENACIDIN”) together accounted for 94.6% and 94.4% of revenue for the years ended December 31, 2014 and December 31, 2013, respectively. LUBRAJEL accounted for 85.9% and 91.4% of revenue for the years ended December 31, 2014 and December 31, 2013, respectively, and RENACIDIN accounted for 8.8% and 2.9% of revenue for the years ended December 31, 2014 and December 31, 2013, respectively.
 
Accounts Receivable and Reserves
 
The carrying amount of accounts receivable is reduced by a valuation allowance that reflects our best estimate of the amounts that will not be collected. The reserve for accounts receivable comprises the allowance for doubtful accounts and sales returns. In addition to reviewing delinquent accounts receivable, we consider many factors in estimating our reserve, including historical data, experience, customer types and credit worthiness, and economic trends. From time to time, we adjust our assumptions for anticipated changes in any of these or other factors expected to affect collectability.
 
Revenue Recognition
 
The Company recognizes revenue when products are shipped, title and risk of loss pass to customers, persuasive evidence of a sales arrangement exists, and collections are reasonably assured.  All products are shipped Free On Board (“FOB”) Hauppauge, New York, the location of the Company’s plant. Both title and risk of loss are deemed by both the Company and its customers to have passed to the customers at the time the goods leave the Company’s plant. Shipments are only made after confirmation that a valid purchase order has been received and that the future collection of the sale amount is reasonably assured. All sales of the Company’s products are deemed final, and there is no obligation on the part of the Company to repurchase or allow the return of the goods unless they are defective. The Company does not make sales on consignment, and the collection of the proceeds of the sale is not contingent upon the customer being able to sell the goods to a third party.
 
Any allowance for returns is taken as a reduction of sales within the same period the revenue is recognized. Such allowances are based on historical experience. The Company has not experienced significant fluctuations between estimated allowances and actual activity.
 
From time to time during 2014 the Company offered discounts and/or rebates to some of its customers in order to retain or increase sales to those customers. In 2014 those sales discounts totaled $119,965, compared with $11,000 in 2013. Of the $119,965 in sales discounts in 2014, $23,965 had been paid, and $96,000 accrued, as of December 31, 2014. The $96,000 of accrued sales discounts consisted of rebates given to one of the Company’s largest customers in order to retain and increase its business with that customer.
 
 
F-8
 
 
Cash and Cash Equivalents
 
For financial statement purposes, the Company considers as cash equivalents all highly liquid investments with an original maturity of three months or less at inception. The Company deposits cash and cash equivalents with high credit quality financial institutions and believes that any amounts in excess of insurance limitations to be at minimal risk. Cash and cash equivalents held in these accounts are currently insured by the Federal Deposit Insurance Corporation up to a maximum of $250,000.
 
Dividends
 
On May 14, 2014, the Company’s Board of Directors declared a semi-annual cash dividend of $0.48 per share, which was paid on June 13, 2014 to all stockholders of record as of May 30, 2014. On November 20, 2014, the Company’s Board of Directors declared a semi-annual cash dividend of $0.32 per share, which was paid on December 22, 2014 to all stockholders of record as of December 8, 2014. Total dividends declared and paid in 2014 were $3,677,151.
 
On May 15, 2013, the Company’s Board of Directors declared a semi-annual cash dividend of $0.47 per share, which was paid on June 14, 2013 to all stockholders of record as of May 30, 2013. On November 22, 2013, the Company’s Board of Directors declared a semi-annual cash dividend of $0.50 per share, which was paid on December 20, 2013 to all stockholders of record as of December 6, 2013. Total dividends declared and paid in 2013 were $4,458,544.
 
Supplemental Disclosures of Non-cash Investing and Financing Activities
 
Cash payments for income taxes were $1,867,089 and $2,605,474 for the years ended December 31, 2014 and 2013, respectively.  
 
Marketable Securities
 
Marketable securities include investments in equity and fixed income mutual funds, and government securities, all of which have a high degree of liquidity, are classified as "Available for Sale" securities, and are reported at their fair values. Unrealized gains and losses on "Available for Sale" securities are reported as accumulated other comprehensive income (loss) in stockholders' equity, net of the related tax effects. Investment income is recognized when earned. Realized gains and losses on sales of investments and declines in value judged to be other than temporary, if any, are reported in other income with cost being determined on a specific identification basis. Fair values are based on quoted market prices. The Company evaluates its investments periodically for possible impairment and reviews factors such as the length of time and extent to which fair value has been below cost basis and the Company’s ability and intent to hold the investment for a period of time which may be sufficient for anticipated recovery in market value.
 
Inventories
 
Inventories are valued at the lower of cost or current market value. Cost is determined using the average cost method, which approximates cost determined by the first-in, first-out (“FIFO”) method. Inventory costs include material, labor and factory overhead.
 
 
F-9
 
 
Property, Plant and Equipment
 
Property, plant and equipment are carried at cost, less accumulated depreciation. Major replacements and betterments are capitalized, while routine maintenance and repairs are expensed as incurred. Assets are depreciated under both accelerated and straight-line methods. Depreciation charged to income as a result of using accelerated methods was not materially different than that which would result from using the straight-line method for all periods presented. Certain factory equipment and fixtures are constructed by the Company using purchased materials and in-house labor. Such assets are capitalized and depreciated on a basis consistent with the Company's purchased fixed assets.
 
Estimated useful lives are as follows: 
 
Factory equipment and fixtures (years)
 5
-
 7
Building  (years)
  
40
  
Building improvements 
  
Lesser of useful
life or 20 years
 
Waste disposal system  (years)
  
7
  

Impairment of Long-Lived Assets
 
Long-lived assets and certain identifiable intangibles are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset to future net cash flows expected to be generated by the asset. If such assets are considered to be impaired, the impairment to be recognized is measured by the amount by which the carrying amount of the assets exceeds the fair value of the assets. Assets to be disposed of are reported at the lower of the carrying amount or fair value less costs to sell.  No impairments were necessary at December 31, 2014 and 2013.
 
Other Assets
 
Other assets at December 31, 2014 consisted of $60,042 expended in connection with the development of a new dosage form and manufacturing process for RENACIDIN, and $8,000 in costs incurred in re-registering the Company’s LUBRAJEL trademark. The Company will determine the appropriate amortization rate for these assets at such time as they are put into service.
 
Fair Value of Financial Instruments
 
Management of the Company believes that the fair value of financial instruments, consisting of cash and cash equivalents, accounts receivable, accounts payable, and accrued expenses approximates their carrying value due to their short payment terms and liquid nature.
 
Concentration of Credit Risk
 
Accounts receivable potentially exposes the Company to concentrations of credit risk. The Company monitors the amount of credit it allows each of its customers, using the customer’s prior payment history to determine how much credit to allow or whether any credit should be given at all.  It is the Company’s policy to discontinue shipments to any customer that is substantially past due on its payments. The Company sometimes requires payment in advance from customers whose payment record is questionable.  As a result of its monitoring of the outstanding credit allowed for each customer, as well as the fact that the majority of the Company’s sales are to customers whose satisfactory credit and payment record has been established over a long period of time, the Company believes that its accounts receivable credit risk has been reduced.
 
 
F-10
 
 
For the year ended December 31, 2014, two of the Company’s distributors and marketing partners accounted for 64.7% of the Company’s revenues during the year, and 56.3% of its outstanding accounts receivable at year end. For the year ended December 31, 2013, two of the Company’s distributors and marketing partners, one the same as in 2014, and the other different, accounted for a total of 69% of the Company’s revenues during the year, and 72% of its outstanding accounts receivable at year end.
 
Vendor Concentration
 
The principal raw materials used by the Company consist of common industrial organic and inorganic chemicals. Most of these materials are available in ample supply from numerous sources. The Company has five major raw material vendors that collectively accounted for approximately 84% and 67% of the raw material purchases by the Company in 2014 and 2013, respectively.
 
Income Taxes
 
Income taxes are accounted for under the asset and liability method. Deferred tax assets and liabilities are recognized for future tax consequences attributable to the temporary differences between the financial statement carrying amounts of assets and liabilities and their respective tax bases and operating loss and tax credit carry forwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in the period that includes the enactment date. Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion or all of the deferred tax assets will not be realized.
 
Uncertain tax positions are accounted for utilizing a recognition threshold and measurement attribute for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. As of December 31, 2014 and 2013, the Company did not have any unrecognized income tax benefits.  It is the Company’s policy to recognize interest and penalties related to taxes as interest expense as incurred.  During the years ended December 31, 2014 and 2013 the Company did not record any interest or penalties. The Company’s tax returns are subject to examination by the United States Internal Revenue Service and by the State of New York for years 2010 through 2013. In March 2014 the New York State Department of Taxation and Finance (“DTF”) commenced a routine examination of the Company’s income tax returns for years 2010 through 2012. The DTF has completed its examination and has accepted the tax returns as filed.
 
Research and Development
 
The Company's research and development expenses, included in operating expenses, are recorded in the year incurred. Research and development expenses were approximately $730,000 and $717,000 for the years ended December 31, 2014 and 2013, respectively.
 
Shipping and Handling Costs
 
Shipping and handling costs are classified in operating expenses in the accompanying statements of income. Shipping and handling costs were approximately $86,000 and $45,000 for the years ended December 31, 2014 and 2013, respectively.
 
 
F-11
 
 
Advertising Costs
 
Advertising costs are expensed as incurred. During 2014 and 2013 the Company incurred $20,000 and $16,000, respectively, in advertising costs.
 
Stock-Based Compensation
 
In 2004, the Company approved a stock option plan ("2004 Stock Option Plan") authorizing the granting of stock options to Company employees and Directors. No options were ever issued under this plan, and it expired in March 2014.
 
Earnings Per Share Information
 
Basic earnings per share are computed by dividing net income by the weighted average number of common shares outstanding during the year. Diluted earnings per share include the dilutive effect of outstanding stock options.
 
Use of Estimates
 
In preparing financial statements in conformity with U.S. generally accepted accounting principles, management is required to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and revenues and expenses during the reporting period. Actual results could differ from those estimates. Such estimated items include the allowance for bad debts, possible impairment of marketable securities, reserve for inventory obsolescence, and the allocation of overhead.
 
New Accounting Standards

In December of 2013, FASB issued ASU 2013-11, “Income Taxes (Topic 740): Presentation of an Unrecognized Tax Benefit When a Net Operating Loss Carryforward, a Similar Tax Loss, or a Tax Credit Carryforward Exists.” This amendment requires that an unrecognized tax benefit, or a portion of an unrecognized tax benefit, should be presented in the financial statements as a reduction to a deferred tax asset for a net operating loss carryforward, a similar tax loss, or a tax credit carryforward with exceptions.  This amendment only applies to entities that have an unrecognized tax benefit when a net operating loss carryforward, a similar tax loss, or a tax credit carryforward exists at the reporting date. This update became effective for interim and annual reporting periods beginning after December 15, 2013. The update does not have a material impact on the Company’s results of operation.

In May 2014, FASB issued ASU 2014-09, “Revenue from Contracts with Customers.” This standard applies to any entity that uses the guidance of GAAP for entering into contracts with customers to transfer goods or services or enters into contracts for the transfer of nonfinancial assets unless those contracts are within the scope of other standards. It requires that an entity should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration the entity expects to receive for the exchange of goods or services. This amendment is effective for interim and annual reporting periods beginning after December 15, 2016. The Company is still evaluating the potential impact on the Company’s results of operations.

In June 2014, FASB issued ASU 2014-11, “Transfers and Servicing: Repurchase-to-Maturity Transactions, Repurchase Financings, and Disclosures.” This standard aligns the accounting for repurchases-to-maturity transactions and repurchase agreements executed as a repurchase financing with accounting for other typical repurchase agreements. These types of transactions will now be accounted for as secured borrowings. It eliminates sales accounting for repurchase-to-maturity and supersedes guidance for accounting transactions involving transfers of financial assets with contemporaneous repurchase financing agreements that leads to off-balance accounting. This update becomes effective for interim and annual reporting periods beginning after December 15, 2014 and is not expected to have a material impact on the Company’s results of operations.
 
 
F-12
 
 
In August 2014, FASB issued ASU 2014-15, “Presentation of Financial Statements-Going Concern.  Disclosure of Uncertainties about Entity’s Ability to Continue as a Going Concern.” Currently, GAAP lacks guidance about management’s responsibility to evaluate whether there is substantial doubt about an entity’s ability to continue as a going concern. This amendment now provides guidance by providing a definition of substantial doubt, requires evaluation by management every reporting period for going concern issues, provides principles for considering any mitigating effects implemented by management, and the disclosures required for the assessment period of one year after issuance of the financial statements. This update becomes effective for interim and annual reporting periods beginning after December 15, 2016 with early application being permitted. The update will be adopted for reporting periods starting January 2015, and is not expected to have a material impact on the Company’s results of operations.
 
NOTE B - MARKETABLE SECURITIES
 
The fair values of the Company’s marketable securities are determined in accordance with GAAP, with fair value being defined as the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants. As such, fair value is a market-based measurement that should be determined based on assumptions that market participants would use in pricing an asset or liability. As a basis for considering such assumptions, the Company utilizes the three-tier value hierarchy, as prescribed by GAAP, which prioritizes the inputs used in measuring fair value as follows:
 
 
•
Level 1 - inputs to the valuation methodology are quoted prices (unadjusted) for identical assets or liabilities in active markets.
 
 
•
Level 2 - inputs to the valuation methodology include quoted prices for similar assets and liabilities in active markets, and inputs that are observable for the asset or liability, either directly or indirectly, for substantially the full term of the financial instrument.
 
 
•
Level 3 – inputs to the valuation methodology are unobservable and significant to the fair value measurement.
 
The following available-for-sale securities, which comprise all of the Company's marketable securities, are re-measured to fair value on a recurring basis and are valued using Level 1 inputs using quoted prices (unadjusted) for identical assets in active markets:
 
December 31, 2014
 
Cost
    
Fair Value
    
Unrealized
Gain/(Loss)
  
                   
Available for sale:
                 
Fixed income mutual funds
   $ 8,373,674     $ 8,575,285     $ 201,611  
Equity and other mutual funds
    622,086       814,216       192,130  
    $ 8,995,760     $ 9,389,501     $ 393,741  
                         
December 31, 2013
                        
                         
Available for sale:
                       
Corporate bonds (maturing within 1 year)
   $ 203,920     $ 200,053     $ (3,867 )
Fixed income mutual funds
    7,325,930       7,425,687       99,757  
Equity and other mutual funds
    1,131,147       1,237,465       106,318  
    $ 8,660,997     $ 8,863,205     $ 202,208  
 
 
F-13
 
 
Proceeds from the sale and redemption of marketable securities amounted to $3,077,588 and $4,139,018 for the years ended December 31, 2014 and 2013, respectively. Losses of $25,127 and gains of $18,675 were realized for the years ended December 31, 2014 and 2013, respectively.

Investment income consisted principally of unrealized and realized gains and losses, interest income from bonds and money market funds, and dividend income from bond funds and mutual funds.

NOTE C – INVENTORIES 

Inventories consist of the following:
 
   
December 31,
  
   
2014
    
2013
  
             
Raw materials and work-in-process
  $ 395,092     $ 488,757  
Finished products
    842,062       1,121,990  
    $ 1,237,154     $ 1,610,747  
 
Finished product inventories at December 31, 2014 and 2013 are stated net of a reserve of $20,000 for slow moving and obsolete items.
 
NOTE D – INCOME TAXES
 
The provision for income taxes consists of the following:
 
   
Years ended December 31,
  
   
2014
    
2013
  
Current
           
Federal
  $ 1,714,387     $ 2,721,068  
State
    (9,579 )     19,646  
      1,704,808       2,740,714  
Deferred
               
Federal
    (4,003 )     (11,810 )
State
    3,749       (351 )
      (254 )     (12,161 )
Total provision for income taxes
  $ 1,704,554     $ 2,728,553  
 
The following is a reconciliation of the Company’s effective income tax rate to the Federal statutory rate (dollar amounts have been rounded to the nearest thousand):  

   
Years ended December 31,
  
   
2014
    
2013
  
   
($)
    
Tax rate
    
($)
    
Tax rate
  
Income taxes at statutory federal income tax rate of 34%
  $ 1,957,000       34.0 %   $ 2,935,000       34.0 %
State income taxes, net of Federal benefit
    (4,000 )     (0.1 )     13,000       0.2  
Domestic Production Activities tax benefit
    (168,000 )     (2.9 )     (180,000 )     (2.1 )
Nondeductible expenses
    1,000       ---       1,000       ---  
Prior year over-accrual
     (56,000 )     (1.0 )     (19,000 )     (0.2 )
R&D credits
     (25,000 )     (0.4 )     (20,000 )     (0.2 )
Other, misc.
     ---       ---       (1,000 )     ---  
Actual income tax expense
  $ 1,705,000       29.6 %   $ 2,729,000       31.7 %
 
 
F-14
 
 
During 2014 and 2013, the Company realized the tax benefits of the Domestic Production Activities deduction, which amounted to approximately 9% of net income from domestic production activities in each year.
 
The tax effects of temporary differences which comprise the deferred tax assets and liabilities are as follows:
 
   
Years ended December 31,
  
   
2014
    
2013
  
Deferred tax assets
           
Current
            
Accounts receivable
  $ 10,164     $ 6,089  
Inventories
    14,037       16,862  
Accrued expenses
    199,238       206,500  
      223,439       229,451  
Deferred tax liabilities
               
Non-current
                
Depreciation
     (93,236 )     (99,502 )
Unrealized gain on marketable securities
     (133,872 )     (70,085 )
      (227,108 )     (169,587 )
Net deferred tax (liability) asset
  $ (3,669 )   $ 59,864  
 
NOTE E - BENEFIT PLANS
 
Defined Contribution Plan
 
The Company sponsors a 401(k) defined contribution plan ("DC Plan") that provides for a dollar-for-dollar employer matching contribution of the first 4% of each employee's pay. Employees become fully vested in employer matching contributions after one year of employment. Company 401(k) matching contributions were approximately $103,000 and $101,000 for each of the years ended December 31, 2014 and 2013.  In 2014 and 2013 employees were able to defer up to $17,500 for each year respectively (plus $5,500 for employees over the age of 50) of their yearly pay as a pre-tax investment in the 401(k)plan, in accordance with limits set by the IRS. (Those limits have been increased to $18,000 (plus an additional $6,000 for employees over the age of 50) for the year 2015).
 
The Company also makes discretionary contributions to each employee's account based on a "pay-to-pay" safe-harbor formula that qualifies the 401(k) plan under current IRS regulations. In December 2014 and 2013 the Company’s Board of Directors authorized discretionary contributions in the amount of $175,000 per year, to be allocated among all eligible employees, for the 2014 and 2013 plan years. The 2014 contribution was paid in 2014, and the 2013 contribution was paid in 2013. Employees become vested in the discretionary contributions as follows: 20% after two years of employment, and 20% for each year of employment thereafter until the employee becomes fully vested after six years of employment.
 
Stock Option Plans
 
In March 2004 the Board of Directors of the Company approved the adoption of the 2004 Stock Option Plan, which authorized the granting of stock options to both employees and Directors. The plan was ratified by the shareholders on May 19, 2004. No options were ever granted under the plan, and it expired in March 2014.
 
 
F-15
 
 
NOTE  F -  GEOGRAPHIC and OTHER INFORMATION
 
Through its Guardian Laboratories division the Company manufactures and markets cosmetic ingredients, personal care products, pharmaceuticals, medical lubricants, health care products, and specialty industrial products.  It also conducts research and development, primarily related to the development of new and unique cosmetic and personal care products. The Company’s R&D department not only develops new products but also modifies and refines existing products, with the goal of expanding the potential markets for the Company’s products. Many of the cosmetic ingredient products manufactured by Guardian, particularly its LUBRAJEL line of water-based moisturizing and lubricating gels, are currently used by many of the major multinational personal care products companies.
 
The Company operates in one business segment. The Company’s products are separated into four distinct product categories: personal care products (including cosmetic ingredients), pharmaceuticals, medical products, and industrial products. Each product category is marketed differently. The cosmetic ingredient/personal care products are marketed through a global network of marketing partners and distributors.  These marketing partners purchase product outright from the Company and market and re-sell those products to the end users.  The Company does not make any sales on consignment.
 
No prior regulatory approval was needed by the Company to sell any products other than its pharmaceutical products.  The end users of its products may or may not need regulatory approvals, depending on the intended claims and uses of those products.
 
The pharmaceutical products are two urological products that are sold to end users primarily through distribution agreements with the major drug wholesalers. For these products, the Company does the marketing, and the drug wholesalers supply the product to the end users, such as hospitals and pharmacies. These products are drug products that required the Company to obtain regulatory approval before marketing.
 
The medical products are not pharmaceutical products. They consist primarily of medical lubricants, which are marketed by the Company directly to manufacturers that incorporate them into urologic catheters and other medical devices and products that they sell. These products are distinguished from the pharmaceutical products in that, unlike the pharmaceutical products, the Company is not required to obtain regulatory approval prior to marketing these products. Approvals are the responsibility of the company that markets the medical device.  However, the Company is responsible for manufacturing these products in accordance with current Good Manufacturing Practices for medical devices.
 
The industrial products are also marketed by the Company directly to manufacturers, and generally do not require that the Company obtain regulatory approval. However, the manufacturers of the finished products may have to obtain such regulatory approvals before marketing these products.
 
The geographic information set forth in table "(b)" below is partially based on sales information provided to the Company by Customer A (shown in table "(c)" below), which exclusively markets the Company's cosmetic ingredients in Canada and China, and also sells some of the Company's products into France on a non-exclusive basis along with Customer B.
 
 
F-16
 
 
(a)  
Net Sales

   
Years ended December 31,
  
   
2014
    
2013
  
             
Personal Care
   $ 9,421,041     $ 11,459,482  
Medical
     2,494,205       3,028,659  
Pharmaceutical
     1,686,563       916,927  
Industrial and other
     169,486       164,014  
      13,771,295       15,569,082  
Less: Discounts and allowances
     (321,616 )     (152,189 )
    $ 13,449,679     $ 15,416,893  
 
(b)
Geographic Information
 
   
Years ended December 31,
  
    2014     2013  
   
Revenues
    
Long-Lived
Assets
    
Revenues
    
Long-Lived
Assets
  
                         
United States 
   $ 4,723,779     $ 1,207,903     $ 4,580,429     $ 1,334,501  
China
     3,500,955       ---       3,519,450       ---  
Canada
     2,436,596       ---       3,390,619       ---  
United Kingdom
     703,142       ---       846,730       ---  
India
     615,890               431,015          
France 
     582,478       ---       856,285       ---  
Other countries 
     886,839       ---       1,792,365       ---  
    $ 13,449,679     $ 1,207,903     $ 15,416,893     $ 1,334,501  
 
(c)
Sales to Major Customers
 
    Years ended December 31,  
   
2014
    
2013
  
             
Customer A
  $ 7,929,208     $ 9,712,382  
Customer B
    582,478       856,285  
Customer C
     615,890       431,015  
All other customers
    4,322,103       4,417,211  
    $ 13,449,679     $ 15,416,893  
 
Customer A had one customer that comprised 32% of Customer A’s sales of the Company’s products in 2014, and 36% of its sales in 2013.
 
 
F-17
 
 
NOTE G – COMPREHENSIVE INCOME
 
Accumulated other comprehensive income comprises unrealized gains and losses on marketable securities net of the related tax effect.
 
Changes in Accumulated Other
Comprehensive Income
  
December 31, 2014
    
December 31, 2013
  
Beginning balance - net of tax
   $ 132,123     $ 178,979  
Unrealized gain/(loss) on marketable securities before reclassifications - net of tax
     152,873       (65,531 )
Realized (loss)/gain on sale of securities reclassified from accumulated other comprehensive income
     (25,127 )     18,675  
Ending balance - net of tax
   $ 259,869     $ 132,123  
 
NOTE H - INCOME FROM DAMAGE SETTLEMENT
 
In May 2012 the supplier of one of the Company’s pharmaceutical products, RENACIDIN, curtailed production due to manufacturing issues. In January 2013 the Company and its supplier entered into a settlement agreement whereby the supplier agreed to pay the Company $518,050 for the profit the Company lost during 2012 as result of the curtailment, plus $97,610 a month beginning January 1, 2013 for each month that the curtailment continued; $48,805 for each of the first two months after shipments resumed; and a final payment of $24,403 for the third month after shipments resumed. Because deliveries resumed at the end of October 2013, the supplier’s obligation to pay $97,610 per month ceased as of that date.  By the end of the first quarter of 2014 all damage payments had been made. As a result, the Company received only $24,403 in damage settlement payments for the year ended December 31, 2014, as compared with $1,070,561 for the year ended December 31, 2013.
 
NOTE I - ACCRUED EXPENSES
 
Accrued expenses at December 31, 2014 and 2013 consist of:
 
   
2014
    
2013
  
             
Bonuses
   $ 225,000     $ 250,000  
Distribution fees
     203,483       196,558  
Payroll and related expenses
     127,585       104,394  
Annual report expenses
     61,000       66,000  
Audit fee
     82,000       73,269  
Sales rebates
     96,000       ---  
Other
     38,791       37,794  
    $ 833,859     $ 728,015  
 
NOTE J - RELATED PARTY TRANSACTIONS
 
During each of the years ended December 31, 2014 and 2013 the Company paid to Bonamassa, Maietta, and Cartelli, LLP, $17,000, and $14,000, respectively, for accounting and tax services. Lawrence Maietta, a partner in Bonamassa, Maietta, and Cartelli, LLP, is a director of the Company.
 
 
F-18
 EX-31.1 2 exh_311.htm EXHIBIT 31.1 exh_311.htm
EXHIBIT 31.1

SECTION 302 CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER

I, Kenneth H. Globus, certify that:
 
1.
I have reviewed this Annual Report of United-Guardian, Inc. on Form 10-K for the year ended December 31, 2014;
 
2.
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
 
3.
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
 
4.
The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
 
 
a.  
designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 
b.  
designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 
c.  
evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 
d.  
disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.
The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 
a.  
all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 
b.  
any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 
Date: March 20, 2015 By: /s/ Kenneth H. Globus  
    Kenneth H. Globus  
    President and Principal Executive Officer
EX-31.2 3 exh_312.htm EXHIBIT 31.2 exh_312.htm
EXHIBIT 31.2

SECTION 302 CERTIFICATION OF CHIEF FINANCIAL OFFICER

I, Robert S. Rubinger, certify that:
 
1.
I have reviewed this Annual Report of United-Guardian, Inc. on Form 10-K for the year ended December 31, 2014;
 
2.
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
 
3.
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
 
4.
The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
 
 
a.
designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 
b.
designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 
c.
evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 
d.
disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.
The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 
a.
all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 
b.
any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
 
 
Date: March 20, 2015 By: /s/ Robert S. Rubinger  
    Robert S. Rubinger  
    Chief Financial Officer
EX-32 4 exh_32.htm EXHIBIT 32 exh_32.htm
EXHIBIT 32


CERTIFICATIONS PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO SECTION 906
 OF THE SARBANES-OXLEY ACT OF 2002


     In connection with the annual report of United-Guardian, Inc. (the "Company") on Form 10-K for the year ended December 31, 2014, as filed with the Securities and Exchange Commission (the "Report"), I, Kenneth H. Globus, President and Principal Executive Officer of the Company, and I, Robert S. Rubinger, Chief Financial Officer of the Company, do hereby certify, pursuant to 18 U.S.C.  Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

(i)  The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(ii)  The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
 
 
Date: March 20, 2015 By: /s/ Kenneth H. Globus  
    Kenneth H. Globus  
    President and Principal Executive Officer
     
     
  By: /s/ Robert S. Rubinger  
    Robert S. Rubinger
    Chief Financial Officer

 
 EX-101.INS 5 ug-20141231.xml XBRL INSTANCE DOCUMENT 0000101295 2014-01-01 2014-12-31 0000101295 2013-01-01 2013-12-31 0000101295 2014-12-31 0000101295 2013-12-31 0000101295 us-gaap:CommonStockMember 2012-12-31 0000101295 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2012-12-31 0000101295 us-gaap:RetainedEarningsMember 2012-12-31 0000101295 2012-12-31 0000101295 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2013-01-01 2013-12-31 0000101295 us-gaap:RetainedEarningsMember 2013-01-01 2013-12-31 0000101295 us-gaap:CommonStockMember 2013-12-31 0000101295 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2013-12-31 0000101295 us-gaap:RetainedEarningsMember 2013-12-31 0000101295 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2014-01-01 2014-12-31 0000101295 us-gaap:RetainedEarningsMember 2014-01-01 2014-12-31 0000101295 us-gaap:CommonStockMember 2014-12-31 0000101295 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2014-12-31 0000101295 us-gaap:RetainedEarningsMember 2014-12-31 0000101295 2015-03-01 0000101295 2014-06-30 0000101295 us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember ug:LUBRAJELAndRENACIDINIRRIGATIONMember 2014-01-01 2014-12-31 0000101295 us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember ug:LUBRAJELAndRENACIDINIRRIGATIONMember 2013-01-01 2013-12-31 0000101295 us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember ug:LUBRAJELMember 2014-01-01 2014-12-31 0000101295 us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember ug:LUBRAJELMember 2013-01-01 2013-12-31 0000101295 us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember ug:RENACIDINMember 2014-01-01 2014-12-31 0000101295 us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember ug:RENACIDINMember 2013-01-01 2013-12-31 0000101295 ug:RebatesMember 2014-12-31 0000101295 2014-06-13 2014-06-13 0000101295 2014-12-22 2014-12-22 0000101295 2013-06-14 2013-06-14 0000101295 ug:SpecialDividendMember 2013-12-20 2013-12-20 0000101295 ug:CapitalizedProductDevelopmentCostForRENACIDINMember 2014-12-31 0000101295 ug:CapitalizedTrademarkRegistrationCostForLUBRAJELMember 2014-12-31 0000101295 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2014-01-01 2014-12-31 0000101295 us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2014-01-01 2014-12-31 0000101295 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2013-01-01 2013-12-31 0000101295 us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2013-01-01 2013-12-31 0000101295 us-gaap:CostOfGoodsProductLineMember us-gaap:SupplierConcentrationRiskMember 2014-01-01 2014-12-31 0000101295 us-gaap:CostOfGoodsProductLineMember us-gaap:SupplierConcentrationRiskMember 2013-01-01 2013-12-31 0000101295 ug:FactoryEquipmentAndFixturesMember us-gaap:MinimumMember 2014-01-01 2014-12-31 0000101295 ug:FactoryEquipmentAndFixturesMember us-gaap:MaximumMember 2014-01-01 2014-12-31 0000101295 us-gaap:BuildingMember 2014-01-01 2014-12-31 0000101295 us-gaap:BuildingImprovementsMember us-gaap:MaximumMember 2014-01-01 2014-12-31 0000101295 ug:WasteDisposalSystemMember 2014-01-01 2014-12-31 0000101295 ug:FixedIncomeMutualFundsMember 2014-12-31 0000101295 ug:FixedIncomeMutualFundsMember 2014-01-01 2014-12-31 0000101295 ug:EquityAndOtherMutualFundsMember 2014-12-31 0000101295 ug:EquityAndOtherMutualFundsMember 2014-01-01 2014-12-31 0000101295 us-gaap:CorporateDebtSecuritiesMember 2013-12-31 0000101295 us-gaap:CorporateDebtSecuritiesMember 2013-01-01 2013-12-31 0000101295 ug:FixedIncomeMutualFundsMember 2013-12-31 0000101295 ug:FixedIncomeMutualFundsMember 2013-01-01 2013-12-31 0000101295 ug:EquityAndOtherMutualFundsMember 2013-12-31 0000101295 ug:EquityAndOtherMutualFundsMember 2013-01-01 2013-12-31 0000101295 ug:DCPlanMember 2014-01-01 2014-12-31 0000101295 ug:DCPlanMember 2013-01-01 2013-12-31 0000101295 ug:AdditionalDeferredInvestmentEmployeesOver50Member ug:DCPlanMember 2014-01-01 2014-12-31 0000101295 ug:AdditionalDeferredInvestmentEmployeesOver50Member ug:DCPlanMember 2013-01-01 2013-12-31 0000101295 ug:DCPlanMember us-gaap:ScenarioForecastMember 2015-01-01 2015-12-31 0000101295 ug:AdditionalDeferredInvestmentEmployeesOver50Member ug:DCPlanMember us-gaap:ScenarioForecastMember 2015-01-01 2015-12-31 0000101295 ug:DCPlanMember ug:DiscretionaryContributionsVestingAtTwoYearsMember 2014-01-01 2014-12-31 0000101295 ug:DCPlanMember ug:DiscretionaryContributionsVestingEachAdditionalYearMember 2014-01-01 2014-12-31 0000101295 us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2014-01-01 2014-12-31 0000101295 us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember 2013-01-01 2013-12-31 0000101295 ug:PersonalCareMember 2014-01-01 2014-12-31 0000101295 ug:PersonalCareMember 2013-01-01 2013-12-31 0000101295 ug:MedicalMember 2014-01-01 2014-12-31 0000101295 ug:MedicalMember 2013-01-01 2013-12-31 0000101295 ug:PharmaceuticalsMember 2014-01-01 2014-12-31 0000101295 ug:PharmaceuticalsMember 2013-01-01 2013-12-31 0000101295 ug:IndustrialAndOtherMember 2014-01-01 2014-12-31 0000101295 ug:IndustrialAndOtherMember 2013-01-01 2013-12-31 0000101295 country:US 2014-01-01 2014-12-31 0000101295 country:US 2014-12-31 0000101295 country:US 2013-01-01 2013-12-31 0000101295 country:US 2013-12-31 0000101295 country:CN 2014-01-01 2014-12-31 0000101295 country:CN 2013-01-01 2013-12-31 0000101295 country:CA 2014-01-01 2014-12-31 0000101295 country:CA 2013-01-01 2013-12-31 0000101295 country:GB 2014-01-01 2014-12-31 0000101295 country:GB 2013-01-01 2013-12-31 0000101295 country:IN 2014-01-01 2014-12-31 0000101295 country:IN 2013-01-01 2013-12-31 0000101295 country:FR 2014-01-01 2014-12-31 0000101295 country:FR 2013-01-01 2013-12-31 0000101295 ug:OtherCountriesMember 2014-01-01 2014-12-31 0000101295 ug:OtherCountriesMember 2013-01-01 2013-12-31 0000101295 ug:CustomerAMember 2014-01-01 2014-12-31 0000101295 ug:CustomerAMember 2013-01-01 2013-12-31 0000101295 ug:CustomerBMember 2014-01-01 2014-12-31 0000101295 ug:CustomerBMember 2013-01-01 2013-12-31 0000101295 ug:CustomerCMember 2014-01-01 2014-12-31 0000101295 ug:CustomerCMember 2013-01-01 2013-12-31 0000101295 ug:AllOtherCustomersMember 2014-01-01 2014-12-31 0000101295 ug:AllOtherCustomersMember 2013-01-01 2013-12-31 0000101295 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2013-12-31 0000101295 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2012-12-31 0000101295 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2014-01-01 2014-12-31 0000101295 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2013-01-01 2013-12-31 0000101295 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2014-12-31 0000101295 ug:DamageSettlementMember 2012-12-31 0000101295 ug:DamageSettlementMonthlyMember 2013-03-31 0000101295 ug:DamageSettlementTwoMonthsMember 2013-12-31 0000101295 ug:DamageSettlementThirdMonthMember 2013-12-31 0000101295 ug:DamageSettlementMember 2014-01-01 2014-12-31 0000101295 ug:DamageSettlementMember 2013-01-01 2013-12-31 0000101295 ug:AccruedAnnualReportMember 2014-12-31 0000101295 ug:AccruedAnnualReportMember 2013-12-31 0000101295 ug:AccruedAuditFeeMember 2014-12-31 0000101295 ug:AccruedAuditFeeMember 2013-12-31 0000101295 ug:AccountingAndTaxServicesMember us-gaap:DirectorMember 2014-01-01 2014-12-31 0000101295 ug:AccountingAndTaxServicesMember us-gaap:DirectorMember 2013-01-01 2013-12-31 iso4217:USD iso4217:USD xbrli:shares xbrli:shares xbrli:pure 13449679 15416893 5317707 5610813 2640997 2504526 7958704 8115339 5490975 7301554 239592 259747 24403 1070561 263995 1330308 5754970 8631862 1704554 2728553 4050416 5903309 0.88 1.28 4596439 4596439 191533 -71711 63787 -24855 127746 -46856 4178162 5856453 2023383 1634262 9389501 8863205 1593260 1790747 48805 1237154 1610747 165691 130001 30643 223439 229451 14663071 14307218 69000 69000 4138875 4090968 2773002 2766319 133532 6980877 7059819 5772974 5725318 1207903 1334501 68042 9147 15939016 15650866 141111 385699 833859 728015 131638 974970 1245352 227108 169587 459644 459644 259869 132123 14017425 13644160 14736938 14235927 15939016 15650866 30000 18000 0.10 0.10 10000000 10000000 4596439 4596439 4596439 4596439 4596439 459644 178979 12199395 12838018 -46856 5903309 4458544 4458544 4596439 459644 132123 13644160 127746 4050416 3677151 3677151 4596439 459644 259869 14017425 181188 189729 -25127 18675 12325 -11089 -254 -12161 -185162 762031 -48805 -469245 -373593 367997 94585 6690 30643 -3602 -244588 234314 -25794 183530 4480752 5805086 54590 288367 3437478 5311313 3077588 4139018 -414480 -1460662 3677151 4458544 -3677151 -4458544 389121 -114120 1748382 UNITED GUARDIAN INC 10-K --12-31 4596439 74690668 false 0000101295 Yes No Smaller Reporting Company No 2014 FY 2014-12-31 <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 12pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 12pt; FONT-WEIGHT: bold">NOTE A - NATURE OF BUSINESS AND SUMMARY OF SIGNIFICANT</font> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 12pt; FONT-WEIGHT: bold">ACCOUNTING POLICIES</font></font> </div><br/><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Nature of Business</font> </div><br/><div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">United-Guardian, Inc. (the "Company") is a Delaware corporation that, through its Guardian Laboratories Division, manufactures and markets cosmetic ingredients, personal care products, pharmaceuticals, medical lubricants, health care products, and specialty industrial products. It also conducts research and product development, primarily related to the development of new and unique cosmetic and personal care products. The Company&#8217;s research and development department also modifies, refines, and expands the uses for existing products, with the goal of further developing the market for the Company's products. Two major product lines, LUBRAJEL<font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">&#8482;</font> and RENACIDIN<font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">&#174;</font> IRRIGATION (&#8220;RENACIDIN&#8221;) together accounted for 94.6% and 94.4% of revenue for the years ended December 31, 2014 and December 31, 2013, respectively. LUBRAJEL accounted for 85.9% and 91.4% of revenue for the years ended December 31, 2014 and December 31, 2013, respectively, and RENACIDIN accounted for 8.8% and 2.9% of revenue for the years ended December 31, 2014 and December 31, 2013, respectively.</font> </div><br/><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Accounts Receivable and Reserves</font> </div><br/><div style="TEXT-ALIGN: justify; TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The carrying amount of accounts receivable is reduced by a valuation allowance that reflects our best estimate of the amounts that will not be collected.&#160;The reserve for accounts receivable comprises the allowance for doubtful accounts and sales returns.&#160;In addition to reviewing delinquent accounts receivable, we consider many factors in estimating our reserve, including historical data, experience, customer types and credit worthiness, and economic trends.&#160;From time to time, we adjust our assumptions for anticipated changes in any of these or other factors expected to affect collectability.</font> </div><br/><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Revenue Recognition</font> </div><br/><div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The Company recognizes revenue when products are shipped, title and risk of loss pass to customers, persuasive evidence of a sales arrangement exists, and collections are reasonably assured.&#160;&#160;All products are shipped Free On Board (&#8220;FOB&#8221;) Hauppauge, New York, the location of the Company&#8217;s plant. Both title and risk of loss are deemed by both the Company and its customers to have passed to the customers at the time the goods leave the Company&#8217;s plant. Shipments are only made after confirmation that a valid purchase order has been received and that the future collection of the sale amount is reasonably assured. All sales of the Company&#8217;s products are deemed final, and there is no obligation on the part of the Company to repurchase or allow the return of the goods unless they are defective. The Company does not make sales on consignment, and the collection of the proceeds of the sale is not contingent upon the customer being able to sell the goods to a third party.</font> </div><br/><div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Any allowance for returns is taken as a reduction of sales within the same period the revenue is recognized. Such allowances are based on historical experience. The Company has not experienced significant fluctuations between estimated allowances and actual activity.</font> </div><br/><div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">From time to time during 2014 the Company offered discounts and/or rebates to some of its customers in order to retain or increase sales to those customers. In 2014 those sales discounts totaled $119,965, compared with $11,000 in 2013. Of the $119,965 in sales discounts in 2014, $23,965 had been paid, and $96,000 accrued, as of December 31, 2014. The $96,000 of accrued sales discounts consisted of rebates given to one of the Company&#8217;s largest customers in order to retain and increase its business with that customer.</font> </div><br/><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Cash and Cash Equivalents</font> </div><br/><div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">For financial statement purposes, the Company considers as cash equivalents all highly liquid investments with an original maturity of three months or less at inception. The Company deposits cash and cash equivalents with high credit quality financial institutions and believes that any amounts in excess of insurance limitations to be at minimal risk. Cash and cash equivalents held in these accounts are currently insured by the Federal Deposit Insurance Corporation up to a maximum of $250,000.</font> </div><br/><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Dividends</font> </div><br/><div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">On May 14, 2014, the Company&#8217;s Board of Directors declared a semi-annual cash dividend of $0.48 per share, which was paid on June 13, 2014 to all stockholders of record as of May 30, 2014. On November 20, 2014, the Company&#8217;s Board of Directors declared a semi-annual cash dividend of $0.32 per share, which was paid on December 22, 2014 to all stockholders of record as of December 8, 2014. Total dividends declared and paid in 2014 were $3,677,151.</font> </div><br/><div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">On May 15, 2013, the Company&#8217;s Board of Directors declared a semi-annual cash dividend of $0.47 per share, which was paid on June 14, 2013 to all stockholders of record as of May 30, 2013. On November 22, 2013, the Company&#8217;s Board of Directors declared a semi-annual cash dividend of $0.50 per share, which was paid on December 20, 2013 to all stockholders of record as of December 6, 2013. Total dividends declared and paid in 2013 were $4,458,544.</font> </div><br/><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Supplemental Disclosures of Non-cash Investing and Financing Activities</font> </div><br/><div style="TEXT-ALIGN: justify; TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Cash payments for income taxes were $1,867,089 and $2,605,474 for the years ended December 31, 2014 and 2013, respectively. <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></font> </div><br/><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Marketable Securities</font> </div><br/><div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Marketable securities include investments in equity and fixed income mutual funds, and government securities, all of which have a high degree of liquidity, are classified as "Available for Sale" securities, and are reported at their fair values. Unrealized gains and losses on "Available for Sale" securities are reported as accumulated other comprehensive income (loss) in stockholders' equity, net of the related tax effects. Investment income is recognized when earned. Realized gains and losses on sales of investments and declines in value judged to be other than temporary, if any, are reported in other income with cost being determined on a specific identification basis. Fair values are based on quoted market prices. The Company evaluates its investments periodically for possible impairment and reviews factors such as the length of time and extent to which fair value has been below cost basis and the Company&#8217;s ability and intent to hold the investment for a period of time which may be sufficient for anticipated recovery in market value.</font> </div><br/><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Inventories</font> </div><br/><div style="TEXT-ALIGN: justify; TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Inventories are valued at the lower of cost or current market value. Cost is determined using the average cost method, which approximates cost determined by the first-in, first-out (&#8220;FIFO&#8221;) method. Inventory costs include material, labor and factory overhead.</font> </div><br/><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Property, Plant and Equipment</font> </div><br/><div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Property, plant and equipment are carried at cost, less accumulated depreciation. Major replacements and betterments are capitalized, while routine maintenance and repairs are expensed as incurred. Assets are depreciated under both accelerated and straight-line methods. Depreciation charged to income as a result of using accelerated methods was not materially different than that which would result from using the straight-line method for all periods presented. Certain factory equipment and fixtures are constructed by the Company using purchased materials and in-house labor. Such assets are capitalized and depreciated on a basis consistent with the Company's purchased fixed assets.</font> </div><br/><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Estimated useful lives are as follows:&#160;</font> </div><br/><table cellpadding="0" cellspacing="0" width="60%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="85%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Factory equipment and fixtures (years)</font> </div> </td> <td valign="bottom" width="6%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">5</font> </td> <td valign="bottom" width="3%" style="TEXT-ALIGN: center"> <div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font> </div> </td> <td align="left" valign="bottom" width="6%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">7</font> </td> </tr> <tr> <td align="left" valign="bottom" width="85%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Building&#160; (years)</font> </div> </td> <td align="left" valign="bottom" width="6%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="3%" style="TEXT-ALIGN: center"> <div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">40</font> </div> </td> <td align="left" valign="bottom" width="6%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="85%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Building improvements&#160;</font> </div> </td> <td align="left" valign="bottom" width="6%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="3%" style="TEXT-ALIGN: center"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Lesser of useful</font> </div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">life or 20 years</font> </div> </td> <td align="left" valign="bottom" width="6%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="85%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Waste disposal system&#160; (years)</font> </div> </td> <td align="left" valign="bottom" width="6%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="3%" style="TEXT-ALIGN: center"> <div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">7</font> </div> </td> <td align="left" valign="bottom" width="6%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> </table><br/><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Impairment of Long-Lived Assets</font> </div><br/><div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Long-lived assets and certain identifiable intangibles are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset to future net cash flows expected to be generated by the asset. If such assets are considered to be impaired, the impairment to be recognized is measured by the amount by which the carrying amount of the assets exceeds the fair value of the assets. Assets to be disposed of are reported at the lower of the carrying amount or fair value less costs to sell.&#160;&#160;No impairments were necessary at December 31, 2014 and 2013.</font> </div><br/><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Other Assets</font> </div><br/><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font id="TAB1-11" style="MARGIN-LEFT: 36pt"></font>Other assets at December 31, 2014 consisted of $60,042 expended in connection with the development of a new dosage form and manufacturing process for RENACIDIN, and $8,000 in costs incurred in re-registering the Company&#8217;s LUBRAJEL trademark. The Company will determine the appropriate amortization rate for these assets at such time as they are put into service.</font> </div><br/><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Fair Value of Financial Instruments</font> </div><br/><div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Management of the Company believes that the fair value of financial instruments, consisting of cash and cash equivalents, accounts receivable, accounts payable, and accrued expenses approximates their carrying value due to their short payment terms and liquid nature.</font> </div><br/><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Concentration of Credit Risk</font> </div><br/><div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Accounts receivable potentially exposes the Company to concentrations of credit risk. The Company monitors the amount of credit it allows each of its customers, using the customer&#8217;s prior payment history to determine how much credit to allow or whether any credit should be given at all.&#160;&#160;It is the Company&#8217;s policy to discontinue shipments to any customer that is substantially past due on its payments. The Company sometimes requires payment in advance from customers whose payment record is questionable.&#160;&#160;As a result of its monitoring of the outstanding credit allowed for each customer, as well as the fact that the majority of the Company&#8217;s sales are to customers whose satisfactory credit and payment record has been established over a long period of time, the Company believes that its accounts receivable credit risk has been reduced.</font> </div><br/><div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">For the year ended December 31, 2014, two of the Company&#8217;s distributors and marketing partners accounted for 64.7% of the Company&#8217;s revenues during the year, and 56.3% of its outstanding accounts receivable at year end. For the year ended December 31, 2013, two of the Company&#8217;s distributors and marketing partners, one the same as in 2014, and the other different, accounted for a total of 69% of the Company&#8217;s revenues during the year, and 72% of its outstanding accounts receivable at year end.</font> </div><br/><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Vendor Concentration</font> </div><br/><div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The principal raw materials used by the Company consist of common industrial organic and inorganic chemicals. Most of these materials are available in ample supply from numerous sources. The Company has five major raw material vendors that collectively accounted for approximately 84% and 67% of the raw material purchases by the Company in 2014 and 2013, respectively.</font> </div><br/><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Income Taxes</font> </div><br/><div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Income taxes are accounted for under the asset and liability method. Deferred tax assets and liabilities are recognized for future tax consequences attributable to the temporary differences between the financial statement carrying amounts of assets and liabilities and their respective tax bases and operating loss and tax credit carry forwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in the period that includes the enactment date. Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion or all of the deferred tax assets will not be realized.</font> </div><br/><div style="TEXT-ALIGN: justify; TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Uncertain tax positions are accounted for utilizing a recognition threshold and measurement attribute for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. As of December 31, 2014 and 2013, the Company did not have any unrecognized income tax benefits.&#160;&#160;It is the Company&#8217;s policy to recognize interest and penalties related to taxes as interest expense as incurred.&#160;&#160;During the years ended December 31, 2014 and 2013 the Company did not record any interest or penalties. The Company&#8217;s tax returns are subject to examination by the United States Internal Revenue Service and by the State of New York for years 2010 through 2013. In March 2014 the New York State Department of Taxation and Finance (&#8220;DTF&#8221;) commenced a routine examination of the Company&#8217;s income tax returns for years 2010 through 2012. The DTF has completed its examination and has accepted the tax returns as filed.</font></font> </div><br/><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Research and Development</font> </div><br/><div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The Company's research and development expenses, included in operating expenses, are recorded in the year incurred. Research and development expenses were approximately $730,000 and $717,000 for the years ended December 31, 2014 and 2013, respectively.</font> </div><br/><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Shipping and Handling Costs</font> </div><br/><div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Shipping and handling costs are classified in operating expenses in the accompanying statements of income. Shipping and handling costs were approximately $86,000 and $45,000 for the years ended December 31, 2014 and 2013, respectively.</font> </div><br/><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Advertising Costs</font> </div><br/><div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Advertising costs are expensed as incurred. During 2014 and 2013 the Company incurred $20,000 and $16,000, respectively, in advertising costs.</font> </div><br/><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Stock-Based Compensation</font> </div><br/><div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">In 2004, the Company approved a stock option plan ("2004 Stock Option Plan") authorizing the granting of stock options to Company employees and Directors. No options were ever issued under this plan, and it expired in March 2014.</font> </div><br/><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Earnings Per Share Information</font> </div><br/><div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Basic earnings per share are computed by dividing net income by the weighted average number of common shares outstanding during the year. Diluted earnings per share include the dilutive effect of outstanding stock options.</font> </div><br/><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Use of Estimates</font> </div><br/><div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">In preparing financial statements in conformity with U.S. generally accepted accounting principles, management is required to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and revenues and expenses during the reporting period. Actual results could differ from those estimates. Such estimated items include the allowance for bad debts, possible impairment of marketable securities, reserve for inventory obsolescence, and the allocation of overhead.</font> </div><br/><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">New Accounting Standards</font> </div><br/><div style="TEXT-ALIGN: justify; TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">In December of 2013, FASB issued ASU 2013-11, &#8220;Income Taxes (Topic 740): Presentation of an Unrecognized Tax Benefit When a Net Operating Loss Carryforward, a Similar Tax Loss, or a Tax Credit Carryforward Exists.&#8221; This amendment requires that an unrecognized tax benefit, or a portion of an unrecognized tax benefit, should be presented in the financial statements as a reduction to a deferred tax asset for a net operating loss carryforward, a similar tax loss, or a tax credit carryforward with exceptions.&#160;&#160;This amendment only applies to entities that have an unrecognized tax benefit when a net operating loss carryforward, a similar tax loss, or a tax credit carryforward exists at the reporting date. This update became effective for interim and annual reporting periods beginning after December 15, 2013. The update does not have a material impact on the Company&#8217;s results of operation.</font> </div><br/><div style="TEXT-ALIGN: justify; TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">In May 2014, FASB issued ASU 2014-09, &#8220;Revenue from Contracts with Customers.&#8221; This standard applies to any entity that uses the guidance of GAAP for entering into contracts with customers to transfer goods or services or enters into contracts for the transfer of nonfinancial assets unless those contracts are within the scope of other standards. It requires that an entity should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration the entity expects to receive for the exchange of goods or services. This amendment is effective for interim and annual reporting periods beginning after December 15, 2016. The Company is still evaluating the potential impact on the Company&#8217;s results of operations.</font> </div><br/><div style="TEXT-ALIGN: justify; TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">In June 2014, FASB issued ASU 2014-11, &#8220;Transfers and Servicing: Repurchase-to-Maturity Transactions, Repurchase Financings, and Disclosures.&#8221; This standard aligns the accounting for repurchases-to-maturity transactions and repurchase agreements executed as a repurchase financing with accounting for other typical repurchase agreements. These types of transactions will now be accounted for as secured borrowings. It eliminates sales accounting for repurchase-to-maturity and supersedes guidance for accounting transactions involving transfers of financial assets with contemporaneous repurchase financing agreements that leads to off-balance accounting. This update becomes effective for interim and annual reporting periods beginning after December 15, 2014 and is not expected to have a material impact on the Company&#8217;s results of operations.</font> </div><br/><div style="TEXT-ALIGN: justify; TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">In August 2014, FASB issued ASU 2014-15, &#8220;Presentation of Financial Statements-Going Concern.&#160;&#160;Disclosure of Uncertainties about Entity&#8217;s Ability to Continue as a Going Concern.&#8221; Currently, GAAP lacks guidance about management&#8217;s responsibility to evaluate whether there is substantial doubt about an entity&#8217;s ability to continue as a going concern. This amendment now provides guidance by providing a definition of substantial doubt, requires evaluation by management every reporting period for going concern issues, provides principles for considering any mitigating effects implemented by management, and the disclosures required for the assessment period of one year after issuance of the financial statements. This update becomes effective for interim and annual reporting periods beginning after December 15, 2016 with early application being permitted. The update will be adopted for reporting periods starting January 2015, and is not expected to have a material impact on the Company&#8217;s results of operations.</font> </div><br/> 2 0.946 0.944 0.859 0.914 0.088 0.029 <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Accounts Receivable and Reserves</font> </div><br/><div style="TEXT-ALIGN: justify; TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The carrying amount of accounts receivable is reduced by a valuation allowance that reflects our best estimate of the amounts that will not be collected.&#160;The reserve for accounts receivable comprises the allowance for doubtful accounts and sales returns.&#160;In addition to reviewing delinquent accounts receivable, we consider many factors in estimating our reserve, including historical data, experience, customer types and credit worthiness, and economic trends.&#160;From time to time, we adjust our assumptions for anticipated changes in any of these or other factors expected to affect collectability.</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Revenue Recognition</font> </div><br/><div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The Company recognizes revenue when products are shipped, title and risk of loss pass to customers, persuasive evidence of a sales arrangement exists, and collections are reasonably assured.&#160;&#160;All products are shipped Free On Board (&#8220;FOB&#8221;) Hauppauge, New York, the location of the Company&#8217;s plant. Both title and risk of loss are deemed by both the Company and its customers to have passed to the customers at the time the goods leave the Company&#8217;s plant. Shipments are only made after confirmation that a valid purchase order has been received and that the future collection of the sale amount is reasonably assured. All sales of the Company&#8217;s products are deemed final, and there is no obligation on the part of the Company to repurchase or allow the return of the goods unless they are defective. The Company does not make sales on consignment, and the collection of the proceeds of the sale is not contingent upon the customer being able to sell the goods to a third party.</font> </div><br/><div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Any allowance for returns is taken as a reduction of sales within the same period the revenue is recognized. Such allowances are based on historical experience. The Company has not experienced significant fluctuations between estimated allowances and actual activity.</font> </div><br/><div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">From time to time during 2014 the Company offered discounts and/or rebates to some of its customers in order to retain or increase sales to those customers. In 2014 those sales discounts totaled $119,965, compared with $11,000 in 2013. Of the $119,965 in sales discounts in 2014, $23,965 had been paid, and $96,000 accrued, as of December 31, 2014. The $96,000 of accrued sales discounts consisted of rebates given to one of the Company&#8217;s largest customers in order to retain and increase its business with that customer.</font></div> 119965 11000 23965 96000 96000 <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Cash and Cash Equivalents</font> </div><br/><div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">For financial statement purposes, the Company considers as cash equivalents all highly liquid investments with an original maturity of three months or less at inception. The Company deposits cash and cash equivalents with high credit quality financial institutions and believes that any amounts in excess of insurance limitations to be at minimal risk. Cash and cash equivalents held in these accounts are currently insured by the Federal Deposit Insurance Corporation up to a maximum of $250,000.</font></div> 250000 <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Dividends</font> </div><br/><div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">On May 14, 2014, the Company&#8217;s Board of Directors declared a semi-annual cash dividend of $0.48 per share, which was paid on June 13, 2014 to all stockholders of record as of May 30, 2014. On November 20, 2014, the Company&#8217;s Board of Directors declared a semi-annual cash dividend of $0.32 per share, which was paid on December 22, 2014 to all stockholders of record as of December 8, 2014. Total dividends declared and paid in 2014 were $3,677,151.</font> </div><br/><div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">On May 15, 2013, the Company&#8217;s Board of Directors declared a semi-annual cash dividend of $0.47 per share, which was paid on June 14, 2013 to all stockholders of record as of May 30, 2013. On November 22, 2013, the Company&#8217;s Board of Directors declared a semi-annual cash dividend of $0.50 per share, which was paid on December 20, 2013 to all stockholders of record as of December 6, 2013. Total dividends declared and paid in 2013 were $4,458,544.</font></div> 0.48 0.32 3677151 0.47 0.50 4458544 <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Supplemental Disclosures of Non-cash Investing and Financing Activities</font> </div><br/><div style="TEXT-ALIGN: justify; TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Cash payments for income taxes were $1,867,089 and $2,605,474 for the years ended December 31, 2014 and 2013, respectively.</font></div> 1867089 2605474 <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Marketable Securities</font> </div><br/><div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Marketable securities include investments in equity and fixed income mutual funds, and government securities, all of which have a high degree of liquidity, are classified as "Available for Sale" securities, and are reported at their fair values. Unrealized gains and losses on "Available for Sale" securities are reported as accumulated other comprehensive income (loss) in stockholders' equity, net of the related tax effects. Investment income is recognized when earned. Realized gains and losses on sales of investments and declines in value judged to be other than temporary, if any, are reported in other income with cost being determined on a specific identification basis. Fair values are based on quoted market prices. The Company evaluates its investments periodically for possible impairment and reviews factors such as the length of time and extent to which fair value has been below cost basis and the Company&#8217;s ability and intent to hold the investment for a period of time which may be sufficient for anticipated recovery in market value.</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Inventories</font> </div><br/><div style="TEXT-ALIGN: justify; TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Inventories are valued at the lower of cost or current market value. Cost is determined using the average cost method, which approximates cost determined by the first-in, first-out (&#8220;FIFO&#8221;) method. Inventory costs include material, labor and factory overhead.</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Property, Plant and Equipment</font> </div><br/><div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Property, plant and equipment are carried at cost, less accumulated depreciation. Major replacements and betterments are capitalized, while routine maintenance and repairs are expensed as incurred. Assets are depreciated under both accelerated and straight-line methods. Depreciation charged to income as a result of using accelerated methods was not materially different than that which would result from using the straight-line method for all periods presented. Certain factory equipment and fixtures are constructed by the Company using purchased materials and in-house labor. Such assets are capitalized and depreciated on a basis consistent with the Company's purchased fixed assets.</font> </div><br/><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Estimated useful lives are as follows:&#160;</font> </div><br/><table cellpadding="0" cellspacing="0" width="60%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="85%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Factory equipment and fixtures (years)</font> </div> </td> <td valign="bottom" width="6%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">5</font> </td> <td valign="bottom" width="3%" style="TEXT-ALIGN: center"> <div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font> </div> </td> <td align="left" valign="bottom" width="6%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">7</font> </td> </tr> <tr> <td align="left" valign="bottom" width="85%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Building&#160; (years)</font> </div> </td> <td align="left" valign="bottom" width="6%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="3%" style="TEXT-ALIGN: center"> <div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">40</font> </div> </td> <td align="left" valign="bottom" width="6%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="85%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Building improvements&#160;</font> </div> </td> <td align="left" valign="bottom" width="6%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="3%" style="TEXT-ALIGN: center"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Lesser of useful</font> </div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">life or 20 years</font> </div> </td> <td align="left" valign="bottom" width="6%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="85%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Waste disposal system&#160; (years)</font> </div> </td> <td align="left" valign="bottom" width="6%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="3%" style="TEXT-ALIGN: center"> <div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">7</font> </div> </td> <td align="left" valign="bottom" width="6%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> </table> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Impairment of Long-Lived Assets</font> </div><br/><div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Long-lived assets and certain identifiable intangibles are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset to future net cash flows expected to be generated by the asset. If such assets are considered to be impaired, the impairment to be recognized is measured by the amount by which the carrying amount of the assets exceeds the fair value of the assets. Assets to be disposed of are reported at the lower of the carrying amount or fair value less costs to sell.&#160;&#160;No impairments were necessary at December 31, 2014 and 2013.</font></div> 0 0 <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Other Assets</font> </div><br/><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font id="TAB1-11" style="MARGIN-LEFT: 36pt"></font>Other assets at December 31, 2014 consisted of $60,042 expended in connection with the development of a new dosage form and manufacturing process for RENACIDIN, and $8,000 in costs incurred in re-registering the Company&#8217;s LUBRAJEL trademark. The Company will determine the appropriate amortization rate for these assets at such time as they are put into service.</font></div> 60042 8000 <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Fair Value of Financial Instruments</font> </div><br/><div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Management of the Company believes that the fair value of financial instruments, consisting of cash and cash equivalents, accounts receivable, accounts payable, and accrued expenses approximates their carrying value due to their short payment terms and liquid nature.</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Concentration of Credit Risk</font> </div><br/><div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Accounts receivable potentially exposes the Company to concentrations of credit risk. The Company monitors the amount of credit it allows each of its customers, using the customer&#8217;s prior payment history to determine how much credit to allow or whether any credit should be given at all.&#160;&#160;It is the Company&#8217;s policy to discontinue shipments to any customer that is substantially past due on its payments. The Company sometimes requires payment in advance from customers whose payment record is questionable.&#160;&#160;As a result of its monitoring of the outstanding credit allowed for each customer, as well as the fact that the majority of the Company&#8217;s sales are to customers whose satisfactory credit and payment record has been established over a long period of time, the Company believes that its accounts receivable credit risk has been reduced.</font> </div><br/><div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">For the year ended December 31, 2014, two of the Company&#8217;s distributors and marketing partners accounted for 64.7% of the Company&#8217;s revenues during the year, and 56.3% of its outstanding accounts receivable at year end. For the year ended December 31, 2013, two of the Company&#8217;s distributors and marketing partners, one the same as in 2014, and the other different, accounted for a total of 69% of the Company&#8217;s revenues during the year, and 72% of its outstanding accounts receivable at year end.</font></div> 2 0.647 0.563 2 0.69 0.72 <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Vendor Concentration</font> </div><br/><div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The principal raw materials used by the Company consist of common industrial organic and inorganic chemicals. Most of these materials are available in ample supply from numerous sources. The Company has five major raw material vendors that collectively accounted for approximately 84% and 67% of the raw material purchases by the Company in 2014 and 2013, respectively.</font></div> 5 5 0.84 0.67 <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Income Taxes</font> </div><br/><div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Income taxes are accounted for under the asset and liability method. Deferred tax assets and liabilities are recognized for future tax consequences attributable to the temporary differences between the financial statement carrying amounts of assets and liabilities and their respective tax bases and operating loss and tax credit carry forwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in the period that includes the enactment date. Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion or all of the deferred tax assets will not be realized.</font> </div><br/><div style="TEXT-ALIGN: justify; TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Uncertain tax positions are accounted for utilizing a recognition threshold and measurement attribute for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. As of December 31, 2014 and 2013, the Company did not have any unrecognized income tax benefits.&#160;&#160;It is the Company&#8217;s policy to recognize interest and penalties related to taxes as interest expense as incurred.&#160;&#160;During the years ended December 31, 2014 and 2013 the Company did not record any interest or penalties. The Company&#8217;s tax returns are subject to examination by the United States Internal Revenue Service and by the State of New York for years 2010 through 2013. In March 2014 the New York State Department of Taxation and Finance (&#8220;DTF&#8221;) commenced a routine examination of the Company&#8217;s income tax returns for years 2010 through 2012. The DTF has completed its examination and has accepted the tax returns as filed.</font></font></div> 0 0 0 0 <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Research and Development</font> </div><br/><div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The Company's research and development expenses, included in operating expenses, are recorded in the year incurred. Research and development expenses were approximately $730,000 and $717,000 for the years ended December 31, 2014 and 2013, respectively.</font></div> 730000 717000 <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Shipping and Handling Costs</font> </div><br/><div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Shipping and handling costs are classified in operating expenses in the accompanying statements of income. Shipping and handling costs were approximately $86,000 and $45,000 for the years ended December 31, 2014 and 2013, respectively.</font></div> 86000 45000 <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Advertising Costs</font> </div><br/><div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Advertising costs are expensed as incurred. During 2014 and 2013 the Company incurred $20,000 and $16,000, respectively, in advertising costs.</font></div> 20000 16000 <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Stock-Based Compensation</font> </div><br/><div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">In 2004, the Company approved a stock option plan ("2004 Stock Option Plan") authorizing the granting of stock options to Company employees and Directors. No options were ever issued under this plan, and it expired in March 2014.</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Earnings Per Share Information</font> </div><br/><div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Basic earnings per share are computed by dividing net income by the weighted average number of common shares outstanding during the year. Diluted earnings per share include the dilutive effect of outstanding stock options.</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Use of Estimates</font> </div><br/><div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">In preparing financial statements in conformity with U.S. generally accepted accounting principles, management is required to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and revenues and expenses during the reporting period. Actual results could differ from those estimates. Such estimated items include the allowance for bad debts, possible impairment of marketable securities, reserve for inventory obsolescence, and the allocation of overhead.</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">New Accounting Standards</font> </div><br/><div style="TEXT-ALIGN: justify; TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">In December of 2013, FASB issued ASU 2013-11, &#8220;Income Taxes (Topic 740): Presentation of an Unrecognized Tax Benefit When a Net Operating Loss Carryforward, a Similar Tax Loss, or a Tax Credit Carryforward Exists.&#8221; This amendment requires that an unrecognized tax benefit, or a portion of an unrecognized tax benefit, should be presented in the financial statements as a reduction to a deferred tax asset for a net operating loss carryforward, a similar tax loss, or a tax credit carryforward with exceptions.&#160;&#160;This amendment only applies to entities that have an unrecognized tax benefit when a net operating loss carryforward, a similar tax loss, or a tax credit carryforward exists at the reporting date. This update became effective for interim and annual reporting periods beginning after December 15, 2013. The update does not have a material impact on the Company&#8217;s results of operation.</font> </div><br/><div style="TEXT-ALIGN: justify; TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">In May 2014, FASB issued ASU 2014-09, &#8220;Revenue from Contracts with Customers.&#8221; This standard applies to any entity that uses the guidance of GAAP for entering into contracts with customers to transfer goods or services or enters into contracts for the transfer of nonfinancial assets unless those contracts are within the scope of other standards. It requires that an entity should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration the entity expects to receive for the exchange of goods or services. This amendment is effective for interim and annual reporting periods beginning after December 15, 2016. The Company is still evaluating the potential impact on the Company&#8217;s results of operations.</font> </div><br/><div style="TEXT-ALIGN: justify; TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">In June 2014, FASB issued ASU 2014-11, &#8220;Transfers and Servicing: Repurchase-to-Maturity Transactions, Repurchase Financings, and Disclosures.&#8221; This standard aligns the accounting for repurchases-to-maturity transactions and repurchase agreements executed as a repurchase financing with accounting for other typical repurchase agreements. These types of transactions will now be accounted for as secured borrowings. It eliminates sales accounting for repurchase-to-maturity and supersedes guidance for accounting transactions involving transfers of financial assets with contemporaneous repurchase financing agreements that leads to off-balance accounting. This update becomes effective for interim and annual reporting periods beginning after December 15, 2014 and is not expected to have a material impact on the Company&#8217;s results of operations.</font> </div><br/><div style="TEXT-ALIGN: justify; TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">In August 2014, FASB issued ASU 2014-15, &#8220;Presentation of Financial Statements-Going Concern.&#160;&#160;Disclosure of Uncertainties about Entity&#8217;s Ability to Continue as a Going Concern.&#8221; Currently, GAAP lacks guidance about management&#8217;s responsibility to evaluate whether there is substantial doubt about an entity&#8217;s ability to continue as a going concern. This amendment now provides guidance by providing a definition of substantial doubt, requires evaluation by management every reporting period for going concern issues, provides principles for considering any mitigating effects implemented by management, and the disclosures required for the assessment period of one year after issuance of the financial statements. This update becomes effective for interim and annual reporting periods beginning after December 15, 2016 with early application being permitted. The update will be adopted for reporting periods starting January 2015, and is not expected to have a material impact on the Company&#8217;s results of operations.</font></div> <table cellpadding="0" cellspacing="0" width="60%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="85%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Factory equipment and fixtures (years)</font> </div> </td> <td valign="bottom" width="6%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">5</font> </td> <td valign="bottom" width="3%" style="TEXT-ALIGN: center"> <div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font> </div> </td> <td align="left" valign="bottom" width="6%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">7</font> </td> </tr> <tr> <td align="left" valign="bottom" width="85%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Building&#160; (years)</font> </div> </td> <td align="left" valign="bottom" width="6%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="3%" style="TEXT-ALIGN: center"> <div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">40</font> </div> </td> <td align="left" valign="bottom" width="6%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="85%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Building improvements&#160;</font> </div> </td> <td align="left" valign="bottom" width="6%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="3%" style="TEXT-ALIGN: center"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Lesser of useful</font> </div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">life or 20 years</font> </div> </td> <td align="left" valign="bottom" width="6%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="85%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Waste disposal system&#160; (years)</font> </div> </td> <td align="left" valign="bottom" width="6%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="3%" style="TEXT-ALIGN: center"> <div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">7</font> </div> </td> <td align="left" valign="bottom" width="6%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> </table> P5Y P7Y P40Y P20Y P7Y <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 12pt; FONT-WEIGHT: bold">NOTE B - MARKETABLE SECURITIES</font> </div><br/><div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The fair values of the Company&#8217;s marketable securities are determined in accordance with GAAP, with fair value being defined as the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants. As such, fair value is a market-based measurement that should be determined based on assumptions that market participants would use in pricing an asset or liability. As a basis for considering such assumptions, the Company utilizes the three-tier value hierarchy, as prescribed by GAAP, which prioritizes the inputs used in measuring fair value as follows:</font> </div><br/><table cellpadding="0" cellspacing="0" id="list-5" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> <tr valign="top"> <td style="WIDTH: 27pt"> &#160; </td> <td style="TEXT-ALIGN: center; WIDTH: 27pt"> <div style="TEXT-ALIGN: center"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#8226;</font> </div> </td> <td> <div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Level 1 - inputs to the valuation methodology are quoted prices (unadjusted) for identical assets or liabilities in active markets.</font> </div> </td> </tr> </table><br/><table cellpadding="0" cellspacing="0" id="list-6" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> <tr valign="top"> <td style="WIDTH: 27pt"> &#160; </td> <td style="TEXT-ALIGN: center; WIDTH: 27pt"> <div style="TEXT-ALIGN: center"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#8226;</font> </div> </td> <td> <div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Level 2 - inputs to the valuation methodology include quoted prices for similar assets and liabilities in active markets, and inputs that are observable for the asset or liability, either directly or indirectly, for substantially the full term of the financial instrument.</font> </div> </td> </tr> </table><br/><table cellpadding="0" cellspacing="0" id="list-7" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> <tr valign="top"> <td style="WIDTH: 27pt"> &#160; </td> <td style="TEXT-ALIGN: center; WIDTH: 27pt"> <div style="TEXT-ALIGN: center"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#8226;</font> </div> </td> <td> <div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Level 3 &#8211; inputs to the valuation methodology are unobservable and significant to the fair value measurement.</font> </div> </td> </tr> </table><br/><div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The following available-for-sale securities, which comprise all of the Company's marketable securities, are re-measured to fair value on a recurring basis and are valued using Level 1 inputs using quoted prices (unadjusted) for identical assets in active markets:</font> </div><br/><table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> <tr> <td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline"><font style="TEXT-DECORATION: underline">December 31, 2014</font></font></font> </div> </td> <td valign="bottom" style="TEXT-ALIGN: center; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: center"> <div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">Cost</font></font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" style="TEXT-ALIGN: center; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: center"> <div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">Fair Value</font></font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" style="TEXT-ALIGN: center; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: center"> <div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Unrealized</font> </div> <div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">Gain/(Loss)</font></font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom"> &#160; </td> <td align="right" valign="bottom"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" colspan="2" nowrap="nowrap" valign="bottom"> &#160; </td> <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" colspan="2" nowrap="nowrap" valign="bottom"> &#160; </td> <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" colspan="2" nowrap="nowrap" valign="bottom"> &#160; </td> <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Available for sale:</font> </div> </td> <td align="right" valign="bottom"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" colspan="2" nowrap="nowrap" valign="bottom"> &#160; </td> <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" colspan="2" nowrap="nowrap" valign="bottom"> &#160; </td> <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" colspan="2" nowrap="nowrap" valign="bottom"> &#160; </td> <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="70%" style="PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Fixed income mutual funds</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">8,373,674</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">8,575,285</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">201,611</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="70%" style="PADDING-BOTTOM: 2px; PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Equity and other mutual funds</font> </div> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">622,086</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">814,216</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">192,130</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="70%" style="PADDING-BOTTOM: 4px"> &#160; </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">8,995,760</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">9,389,501</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">393,741</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td valign="bottom" width="70%"> &#160; </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="70%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-DECORATION: underline"><font style="DISPLAY: inline">December 31, 2013</font></font> </div> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="70%"> &#160; </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="70%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Available for sale:</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="70%" style="PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Corporate bonds (maturing within 1 year)</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">203,920</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">200,053</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(3,867</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> </tr> <tr> <td align="left" valign="bottom" width="70%" style="PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Fixed income mutual funds</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">7,325,930</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">7,425,687</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">99,757</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="70%" style="PADDING-BOTTOM: 2px; PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Equity and other mutual funds</font> </div> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">1,131,147</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">1,237,465</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">106,318</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="70%" style="PADDING-BOTTOM: 4px"> &#160; </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">8,660,997</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">8,863,205</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">202,208</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> </table><br/><div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Proceeds from the sale and redemption of marketable securities amounted to $3,077,588 and $4,139,018 for the years ended December 31, 2014 and 2013, respectively. Losses of $25,127 and gains of $18,675 were realized for the years ended December 31, 2014 and 2013, respectively.</font> </div><br/><div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Investment income consisted principally of unrealized and realized gains and losses, interest income from bonds and money market funds, and dividend income from bond funds and mutual funds.</font> </div><br/> <table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> <tr> <td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline"><font style="TEXT-DECORATION: underline">December 31, 2014</font></font></font> </div> </td> <td valign="bottom" style="TEXT-ALIGN: center; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: center"> <div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">Cost</font></font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" style="TEXT-ALIGN: center; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: center"> <div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">Fair Value</font></font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" style="TEXT-ALIGN: center; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: center"> <div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Unrealized</font> </div> <div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">Gain/(Loss)</font></font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom"> &#160; </td> <td align="right" valign="bottom"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" colspan="2" nowrap="nowrap" valign="bottom"> &#160; </td> <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" colspan="2" nowrap="nowrap" valign="bottom"> &#160; </td> <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" colspan="2" nowrap="nowrap" valign="bottom"> &#160; </td> <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Available for sale:</font> </div> </td> <td align="right" valign="bottom"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" colspan="2" nowrap="nowrap" valign="bottom"> &#160; </td> <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" colspan="2" nowrap="nowrap" valign="bottom"> &#160; </td> <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" colspan="2" nowrap="nowrap" valign="bottom"> &#160; </td> <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="70%" style="PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Fixed income mutual funds</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">8,373,674</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">8,575,285</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">201,611</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="70%" style="PADDING-BOTTOM: 2px; PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Equity and other mutual funds</font> </div> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">622,086</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">814,216</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">192,130</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="70%" style="PADDING-BOTTOM: 4px"> &#160; </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">8,995,760</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">9,389,501</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">393,741</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td valign="bottom" width="70%"> &#160; </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="70%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-DECORATION: underline"><font style="DISPLAY: inline">December 31, 2013</font></font> </div> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="70%"> &#160; </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="70%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Available for sale:</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="70%" style="PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Corporate bonds (maturing within 1 year)</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">203,920</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">200,053</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(3,867</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> </tr> <tr> <td align="left" valign="bottom" width="70%" style="PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Fixed income mutual funds</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">7,325,930</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">7,425,687</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">99,757</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="70%" style="PADDING-BOTTOM: 2px; PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Equity and other mutual funds</font> </div> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">1,131,147</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">1,237,465</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">106,318</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="70%" style="PADDING-BOTTOM: 4px"> &#160; </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">8,660,997</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">8,863,205</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">202,208</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> </table> 8373674 8575285 201611 622086 814216 192130 8995760 393741 203920 200053 -3867 7325930 7425687 99757 1131147 1237465 106318 8660997 202208 <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 12pt; FONT-WEIGHT: bold">NOTE C &#8211; INVENTORIES&#160;</font> </div><br/><div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt">Inventories consist of the following</font>:</font> </div><br/><table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> <tr> <td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"> &#160; </td> <td valign="bottom" style="TEXT-ALIGN: center; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="6" nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: center"> <div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">December 31,</font></font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"> &#160; </td> <td valign="bottom" style="TEXT-ALIGN: center; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: center"> <div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">2014</font></font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" style="TEXT-ALIGN: center; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: center"> <div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">2013</font></font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td valign="bottom"> &#160; </td> <td valign="bottom"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" nowrap="nowrap" valign="bottom"> &#160; </td> <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" nowrap="nowrap" valign="bottom"> &#160; </td> <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="80%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Raw materials and work-in-process</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">395,092</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">488,757</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="80%" style="PADDING-BOTTOM: 2px"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Finished products</font> </div> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">842,062</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">1,121,990</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="80%" style="PADDING-BOTTOM: 4px"> &#160; </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,237,154</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,610,747</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> </table><br/><div style="TEXT-ALIGN: justify; TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Finished product inventories at December 31, 2014 and 2013 are stated net of a reserve of $20,000 for slow moving and obsolete items.</font> </div><br/> 20000 20000 <table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> <tr> <td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"> &#160; </td> <td valign="bottom" style="TEXT-ALIGN: center; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="6" nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: center"> <div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">December 31,</font></font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"> &#160; </td> <td valign="bottom" style="TEXT-ALIGN: center; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: center"> <div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">2014</font></font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" style="TEXT-ALIGN: center; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: center"> <div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">2013</font></font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td valign="bottom"> &#160; </td> <td valign="bottom"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" nowrap="nowrap" valign="bottom"> &#160; </td> <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" nowrap="nowrap" valign="bottom"> &#160; </td> <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="80%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Raw materials and work-in-process</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">395,092</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">488,757</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="80%" style="PADDING-BOTTOM: 2px"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Finished products</font> </div> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">842,062</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">1,121,990</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="80%" style="PADDING-BOTTOM: 4px"> &#160; </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,237,154</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,610,747</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> </table> 395092 488757 842062 1121990 <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 12pt; FONT-WEIGHT: bold">NOTE D &#8211; INCOME TAXES</font> </div><br/><div style="TEXT-ALIGN: justify; TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The provision for income taxes consists of the following:</font> </div><br/><table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> <tr> <td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"> &#160; </td> <td valign="bottom" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="6" nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">Years ended December 31,</font></font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" style="TEXT-ALIGN: center; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: center"> <div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">2014</font></font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" style="TEXT-ALIGN: center; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: center"> <div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">2013</font></font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" style="PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Current</font></font> </div> </td> <td align="right" valign="bottom"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" colspan="2" nowrap="nowrap" valign="bottom"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" colspan="2" nowrap="nowrap" valign="bottom"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="80%" style="PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Federal</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,714,387</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2,721,068</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="80%" style="PADDING-BOTTOM: 2px; PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">State</font> </div> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(9,579</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">19,646</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="80%" style="PADDING-BOTTOM: 2px"> &#160; </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">1,704,808</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">2,740,714</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="80%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Deferred</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="80%" style="PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Federal</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(4,003</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(11,810</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="80%" style="PADDING-BOTTOM: 2px; PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">State</font> </div> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">3,749</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(351</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> </tr> <tr> <td valign="bottom" width="80%" style="PADDING-BOTTOM: 2px"> &#160; </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(254</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(12,161</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="80%" style="PADDING-BOTTOM: 4px; PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 36pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Total provision for income taxes</font> </div> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,704,554</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2,728,553</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> </table><br/><div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt">The following is a reconciliation of the Company&#8217;s effective income tax rate to the Federal statutory rate (dollar amounts have been rounded to the nearest thousand):</font><font id="TAB2" style="LETTER-SPACING: 3pt; COLOR: black">&#160;</font><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman">&#160;</font></font> </div><br/><table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> <tr> <td align="left" valign="bottom" width="59%" style="PADDING-BOTTOM: 2px"> &#160; </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: center; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="14" nowrap="nowrap" valign="bottom" width="39%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: center"> <div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">Years ended December 31,</font></font> </div> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="59%" style="PADDING-BOTTOM: 2px"> &#160; </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: center; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="6" nowrap="nowrap" valign="bottom" width="18%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: center"> <div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">2014</font></font> </div> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="2%" style="TEXT-ALIGN: center; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="6" nowrap="nowrap" valign="bottom" width="18%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: center"> <div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">2013</font></font> </div> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="59%" style="PADDING-BOTTOM: 2px"> &#160; </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: center; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" nowrap="nowrap" valign="bottom" width="8%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: center"> <div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">($)</font></font> </div> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" nowrap="nowrap" valign="bottom" width="8%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: center"> <div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">Tax rate</font></font> </div> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="2%" style="TEXT-ALIGN: center; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" nowrap="nowrap" valign="bottom" width="8%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: center"> <div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">($)</font></font> </div> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: center; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" nowrap="nowrap" valign="bottom" width="8%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: center"> <div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">Tax rate</font></font> </div> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="59%"> <div style="TEXT-INDENT: -18pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Income taxes at statutory federal income tax</font> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">rate of 34%</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,957,000</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">34.0</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">%</font> </td> <td align="right" valign="bottom" width="2%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2,935,000</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">34.0</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">%</font> </td> </tr> <tr> <td align="left" valign="bottom" width="59%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">State income taxes, net of Federal benefit</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(4,000</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(0.1</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="2%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">13,000</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.2</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="59%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Domestic Production Activities tax benefit</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(168,000</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(2.9</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="2%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(180,000</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(2.1</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> </tr> <tr> <td align="left" valign="bottom" width="59%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Nondeductible expenses</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,000</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">---</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="2%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,000</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">---</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="59%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Prior year over-accrual</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(56,000</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(1.0</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="2%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(19,000</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(0.2</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> </tr> <tr> <td align="left" valign="bottom" width="59%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">R&amp;D credits</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(25,000</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(0.4</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="2%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(20,000</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(0.2</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="59%" style="PADDING-BOTTOM: 2px"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Other, misc.</font> </div> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">---</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">---</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="2%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(1,000</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">---</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="59%" style="PADDING-BOTTOM: 4px"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Actual income tax expense</font> </div> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">1,705,000</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">29.6</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">%</font> </td> <td align="right" valign="bottom" width="2%" style="PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">2,729,000</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">31.7</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">%</font> </td> </tr> </table><br/><div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">During 2014 and 2013, the Company realized the tax benefits of the Domestic Production Activities deduction, which amounted to approximately 9% of net income from domestic production activities in each year.</font> </div><br/><div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The tax effects of temporary differences which comprise the deferred tax assets and liabilities are as follows:</font> </div><br/><table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> <tr> <td valign="bottom" style="PADDING-BOTTOM: 2px"> &#160; </td> <td valign="bottom" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="6" nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">Years ended December 31,</font></font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"> &#160; </td> <td valign="bottom" style="TEXT-ALIGN: center; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: center"> <div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">2014</font></font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" style="TEXT-ALIGN: center; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: center"> <div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">2013</font></font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Deferred tax assets</font> </div> </td> <td align="left" valign="bottom"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="left" colspan="2" nowrap="nowrap" valign="bottom"> &#160; </td> <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="left" valign="bottom"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="left" colspan="2" nowrap="nowrap" valign="bottom"> &#160; </td> <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" style="PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-DECORATION: underline"><font style="DISPLAY: inline">Current</font></font> </div> </td> <td align="left" valign="bottom"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="left" colspan="2" nowrap="nowrap" valign="bottom"> &#160; </td> <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="left" valign="bottom"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="left" colspan="2" nowrap="nowrap" valign="bottom"> &#160; </td> <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="80%" style="PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 36pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Accounts receivable</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">10,164</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">6,089</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="80%" style="PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 36pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Inventories</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">14,037</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">16,862</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="80%" style="PADDING-BOTTOM: 2px; PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 36pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Accrued expenses</font> </div> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">199,238</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">206,500</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="80%" style="PADDING-BOTTOM: 2px"> &#160; </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">223,439</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">229,451</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="80%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Deferred tax liabilities</font> </div> </td> <td align="left" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="left" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="80%" style="PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-DECORATION: underline"><font style="DISPLAY: inline">Non-current</font></font> </div> </td> <td align="left" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="left" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="80%" style="PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 36pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Depreciation</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(93,236</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(99,502</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> </tr> <tr> <td align="left" valign="bottom" width="80%" style="PADDING-BOTTOM: 2px; PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 36pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Unrealized gain on marketable securities</font> </div> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(133,872</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(70,085</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td valign="bottom" width="80%" style="PADDING-BOTTOM: 2px"> &#160; </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(227,108</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(169,587</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> </tr> <tr> <td align="left" valign="bottom" width="80%" style="PADDING-BOTTOM: 4px; PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 54pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Net deferred tax (liability) asset</font> </div> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(3,669</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">59,864</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> </table><br/> 0.09 0.09 <table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> <tr> <td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"> &#160; </td> <td valign="bottom" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="6" nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">Years ended December 31,</font></font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" style="TEXT-ALIGN: center; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: center"> <div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">2014</font></font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" style="TEXT-ALIGN: center; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: center"> <div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">2013</font></font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" style="PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Current</font></font> </div> </td> <td align="right" valign="bottom"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" colspan="2" nowrap="nowrap" valign="bottom"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" colspan="2" nowrap="nowrap" valign="bottom"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="80%" style="PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Federal</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,714,387</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2,721,068</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="80%" style="PADDING-BOTTOM: 2px; PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">State</font> </div> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(9,579</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">19,646</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="80%" style="PADDING-BOTTOM: 2px"> &#160; </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">1,704,808</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">2,740,714</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="80%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Deferred</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="80%" style="PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Federal</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(4,003</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(11,810</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="80%" style="PADDING-BOTTOM: 2px; PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">State</font> </div> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">3,749</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(351</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> </tr> <tr> <td valign="bottom" width="80%" style="PADDING-BOTTOM: 2px"> &#160; </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(254</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(12,161</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="80%" style="PADDING-BOTTOM: 4px; PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 36pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Total provision for income taxes</font> </div> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,704,554</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2,728,553</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> </table> 1714387 2721068 -9579 19646 1704808 2740714 -4003 -11810 3749 -351 <table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> <tr> <td align="left" valign="bottom" width="59%" style="PADDING-BOTTOM: 2px"> &#160; </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: center; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="14" nowrap="nowrap" valign="bottom" width="39%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: center"> <div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">Years ended December 31,</font></font> </div> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="59%" style="PADDING-BOTTOM: 2px"> &#160; </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: center; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="6" nowrap="nowrap" valign="bottom" width="18%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: center"> <div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">2014</font></font> </div> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="2%" style="TEXT-ALIGN: center; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="6" nowrap="nowrap" valign="bottom" width="18%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: center"> <div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">2013</font></font> </div> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="59%" style="PADDING-BOTTOM: 2px"> &#160; </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: center; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" nowrap="nowrap" valign="bottom" width="8%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: center"> <div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">($)</font></font> </div> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" nowrap="nowrap" valign="bottom" width="8%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: center"> <div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">Tax rate</font></font> </div> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="2%" style="TEXT-ALIGN: center; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" nowrap="nowrap" valign="bottom" width="8%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: center"> <div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">($)</font></font> </div> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: center; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" nowrap="nowrap" valign="bottom" width="8%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: center"> <div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">Tax rate</font></font> </div> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="59%"> <div style="TEXT-INDENT: -18pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Income taxes at statutory federal income tax</font> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">rate of 34%</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,957,000</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">34.0</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">%</font> </td> <td align="right" valign="bottom" width="2%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2,935,000</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">34.0</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">%</font> </td> </tr> <tr> <td align="left" valign="bottom" width="59%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">State income taxes, net of Federal benefit</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(4,000</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(0.1</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="2%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">13,000</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">0.2</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="59%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Domestic Production Activities tax benefit</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(168,000</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(2.9</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="2%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(180,000</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(2.1</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> </tr> <tr> <td align="left" valign="bottom" width="59%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Nondeductible expenses</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,000</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">---</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="2%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,000</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">---</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="59%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Prior year over-accrual</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(56,000</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(1.0</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="2%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(19,000</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(0.2</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> </tr> <tr> <td align="left" valign="bottom" width="59%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">R&amp;D credits</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(25,000</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(0.4</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="2%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(20,000</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(0.2</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="59%" style="PADDING-BOTTOM: 2px"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Other, misc.</font> </div> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">---</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">---</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="2%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(1,000</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">---</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="59%" style="PADDING-BOTTOM: 4px"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Actual income tax expense</font> </div> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">1,705,000</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">29.6</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">%</font> </td> <td align="right" valign="bottom" width="2%" style="PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">2,729,000</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">31.7</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">%</font> </td> </tr> </table> 1957000 0.340 2935000 0.340 -4000 -0.001 13000 0.002 168000 -0.029 180000 -0.021 1000 1000 -56000 -0.010 -19000 -0.002 -25000 -0.004 -20000 -0.002 -1000 1705000 0.296 2729000 0.317 <table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> <tr> <td valign="bottom" style="PADDING-BOTTOM: 2px"> &#160; </td> <td valign="bottom" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="6" nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">Years ended December 31,</font></font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"> &#160; </td> <td valign="bottom" style="TEXT-ALIGN: center; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: center"> <div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">2014</font></font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" style="TEXT-ALIGN: center; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: center"> <div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">2013</font></font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Deferred tax assets</font> </div> </td> <td align="left" valign="bottom"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="left" colspan="2" nowrap="nowrap" valign="bottom"> &#160; </td> <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="left" valign="bottom"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="left" colspan="2" nowrap="nowrap" valign="bottom"> &#160; </td> <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" style="PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-DECORATION: underline"><font style="DISPLAY: inline">Current</font></font> </div> </td> <td align="left" valign="bottom"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="left" colspan="2" nowrap="nowrap" valign="bottom"> &#160; </td> <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="left" valign="bottom"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="left" colspan="2" nowrap="nowrap" valign="bottom"> &#160; </td> <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="80%" style="PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 36pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Accounts receivable</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">10,164</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">6,089</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="80%" style="PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 36pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Inventories</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">14,037</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">16,862</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="80%" style="PADDING-BOTTOM: 2px; PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 36pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Accrued expenses</font> </div> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">199,238</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">206,500</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="80%" style="PADDING-BOTTOM: 2px"> &#160; </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">223,439</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">229,451</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="80%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Deferred tax liabilities</font> </div> </td> <td align="left" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="left" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="80%" style="PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-DECORATION: underline"><font style="DISPLAY: inline">Non-current</font></font> </div> </td> <td align="left" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="left" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="80%" style="PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 36pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Depreciation</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(93,236</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(99,502</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> </tr> <tr> <td align="left" valign="bottom" width="80%" style="PADDING-BOTTOM: 2px; PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 36pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Unrealized gain on marketable securities</font> </div> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(133,872</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(70,085</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td valign="bottom" width="80%" style="PADDING-BOTTOM: 2px"> &#160; </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(227,108</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(169,587</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> </tr> <tr> <td align="left" valign="bottom" width="80%" style="PADDING-BOTTOM: 4px; PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 54pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Net deferred tax (liability) asset</font> </div> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(3,669</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">59,864</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> </table> 10164 6089 14037 16862 199238 206500 223439 229451 93236 99502 133872 70085 227108 169587 -3669 59864 <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 12pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 12pt">NOTE E - BENEFIT PLANS</font></font> </div><br/><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; TEXT-DECORATION: underline">Defined Contribution Plan</font></font> </div><br/><div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The Company sponsors a 401(k) defined contribution plan ("DC Plan") that provides for a dollar-for-dollar employer matching contribution of the first 4% of each employee's pay. Employees become fully vested in employer matching contributions after one year of employment. Company 401(k) matching contributions were approximately $103,000 and $101,000 for each of the years ended December 31, 2014 and 2013.&#160;&#160;In 2014 and 2013 employees were able to defer up to $17,500 for each year respectively (plus $5,500 for employees over the age of 50) of their yearly pay as a pre-tax investment in the 401(k)plan, in accordance with limits set by the IRS. (Those limits have been increased to $18,000 (plus an additional $6,000 for employees over the age of 50) for the year 2015)<font style="DISPLAY: inline; FONT-FAMILY: Times New Roman">.</font></font> </div><br/><div style="TEXT-ALIGN: justify; TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The Company also makes discretionary contributions to each employee's account based on a "pay-to-pay" safe-harbor formula that qualifies the 401(k) plan under current IRS regulations. In December 2014 and 2013 the Company&#8217;s Board of Directors authorized discretionary contributions in the amount of $175,000 per year, to be allocated among all eligible employees<font style="DISPLAY: inline; FONT-FAMILY: Times New Roman">,</font> for the 2014 and 2013 plan years. The 2014 contribution was paid in 2014, and the 2013 contribution was paid in 2013. Employees become vested in the discretionary contributions as follows: 20% after two years of employment, and 20% for each year of employment thereafter until the employee becomes fully vested after six years of employment.</font> </div><br/><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; TEXT-DECORATION: underline">Stock Option Plans</font></font> </div><br/><div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">In March 2004 the Board of Directors of the Company approved the adoption of the 2004 Stock Option Plan, which authorized the granting of stock options to both employees and Directors. The plan was ratified by the shareholders on May 19, 2004. No options were ever granted under the plan, and it expired in March 2014.</font> </div><br/> 0.04 0.04 P1Y P1Y 103000 101000 17500 17500 5500 5500 18000 6000 175000 175000 0.20 P2Y 0.20 6 <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 12pt; FONT-WEIGHT: bold">NOTE&#160;&#160;F -&#160;&#160;GEOGRAPHIC and OTHER INFORMATION</font> </div><br/><div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Through its Guardian Laboratories division the Company manufactures and markets cosmetic ingredients, personal care products, pharmaceuticals, medical lubricants, health care products, and specialty industrial products.&#160;&#160;It also conducts research and development, primarily related to the development of new and unique cosmetic and personal care products. The Company&#8217;s R&amp;D department not only develops new products but also modifies and refines existing products, with the goal of expanding the potential markets for the Company&#8217;s products. Many of the cosmetic ingredient products manufactured by Guardian, particularly its LUBRAJEL line of water-based moisturizing and lubricating gels, are currently used by many of the major multinational personal care products companies.</font> </div><br/><div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The Company operates in one business segment. The Company&#8217;s products are separated into four distinct product categories: personal care products (including cosmetic ingredients), pharmaceuticals, medical products, and industrial products. Each product category is marketed differently. The cosmetic ingredient/personal care products are marketed through a global network of marketing partners and distributors.&#160;&#160;These marketing partners purchase product outright from the Company and market and re-sell those products to the end users.&#160;&#160;The Company does not make any sales on consignment.</font> </div><br/><div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">No prior regulatory approval was needed by the Company to sell any products other than its pharmaceutical products.&#160;&#160;The end users of its products may or may not need regulatory approvals, depending on the intended claims and uses of those products.</font> </div><br/><div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The pharmaceutical products are two urological products that are sold to end users primarily through distribution agreements with the major drug wholesalers. For these products, the Company does the marketing, and the drug wholesalers supply the product to the end users, such as hospitals and pharmacies. These products are drug products that required the Company to obtain regulatory approval before marketing.</font> </div><br/><div style="TEXT-ALIGN: justify; TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The medical products are not pharmaceutical products. They consist primarily of medical lubricants, which are marketed by the Company directly to manufacturers that incorporate them into urologic catheters and other medical devices and products that they sell. These products are distinguished from the pharmaceutical products in that, unlike the pharmaceutical products, the Company is not required to obtain regulatory approval prior to marketing these products. Approvals are the responsibility of the company that markets the medical device.&#160;&#160;However, the Company is responsible for manufacturing these products in accordance with current Good Manufacturing Practices for medical devices.</font> </div><br/><div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The industrial products are also marketed by the Company directly to manufacturers, and generally do not require that the Company obtain regulatory approval. However, the manufacturers of the finished products may have to obtain such regulatory approvals before marketing these products.</font> </div><br/><div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The geographic information set forth in table "(b)" below is partially based on sales information provided to the Company by Customer A (shown in table "(c)" below), which exclusively markets the Company's cosmetic ingredients in Canada and China, and also sells some of the Company's products into France on a non-exclusive basis along with Customer B.</font> </div><br/><table cellpadding="0" cellspacing="0" id="list-8" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> <tr valign="top"> <td style="TEXT-ALIGN: left; WIDTH: 36pt"> <div style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">(a)&#160;&#160;</font> </div> </td> <td> <div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; TEXT-DECORATION: underline">Net Sales</font></font> </div> </td> </tr> </table><br/><table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> <tr> <td valign="bottom" style="PADDING-BOTTOM: 2px"> &#160; </td> <td valign="bottom" style="TEXT-ALIGN: center; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="6" nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: center"> <div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">Years ended December 31,</font></font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td valign="bottom" style="PADDING-BOTTOM: 2px"> &#160; </td> <td valign="bottom" style="TEXT-ALIGN: center; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: center"> <div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">2014</font></font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" style="TEXT-ALIGN: center; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: center"> <div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 45pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">2013</font></font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td valign="bottom"> &#160; </td> <td valign="bottom"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" nowrap="nowrap" valign="bottom"> &#160; </td> <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" nowrap="nowrap" valign="bottom"> &#160; </td> <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="80%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Personal Care</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">9,421,041</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">11,459,482</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="80%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Medical</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2,494,205</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3,028,659</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="80%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Pharmaceutical</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,686,563</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">916,927</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="80%" style="PADDING-BOTTOM: 2px"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Industrial and other</font> </div> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">169,486</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">164,014</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td valign="bottom" width="80%"> &#160; </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">13,771,295</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">15,569,082</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="80%" style="PADDING-BOTTOM: 2px"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Less: Discounts and allowances</font> </div> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(321,616</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(152,189</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td valign="bottom" width="80%" style="PADDING-BOTTOM: 4px"> &#160; </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">13,449,679</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">15,416,893</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> </table><br/><table cellpadding="0" cellspacing="0" id="list-9" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> <tr valign="top"> <td style="TEXT-ALIGN: left; WIDTH: 36pt"> <div style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">(b)</font> </div> </td> <td> <div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; TEXT-DECORATION: underline">Geographic Information</font></font> </div> </td> </tr> </table><br/><table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> <tr> <td valign="bottom" width="59%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: center; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="14" nowrap="nowrap" valign="bottom" width="39%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: center"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">Years ended December 31</font>,</font></font> </div> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td valign="bottom" width="59%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: center; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="6" nowrap="nowrap" valign="bottom" width="18%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2014</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="2%" style="TEXT-ALIGN: center; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="6" nowrap="nowrap" valign="bottom" width="18%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2013</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td valign="bottom" width="59%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" nowrap="nowrap" valign="bottom" width="8%" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">Revenues</font></font></font> </div> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: center; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" nowrap="nowrap" valign="bottom" width="8%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: center"> <div style="TEXT-ALIGN: center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Long-Lived</font> </div> <div style="TEXT-ALIGN: center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">Assets</font></font></font> </div> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="2%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" nowrap="nowrap" valign="bottom" width="8%" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">Revenues</font></font></font> </div> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" nowrap="nowrap" valign="bottom" width="8%" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Long-Lived</font></font> </div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">Assets</font></font></font> </div> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td valign="bottom" width="59%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" nowrap="nowrap" valign="bottom" width="8%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" nowrap="nowrap" valign="bottom" width="8%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="2%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" nowrap="nowrap" valign="bottom" width="8%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" nowrap="nowrap" valign="bottom" width="8%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="59%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">United States&#160;</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">4,723,779</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,207,903</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="2%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">4,580,429</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,334,501</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="59%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">China</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3,500,955</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">---</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="2%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3,519,450</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">---</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="59%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Canada</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2,436,596</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">---</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="2%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3,390,619</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">---</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="59%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">United Kingdom</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">703,142</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">---</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="2%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">846,730</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">---</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="59%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">India</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">615,890</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="2%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">431,015</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="59%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">France&#160;</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">582,478</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">---</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="2%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">856,285</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">---</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="59%" style="PADDING-BOTTOM: 2px"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Other countries&#160;</font> </div> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">886,839</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">---</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="2%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">1,792,365</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">---</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="59%" style="PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">13,449,679</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">1,207,903</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="2%" style="PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">15,416,893</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">1,334,501</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> </table><br/><table cellpadding="0" cellspacing="0" id="list-10" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> <tr valign="top"> <td style="TEXT-ALIGN: left; WIDTH: 36pt"> <div style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">(c)</font> </div> </td> <td> <div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; TEXT-DECORATION: underline">Sales to Major Customers</font></font> </div> </td> </tr> </table><br/><table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> <tr> <td valign="bottom" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" style="TEXT-ALIGN: center; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="6" nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Years ended December 31,</font> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td valign="bottom" style="PADDING-BOTTOM: 2px"> &#160; </td> <td valign="bottom" style="TEXT-ALIGN: center; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: center"> <div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">2014</font></font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" style="TEXT-ALIGN: center; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: center"> <div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">2013</font></font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td valign="bottom"> &#160; </td> <td valign="bottom"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" nowrap="nowrap" valign="bottom"> &#160; </td> <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" nowrap="nowrap" valign="bottom"> &#160; </td> <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td valign="bottom" width="80%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Customer A</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">7,929,208</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">9,712,382</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td valign="bottom" width="80%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Customer B</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">582,478</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">856,285</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td valign="bottom" width="80%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Customer C</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">615,890</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">431,015</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td valign="bottom" width="80%" style="PADDING-BOTTOM: 2px"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">All other customers</font> </div> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">4,322,103</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">4,417,211</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td valign="bottom" width="80%" style="PADDING-BOTTOM: 4px"> &#160; </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">13,449,679</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">15,416,893</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> </table><br/><div style="TEXT-ALIGN: justify; TEXT-INDENT: 45pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Customer A had one customer that comprised 32% of Customer A&#8217;s sales of the Company&#8217;s products in 2014, and 36% of its sales in 2013.</font> </div><br/> 1 1 0.32 0.36 <table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> <tr> <td valign="bottom" style="PADDING-BOTTOM: 2px"> &#160; </td> <td valign="bottom" style="TEXT-ALIGN: center; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="6" nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: center"> <div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">Years ended December 31,</font></font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td valign="bottom" style="PADDING-BOTTOM: 2px"> &#160; </td> <td valign="bottom" style="TEXT-ALIGN: center; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: center"> <div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">2014</font></font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" style="TEXT-ALIGN: center; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: center"> <div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 45pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">2013</font></font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td valign="bottom"> &#160; </td> <td valign="bottom"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" nowrap="nowrap" valign="bottom"> &#160; </td> <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" nowrap="nowrap" valign="bottom"> &#160; </td> <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="80%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Personal Care</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">9,421,041</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">11,459,482</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="80%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Medical</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2,494,205</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3,028,659</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="80%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Pharmaceutical</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,686,563</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">916,927</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="80%" style="PADDING-BOTTOM: 2px"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Industrial and other</font> </div> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">169,486</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">164,014</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td valign="bottom" width="80%"> &#160; </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">13,771,295</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">15,569,082</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="80%" style="PADDING-BOTTOM: 2px"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Less: Discounts and allowances</font> </div> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(321,616</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(152,189</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td valign="bottom" width="80%" style="PADDING-BOTTOM: 4px"> &#160; </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">13,449,679</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">15,416,893</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> </table> 9421041 11459482 2494205 3028659 1686563 916927 169486 164014 13771295 15569082 321616 152189 <table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> <tr> <td valign="bottom" width="59%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: center; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="14" nowrap="nowrap" valign="bottom" width="39%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: center"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">Years ended December 31</font>,</font></font> </div> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td valign="bottom" width="59%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: center; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="6" nowrap="nowrap" valign="bottom" width="18%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2014</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="2%" style="TEXT-ALIGN: center; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="6" nowrap="nowrap" valign="bottom" width="18%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2013</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td valign="bottom" width="59%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" nowrap="nowrap" valign="bottom" width="8%" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">Revenues</font></font></font> </div> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: center; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" nowrap="nowrap" valign="bottom" width="8%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: center"> <div style="TEXT-ALIGN: center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Long-Lived</font> </div> <div style="TEXT-ALIGN: center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">Assets</font></font></font> </div> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="2%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" nowrap="nowrap" valign="bottom" width="8%" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">Revenues</font></font></font> </div> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" nowrap="nowrap" valign="bottom" width="8%" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Long-Lived</font></font> </div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">Assets</font></font></font> </div> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td valign="bottom" width="59%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" nowrap="nowrap" valign="bottom" width="8%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" nowrap="nowrap" valign="bottom" width="8%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="2%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" nowrap="nowrap" valign="bottom" width="8%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" nowrap="nowrap" valign="bottom" width="8%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="59%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">United States&#160;</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">4,723,779</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,207,903</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="2%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">4,580,429</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,334,501</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="59%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">China</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3,500,955</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">---</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="2%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3,519,450</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">---</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="59%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Canada</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2,436,596</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">---</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="2%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3,390,619</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">---</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="59%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">United Kingdom</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">703,142</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">---</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="2%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">846,730</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">---</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="59%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">India</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">615,890</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="2%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">431,015</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="59%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">France&#160;</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">582,478</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">---</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="2%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">856,285</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">---</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="59%" style="PADDING-BOTTOM: 2px"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Other countries&#160;</font> </div> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">886,839</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">---</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="2%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">1,792,365</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">---</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="59%" style="PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">13,449,679</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">1,207,903</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="2%" style="PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">15,416,893</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">1,334,501</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> </table> 4723779 1207903 4580429 1334501 3500955 3519450 2436596 3390619 703142 846730 615890 431015 582478 856285 886839 1792365 <table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> <tr> <td valign="bottom" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" style="TEXT-ALIGN: center; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="6" nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: center"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Years ended December 31,</font> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td valign="bottom" style="PADDING-BOTTOM: 2px"> &#160; </td> <td valign="bottom" style="TEXT-ALIGN: center; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: center"> <div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">2014</font></font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" style="TEXT-ALIGN: center; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: center"> <div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">2013</font></font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td valign="bottom"> &#160; </td> <td valign="bottom"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" nowrap="nowrap" valign="bottom"> &#160; </td> <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" nowrap="nowrap" valign="bottom"> &#160; </td> <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td valign="bottom" width="80%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Customer A</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">7,929,208</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">9,712,382</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td valign="bottom" width="80%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Customer B</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">582,478</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">856,285</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td valign="bottom" width="80%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Customer C</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">615,890</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">431,015</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td valign="bottom" width="80%" style="PADDING-BOTTOM: 2px"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">All other customers</font> </div> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">4,322,103</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">4,417,211</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td valign="bottom" width="80%" style="PADDING-BOTTOM: 4px"> &#160; </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">13,449,679</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">15,416,893</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> </table> 7929208 9712382 582478 856285 615890 431015 4322103 4417211 <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 12pt; FONT-WEIGHT: bold">NOTE G &#8211; COMPREHENSIVE INCOME</font> </div><br/><div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Accumulated other comprehensive income comprises unrealized gains and losses on marketable securities net of the related tax effect.</font> </div><br/><table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> <tr> <td align="left" valign="bottom" width="65%" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Changes in Accumulated Other</font></font> </div> <div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">Comprehensive Income</font></font></font> </div> </td> <td align="right" valign="bottom" width="10%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" colspan="2" nowrap="nowrap" valign="bottom" width="11%" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">December 31, 2014</font></font></font> </div> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" colspan="2" nowrap="nowrap" valign="bottom" width="11%" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">December 31, 2013</font></font></font> </div> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="65%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Beginning balance - net of tax</font> </div> </td> <td align="right" valign="bottom" width="10%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="10%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">132,123</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="10%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">178,979</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td valign="bottom" width="65%" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <div style="TEXT-ALIGN: left; TEXT-INDENT: -18pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Unrealized gain/(loss) on marketable securities before</font> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">reclassifications - net of tax</font> </div> </td> <td align="right" valign="bottom" width="10%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="10%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">152,873</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="10%" style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(65,531</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td valign="bottom" width="65%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <div style="TEXT-ALIGN: left; TEXT-INDENT: -18pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Realized (loss)/gain on sale of securities</font> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">reclassified from accumulated other</font> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">comprehensive income</font> </div> </td> <td align="right" valign="bottom" width="10%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="10%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">(25,127</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="10%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">18,675</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="65%" style="PADDING-BOTTOM: 4px"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Ending balance - net of tax</font> </div> </td> <td align="right" valign="bottom" width="10%" style="PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="10%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">259,869</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="10%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">132,123</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> </table><br/> <table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> <tr> <td align="left" valign="bottom" width="65%" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Changes in Accumulated Other</font></font> </div> <div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">Comprehensive Income</font></font></font> </div> </td> <td align="right" valign="bottom" width="10%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" colspan="2" nowrap="nowrap" valign="bottom" width="11%" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">December 31, 2014</font></font></font> </div> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" colspan="2" nowrap="nowrap" valign="bottom" width="11%" style="BORDER-BOTTOM: black 1.1pt solid"> <div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">December 31, 2013</font></font></font> </div> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="65%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Beginning balance - net of tax</font> </div> </td> <td align="right" valign="bottom" width="10%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="10%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">132,123</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="10%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">178,979</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td valign="bottom" width="65%" style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <div style="TEXT-ALIGN: left; TEXT-INDENT: -18pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Unrealized gain/(loss) on marketable securities before</font> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">reclassifications - net of tax</font> </div> </td> <td align="right" valign="bottom" width="10%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="10%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">152,873</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="10%" style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(65,531</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td valign="bottom" width="65%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <div style="TEXT-ALIGN: left; TEXT-INDENT: -18pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Realized (loss)/gain on sale of securities</font> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">reclassified from accumulated other</font> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">comprehensive income</font> </div> </td> <td align="right" valign="bottom" width="10%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="10%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">(25,127</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="10%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">18,675</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="65%" style="PADDING-BOTTOM: 4px"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Ending balance - net of tax</font> </div> </td> <td align="right" valign="bottom" width="10%" style="PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="10%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">259,869</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="10%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">132,123</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> </table> 132123 178979 152873 -65531 25127 -18675 259869 <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 12pt; FONT-WEIGHT: bold">NOTE H - INCOME FROM DAMAGE SETTLEMENT</font> </div><br/><div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">In May 2012 the supplier of one of the Company&#8217;s pharmaceutical products, RENACIDIN, curtailed production due to manufacturing issues. In January 2013 the Company and its supplier entered into a settlement agreement whereby the supplier agreed to pay the Company $518,050 for the profit the Company lost during 2012 as result of the curtailment, plus $97,610 a month beginning January 1, 2013 for each month that the curtailment continued; $48,805 for each of the first two months after shipments resumed; and a final payment of $24,403 for the third month after shipments resumed. Because deliveries resumed at the end of October 2013, the supplier&#8217;s obligation to pay $97,610 per month ceased as of that date.&#160;&#160;By the end of the first quarter of 2014 all damage payments had been made. As a result, the Company received only $24,403 in damage settlement payments for the year ended December 31, 2014, as compared with $1,070,561 for the year ended December 31, 2013.</font> </div><br/> 518050 97610 48805 24403 24403 1070561 <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 12pt; FONT-WEIGHT: bold">NOTE I - ACCRUED EXPENSES</font> </div><br/><div style="TEXT-ALIGN: justify; TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Accrued expenses at December 31, 2014 and 2013 consist of:</font> </div><br/><table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> <tr> <td valign="bottom" style="PADDING-BOTTOM: 2px"> &#160; </td> <td valign="bottom" style="TEXT-ALIGN: center; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: center"> <div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">2014</font></font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" style="TEXT-ALIGN: center; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: center"> <div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">2013</font></font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td valign="bottom"> &#160; </td> <td valign="bottom"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" nowrap="nowrap" valign="bottom"> &#160; </td> <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" nowrap="nowrap" valign="bottom"> &#160; </td> <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="80%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Bonuses</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">225,000</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">250,000</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="80%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Distribution fees</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">203,483</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">196,558</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="80%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Payroll and related expenses</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">127,585</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">104,394</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="80%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Annual report expenses</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">61,000</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">66,000</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="80%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Audit fee</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">82,000</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">73,269</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="80%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Sales rebates</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">96,000</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">---</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="80%" style="PADDING-BOTTOM: 2px"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Other</font> </div> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">38,791</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">37,794</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td valign="bottom" width="80%" style="PADDING-BOTTOM: 4px"> &#160; </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">833,859</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">728,015</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> </table><br/> <table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"> <tr> <td valign="bottom" style="PADDING-BOTTOM: 2px"> &#160; </td> <td valign="bottom" style="TEXT-ALIGN: center; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: center"> <div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">2014</font></font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" style="TEXT-ALIGN: center; PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: center"> <div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">2013</font></font> </div> </td> <td nowrap="nowrap" valign="bottom" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td valign="bottom"> &#160; </td> <td valign="bottom"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" nowrap="nowrap" valign="bottom"> &#160; </td> <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td colspan="2" nowrap="nowrap" valign="bottom"> &#160; </td> <td nowrap="nowrap" valign="bottom" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="80%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Bonuses</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">225,000</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">250,000</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="80%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Distribution fees</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">203,483</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">196,558</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="80%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Payroll and related expenses</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">127,585</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">104,394</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="80%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Annual report expenses</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">61,000</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">66,000</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="80%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Audit fee</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">82,000</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">73,269</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td align="left" valign="bottom" width="80%"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Sales rebates</font> </div> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">96,000</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">---</font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr style="background-color: #CCEEFF;"> <td align="left" valign="bottom" width="80%" style="PADDING-BOTTOM: 2px"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Other</font> </div> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">38,791</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">37,794</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 1.1pt solid; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> <tr> <td valign="bottom" width="80%" style="PADDING-BOTTOM: 4px"> &#160; </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">833,859</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> <td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font> </td> <td valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">728,015</font></font> </td> <td nowrap="nowrap" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.75pt double; TEXT-ALIGN: left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> </td> </tr> </table> 225000 250000 203483 196558 127585 104394 61000 66000 82000 73269 38791 37794 <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 12pt; FONT-WEIGHT: bold">NOTE J - RELATED PARTY TRANSACTIONS</font> </div><br/><div style="TEXT-ALIGN: justify; TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">During each of the years ended December 31, 2014 and 2013 the Company paid to Bonamassa, Maietta, and Cartelli, LLP, $17,000, and $14,000, respectively, for accounting and tax services. Lawrence Maietta, a partner in Bonamassa, Maietta, and Cartelli, LLP, is a director of the Company.</font> </div><br/> 17000 14000 EX-101.SCH 6 ug-20141231.xsd XBRL TAXONOMY EXTENSION SCHEMA 001 - Statement - Statements of Income link:presentationLink link:definitionLink link:calculationLink 002 - Statement - Statements of Comprehensive Income link:presentationLink link:definitionLink link:calculationLink 003 - Statement - Balance Sheets link:presentationLink link:definitionLink link:calculationLink 004 - Statement - Balance Sheets (Parentheticals) link:presentationLink link:definitionLink link:calculationLink 005 - Statement - Statement Of Stockholders' Equity link:presentationLink link:definitionLink link:calculationLink 006 - Statement - Statement Of Stockholders' Equity (Parentheticals) link:presentationLink link:definitionLink link:calculationLink 007 - Statement - Statements of Cash Flows link:presentationLink link:definitionLink link:calculationLink 008 - Disclosure - Note A - Nature of Business and Summary of Significant Accounting Policies link:presentationLink link:definitionLink link:calculationLink 009 - Disclosure - Note B - Marketable Securities link:presentationLink link:definitionLink link:calculationLink 010 - Disclosure - Note C - Inventories link:presentationLink link:definitionLink link:calculationLink 011 - Disclosure - Note D - Income Taxes link:presentationLink link:definitionLink link:calculationLink 012 - Disclosure - Note E - Benefit Plans link:presentationLink link:definitionLink link:calculationLink 013 - Disclosure - Note F - Geographic and Other Information link:presentationLink link:definitionLink link:calculationLink 014 - Disclosure - Note G - Comprehensive Income link:presentationLink link:definitionLink link:calculationLink 015 - Disclosure - Note H - Income From Damage Settlement link:presentationLink link:definitionLink link:calculationLink 016 - Disclosure - Note I - Accrued Expenses link:presentationLink link:definitionLink link:calculationLink 017 - Disclosure - Note J - Related Party Transactions link:presentationLink link:definitionLink link:calculationLink 018 - Disclosure - Accounting Policies, by Policy (Policies) link:presentationLink link:definitionLink link:calculationLink 019 - Disclosure - Note A - Nature of Business and Summary of Significant Accounting Policies (Tables) link:presentationLink link:definitionLink link:calculationLink 020 - Disclosure - Note B - Marketable Securities (Tables) link:presentationLink link:definitionLink link:calculationLink 021 - Disclosure - Note C - Inventories (Tables) link:presentationLink link:definitionLink link:calculationLink 022 - Disclosure - Note D - Income Taxes (Tables) link:presentationLink link:definitionLink link:calculationLink 023 - Disclosure - Note F - Geographic and Other Information (Tables) link:presentationLink link:definitionLink link:calculationLink 024 - Disclosure - Note G - Comprehensive Income (Tables) link:presentationLink link:definitionLink link:calculationLink 025 - Disclosure - Note I - Accrued Expenses (Tables) link:presentationLink link:definitionLink link:calculationLink 026 - Disclosure - Note A - Nature of Business and Summary of Significant Accounting Policies (Details) link:presentationLink link:definitionLink link:calculationLink 027 - Disclosure - Note A - Nature of Business and Summary of Significant Accounting Policies (Details) - Property, Plant, and Equipment Useful Lives link:presentationLink link:definitionLink link:calculationLink 028 - Disclosure - Note B - Marketable Securities (Details) link:presentationLink link:definitionLink link:calculationLink 029 - Disclosure - Note B - Marketable Securities (Details) - Available-For-Sale Securities link:presentationLink link:definitionLink link:calculationLink 030 - Disclosure - Note C - Inventories (Details) link:presentationLink link:definitionLink link:calculationLink 031 - Disclosure - Note C - Inventories (Details) - Inventories link:presentationLink link:definitionLink link:calculationLink 032 - Disclosure - Note D - Income Taxes (Details) link:presentationLink link:definitionLink link:calculationLink 033 - Disclosure - Note D - Income Taxes (Details) - Provision for Income Taxes link:presentationLink link:definitionLink link:calculationLink 034 - Disclosure - Note D - Income Taxes (Details) - Reconciliation of the Effective Income Tax Rate link:presentationLink link:definitionLink link:calculationLink 035 - Disclosure - Note D - Income Taxes (Details) - Deferred Tax Assets and Liabilities link:presentationLink link:definitionLink link:calculationLink 036 - Disclosure - Note E - Benefit Plans (Details) link:presentationLink link:definitionLink link:calculationLink 037 - Disclosure - Note F - Geographic and Other Information (Details) link:presentationLink link:definitionLink link:calculationLink 038 - Disclosure - Note F - Geographic and Other Information (Details) - Net Sales link:presentationLink link:definitionLink link:calculationLink 039 - Disclosure - Note F - Geographic and Other Information (Details) - Geographic Information link:presentationLink link:definitionLink link:calculationLink 040 - Disclosure - Note F - Geographic and Other Information (Details) - Sales to Major Customers link:presentationLink link:definitionLink link:calculationLink 041 - Disclosure - Note G - Comprehensive Income (Details) - Accumulated Other Comprehensive Income link:presentationLink link:definitionLink link:calculationLink 042 - Disclosure - Note H - Income From Damage Settlement (Details) link:presentationLink link:definitionLink link:calculationLink 043 - Disclosure - Note I - Accrued Expenses (Details) - Accrued Expenses link:presentationLink link:definitionLink link:calculationLink 044 - Disclosure - Note J - Related Party Transactions (Details) link:presentationLink link:definitionLink link:calculationLink 000 - Disclosure - Document And Entity Information link:presentationLink link:definitionLink link:calculationLink EX-101.CAL 7 ug-20141231_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE EX-101.DEF 8 ug-20141231_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE EX-101.LAB 9 ug-20141231_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE EX-101.PRE 10 ug-20141231_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE XML 11 R39.htm IDEA: XBRL DOCUMENT v2.4.1.9
Note F - Geographic and Other Information (Details) - Net Sales (USD $)
 12 Months Ended
Dec. 31, 2014
Dec. 31, 2013
Segment Reporting Information [Line Items]    
Sales $ 13,771,295us-gaap_SalesRevenueGoodsGross $ 15,569,082us-gaap_SalesRevenueGoodsGross
Less: Discounts and allowances (321,616)us-gaap_SalesDiscountsReturnsAndAllowancesGoods (152,189)us-gaap_SalesDiscountsReturnsAndAllowancesGoods
13,449,679us-gaap_SalesRevenueNet 15,416,893us-gaap_SalesRevenueNet
Personal Care [Member]    
Segment Reporting Information [Line Items]    
Sales 9,421,041us-gaap_SalesRevenueGoodsGross
/ us-gaap_ProductOrServiceAxis
= ug_PersonalCareMember		 11,459,482us-gaap_SalesRevenueGoodsGross
/ us-gaap_ProductOrServiceAxis
= ug_PersonalCareMember
Medical [Member]    
Segment Reporting Information [Line Items]    
Sales 2,494,205us-gaap_SalesRevenueGoodsGross
/ us-gaap_ProductOrServiceAxis
= ug_MedicalMember		 3,028,659us-gaap_SalesRevenueGoodsGross
/ us-gaap_ProductOrServiceAxis
= ug_MedicalMember
Pharmaceuticals [Member]    
Segment Reporting Information [Line Items]    
Sales 1,686,563us-gaap_SalesRevenueGoodsGross
/ us-gaap_ProductOrServiceAxis
= ug_PharmaceuticalsMember		 916,927us-gaap_SalesRevenueGoodsGross
/ us-gaap_ProductOrServiceAxis
= ug_PharmaceuticalsMember
Industrial and Other [Member]    
Segment Reporting Information [Line Items]    
Sales $ 169,486us-gaap_SalesRevenueGoodsGross
/ us-gaap_ProductOrServiceAxis
= ug_IndustrialAndOtherMember		 $ 164,014us-gaap_SalesRevenueGoodsGross
/ us-gaap_ProductOrServiceAxis
= ug_IndustrialAndOtherMember
EXCEL 12 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx M4$L#!!0`!@`(````(0#+EA$:#@(``)0<```3``@"6T-O;G1E;G1?5'EP97-= M+GAM;""B!`(HH``"```````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M``````````````````````````````````````#,F=%NVC`8A>\G[1TBWT[$ MV,[:;B+THNTNMTIK'\!+?DA$8ENVV\';SPDMJBH&0D/:N2$BL?_S8:'O(F=V MO>Z[[)E\:*TIF:S6UKHIRYF=^MT>TOBJ0LLN]DN'+)*IIWKVDK'1,J?3?TN9?*2D*>=XYK0 MM"Y\2AB,[TT8GOP]X&7?CW0TOJTIN]<^?M=]PN#KCO^V?O7+VE5^>,@>2KM8 MM!75MGKJTPGDP7G2=6B(8M_EXS7O=6M>N0_DCXL#'R_BS"##[QL'G\@A03@4 M"$8HH"@&%6@*%6@.%6@2%6@6%6@:%6@>%6@ MB%6@F%6BF%6BF%6BF%6BF%6BF%6BF%6BF%6BF%6BF%6BF%6AF%6AF%6AF%6A MF%6AF%6AF%6AF%6AF%6AF%6AF+5`,6N!8M8"Q:P%BED+%+,6_\NL,74NQ,?/ M?_^;CF..O/0/<=-1./.+NNW08\F-]E3_C#ZU4V<'>#O["$>EN^JF237-F0]A M-_=0?NJ.[KUU(;5HGDX'>*W)AMT3EP:1CRWMBK)]A=,N,35PIP>^:[QHZ/AJ MJO=D\[%3G/\!``#__P,`4$L#!!0`!@`(````(0"U53`C]0```$P"```+``@" M7W)E;',O+G)E;',@H@0"**```@`````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M````````````````````````````````````````````````C)+/3L,P#,;O M2+Q#Y/OJ;D@(H:6[3$B[(50>P"3N'[6-HR1`]_:$`X)*8]O1]N?//UO>[N9I M5!\<8B].P[HH0;$S8GO7:GBMGU8/H&(B9VD4QQJ.'&%7W=YL7WBDE)MBU_NH MLHN+&KJ4_"-B-!U/%`OQ['*ED3!1RF%HT9,9J&74"T\U<%J"`=[ M!ZH^^CSYLK$SO+=N5#9@NIS]NHFD++28,5\YS3$$X4UD^&'! MQ0]47P```/__`P!02P,$%``&``@````A`,-3XPDY`@``QQL``!H`"`%X;"]? M]'7WUY/?!\GJ]L=/E'&;[;,[BH2[- M]%"3F.+Q..:E7Y]\V.W:*GP5(_[4,JS3P4[>D. MR2HS&_L"3MX/79P;A,,;91S>(!RY5<:16X3#I(S#A'#$*>.(0SB.E7$<0YSK M)7%B.G99JN8N_WV-UE]T^5E4S@3ST!^=N48PVD<#3X:T18:@R+"VR#`4&=(6 M&8(BP]HBPU!D1+N2!9:R:'>YP#9W.6ZII@FW1JKCKK1QKA".-@V$(6T:@CBL M'8L9QF+6CL4,8[%H.Y9`QW*+.E;EN^I#X]O^G"WF(=1.I"TV!,6&%MV4.5V= M-V4>^OM@!VU8MAWF+MO,4P M;XFV!`J40-'.%`(SA=/.%`YF"K=HIHB-GT+])4WYS>;E>X'+820ZB\+,UO2R M6^%\HYS3X3F1MN00E!S2EAR"DL/:/>W[2\```#__P,` M4$L#!!0`!@`(````(0`KS(B.!@0``"L.```/````>&PO=V]R:V)O;VLN>&UL ME)?;;MLX$(;O%^@["+IO99W<)HA3Q''2IL"F1N-M+PE&HBTB$NDEJ=A^^QW1 M:V4D44%R98^D^3V';X;6Q==]57K/3&DNQ

_+G92/3U*^>2!@-`SOS!F>QX$.BM81?4GN64"[JRE MJJ@!4VT"O56,YKI@S%1E$$TFTZ"B7/A'A7/U%@VY7O.,+6165TR8HXAB)340 MOB[X5ON7%VM>LM_'C#RZW=[3"N+>E[Y74FUNCNO>0EW MS^))[`>7;9)+Y>5L3>O2K""]DSK4*TJB:-H\V93B-V<[_>+4F-[^#Q>YW#6/ M0FD/K15#`#M[ZP_/30'W)Y-)>^T[XYO"G"Z"?(#T;07A=^RG)VQZIXJ0*Y&3 M&V&X.9`[<:P^E]#"INIWD%GH>^JNJ2[(+?"*DX'!;)/YTO>_EX:1*W)/3:U8T\QYK;E@6A,8 M98*B2'`V9TZ9.?F;JB=FZ&,)C6%9K;CAL`9>4DEP+N'$J7(-%#Q#6Z3J^>(\ MP@&2-I'%_RR2%=UW?_@,%2$<,&F=;\B<";;FABR!+1QV"A/9EC`*;@N>V=K]!+!4E^BT,U0#.JW.-](?B=YPI7BZP@&=5N3[J0ZW2E9D02NZ M:3IB#.I%&N.D!GQ:G3MRE66J9K`J]K"G=:>F*1ZU<$"F%?A!?C5+%P1@UF#5 MK!14EF8&CTF*IRT<$`H1R!H6E=B0I2QY!E20Q\/Q^P$3FF)"0S>BHZ3C@4LQ MI;"->\O/)C;".EGA"F-B(S>Q'=H!6QB=#GF8V\C-;1?ZH<84TQN]DUYC/$;@`K.0QCW'8PWJS1+'*45(S; M#H9+I\>R(QC<\]@-LUN$+!4.!B^OV,WRB,XO_%>G^7O6'@U@O#TILNCHX.45 MN[=Q[X`"@4&K,,BQ&^31@PI/1(Q!!L.5UJ@0GH@8DPS&NX2@1^UH)9AD,-XE M!$UZ$<(X)VZT00C#89+R+$.C]W'B6&D$S?2H^=Q M)R#,=&*9#FSYX%T"_BAG\)+3?-BWA"2='D^VX/2>=_D?````__\#`%!+`P04 M``8`"````"$`SI5=++,%``#Y%@``&````'AL+W=ODAB?KCY]JOI4T[>?7^N]]URV7=4_Z_G@3!%VQ M*^N\6S7'\@#?;)NVSGOXV#X$W;$M\\TPJ-X'@C$=U'EU\#'"37M-C&:[K8KR M:U,\U>6AQR!MN<][X-_MJF/W%JTNK@E7Y^WCT_%3T=1'"'%?[:O^QQ#4]^KB MYOO#H6GS^SVL^Y6'>?$6>_@P"U]71=MTS;9?0;@`B<[7G`1)`)'N;C<5K,#( M[K7E=NU_X3>9E'YP=SL(]$]5OG23_[UNU[S\TE:;WZI#"6I#GDP&[IOFT4"_ M;\PC&!S,1G\;,O!'ZVW*;?ZT[_]L7GXMJX==#^E6L"*SL)O-CZ]E5X"B$&8E ME(E4-'L@`+^]NC*E`8KDK\/?EVK3[]:^U"L5,\S^]NV^;%@ZJ!.;MC;FJ0WT#D M]U<$2S'8+P8\#`&R':3A^2Y,;H-G4*ZPD'0.$2XB>P<1G2`!T#IQ@Q5?S\V` M05??.W%3[!1VH)\B)!Q4->O))@^2LI,XA0)-JD"$&*7"52:)+8S$%$"8O",Q6EYQ0EN,'EJC>#",7P MI`"JB)!)9>$#Y!S&\3G)(I?/91X&3'B,F4`>"+%2"1EQ19AF#D+S\U*9WC4Q M!I/-CZ4R@PA%3:1"B*6HE4YHO3D`R=BD()UR2UR"E[4S8$)L+!'4#B%(3#(= MDC+,\/LAQPX/#@4T5>HRD0%-F,1$(HM!*D+(4!*7S0@B"=6HHDMNF;^C-SM> M1J9..6)L`D.M)8O&R0NC8X)8GLZ5FD'+$3#;C M](D[N;'=ZR='DYZJH\G*4XX85$?-!"L;XM!:B&7 M<1P1^\A<"$M8HL^ES5CN]"E$J.?%TRBUR>SVU>DSRE%O-693&+(^)FF0.) MF$KBLUH1I_]`J[G%:VKQ?&KA*HI$$A$Y,P(12IXUB$4^S^=&KXDTJ<78Q`D& M!P92C)D+D3*<'HN?[##))?;C2+;)^,;?^B)AK:C$3ZY\^<2=? M9/UB;OVTZ:468U<>`%1X]2V MJC`*(B(1,SZZCDMND?6;5U-R\HK(;DLM9IJV:3/@$MZ(SO0ALA"Z[CUI&$4*D20RM1B;:FC@FFY9!\&EX&+<62[) M1:U`HLU/S[D1F3JU&%ME(>-1*$:_0$=Q,1)$YI/#NDMP42N0V`JF!&/:"BSF MC6`D-=QN$#\F&"%5(LYL%KA=_#]IGK>-F#2%=(B\]O%RR%QOO--4">;=IHJ7 MEWBW=\P?RM_S]J$Z=-Z^W,*^82NS-LT_=L'X,`!``` M%0X``!D```!X;"]W;W)K&ULG)==;ZLX$(;O5]K_ M@+@/8`(D1"%'3;K=/=)9:;7:CVL"3H(*&&&G:?_]SF`@V"&AVURTP7X]///Z M8YSUM_JYF"2LJ"+'/\DQ\-$%-HTA6WX\EJ^-]#GF_$R].NMC-PTWX(DMJQME!6!#. MEJ"W.8=V:$.DS3K-(`.TW:CI(3*?R&I'%J:]63<&_9/1"Q]\-_B)77ZML_1' M5E)P&^8)9V#/V"M*OZ?8!(/MF]$OS0S\41LI/<3G7/S)+K_1['@2,-T^9(2) MK=*/9\H37B M)<.0II&Q;@&R0HB8V9S\$=R]+G>2Q5RQ"!/&"4R8;G#<`[S\[;Q@L7:?@-/DU:S MO=405;'K%#@5@-`.^Q5`K&LCA\;C M;8"#=,#K-I-[56I:`TFP'%HD+505*+@N4X4Q_`HC#IIBE)K.1-<*D>'Z`5>U MK;731Y"K&K\I(Y0<")S$0Z,?&]RH-7I?8]FV(FDQ@F@KX'Z_2H9G]6`)3)#) MDUTY@'Q]\Q`I:B??#T;8%`5!XWMZE0Y/],_3R?-_@DZ*NFEW+.>F>JF*^[N' MX-G^>3I9"52ZL,];[ILF9&2VWKG*T2SWC:8`Z^YYIU68B9D=*2W^#9T4==YY M%KY]\!DYB(@ZY(&96K&9P!VI,H%V"&[Q9@>GP*`8MRW=N03HO?_JNM,JRP3, M2$D)_#YR.[-2U-;EA3,VM4.)NW`?[`NMLDSPC9246SZE9,#]-_1#Y:/F@]=T M-+=="U##R;4&2"_E+5Q>4@M:'^F.YCDW$G;&&S;6_KZUO_T_N7ASTMJW^*L` MV^V^`R[E57RDO\?U,2NYD=,#A'2L!`+^A_T&W^`P``__\#`%!+`P04``8`"````"$`<""].3X#``!W M"0``&0```'AL+W=O^)&`?'Y][[K4OZYOG MIK:>,..$MAO;=SS;PFU."](>-_:OG_>+U+:X0&V!:MKBC?V"N7VS_?AA?:+L M@5<8"PL86KZQ*R&ZE>ORO,(-X@[M<`LS)64-$O#*CB[O&$:%6M34;N!YB=L@ MTMJ:8<6NX:!E27)\1_/'!K="DS!<(P'Z>44Z?F9K\FOH&L0>'KM%3IL.*`ZD M)N)%D=I6DZ^^'%O*T*&&N)_]".5G;O5R0=^0G%%.2^$`G:N%7L:)`3U_7S@!&GLQ\G_65RM2`5XAP3:KAD]65`UL"?OD*Q!?P7,,K+HGY%! M2'+-K5RDE@*:0SJ>ME&2K=TGL##O,;M+3&`B]J\@E@/$!7V#2`A]*O)UV\_B M)!@,MJU!7!"D`Z\*8*9[ M?A*9\_OI?.*EHZN&K.@]LB1X+FN6BYW&Q%I6Y(5C(I1A>V,^29-QO:$+*N=Z MNR38U+4<:76>-*27E65!.$OD?@H(O"3V1K\-8$Y!%L3^DU9"Q?(\,"9X5\G(,3RO3F$DA3P:,G64KFISSMX^0!)N9 M"99C1'IGC=&>++(P"),A9.V)"PH[32F M5^B'83HOK[V!6'I>&@\Q&!)]T'.]>PIMU$\_TDL)P$QO7L@FQ$^R.!W/H"EF M=F6_;12TQ4NG9N6[ZT'Z5EJ$R?PRE\U5LFA`G*63:TMKTZU3=Y8.'?$WQ(ZD MY5:-2\BGYRSAH#+=./6+H)WJ(`LO\Z,J7LN]E)4%$?)R M8>^KZC!SG#+>RRPJ!^H@UK2R>_=CEJHC6*:S[PQM%<1N[_M`+GR5QH4JUK080SB'0_IJ?G"<'(BWG MFP16@&FW"KE=V,_>3/ACVUG.ZP3]F\ACR?ZVRKTZ_E8DFS^27$*VH4Y8@;52 MKRC]L4$3.#L][Y>Z`G\6UD9NH[>T^DL=?Y?);E]!N<>P(ES8;/,I9!E#1B', M@#!BE0(`_&ME"6X-R$CT4?]_3#;5?F$/)X/QU!UZ(+?6LJQ>$@QI6_%;6:GL M/Q)Y"-4%\9L@(Z!OGOL#/QA[X\GM*`X1U0L4414MYX4Z6K!KX#O+0X1[T)M! MY'9EQ-&M]=)2`0^#/&.4A0W;'5910GW>EZ.I.W?>(:=QHPG[&D]7K%H%KAK# M"F9P@+>#AE1PZ/-E:-E0C&QMU)`,$)O!FBA]C:_#BC.*:2?1:(`$%"2:-P.,"#7G:1[Z].=#)1#Z]#[0Y2,.0 MR=`@3\<]XLO/-6`\ M##0%-,S`/%AX).+I,RV":_2R8M=^G(MZ_8VRDHASF1;A,8O.A;W9X+JCK-31 MM7Q-S4.$1R+.U5K8,2(P#DN"N^FHV)@?1Z5VKJ$&/536\YL.0I;NB&9L!N$Q M#XW2/S,E;F_`VLN<$L8!*VQ$+*$]B^`6G>M+4\*_9THT(L[5FQ)9K[,JC8BSD5N%ZO*/71*8TKF80_AQJ6^GG"Z!W#A<8AV\F=4 M[)*\M%*YA9#N8`K(!5V9T(=*'>IKA[6JX*JC_G,/5UL2?O"[`Q!OE:K:#W@P M[2[+EO\#``#__P,`4$L#!!0`!@`(````(0#T%D[@U0(``.<'```9````>&PO M=V]R:W-H965T%VD^.>/AYL$(VU(G9%*UBS%KTSCV_7'#ZN#5$^Z9,P@<*AUBDMC MFJ7O:UHR0;0G&U;#3BZ5(`8>5>'K1C&2M8=$Y4=!,/,%X35V#DOU'@^9YYRR M>TGW@M7&F2A6$0/\NN2-/KD)^AX[0=33OKFA4C1@L>,5-Z^M*4:"+A^+6BJR MJR#NES`F].3=/IS9"TZ5U#(W'MCY#O0\YH6_\,%IOK-C^_.#OHWF^D2WGXI'CVA=<,D@UEL@782?EDI8^978+#_MGIA[8`WQ3* M6$[VE?DN#Y\9+TH#U9Y"0#:N9?9ZSS2%A(*-%TVM$Y45`,`G$MQV!B2$O+3? M!YZ9,L63F3>=!Y,0Y&C'M'G@UA(CNM=&BM].%!ZMG$ET-)D`_7$_\J)D&DYG M;[OXCJ@-\)X8LEXI>4#0-'"G;HAMP7`)SJ?('$<7Z[]"A1BMR9UU23%T.T2A MH3S/ZSB9K_QGR"D]:C;GFG"HV)X4MA2`US%"Y'W&RUD_H5BQ1;%5L&P;MP#> M'5LTNO>"XB_\@`0RU">QV9I`-UTGLH=`UP.(DV2(L'&:N*/>]A8&!/&0X/K- M5IQB"*\+/4X6HYN=)FZ+-B[(Y;T!#_1O/R/7>:QXQ!.-[MPXC>,9%^KRWH!G M-N1Y7X7LH1'79#K*D]/T*M1;&!#,_X?`'GJK1YRF1]!;&!#8MT[O/WV])E8\ MCCT8Q>XT2=0V2>!-QG49[\^Z\X[+#58W=P13!=NRJM*(RKT=FM:V6^WF^5UD M_PRC]0W,^78J^MT&S-F&%.PK406O-:I8#I:!-X=>46Y2NP&PO=V]R:W-H965TP%R3**1J4G6WTE9:K?;R[(`)5@$CVVG:O]\Q)ES;W>0E`?MPYIR9 M,T2TPK4S.L^"4<+,MH0NY9.A8ASO"_#]BGR&R-GI"Z?I-UH1R#;4255@ MS]BS@CZF:@D>MF=//S05^,Z-E&3X6,@?[/25T$,NH=P!.%+&5NG;/1$)9!1H M+#=03`DK0`#\&B55K0$9P:_-_XFF,H]-+[2"R/$0P(T]$?*!*DK32(Y"LO*/ M!C6..A*W)?%`?;OO6NXB0$'X?Q9;*VH,WF.)-VO.3@9T#<04-58]B%;`?':F M=71>/[(*'A7)G6*)36AW<"&@/B\;/PS7]@OD-&DQVSD&C1&[,T*5`N1U&L'Y M4./[63]+46`E155!:=OJ!>#NM+F3N.\@H@XR4@(9NER)`D.EAX'=1<>KQ6F, MWZG=#19&D?UK(BMP;(*MWK*[G$36F+`I%HJ0[RUZSXVVW1#A1BYRPE[]2!OT M\.594>")-L^9:-.8H-%VLPRBB?;=M(TWZ=BMQ@S:9K`PBJPFT.!X__OH*/"D M-+.VT9BV-+[C>)UCG9/1/D(+U-=V)&QYC3`%G@B;]8S&:&%>Y$];1F_[NJ6\ MH'_UC%0A&`V7YZM!CWJF76G#N$'?#SH[[7Z;/N2B\",AZEUX<>%@]LT3-.G6 M;0LZGWC'#^;R-(^&P)%?!$%?7YTH/2/U""D)/Y`=*0IA).RHYI\+^>U6N]E\ MUYRJR?I6S6QUVNQN`T9FC0_D"?,#K811D`PH'2N"X\[UT-4WDM7-X-HS"<.R MN+F:=M?":UZI-C( M5KK70$J)$HO'NM.&;UKT_9*-N3APA\4%O9+":*LKER`=BT(O/<_9G"'3:EE* M=.#33@Q4!;W-%NLQ9:MER,\O"3M[]$ULHW>?C"R_R`XPV5@F7X"-UD\>^ECZ M$!YF%ZM^ZYWGT'6C<-J3]"0][4H7^_!"DPHTB3YQ#,)W:(` M?!(E?6=@0OA+>.]DZ9J"CJ;)Y#H=90@G&[#N07I*2L36.JU^1U"VIXHD^9YD MA.KW^WF2SR;99/I_%A85!8/WW/'5TN@=P:;!.VW/?0MF"V0^.(LZ!J]_LXH> M/Y]5X.EZR9\RIV&/N+C'9*6)]0/A2H+Q!(SH_UOAVU@]2 M/-A+\57PVNYB`+D';?G9O6\@K@?(B1+,T/N5>#!6^OCB?#3P1G$1$UHW!-9' M@9.;QZ' M)O:4`E/#&MK6$J&W?B#\L2$ZS.IM[LMS%K_#&0X=SX8-G*&>U_"5FUIVEK10 M(66:7./0F#B%<>%T'SIYHQU.3_AL\&<)6/XT07"EM3LL?',-O]_5'P```/__ M`P!02P,$%``&``@````A`#IB*:E^`@``!08``!D```!X;"]W;W)K&ULE%1=;]L@%'V?M/^`>*]M_)$OQ:G:5-TJ;=(T[>.98!RC M&&,!:=I_OPLD6>)T6_:2&/O+O MWQYO)A@92[N*MJKC)7[E!M\NWK^;[Y3>F(9SBX"A,R5NK.UG<6Q8PR4UD>IY M!U]JI26UL-3KV/2:T\H7R39.DV042RHZ'!AF^AH.5=>"\0?%MI)W-I!HWE(+ M^DTC>G-@D^P:.DGU9MO?,"5[H%B)5MA73XJ19+.G=:*" M7@JFE5&UC8`N#D(O/4_C:0Q,BWDEP(&+'6E>E_B.S)8%CA=SG\\/P7?FY!F9 M1NT^:%%]$AV'L*%-K@$KI38.^E2Y5U`<7U0_^@9\T:CB-=VV]JO:?>1BW5CH M=@&&G*]9]?K`#8-`@29*O0RF6A``OT@*-QD0"'WQ_SM1V:;$V2@JQDE&`(Y6 MW-A'X2@Q8EMCE?P90,2).I*D>Y(,U.^_IU$Z*4@Q^C=+'!1Y@P_4TL5JXP1(Y*, M\V%&X22'0>_IFG^F>BTZ@UI>0V^2:`P4.ISCL+"J]P.]4A;.GW]LX+KE("B) M`%PK90\+=U,<+_#%+P```/__`P!02P,$%``&``@````A`!I;\P&ULC)1=;YLP%(;O)^T_6+XO M!D+2%D&J-E&V2ILT3?NX=HP)5C!&MA.2?[]C.T%M$VFY`8Q?/^>\YQPHG@ZR M17NNC5!=B9,HQHAW3%6BVY3X]Z_5W0-&QM*NHJWJ>(F/W."G^>=/Q:#TUC2< M6P2$SI2XL;;/"3&LX9*:2/6\@YU::4DM+/6&F%YS6OE#LB5I',^(I*+#@9#K M6QBJK@7C2\5VDG_10C"3+ M7S>=TG3=@N]#DE%V9OO%!5X*II51M8T`1T*BEYX?R2,!TKRH!#AP94>:UR5^ M3O+%!)-YX>OS1_#!O'E&IE'#%RVJ;Z+C4&QHDVO`6JFMD[Y6[A4<)A>G5[X! M/S2J>$UWK?VIAJ]<;!H+W9Z"(>Q/^VF4/DR3 MZ>S_%!(R\@:7U-)YH=6`8&@@INFI&\$D!_)U1V#%:9^=V!^!9`UT83_/9G%! M]E`Z=M*\7&K2]XK%%<7]*"&0UY@<6+X].2>&PF(T)IXMA_R"K,96M?3#?]. M]49T!K6\AJAQ=`^#I,-DAH55O6_56EF8*/_8P`^$@^LX`G&ME#TOW.R/OZ3Y M/P```/__`P!02P,$%``&``@````A`/5/WH`\!```2`\``!D```!X;"]W;W)K M&ULE%?;;J,Z%'T?Z?P#XKW!-OFWC!;(M M6F'R+9XE]9Y6K*:KNUWRNVOFS^^K,ZL?>%'2CL+&&J^MH]= MURP=AV='6J5\P1I:PS][UE9I!Y?MP>%-2].\OZDJ'8)0X%1I4=N28=G>P\'V M^R*C3RP[5;3N)$E+R[0#_?Q8-/S"5F7WT%5I^W)J'C)6-4"Q*\JB>^]);:O* MEM\/-6O370EYOV$OS2[<_<45?55D+>-LWRV`SI%"KW..G=@!ILTJ+R`#47:K MI?NU_8B7"<&VLUGU!?JOH&>N_+;XD9W_;(O\1U%3J#;T271@Q]B+@'[/Q1+< M[%S=_=QWX*_6RND^/97=W^S\C1:'8P?M]B$CD=@R?W^B/(.*`LV"^((I8R4( M@$^K*L1H0$72M_[[7.3=<6V[P<(/D8L!;NTH[YX+06E;V8EWK/I?@OJ,1A(R MD+B@?OB?+$CD8S_XG,61BOH$G](NW:Q:=K9@:B`F;U(Q@W@)S)?,I(XQUUNI M0HZ"Y%&PK&T8=\B"0W]>-Y[OKYQ7J&DV8+;7&*PCD@M"M`+DC1HA2.O%"$<90)L*INZ(6=)8I194A:TR.*QI.SYW^\G`?YLBB5&B:PL:)'C.9$% M6,\9'GMC+67.$B.[$;FA&X3&#DM41.@2/W8G#DT;AL?"_67IT:8Z8Q2V`VB0 MYX<^V+6>0*)!0H_X033U5=8MA1HB$P=C'V;K5HEDV+UYNKW6=,QW8` M#?.-/8*OY*E&C0G893#M`+UZLYP:WV/5`TC*PS'!RM8?>JF:-4:!BZ?IT]7- M0&KT6Z:-9[EVCS:-<;+<84]+5U:C MJSY-D!N3Z1ZM$V263?=H4XTYQ@-(43.L7(P1(=\=NZ>KF67*Y!Y3'D"J&GF; M?%=[<*/`W.'RX"+?ZRO:'FA"RY);&3N)0PF!]ZAQ=3PP/1+QTFFL;^$@U9\Z MG/$/.,@3>_````__\#`%!+`P04``8`"````"$`$[7EB4`$``"Z M#@``&````'AL+W=O M$S!)R"5*Q^^YO!V-C.=4M>(`Q_CW^>\4SP MYO-;77FOM.4E:[8^F8:^1YN"'?/(]+O+FD%>LH5O_G7+_\^[G MGS8WUK[P,Z7"`P\-W_IG(2[K(.#%F=8YG[(+;>#-D;5U+N"Q/07\TM+\T`VJ MJR`*PSBH\[+QI8=U.\8'.Q[+@F:LN-:T$=))2ZM<`#\_EQ>NO-7%&'=UWKY< M+Y."U1=PL2^K4KQW3GVO+M9?3@UK\WT%ZWXC\[Q0OKN'._=U6;2,LZ.8@KM` M@MZO>16L`O"TVQQ*6`&&W6OI<>L_D75&EGZPVW0!^KND-V[\]OB9W7YIR\-O M94,AVI`GD>__HA4M!#U`YGP/,[)G[`6'?@%3")/P3H"3\'_5-$\1SA+H:3H+F&D!84%I`'FFD8+]%JP"ES` MU:M+W$\0QOQ-TI4'<=[ZLWBZ6(8S`G)O3[EX+M&E[Q57+EC]CQ21WI5T$O5. MX'Z3[Z-X2N9A_("/6>\#[KT/$CT,,N^=P%T[^;]5!#(B7;"S7.2[3MC[4*$210[Y?=^$F>(6,%KTBD0JX M:@6Q%:E28/K0:688`J#5R)``$_G'FT"1H1C)E-=$&DR0R`&Y5\QL17:OF&N% MA0IY-E$QNC,HF8^1<1#HC%`MM/0&08+"%)L`GT,@N*M#XO5 M.8L=$*F`JU8L;46J%"K^F6&PR*`0QY.AV";[9,^;2(5)MK(5J5)H,L-@D<6/ MD*'8)B-N*4C)',KDN)M,2#2902DP=&;E\'0?3+38M-ASQY/)SN\1>=V%Z+^!;"`HY#< MP:GW0^@,BPV'W7H\G.SM%IPS>0*G!PR=F=O(*?%4:P9`-4IO/GDRD!^K-6U/ M-*55Q;V"7?%+GT!FM%4?7?HSA7X!AX!+?J*_Y^VI;+A7T2,,#:=+R&XKCQ'R M0;!+]RF\9P(^_[N?9S@C4O@,#:<@/C(FU`,"ZE/G[CL```#__P,`4$L#!!0` M!@`(````(0#JI_.B_@,``',-```9````>&PO=V]R:W-H965T32_?;XM=?9D?1OLD=Y\J!"(V2^Y5G1;:HK+_#]Q*NSLG$IPK2])X;8;,JI\^GW;2/:;%U!WA\L MRO)3[.[A2_BZS%LAQ4:-()Q'1+_FG'JI!Y$6LZ*$#%!VI^6;N?O,IBLV<;W% MK!/HWY(?I?;9D3MQ_*TMBS_*AH/:4">LP%J(-X1^+W`)-GM?=K]V%?BS=0J^ MR0Z5^DL@W#%DA(E-B\\7+G-0%,*,@A@CY:("`O#7J4ML#5`D^^C^ M'\M"[>9NF(SBL1\R@#MK+M5KB2%=)S]()>K_",3Z4!0DZ(.$P+[_/A@%DYC% MR>TH'C'J$GS)5+:8M>+H0-?`F7*?80^R*40^948\AEQ_EBKDB$&>,P=-\QZS_(IA)F)U0F`I@-[`$3+7.5Y6_40%P4@%JX#$B^4W!E0.(X2?W).8K!#KI9U^H(-B4*=+BDDR$T=I'6S!$P#>2==UO-S!NNM7`A-$8 M:`L&@]1D<+U%$&SG?FX]RITP5)DT"I@?69=KI2,8B^(T^EG_,KC,NC[7V75H MFUXTE)SH]2!-&7W%D(:A`3YY!>(]IVH48/&2V.*C>O40_J'2X!_9.S>_6BZ%Z;LB0-SG9M MBO20U[*3V>KB6#:_[$&Z.+3M@CB6O=Y9(K+,&R72?+771%LQ-;"L]L8U(KLT MV]1V.AAQL8[]NSH!&[-4PB%81T0^.]L1L:,9ET;`FK=;ON)5)9U<''!^#>!% M.ZP.L_5S]QZTUI&PO=V]R:W-H965TI=5K*:+NU/RNWOJY]_6IQ9\\J/E+869*CYTCZV[6GN.#P_TBKC,W:B-7RR M9TV5M?"V.3C\U-!L)Q=5I>.Y;N1465';F&'>3,G!]OLBI\\L?ZMHW6*2AI99 M"_SYL3CQ2[8JGY*NRIK7M].WG%4G2+$MRJ+]E$EMJ\KG/PXU:[)M"75_D"#+ M+[GEFT'ZJL@;QMF^G4$Z!XD.:TZ=U(%,J\6N@`I$VZV&[I?V$YEOO-AV5@O9 MH'\*>N;*:XL?V?F7IMC]5M04N@TZ"06VC+T*Z(^=",%B9[#Z12KP1V/MZ#Y[ M*]L_V?E76AR.+<@=0D6BL/GN\YGR'#H*:69>*#+EK`0"\->J"C$:T)'L0_X_ M%[OVN+3]:!;&KD\`;FTI;U\*D=*V\C?>LNI?!)$N%2;QNB0^L.\^]V9>$I(P MNI_%04:RP.>LS5:+AITMF!K8DY\R,8-D#IE%93[T!WGTM7Y5*M0HDCR)+$L; MQAV6<]#G?16D\<)YAY[F'68]Q!`=L;D@A!1`K^<(E:L<;W?]0D6`!16A@N"V MQ@#D[KEYQKXW$%?R&A/HD,KDTJUQ1F(1=%4A$*2)3F&-F*!GO5$"&H-`9S"^ MLP`O;2BO+QTFSM@9,9$4C?A!D$9QJD,V&B0,2)2D?@_1V,$TJ_T99R?`.KL@ M-;9>(R9$=IX;I^YU9RGO1D/X?A"ZU['2N$6/TX%0(A].5AJ&^N':&!"2PL'N M(3H_8973^:&QJOQ"U_1$HK@ONHP:T7`="C;S`C\(TZ@7HFJ)ZK^^G;D2^../D(?.5:/,<&;Z_[D!J M=[[R7_*_#%BNNGN.%,?MFJ)$=(T>,F$RQ84[$&HD?DX&QB1O-$021+'_U2EZ MR(;)T(=#-]#'8]V!5(5PV=!C/,-GIYTBN>J>0AU(8:%&-(4\PV_'G4ZB]2D= MGJ(.A`I%)$S2:_]Q7C1$X!.77*U09_>0#WM#'P[=:V:Y][H#J;W!93<4,EQV MHD)HI.,^YR%(9:%$]!X8;GM'(;1+U>MO*(0@5"A,O"`V?IMO/!61P&TKN?91 M9_>0"XM+F^'"H6M8[+H#J;W!93<4,CQVHD)HFG<44IRUFUHEHO?`\-H["J%9 MWE$(07A%29(H\:_?,AT;%4'BU(-OJ]Z,D![>[?'J6]'F0#>T++F5LS=Q;_?@ M@M%'^V<*3YZXCQGQ-3QKD!=SI_\`KOJG[$!_SYI#47.KI'M(Z>'>LA8N^?+E$1[J4+BENC,`[QEK+V_$';A_3+3Z#P``__\#`%!+`P04 M``8`"````"$`$HP9K;L#``!"#```&0```'AL+W=O8U_NXN&]KJPWUHF2-TN;S%S;8DW.B[+9+>T?_SY_ M26Q+2-H4M.(-6]H?3-@/JS__6!QY]RKVC$D+&!JQM/=2MG/'$?F>U53,>,L: M>+/E74TE/'8[1[0=HT6_J*X>'ZH62.1I&,5 ME:!?[,M6G-CJ_!ZZFG:OA_9+SNL6*#9E55N+\'N$#)2BJ2W4TH"+TO?]_+`NY M7]I^-`MCUR<`MS9,R.=24=I6?A"2U_\AB`Q42.(-)#ZH']Y[,R\)21C=9G%0 M49_@$Y5TM>CXT8)3`WN*EJHS2.;`K#+SH3ZH8\SU=ZE"CHKD4;$L;3CNL%R` M/V^KT(T7SAO4-!\PZW,,,1'9":&L`'FC1LA4MC4&@'O4 MYDWVO8#X%&\H@0KI2D[5NJY(+8*J:@)"-S$EK!$3C*HS+6`H"$P%UW=6X*4- MZ8VI!^DD^35BHMXTX@=!&L6I*2XS(&%`HB3U1XBA#DZS7I_KZA385!>ZDZW7 MB-'JH@6,G2-SY_N<48MN.8,838$6,!3$IH+KN2NPF?NY,X@)>V?BU$N]Z:G) M=$0:$\]//MTUM*D/D7;+KVM38%-;2-S1;[Q4B-&JH@6,G5-SY_M\48MN^8(8 M38$6,!00:&?W)]^CS>S/G1E`:$V8>$$\N<^9@4B@0R?A6$%3G6IZ=UM#L$7J M-SHDDS:Z'D!::?2(N;MJ?=KN]]E#L&%>[V@#2%>!R_J(J4(U.TW%]>-)L#7J M-;C@$(+0H8B$23HYP=E`@XC`)R[YG4/_J^62\YX;DL];B;=G`.FUP647:C-I MJ7P/<\XGY^5`8Y!B0@ ML:>==3Q!.++A1%.S;L],XQ.HZ*CY[ZS$[B:S5"JK@SOH`) MKJ4[]HUVN[(15L6V0.G.8BA2AS,@/DC>]G/4ADN8W?J?>YC5&0P?[@S`6\[E MZ4%M,$[_JU\```#__P,`4$L#!!0`!@`(````(0!),2KS*`0``*D-```8```` M>&PO=V]R:W-H965T&ULE)==CZ,V%(;O*_4_(.XWV`$#CI*L M)HRF7:F5JJH?UX0X"1K`$2:3F7_?8XX#V-F=)C6^B M5:5L5CZ=$=\332%W97-8^7__]?(E]3W5YSSD?E\6XED6YUHT'9JTHLH[X%?'\J2N;G5QCUV=MZ_GTY="UB>P MV)95V7WTIKY7%XMOAT:V^;:"N-]IE!=7[_[BQKXNBU8JN>]F8!<@Z&W,/.`! M.*V7NQ(BT&GW6K%?^4]TD='$#];+/D'_E.*B)I\]=9277]IR]UO9",@VU$E7 M8"OEJY9^V^E;\.7@YMLO?07^:+V=V.?GJOM37GX5Y>'80;D91*0#6^P^GH4J M(*-@,YLS[53("@#@KU>7NC4@(_E[__]2[KKCR@_C&4M(2$'N;87J7DIMZ7O% M676R_A=%U%BAR=R8A$!OGL]G\Y11%O^_2X!$?8#/>9>OEZV\>-`UL*8ZY;H' MZ0*(.4%D:RN9506Y%=%;H2 M0#<@0N!3Q.\G_4JBQ9I$%T&C;?`&>(]HSKK?422#Q"*!!-U/HL4K'\S'A=/! M%ME0$O<)HV$4\3CAMB2S)"RB<3&O4&+@H(DY-,V."`DH2PN+Q9;'A]'R]'PZGL04W1HU%HZ@Q<''(N9/; MS%+0,"0A&6>O3:<'[(1.;X`AU/KSIJ.),NLS8H"2- M0YK&8P_8F`]-=XJCVL(;WW6#AQI30)@6TW>NEV3&QN0Y@;,&&]O`QGMH#]!' M)V=F1$YJ-D:#>V-$8))2IT\/92- M\BJQ!TLR2Z!)6CQJXT4G3_UQ=2L[."+W'X_PDTC`(8_,0+R7LKM>Z`6&'UGK M_P```/__`P!02P,$%``&``@````A`$XU@^X*`P``,0@``!@```!X;"]W;W)K MJ)",MRG"MHLLVN:\ M8.T^13]_W"\29$E%VH+4O*4I>J$2W6P^?E@?N7B4%:7*`H=6IJA2JELYCLPK MVA!I\XZV\*;DHB$*'L7>D9V@I.@W-;7CN6[D-(2UR#BLQ'L\>%FRG-[Q_-#0 M5AD306NB@%]6K)-GMR9_CUU#Q..A6^2\ZZ9MD16?I"*-[^-")^LC(EW,O&!_O3>L[TDQ&'T;Q?' M$/4!WA%%-FO!CQ8T#9PI.Z);$*_`^1R9X1AB_5NH$*,VN=4N*8)NAR@DE.=I M$_AKYPE2FI\DVVL)GBJRLT)7`N@&1`A\C/AZTL\D6JQ)=!$TVM8L@/>`YLW. M?441#Y()"23H_21:G"(P'PX.W,'6L!E)9!+FAFZ`HZDB&RO"I>O[[G)03-"" M_T'38NC!,5HPV!HT(PF&/&:CA,KUOL3I33.^V?%;(SDESHOC8!9`-A8L@B@)+X()H+Z\1J/A[<1I\0PL MF5742$[=CN,$1_-_XE@1`E<07HINT,R(-A.LH6)/,UK7TLKY08]?#[IE6!UN MAEM/=_%L?0LW1C]?G>$%3.R.[.E7(O:LE59-2[!T[1@:39B9;QX4[_JYN>,* M9G7_LX*KF<*T<6T0EYRK\X.>9<-EO_D#``#__P,`4$L#!!0`!@`(````(0!N MAU5>`T```%+,```4````>&PO^>?3P_6'GU+,FGZ:B?#L>C['?/[K+\V;^\ M^:__Y9L\GR:\.\I_]^QZ.KW]^L6+O'>=W:3YZO@V&_'D?%33H8/4MZX]EHRKH;&RP\&PW^,LMV_:?MS>UG;[[) M!V^^F;[9&_=F-]EHFG1'_61_-!U,[Y+#D2\`W,GRQ[.]9.GY-R^F;[YYH5?\ MM?6-Y,-X-+W.>:>?]>N/][+>:K*YWDDVUM:WZ@\_I)/59,T?;M'9[O[R7O/G9/ M]PZ[1\GAT6Y]2`'"^=UMX_WUM94_U%_8G4TFPN_!(.^EP^3[+)T(9\E>.FV\ M'Z#<'=_<@/JSZ;CW0R.G M,,-WX^%L-$TG=Z!EB(34WSP:UW\)+]KP9!?<78TG#?C.;M(ATR4E8*#R-ATU M!H;9_I@-ARL_C,:?07:6YDAA/SG,\UDVJ2]?D/TDFPS&8KYV"A;CJN0^0,8: M6ZR/#!.WCCWXO@Z/$)Z)GGDROH1@O?%-MDA6J\*X69_H*)LF>3IL4FIWG#.Y M!"W[@M;)L_SK^KL:HN5;WS^^S2:I,4=\O_[Z^7@*L_4:Z]3'A=U=3L8W"0I0 MLXY'#7P>3Z^A_,`PT8#TD:)<^V;VT\D(J?)\F"4[(V'PW3B+]C(Y_4=_3$;7%TS/DFQ:(8> M5TN+9G2MU9AFGF\EG9/L&NX:?,H>X&*G+[NIO.';3Y:'XSQ_WB#ZQQ&6<3CX M*T!?I6S2AR6@]B:=_)!-TXNAJ-R;30;309,2@890*5D.+/P<"HZRRT%#O3X( M7"<902YDA>GJJ)W'0CM)WZ;#=-3+,`;8^7R1I$=;D^8P;XN\IOFUT;ZG?V1_ MF0T^(?GHD#I$6.B'\=/MF8>1)Y.LES$3V"QVB1H>?S:`Q<7]\>QB>CD;)FE\ M!40L8>37UM9@87,2#*ZE]5>5WQJZZK182&_UQJ-1UI,N2#X/IM?)@V(K)3": MCB?0.EF&'`WF/)EDM^F@5'@&DXLY3&)6W#%;QU=\,?!CJV#O99<9<_3OE>F@ M$A]83$IP>M=);N&):<>@%#%OI=\:4O`>8:_#>X"+A/DT%K"W;([+P9?I#%>C M/OKM;#"4TVJ#!LC?^).;GOK`/Z;Y-$.QY+=C3$*2W_'G37V0;Y%)JIN8WT/] ME?=9CB7JX:C.AI@]=%>&$N@-S!#4!TLMUF:OH:C^A@OO`IEQ<-O)'L5M.$@O M!D-3(@WT%U)RF]Y)1.J+\WPR8TN+C&2IA>#:!7/,HW` MH8)_FVQUME_O=+8V7R?AX4">%@8%8S0NG=LDG29X+-G-!<8KAA`VB%ABLX.V MR6\E]I^RX5T=/)!9\$B0VQ9[47_K%%,PD.N':VYVLS[`\6N;OAX/^_BK__?? M?_[O__'S__AWDZ!I`PY_H4((@_\)$]35_0G&FV@KFPZ((7)L=GM45C!;5267 MNKABZ1NZ3ZQ14K8@ZB.]@_FW&\2O([1UN+/#HX96V*4^OG`PDN-+CZ`"R7Z3 M[*,CB6X7X"[`=";63O[TP?BO$496&, M5-]B9`X7E"+.WE@T;CGX8D;+^.^'7MZ]3E$,LK.S>3>*@&.!`U58_W[3U-5A MVQM\&O0)27-T>0_7LYE"6+#+AE,0QSUFEPM?KF&CD;)XRB*-EQ_!DH^4[[^+ M*"W46.3&%I!:5+DK+Y%LPN?%_J9&7-J(:G0F5T$:>H%%[/]YYK%8GDS'Z'.L M4(\L@'G(T8,:VU_FI\K?@%?ZR<5=#/_N7V"OXAV8XDUOE*;X:ZN[?B<(MIY;`_-E8@UL@)L&!G^]=SB4ZI>N4&7Z3R7"Z:[C8VONUMVSWF M;C:T,-HPW#.QS#5Y"(6%"W/W;:L5F[/8%2FM0UTL3TL/VY9[BD]=G^OD$=XT MIG\T'JW<[UW7723;J/G8BQPB^8"/XITZS,;R%88>6-[`?-][&+J'8A+H\O3N+-`QRQ'C&"=MFW50:RC MXG(P(J![`!6E6E<@59^R`4?;G&TOH146"HC<1Z/U/?&L[:5M8`=->#48R>L3 M)>[P`.OKW_,N]FO16T=C(J%NLD*:63&5AKV=Y7B9BF1X[6QV@V)!H>&D#*Y& M@TL<.R7A/4`6."=CDKDM;GG+D&1QWOMXM0^#_7Z`DS^=9U^FR=LACE3-@9JHXG!T?+[OJ.F> M?SS=3XX/DK%':IO/'OQYIO>>(B&Q4.^H9"RKE\F!P0W/N1\<(.D'66?D]/Q33K2 MT\OT9C"\"S/HAQ13]NQ-TEC]@E=^'0C>='=WCS\> MG1\>O4M.CM\?[A[NGQ7+5RHP3<;R4;%&8[C^.!H0+Z^\FZ63_B`==91C6TV6 MP5/R3)XKJ?%G6"IXDIAKF'Y6CK`WGI#6=XZ87JE,?7]6<]^)[MX`Q5F'O$P+Z\0^R3#V<7$9(67K['=)'YJKXI%%2(.>'C' M:GV\C0E_%+.O)H=33',^5@K)UL,)R1']GF?'`A38:F+,L>5'`'0R8"?BF0F( M4A("WT5XK(R2-(_@,D'@!;=RU_JM?;.KR3G3!&K\_+?_I81:!9KJ_.0]THFG ML0W^&XJ)E^@(1<7H4OU#ZY!+X#]X5\P[DY&1]Y%]H?(EQ5(BV=)F&G0U!CT` M?SF;\"<).]^Y1NNQD]!FT9\!U-^0CPCT8@N?QPS[,^M$[`T=GO'IZ^*Y[?GA\E"S__+?_72#@Y[_]G^>(RE5FC)6Z?4-ZQ)*O MMU9WOC*.Y5];7XD#)W#>:)85O":+G%,VE__?GA6J_[HYGR):32('QNQS6/S5 M]NKKL/CZK[6XBV.!BSH$JZ\<@`U!\JMLON")BN$(#D2>5)Q]XUFW=HWT[SDB MCXJ=W$D=$$K-,*L`&TA93?_+D*#:9SU03+"66EXP^!I%04`F1>IJ2!(/]W=& M7$1I+N'_4+`X34PM)>,+28!H+TP($>Y<3S)LV"AGE4,"N7[?_'L/6#\-LL]"1C]#R=%6 M`4):5NXDGP4MM2TRAK*+=XD,XQA^Q@4/^]4TPD'818='O>',LNW7Z&NLJXP> M#EO:L10QQ0O*0)V$@O*4DB\N#VT(;FAQD0$R^4RL>VV.9C`&@#"^P>Y.22'V MM9\#%5+!=F8FC/\:I*F%Y08,\>3LYM;C&:$)SQ17]-:L7B4`U8Z<6@2^#/., M:]RC$MHBDQ9)+R_Y=R2=)\OO5ITYH[\R?7,:9!^^'.,2:_WZ$!$\F!]09L/^ MRO:CUOA,'BX:()""1Y%?#VYOLSX^S(!BKND:F.$'P6T!_RU[%801GUA06>D9 M95)X*K,D%64W\7O@"R1!F3&K)9M-Y15Q3>!+"P*UL@(6/)L+/`;A$^*`^I]^ M[,+)T6Q6(4P.)EF6'(^2MV-\-=.A!\=O37M^F\YN;]/9%722#_O]>$)7B)@9 M#[MPW/5WU8>P('25V7"0%NQ=4/8S=F+2>F$CRUEL4_+X"M0(3]>4?XFZ23@4 M#E#Y'$D5&,Y:_.-J/,8+&69Z9P%\9]#'VQ@$S7@$MF[2/H2ZG,+2+F)I=`/$ARFH10*<2&)O:.'+F05A)8FBEI&H1YUF MRJM!LT0$8&UVQ<2C<3*F.>E_,?C8/K#GHE8"0V5='$TFJN@^$*2B;*C6(Q@O4-:3[`)];KHO5^\0N)L7=O#GLF4LJ0J9 M='R1B7%$\XP"'^H_TCPGN`H%?7_@X\KEIVKZ`:"E]?77G=<[VY@RQ:&"T<(1 M?J^V`*RJC".ZQ?&RG?4Y^4D;[R1+&YN:$W6`2A.&E85RUEZB]JAV`PRUZJW\ M:+FWNO>XY62-H\%*>*&QJ`D/!6Y+`45L7B%Z\!W2/C*4"O)`"HOLJ'1<0?42 M7=I.'192+F#D*`1MZ,.*[842+=)7]0R6O!3T>!U`SY-]@M9P4D-LT ME`_E>X62%>!=5:CR*;SU:NTC8E^$Y.H:[3VDSQ3][!E&U^P&=:I]#LBUL1@* M73TWP7N0W:/TJ%Y20#)]Q@9!0&8NR+R<$0&/2;4&&,SNUH&QY01-$CRBOR!+ M6JW<[6"$MSDEMZ",K2:YP)/#^Y`FE9&1YC%'UUVU+STI64G("$-N;2W#`87T M(,Z0^P(K@G8=C/!AAXD\C%6:%"F.M$)XG0TM#0N"$9W"=90"#YEP$&EKP5TX MTB+$00;VF9OBAA"`E$50=BOYFMFMF"\%PU\&-S/:Y>BSV=BVLGR#4XI<;=W) M.AXE']*[1`+E8E5A!.-B=U&8>V^`O36/EK*'5?%8.\]N!BOI:"0-9IS2#[4^ M@V9M=>N5]+$W`>!Y7@_0O)_A*FN]0=O2`9PEJO2[,F,[LL`JRX9*KN:1\X?E M<"$6M+%E&(4Q2H[4H:+^@8W02#S'S+_`'C8W[M]#H58V-IZPC^*M5_X2K&\M MDA&!9;'4^,H0%G0?L0;\@MU?F*@O[T>($]4Y M:M-X]`E$W:P1U7'ZB^]AFV:6^QBS($_@JL?MHWAKQS'_>*)N!J)N=;:V7W6V MM[8:1#TC,/`6562MS-*;KCI274TJ2&UOGOF3,CHHRCA=.8I6HJTK`--<]!JY M^E8$B#:6D^!%-V>U]=M5>OC1>7-CH[:]N=K9=;3TC=.",2^A8-/:M) ML^?H0]F,>+:P6;,RJ.SH%-@$T^IBB.V_KM"]$43HH.<-'1NV=T.8`"(O9\3) M[C5LE"JP$F.^7_6;\5KE:MP]5MF>): M]^\?6,8`*U?@[4>U3\4^6C1/52O_)O1"%5T@4C!%KIPFVLR2`.8@1FI$Q,\Y MXZ!5OC&]6(3,R6E6:>&M;]`=02A1);#(VL<<*0?"`T=6\N=9_PH\NJWV3`6V M'E\MNP'%E.)(O>#LC0*]"K0P@8\./&+>A7K6L?F>`R)0Q?`S-[8+ZZ?*`]6\ M1.TM4ZOK66RBQFOV?E"2S]!?Q!A_F5$Q[&.XU7E+AF"`SS'O^F2BNOGL\G^J M._;P1IDB_`:)*RY"/A!WT:W)@I)CDU*"'U)7U`-"'BJWJ$=>#\F$;'1%K@!D M6OPN+%+&TYO@S#F]Y+TRX,9S&G_&/11"M$5;IVY;0L;'G@U&<5*9/;/A?E9P@/QT+YG$+GF;@KK7]9B0P_>1WA)0 MXYX9*>UY98;@[9'UR*4,*?VY[!#;1LA`,P6$NJ=+T%M?;^OH-I;`Y MY4E*6RI4&7>9AZY7F0OV]]<4F7.*!2H;EM1BC7KIAM89YB6T@(%H*F8,%@`6 ML)082C'C3)']K#EU?$Q'(5:D8"A+BK1(*GZYOZU4%4E2XCS3-D%ML*@R%>KE M$6SQ"A,*TUAI0:;#"4-B=V<5B'5)E8'&MZ^;[LA!D**BM\=E*_3.)\M6L6JT MUZ[4EX]-]3_]N.B5.$)*O&BY;\+S'J%R=>7[J"\T'%SBD"@4LO:61GFGM6E_ M,52'I46!C]^/1U<-(9Y`\DZ.H:H*I4I(+;*EE*)`(; MS'H7JTS!E`@P^2!F5Z(58]]A+^Y-6#@OU0`!\"5SE$)*<,Z_$8X4W:?\UB"' M@7E3IO$^&)@R9*M'0&0.O/>C5>LIF$&:]H-2"A)H(&$0R(&Z57=L2V&&&A0` M.<#N%5A5!&@J/H(_UMZIO^C<5&TS`CY4`%G5S=F"#=E0IWA&_D2=:_JIXD($ M9#@J"TWL()`O5!+*7`#I_,(=]9#!7UJGC=K,-KNT0[)F:\/RR%;T M1B,S8.Z@D_9<[0H1/UK?29]C-_1L(R\W)F9E+X[<$I2(MF?B5)2D/=18*HY= M.:(P6F8?Y4A-LI6)G9K&GPC.336C6537,8M]SJA/?ICW6JUT6S@XQ@/F`.'A M2B[AIJ(U-Y&1-?#8H1)C06%,G:/=+34V@D`PQ2U.$4I#1)U\PE]NT,6<[>]T M-D62%R)?`CQR9Y@O\RCJY/J0CD"A.9:JL']4.A:A@[=&5.OIE1_#R9\0&=;.#"5S+B6@$2(6.L9\6^H#5H/Q M9SEG./.R3@6CZ:-+;5!E`!##<5=&CA@V"H"M2M^CY]3=5L M5%Z#=JICNPNL]33]+#8`R!U$3^>S"UF]@.!;CN(9T2&5MAZS.?/"F9/4D5B) MZ?#S<0;C0$E^VO]DGK0YEG$]5*45?"*.9"Q(Q`(`C1#PN96\,R]UPU5,''U> M@1&H)D4"3;3URE&>B#)#)[I?=M_(%]>&^Z6I\5_YKUY6',L_0(#^LOZSHJPP MCU7/%$AKB,T"[N)>V=UTU[3 MGJO4;ML_E(R[(5?R\/XV_Y']=:Q*)PQ:D1B>@NF]XB&$Z(&G?HH`C!VY8@LH MH8!M"7KPN^,M7'JIBN;[<`AG:C@_\6"SA) M46)86Z4(>0C]ON_0A///TNN%HCLT\&R'6,I?(5HP'?>B7L12$,A!D"=`5 MRM+[0"08/HXC=>Q=VG8$&WH):Q-CAU0AQE#IZX?+#9#:6KY(EE:Y"0T M,K8S:$3I!945Y<(5<3-M=CWZ=G7X7.[P7[`;H2I@^U&>U+=3'GNR!BZ35,'N MYM;6DN6@E=W3,H]#2A&R>0(E&V%9`BKEE>)'5-O9C%NAOW9L\;XT1PR'U`[1 MCBAAOSK/A1,#"\)2D(*(C28U.A![H\%:2KF=&UZ"V%4:O7N%0 MZIAO&?<7]3ZDVVX\4>,HK;`/N*S%%)`>ZX*C9"J(S"N',:2`BH(0"D6:4)Y< M,53[1`/Y;QZ!VJI[\W[%_?W@4L7&=5%/QYT*-K4,L-=B19!;P#9G:"P:*+'K M#(*+_6?Z'>1"9E\X0$2@)+8.=L'/VOBYJ9P8D_VKV>4T=+6>>9!J^`AOG*GI M1D2+;9WF\KI"81MKXC4[>*,]66,594XB#_[^8'5$&37I>O!29%!K^Z+.:3@`AX-(RB+4`<.;.?IA':0-QRC M+&>^+&]BZZ55Y0E6%Q*`,NP((#T_4KLL.X=\&7UIQKI1/25/4)S;V0/3X;Q. M?9P4:M@'&6+XLGRKFDD)#)C'-FS!2JB+N@23:(+R>32D=)_:&$%LGBL8"J6% M.=C:5O&D4R5V1P,NO0S7X@@G2R_7J;#3M"8['5=XF/MK!R#JN%#+[:WI-9;X MEG4H9%R!'3)D]PY%-_M0SQ$)`Y6J=BN>A#W!+Z_P(P&FZ%3H2Y:?Z06_6B,Y]@Z:%%_H$FL52!,A*\Q+A:C_CXRYZ"A;I8FK&&X,8#G_<&=,](CQ M;@241YKX$Z"?+(9)9*DJ&\C9C_>CG1"[G]G%:)4K+^LH`HF$.BB,\DZUW-XQ M"0"WND9-1L#:M+1=9>Z#I@R:_G/]]C2B'/6G@1@DPRY>T93S`7(MG,8;\RO; MVF!A.>MT$=KM9C?%2-&%O)R+N^%S"68A-*?[8&=*8A#7WU5)36`4= M,:1_':\B5,_%,402Q6$5`T=EDK"J?-.<%B#RK$.T2J9Z/D(#Y>] MR[I`2:BIQK^1!$(14T4%>UAZS1-[F)7B4@H.OK1TC8`#3PQ9&%AM49(1C>>N MU,"AF]7H+;C(Q]"0+*Y.*6F?PHB6+(^J+.P_D#O3]2@>_:6-*1=*=4]^VB_KM!,GN#Q'%9B[V3Y?'R+0+_<6GO^=7*B M;53.OZ/@U%15.,(X4&[.IX7`@ZV75R1G

<"6B,J*9&P]%:IBRHT/X"&19S;RP)^MM MA/_(!H4H9S[(J:!/F7O1]I<'W8^(A?X]4&@4@KD]OK9-S&Y->UQD/9U5<:4M M]VW2&",B2_>1M*2D MI*.@9BEV9U[6J$@#_J*I`;DED;H*XHS"EC/@[)&R0X+ZBL,'IML`]5VW>V)( M%'^;O0*;5F2JKE@6`WC&@U%.QB@<78,`H;:(95:.G7DL7JW.(C)IZ>)=EN92 MFU*.@L4ISFHI082%#$#(B]#6!X[VO`>&98$]]1PWGQ/^Z=ALJ-)$=1!P$,2Y MT%L,1"%[R8\>FH%BUAJ$5(-O.!7+U:AV2*^Z4^$HDD$>/)HD%-ALV>+LKJ94 MRE#G6SW2U"\!))DW497)`$MG\HHH!D'&P:=0S2X;JXM5YU0@?_P*(K$S%^U; M_8Q\SY">$FNRE/G19HJ:Y1.%H]ENA'18#_P]XA&,U7G@07>(/6T`/%\GI\7! MP)7I>.5#/$1CXY$@Y;$ZE4&QX,U%P&Z)]PK7IE6Z.)Y((DR[KKAE8FX43FBI MRK4P^F)FIW>,X9V`:-(9VD= MM$FH&);NR#PJYC`A/X<:!LJ!4SIYJ81LL7*&.?#PF<;#3\9H!<'90D-M&&ZD M+KQ1>92I-E)!1W@!+%9P;H+*P5N,`P+((<"5BW"!<(GE(&FE]2&S\ZO(VI8Q M!W(\"@U!R_`S\7D58O/EIY-Q9],%$] MBBQD2-JKR"9;;I-&6SI2]N5XW)G9[-JML%;+9PXOY)L0S,\KOV]72:/1 M=$C[N9DM6F!_J#"23UTFSZ-5OI7Z+5>)+>)%(P+2C'D!]97N`+^..?$IT>VN ML&W&V.$F"S`'\)4A@M\,$745S07ZQ&]V2U\%9D)?_U$X-'>1*H"YCV"N`8^R M',&X11WLJ=5RTVKX(\2`]U438%+W?TRDYP#T,`"M5P!51I$3D&,-FU M3H5:EM#]-$4KT5G1.Z7LESFR?YJ4[@0O.YTH0I>K%2(V/^?`)L`2V'##&;2& MZ5CIUSXIHJ!=Z_2!^?C2@Q'L]UP.I?8ZC"!2*#S^$[3"D:YB>\M5;&2$XJWF M9\59FV9L&0^GP#][W-9H8.Y#79(9Y6OW7+FFEOQXOR7>4S%'9?GF=,M"QFXH M36'1^V+-KC7`/:^<[+KG;K5PL9IMM'OZA_WS[MOW^\G9_N['T\/SX@ZQ\K:- MK+K]K9&_U9"+ACY+MV)8J8= MED$/FICX?3)FKS['3JG@,%K&QVX-D`^)V:!(]4+@8=BI3,US7+:HD"(.%/G:,4R&$]YRJ%&;#)M M`)=1=`4?/A;=!<3SB:F6I;FM10D=PABD3XRZ,JWZ9K6"PPC$R#J[AOE-6TLDGTJG8Q1Z-0:[V`B7ML`'0 M<8*;>U3#1(,1F<_0/`+PCAV!7T$B$\9.^KJ@_?RW<$]7R9+O5GWNO`77]7Z"@L6S@U)<0!U?)LY+?8Z+,60I'WE].2XOBT("XB5'D" MP);_2FSBM&FZ%`[2QB-!BEG8>;`$24QXA%A0TGXO($$[.HJ-V;1=LFODW"P5 M5[4S)A=Q.LB8(7F0MV^GLY$#88)&>,3*'`R#9ZY;4$CF",20O@5:AX,F**T1 M1]%#OVPCZ'?\;.)1_<]'$VTVJNQ#F*A>E!%(7N&ABM@UEC\7X'94P^3F4^@L M6F&+*W+@W<^W1%`\?D6^'79!X"KM!$'I41IT/F@D.X5\&J&++A&@K$`H8>>Q M2C@"`PT@Y<'&])KUWTK$]2AR>"$[^G&>6QYFX@;7-F[Z53&O+F\'4FW?J1FZ M_J0\15I_\HX#02^6E<%L'&B9/\$J7#>@.%ATMK:^S%+]AV`?A4(/`ZLG<^N# M=\/]!QG!G&X]7/8`%<3*`H&L=?.Y&CM8WM0)YOILC6$G\?8;2U=)4HRQ!!L) M48*RZ-*VLD[(G*!-81F.YZ]Q/'_[U2OCCJ6MSOKFZ\[:^BM35IK:"^ED?WFA MR.(U#B#,5P2YX0X"H;GNY.7;&_&-+UK%6 M^CQH`20L)(;L>A2DS;L.I8DX^E9>)^\X7'"^5X5.U!&N5)S2".`TUIM4S3(Y MYG9@MG)F.]Z6T'C-#W8;;JK\U%`J1W(8=U'YVE7X8$S;AKWB4695'O`)F\,7 MWI,;?+E=4ZN'1]_M'YT?G^+#-4]_54!TAP!T1?T=]6)#,*N<5=_8Z5QGJ/#, MA7(_R'``="G0>O]!&].?%@K1JR3O3TUNBMM5 M=S)N]V*Y&30=0[XA!D7N!;47HB"D%<#::;QG-#9V/;^G+9-G!-V:9'"(C8H_SUE;'(\ M#?U2YX*0CJC_'"ZAJ?]\-J7Z6?]Q^75G^^7K^J^QH;#^^_(6;0^;C5])B;Y: M7VO\O+F]WOAM8WNK\=OZ1F=]IS'4+U59C,_Y:>P>91&@P*J'!MA[TB'T"'KJ M.PA=\"0LFU*FK8-.5,%)79FR!:)3O--'+*Y&?'(;>KK<1W*I'L9V64N37=CM M=ER^*=,0WA]!3>E':L"S'*:/GT#3%;OU6[(K-]].KBY^]^S@@#83_D<7XOY] M5V6_B=KH@>78Z3]X*7=UI1).WP3)A`#82>J!)<8OL>&Z M5ZE.(NBYN?55?9[&#\;ZE9?5OA!45:1NJ-#6IS*.;[+VVFJ#7_>4F"5:I5AM M&E85V*["%O-KK5%NT1KK.W:RK[$V-\XV?EM_9=JT\?M&$R+NEH$-50S6)1.Q MDZ'^YLI*X]3SB9VOLA28N@!6R!Q,N'*E_N;RMG4^-7[F&[K-W_"@UIH_KZTV MOH=S^M\X;?#;O5!A;MBI97RG]IF:BL6[M.JP',/JG'JAKM9K&)QEN]:N_@9D M9/L5_HG(K`]LZR";#_(+QTZ:19HF\$1A%1Y@HT#0,82\1O8.0\PQ^RKM*G7.U"*\?B-0GP' M#9/M,9SV^ICV>`5B]^0BHE4RO'F(WB!`]71%C+7)(=3'V;5+GLRO/ZI>$5%_ MMOQZL[.QN=/\&2NZUN#D,F+S+ULJ,U(F-\LNG<9TZYL$/2\;\RV_1/1?;3>& M;VQPF=C:J\;OZSN`]:H1.QW!$7/46(Z(NJ,Y4`F\QDQ<6+;34$5' MALX;]14[Y2SCQ'+V<^[70G?MA+>-27$7373YY@:)CG*6L'P^ M-]U#WIS!O7^T?W!XGIR\[QZ=U?<,LUD&=%ER=;:^O(/SXM$*EY(.8V:(>G0W-NU"6G)M-21N3HJ3,I1IA)C[H7E2(*G M@:BI!U.W5$][A,Q75OXI@`N^C5U%DVQ])=?;1#F\EI$WX:CD:K)?M')>X!P1 M!"JGQ$]=ANOP32O.'WS`J9-@VPO8>%WM;%?`P7'&J^=1]%C MGO&]D',[\AN>ENXHVA^KH]2XDAOAVZV^"=@PWIF.?5OR9FW#^+U;T@CMTCP$ M58F>MYJ*R`G^$0QZ0CE[BM&5Z'+^&)-1%0HK@=?Y-93!E:L#?%FJY!GX4U6? M_W`96WJ9K="2J[N3`$H?'G59LLM$],W96`^M]&X6DQB->5($_EM9?>F\\Y3M# M*CZ#WU;J'9G,1Y2AD%F]+W2`N$,7:41!)!!D'F)3,R8O7@VTIU6 M>CY;P-F6[QN[V:)(2A6B*>Y#0<7*L]170:7H$+3+-T@I=8I#I6'&FKHJP#AO M;I!0"IN;:II1Q2=+#@Q!E9%T-%6';JWJ.A^=#[ZTK=I@:6O6K_;2-VP=S/,A M'/VA]U[KMS")ZX/(2F47OX9;@5:&)@QJ[^$O7+\9(:5]MM76NK>/WR[)BMA` M^Z`2*TW\YZQMW*(;7M4E9E<@7JAMCT2J>MZ+2UV]?9!;H:';VM9J>_^_@0+7 M*@YV5>'*3,L^NO_?_(L#_(MWV9@);REO&=SN!-QS%.`LN[+JWVG1@K#XRUO- ML=5,X0->A,[:`:#^\V[_^-UI]^3;PUV'\?S;_=/D\.C@^/2#?6ZEZ37XF3$= MLFK_6),2I.;XB`91E=+@\/_]=YN$#KH@3>NC02S;B))M/\RE[@^."?R3/MD4 M8TNZ+>,1O!'=3M:5',Y^T?]$?WL(CG2I=]A)_(B3D3=\QXDP,%P:$\>'>KI( M%K_61-P-V\M;TZ]EJZ*'`N[M54ALMB5.QQ%]N5)!&W"&2!>!]/`8XK>Y2D`K MG&&M,)&I0+`5T3%Q\C[$;\5E0'8W'I-_)A7S,5NB<]#/U"*OX5->UAER ME0W)G"A,"P:4&:F*Q]Z;`E+_QA3FF+?,LN)=8-ORYC?$\`'D+F*I&_KVO,+W MWL^,.<=0R?$L[EK/7=;=P%7-JEON6">@*ZG6SPM7\-= M/-/L"GV:Y5\O`G:9%SBAX:YW@QCY^XA25>+$"TJ.8\QT3QR&J:7`W'-!TJ&Z8*@EC-!VF/XAR_8@0^ M$+[B523F7D,?ZK,MHV,?:K$7&NZX5/YZ&L_"E/I,!L%G"'*U$KX_H>[KB#(Y M0Y(0$N+BMDD\65!.4S3+V\DCB8RJ?^14YKZ>T>`PSJZA??"=@@NHW*[%)%2# M_8I';D1S[JY(J,`)_2[6.^<*SBN@!'+A)I\Y/BBV$A%7[D48EU`6F]7U=H`4 M;[D;`4(;?,@A6@R4B%#L4P"J%&>99TY\#L)M42`LY):J*&V@`F+6>+>$2)PC MUVPV44N'-?H6T!9-#QPHL@"C())0"VGU+;[(;04+R<6I],%:#Y(VX'JC/YE1 M%<;CR$1%R!WOF*GPQ'Q6S>CO$ZC."$I*3[8^6[S&1,.CL-49K,,@9!%GB)#J M5O>8NLL4I%O:2K<_5.`Q-6-+S:.FZ#C46L5NVBH`[CSE3,M]R/3*Y M^P;DQCC M%$M;5]2SY8OGSUA#Y7;858;1-Q?=ZN=5'7?YV[K:5)#..1^CO.0_5?PTQ_0%%1`JL_!=6#M/ZC M\U%S54]`V(>Z%"TT!RSW&F@SEI&I].O3(]\U$!0?)-TZ-,63MPN?[-:?=,D7 MNFWMS<*)S?J08MHNNDLY5L5V/M8U9B]4\?K)IM^#5[YAL:HKDGF1G`MBI2O* MY.+FCE4FY/)&%63)QH;\':F\]([TC\2G^M_M'9X??[9/O47-0';;NX[[7$?%, MKW;9>^?=@9)^G;_VB,8U:JWY-;8S2'$7MS=17/!2;0.YNW:TTU1N%3SC[#K\ M;;BJCWE;G&V.)]A6"HC2+_71M<+HBV5MCDK)@OIHM)7T\H3OL_B9EQSF4'E; MO-=<9)FOUFUO-MHT3L.=8^'[*"^$8:TL9M1,95D6/,;U,(KF3N(,S51DD%<2 MY&J..>7TWC24OUH6:/>L8V'?8[?'(.Q(+/DMVW7NYRND7,&XE]ZHS'1FU]$I MX5E?X#!V9HI_7&F%]Q_D;EO+N#DY.#W^D.QU/W3?Z9S*^?G[_0\T.C;70K/9 MD:$->3(>9.GT`BB53FG3#W/&K_#T.1P;/\NM#^CJ&CA]B3"8>$6.X9;DTBN3 M\VEW2A#F''*"MSR_M&G`B(.5%!`>3/'H(DL!!](H&H2LD+Z)IIO]+'=<1*>X M-`R)J?#XHCTV3TGEO*JWM+2M"AL?J9(/K`<`?DG.NSH&=J<$3Y(-N-&,&PHT M\)A"WRR4:5K71PE9(HV2$3Q@# MI^J<5GG3C<7]WW(OTZO.J[5M@]=>"Z3R.K+B?IL'U\)J*WEQQ;$@)O#XK;MH M=BR.+%^XKII)EC;X)-;:9H$(NKRYV,V!6C`77\+E>@52%N0V]#D"F5?##.O$ MRQF48&#VX]YT[-^.BY])L^M)H:H9G\IW7#&Z(M)20*!J;`Y$SZNB(-^V3$QE MUSW(ZWOK1`UKB2*.#NJ*?.C)N%HFS0IR?9?#L'-2!O&SEOI$;C@/Y-2=#\90 M+_X17$L_1VRAC<*$%6XLYHY,9?4OH`,M1;DR-J#C,\O!AN7%VN;F+E%+IWED M>V>]H,8],VPVS(7IGT/T#\9"W^7D+A123]BCNAIP+?,^G/02]21S-!_CD1.` M()WQC$K.QUR+>_J((T&]TF^G9;/^XJ)-H+M M;K;RQGW&IKD'.J`IR1[^''TXS M-X8GB,5=PHE(+C`C!P`ZZJ\L'GF/FW;/2T^AN$&Z_[Y[#L5/NJ?GWR?GI[3\ M='?/#X];.G]<,5=UH1>E%\B;D<@T;U7'QP.0T!_]P/?^>8YBT`*CWQ>/=)2KQ]H>2-1P'LTC:J_QX(`KT9#DD6>H?4:.]LBZ< M,$D_3W2E4V6EF,.7$_Y(4'0JBFP_Z@F)K!GNAF9`4"(\)[H2'Y'OJ"O%_KA+ MEN./C8#H_1A>L3V\EQK.826I0[FU'7W->_S9@G@I/`V-IV?"O'\*_RV=_7]K M,IQ?KL*\\3OUG0C6(U[?C=^%M7_HJ!,).LPQVWL\#&>5[Z'^)O'S4D]Z_X$O M1QIL.ERB4I9S1-"U_$77:FP^?NQ^Y^R,.[-B,:AC#5.8D5_C:Y)URGTHFR3+ MH]Q/05L\;G/WE)=.[ONLVE,FJGY[::+4##>V8?KP,AYFB1Y M!$'+DX1:NM4$/V7YW>I'/^QK(IWJIT6>,M5W*%+$>G[&1^PH!"_GZ9>GK'9* MKEU-.;HGH+AYUO6LX@+NO)DD9^/+*5>1HWF>(-O5JU"_11D7%[0^99;J_:0Z M#_HT]4($E86ZO?82^VP[L4M))@*LH;:4.CE1?^X3=K@?+],DM>D7<#YE9Q_Q MXF&\?503/:`R"X_';>V*041SA)4)GQM\TD1R5+HX*D?VM1P!]%9G?/6%)2'G M;'9#.L7Z%LZX6,D^!$I;8(M5H[U2MJEYQ+:F-S!>S"M5?VN!)&C09^OT];6< MK)*E;>ZQ6N99+;P&8R$09WS5H3_S#$9QYK<\7UVJ49G9ZH&H1T+T_YB[NMVV M;AC\*KI;!GCIT+7835'`C9/46'T2Q&F!H5=IXQ8#5FR(XP$%]O#[2(DZ-"7J MR&D*["Z(=2B*HL1_RM19=N&A;N&3F&K?NWY;\=!K("8Y='N\*L57" M44H4_[$##4W/4WX1EPZ0`GH%ECZBJDZV1U)>TDUO89*A@G:C"Z3'P@6T(\?4G-/?BX&QSS8;3M#88,#< M0ELDY6'40=CJ(:P"\O'"@NMD$./&`$Y5+DQ-N%)(%+-(S7OD0WS5*:&V_HN&'UYL_;UD0PPMD@6N5?H:X4VPO7SKRQTW.5Z8% M-0Z)VG6QJQ1SR2V)2>1(V92%Y`Z<:?EWF=\*B3HF^='AU$Y\86&*#LX"3JGA M(IOM^'72K6?CRP(EC% M"++1_5*WVBS&\K3X.)J^11LEI,VKA>#LK9`B]F7WY7^\MM#2+48:4?4.ZB"P MS$TV;"'/R+"E,%TA;)['@JIOH-P-RD(;E/NU/D%^C%VN)HO!,^=Y]?PAQ'E^ MQ3WO&VWE!$+M=]NS$W#]%46V$PS1L/ZS2N@HQ-BQ^(AWM&4HI8$V;26]H'&$ MJ\Y52Z;J(.I:G;I`G=]`\:IW'!OHO/8L`<'$?Z01W!D:P=%%B&0&1+YC)P)G MB2IWA+!P^I[%IF9)>5OMN'W#V8[ZCGF<0:<9(:PYR!75LJZOQJYF"VI"JM#W MYF'Z%.Z4J8W-OA3N#1>%%BE5:+%4'+Z)&?8:9GF6EGQ#FM-P\Q. M@[@#6`6%_'P'D3/1H6`>O`,@0X^;R4&3Z5$T>`A'LK_X*W8PR(=J%NJ&.MO, M*3_A>74K6].T9)3;IF$F?0[NZ/K[R.T2H);DH'O6HXD73Z64^H=P?H=<-%AZ M7RV:C9G(HAZKVO4LX5T*S8'W\0B(A1E['MK_-F9*B')8R9NR;E@W@(IL2VD$ M&G]0`F:UD`>^[:K1[L*6+SOPY8E^1Z0FS'-9\P&$\;=@&\ZXYIMV`FZ':_1. MG06:J+@XU[B=4+#T%QP5*,#Y>`.=5VYQ:`#S6Z1/(+.!#$?I,D/79&K=(#3: MA@OD+:'S0_[6KJ(QC1WJKRHS%K*6KI&CQ0MRIWQ:5Y?Q"E5/BH",Q\([2U1U+AOVXB!5)4^W[E<>1:7!X!HJMRC&^<"Y@FD M##QKXI)^C+D1")/Z!4_TBX=_K)Y7,8`F\FS*6BQQ?VQS683+H*D^POW]T$>3S$46@27YVV%)F4[K:R0\ MK>V/)Z^70UE;,!_FB^*_"34]Y,0= M0O4&POV_C MQA'_OT"_`\%KBP2H+8FB+,FQ')QT9G/`]1KD7+1`4Q2T1-F,^5`HZLY.T>_> MF>5KUA3)I;C2.D4CY"Q1VIG?/'=VR"6OOGWR/>VS$VW=,)CI@_.^KCG!,ERY MP?U,_^NM=3;1M6UL!RO;"P-GIC\[6_W;Z]_^YFH;/WO.IP?'B34@$6QG^D,< M;RY[O>WRP?'M[7FX<0+X9AU&OAW#Q^B^M]U$CKW:XB#?ZQG]_D7/M]U`3RA< M^DL1(KX=/>XV9\O0W]BQ>^=Z;OS,:.F:O[Q\?Q^$D7WG`=2G@6DO,]KL0XF\ M[RZC],>4+J^"G:^Y<=;;1GN@GBF&_DA+?GF_6JF M7^A:(O(B7`&(/_R\"^-O?I?\>?/'-V_Z__KZFW_\X*S^^>-7Y>]^_%KO96P( M3;!!/1C1P+;=Y)?+&S/O8M<_-G:]EWO.3ELX`'F&.GO?!?, MA`=["8?3\KE#-)E,$X3!R33$(U0F'T2R\6"]3/9/>V3B>(V:>771'\>+25$O MES1>9;\HZ;`+K]Q6A$]T?S?3+0MRR*#?1[52@QV)V731!WXG8W8Q.IED0VMH MC:5*QOEBV6[(<&C)5&4#0^OM^-W)U"F?695T:1H^501@P,G5H@NA6Q/?8PM? MI_"3$T]HQ[$8FVBYI,]"K\B-MZ[O;+6/SA?MA]"W`U0LG=38K[DYF7.\(Y-G M.I&*/O>LXY$>GX]1BU)AH])W-#".!W]`2.=S:CG(6_O-T>`S[]R"V[J>EY?B M0Q.+53AR?06K@MB)`@L^:.G[V^<-E*H!+KWD=PV_OH_LYX'!"C:Q`=O0 M(XG[!"N14F8N+&VMQP_@29*(H*HA:UF)\!*(W\^E"/M+%="J;J&'!2S+1 MMR-\229JP7\+:3I-IRA3%LB[ MP)8)0@4694@4&155O%)M.I8N54) M`D56)0@4695U`B5:%=JVBF.5(%!D58)`D56E%9]I!IXJMRI!H,BJ!,&IK9HM MJQ8W-Q;K"Y4KL^KZF*WD8.UX%T8K..>5G<@9X.HQ.79]Y3GK&%:)D7O_@'_C M<`/_WH5Q#&>(KJ]6KGT?!K8';WO9B.QOS4@XAP:GRV9Z_.`N'X$9URU(\"8L MCL4AST0F5OCFV.R/S9%QD2RB)+'VG96[\\O2Y;SW^@JH$77;+#C189`S2=VA M:!/VT`JI^01',%,S2PL.`)_(7$)PA`P9BY:YJ(QDA)B,9("@C&2$J(P0.ON" M*]/D*MS!Z=N7!K:L2;^?="=%^=03),#W>,Q^$&1,69^-0_9HM'%,6UDAOY1B M8V[@B_4,]DC:,*(L9\.`/5(VC!"5D?>;S+H<\;R=@.EY#Y(7^N9^?A@,8)0, MS/"\2()I?L*&:G+>1#C=\>*6^+P0118?83&(=@%;NVGQ$";"8^KLF$[94`$L M'<_[A'/RW]=Y&0#=KNNKIS6Y\`*NAL$K$_"Z#GP++>7T;3+E)Q]`_*I!1N4@ MS=YLO.>/.__.B2QVB0QCP8YBZ[KX-&>U2O'YK>?>![[#^G5Z0N;[*(R=927)N<"S`%"O MD;G$.H0X!:8BU1``CA((Q!`#1?/O@&)0-`-3;U`T!5,(W!Q\PIB@EN!F2$48 M`(^2J"CJA`$W8YQ0#02"J@Q)O,%0E2(I!E4YLC"%H2I%$@BJ,B2UA*H423&H MRI'$%*I2)($`&E&2(:DE5*5(BD%5CBQ,,525(@D$51F26&)XY!39HVW3I(E* M^J>3X4']4^UIW=A('50MFL#NV?!D]92L',$6;"U%EM*XGJ?:0QBYO\`B M$[>U+:&9ZD0Z;H.,W24]\B6R-[?.$RQ%DU-/3^OJ7B\@R?H;+YV11UB)J>`/ MS75=:\-JQL":&ZI!H+U3#-+= M4%*8PB29013V3MG^0M4$$Z98KK!`L9A\&K)9H[,2Y@90^]]A3AWDI]TV=M?/ M[3(G5&$F;N-$T%"">?G^]Z-BI_M<++YNEE?JZ/&M"1')KASI7 MJZP8*)RN^CFV\Z?XX&QYKZZ,>MWQ*#Q[5)JLC?MVY]:AC!LHG:2$1>>3LA2U M4Q>4$J9M;"Z=.KHX)1'U4Z60=OBHU6X@4N3]'*">F7MKR\%W9D: MM5M540_R4#AMLKQT!*^\D&'V4JJ@LL=HN+<3EQK)=:*E"9HLN,5#4)J'_QH, MRK5KFM0)+K].E\Q4G7P)AF?&ZZI"?@$R3T_/'V-!4F'])K@B]I<@A%3O.)72 M#XY_N`=7K5^0I%=PF+ MB%7YX*Y$2(L949O^O^:B6LLJUU>ST#A@L<^'8\G?)(1C5U`-F(3\NW5*.+Y: M.D*"4XYU5;EKF(_>P\E&"$+]*I1^>`,#EI6?M MKO,K7@,M!@KDKMKB1M?37``WY!?QV9M;Z;>Q`._I#7AXESX07=Z':+Y\A>J- M!WJ")7''X./LW`3WH!37$2"OT)-:/KFM6*FA!Q@$YHZ&@.1]M(-BVT01;^R& MV:T#IG9A7K/+J"ZE=8WKBG9MA74YU<&'8R)KYW>G1);@D-$64-=MFJZ8('TM%=3XJ5.PY5?5'6GJ[]: M@!)S9Q5Z:I?@CXZP5016HFG(Z@?-AZE?R=%7`\#*!$4=7;0:XYK$52HK`1)9 MUPO!K(M'(6CE4E8$6Q<;[RW$$$:67?&M4.K?C[12;_N\G^TV@/T%Y&XM_+U: M\MT(&M[@'DY>]W^OG6EOEZAX,'=2WF!/[F[G>G`K1MQF@#M%EG"A:.C/DX/I MM?UUM/(R&*_NH+1@*U9;6OG"V\#=0P077*/'@KY*:15VY'T516Z+J[`C4"7Z,N&+MK0*._)YPA3,$U3& MPHZ\[D>"NG^947F/-P0]/J%2V`[>$1UABT1$1PF5PFJ\EP\%O3RA4MB+]V]3 MT+\3*H6E@!Z1R(0OQ"7*;33DM6L*:G=NK[*LRSL,SC,B,.#1;UG!`?#SB-BA"Z>=IX=F#'8?2LX3:\G!QO M])$@N3^%8:XCGH(!'T4`?0>/+X0G(VJ@ET1#O`_C]JA,BM&\,=5+,@YD@@+"$2(6R-S4F\R"B"-/YF1P%&"Q>Z M+WRT0J)BHS%4_ZNGXAZ-3.\Q/N"3W;TQ7P^`HE;.VMYY\6W^Y4POWO^9W9L8 MG"G]U??NYS!F)&9Z\?X#WO09HAB609!N/FSA1L+P5]M%[DS_]\U\/'UW8QEG MD_Y\A7L+C-#L\;90]%17.<0W, MRZT'SR2-4F%3\)^*8S.=?$C@LSN]`FS8:),)T=OF3VN]_B\```#__P,`4$L# M!!0`!@`(````(0#[8J5ME`8``*<;```3````>&PO=&AE;64O=&AE;64Q+GAM M;.Q93V_;-A2_#]AW('1O;2>V&P=UBMBQFZU-&\1NAQYIF9984Z)`TDE]&]KC M@`'#NF&7`;OM,&PKT`*[=)\F6X>M`_H5]DA*LAC+2](&&];5AT0B?WS_W^,C M=?7:@XBA0R(DY7';JUVN>HC$/A_3.&A[=X;]2QL>D@K'8\QX3-K>G$COVM;[ M[UW%FRHD$4&P/I:;N.V%2B6;E8KT81C+RSPA,S*A/D%#3=+;RHCW&+S&2NH!GXF!)DV<%08[GM8T0LYE MEPETB%G;`SYC?C0D#Y2'&)8*)MI>U?R\RM;5"MY,%S&U8FUA7=_\TG7I@O%T MS?`4P2AG6NO76U=VJ^>?__J^5/TZOF3XX?/CA_^=/SHT?'#'RTM9^$NCH/B MPI???O;GUQ^C/YY^\_+Q%^5X6<3_^L,GO_S\>3D0,F@AT8LOG_SV[,F+KS[] M_;O')?!M@4=%^)!&1*);Y`@=\`AT,X9Q)2"M M.69EN`YQC7=70/$H`UZ?W7=D'81BIF@)YQMAY`#W.&<=+DH-<$/S*EAX.(N# MUO5D"53,+2L?VW9`X8NXS'"LY1 MZMAUC_J"2SY1Z!Y%'4Q+33*D(R>0%HMV:01^F9?I#*YV;+-W%W4X*]-ZAQRZ M2$@(S$J$'Q+FF/$ZGBD".S1P1%H$B)Z9B1)?7B?-AOZ'&(KA\1JCX_M\+H>SHX;.1DC56#.M!FC=4W@K,S6 MKZ1$0;?785;30IV96\V(9HJBPRU769O8G,O!Y+EJ,)A;$SH;!/T06+D)QW[- M&LX[F)&QMKOU4>86XX6+=)$,\9BD/M)Z+_NH9IR4Q>Q,O91&\\!)0.YF.+"XF)XO14=MK-=8:'O)QTO8F M<%2&QR@!KTO=3&(6P'V3KX0-^U.3V63YPINM3#$W"6IP^V'MOJ2P4P<2(=4. MEJ$-#3.5A@"+-2[\JIB4OR!5BF'\/U-%[R=P M!;$^UA[PX7988*0SI>UQH4(.52@)J=\7T#B8V@'1`E>\,`U!!7?4YK\@A_J_ MS3E+PZ0UG"35`0V0H+`?J5`0L@]ER43?*<1JZ=YE2;*4D(FH@K@RL6*/R"%A M0UT#FWIO]U`(H6ZJ25H&#.YD_+GO:0:-`MWD%//-J63YWFMSX)_N?&PR@U)N M'38-36;_7,2\/5CLJG:]69[MO45%],2BS:IG60',"EM!*TW[UQ3AG%NMK5A+ M&J\U,N'`B\L:PV#>$"5PD83T']C_J/"9_>"A-]0A/X#:BN#[A28&80-1?F#R`Y+<&ULG)7;CML@$(;O*_4=$/=K M?(B3W2C.*@>E7:F5JJJ':X*QC6*,!239??L.)K&<9-MN>Y,8^/G]S3"#9X_/ MLD8'KHU038:C(,2(-TSEHBDS_/W;YNX>(V-ID]-:-3S#+]S@Q_G[=[.CTCM3 M<6X1.#0FPY6U[900PRHNJ0E4RQM8*926U,)0E\2TFM.\VR1K$H?AF$@J&NP= MIOHM'JHH!.-KQ?:2-]:;:%Y3"_RF$JTYNTGV%CM)]6[?WC$E6[#8BEK8E\X4 M(\FF3V6C--W6$/=S-*+L[-T-;NRE8%H95=@`[(@'O8WY@3P0<)K/<@$1N+0C MS8L,+Z+I*L5D/NOR\T/PHQD\(U.IXP%#FHWB0^F21`?UJ/ M@_@^C=+QWUV()^H"7%-+YS.MC@B*!MYI6NI*,)J"LXML!$R>HX_U=Z$"GC-9 M.)<,0[7#=@/'JL<$#TC1#YD?#WK9Q0G=B@N M=8YMZ2?`NV>++\E6KR@FO>2"!#(T)''92J":_DSD-F487M(#I,D5PM)K1CWU M:C!Q03#Z'P*W"4@O")(^0I\FKQD0#"8N"*`Z_CT';M-U#D97!%XS[LHGFH1A M>+D.#>X\3NNCX;KG\^WKJUMR7?(5KVN#F-J[UHS!MY_M;XU%[%)^-;^$VZ3K M/=(O0#>WM.2?J2Y%8U#-"[`,@PDP:7\?^(%5;==36V6AC[O'"JYM#H48!B`N ME++G@2OS_D,P_P4``/__`P!02P,$%``&``@````A`+:X,6]O`P```@L``!D` M``!X;"]W;W)K&ULE%9=;YLP%'V?M/^`>&_`$`.) MDE1-JFZ5-FF:]O'L@)-8!8RPV[3_?M>^*<&D:Y,7$NQSC\_]\.7.KI^KTGOB MK1*RGOMD%/H>KW-9B'H[]W__NKO*?$]I5A>LE#6?^R]<^=>+SY]F>]D^J!WG MV@.&6LW]G=;--`A4ON,54R/9\!IV-K*MF(;7=ANHIN6LL$95&41AF`05$[6/ M#-/V'`ZYV8B*U1I*6ETR#?K43C7IEJ_)SZ"K6/CPV5[FL&J!8BU+H M%TOJ>U4^O=_6LF7K$OQ^)F.6OW+;EQ/Z2N2M5'*C1T`7H-!3GR?!)`"FQ:P0 MX($)N]?RS=R_(=,5&?O!8F8#]$?PO>K]]]1.[K^THO@F:@[1ACR9#*RE?##0 M^\(L@7%P8GUG,_"C]0J^88^E_BGW7[G8[C2DFX)'QK%I\7++50X1!9I11`U3 M+DL0`$^O$J8T("+LV?[N1:%W!9#?-[V M#%PR-C?&R)H"6D$ZGA8T2F;!$X0P/V"6IYC(1:S>0*0=)`!]G4AP_7*1Q@B< M\;V>R"._=62)&%LY=F'56W`4`$U?P?OA,>"Y#U3=R3$EG6=X,F(2&[PHHF$8 MNH"5`S#[1X"C;'R),@,>*AND98D8BLK">)S%`V5]`)DDE&8=P%$&I7U^S`QX MJ&QP\!(QJ(Q$*&ATK$Y4AIG??>PO.R01Z8#\" M9_9%8_51S['4<[\GHK_BJAATY_?S0+"A]OL.C0:A7QY`F)R$G):J"W!JV=5F M6N79-4*PL3K:XF-'P^P<0/W(H-GIQ2&#AGQF?K"IPK/KS#0:7B%+[>8'S=Y0 M<5'SA0GEM$)/\H,@_#!D,.<-@F3F',."@#2.DB,#Y@>G&/S(-VS+O[-V*VKE ME7P#7H>C%+IDBS,,OFC9V(_Y6FJ8/>S?'&PO=V]R:W-H M965TC=27:3R60_ MGA%+)0V4H;#M_O=S+Q>QJG!M^D7E<.IP[H=UJ<6WMSQS7D6I4EDL73;P74<4 MB=REQ6'I_O/W\]>IZZ@J+G9Q)@NQ=-^%YY*CF*/%8#>1(%W-G+,H\KN"P/GCJ5(M[5B_+,"WQ_[.5Q6KBD,"_[:,C] M/DT$E\DY%T5%(J7(X@K\JV-Z4E>U/.DCE\?ER_GT-9'Y"22V:996[[6HZ^3) M_/NAD&6\S2#N-S:*DZMV?=&1S].DE$KNJP'(>62T&_/,FWF@M%KL4H@`T^Z4 M8K]TG]@\8A/76RWJ!/V;BHO2?COJ*"^_E^GNS[00D&VH$U9@*^4+4K_O$(+% M7F?U4/D1Z.%90[A(@PL/GNG0N50$9!9A"$J)3(#`S` MIY.GV!J0D?BM_KZDN^JX=(?C03CQAPSHSE:HZCE%2==)SJJ2^7]$8HT4B02- MR`C<-_>#03`-63C^A`H\K[8"WS>5GE8\"JO.$H^K>+4HY<6!U@/CZA1C([,Y M"%_30\&T"?N_?$&B4.0)598N_&<@%0J*_+H*V7CAO4)ADH:S[G*8R=A<&5@% ME.4$4"X1B#3`@P#:*"#!>A3WBWLUBV0T>WW,F@#0;MT'EK,[C(E)X5U*R"Q. M=(\S;76,B(9F1%B7(33_X\AP$?"T0$(V:_7KG*Z),VJCW]@`MX%(`PR/T,[] MLX[DI0L9:),-IE,_-!=P>T&D`895:.W^5I%L6[5Z=4T< MS:H-K7__FCCD)!B-_*'9A1O]/O,G?CBV MNH43XQ9MI`&&]YGIO5\OX"([!LOCFC@W!QL;X#80:8#AD<$^I">XG\EZU4<= MVY`TFQV$=Y!(1TRG."]ZMP*CZ?)XBVI(ND-:=D-XAQ,U"+70;#)FMUXV#>.$ MT`SW3"W-%=/XR&S2-2/2S>:F@_`.$NF(Z12'PN>=TBB!S]L4Z$PHILV;>F9M M.@CO()&.F$YQ)FA.'^\'C":(F?=TI#YH,FT"91TP0VPIF-1#IB M.L5AH3G]H`EHM)BY[#2!-G\:AX30Z\J=0<'AH&.F'X\^+4*&Z21#[^BY*`]B M([),.8D\XRDE@''8HNT)ZBG`USD+7[,YO%$#[K4WX&!SB@_BK[@\I(5R,K$' M27\P@1XHZ6A$%Y4\U2>#K:S@2%/_/,(15L`KN#\`\E[*ZGJ!#V@/Q:M?```` M__\#`%!+`P04``8`"````"$`\2\6:S`#``!%"0``&0```'AL+W=O,Z: M78I^_KB?S)`C%6ER4O&&INB%2G2S^OAA>>#B49:4*@<<&IFB4JEVX7DR*VE- MI,M;VL"5@HN:*#@5.T^V@I*\VU177N#[L5<3UB#CL!#O\>!%P3)ZQ[-]31ME M3`2MB`)^6;)6GMSJ[#UV-1&/^W:2\;H%BRVKF'KI3)%39XN'7<,%V580]S.> MDNSDW9U#UP@UF$H_AM%\\0 M=0'>$4562\$/#G0-W%.V1/<@7H"SCBR$_!B./M:_A0HQ:I-;[9(B:'?8+J$^ M3ZL(ATOO"7*:'37K2PVV%9N30I<"\'I&B'S(^'K63RA:K%%T%33;VBR`=\\6 MC.[[BB+I)18)9&A(CI*^-)NZ*%D3S63RWT39#`0X#')P+:Y%!)_][;O0FFQ#ZV098&\T@ M-X,%BR#^'P*]Z:WJ&,V`8+!@$20VP?7J:+$=>QC&H]B-)NJJ,TI^US@;2Y#, MYLFY?!:9'D6CYWP*>;Q.J#>-"<]/ANE'(1P*)G$4A><.M`CG MEX0QO(FN$^I-8\)S!@RAT1C"21#A8!3"9BC`LS@Y-Z`%"!/&RN%ULDX]0KMX M^(ZB*T^?I1AU@*$S4\N\U&LJ=G1#JTHZ&=_KB11`Z_2K_;2\#?2;9K2^UE-4 MKWO]!1AB+=G1KT3L6".=BA9@Z;L)=(XP8]"<*-YVHV3+%8RO[K"$SQ4*[U_? M!7'!N3J=Z!OT'T"K/P```/__`P!02P,$%``&``@````A`*0'D#!3`P``9`L` M`!D```!X;"]W;W)K&ULG%9=;]I`$'ROU/]@W7ML M#`8"PD1)H[216JFJ^O%\V&=\BNVS[HZ0_/ON>N&";1)(7@";W9F=N?5Z%U=/ M9>$]"FVDJF(6^@/FB2I1J:S6,?OS^^[BDGG&\BKEA:I$S)Z%85?+SY\66Z4? M3"Z$]0"A,C'+K:WG06"27)3<^*H6%?R3*5UR"Y=Z'9A:"YXV2641#`>#25!R M63%"F.MS,%26R43#40CAWDH8>R<1DGG)QEA5_J.@<`=% M(,,="'SO0,*)'PW'T\LS4`*JJ!%XRRU?+K3:>M`UP&EJCCT8S@$9E450$]7A MM+XF%30BR#6BQ`S:'=(-G,_C,HH&B^`1/$UV,3<4`Y\N)G01`53C2H(R#DLZ M;O*>&8.1&4W'4F[HQB'-\#C-J$V#RD?0&6_385+,@,.)B*(7&50!Q41-1QWJ MBOJ$DY.$F`2%M0A?!!$AQ?0)X1P/C3Q/(29U%8Z<@T1(,4![X$+D8EJ'.?E( M#9C4K6'L\*D&BNF+GO8)3[N,2:=.!=: M+L_:-;S=PQCKQ.SNEW5LYN"6G:/7]X3;;L[T^OMGL:W<9=^W!W,NZ`C-A^94F?83"/H MA,VOS2G85SYB,TVA=COU;-Z/JL/YW)T(F[ MNV[)NAXV'>K^@!VGYFOQ@^NUK(Q7B`Q2!_X4#D/3ED075M7-IK%2%K:;YF<. MVZR`]_7`A^!,*;N_P#W,[&ULG)5;;]L@&(;O M)^T_(.YC&Q]R4IPJ2=6MTB9-TP[7!&,;U1@+2-/^^WV8Q,VAV[K=)`:_O'G> M[P.RN'F2#7KDV@C5YI@$$4:\9:H0;97C[]_N1E.,C*5M01O5\AP_`MO2J4EM3#456@ZS6G1+Y)-&$?1 M.)14M-@[S/5;/%19"L9O%=M)WEIOHGE#+?";6G3FZ";96^PDU0^[;L24[,!B M*QIAGWM3C"2;WU>MTG3;0.XGDE)V].X'5_92,*V,*FT`=J$'OD:G5_H,6Q2?1 M%VX*%H=7J^_Z!GS1J.`EW37VJ]I_Y**J+70[@T`NU[QXON6&04'!)HA[#*8: M`(!/)(7;&5`0^M1_[T5AZQPGXR";1`D!.=IR8^^$L\2([8Q5\J<7$0`-C)#\E/'UJA]1 MG-BAN-(YMK6?`.^![8)L\XIB,J"=D4"%3DE5&< M,<*>_O&,(/L\/%LHI=5R[FUW#A],]HQ3]378G6H(:78!D% M$V#2_LKP`ZNZ_MAME86CWC_6<+-SV*M1`.)2*7L&ULK%A;CZ,V&'VOU/^`>-]PSP4E64U""*!6JJK=]IDA3H(FX`B8 MR77]^IBO*&F+7&],IV);1JH+O"AK$\K M\_NW^,O<--HNKP_Y!==H97Z@UORZ_O67Y0TW+^T9H>NNX:6U19G M5.7M!%]1#;\<<5/E'=PV)ZN]-B@_](VJB^7:]M2J\K(VJ4+8W*.!C\>R0!$N M7BM4=U2D09>\@^=OS^6UY6I5<8]'$D9`;#<:=%R9 M3TZ8.9YIK9>]07^5Z-8*_QOM&=_V37GXK:P1N`WS1&;@&>,70DT/!(+&EM8Z M[F?@C\8XH&/^>NG^Q+<$E:=S!],=P(C(P,+#1X3:`AP%F8D;$*4"7^`!X*]1 ME20:X$C^WE]OY:$[KTQO.@EFMN<`W7A&;1>71-(TBM>VP]7?E.0P*2KB,A&X M,A'7N[NQSQK#E35V)O,@\*?SV?U/`,Q^&'!E(H^/`I9$KP'7?_\@"R8"UTMG@FP'+!\QOKSE9C$[H0$+X'-,9&6;]GR8=9INH/!&9E0FC M@_EL(:EO:]]VE]8;I*M@G(W.<63&EC-(E(ALI`([%8A58*\"B0JD*I`)@`6V M#-Y`Y/X/;X@,\8:/:L.!T2S%JBUG\":1"NQ4(%:!O0HD*I"J0"8`DA&PX#0C M?%@.GV\$/!.D%2QY(1.>/Y-G?$,Y;K\/]5.^U9!(0W8:$FO(7D,2#4DU)!,1 MR0+8030+G&!"MI'N7!8O&TQWLD\L\6`]T%5"1%:F"WD3EHFG6$))#MT%R2K8 M,F0V)"BBB#_M5YIK.[ZLL1M^YP&**1*X@\9>4TV&5F3]@JKR9.GP.U?-1%7) M+K!%LNL36^`=P'TA[-X7+KRAB&B"AD04"1;#D'8:$E/$'3E[32?16J4:DHDZ MTD"G#PV4L.6!4@3>XF,DO$#=%QG)'T8:?=+,M:=*"BC)=VE*W,"V;9D14X8W M9FVO=97H&ZHE.2-^TPT-..9 MVS$.6:XD_IX_5Q9`3!EBFC3=1---)5UG,0V"N3P-F:@K>4,J:?'M_/-E1-BR M-Q11TJ6,:LM(0KJ&9H,W%&%10-5T`/>$+;L#464W"B];RE)S,W0;/"&<6ANIHX6_9@2Q-AHLHDFF\JR4TTV M$V4E9T@=]X`U/5WVAD%*<)0IWW*6D!P.]5\E_4MOQR"6G3E\PRE;0\P88G:X MSBB=<&B43F7IF>=.%W(J,TE:-HE4??>O+7@5J0%BD)(@91/>,I88H;'AD"'. MHB%:Z+,=,X:8(MYHW-4273H=6>,&Z0;*)I!)\K)1I"H4C:*?"`^6/@ZM+:'V MX6/>,$@)F5(A;CEK3$+$((]^8?&G#%647M=.N&L43KE M$).>S;0MBC-Z:=D[4D_^=^]852IZ1R&8-6[GEO@(6YP4-`;!'CJ\&_4R@3=< M]"^^N>?-`V49Q8SBCTG;\U8CE'#HI]VEG$6[F[ESVU$V%G*H089"NZ.&TD,* M^NE:H>:$MNAR:8T"OY(#"*(UH/1P)/)#*(/!'05/_!`*61V/@A#J1QU/@A#J M01V'PY>GOII6]#?D4.83_L8-X?M*U]EX(7QUZ/B3'SZ!#_"#-?0`ARO7_(1^ MSYM36;?&!1UA[':_$AMZ/$-O.GSMO^R?<0?'*OV_9SA&0[!2[`F4LD>,.WY# M.A@.YM8_````__\#`%!+`P04``8`"````"$`$KGU+`D#``!E"0``&0```'AL M+W=OR!#HF_F-L"_15\IQOOGL[D[JL2R7=1\( M'T1K95"[7AG!J`SUM:D\N$!3)JP3:`P M`UO=IJ]!5Y`.>^.S&WTH+JZ#S6U9FO1K4T[4@2@8J,L;3@8UJ.4<%*\O,(*M M>EUA%^GZ&]U"B^`VK8N,VS:'IQV,;Y%"<%O*1;H.\$)M]#RV1#B`[;S<$[BJ MS>\BM&UE=-K*M*UY60K!;2D7Z5K!3NAXH>/>A]UF%[8U]B$*1ZO17./3?M!U M4_BR(8L^4D."B)RP=-/%@-D>U6H?.FJQR1D?>(P;S?"!#W?HX9#6QX2>NP?H MJ8L@"*^X">S*HVKM#WZ[UZ9G/-UT\G$$'5>P<_;=4'.3H^!JS;_P/-=>++&UL MK)Q;<]NX#L??S\SY#IF\;V++M\33=*?1Q9)\]YS+LYNXC6>3.!.[V]UO?T"1 M,`G\%=MISDN=_@0"(@B")&3KT^]_/3V>_;EZW:XWSS?GS8O&^=GJ^6YSOW[^ M?G/^[W]EOUV=GVUWR^?[Y>/F>75S_O=J>_[[YW_^X]//S>L?VX?5:G=&&IZW M-^_>P>EIN+S8OJV>Z\FWS^K3QU]>WF_$NSO^A$YY>? M/U4.^L]Z]7,;_'VV?=C\'+RN[T?KYQ5YF\;)C,#7S>8/(UK<&T2-+Z%U5HW` M[/7L?O5M^>-QM]C\S%?K[P\[&NX.]63Y5_7Y[@Y;T47S7:C2])G7U?;7;8V&L_/[GYL=YNG_UJ9 MIM-D=41.!WVRCNY%I]=H-=^AI.64T*=3THPNVE&G=U5I.6"^[5K2IVL97417 MG6:GZL.!AM3#JN_TR28;%[UFX[K5(W2@8=%"^Y^3IDPV=V#>:IM4M MTB=;.JUOUZXA?;+)T_K6I!"T$6%BT87$:0/1W`<3_<%63^QHDX/(_/&^KC8Y M=,P?;/;$SG+L-(/@.3B49FY9]_C!/S50FQP'Y@]WHYV+JTZGW;TZ$G%-#@3S MAVO:.C@JEW:B5WDC6>Z6GS^];GZ>43*FL=F^+$UJ;_:--LX8-M[W.>2M%$*Y MPVCY8M3(YL#_8XR,&C-&[-U;!L&@ MJ0%A"6Z2:)!JD&DPT"#7H-"@U&"HP4B#L083#:8:S#28:[`(@!@0RBQB0.J7 M5YX;1IH64C$W6M+1MU8FJE;W*O1C(`F0%$@&9``D!U(`*8$,@8R`C(%,@$R! MS(#,@2Q"(H:",K48"IN_+GP"/3F%&4TWYQ%-PB"'M=4X.2$*C$"H(X7BO=!^ MV@!)@61`!D!R(`60$L@0R`C(&,@$R!3(#,@EJ>-BI MMXX$Y1V.-]+2 M\8Z0_F`2=-4DV`OQ>"5`4B`9D`&0'$@!I`0R!#(",@8R`3(%,@,R![((B1@+ MVON]8RR,M!P+1X))`"0!D@+)@`R`Y$`*("60(9`1D#&0"9`ID!F0.9!%2(3C M::\J'!\L'+N']=T?MQL*;EH,:K)2BS:X=MMKE,CQL*39W>^R8D?L(;G:U5K2 MII@(YD]/SI]T+\3S)P,R`)(#*8"4EM@RA'`)G0X_[A*C1+K$DM`ECO3V3DHL MZ5S9HT.CJ=;==']][PU'JF)*-1@#T)KO6U4'DD93[;J*_7766H9:A6_,05@X MIR8NJ+[!@5&)2S2TQ]03217$43)N&6G92)]4R M<_3/S\U>L]VZ4E,K4GV2NXH;47]:)FHZO&M!3VI#O-"2-T MYR]E(5,DT5ZVJ$6;+Y]C6@WM92LE@LTU#(/-HBY]!+K4V3US-]&BA.NEFLKB MP$D%%G-NZ"T6C+IV$*^[;37,)4M4*42ZU!P5/NY2=^#PL^G6U)-L_/',C!UJ M^:A)'.JT]K&5,FJ[D&RTKQHJ1#*6"=(9*L]9RBLO&%GE4:_=H)"7PURR3*5< M.LMLSD-G'9G.;B\?>L4B8\(/>TN5?F(:[\IW85;;-V1WIBB5.22R&NC*N6'H M%Y`JA2[I!K-5?H<;W,XZ=(-%Q[*:DPKCQ:)@=4Q-49$"C:(J=*E:NS(G14DL MD,+YMM?%7LY=P\!B46\1PLCJ>M.B=*G9\88N_;7,YO;-H:I@_8*EK+V:*-#3RI43BI9IF95 M-AOK0U[^U^;EK>-6N*VV^W/A9H=\3HV;@!)$*:(,T0!1CJA`5"(:(AHA&B.: M()HBFB&:(UH()&8"59_E&!W>#%3BW_V( MI:1Z=?=C+\7J)XR\^BFJG[&45*_N?NZE6/V"44#W:) M1D+G58ODJ;&MRQ2N8;`Y3AB),PYLQIU4.W(%*_JZ6T/Y-G,R82F#E?M3:LXH M./0PLB6>EMKDEUYO&)=JU@Z]$G;]B-'!KHV=E.M:=-WJ0-*M2E"@"9DWJSI&(?;'A=[-X<+19>*K2H3N/E21:'7A=;'*'%,4NY6GNK M)C"G;JO)DNW#7;0E?AH$I$;PC#&Q%082!1;*D MV59%ACAR4C[`$T8^P%-&M)P$(:6*`)F3HM002$&)Q.OB08L%(VE1G<'* MDRP.O2ZV.&+D+8X9"8L=E?XF)UF<>EUL<<;(6YPSDA;5:K,X9E&&#:U<[PD; M(ZZV[A91$@@&L:,"-XZLE,@>^X;H?LQ2;]WX!#5/N4V8$<`E"PO./7>8L[J_9PI&,DY`\O# M*1:'7A=W:,3(6QPSDA95'ITXJ<-]G'I=;''&R%N<,Y(65;9='+,HPL8\A7E' M7JC$95YP2.4%E9!C)T4?W,'$-V24>JD@;+HJU69.RO33+SJPG'A=K#Y'BX67 M"G1U5:HM3[(X]+K8X@@MCKU4:%'ET%UNRY,T>*,&WJ+\UJ+VE\+;EAU2`;% M_Z5J:)XQZZ#85PV#3G;5:A*[AA3'/!D21K3<>N_`Z9:EKOD+#'@$S)Q,VRL? M<#./:UW#;FOB M;X$]-^5FWMZ,D>_6RH+:VSF:Z(FN?EY$2-* M$*6(,D0#1#FB`E&):(AHA&B,:()HBFB&:(YH(9`<"U,J"<=";PI.^B%#RQ9< MQ!!9%'XMS$D%*''HR*-H+\7S+$,T0)0C*A"5#M4\\FV9>L;'O6.K(L([%@6E MM;BR1?4A?Y))''K[D:\7\(ZQFFUG;&D/->>^X1N_;?`"K+EDA,_::-LNW71X M[:O$997#(74N56?HV$OQ324.]7PF2!%E#M'9BAL.4%>.#0M$I=`EYE);G]J/ MN`&/YY4&^M*?.&Y&X`;;,`B>Q#5L^^!)$64.467'NP%TY=BP0%0*7=(-^IQZ MQ`UX(*6GA2:]B^\^-G4%*G92X>-61@>?2:9.BCZJ'WDTFOK8GSD)$2_ND.RW MQ?E)U@IIK=NX4K6[4AB3GM0GMB.>Q)-9VZ)N>(AM-E4U+'92X='>H2#&4I9R MQ?EVHZ7V0YF3$/%E;R!0G:/J0JGN7G75+99"M722.9Q\.$>WW1''9XA;AT04 M]M1]Q4Y(!*%51=M3GF6IDZ(M415QU]=12TWJC$7\#!Z@[IREO.Z"D:N`-+I4 M7I&/.TL6P9I26Y]:?FGYK[2HA&X/,T'\Q$XJ"(7$H?!;X8S<+U*B5KNE)DS& M(OX[)0/4G;.4+_`7C%CW=;NC2]$L4K/(O>]08;8TZOSMD%KD5.]B+\7ADR!* M&?ETE#DDDI:]";+(NG)NZ%'!R.LJA2XYW=ZW>:<5"=Q@D5SD>BIF8]I0$%,96PP7.6LQT)6CK@)UE4*7=(/>-Q])S;A!;ELDTDO44_$8.RF17VS# M8%!3+Q74`76NRIR4J3#[5@=>EX\9L%AXJ4!73Y55RV,6I4OK-MOF*?SI M/ZANXT[;(;$"TN_<9(:,G5001XE#(C=9]?(7*SU5*,^X(6T8#KG9Z@HLYMPP MG)JU%E7)KN2&;UD4;N[HS?HOI?Q*BTSY#M'&D`,G=BB,7H?"U=$A^2"IIS<7 MW-`$Q/XM41"]:#'GAL&:66]1+!O2L=OQ\*CH4)[ MIU<-)Q6$4\*()J]O"$]G6#VM%%[J2F7CS$F9LX^70N?;NP]N(C_I)@J6LD]1 M.M=7>D=>^AN@X)*.-QOS0XX_[;$&'9CU0L7(GRUC1`FB%%&&:(`H1U0@*A$- M$8T0C1%-$$T1S1#-$9E74U8NK/QEQ\B^:M*^,NYI]?I]%:\>'[=G=YL?YC62 M5);Z_&F/[3LN;UNMOGE`0L,,5]ITI=JDP)4.7:GF-USITI7JYQ!PI4=7JAVQ MOM*)^#6;Z@J]?_-+M3%4_);>RUEE/%RC5] M4Y^I:4-73+4%KU!M@]K4N9LB;]W+@%?KI#]U5;81%#8K5NC:W$46W79`N]\%!;WU]67Y?C9>OW]?/ MV[/'U3>:SO2:3#KUO=KWQMK_[-SO,K]N=O3"U^HGF@_T?M\5O86D81YJ?MML M=OP?NMW+_1N#/_]/`````/__`P!02P,$%``&``@````A`%V:)I\,!@``F!<` M`!D```!X;"]W;W)K&ULK)A;;ZM&$,??*_4[(-Z/ M83'8!L4YBLU=K515I^TSP=A&,<8"9:?Z7*SU]Z+5O]__ M^LO=:]T\M<>BZ#3P<&[7^K'K+IYAM/FQJ+)V5E^*,[S9UTV5=?"S.1CMI2FR M'6M4G0S+-!=&E95GG7OPFL_XJ/?[,B_\.G^NBG/'G33%*>M@_.VQO+326Y5_ MQEV5-4_/EV]Y75W`Q6-Y*KMWYE37JMQ+#N>ZR1Y/$/<;L;-<^F8_D/NJS)NZ MK??=#-P9?*`X9M=P#?!T?[K^6N.Z[UN3E; M$M.=+\'+8]%V84E=ZEK^W'9U]0\W(L(5=V())_"43IP9L>(J&[FSE./9B1>.]$>-"-%SV M#3\[5EAJK$MX?FVLKF@(SZ^-E4`:\5FE^21F[+:R!L\+EF9^UF7W=TW]JL': MA9EO+QG="8A'_I1KT\4#=K'22`9&IAF;S<6V1^9[Q`:N?" M9H-MB&JQE18TCZE;?PJ"*0BG()J">`J2*4A'P`!9>FT@WW^&-M0-U49&M9%@ M)-9$"&DAF_A3$$Q!.`71%,13D$Q!.@**$+"`%2&N[SXR%Z@U[#-*+MAJ@!MN M8['-CTWU%A$?D0"1$)$(D1B1!)%T3)3080=20N?K8S;L)I]>(M336K<@V49K MQ)GHPHTR?`X'(#\6J1,U?DYXR<@W/D&6_?G@JP%0WGP\;L"^3,>]D#B6PFZ,JVX!M0=11*D]'"P[YC:37X3B3BO@FQB.M. M1IE*&[PWT13Z"?)1+Y-ER1'XEUF[97U!U@X)X@OD0,TP)#+.1^[+63#YB#5? M$F>RDX72T[#Y1;B_6%K=["^15J*_!3&7-LI(,2;6GYJ1M-*[E9$_Z@O[@/Q@ MV?."44E)@89DVX*83/D!^1@%&(4811C%&"48I0I2M:#%X%B+#V(6M>.PJVSH MK0U-+67&+/0%W%O);/.'AA(%&(4811C%&"48I0I29:!UX1=DX&6D,O4"#?.\ MI3L3569`/D8!1B%&$48Q1@E&]!)O&`2/F5_*\=N2JF@.Q;8XG5HMKY_IA1M9 MPB+N,;\-W)"%O`Z%NQ[44YC'K@<5$>90DWBT",%OH,+P:$F!W\"]Z0/;Q*?Q MT?O4*_8;RX/;">QG,_?@VQWS!]M[@"F%%T;?`]R+7K)#\7O6',ISJYV*/4PC MW(;"DFOXS2K_T8EM[;'NX$:4[7!'N`$OH"(S9V"\K^M._J`=]'?J]_\"``#_ M_P,`4$L#!!0`!@`(````(0#65?HBP`L``*@W```9````>&PO=V]R:W-H965T M+BO#3-3\,_J9DA.33C3W_^V#_WOM>'XZYYN>U[ M-\-^KW[9-O>[E\?;_G_^BOZ8]7O'T^;E?O/O+0'/:;$_UZ>!P<7P_UYKYM MM'\>^,/A9+#?[%[Z4F%Q^(A&\_"PV];K9OMM7[^'K]]>_]@V^U>2^+)[WIU^MJ+]WGZ[2!]?FL/FRS.]]P]OM-FR=OL+ MR.]WVT-S;!Y.-R0WD`/%=YX/Y@-2^OSI?D=O(-S>.]0/M_T[;U$%X_[@\Z?6 M0?_=U6]'X_^]XU/S%A]V]\7NI29O4YQ$!+XTS5=AFMX+1(T'T#IJ(_"O0^^^ M?MA\>S[]NWE+ZMWCTXG"/:8W$B^VN/^YKH];\BC)W/CM,+;-,PV`_NWM=R(U MR".;'^W/M]W]Z>FV'TQNQM-AX)%Y[TM]/$4[(=GO;;\=3\W^?]+($X,ZB_A* MA'YVB%QH&*B&]),;WDR]X3R84N<7VHU4._K)[:X?-771OCK]5"+>_,8;#2?B MS2]T/E'MIN=VOG_CS\;>^+V6-.G:'NFGZG%T,_+'TUGK[`M=SE5#^GG54#W* M)QE>"J!J^='!>AQ5\9_KANMQ7,5_>,#DM@MOZ'%(Q7]4D^!2+@QD(K?S8KTY M;3Y_.C1O/5ILZ$V/KQNQ='D+(<8S0G9^GB._FB*4UD+E3LC<]BE2E/U'FM?? M/WOSX:?!=YJ+6V6S[+"Q+59L(6:+D%V[('1!Y(+8!8D+4A=D+LA=4+B@=$%E M@`&Y]NQ?RH:_P[]"1OB7/;-DH!WN.\YD"VZR=D'H@L@%L0L2%Z0NR%R0NZ!P M0>F"R@"6,VE^@#,#FK3=RS?GIFA%"[65FY[MK*6T\=O=HTV]%9`UD!!(!"0& MD@!)@61`^$;O)!^>^D+IMN_3!##FOI.,2VDTMHT" M.PBKL]$Y98&$0"(@,9`$2`HD`Y(#*8"40"J36"ZG?=)R^>6L%=:M6]D92T6, M'`6R!A("B8#$0!(@*9`,2`ZD`%("J4QB.8SV0,MA8F\*9J(R4WOCAW-4*-G. M5(2"963MR$G(LQ''8`TD!!(!B8$D0%(@&9`<2`&D!%*9Q/(OE626?R\GI+"V M?:B(D9!`UD!"(!&0&$@")`62`)8Z!;+*F$O.P[T=#VG2*3 M\XZ^4H0Z-S)R;&?D^MS,-)J&]8BI.?F$)FR!5Z)^3GAF;(9[\(N2CIS"&_,TY5 M`9KC-(M"6>R*DZ<8NAER0"%:18AB1`FB%%&&*$=4("H151:R0R[JLRO\)\LY M*\X*V;7#_!PNY=*S%2?(6IROA9='YYP)$46(8D0)HA11ABA'5"`J$546LETJ M*K@K7*H*/C,E%=+YMQ(?R[DI"2A$JPA1C"A!E"+*$.6("D0EHLI"MO]$A7:% M_U1!9_I/HE'0?O0RHD^5W5+64Q8Z]]:,R*OGG89:VGD<:BO.XXC1])S',2,M MGS"RY9V#=ZJM6#YCI.5S1EJ^8&3+.^?.4ENQ?,6HE;?C(`H_,P[RP[#V4'QZ MVFV_+AMR%&V8'4NN\'P[\>\\H>)LLA)1>'@4*V4UTF^T9J3WCQ!1Q$A_%A0S MTEH)(ZV5(LH8::V(@LG=K3R)Z`,A1FN%1O,S"A%%"OG:*D:M!!NFB#+4RE&KP(8EHLK2 MLOTG:M@K_*=*7M-_$HE]T@@JK!K*2F?#VI-HK+T<(HH4"G2/L4*TC7!X$FR8 M(LI0*T>M`AN6B"I+RW(IU3[7N+0UMV>Y0@%5VZ$G)#N<;/@FDPF3KQBI2-F7?*B_E!NJ_L;3,=W:V)M#AOWEW$SW M5WRHOY(;RO[\H3?QG,VBLKJSH^<>A'YKZ18?8CI+MT*!6>SY0WTLC)R M>\T-Y36BN,T(&4W:77KB^\.9$^2(3?3>%Z-VPE9:.V4DM6?>R/<<[8Q-M':. MV@5;:>V2D=3VYKX7.%5"Q2:XJ?KB<&,N5;\7&75$TNO)LA6F[=C8`10R=P!& MM#=GP"G<*=9N:1/OEIGV76, M4Z.LE)65DN>&K!6B5:205=S(AH96H@?!6BEJ9:B5HU6!6B5:59:6[5+W0/G. M#,>3HR^14W[HCP95^2&MK"Q5R*[OG9(@5/(COUU`_&$P]V';4R/0<8Y5*Z.[ MA-'%[E*WN^%P[!PC,V5BS)NR%2UXQM[O+)&5[M&P\K0;[(B* M,^85DT28.XN,1.^=$I25WNG7OD3&6ALJ%,B2>1KXX[E;F47*QIHU()Z@>.J( MTU]>369.W9NA>,[-],@+%"_92HY\/I^.'>G*DK9C($Z@9@Q^KZ*4YUAK_9+( MF6S.P%;D2=@25$-=,X?**E`ULQ=XWLA1BMA&%^0QBB=LI<531DK3P'/6FXI-L-JGE?AOB$VK8D\;A8SL7RE$/WBE7S.B M!#=FO+OJL96J]B>3(26@?;*-E(U9[7,SW5_"Z&)_*5NI_F:3P!^ZX<+^RO9"O9GS\4!TW[]2JK.VMVT$ZG2MWV?%5AJM$86( M(D0QH@11BBA#E",J$)6(*@O9?G7/P9=K`;$_.#L'(VL[X3]Y<#1W3+%5"I?:*>ED_^94-^:?I^_KP6*_JY^=C;]M\$U_' M:,NH,Y;?%5EZXX6X5*4$?+NBORSKX?$%_EM3!/7H3^O.5KB0.^R6YOM->.+[#_FZT MN.MV+KU?9S@H&EW!H`OEA;CJQ%>@>^6%N/'$)W2]3*_=%4*Z#J4G76WH9IG> MO.L)W4.2X]MK4"$U$_7DR7UL^SL9T5/Q,TRO@]=]M,(NI[0 M;?Y"7"IC&[K47XB[97Q"=_LTZO;)X/Q"]#VIU\UC76X.C[N78^^Y?J").VPO MSP_RFU;REY/ZM/A+VB:$_]"70_.W['[_'\` M``#__P,`4$L#!!0`!@`(````(0"ZUWS8J!```$I<```8````>&PO=V]R:W-H M965T&ULI%Q=;R,W$GP_X/Z#H?=8&GW+6&^P'C)W`>Z`P^$^ MGA5;7@NQ+4/29I-_?]4SY+"+35L:W4N%CE?GW[\_>7YZK?-_K#= MO=X.JNO1X&KS>K][V+Y^O1W\^U\__;`<7!V.Z]>']?/N=7,[^&-S&/SX^<]_ M^O1]M__U\+39'*_0P^OA=O!T/+[=#(>'^Z?-R_IPO7O;O"+RN-N_K(_XY_[K M\/"VWZP?FD8OS\/Q:#0?OJRWKX.VAYO].7WL'A^W]QNWN__VLGD]MIWL-\_K M(_@?GK9OA]C;R_TYW;VL][]^>_OA?O?RABY^V3YOCW\TG0ZN7NYO?O[ZNMNO M?WG&N'^OINO[V'?S#]/]R_9^OSOL'H_7Z&[8$K5C7@U70_3T^=/#%B,0V:_V MF\?;P9?JQE?58C#\_*E1Z#_;S?>#^O^KP]/N^U_VVX>_;5\WD!L'2@[!+[O= MKY+Z\X-`:#PTK7]J#L$_]EDZ.9Z/).>[G?/((#_7KULI38@R?KWYN_W[E&-5I,3#=%M,U[\/>L7AZU>C?QN?5Q__K3??;]"44.1P]M: M3I'J!IV)[A,.Q`X`M+)%^GE=H"S$!-*QQ1CEFQ"8N M![P"B#)J15,N%WK45Y)Q8$C?)5.Y:W/&S7G6R%<;Q!G$:X3XH20UOZ8PJNO^ MHDH_MX,QCIRJC57&/21!JY0T&7%2W25U8AO$:X2&`^)Z.!_++5R=4EQ4$X@WB-$,%%'X*2S`0#HN0RB#.( MUPBQ$9O/)JEJ/KM.<^39$Y7TQ%0#@L)16N:G>9?4:6D0KQ%BOV+V'Y>>)#/! M@"@M#>(,XC5";"K,[EK,C^DTVJ$*>Y MK%U6'*B+?;7+(O%-3Q`/0>9[-803L@9WT+(&2,MJ(%<9R!/$G&32/I]3F.(U MIP#A1Y5TLURZ+BM)9R!?:8AIRFQ^/LTP]VN:`=+2&=JLD7N79/`"33A`D$3I.L]U[;*2K@;RE89X##+MJS&<*,E@$IJF]HUV MY8.M2B:BLY`GB#G)9*XX-:N?Y45G>K`%S;=S"BUKMERNJRXKR6H@3UD\!'$` M-803L@:_T#2UA019#>0J`WF"B!.*FCB)K`OLTWK/GTU';$L1XF+-%LEURNI4 MM9`GB$?0RY9DU9NY>832Z5U;R%G($\2<,EOZ^$B/K?5$B.?/;(U>IZPD7>AK MTMFNIRRF*9YP=D&.@X.H@HR0EBYD))S:<=B>ULY`GB(<@CJ"&<*(B@W]HFL92ZK&!G(4\0<1)+FEI M3I?+VO3$SA,A/M'S#5'*ZJK50IX@'D(OYYE8YXF0JE8+.0MY@IA3+^>96.>) M$)_H^:8G927IK/-0%M,4ESB[(B?!4U1%1DA+%[(2Y&R6)X@YR22O.$E%CF<7 M+(4FP2TTW0!A&D_K]FF^'XH-T[[16<@3Q",0EU`C^/@\GP1/T32-S=0Q2ZMJ MLCQE,2>9_\_G%-Q"<^H,1$N7;WDF758J2`-YRF*:O9QG8ITG0DFGVD+.0IX@ MYE1PGFJ&*N]Y$7UB?2="/$'F&YZ4E43M#"M"GK)X`+U\9V)])T):5.L[-LL3 M1)RFF>]\?(XTV>PM$<)Q2*=RE5MVRHHZ.0MY@IAF+V^96F^)D)+.0LY"GB#F ME'F+3)"3B[;@4^L[$<+,#=7*W$*>(!Y` M+]N96MN)4"J^VD+.0IX@YI39SHEZM.8R[3Q"2Y?O%5-6+#YG(4\0T^QE+E-K M+A'2TEESL5F>(.(TZV4N33:;2X#DRKRJNMQ<8M:TN:^?K2)=C.+<4GUDFQ\? MLR9-'\GY>3R]7&AF72A` MF36B`,DE4T4Y$[E.68ERVY=<_U4-LX6JIX;,7'Q$368GF`?745.6+`UQD0C, M(Z?:0BY"3#,50'-=V<>LIB^F*:9Q/LU@,9IF"V4UD3O]K,N*@W$1:FO",-8- MF+&XS/F,@R=IQL:FZIF!G(4\0(.8F]J,-YJ>G/@DWI`QT@E%(ZA>>YZ<>&RO0MY`GB M`?1RKIEUK@AI4:USV2Q/$'&:]W*N)IN=*T)4C_/<]%-6+#YG(4\0T^QE2'-K M2!%2TEG(6<@3Q)PRQY%ZO.P"\=RZ482X(O,%0^@QN?\5?NXN0EC5D)Q/G`+$%9FM@^IYEQ4'XRSD M"6*:O(.67&<^(LL?8R#Q!79+ZT3%E)NJYAA#QE, M]C*W]A*AI%-M(6''!Q?6F)[:>"'%%9@OO.F5%#9V%/$$\ MA%[6L[#6$R$EJX6R>`3B$F?/ M\HO@*SZ+*2=`;RE,4T>SF/ M/)F;TPQ0TJF.60ER%O($,:>"\URV%EI8YXD01%+.DV]Y4E:25=M,N[^E+!Y" M+^=96.>)4-*PMI"SD">(.?5RGH5UG@A112[RC4W*2M)9YZ$LIMG+>1;6>2*D MI0M9"7(VRQ-$G)8EYZFFESR_T73%9WJ$J"07^:XG976Z6L@3Q&/H93U+:ST1 M2B+6%G(6\@0QIX+U5)<]Y[JTYA,AS%#I5%_DVYZ4E70-?:F[093%8Q"C.'NB M7P9;4>83(:UKR$J0LUF>(.8D%G`^IV`8FE.`^%3/MSW++BM)9R!/64RSE_DL MK?E$*.E46\A9R!/$G`KF<]G]R:4UGPA!)%61^;8G9259K?E0%@^AE_DLK?E$ M2,L:LA+D;)8GB#GU,I^E-9\(<47FVYZ4E:2SYD-93+.7^2RM^40HZ51;R%G( M$T2<5@7SN:PBFY[8>R+$%9EO>U)6)ZN%/$$\A%[>L[+>$R$EJX6RI?279VA`.DI3.0BPU3EB>( M.02_G65GGB5#2J[:0 MLY`GB#EESG.B(*V[K`*$HZO<)=_:I*PD7=CXNR3:=9Y\.HZ)2L@F^P[A`\WV.2E,2!RM2DR;G90,1XU`3_ZEZ M"#ZCIO=J%#"2V&"0V&"06&,9,YG]>S`+9D',`H8?2=/G,M_S5*,N3+E6-K$UU6)(3DX$UJ@(&B75>QBSSJE/GD#6D:A0PKM1\+Z32 ME(Q=TXB!K,8RLKU<"1^X:6=G.JV,"4%&@Z%2#09F&F-FS2<&U`DOE8J/TUQP M,ZB*7RO0K".&4T55:KXOZIJF*T7X]$"PJ(3AVP,:RP;2S[;B9PR(K+:>\$IO MS$O5"V8F#\PTEC$KV%9UV57/*GZZ@&@'\V&-\PU4US3IB9%T35,9$Y:-1(Q# M%?5/)'ON;JF)'#75-6PQK)A]'.T^!$$(JM=*0IL,-2PP2"PQEIF[5??VL^. MO6SV7S?UYOGY<'6_^R9?=),6GS]U>/O!.7R^92*?G&N6[S8VE5CC\#8VDUBC MGXW-)=8\QFMC"XDUG[@SL9'$8-70W\:6$FL^&F9C*XDU3[6:6#62WVO*U<:: MS^TU1\3&QM)N7.8B[;"_*/*4=GA;H1@3K;%H+L9$:ZQ1BS'1&JO$8DRTQCJN M$%NA&2YOE")HA"L*I0@.`?;UI0@.`+;+I0CDQZ:U$,'V4-@5U5^B%2ZR%EJM MT`C7+DL1"(\KB*4(9,=%NU($HN/262D"R7%)JA!9H@WNYI0B:(,;**4(U,9M MC%($:N/N0"D"M7&-OA2!VK@L7H@LT`8WE4L1M,%]W%($6N-N:B&RA-:X1UF* M0&O<*2Q%H#7NOQ4B"[3!@RVE"-K@@9%2!%KCL8U2!%KC28E2!%KC>852!%KC M,8!"9(XV>+JN%$$;/-I6BD!K/#I6BD!K/*U5BD!K/#-5B"R@-1Y%*D1F:(/' M>`N1.=K@R=E2!%KC^=52!%KCL=!2!%KCXNBI$)FB#5Y-+$;3!"\*E"$:*-V]+$6B-]U\+D2DJ M!*^_2]%H#7>P"]%H#7>;"]%H#7> M+R]$QFB#[["4(FB#KZ&4(M`:'R`I1:`U/@-2BD!K?%VC%('6^,9%(5*A#5X% M*D70IGU')U])C*$U/G14:#.&UNVSS:8-M,87?DIMH'5[L35O4Z'-.^L5M'EG MA0>MWUG?0>MW5G?0^IVU';0NK^S0I'ATT*!X;"!S466(7#XNT/B]-1XBQ7J> MC6_N\$*4U1BO@=W(.U8V@O>\,!.5(OAP\Y?B\<(A+OZZ'.#"+]S)J53`OTQO MOKRS:I;IK-#B#@>P.5>&7:'@0\YOZZ^;OZ_W7[>OAZOGS2.V!:/FH:E]^RGH M]A_'W1NV"_B<\^Z(3S@W__N$;W9O\,G#D5S/>=SMCO$?$&G8?07\\_\$```` M__\#`%!+`P04``8`"````"$`>@&##I0%``#R%```&````'AL+W=OEX5XK(O72NP[#-*(7=X!_W9;'MI3M*JX)5R5-R^OATE15P<(\5SNRNZC M#^HZ53'[OMG73?Z\@[S?"4CT/.?$2SR(M)RO M2LA`RNXT8KUP'\@LHXGK+>>]0/^6XMAJGYUV6Q]_:\K5'^5>@-I0)UF!Y[I^ MD=#O*WD)'O;.GG[J*_!GXZS$.G_==7_5Q]]%N=EV4&X.&19M]U3*D*Y3O+9= M7?V'(*)"81"J@@3`7MVG4QISPL.OHWC(J$_P,>_RY;RICPYT#:S9'G+9@V0& MD4^9(8\AU\]2A1QED`<99>%"NT,6+=3G;4G\8.Z]@::%PJ07,"8B.R%D*8#> MP!$RUSE>5OU$18(E%5D%R2W%"Q![X$:M=2\@H@%B,`&%;FH-(L"D.\:W<4\1P[.28 MD#@VJ64F((GH)]I$)C.I30#CYSI#^9#-<&Q(U`8QR)!R0JW[F7Y_0N(P&L4U MI),69>W_KPG*AVR"ED(I8I2$-*#C^GT"F7Y_0H@??Z)@8A*\KIP$F\2XS0LA MK"_MA')K0V9X&VE/""4A&2IOZ$:@BK9P7W=]_Y3=]F/B6%H%TOI>OV*RD"-3 M*]]U=0@.6'TN@/!#?FIU!)UZGY/0'I1P,)OD+&52@B`D%T0!3RP3S`S$)`BC M)!EWKDG/FOBWC0YR/OH)L4BD"J0*F#`>CQ+AYC0189B,76*2E!/Y=@UQ?NL: M\C%[55_$*&Z!'S*+?29?O&"3*Y%#?RR"2>TN4R#GKA"=M9X^]">4@6[6<,E4 M&.1&`Q:0<;Z8["QC^&+C7G`$+;)2SACYE$?)N+:JJHX@<<"#S\KZ4ZY`+M@" ML3HK52!4B+'8C_A80$53MP8..]R/1W\V5;S+'`C.=MBCPVL1L=]Z4@72A^_) M,2RT+N%Y#*M&F-Q%B=[\"J>[G#-Z[ALF*XI@(&L]6`,!(D/AES,7G>Y13T@E-0JXRI`BDE&9$[82BCJK1N)A/"0C_4K-@D:'G% M%YV('F'L`VH/.XH@;1_H5\S5[S(!^5O5W@?4&@&I`IT:+8PBPBV&F8F1TYBS M<>*9#._R`GKN!81:+I0JT'6&AF%<9VCYP8U;X8(OT%&#OH]2JD_]($[@I=;N M-!T![^*,:/UJ"OE3QD`O&(/]>R!5(!24A`&C6K>K':$;`XE8',1CXY@\[S(& M.#HZ;\G1Y[N"LJ?^XA;-%`8U*RI8&P,!]AZ+*4`FZUV"EH78`8:+A#_[:6 MG1UH2GP$I[AYW'470JL.$5O92/?20RE18G%?M=KP;8.YGY-++@9VOSC!*RF, MMKIT$>)8,'J:^8I=,22MEH7$!+[LQ$"9TW6RN)E0MEKV]?DM86]?71-;Z_T7 M(XMOL@4L-K;)-V"K]:.7WA=^"P^SD]-W?0.^&U)`R7>-^Z'W7T%6M<-N9QC( MYUH4+[=@!184,5&:>9+0#1K`7Z*DGPPL"'_N__>R<'5.)],HF\63!.5D"];= M28^D1.RLT^I/$"4'5("D!\@$W1_NIU$ZSY)L^G\*"X[Z@+?<\=72Z#W!H<%G MVH[[$4P62!Z2!1]CUO>B8D8/67M*3G':,87%]CRMDCA9LB>LJ3AH-F]N$#62/WM*CYYY1S$;)&R=8H==.?+4N MWYV#P9$_E%-\R&@@B8\L;()FVI?N8CJ9S?\9Z%/@='M($*27\RP[,AAF-[16 M@:G@!IK&$J%W?BY3!(^[XRNS3GV5CO8W^"KU@\?&&SC*':_@@9M*MI8T4"(R MCF:8W(27(2R<[OJ!VFJ'0]Q?UOC-`NQ"'*&XU-H-"]_C\2NX^@L``/__`P!0 M2P,$%``&``@````A`+=MY54%!```*0X``!@```!X;"]W;W)K]+$ZI/G9Q35;YD\^FUKHP7TK&2-EL3K6S3($U.B[(Y;$&,#1L:YXY;]>6Q?(SJ3%; MT98T\)\C[6K,X;4[6:SM""[ZI+JR'-L.K!J7C2D9UMT]'/1X+'.2TORY)@V7 M)!VI,`?][%RV[,I6Y_?0U;A[>FX??K;Z>&=OA0@>]7 MY.'\RMV_S.CK,N\HHT>^`CI+"IU[CJW8`J;=IBC!@2B[T9'CUOR,UAER36NW MZ0OT=TDN;/+98&=Z^=*5Q?>R(5!MZ)/HP('2)P']5H@0)%NS[,>^`S\[HR!' M_%SQ/^CE*RE/9P[M]L&1,+8NWE+"H2S$:4!'\VC\O M9<'/6],-5GYHNPC@QH$P_E@*2M/(GQFG]3\2A`8J2>(,)/`<2!QOA3P[^`"' M.W#`\_\+\082>%Z%A'>[`+]]*>`Y)"-T;RDL6=:^2RGF>+?IZ,6`T8?"L1:+ MA8360"S:XT*3WV\/]$7D?!9)?2J@&KT/VIU66+`KPUX>_-8NS>:/LJ)!(2]/X]/PX\3P7L MIP`41G&H52!5``Z*8S?V58Y,A41N9*.QU(H]&,RIO?LZ*9(TFYJ+1$+\T::K MV=A+A-1=(@,7;%]&T9''<]L$:):$*?B9'1^84&>H7#4 MC(>=]MT)DIBI!3V2#AAIX<$-PA#YL^-:9OT'1C4ASK[[3=67+YRV_77Q0#E<>GW/OC3.]>9$->N;:"-46.(EBC'C+5"G:58%_ M_;R_&F%D+&U+VJB6%_B5&WPS^_QINE'ZR=2<6P0,K2EP;6TW(<2PFDMJ(M7Q M%B*5TI):6.H5,9WFM/1)LB&#.,Z)I*+%@6&B/\*AJDHP?J?86O+6!A+-&VI! MOZE%9W9LDGV$3E+]M.ZNF)(=4"Q%(^RK)\5(LLG#JE6:+AOP_9(,*=MQ^\4) MO11,*Z,J&P$="4)//8_)F`#3;%H*<.#*CC2O"GR;3!8Y)K.IK\]OP3?FX!F9 M6FV^:%%^$RV'8D.;7`.62CTYZ$/I_H)DL=-PP*"C31('-,3#4@`.Y("C<94!#ZXG\WHK1U@=,\RJ[C-`$X M6G)C[X6CQ(BMC57R3P`E6ZI`,MB2I*!^&Q]$@U&69/G_64A0Y`W>44MG4ZTV M"(8&]C0==2.83(#9.4NA/N\[`TLNY]8E^51`&^C&\VPTF))GJ"#;0N:GD"/$ MXAW$]9Z$@+R]1G!^N4:75&"XOVE,]_3>QCQ`'JQQ>'\61T&._)@[)= M+L\E'?!\C8RXNCI!]=_"O:DS;L2SO?50<^DI3U-YT'2.8E):YB3NZXH]4KT1K4,,K&/$XN@9W.IQ-86%5YU_2I;)PIOC' M&CXA'-[@.`)PI93=+=SIM_\HS?X"``#__P,`4$L#!!0`!@`(````(0!<:(RY MEPD``,LQ```9````>&PO=V]R:W-H965T)LFG M0TJ'O"*/%BO/#-)@MII/\O"OVA_/+P_2O/]6G]7125MOS M?GLLSOG#]'M>3G]Z_/&'^_?B^J5\S?-J8GHXEP_3UZJZW,WGY>XU/VW+67') MS^;(\F6_FIJ?'^_W! M.+##/KGFSP_3S\&=3J+I_/&^'J"_#_E["7Z>E*_%N[X>]K\>SKD9;3-/=@:> MBN*+E?ZRM\@TGK/6JIZ!WZ^3??Z\?3M6?Q3O/^>'E]?*3'=B'%EC=_OO(B]W M9D1--[,PL3WMBJ.Y`//OY'2PI6%&9/NM_OY^V%>O#]-H.4M6BR@P\LE37E;J M8+N<3G9O956<_G&BP'?E.@E])^:[[R0(9^$Z"9+E!WJ)?"\QZ&7T)9B+K7TL M0>./7\+*]V*^-T:261PFJ_6(X9B[H:UG2FRK[>/]M7B?F/(W@U=>MO9F"NY, MSW:*(C/1;D#;2?NO.3.393OY;'MYF)K[UC0O3:%]?8P7\?W\JRF.G=>D?9H$ M:[)&8VO!=BPHD`WHSA3@/E2C:/K0#IA_P<5U)YZ;@6A'PQ0)'(W^0FU,6[$U MW9PH=0"?:(FO+NO3K+!&]&G66".Y)L0*U:,@)])<$B\V;3=H9,P-`$?&UDG\ MG[=R,T*VD:DG./+!HNV_GN'4:>)V%#,*!`62`D6!!@"Y,+@1V3.K)/CS5DQ-1>1&G,:8(X"08%T(*G- MA1'W1AMH`)`9LZB.-V/%U`Q=1YT&F*%`4"`=<&8V2S81BC;0`"`S-IF!W>+V M_6/%U`PID=1I@!D*!`72`3\SB3%#RDK1%AH`Y&:#W31[WVU7MA%U11;YU&DV M=?$L9A&YUS)\."9+NR"'R:(MW>%NR!0%&@#D-S`;.YR^<8;K5M0QN:C4B[JK MRA@1C$A/W%Q&R]4J2,@"JY`DCI-U$I,;0L-^L5^[\X\NU\#E!+S>D[E)O0CZ M=,TZ(IA&>N)\!NOE:K'NMEFW5B))N%PD\8KY!&?"/NT^#GR.G%>W^V._Y++2 MP(DZ=QDC@A'9$KO'T=OSUD'='C0[(/9HMW3@\?9-&K@`@+R%Y$)2+X+>0&[P M^9,2Z5NYN5RN%S&YNQ42;(*8W"H:GA9;M)O]>(LN&F"+Y.Y)`Y`?:D,9(X(1 MV9*^B'+KH&X/LNFS>_UX;RX98&]DG%/[2=*LQ'#Z*!%,(UMBO9'=2-TZJ-N# MS)O=^L=[Z.!)0!IPL\;)8)I9$MZ;[NF@YZ#NFW)O-DD`+R-7%I MR7*6!B!D>(^4"*:1+>FQH6X=U.U!YM'F`^!Q8&EQ:0)[(X64!B!R>&^4"*:1 MGKBE917U1!NL"%8L_&C8*UY=;"H`+D?.I,L2V"V-.P$('-XM)8)II"?.[;HG ME2)!;),>CO4:]HF\AB3HW)[16DT"3DA6[=2+P&K#B&!$>N(\FJ>/U()"@H`/ M@H9]8H\?"C=A3[@):;CQ(N@11(YZ9@732$84(QH2[,)4%JW*X><*H6TU]&#! MBZ`;UZPC@FDD(XH1#0EV0T+*N'LL[`DK`;W'O*B[]HP1P8AD1#&B/6D^K71+ M&;9&PHFUMC2WV<"MU1=2:,8,64AA1#`B&5&,:$BP&Q)'K)L19>?RA9DN\$2( M+$JI?:B,8PDC@A')B&)$0X+=V*T=+.T#<^*"`%K2(^:B20MFLW1+>DB)8$1Z ML@[])]]-G&S@5U=;=9^*ZR,HWQ"]AF?$(]`34T;,9T],B6B$#FDHR1@1C$A& M%",:$NR&!)*1U>D2QD!UTAB2A90(1B0CBA$-"79#@L=`=?8$#EZ=-%YD(26" M$>E)6YWK9(VJC:Q+BNK-9SF[@[=?)+1K>$8T`O8/*O#^'#>?=2L22^BCI-2+ MP+;`B&!$,J(8T9!@-R1XC'3CDL3MZHQHW,@8$8Q(1A0C&A+LA@20V]49N01Q M>^WT(C@GKEE'!--(3WQUKFDD1-UWC-&!".2$<6(A@2[Z,"$8D(XH1#0EV0^+"0/VY M!#!0?RPFQ)0(1J0G;?TM8_N`M_NB`9#IR2<8#4^!+9-,,2[#VX)EY4@?E'H1 MG$":-@332$84(QH2[*8G3%CQP$2ZG#!0CBQ,Q)0(1B0CBA$-"79#PL2`"[?W M#Y0C#0A93(E@1'K2EJ-Y81)])B'!2U']BM2KAJ?`EDGB&%F./L(X)I)".*$0T)=F.#`'`S4'=63>HN(`62 MFG?=K:B[YHP1P8CTQ+WGV/?V'&MB7ZIO3^1,N7?DW9O7I_SZDF?Y\5A.=L6; M??\],L_+6]J^F_\YM"_%$IX&=Z)^P9UP&=R9-Y_MG[;;`^95^LOV)?]M>WTY MG,O),7\VIUK,5F9GO+J7\=TO57&IWP-_*BKS$GW]XZOY3Q.Y>?]Z,3/BYZ*H MFE_L"=K_AO'X+P```/__`P!02P,$%``&``@````A`'%[JQUG$P``PV8``!D` M``!X;"]W;W)K&ULK)U;<]NXDL??MVJ_@\OO)Q8O MDBU5DE.Q>+^(ESJ[^^PX2N(:VTI9RF3FVY\&@28N?X:Q;%_OC]\>GC^\N[R?_Z5_./F\N)XNGO^ M=/=X>-Z_N_Q[?[S\Y_O__J^W/PXO?QR_[O>G"[+P?'QW^?5T^K:YNCK>?]T_ MW1W?'+[MG^G*Y\/+T]V)_O?ER]7QV\O^[M.@]/1XY2\6JZNGNX?G2VEA\_(: M&X?/GQ_N]]'A_OO3_ODDC;SL'^].U/_CUX=O1[;V=/\:'QX?3W8/3RXNE^DW]Y/KS'^Y7`\?#Z] M(7-7LJ-XS^NK]159>O_VTP/=@1CVBY?]YW>7'[Q-O_(NK]Z_'0;H?Q_V/X[& MOR^.7P\_TI>'3]7#\YY&F_PD//#Q?]I_OOC^> M^L./;/_PY>N)W+VD.Q(WMOGT=[0_WM.(DIDW_E)8NC\\4@?HOQ=/#R(T:$3N M_AH^?SQ\.GU]=QFLWBRO%X%'XA#D__)X6&.QJ-^,I( M0+U'(S.*H5*D3Z6X>A/ZR^N;H?491>K;T&WZY!87K]-<*4WZ5)K+URE>*T7Z MY";IOF?Z2"DV])$^S[NYM5*D3V[IE3?G4?Q(=XI`DJYXY>UY8R30/[C9^1OT MV._B'^?=HD>A(CMJQ,QK;Y*C1L3Y*WO*7O>TVU\9:1[[7?Q#M>9?ORYD/`X! M\8_9GE[)M!RR/+H[W;U_^W+X<4%3)SGC^.U.3,3>1ECA_)9Q-V;\SQ*>,EU8 M^2#,O+LD?T+NAD-XGE"IJK+5?(^>O--4W=9TYAPM*[2Y^2T)C#?#LA;I40!88A%-A"VU%H M3!L@,9`$2`HD`Y(#*8"40"H@-9`=D`9("Z0#TIO$*D,^-_`B=_!B%V)41D!A(`B0%D@')@11`2B`5D!K(#D@#I`72 M`>E-8KF)UH.6F^;S0TC;OE#$R`\@$9`82`(D!9(!R8$40$H@%9`:R`Y(`Z0% MT@'I36(-/"UCK8'_[?P0AFR?*&+GQ]+)CU%HS`\@,9`$2`HD`Y(#*8"40"H@ M-9`=D`9("Z0#TIO$E-8@V\V`4X8^0'<7OH&=EYL'+R0$N-B8`H1I0@2A%EB')$ M!:(2486H1K1#U"!J$76(>@O9[A%UI%G3SR>&V)AQ,H.1D1J((D0QH@11BBA# ME",J$)6(*D0UHAVB!E&+J$/46\CVA2@AS_"%K#BI".&(OQ5[7\(]=JI=GG"DO/`48AJ'*,PN7&S:)3BE(G8EGRW(38E8T0)HA11ABA'5"`J$56( M:D0[1`VB%E&'J+>0[3E1:9Z11:HP-;-((9TR6['Y[F81H!BE$D0IH@Q1CJA` M5"*J$-6(=H@:1"VB#E%O(=L7HIP\PQ>J^C1],1:D9JJLW509I72J`(K%ZQ#Y M\&*I!%&**$.4(RH0E8@J1#6B':(&48NH0]1;R':/*#K/<(^J44WWF&6K>N`` MBL3+)#M[8D0)HA11ABA'5"`J$56(:D0[1`VB%E&'J+>0[0M169[A"U6(FKX8 M:U.=*L'">>^U%:_5["2($,6($D0IH@Q1CJA`5"*J$-6(=H@:1"VB#E%O(=L] MHOX\PSVJ7#7=8U:P*E4`11Z@&%&"*$64(+-CDA#(T`8 M&Q$!G1<8LO.#KZI8TT42487-*XBMDJ*)G5&D4$C+C3%N?-\I MDF,MQ8H)HA11ABA'5"BT]$6_[-$1%>%_/CJJKM1#<>M+9(V.0N;H2+2\D0UE=2.A`B1L$8B[%"*LJ\%=W* MR@GA1,E840;&,S2>V\;7WFKM/AH*R[8]3FZ5\'M/-BP>?(F<.'/2;ZNDC%"( M%%J:PR=M+<,ASN@&PQO'4,):YH0NM0S;&4MIVSDCMAW"\Z-@D8DI72RNSX@R MM18WHTRB4*,MI0K,90KI?L=*BD,JN+[V_+43G8D2LF(*K&?.]:7R]5Z M@=.4-"6M6U%%8VZ/RV]%U6#%7M(JY$25LQ+:*BGZX*DJ4LB,*H56YH0=+)Q- MTX05S96][SE%<*JDZ(-;S%C1&%6%G!;=28T5?]:B/=)NE?![(XW%`WE51*$9 MF`J9#UF%EO3X'9\F^)!EJ97,WR`,UZMKY[83%M+KKQ0;S%AJML&RL+!R6"*S"E-29LVNT"]J=BW%4T2"*$64 M(.Z@[YS9[_%B[44 M#T/"2+_P3AFMQL=TQL@V[XQRKJ78?,%(FR\5,GI?L91MWNE]K:78_(Z1-M\P MTD'<,K+-.[WOM!2;[QD-YNW)5-12IE_=%='K)E-9D5GN5DC[=AL`BA2BR93[ M&B-*&.E]OI21-I\QHJPU0L?9`,FU%+=8,-+F2X4LW\K>&UVM65'W?L=(VVK0 M5LM2LUWMM!1WM64P6D7M5N`T"10N8F)*)$(:HV MN>LIVLI0,4=4H*T2;56H6"/:H:T&;;6HV"'J+5N6+T*W2I[WQ2!N+V$5LO>H M/&<78,M2.@DB1N:J%NLV):7V&,)KGW89W+)-R5`Q-;J0C>OV,D:S[>5V>YZ_ MN%Z[.[T%ME>R<=U>Q6BVO=IN+US>+$+?N;\=MM>P<=U>RVBVO(F2,=.;U70QDZ'Q7$OI.=I?.D^P`LV76I$[6J'YFJ6X[]Z:'&&O'79HO&$U MW?<6C7=::J;OO67>=K.[^?`+-^,F`^7KX&8S&`//W21C*1W%$2.]914K1!]R MBS^@37@G8!(E8TT!J@O:>(;&^5E.R[[6;RSAD/XE"(.Y._1/9>J.?L7VZ5HI7- MHR(/5$SG(TX1X8SVK6T@F1*42=8MNYEII)B`+-EUJ1;55HOF8I MV?6;<'4=0"ZKP=-=;UA+=[U%VYV6FNEZKZ3D-&<[F:+C'"<+<">* MMZ&2TND6,=(A&RM$,2GR8>4M;]P?,4B4B)%K*6OI!WR&MG-&N@<%VBI1JF*D M^UDKI/H9!M["7=+LT';#6KJ?+=KN&.E^]I8MVWWN%M(OIF+<*PK57I'UQ/6= M^-PJ*2M'1T6._9BE9*`O;_SPVDGV1(E8#UQIR+"=Z4ZQ[9QMTXIT+(HF9F)U M@SJ/2JW(MBHT7[.4RM'ERK]QU@H[)6)TO6$M,T=A6#HM-=/UWC)O.YE\8^7H M;Y6V8I_/35V)[-3U]H/&6+>F^ M=PK-][UGQ:'OMO/=_:K?].O MSY00E0_LGY3U-,H8S3:8LY1J<+H.DS=HM%>RFFZO8C3;7LU2JKW)UW4[)60T MV+">;K!E--M@QU(\HI.%F'F#=M"0\=D9XW6O!T-AQGG:*Z1O:,M2&D6(8D0) MHA11ABA'5"`J$56(:D0[1`VB%E&'J+>0[:/S]KE"W.=2R'X]Z#NKXBU+T0IS MS.#`UY6JU:GE>1L^@[@=((QT-&P118AB1`FB%%&&*$=4("H158AJ1#M$#:(6 M48>HMY#M"W(4D09HAQ1 MH=#$:SA"\U/,$5*?3SUW!:0`^,M$Q7&*5H.=.* MPWX&'NG5`FRF8(2ON^@XD3U,\P7"(.Z,AZK%S?$`%"E%;K>WIG-X`1R5L]JSAU-4-*]_(2-.6CF+!H7( MQ^9P.DOLK9(R5Y^LJ/=J8I::J3&5B%&HI:REGTH9VLY9ZN=%8&'9MH=)5`AG M#),L*,SW5DN)G*AS]C*W2LJ*.JE(=1S/"#';FME)42)6A"E#9H2![=RV/;7[ M45BV[6$2BU9SF'[OJ2:7OM;H2>0$F;NGO)125I!)1/.)'CV%Y)';,/!]SWW- MDRA+-/6R6HK&,Y;2QG-&RGCH7?O&:2UYOIYE)B;T7RWM7_??IJ9;M>N+9LI1&$:(848(H190ARA$5B$I$%:(:T0Y1@ZA%U"'J M+61-'*OS2I-!W/8%(S.4`M_9H=QJ*0[+"%&,*$&4(LH0Y8@*1"6B"E&-:(>H M0=0BZA#U%K+=XU8K\PM-^LET=Y7`2.?%%E&$*$:4($H198AR1`6B$E&%J$:T M0]0@:A%UB,2OS@]#.(R7](7\%7GY^])/^YOQVQ M_/GZV^5Z(Y*.8MV]LEK0+]L/QN'*^)OW[A7O>B.^\#]AS;NA*\-I']"A'M`W MGR=T?&I'/N)=G<#?B)/7$SI!2%>&]8NKXY$U66;`%;)&OU$T8X54)C5(85*>AGERE&F0)\>8AGARA#WR,?V0 M&=XY%;B;6*YMG+Y2@;K))Z]0$4@Z4Z-%)1WI3%VA/Y_P87KDJ6,3_;HE5TW* MDZ,F[8>;#Q3W>(.WY+^I,*$CAF1I:A#IQ-@FIK-2:(O.?VW$@2^\0J>Y-N+X M%EZALUD;<1@+K]#."PW6=)_)O[2CB#JW2W(D;27A%3K=N1&G`/$*'?*DODU= MH5.<&W$`$'7H,.=&G`/$*W2FD^YG*BCID"!=F=*AP\PT;E,!3@>(26?JRBVU M'Y>/&X_TP/D,7PL]XO\H^0R/\YJ>\9 M?3R&ULE%5;;YLP%'Z?M/]@^;T8`DE6%%(EJ[I5VJ1IVN79,0:L8(QL MIVG__8[MA4'3;ME+!.;XNYUC9W7S*%OTP+41JBMP$L48\8ZI4G1U@;]_N[MZ MAY&QM"MIJSI>X"=N\,WZ[9O54>F]:3BW"!`Z4^#&VCXGQ+"&2VHBU?,.OE1* M2VKA5=?$])K3TF^2+9G%\8)(*CH<$')]"8:J*L'XK6('R3L;0#1OJ07]IA&] M.:%)=@F"T'//U^2:`-)Z50IPX&)'FE<%WB3Y=HG)>N7S^2'XT8R>D6G4\8,6 MY2?1<0@;VN0:L%-J[TKO2[<$F\G9[CO?@"\:E;RBA]9^5<>/7-2-A6[/P9#S ME9=/M]PP"!1@HMG<(3'5@@#X15*XR8!`Z&.!9T`L2ML4.%U$\V6<)E".=MS8 M.^$@,6('8Y7\&8H2+RI@>6FWU-+U2JLC@G9#M>FI&YXD!^"3IH`PJ'Q-)*AS M(!N'4F"84^`W$.S#.LUF*_(`:;#?-=M0`[]#33)4$%`S2`(98TDOQW-B=L6. MV<7EI&S#PICFCY`)3?H_-*X8\AZ)3]-XD!^80TWFXQ[[R:9$+N(TB5YM_,F9 MVP;-'CM)L_099RA*8!:'5-,L&XHFAH'Q\EQ=L6O^QF.:7]^Y2XXBE56!FY"<&PO=V]R:W-H965T&R^_?Q2Y\4:J.J/ERD23J6F0,J6GK+RLS#__"+[-3:-NDO*4Y+0D M*_.3U.;W]<\_+=]I]5I?"6D,4"CKE7EMFIMO675Z)4523^B-E/"?,ZV*I('7 MZF+5MXHD)SZHR"U[.G6M(LE*4RCXU3,:]'S.4K*GZ;T@92-$*I(G#:R_OF:W MNE,KTF?DBJ1ZO=^^I;2X@<1+EF?-)Q2+ M+*UH3<_-!.0LL5`]YH6UL$!IO3QE$`&SW:C(>65ND']BW M45_I>UAEIU^RDH#9L$UL`UXH?674^,0@&&QIHP.^`;]5QHF_$[?(Y)= MK@WL]@P"8G'YI\\]J5,P%&0F]HPII32'!?>\R+`Y"N! M9ROR]86XK08\^X5\-1@X&'P=\.PUOAS,HA6!YW\.!D$R\)6P'_U2G@S'$OO, MTV:?-,EZ6=%W`XXB[&1]2]C!1CX3[A)&;&^?0O^609`Z3&7#9%8F>`3)44/6 MOZV=Z71IO4&JIBUGJW.0S-AU#):73':O`@<5"%0@5(%(!6(5.(X`"VSIO8%# M\']XPV28-UU4VPX8S+(5(SI&-V2O`@<5"%0@5(%(!6(5.(X`R0BL&/&XFG2Y MP-A0-T:Y@+&:"X)C\V+&MWJG(7L-.6A(H"&AAD0:$FO(<8Q(H4,-DW+@QZ$S M-A1/2*C1.5"R?"M(R!N1,':4#!`DC[<*<18$,I^*TP5M51ERZ`E=U@0"<;P^ M]4)--NI'\4.+7+R05Q+WA$[V.):5S():+9DEBLF$5?WFFJ6O6RIZQP,3,80E M2@D3X1YV\VT%XHVK"\8S>9F[EC0R3"!ST9M8.3EH2"`09SB+`RUJ:)GIHKEJ;SYPE/2[#B>2G(0SHGD($LJ#(WTQTZR4;*3 M`L%0XT9.>G+`NY8TU*6]0)#;>WMH.2QCW]9H9L\]U3;!L(=<##7=2-.->\YX M@7-Y@<=>>B#9:*BNDG-P8!XX]\7CR$1D(P6"H0J,C%2V<(19>#H)V&,3=SS8.F)-";;9(FRUN$5=LV]SUE`IR[&>"PB/Y",FF M^8AF7_21B<@^"@0R:X@,.TJSV`D2'B5DB\!J!T.TH]V2%CQ8>[:8N\H&!8+A M#,*A-E7TS%2Q--6C*@+W'1:ZF$H8*^XOXD.T(-6%[$B>UT9*[^QN@A`LNX?[ M>]/&9F=0P;=PG^+E2<5M'SYG'O"Q#\U>QS>.O^'G5='9.3ZT%IV_=WQH)SH> M.#XT%1T/'1]:BXY'C@_M1,>/C@]-!7"K7Q#LK(V&ULK%O;X)'UMNG=M)N- M[>OF\+![?;IM_N>/]+=>LW$ZKU\?UB^'U^UM\^_MJ?G[YW__Z]/WP_'KZ7F[ M/3=`X?5TVWP^G]^25NNT>=[NUZ>;P]OV%9X\'H[[]1G^/#ZU3F_'[?JA--J_ MM/QVN]/:KW>O3:V0'#^B<7A\W&VVP\/FVW[[>M8BQ^W+^@SU/SWOWDZDMM]\ M1&Z_/G[]]O;;YK!_`XDONY?=^>]2M-G8;Y+\Z?5P7']Y@7;_Y87K#6F7?PCY M_6YS/)P.C^<;D&OIBLHVQZVX!4J?/SWLH`7*[8WC]O&V>>IKO7+7@;^DGUP)?#X:NBY@\*`N.6L$[+'E@<&P_; MQ_6WE_/J\#W;[IZ>S]#=$;1(-2QY^'NX/6W`HR!SXT=*:7-X@0K`OXW]3H4& M>&3]5_G[??=P?KYM!IV;J-L./*`WOFQ/YW2G))N-S;?3^;#_GR9Y**5%?!2! M7Q3Q.Q\V#M$8?M'8N^E%4=CI=3]>`V"6S8!?%.G==+UV'%RA`54N->"WJLBU MGH"T*C7@M]*XNC$QBL#O3S?&@TC2':M""COMZH[UJ&?5?RJ5JQOD!509^,_/ M-XDZR+-[Z/K*=*DR\!^L3/?#$=?2^5.FXW!]7G_^=#Q\;\`8!QER>ENK$=-+ M/.A^2D2=-E5JOI>9D))*Y4[)W#;!'I+N!,/)GY^#N/.I]2<,`1OD]"7'''+/+[FN.7DV89^@.!#`4R$D@J MD+%`,H'D`BD$,A'(5"`S@=P+9"Z0A4"6`EG9B-,5,/TZ7:''KQLU?YZ?=YNO M_8->!M1T40#CE!Z]E,AMTX?\LX:OKIL+?4WR]!)"C4X#1+I51@TU$L)`7PGY M/A,:523*JE0@8X%D`LD%4F@D\E6%'"^!-W[=2TJD]!+5NZ\1VR6(6"[12-0K M)P6_[86N6T?5,T%-8-5S14L=V& M:D0MBJK@#MK,\0,DE5L'/8?7F/EMMC88:5+HEU$2A[[7#MD0F6I*8/)O+,K* M/E)6[I3E>6$4ASTV\15V88X388ESA1,5VW6B1M12T'(BRXF!)@5F-AA69A3/ M(^2H00PR(`2?M2,W"5)-L2-*"&=".'>$@[;?ZT2Q*US8PHYW8.E_A7<4V_6. M1EB(L68-D&2%6&56>4!]K089&::HH=3T(X$\*Y(QQ[G9@/[X6MZSA' M[6T<[_S47%6JN%Y#B`452[$!LNRH0B@*S+A$4%C&%;0O[#&AE"C6`"VU,V(9 M[9P@T@[%;%`014YA,,"ZWKL\3I=TYB:]O@[-"#)`EF?%$D&FWB.$*)J";M?S M8Q:5*9+L>"(IHYX19-1SIAY%G;@MQB-'W8TJM4B5.[@K5T!JH\QR$2$656PQ M,T"6$U5:RXDJ#770$IH8B6,A44X><2%$KZNC\#<(P[G19LU,B MF67:&"&KP(Q8%PO,B84%1B&,MC$;:PLBE06Z3E5K5N%4.,N#5JKU^Q^'M_*0 MXN.+>6@"AK+Q4Q"S6.LC"_**YHP!0<8K0X1^L*`W+-)*)3264":A7$*%A"82 MFDIH)J%[">U7YF6"1_3Y"1GQ-D MPF-!D"O/:K\T+))?$53*NV.MVM78_?IS"U"]-X+3$BJR#V$MNEM`0V3!8$J& M(PFE!)G<'!-DHBDCR-E'\;.%W+"HQ((@(S]!R.E;77NKJC,R-+6_)\AHS:76 M@E@7J[HT+*KJBJ!2WNU(M0&S._('"8K[-;O'-.0,I`(:J@L!2&/[W$)"*4+V M/A,A2SZ3AKF$"JDUD5I3:3B3T+W4FDNMA31<2FCE:+E]H?9[5_2%WAXZV:,A MM4:RAD&VOQAXR#)),"3(-JQ9$6I#W+V$71_V+V)!J#G.YD64EWVHO!Q9M%OR MV]V8GQ(5R+'*FY"X:=^4H(OMF[GEA5&O'?JL??>RO#F)F_(6!%TL;^F6YP5! M&+796=7**<\)%SCBOR9<2KJ[!D)(#?-6N+!-^@!9]K[,&-(0,R*6/D4*HG8[ MCEC@I=5JBK![;418B-"GS[32P3Q4."S&9XA!"FI!\& M<*3'`B9%CI628U(RXAE!1CPGR%ZHU'2S;J$E/S&&IILU"QI-T`Q96/<@B-L= MCZ[69TR?'SP]_6A!.A1\_H(L6QFN]4!LIQL MUEI@2%HC8NF,4"_#A&PYFE(-K%L&LC()D2%D:>>&=2$A"BD_,894SZF4GQ%+ M5[T7=KJ!R&5TGJGZG*Q,U1=2>VE8%ZJ^0I8>YMQ.AOG@FDY6=#9D:XCE,HOB M@8\LDVY#@DS(CA#"?.AX42]FGDJ18J7#F*Q,Y&52.R?(U*"06A/)FA)DZCE# M".L9!E[;8S/+O=2>DY6IYT)J+PDR]5PY6F[W07)?TWV*SKI/0VZ.^LSK`]@_ M*$,G1RM#BOT1L72@1ST_[+)D3Y'B3+A".T.6DZ,5ZT*@%U)^0I4R>325\C-B M88Y&';\G>E37P*KZG*R,]D)J+PWK0M57R*K+475\8P_$/[6U5>\.\K[7D)NZ M/EOO#=`03L2HHX<(!6:7/R)('Y7V>IU>P,:`E"CF(&`LM3-B&>T[47`O2QP3G:FP`5!%PM<$HL\6K<1<\IS M@T8=\8B@^96+!Q^/O&`-6\5!$+,,[R/+.AH9$&2R#(N&G51"8PEE M$LHE5"!4<\#O0\](YUU[P%^JL(Q3PG#A8^;_`;+@-(P:.43H_0-^0R";E"!S M*#^6RAFQWCN4SPV!E`N"Y$$Z3%2NFRZ?TY5TY@\\A;'](:`A&MKG=!)*2=XL MH,<(6>[.I&$NH<+1\&-X=",3UOE.>ZTZU([:'J[1D`(M,FY" M(3O"A';N:M?MJPI'VW63VF)6;H),_:EE/T!.B6.-YE(\(Y;9EN8$H7CH=7V/K>8+XL@!'3Z)^B?\A[LD MT_?]4MA]!00A)]2TX0]>`4'#RZ^`$,G,JF-98$8L6-F_/Z+FQ+KX"@B1K.6[ M_CI,?XZRWQZ?MH/MR\NIL3E\4U]^!6I=5\'X69K?3>Y`"7*&/8$U03*"F5@^ M@3D]4=.V?`+S)MB4`Q53@UD0;.J>P(=Q=V5<,(L^?#!7]B?'_615RP_@`[N: M.MV%R9T>2IC0G0=/8#DKFP$WOE!VZ5=F`Q=XR0BNKJ0-7,AS&_P;@;8U#V!-QL2==TM:P`O."2#VB?P MG@/T0IT-O,B0J`MOJ0;O,R3JWEL^@=<:H-9U+85+<7A29P-O-"3JYENJ#<,$ MOB.HP:,$WLR7>`8NJ\.'T,3:.D%EZW!XLPH\7);&PO=V]R:W-H965T92J52*:KFZL]? M+\^5'\O-=K5^O:X&%_5J9?FZ6-^O7A^OJ__Y*_WCLEK9[N:O]_/G]>ORNOKW M%J?0OW3^F=_L[H?KEZ7X&U8)[,"7]?K M;T8TOS<0*->4=EJNP&13N5\^S+\_[V;KG]ER]?BT@^5NP(S,Q#KW?W>7VP5X M%&@NPH9A6JR?80#PW\K+RH0&>&3^Z[H:@N'5_>[INAHU+QJM>A2`>.7K`328*+RT8C;EZV3BY#J[9K53NS.Y\ M-[^YVJQ_5B#=P6;9OLU-\@PZAICVI-U!^UWZWB:%W6E8OAB:ZRKHP_[;0F;Y M<1.UPZO:#\@&"Y2YU3(!ETA(PFQ]0]N50$\"J03Z$L@DD$N@D,!``D,)C"1P M)X&Q!"82F$I@Y@$U6)[]&L%6^"?6R-"8-2+OWA+@%DTL64(2I-*50$\"J03Z M$L@DD$N@D,!``D,)C"1P)X&Q!"82F$I@Y@%L02"IL`4Y?(#1WC#2<%1Y>R,, M(Q[YMU8F+,_/,O03A705TE-(JI"^0C*%Y`HI%#)0R%`A(X7<*62LD(E"I@J9 M^0A;"DC,;"EL_KHP9_GN:;7X=KNV%<&!)8H@3]GL94B@K(#]YZ4ON416*&CN M]T^"B*TORGQED1A.]#U1&+;X6O?V0K2K4H7T%9(I)%=(89%&:(;(O`3>^'TO M&9+22S3N6XOX+D&DM7=2UR*-R_)0".M!++RQ_YY84T3*693KTU>LV5[+'#7` M*A8KWW]/K(7/RGP#B\5\#*EE2ND\'G8W*$@.6/N1IK/W2(1Y$DOWMMB[BCDM12+8TLZU49W[*+%"?EBAFA=6%FFR-8I$Y96B&DS2 M60N$M;ZREBEK.2)-NVKM9BR6M=A;@IW`_`BWC]_WHR'A?K2(GZ,L$GGQ:)%& MM-^=/41B#+YZ?%D7`9&BB)>F%'&FB'-&'+;B.@0V7]3")V8>,CN76.9-5'4EZV(LAS$4%.*D7(3UA:*B/(<>4$.:Z"<7$WF#K9O[,< M<8,MJ^%TI]Q[&UCH2-XB*2]0$/*BJ>>D?)>*\RA%*4A5GI3:8(Z+AIIIB[F3 M\K@B&47'+'*7FDK7=^FGDIBYO(O=A]"1-(92?AXC12^1$61S2]2*Q4&3DH"K M/OJ:.2,IQYPC)')D0^Q+4GPO27*/FHKU]SV*=:\?NQ:"Y:482G1E(? MVLM)RMJ#B@::@B(G%213VN->-L6R\C+T6F&.YE+UU_JM[!R=?L,R;5Z;&IR7 MHK;PP"U*>>DU(<@YI8O0D5N6DZ)]DFJHKZ%,0[F&"@T--#34T$A#=QH::VBB MH:F&9@@=N`.:[U@JX:0OVH6>O\BB,P@X!9LKT-07TME M&LHU5!#DZK4!0M"?)?HA2>VOJV+3C)P`Z=QI:*RAB8:F&IH1I*_PIHO\#RP? M7F/'FU6,0[STP0\D M=>';%)G8U4#9RYP]&D).D+V*Z3(7I\;:+['8M0-'0KQ#@CZU,9$[5TX(129"^9K`*RD,E` M;JUC<40G@95BM>9>D9S;.BG3^X)?PWFE.,/O+3$+`_@%X9PP M*,7Y:8X0W_*Q*-H3DG(!WB7(!7B/(%94QZ*H3E$*]H\7+.K*X;AH43*"G,6< M(&Y17!2+DRP.'!=9'!+D+(X(8A8;(OW=G61Q[+C(XH0@9W%*$+P._T\QCTG$#GVCFJ9/Z8.`S1L\76#9X/CX> M0MW)08CG!7F'34C*SPN6"Q3)=3TGY<]&'@\H=2PO(+VSF!&]LY@3Q/>,/!Y. MLCAP7#2A(4'.XH@@;E'DT;N3+(X=%UF<$.0L3@GB%D6VG1VSR,/&='#.R`NV MX0-A2..\#2TD\H)(R`E*L;RP5R2NGI/RPJ8I4FV*4D>J"L=%]!E"?E7AI'R+ M(M46)UD<."ZR.-061T[*MRCRZ-U)%L>.BRQ.M,6ID_(L-E38X-)"2>.J0^^0 MYF$#(3&Y&4 MG1STB=NJVKI#&6]R8U)S]B8$N5W MFM*A;2^:JFF__E%;!,XM2OD_N&BHB]"1IK23HHR<:JBOH4Q#N88*A`XT?\-_ MI'M8LHB,;!N*WJ&9H!3TMFB2783>;_XZ`=))"7*MM[YFSDCJO89M[@2(N2!( M=]U"TTWR8^Q(F6R;3ZS>L9`XH<1IFI1VH.?JJKDU]S95I MQ5Q#!>/B6\TT+LYP`_8Y_++/0DUV\*BGHDR-!LG<"YXN0K$+GIZ&4H3@@Q:U MCY#'E6G%7$,%0O`!7,P-<%:R`$A1PH\7HO8N3`1]:"WGUIKU2U'%%\P8]^1Y_05SY1.'/$)- M_S@+`E$7)R@%`Z&XZ"+DQ46/I/":'M7S2C5(2_8[?;821R6THB M;@?W-7=&4J[`S`G"6JC>A$*+-SX+$M'5963N)_N4!1OW<\[#6XZ7R4IBEJ,2 MA%B4647_>0N4:MCN/CSR'4=BPZ0DXAUQFCLC*7=8Y`01=SMNR$LIB>A#SOP, MQ%SU\2%7BHNT=O`:)F:7H*)_R&FH1Y!+1RE"L%-H%_=)ROD@TU!.D.,J&!?? M;J:R]B/FB!ML(>Z?];`QS%;CAUQ+Q&R"4EX"ZFJHAY`74RE"+`E9BQY7IKER MS54P+NX&5E;#QCGBAGW-3&MS"\F@=`,$A3NK6B(>$Y1B^<4J>@'2/93B+:66*BY0$3SRD5NM ME&`5XO+/`$?;MXM=6I8*2^)9XV)D=E(_@7?!#_''GBXU)0?0E:(#EI`8 M]3=PKP>=0]_`11ETRBZ3L`/77M`Y]`W<*D'GD+O@C@@ZA[[I!C!J>]`*._"0 M6,<\NZ5'#4])=,`)V`Y]`\\F=^Z<8=>/M+:W0; MG=ZA%<@:'7@CZH!\LP-O'6D\@ZD?PN'12QA1R53;.P7>T'^;/RY'\\WCZG5; M>5X^0-#6R\<*-_8=?_N/'3XT^G6]@W?SH:*&&AW^7PQ+>/6I;IXL?5BO=_0/ M&%)M_W]WN/D_````__\#`%!+`P04``8`"````"$`<%```"%@``&0`` M`'AL+W=OF=VW3_7)[NYBR8R4F_7R355UU]_5W66OOGZO M+\9;V795W3D2KBX^$ MJ_/VY?7VI6CJ&X1XKBY5_X,&-8VZ"-+3M6GSYPOD_=WV\D+$IC]0^+HJVJ9K MCOT$PEELHCCGI;6T(-)F=:@@`R*[T9;'M?ED!YGMF=9F107ZNRK?.^G_1G=N MWN.V.OQ674M0&]:)K,!ST[P0T_1`$#A;R#NB*_!':QS*8_YZZ?]LWI.R.IU[ M6.X99$02"PX_PK(K0%$(,W%F)%+17&`"\*]15Z0T0)'\^]IT8.#JT)_7ICN? MS!93UP9SX[GL^J@B(4VC>.WZIOZ'&=D\%`OB\B#PY$%L9^+/9M[<7T"4!YX> M]X0G]W3&T1_X050Z;7ARO^7$]J9S,ND';G/N!L]AN`^X+;@;/#^9'VPS.D]X M#@,.ZCZ8Z)+[P?,S^=E0/W0\\I]AP)]G:+%JH,45YGV^6;7-NP$[%M:[N^5D M_]L!B27*BDUY*+2?U1D4&(GR1,*L34@>2JB#S?&V<9WERGJ#@BZXS1;;V*K% M3EB0ZB5A0QWL=1#I(-9!HH-4!YD$+)!ET`:VRO^A#0E#M!%9;048Q7(T(82% M<`EUL-=!I(-8!XD.4AUD$E"$@.VN"''_S!&U0*SA=)%KP9VJ"6Z9C4.//+K4 M.T1"1/:(1(C$B"2(I(AD,E%2A_-*29WMC\EXVGUXBY!(2"R1R1")$8D021%)).)(A6/V)M9H[)]+Z(Q(BLDO6@_=9<]H.!J(N( M$6\Q!(E1V&3P(K>V9\]=[=Y.!P,1-I/#*LI`%Z,H(YV6_;DJ7K8-9`PGX!W% M7$B+]1(DB"H8(PL85A)LI@G&C23!&/%9"TOZB3TB$2/>>#O'*$Z"O%)$,CF. M(@EIJA1-[N0.S:Q(GIJKV7-DPQTEI3_7TA=6]!6$=T]D:-!;=G2FFN.>.WH. MK2O;=6Q'.W`B;N*.2L9XN$2@A\.EVG`+?[G0"BY3AE/%)*V:O/5(@;F@_7^( MRCH\N'M%"6]MAESUIEWHHG*K\4P*N:,]'V+M12Q2PF\;>^;X"Z0@G\%8G;'P M&F,G.'8Z6LF+[ZOSS+B5`TH,)>+88].EBDC:/"PB[6D^ODMMUBPJFC+DJK>7 MMKH[[LC>E7FA:PU^&C%QOS(@Z1MS*E8]2.6]J%>,1$^$XCI@* M-&>KZ,\7V@F3"0MZG*J2DOY1E]2>?592$D7;^PQ!MCA<*JS8.FDP93M68-)Z/ M-/[6W'YVN<@'+.]?Y;.`HS&?'50G78H1A1CM,8HPBC%*,$HQ(I^3QDDP+=CG M(?8&7Y?MJ=R5ETMG%,TK^?0#9;)9#7CX+O7DD+-*XUORO>H>=P)X#[QC[P;P MEH3YDQ<\P43Q'[9>`.\*=_@L@-;Z#I\'T%O>X8L`6K$[W(8![HZ\\X,=/6BU ME$,_@`X`1XK\`/H`S&,_@&X`\\0/H`/`//,#Z`.`6\/`\`7NEI_*W_/V5%T[ MXU(>89FF]%QHV3<\]J/GM?O<]/#MC9;Q&;ZUEM"T3,F+Q;%I>O&###!\O=W\ M"P``__\#`%!+`P04``8`"````"$`PEALZWL$``!0#P``&0```'AL+W=OBBOMV:K\&;HJ:UYOUV\YJ:Y`\5*41?O!24VC MRL/T7),F>RG![W?D97G/S5\T^JK(&T+)J9T`G246JOL\M^86,*T6QP(\8+(; M#3XMS34*#W/36BVX/G\5^$Y'_PUZ(?=]4QQ_*6H,8D.86`!>"'EEINF103#8 MTD;'/`"_-<81G[);V?Y.[@DNSI<6HNV#0\RO\/@189J#H$`S<7S&E),2%@"_ M1E6PS`!!LG?^O!?']K(TW6#B3VT7@;GQ@FD;%XS2-/(;;4GUMS!"'94@<3H2 M>'8D#J37DX.];C`\N\%H,O-]+YA-GU\!6'(WX-F13+].`FOF)/#\[RN9=R3P M_/)*+!$<'NLH:[/5HB%W`^H'Y*?7C%4C"A'D2!]E$9,A[O\6=H@W8UDSFJ4) M[D%$*:3JV\J=VPOK#?(K[VPVN@V2+;:]!4LF1ANIP$X%8A78JT"B`JD*'$:` M!;(,VD#2_1_:,!JF3>_5I@<>8CF*$+U%/R12@9T*Q"JP5X%$!5(5.(P`20A7 M$>+S%M#G`K.&8A_E@H,\V<&-L'%X!^*AWFI(I"$[#8DU9*\AB8:D&G(8(Y+K MT#L^R8$):R#MIO>"&0L M28>,)!&(/^--Q['53-L-WWO6N$.X%SP^>XTU&4:Q5@:LKJQQ.GSO60]C5DD; M"):DS2>9`AMBGRK,6A9!($CLBZPK;C4D$HC/3P/S&$\E:0@[)]2JHC-^(O-AI'(P@H$RF@D MK*/LSEMAY#XZ8X=J"IV%J/:TG@3C3>5>!&"J*N'A\.8 M6-(,3D,_KADCD343""1C7^#;#AEEGD!\J/Q'PFJ9UQD%7#/DN%/D*YMAW)D\ MFMI>FRMY9JY4GBM`]M133((2^H^-PX5GSS%+FWM MBCLA'&ETGHT;PH:OXVLO7//V:`U$<*&Y9F?\:]:&PO=V]R:W-H965TE+*2?G.YSOXLOFXU-=68^8<4*;Q/:OG_8?(MKA` M38$JVN#$?L;<_KA]_VYSI>R!GS$6%B@T/+'/0K2QZ_+\C&O$'=KB!GXI*:N1 M@%=VE<$#.U4;G.=^Y=RXH;3<%@0QDV2V&R\3>>?$ALMWM1M7G-\%7/OK?XF=Z M_<1(\94T&(H-;9(-.%+Z(*E?"@E!L#N+OE<-^,ZL`I?H4HD?]/H9D]-90+<# M2$CF%1?/&>8Y%!1D'#^02CFMP`#\M6HB)P,*@I[4\TH*<4[L9>@$Z\72`[IU MQ%S<$REI6_F%"UK_T22OD](B?B<"SUX$`FX,7G;!\.R"/2<*@E48K6]WL.I$ MX-F++!T_"KP@?$,>\#U5#'CV*C=;<75A59\R)-!VP^C5@MF'2O`6R97DQ2`L M&[2$-NMR#BW[5\>@55)D)U42&Q8MA'.8LL?M,@HW[B.,1MYQTCG',QG[GB'G M0,IF4^`P`EQ(8,@"6CO-0H[9&[.0*C*+_OMI#[RDY4\L]XP^))L"AQ%@6(:! M&EM^?47T]95D:,RHOIX?F592S?'5@E3EV\^0;(8U(*S5$@:F0=3]"9T<*2Y-T Q_#%@Y$<*-R>G"2K MY/HFIQKQ0L/'RO2Q'TA]6-8A:Y7;:F'R#V.^818^<[M923;-:L2[,\Q.*KL? M2(/9#AFO:=BN)I['88;G]5L\2[+I62/@N;>SGR%9AY@&7_JMEL!A'&88E!>, MT;[W_^4GR:9!C4PF8+(B]P.ISR+K$#T!4Z]CNO:JSU6]7]>8G?`>5Q6W(\O[(,X0(."WD6:U45=?V=38$B)80E&27O6]_X]A.8@_= M+FW?',>/\=^9\7@\\:Z^OE=GY:UHVK*^K%5CIJM*<VE-1=`HH7-JU>NJZJZ=I;7XJJJR=U=?B M`K\*F;[/D, M?K\;=I9S[?X+DJ_*O*G;^M#-0$ZC#XI]7FI+#90VJWT)'I"P*TUQ6*M/AI<: MKJIM5GV`_BR+6SOYO]*>ZEO4E/M?RDL!T89U(BOP7-.EAN!SPBCGG[[W[1YA!1D)F9#E'*ZS,\`/RK5"5) M#8A(]MY_WLI]=UJKUGSF+'3+`'/EN6B[L"22JI*_MEU=_46-#"9%14PF`I], MQ+0^/=AF@^&3#39FKN/8F7VD_Z[+-JJEO"FP?"'Y[SSY2GN#[,J9S1;;&*+%CEN05"*RO@P"&80RB&00RR"103H!&H1E MB`VDW/\1&R)#8L.]VG(P!LN4`L$M^!!?!H$,0AE$,HAED,@@G0`A$+#A4"!L MV`[W"P'/"3(*MKR0$PO1T2VU,?LZU"_Y#A$?D0"1$)$(D1B1!)%T2H000`5! M(3"<&2DC#VX5HK1634BZR5YQI;A0(T7%GDPXO'Q$0D0"1&)$(D121!)IT3P??&0[\1:])V1R2(CXB,2(!(B M$B$2(Y(@DDZ)X"AI9O$!V6_\[E3F+]N:MC!WLMR"@Y`>CT1$])\2@_8ZY*S; M,;(8S@F?$GO>GZ>F;MAB:@3#[SPU0DH<<]"(D&H\C"*G-*A:HFHR_,Y5TZFJ M$!MH1(38W(D!='H\",1:#`(ETR`@XE/B+`>7`D1"2LS1)D(Z,1J5()).=01' M26?T@*>]N>@J0P8<,)/-CAH@,@^T8O;@K7]OH*E+O57`K&R3YHKIZ+I42$)F M8HTI%W'M<;J8H^ESHND2:3HRFS1=*DPG!I/T6],M]7':0'K(><.0`=5I$DRY MB6)6UEAC_'$@3^Z`6Y'-2O:#9;O2C@B9R32_^*A1.\;:";>BVL9R[CC209\* MVF*82#?V0)AH\P9]!7=M:U`DY9SDW8Y;C4G@-,P421ED_0$.Q)%V)I"-@T# M><@#;D57?&Z@?1$R"R&9D'3,K."9N'0B2<^1="I(BT$BS=H#0:*]G9!+%)$I M)EM.2H$=%"Y4OX:!W).`6;%<(;,04@E)QWRV,4T347IAF7.I:4X% M:3%(I-%[($BL+YQF$D52)DFU>D>N4.1,&@:.06)6-).6>+E#IB-D$I*.F960 M28/5N):F(]6%5)`7`T6ZPFF@Z*7!@ST1B9+4#S`D)9GTSKCC5F-1\1FRZ"T4 M::<"CFCW9+F+I738AMQB[+@B+!USJU$ZX8A)+Q:X7%'?K%Y:C!UI-/][[%B[ M.LT]BN`\X2FT,R@22A9#T-(-VQ@=[P$?N.S/1->R7$?:1B$SL<<#,.*C1A1S M].%T";>BTRU,5S>DPI(*TXD!)=WI1P']5E_[:ZY_Z#)HDRN4/(9&?W9PV]KG M[(A\C`*,0HPBC&*,$HS(E>_X$#06]`J77NQ517,L=L7YW"IY_4JN9Z'D;58# MIG?'6\>#%UM(%9G//7CIN\,7'KPCW>&&RR^A)27?]>`-!8^(70_>,3#WEQZT M]IC'2P]:=W! MY0=P;9@9;KVOV;'X-6N.Y:55SL4!PJ[W!;&A]^;T2\=R\;GNX+Z[3\L3_'VC M@(*ESZ`J'^JZXU_(!,-?3#8_````__\#`%!+`P04``8`"````"$`J9BV5W\" M```L!@``&0```'AL+W=O^8*D57%_C']^W-+4;&TJZDK>IX@5^XP7>K]^^6 M!Z4?3<.Y1<#0F0(WUO8Y(88U7%(3J9YW\*=26E(+G[HFIM>AP8,CU-1RJJ@3C&\7VDG4@OYFT;TYL@FV35TDNK'?7_#E.R!8B=: M85\\*4:2Y0]UIS3=M5#W95@==)?C_'9+7T_OP4_&!&[\@TZO!1B_*SZ#B8#6UR#=@I]>B@#Z4+ MP6%R=GKK&_!5HY)7=-_:;^KPB8NZL=#M*13DZLK+EPTW#`P%FBB=.B:F6D@` MGD@*-QE@"'TN<`K"HK1-@;-9-)W'60)PM./&;H6CQ(CMC57R5P`E/JG`Y5/; M4$M72ZT."-H-:--3-SQ)#L1OYP))..S:@0L,XP@R!OQ[6F73VR5Y@J+9'\Q] MP,!SP"0#@H#HH`QJURL[L%-VKKA4[D-@+).^+9/]CXP#@ZVCY+/I8N`-R@$S M\:Z.ZYF<"KGN9DETL;]'3]TQZ.FXDFP6O](,H`1&;G`UFUWP%12O]]6!O?I@ M;(BK]X.V5A3?UK`[0J"```82$``!D```!X;"]W;W)K&ULK%K;6ZOIZJ'G]>7>7>YUM5^,#H=YY9A>/-3U9RG M5"&X?D2C?7YN=O6ZW;V>ZG-/1:[UL>IA_-VAN71<[;3[B-RINGY]O7S9M:<+ M2#PUQZ;_,8A.)Z==D+RYG(#>G`\7/ M[,_].2@]W.T;>`(2]LFU?KZ?/II!:2ZG\X>[(4#_:>JW3OH^Z0[MV_;:[//F M7$.T(4\D`T]M^Y50DSV!P'B.K*,A`_^Z3O;U<_5Z[/_=OL5U\W+H(=TN/!%Y ML&#_8UUW.X@HR,PLERCMVB,,`/Z=G!I2&A"1ZOOP^=;L^\/]U/9F[L*P3:!/ MGNJNCQHB.9WL7KN^/?V7DDPF144L)@*?7,2=+4S#MQ1&8&X,(?/[\2'PF`I\_/Q*31Y9\83+P[48J3)OY)5]& MQV-";UGR!)AR!D;+VZ4PIV4U5.FZZJN'NVO[-H&I#X7372JRD)@!$>;U20B%"U@C9("1"R!8A,4(2A*0(R1"2(Z1`2"DC2BAA MJBNAO!U"PKZ?6E#DTOSVU8);49)C#]/?@3[#40DA(SAC%:\9`KO!J`MVJMEF M)/%*CABR&(6V2#H>K61I+>W)2.+2*9+.D'0^6LG2VO0K1A*7+F5I)1?P^$HN MZ!H\(]MJ?VAV7U'?R1$)-EV!B30VFI!%".)/U@I2RNA];30OA-"Z*-X#`E;C2%% M3!&?D"*PZG#G:XHX_HAL$!)1Q!*<+=*)D56"D!3I9$@G1U8%0DI91PG8XE,! M(VPU8!0AS8TTH_6%@)&D.J2(*Z*Z04A$$9NVMJ0]V"*=&%DE"$F13H9T!4F5;QCB#?NJ9UG& M4DMJQ!C2?HAT8Z2;*+I+T[%,33=%NAG2S9%NH>B:OF7:VHY>RKI**DQHYGX] M%X.*F@P&R0LY@^25G$-0*E+.M*AL.,L?$K+T?7?A:4\8,8XCIN>6FPDHYM!- M?PEG47^^O?1=0RON%/O+N)GPEW/HIK^"LZ@_&RX)',U=J;A3,T@.0O+BI\^F M/]O+<.J\O2B:]#P%'2>?&"L&.0(*,;1F$&Q`W'##(3')(@;)>PG6BKFAT$HX M)+12K)5AK9P;"JV"0T*K5+34N)(SD1S7_Q$_>H12XL>@Y5"VCNG96@,?DDL, M6,24&4$A:=YL,"MBD+QE8%;,($DKP:P4:V68E6.M`K-*14L-)SD8?2*<[!PE M:F]%6AP(EE1H(8=$0M<<$FG?<$BP(@8IY.M0K,*A4M-:3D$/.)D-(SCQ)2"FDMAW8-%Y+;9U*X(L]K#D'- MW=KWJ*%C#0N(9=B^A;8]-@(Q3[9<6[B+.7337<)8HSO#<+6#8,HHTKS)N+9P MEW/HIKN"LR#]4@RT);(4'B66*<*@9I2RH.YI!^KZ3ODDZU=>7.JR/QVZR:U_)NTR+;!$C3%^T MKA)V"=E1W`[3C& M'YW@$1X8_T?J!'"%B?',">`B$^.Y$\`E\#NX&\`-)L9+)X![3(ROO0`N%#$> M>P%<$&(\]P*X\,/XR@G@2ACCH1/`Q3#&UTX`E\$8CYP`KH0QOG4"N!C&>.P$ M7FT/Q\8# M_"E##;>V[?D/XF#\XXB'OP$``/__`P!02P,$%``&``@````A`&G\ M"D6\#@``B$P``!D```!X;"]W;W)K&ULK%Q=;^LV M$GU?8/^#X??&D25+CI&DL$1VMT`76"SVX]G7<1+CQG%@^_:V_WX/90[)F>'& M']V7IO?P<'0X'/+0LN3['W_;O`U^7>WVZ^W[P["XN1T.5N_+[=/Z_>5A^*]_ M_O3#=#C8'Q;O3XNW[?OJ8?C[:C_\\?'/?[K_OMU]W;^N5HD?+\W:W61SPS]W+:/^Q6RV>^DZ;M]'X]K8>;1;K]^$Q MPFQW3HSM\_-ZN3+;Y;?-ZOUP#+);O2T.T+]_77_L*=IF>4ZXS6+W]=O'#\OM MY@,AOJS?UH??^Z##P68Y^_GE?;M;?'G#N'\KJL628O?_4.$WZ^5NN]\^'VX0 M;G04JL=\-[H;(=+C_=,:(W!I'^Q6SP_#>3&S=[?#T>-]GZ!_KU??]\G_#_:O MV^]_V:V??EF_KY!MS).;@2_;[5='_?G)0>@\4KU_ZF?@[[O!T^IY\>WM\(_M M][^NUB^O!TSW!"-R`YL]_6Y6^R4RBC`WXXF+M-R^00#^.]BL76D@(XO?^K_? MUT^'UX=A6=],FMNR`'WP9;4__+1V(8>#Y;?]8;OYSY%4^%#'(&,?!'\S03[I M6/J.^$L=;Z:3255/&US]DXZ5[XB_ON-X>M,4MW?EB8X(VX\7?\^ZXNB8KS[] M9G%8/-[OMM\'J&ED9/^Q<"NDF"$8Y?VH.C7S'C2\]I-:?@C(X8;GI=6",!FP`C#"",`C/V?QB%B^)&0==O"8C# M&@O)Q*`N1@(V`9ADU$HJ.5_HE%]'1DDG^2W&4RZE/7+&_3KKT]$LU>7"\25>@2ADE2*?'>!1`,T"K$IPL0W M7/SGY>G(:OHG8OH]B4^_('6!%#0KQ*8(T^P.`\E>]KEF1^9)]4@R_0HQ"K$I MPM3<<37]SEKU]G7I_+M(7*I'L!"2^:]YPKM`"KE4B$T1IKZ`A9^?S)[-)1*4 MI%-#1D.605R3V_Z3"78I+:?7K*CB:"38L"@W+4$\IXW(:6111Z,ARR`^!&<' MR1`^K]'B:!Y,IH?2M"K(4,?(L@SBFIP'))I<6ANIPIO)FE6/<2S*JRK MHXY5F`ZC(0C;%4/3@[.5^Y-Y\T MP:D?'8^!A8*,ABR#>#:=222:7#W4Y4W\A'+V0:;P=I/J#0Z4IE4>LZECND&$ MCI1IRUAL"%@+;`B?%T3/YLN,H+BF.@T9#5D&<4T9-[LNK>[<+;8%@O@ZDX?M MR*(<&@U9!O$A"#=SE>'VE0L_/8Z#S<4:*&MA$BVQV(9DH(>>RBM%`49S;(,XIJNRM*97K(>ND_FVO(,HB/P%E2,H(36?4&QC;D1IA$ZSY(N:I'%&3&"K(,XIJ;ATW7EG M2M5ZB.\;P@N[<6!1!HV&+(/X`"YRN7%PN3C192.4^?+H] MI!!7+KSP1"%KOQM[*"T'!1G-L@QBFDIA;JXW$56 M2*N&+(/X$(07?I[6,OA=U%0V8JI;8K&"J.3.%EE1N0^?%`1C<>7"`D\H#TY' M5VM+#R4%H2&C()V)H[ZI@!.)-5;6+*-E1Y*DZH@HUF605R3$M,/(HAP:#5D&\2%$&(U=A%5DBKABR#^!`NLKA)L+BT((3OM\3B!2'*IHNLJ-R'3PJ" ML;CRBZQN$JR.KM82%&>_TY#1D&40U^1L*=FU>L,8-U?'3(7QN&1/'%C(]E*95088Z1I9E$-`@2@^D5M3AQ==0QS6KH2+$L8_$17&1GDV!G45/9"$TML?@RDX?+R"*91D.6 M05RY,+T3]:"-;>*A.-.=AHR&+(.X)N%BUQOQ)#@<9:$/.Y&%G4T&K(, MXD.XR,XFP<[2@A!3W1*+%82\Q=Y%5E3NPZ?[;@HQY;4PO<\+HF?S#8*@I"`T M9#1D&<0U"1?K]]VBNN;KS#I8'*6G)8A5A+Q7W446=30:L@SB8[C(SVKM9P2E M>?6L"!G-L@SBFISE2#^[[GFGVKM7?:SXS95E+#X& M9S[)&$[4JV/W]1HUE8U8_6WM67RER2-O9$7EH2-!EK&XDLL7A#RR!M94;D/GVR]C,65"]\[40H.VWM(5X0\L@;6=31:,@RB`VANK;<(:;B_D=++%X0X@C71590 MKB'+(*Y<^-[G!=%H:R,H*0@-&0U9!G%-PL=<05SU8$.C+8X@7@_B'-1%5LRJ MCQ7/[Y:Q^`BI!W+AIB<7K0?A*%UE1N0^?;!",Q94[>SE?N6/W MRNEJ;>.AM!X49#3+,HAK$BYV_0;A'DZ3>CT$C=$QY.[<4<Q0M" ME$T765%YZ$B092RF?'J1U_5LOD,0%&>_TY#1D&40UR1MU=DFGP.*JZEB">5WGB MC2SJ:#1D&<3'<)&A3;6A$93F51N:9ED&<4T90[NR7+6A33W$TRJ/O)$5TQHZ M$F09BP_A(D.;!D.CT"U!:5H]*T)&LRR#F":\FJYW`??%Q85/O/5Q^!Y`$$^J M/(U'%@W3:,B]0=]O,?U.<1S`\8WXXRO9F]7N9=6MWM[V@^7VFWO;O<#+<(_W M`??OXD_'LSE"X4JB!3XPL]B_L#;?A")M-2HT+PA4>N!16"KQ%R+:@0W,S/ MM:`.L@KFU10YR%X'+19/;62B55"-IR(R+1.HSD:;3PI<)UL':+'XFC\7#>/! ME^VY%HP'5I!K027BF^1<"RHQKZ#$;.-)5]UG7F%7QN-5N@5/Q2$'66T5M.&9 MLEP?:,M&FU<37"=;56AQCTGEHD$U'E;*M:!&L]'F8\PVGMC/]$&+Q8L4N1;, M-EY4R+24F.ULM'F)V<8SC+D^F&T\>9]K04;Q_'NN!1G%@^6Y%F04CW?G6I`W M/%&M6^9CS"G>:M(M>!L-(\TJ&$,!7DK*]8&";+3Y&'.*UV5R?:`-;R?E6C"G M>$$IX5P+JNKX^*Y4/495X0W+3)\Q:B>O`*)S69M#,AXPSX2"XJQ@ MZ,W*A=KL$B@@%N>YS!4*B,5O!N1:4&9X5-9]\'CVS#W[ MK%OP_#6V@5P+?OAIGK\^+I^)U+IUD_PO````__\#`%!+`P04``8`"````"$` M"00_>#8#``"("P``$``(`61O8U!R;W!S+V%P<"YX;6P@H@0!**```0`````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M``````````````````````````````````"<5M]/VS`0?I^T_Z'*.Z1`F2:4 M!O4G,`VHUL(>+>-<&JN)G=ENU^ZOWR6AI2FQ*WAS[+OS=]]]OEQPO<[2U@J4 MYE)TO;/3MM<"P63$Q;SK/!K1W'7[]$DR4S$$9#KJ% M(83N>HDQ^97O:Y9`1O4I'@L\B:7*J,%/-?=E'',&0\F6&0CCG[?;WWQ8&Q`1 M1"?Y+J!71;Q:F<\&C20K\.GGV29'P&'0R_.4,VHPR_">,R6UC$UKM&:0!O[^ M88#HIL"6BIM-V`[\_<]@RF@*`PP5*A\'*7*V`&:E: MFO]#VLZ]U@O54,#I>BNJ.!4&815FU4>Y3G-M5/A;JH5.`(P.?#2H-LOEONW^ MFG?"SF5I@:NZ91&A0H('=8PS;E+0C_&$*M,`N7.YC[E$42&N`&VK2'HB(B-A MD"]R)ZIJ<[F/?)?#U%`#1>4UD3$:,YDAA[OC@HTJ=MUP(+-<00)"\Q6@6Z-+ MGZ94,"#3=\3MHM9-"*:-4!(PJ(NT1O7.8X>#/,9D:B1;)#*-\+&0T9\E;\3A M=CES^Y2\#*A.R#B5?YLQ/4@#I$<>J%DJ*'CL+S47H#7!1TH:XYH4,2>4T&[X6DLSHVA5N1/H@(.:&3+!2CGO'Y`;D7-$\ MX:S,Z1&+I&QU+W.[(8<:L4JKM+_=8AXKF9$AS>B\X,08.QMWI,>86@)J?8V- M3;M2_4%^08I2CPJ-X;.8*4R8,M.L&(PKE_A^Q)Q,)#8I9)N\;*KUQE%0JP:: M1>82`9G9$Z_)`(N,\G$4KZZ&H^;66CMR:"XV7F7/X7WQCB*SLGMNO\;JA6'V`:XI>>5.FDT+_J!'=5!Y8]>T6Q/)NJC5^!C^[#+T.%R MT*C(T4RL(G9(Q>KCD(K5IV//W^I3C0NOL\7NA^?HILB#_1IK0W5(LN%15E3; MK[$VUMHUM9'G8,CYR<5"/^4S.<3^O)WBZIO!-,')(,+Y9GO^MA'-8Y;5^T<9S&UL/(Y!"@(Q M$`3O@G\(G[GI%Y4)18V ML!]&4,2^+)&?!NZWZ^X(2IKCQ:7"9.!#`K/=;K1WR5^"BZRZ@<5`:&T](8H/ ME)T,927NS:/4[%K'^D19*[E%`E'+"0_C.&'N`K#:JVK@/(&*_0.H]$NT&O\C M]@L``/__`P!02P,$%``&``@````A`/9DD%XR`0``0`(``!$`"`%D;V-02^3;OB<*'-0&57#@0GBGWJSK MZD2OO`S_GR_?.:GF.],DG^!1M[8F19:3!*QLE;:;FCRM%NDU23`(JT336JC) M'I#,^>5%)1V3K8<'WSKP00,FD62125>3;0B.48IR"T9@%ALVANO6&Q'BT6^H M$_)=;(!.\GQ*#02A1!#T`$S=2"0#4LD1Z3Y\TP.4I-"``1N0%EE!O[L!O,$_ M+_3)6=/HL'=QID'WG*WD,1S;.]1CL>NZK"M[C>A?T)?E_6,_:JKM85<2"#_L MIQ$8EG&5:PWJ9L]W;[Y)$+<5_9U52O9V3'H0`502WV-'NU/R7-[>K1:$3_+B M*LW+=#)=%3-63EDY>ZWHJ37?\"P``__\#`%!+`0(M M`!0`!@`(````(0#+EA$:#@(``)0<```3``````````````````````!;0V]N M=&5N=%]4>7!E&UL4$L!`BT`%``&``@````A`+55,"/U````3`(```L` M````````````````1P0``%]R96QS+RYR96QS4$L!`BT`%``&``@````A`,-3 MXPDY`@``QQL``!H`````````````````;0<``'AL+U]R96QS+W=O&PO=V]R:W-H965T&UL4$L!`BT`%``&``@````A`"SM>F:Z!```<1,``!D````` M````````````KAP``'AL+W=O&PO=V]R M:W-H965T&UL M4$L!`BT`%``&``@````A`"[JYH5_`@``PP4``!D`````````````````,"@` M`'AL+W=O&PO=V]R:W-H965T&UL4$L!`BT`%``&``@` M```A`/5/WH`\!```2`\``!D`````````````````!3```'AL+W=O&PO&PO&UL4$L! M`BT`%``&``@````A`"X8DMF6`@``308``!D`````````````````1:$``'AL M+W=O&PO=V]R:W-H965T&UL4$L!`BT`%``&``@````A M`/$O%FLP`P``10D``!D`````````````````&ZP``'AL+W=O0,%,#``!D"P``&0`````` M``````````""KP``>&PO=V]R:W-H965T&UL4$L!`BT`%``&``@````A`,&PO=V]R:W-H965T$?G M>Q$``'98```9`````````````````-R^``!X;"]W;W)K&UL4$L!`BT`%``&``@````A`%V:)I\,!@``F!<``!D````````````` M````CM```'AL+W=O&PO=V]R:W-H965T M@&##I0%``#R%```&`````````````````"F\P``>&PO=V]R M:W-H965T&UL4$L!`BT`%``&``@````A`&HC(75K`@``2@4` M`!@`````````````````55!00``"D.```8`````````````````!'\``!X M;"]W;W)K&PO=V]R:W-H965T&UL4$L!`BT`%``&``@````A`%QHC+F7"0``RS$``!D````````````````` M"`,!`'AL+W=O&PO=V]R:W-H965T&UL4$L!`BT`%``& M``@````A`)2SD=G#!```)Q```!D`````````````````-B,!`'AL+W=O&PO=V]R:W-H965T&UL4$L!`BT`%``&``@````A`!H5EM9N!@``=AD``!D````` M````````````L%(!`'AL+W=O&PO=V]R M:W-H965T&UL M4$L!`BT`%``&``@````A`&G\"D6\#@``B$P``!D`````````````````;&0! M`'AL+W=O#8#``"("P``$`````````````````!?&UL4$L!`BT`%``&``@````A`/9DD%XR`0``0`(``!$` M````````````````CG@!`&1O8U!R;W!S+V-O&UL4$L%!@`````W`#<` *Z@X``/=Z`0`````` ` end XML 13 R33.htm IDEA: XBRL DOCUMENT v2.4.1.9
Note D - Income Taxes (Details)
 12 Months Ended
Dec. 31, 2014
Dec. 31, 2013
Income Tax Disclosure [Abstract]    
Percentage of Net Income from Domestic Production Activities 9.00%ug_PercentageOfNetIncomeFromDomesticProductionActivities 9.00%ug_PercentageOfNetIncomeFromDomesticProductionActivities

XML 14 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; word-wrap: break-word; } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 15 R25.htm IDEA: XBRL DOCUMENT v2.4.1.9
Note G - Comprehensive Income (Tables)
 12 Months Ended
Dec. 31, 2014
Disclosure Text Block [Abstract]  
Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]
Changes in Accumulated Other
Comprehensive Income
 
December 31, 2014
   
December 31, 2013
 
Beginning balance - net of tax
  $ 132,123     $ 178,979  
Unrealized gain/(loss) on marketable securities before reclassifications - net of tax
    152,873       (65,531 )
Realized (loss)/gain on sale of securities reclassified from accumulated other comprehensive income
    (25,127 )     18,675  
Ending balance - net of tax
  $ 259,869     $ 132,123  
XML 16 R42.htm IDEA: XBRL DOCUMENT v2.4.1.9
Note G - Comprehensive Income (Details) - Accumulated Other Comprehensive Income (USD $)
 12 Months Ended
Dec. 31, 2014
Dec. 31, 2013
Accumulated Other Comprehensive Income (Loss) [Line Items]    
Ending balance - net of tax $ 259,869us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax $ 132,123us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax
Accumulated Net Unrealized Investment Gain (Loss) [Member]    
Accumulated Other Comprehensive Income (Loss) [Line Items]    
Beginning balance - net of tax 132,123us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember		 178,979us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember
Unrealized gain/(loss) on marketable securities before reclassifications - net of tax 152,873us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember		 (65,531)us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember
Realized (loss)/gain on sale of securities reclassified from accumulated other comprehensive income (25,127)us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember		 18,675us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember
Ending balance - net of tax $ 259,869us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember		 $ 132,123us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember
XML 17 R37.htm IDEA: XBRL DOCUMENT v2.4.1.9
Note E - Benefit Plans (Details) (DC Plan [Member], USD $)
 12 Months Ended
Dec. 31, 2015
Dec. 31, 2014
Dec. 31, 2013
Note E - Benefit Plans (Details) [Line Items]      
Defined Contribution Plan, Employer Matching Contribution, Percent of Employees' Gross Pay   4.00%us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent 4.00%us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent
Defined Contribution Plan, Discretionary Contribution Vesting Period   1 year 1 year
Defined Contribution Plan, Employer Discretionary Contribution Amount   103,000us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount $ 101,000us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount
Defined Contribution Plan, Maximum Annual Contributions Per Employee, Amount   17,500us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeeAmount 17,500us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeeAmount
Defined Contribution Plan Employer Discretionary Contribution Amount Per Year Authorized   175,000ug_DefinedContributionPlanEmployerDiscretionaryContributionAmountPerYearAuthorized 175,000ug_DefinedContributionPlanEmployerDiscretionaryContributionAmountPerYearAuthorized
Defined Contribution Plan, Discretionary Contributions Fully Vested Term, Years   6ug_DefinedContributionPlanDiscretionaryContributionsFullyVestedTerm  
Scenario, Forecast [Member] | Additional Deferred Investment Employees Over 50 [Member]      
Note E - Benefit Plans (Details) [Line Items]      
Defined Contribution Plan, Maximum Annual Contributions Per Employee, Amount 6,000us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeeAmount
/ us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsByTypeOfDeferredCompensationAxis
= ug_AdditionalDeferredInvestmentEmployeesOver50Member
/ us-gaap_DefinedContributionPlanNameAxis
= ug_DCPlanMember
/ us-gaap_StatementScenarioAxis
= us-gaap_ScenarioForecastMember		    
Scenario, Forecast [Member]      
Note E - Benefit Plans (Details) [Line Items]      
Defined Contribution Plan, Maximum Annual Contributions Per Employee, Amount 18,000us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeeAmount
/ us-gaap_DefinedContributionPlanNameAxis
= ug_DCPlanMember
/ us-gaap_StatementScenarioAxis
= us-gaap_ScenarioForecastMember		    
Discretionary Contribution Vesting at Two Years [Member]      
Note E - Benefit Plans (Details) [Line Items]      
Defined Contribution Plan, Discretionary Contribution Vesting Period   2 years  
Defined Contribution Plan, Employers Matching Contribution, Annual Vesting Percentage   20.00%us-gaap_DefinedContributionPlanEmployersMatchingContributionAnnualVestingPercentage
/ us-gaap_DefinedContributionPlanNameAxis
= ug_DCPlanMember
/ us-gaap_StatementScenarioAxis
= ug_DiscretionaryContributionsVestingAtTwoYearsMember		  
Discretionary Contributions Vesting Each Additional Year [Member]      
Note E - Benefit Plans (Details) [Line Items]      
Defined Contribution Plan, Employers Matching Contribution, Annual Vesting Percentage   20.00%us-gaap_DefinedContributionPlanEmployersMatchingContributionAnnualVestingPercentage
/ us-gaap_DefinedContributionPlanNameAxis
= ug_DCPlanMember
/ us-gaap_StatementScenarioAxis
= ug_DiscretionaryContributionsVestingEachAdditionalYearMember		  
Additional Deferred Investment Employees Over 50 [Member]
      
Note E - Benefit Plans (Details) [Line Items]      
Defined Contribution Plan, Maximum Annual Contributions Per Employee, Amount   5,500us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeeAmount
/ us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsByTypeOfDeferredCompensationAxis
= ug_AdditionalDeferredInvestmentEmployeesOver50Member
/ us-gaap_DefinedContributionPlanNameAxis
= ug_DCPlanMember		 $ 5,500us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeeAmount
/ us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsByTypeOfDeferredCompensationAxis
= ug_AdditionalDeferredInvestmentEmployeesOver50Member
/ us-gaap_DefinedContributionPlanNameAxis
= ug_DCPlanMember
XML 18 R9.htm IDEA: XBRL DOCUMENT v2.4.1.9
Note A - Nature of Business and Summary of Significant Accounting Policies
 12 Months Ended
Dec. 31, 2014
Accounting Policies [Abstract]  
Organization, Consolidation and Presentation of Financial Statements Disclosure and Significant Accounting Policies [Text Block]
NOTE A - NATURE OF BUSINESS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Nature of Business

United-Guardian, Inc. (the "Company") is a Delaware corporation that, through its Guardian Laboratories Division, manufactures and markets cosmetic ingredients, personal care products, pharmaceuticals, medical lubricants, health care products, and specialty industrial products. It also conducts research and product development, primarily related to the development of new and unique cosmetic and personal care products. The Company’s research and development department also modifies, refines, and expands the uses for existing products, with the goal of further developing the market for the Company's products. Two major product lines, LUBRAJEL™ and RENACIDIN® IRRIGATION (“RENACIDIN”) together accounted for 94.6% and 94.4% of revenue for the years ended December 31, 2014 and December 31, 2013, respectively. LUBRAJEL accounted for 85.9% and 91.4% of revenue for the years ended December 31, 2014 and December 31, 2013, respectively, and RENACIDIN accounted for 8.8% and 2.9% of revenue for the years ended December 31, 2014 and December 31, 2013, respectively.

Accounts Receivable and Reserves

The carrying amount of accounts receivable is reduced by a valuation allowance that reflects our best estimate of the amounts that will not be collected. The reserve for accounts receivable comprises the allowance for doubtful accounts and sales returns. In addition to reviewing delinquent accounts receivable, we consider many factors in estimating our reserve, including historical data, experience, customer types and credit worthiness, and economic trends. From time to time, we adjust our assumptions for anticipated changes in any of these or other factors expected to affect collectability.

Revenue Recognition

The Company recognizes revenue when products are shipped, title and risk of loss pass to customers, persuasive evidence of a sales arrangement exists, and collections are reasonably assured.  All products are shipped Free On Board (“FOB”) Hauppauge, New York, the location of the Company’s plant. Both title and risk of loss are deemed by both the Company and its customers to have passed to the customers at the time the goods leave the Company’s plant. Shipments are only made after confirmation that a valid purchase order has been received and that the future collection of the sale amount is reasonably assured. All sales of the Company’s products are deemed final, and there is no obligation on the part of the Company to repurchase or allow the return of the goods unless they are defective. The Company does not make sales on consignment, and the collection of the proceeds of the sale is not contingent upon the customer being able to sell the goods to a third party.

Any allowance for returns is taken as a reduction of sales within the same period the revenue is recognized. Such allowances are based on historical experience. The Company has not experienced significant fluctuations between estimated allowances and actual activity.

From time to time during 2014 the Company offered discounts and/or rebates to some of its customers in order to retain or increase sales to those customers. In 2014 those sales discounts totaled $119,965, compared with $11,000 in 2013. Of the $119,965 in sales discounts in 2014, $23,965 had been paid, and $96,000 accrued, as of December 31, 2014. The $96,000 of accrued sales discounts consisted of rebates given to one of the Company’s largest customers in order to retain and increase its business with that customer.

Cash and Cash Equivalents

For financial statement purposes, the Company considers as cash equivalents all highly liquid investments with an original maturity of three months or less at inception. The Company deposits cash and cash equivalents with high credit quality financial institutions and believes that any amounts in excess of insurance limitations to be at minimal risk. Cash and cash equivalents held in these accounts are currently insured by the Federal Deposit Insurance Corporation up to a maximum of $250,000.

Dividends

On May 14, 2014, the Company’s Board of Directors declared a semi-annual cash dividend of $0.48 per share, which was paid on June 13, 2014 to all stockholders of record as of May 30, 2014. On November 20, 2014, the Company’s Board of Directors declared a semi-annual cash dividend of $0.32 per share, which was paid on December 22, 2014 to all stockholders of record as of December 8, 2014. Total dividends declared and paid in 2014 were $3,677,151.

On May 15, 2013, the Company’s Board of Directors declared a semi-annual cash dividend of $0.47 per share, which was paid on June 14, 2013 to all stockholders of record as of May 30, 2013. On November 22, 2013, the Company’s Board of Directors declared a semi-annual cash dividend of $0.50 per share, which was paid on December 20, 2013 to all stockholders of record as of December 6, 2013. Total dividends declared and paid in 2013 were $4,458,544.

Supplemental Disclosures of Non-cash Investing and Financing Activities

Cash payments for income taxes were $1,867,089 and $2,605,474 for the years ended December 31, 2014 and 2013, respectively.  

Marketable Securities

Marketable securities include investments in equity and fixed income mutual funds, and government securities, all of which have a high degree of liquidity, are classified as "Available for Sale" securities, and are reported at their fair values. Unrealized gains and losses on "Available for Sale" securities are reported as accumulated other comprehensive income (loss) in stockholders' equity, net of the related tax effects. Investment income is recognized when earned. Realized gains and losses on sales of investments and declines in value judged to be other than temporary, if any, are reported in other income with cost being determined on a specific identification basis. Fair values are based on quoted market prices. The Company evaluates its investments periodically for possible impairment and reviews factors such as the length of time and extent to which fair value has been below cost basis and the Company’s ability and intent to hold the investment for a period of time which may be sufficient for anticipated recovery in market value.

Inventories

Inventories are valued at the lower of cost or current market value. Cost is determined using the average cost method, which approximates cost determined by the first-in, first-out (“FIFO”) method. Inventory costs include material, labor and factory overhead.

Property, Plant and Equipment

Property, plant and equipment are carried at cost, less accumulated depreciation. Major replacements and betterments are capitalized, while routine maintenance and repairs are expensed as incurred. Assets are depreciated under both accelerated and straight-line methods. Depreciation charged to income as a result of using accelerated methods was not materially different than that which would result from using the straight-line method for all periods presented. Certain factory equipment and fixtures are constructed by the Company using purchased materials and in-house labor. Such assets are capitalized and depreciated on a basis consistent with the Company's purchased fixed assets.

Estimated useful lives are as follows: 

Factory equipment and fixtures (years)
5
-
7
Building  (years)
 
40
 
Building improvements 
 
Lesser of useful
life or 20 years
 
Waste disposal system  (years)
 
7
 

Impairment of Long-Lived Assets

Long-lived assets and certain identifiable intangibles are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset to future net cash flows expected to be generated by the asset. If such assets are considered to be impaired, the impairment to be recognized is measured by the amount by which the carrying amount of the assets exceeds the fair value of the assets. Assets to be disposed of are reported at the lower of the carrying amount or fair value less costs to sell.  No impairments were necessary at December 31, 2014 and 2013.

Other Assets

Other assets at December 31, 2014 consisted of $60,042 expended in connection with the development of a new dosage form and manufacturing process for RENACIDIN, and $8,000 in costs incurred in re-registering the Company’s LUBRAJEL trademark. The Company will determine the appropriate amortization rate for these assets at such time as they are put into service.

Fair Value of Financial Instruments

Management of the Company believes that the fair value of financial instruments, consisting of cash and cash equivalents, accounts receivable, accounts payable, and accrued expenses approximates their carrying value due to their short payment terms and liquid nature.

Concentration of Credit Risk

Accounts receivable potentially exposes the Company to concentrations of credit risk. The Company monitors the amount of credit it allows each of its customers, using the customer’s prior payment history to determine how much credit to allow or whether any credit should be given at all.  It is the Company’s policy to discontinue shipments to any customer that is substantially past due on its payments. The Company sometimes requires payment in advance from customers whose payment record is questionable.  As a result of its monitoring of the outstanding credit allowed for each customer, as well as the fact that the majority of the Company’s sales are to customers whose satisfactory credit and payment record has been established over a long period of time, the Company believes that its accounts receivable credit risk has been reduced.

For the year ended December 31, 2014, two of the Company’s distributors and marketing partners accounted for 64.7% of the Company’s revenues during the year, and 56.3% of its outstanding accounts receivable at year end. For the year ended December 31, 2013, two of the Company’s distributors and marketing partners, one the same as in 2014, and the other different, accounted for a total of 69% of the Company’s revenues during the year, and 72% of its outstanding accounts receivable at year end.

Vendor Concentration

The principal raw materials used by the Company consist of common industrial organic and inorganic chemicals. Most of these materials are available in ample supply from numerous sources. The Company has five major raw material vendors that collectively accounted for approximately 84% and 67% of the raw material purchases by the Company in 2014 and 2013, respectively.

Income Taxes

Income taxes are accounted for under the asset and liability method. Deferred tax assets and liabilities are recognized for future tax consequences attributable to the temporary differences between the financial statement carrying amounts of assets and liabilities and their respective tax bases and operating loss and tax credit carry forwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in the period that includes the enactment date. Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion or all of the deferred tax assets will not be realized.

Uncertain tax positions are accounted for utilizing a recognition threshold and measurement attribute for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. As of December 31, 2014 and 2013, the Company did not have any unrecognized income tax benefits.  It is the Company’s policy to recognize interest and penalties related to taxes as interest expense as incurred.  During the years ended December 31, 2014 and 2013 the Company did not record any interest or penalties. The Company’s tax returns are subject to examination by the United States Internal Revenue Service and by the State of New York for years 2010 through 2013. In March 2014 the New York State Department of Taxation and Finance (“DTF”) commenced a routine examination of the Company’s income tax returns for years 2010 through 2012. The DTF has completed its examination and has accepted the tax returns as filed.

Research and Development

The Company's research and development expenses, included in operating expenses, are recorded in the year incurred. Research and development expenses were approximately $730,000 and $717,000 for the years ended December 31, 2014 and 2013, respectively.

Shipping and Handling Costs

Shipping and handling costs are classified in operating expenses in the accompanying statements of income. Shipping and handling costs were approximately $86,000 and $45,000 for the years ended December 31, 2014 and 2013, respectively.

Advertising Costs

Advertising costs are expensed as incurred. During 2014 and 2013 the Company incurred $20,000 and $16,000, respectively, in advertising costs.

Stock-Based Compensation

In 2004, the Company approved a stock option plan ("2004 Stock Option Plan") authorizing the granting of stock options to Company employees and Directors. No options were ever issued under this plan, and it expired in March 2014.

Earnings Per Share Information

Basic earnings per share are computed by dividing net income by the weighted average number of common shares outstanding during the year. Diluted earnings per share include the dilutive effect of outstanding stock options.

Use of Estimates

In preparing financial statements in conformity with U.S. generally accepted accounting principles, management is required to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and revenues and expenses during the reporting period. Actual results could differ from those estimates. Such estimated items include the allowance for bad debts, possible impairment of marketable securities, reserve for inventory obsolescence, and the allocation of overhead.

New Accounting Standards

In December of 2013, FASB issued ASU 2013-11, “Income Taxes (Topic 740): Presentation of an Unrecognized Tax Benefit When a Net Operating Loss Carryforward, a Similar Tax Loss, or a Tax Credit Carryforward Exists.” This amendment requires that an unrecognized tax benefit, or a portion of an unrecognized tax benefit, should be presented in the financial statements as a reduction to a deferred tax asset for a net operating loss carryforward, a similar tax loss, or a tax credit carryforward with exceptions.  This amendment only applies to entities that have an unrecognized tax benefit when a net operating loss carryforward, a similar tax loss, or a tax credit carryforward exists at the reporting date. This update became effective for interim and annual reporting periods beginning after December 15, 2013. The update does not have a material impact on the Company’s results of operation.

In May 2014, FASB issued ASU 2014-09, “Revenue from Contracts with Customers.” This standard applies to any entity that uses the guidance of GAAP for entering into contracts with customers to transfer goods or services or enters into contracts for the transfer of nonfinancial assets unless those contracts are within the scope of other standards. It requires that an entity should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration the entity expects to receive for the exchange of goods or services. This amendment is effective for interim and annual reporting periods beginning after December 15, 2016. The Company is still evaluating the potential impact on the Company’s results of operations.

In June 2014, FASB issued ASU 2014-11, “Transfers and Servicing: Repurchase-to-Maturity Transactions, Repurchase Financings, and Disclosures.” This standard aligns the accounting for repurchases-to-maturity transactions and repurchase agreements executed as a repurchase financing with accounting for other typical repurchase agreements. These types of transactions will now be accounted for as secured borrowings. It eliminates sales accounting for repurchase-to-maturity and supersedes guidance for accounting transactions involving transfers of financial assets with contemporaneous repurchase financing agreements that leads to off-balance accounting. This update becomes effective for interim and annual reporting periods beginning after December 15, 2014 and is not expected to have a material impact on the Company’s results of operations.

In August 2014, FASB issued ASU 2014-15, “Presentation of Financial Statements-Going Concern.  Disclosure of Uncertainties about Entity’s Ability to Continue as a Going Concern.” Currently, GAAP lacks guidance about management’s responsibility to evaluate whether there is substantial doubt about an entity’s ability to continue as a going concern. This amendment now provides guidance by providing a definition of substantial doubt, requires evaluation by management every reporting period for going concern issues, provides principles for considering any mitigating effects implemented by management, and the disclosures required for the assessment period of one year after issuance of the financial statements. This update becomes effective for interim and annual reporting periods beginning after December 15, 2016 with early application being permitted. The update will be adopted for reporting periods starting January 2015, and is not expected to have a material impact on the Company’s results of operations.

EXCEL 19 Financial_Report.xls IDEA: XBRL DOCUMENT begin 644 Financial_Report.xls M[[N_34E-12U697)S:6]N.B`Q+C`-"E@M1&]C=6UE;G0M5'EP93H@5V]R:V)O M;VL-"D-O;G1E;G0M5'EP93H@;75L=&EP87)T+W)E;&%T960[(&)O=6YD87)Y M/2(M+2TM/5].97AT4&%R=%\V835D9F,S-E\T,6,W7S1A-C!?.#=F-5\Y,65A M9C$Y96-C96$B#0H-"E1H:7,@9&]C=6UE;G0@:7,@82!3:6YG;&4@1FEL92!7 M96(@4&%G92P@86QS;R!K;F]W;B!A'!L;W)E&UL;G,Z=CTS1")U&UL;G,Z;STS1")U&UL/@T*(#QX.D5X8V5L5V]R:V)O;VL^#0H@(#QX M.D5X8V5L5V]R:W-H965T5]);F9O#I%>&-E;%=O#I7;W)K#I7;W)K#I. M86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I%>&-E;%=O#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/E-T871E;65N='-?;V9?0V%S:%]&;&]W#I. M86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/DYO=&5?0E]-87)K971A8FQE7U-E8W5R:71I97,\+W@Z M3F%M93X-"B`@("`\>#I7;W)K#I7;W)K&5S/"]X.DYA;64^#0H@("`@/'@Z5V]R:W-H M965T4V]U#I%>&-E;%=O#I7;W)K#I7;W)K#I7;W)K#I7;W)K'!E;G-E#I.86UE/@T*("`@ M(#QX.E=O#I%>&-E M;%=O#I.86UE/DYO=&5?2E]296QA=&5D7U!A#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I. M86UE/D%C8V]U;G1I;F=?4&]L:6-I97-?8GE?4&]L:6-Y7SPO>#I.86UE/@T* M("`@(#QX.E=O#I% M>&-E;%=O#I.86UE/DYO=&5?05].871U#I7;W)K#I7;W)K#I% M>&-E;%=O#I7;W)K#I% M>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O#I.86UE/DYO=&5?05].871U M#I7;W)K#I7;W)K#I%>&-E;%=O#I7;W)K#I7;W)K M&5S7T1E=&%I;',\ M+W@Z3F%M93X-"B`@("`\>#I7;W)K&5S7T1E=&%I;'-?4'(\+W@Z3F%M93X-"B`@("`\>#I7;W)K M&5S7T1E=&%I;'-? M4F4\+W@Z3F%M93X-"B`@("`\>#I7;W)K&5S7T1E=&%I;'-?1&4\+W@Z3F%M93X-"B`@("`\>#I7 M;W)K#I%>&-E;%=O#I.86UE/@T*("`@(#QX M.E=O#I%>&-E;%=O M#I.86UE/DYO=&5?1E]'96]G#I7;W)K#I%>&-E;%=O#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/DYO=&5?1U]#;VUP#I.86UE M/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/DYO=&5?2%]);F-O;65? M1G)O;5]$86UA9V5?4V5T=#$\+W@Z3F%M93X-"B`@("`\>#I7;W)K'!E;G-E#I7;W)K5]4#I%>&-E;%=O#I!8W1I=F53:&5E=#XP/"]X.D%C=&EV95-H965T/@T* M("`\>#I0#I%>&-E;%=O7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X- M"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP M92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA2!) M;F9O2!296=I2!#;VUM M;VX@4W1O8VLL(%-H87)E'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$2!6;VQU;G1A'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T* M("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T* M("`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`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L M87-S/3-$F5D(&=A:6X@*&QO'0O:F%V87-C M3X-"B`@("`\=&%B;&4@ M8VQA&5S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XR M,C,L-#,Y/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S2P@<&QA;G0L(&%N9"!E<75I<&UE;G0Z/"]S=')O M;F<^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\2!E<75I<&UE;G0@86YD(&9I>'1U2P@<&QA M;G0L(&%N9"!E<75I<&UE;G0\+W1D/@T*("`@("`@("`\=&0@8VQA6%B;&4\+W1D/@T*("`@("`@("`\=&0@8VQA&5S M('!A>6%B;&4\+W1D/@T*("`@("`@("`\=&0@8VQA'0^)FYB'0^)FYB MF5D.R`T+#4Y-BPT,SD@3PO=&0^#0H@("`@("`@(#QT9"!C;&%S3PO=&0^#0H@("`@("`@(#QT M9"!C;&%S3PO=&0^#0H@ M("`@("`@(#QT9"!C;&%S3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\V M835D9F,S-E\T,6,W7S1A-C!?.#=F-5\Y,65A9C$Y96-C96$-"D-O;G1E;G0M M3&]C871I;VXZ(&9I;&4Z+R\O0SHO-F$U9&9C,S9?-#%C-U\T838P7S@W9C5? M.3%E868Q.65C8V5A+U=O'0O:'1M;#L@8VAA3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT M4&%R=%\V835D9F,S-E\T,6,W7S1A-C!?.#=F-5\Y,65A9C$Y96-C96$-"D-O M;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO-F$U9&9C,S9?-#%C-U\T838P M7S@W9C5?.3%E868Q.65C8V5A+U=O'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T* M("`@("`@/'1R(&-L87-S/3-$'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R M(&-L87-S/3-$'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'1087)T7S9A M-61F8S,V7S0Q8S=?-&$V,%\X-V8U7SDQ96%F,3EE8V-E80T*0V]N=&5N="U, M;V-A=&EO;CH@9FEL93HO+R]#.B\V835D9F,S-E\T,6,W7S1A-C!?.#=F-5\Y M,65A9C$Y96-C96$O5V]R:W-H965T'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0O M:F%V87-C3X-"B`@("`\ M=&%B;&4@8VQA2!O<&5R M871I;F<@86-T:79I=&EE&5S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B@S M,"PV-#,I/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S6%B;&4\+W1D/@T*("`@("`@("`\ M=&0@8VQA'!E M;G-E2!O<&5R871I;F<@86-T:79I=&EE'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA M'0@0FQO8VM=/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\ M9&EV('-T>6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K M.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX] M,T1J=7-T:69Y/B`@("`@#0H@("`@("`\9F]N="!S='EL93TS1"=&3TY4+49! M34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$R<'0G/CQF;VYT M('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ(%1I;65S M($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,G!T.R!&3TY4+5=%24=(5#H@8F]L M9"<^3D]412!!("T@3D%455)%($]&($)54TE.15-3($%.1"!354U-05)9($]& M(%-)1TY)1DE#04Y4/"]F;VYT/B`\9F]N="!S='EL93TS1"=$25-03$%9.B!I M;FQI;F4[($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)' M24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1J=7-T M:69Y/B`@(`T*("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T)SY5;FET960M M1W5A2(I(&ES(&$@1&5L87=A2!I;F1U2=S('!R;V1U8W1S+B!4=V\@;6%J;W(@<')O9'5C M="!L:6YE65A2X\+V9O;G0^("`@#0H@("`@/"]D:78^/&)R+SX\9&EV('-T>6QE/3-$)U1% M6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@ M,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1J=7-T:69Y/B`@(`T* M("`@("`@/&9O;G0@6QE/3-$)U1% M6%0M04Q)1TXZ(&IU6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T M)SY4:&4@8V%R2!A('9A;'5A=&EO;B!A;&QO=V%N8V4@=&AA="!R969L M96-T2!F86-T;W)S(&EN(&5S=&EM871I M;F<@;W5R(')E'!E M8W1E9"!T;R!A9F9E8W0@8V]L;&5C=&%B:6QI='DN/"]F;VYT/B`@(`T*("`@ M(#PO9&EV/CQB3X@("`-"B`@("`@(#QF;VYT('-T>6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2 M;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9"<^4F5V M96YU92!296-O9VYI=&EO;CPO9F]N=#X@#0H@("`@/"]D:78^/&)R+SX\9&EV M('-T>6QE/3-$)U1%6%0M24Y$14Y4.B`S-G!T.R!$25-03$%9.B!B;&]C:SL@ M34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$ M:G5S=&EF>3X@("`@#0H@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I M;FQI;F4[($9/3E0M1D%-24Q9.B!4:6UE&ES=',L(&%N9"!C;VQL96-T:6]N2!A2!A2!D;V5S(&YO="!M86ME('-A;&5S(&]N(&-O;G-I9VYM96YT+"!A;F0@ M=&AE(&-O;&QE8W1I;VX@;V8@=&AE("`@("`-"B`@("`@('!R;V-E961S(&]F M('1H92!S86QE(&ES(&YO="!C;VYT:6YG96YT('5P;VX@=&AE(&-U2X\+V9O;G0^("`@#0H@("`@/"]D:78^/&)R+SX\9&EV('-T>6QE/3-$)U1% M6%0M24Y$14Y4.B`S-G!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z M(#!P=#L@34%21TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$:G5S=&EF>3X@("`@ M#0H@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M M1D%-24Q9.B!4:6UE'!E2!H87,@;F]T(&5X M<&5R:65N8V5D('-I9VYI9FEC86YT(&9L=6-T=6%T:6]N6QE/3-$)U1%6%0M24Y$ M14Y4.B`S-G!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@ M34%21TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$:G5S=&EF>3X@("`@#0H@("`@ M("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9 M.B!4:6UE28C.#(Q-SMS(&QA3X@("`-"B`@("`@(#QF;VYT('-T>6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@ M1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9"<^0V%S:"!A;F0@ M0V%S:"!%<75I=F%L96YT2!C;VYS:61E&-E2!T:&4@1F5D97)A;"!$ M97!O&EM=6T@ M;V8@)#(U,"PP,#`N/"]F;VYT/B`@("`@#0H@("`@/"]D:78^/&)R+SX\9&EV M('-T>6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!- M05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1J M=7-T:69Y/B`@(`T*("`@("`@/&9O;G0@2`Q-"P@,C`Q-"P@ M=&AE($-O;7!A;GDF(S@R,3<[28C.#(Q-SMS($)O87)D M(&]F($1I6QE/3-$)U1%6%0M24Y$14Y4 M.B`S-G!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%2 M1TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$:G5S=&EF>3X@("`@#0H@("`@("`\ M9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!4 M:6UE28C.#(Q-SMS($)O87)D(&]F($1I2`S,"P@,C`Q M,RX@3VX@3F]V96UB97(@,C(L(#(P,3,L('1H92!#;VUP86YY)B,X,C$W.W,@ M0F]A&5S('=E6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^/"]F;VYT/B`@(`T*("`@(#PO M9&EV/CQB3X@("`-"B`@("`@(#QF;VYT('-T>6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA M;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9"<^36%R:V5T M86)L92!396-U2!A;F0@9FEX960@:6YC;VUE(&UU='5A;"!F=6YD M2!E=F%L=6%T97,@:71S(&EN M=F5S=&UE;G1S('!E2!F;W(@<&]S'1E;G0@=&\@=VAI8V@@9F%I3X@("`-"B`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D]. M5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9"<^4')O<&5R='DL(%!L M86YT(&%N9"!%<75I<&UE;G0\+V9O;G0^(`T*("`@(#PO9&EV/CQB&5D(&%S3X@("`-"B`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SY%6QE/3-$)U1%6%0M04Q)1TXZ M(')I9VAT)SX@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-0 M3$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E M6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXT M,#PO9F]N=#X@("`-"B`@("`@("`@("`@(#PO9&EV/B`@("`@#0H@("`@("`@ M("`@/"]T9#X@(`T*("`@("`@("`@(#QT9"!A;&EG;CTS1&QE9G0@=F%L:6=N M/3-$8F]T=&]M('=I9'1H/3-$-B4^(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1% M6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@ M,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1L969T/B`@("`@#0H@ M("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SY"=6EL9&EN9R!I;7!R;W9E;65N=',F(S$V,#L\+V9O;G0^("`-"B`@("`@ M("`@("`@(#PO9&EV/B`@("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@ M("`@(#QT9"!A;&EG;CTS1&QE9G0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$ M-B4^(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1) M4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z M(#!P="<^("`-"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$ M)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5& M5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<^("`-"B`@("`@("`@("`@("`@ M/&9O;G0@65A65A M6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@ M(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$ M8F]T=&]M('=I9'1H/3-$,R4@3X@(`T*("`@("`@/&9O;G0@6EN9R!A;6]U;G0@ M;V8@86X@87-S970@;6%Y(&YO="!B92!R96-O=F5R86)L92X@4F5C;W9E6EN9R!A;6]U;G0@;V8@ M86X@87-S970@=&\@9G5T=7)E(&YE="!C87-H(&9L;W=S(&5X<&5C=&5D('1O M(&)E(&=E;F5R871E9"!B>2!T:&4@87-S970N($EF('-U8V@@87-S971S(&%R M92!C;VYS:61EF5D(&ES(&UE87-U3X@("`-"B`@("`@(#QF;VYT('-T M>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ(%1I;65S($YE M=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9"<^ M3W1H97(@07-S971S/"]F;VYT/B`@("`-"B`@("`\+V1I=CX\8G(O/CQD:78@ M2!A3X@("`-"B`@("`@(#QF;VYT('-T>6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@ M1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9"<^1F%I6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA M;CL@1D].5"U325I%.B`Q,'!T)SY-86YA9V5M96YT(&]F('1H92!#;VUP86YY M(&)E;&EE=F5S('1H870@=&AE(&9A:7(@=F%L=64@;V8@9FEN86YC:6%L(&EN M6%B;&4L M(&%N9"!A8V-R=65D(&5X<&5N&EM871E6EN9R!V86QU92!D=64@=&\@=&AE:7(@6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SY!8V-O=6YT6UE;G0@:&ES=&]R>2!T;R!D M971E6UE;G0@:6X@861V86YC92!F65A65A28C.#(Q-SMS(&1I65A6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!- M05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1J M=7-T:69Y/B`@(`T*("`@("`@/&9O;G0@2!H87,@9FEV92!M86IO2!A8V-O=6YT960@9F]R(&%P<')O>&EM M871E;'D@.#0E(&%N9"`V-R4@;V8@=&AE(')A=R!M871E3X@("`- M"B`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4 M+5=%24=(5#H@8F]L9"<^26YC;VUE(%1A>&5S/"]F;VYT/B`@("`-"B`@("`\ M+V1I=CX\8G(O/CQD:78@6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2 M;VUA;CL@1D].5"U325I%.B`Q,'!T)SY);F-O;64@=&%X97,@87)E(&%C8V]U M;G1E9"!F;W(@=6YD97(@=&AE(&%S"!C;VYS97%U96YC97,@871T2!F M;W)W87)D"!A"!R871EF5D(&EN('1H92!P97)I;V0@=&AA="!I;F-L=61E"!A6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ(%1I;65S($YE M=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T)SX\9F]N="!S='EL93TS1"=$25-0 M3$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!4:6UEF5D(&EN8V]M M92!T87@@8F5N969I=',N)B,Q-C`[)B,Q-C`[270@:7,@=&AE($-O;7!A;GDF M(S@R,3<[&%M:6YA M=&EO;B!B>2!T:&4@56YI=&5D(%-T871E65A"!R971U&%M:6YA=&EO;B!A;F0@:&%S(&%C M8V5P=&5D('1H92!T87@@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=( M5#H@8F]L9"<^4F5S96%R8V@@86YD($1E=F5L;W!M96YT/"]F;VYT/B`-"B`@ M("`\+V1I=CX\8G(O/CQD:78@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ(%1I;65S($YE M=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T)SY4:&4@0V]M<&%N>2=S(')E'!E;G-E&EM871E;'D@)#65A2X\+V9O;G0^("`@("`-"B`@("`\+V1I=CX\8G(O/CQD:78@6QE/3-$ M)U1%6%0M24Y$14Y4.B`S-G!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q% M1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$:G5S=&EF>3X@ M("`@#0H@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/ M3E0M1D%-24Q9.B!4:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T)SY!9'9E2P@:6X@861V97)T:7-I;F<@8V]S=',N/"]F M;VYT/B`@("`@#0H@("`@/"]D:78^/&)R+SX\9&EV('-T>6QE/3-$)U1%6%0M M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T M.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1J=7-T:69Y/B`@(`T*("`@ M("`@/&9O;G0@2!E;7!L;WEE97,@86YD($1I2!T:&4@ M=V5I9VAT960@879E3X@("`-"B`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D]. M5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9"<^57-E(&]F($5S=&EM M871E6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T)SY) M;B!P2!W:71H(%4N4RX@9V5N97)A;&QY(&%C8V5P=&5D(&%C8V]U;G1I;F<@<')I M;F-I<&QE2!O8G-O;&5S8V5N8V4L(&%N9"!T:&4@86QL;V-A=&EO;B!O9B!O=F5R:&5A M9"X\+V9O;G0^(`T*("`@(#PO9&EV/CQB3X@("`-"B`@ M("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=% M24=(5#H@8F]L9"<^3F5W($%C8V]U;G1I;F<@4W1A;F1A3L@5$585"U)3D1%3E0Z(#,V<'0[($1)4U!,05DZ(&)L;V-K.R!-05)' M24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<^("`@(`T*("`@("`@ M/&9O;G0@&5S("A4;W!I8R`W-#`I.B!0F5D(%1A>"!"96YE9FET(%=H96X@82!.970@3W!E2!A<'!L:65S('1O(&5N=&ET:65S('1H870@:&%V92!A;B!U;G)E8V]G;FEZ M960@=&%X(&)E;F5F:70@=VAE;B!A(&YE="!O<&5R871I;F<@;&]S69O&ES=',@870@=&AE(')E<&]R=&EN9R!D871E+B!4 M:&ES('5P9&%T92!B96-A;64@969F96-T:79E(&9O7!E2!A;F0@ M3L@5$585"U)3D1%3E0Z M(#,V<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)' M24XM4DE'2%0Z(#!P="<^("`@(`T*("`@("`@/&9O;G0@2P@1T%!4"!L86-K2!R97!O2!M86YA9V5M96YT+"!A;F0@=&AE(&1I'0O M:F%V87-C3X-"B`@("`\ M=&%B;&4@8VQA'0^/&1I=B!S='EL93TS1"=415A4+4E.1$5.5#H@,'!T.R!$25-03$%9 M.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G M(&%L:6=N/3-$;&5F=#X@("`-"B`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D]. M5"U325I%.B`Q,G!T.R!&3TY4+5=%24=(5#H@8F]L9"<^3D]412!"("T@34%2 M2T5404),12!314-54DE42453/"]F;VYT/B`@#0H@("`@/"]D:78^/&)R+SX\ M9&EV('-T>6QE/3-$)U1%6%0M24Y$14Y4.B`S-G!T.R!$25-03$%9.B!B;&]C M:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G(&%L:6=N M/3-$:G5S=&EF>3X@("`@#0H@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9 M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!4:6UE2X@ M07,@82!B87-IF5S('1H92!I;G!U=',@=7-E9"!I;B!M96%S=7)I;F<@9F%I6QE/3-$)T9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U=)1%1( M.B`R-W!T)SX@("`-"B`@("`@("`@("`@("`@)B,Q-C`[("`@("`-"B`@("`@ M("`@("`@(#PO=&0^("`@(`T*("`@("`@("`@("`@/'1D('-T>6QE/3-$)U1% M6%0M04Q)1TXZ(&-E;G1E6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E3X@("`@#0H@("`@("`@("`@("`@("`@/&9O;G0@2!I;F-L=61E('%U;W1E9"!P2P@9F]R('-U8G-T86YT:6%L;'D@=&AE(&9U;&P@=&5R;2!O9B!T M:&4@9FEN86YC:6%L(&EN6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ(%1I;65S($YE M=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T)SY4:&4@9F]L;&]W:6YG(&%V86EL M86)L92UF;W(M"<^("`@#0H@("`@("`@("`@("`\9&EV M('-T>6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!- M05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1L M969T/B`@("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9"<^/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E"<^("`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^ M("`-"B`@("`@("`@("`\=&0@8V]L6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO M=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$ M)U1%6%0M04Q)1TXZ(&-E;G1E"<^("`@ M("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@ M("`@("`@("`\=&0@8V]L6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SX\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4G/D=A M:6XO*$QO6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@ M("`@/"]T6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\ M+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@ M86QI9VX],T1R:6=H="!C;VQS<&%N/3-$,B!N;W=R87`],T1N;W=R87`@=F%L M:6=N/3-$8F]T=&]M/B`@("`-"B`@("`@("`@("`@("8C,38P.R`@(`T*("`@ M("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@;F]W6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@ M("`@("`@("`\=&0@86QI9VX],T1R:6=H="!V86QI9VX],T1B;W1T;VT^(`T* M("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ M(&QE9G0G/B`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)V)A8VMG6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^ M("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@86QI9VX] M,T1R:6=H="!C;VQS<&%N/3-$,B!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$ M8F]T=&]M/B`@("`-"B`@("`@("`@("`@("8C,38P.R`@(`T*("`@("`@("`@ M(#PO=&0^("`-"B`@("`@("`@("`\=&0@;F]W6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF M(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@ M("`\=&0@86QI9VX],T1R:6=H="!V86QI9VX],T1B;W1T;VT^(`T*("`@("`@ M("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G M/B`@(`T*("`@("`@("`@("`@/&9O;G0@&5D(&EN8V]M M92!M=71U86P@9G5N9',\+V9O;G0^(`T*("`@("`@("`@("`@/"]D:78^("`@ M("`-"B`@("`@("`@("`\+W1D/B`@#0H@("`@("`@("`@/'1D(&%L:6=N/3-$ M6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\ M+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@ M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXX+#,W,RPV-S0\ M+V9O;G0^("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@("`@(#QT9"!N M;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U1%6%0M04Q) M1TXZ(&QE9G0G/B`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@("`@#0H@("`@("`@("`@ M("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9 M.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`@(#QF M;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^ M("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@86QI9VX] M,T1R:6=H="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X@(`T*("`@("`@ M("`@("`@/&9O;G0@6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXD/"]F;VYT/B`@("`@#0H@("`@("`@("`@/"]T M9#X@(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0W M)2!S='EL93TS1"=415A4+4%,24=..B!R:6=H="<^("`@(`T*("`@("`@("`@ M("`@/&9O;G0@6QE M/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`@(#QF;VYT M('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@ M(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@/"]T2!A;F0@;W1H97(@;75T M=6%L(&9U;F1S/"]F;VYT/B`@("`@#0H@("`@("`@("`@("`\+V1I=CX@("`@ M(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@86QI9VX],T1R M:6=H="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=0041$ M24Y'+4)/5%1/33H@,G!X)SX@("`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O M;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L M:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SX\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4G/C8R,BPP.#8\+V9O M;G0^/"]F;VYT/B`@("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@("`@ M(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$ M,24@6QE/3-$)U!!1$1)3D6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T M('-O;&ED.R!415A4+4%,24=..B!L969T)SX@(`T*("`@("`@("`@("`@/&9O M;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN92<^.#$T+#(Q-CPO9F]N=#X\ M+V9O;G0^("`@("`-"B`@("`@("`@("`\+W1D/B`@#0H@("`@("`@("`@/'1D M(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S M='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`Q+C%P="!S;VQI9#L@5$58 M5"U!3$E'3CH@;&5F="<^("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE"<^("`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@ M(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H M/3-$,24@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K M(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!R:6=H="<^("`@#0H@("`@("`@ M("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%- M24Q9.B!T:6UE6QE M/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%, M24=..B!L969T)SX@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@ M(#PO=&0^("`-"B`@("`@("`@/"]T6QE/3-$)U!!1$1)3D"<^("`@ M("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@ M("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#(N-S5P="!D;W5B M;&4[(%1%6%0M04Q)1TXZ(')I9VAT)SX@("`@(`T*("`@("`@("`@("`@/&9O M;G0@6QE/3-$)U!!1$1)3D6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#(N-S5P="!D;W5B M;&4[(%1%6%0M04Q)1TXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`@(#QF;VYT M('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXD/"]F;VYT/B`@("`@#0H@ M("`@("`@("`@/"]T9#X@(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T M;VT@=VED=&@],T0W)2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`R M+C6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXY+#,X M.2PU,#$\+V9O;G0^("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@("`@ M(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$ M,24@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@ M(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@86QI9VX],T1R M:6=H="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=0041$ M24Y'+4)/5%1/33H@-'!X)SX@("`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O M;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@/"]T6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@(`T*("`@("`@("`@ M("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@ M("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@ M("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI M;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@ M(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H M/3-$-R4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V M,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\ M=&0@;F]W6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`@ M(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O M;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@/"]T6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L M;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI M9VX],T1L969T/B`@("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9#L@5$585"U$ M14-/4D%424]..B!U;F1E6QE/3-$)T1)4U!,05DZ M(&EN;&EN92<^1&5C96UB97(@,S$L(#(P,3,\+V9O;G0^/"]F;VYT/B`@("`- M"B`@("`@("`@("`@(#PO9&EV/B`@("`@#0H@("`@("`@("`@/"]T9#X@(`T* M("`@("`@("`@(#QT9"!A;&EG;CTS1')I9VAT('9A;&EG;CTS1&)O='1O;2!W M:61T:#TS1#$E('-T>6QE/3-$)U!!1$1)3D6QE/3-$ M)U1%6%0M04Q)1TXZ(&QE9G0[(%!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@ M("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4@6QE/3-$)U!!1$1)3D6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[(%!!1$1)3D6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO M=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$ M-R4@6QE/3-$)U!! M1$1)3D6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[(%!! M1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T* M("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T M=&]M('=I9'1H/3-$-R4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@ M("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@("`@ M#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[ M($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@ M("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@ M("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI M;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`- M"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT M)SX@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I M;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O M;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L M:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@("`@#0H@("`@("`@("`@ M("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9 M.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\ M+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@ M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@("`@#0H@("`@("`@ M("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%- M24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V M,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\ M=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@("`@#0H@("`@ M("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M M1D%-24Q9.B!T:6UE6QE/3-$)V)A8VMG65A6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@ M(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$ M8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXR,#,L.3(P/"]F;VYT/B`-"B`@ M("`@("`@("`\+W1D/B`@#0H@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A M<"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4+4%, M24=..B!L969T)SX@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$ M25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T* M("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T M=&]M('=I9'1H/3-$,24@6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXR,#`L,#4S/"]F;VYT/B`-"B`@("`@ M("`@("`\+W1D/B`@#0H@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V M86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4+4%,24=. M.B!L969T)SX@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-0 M3$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@ M("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M M('=I9'1H/3-$,24@6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXH,RPX-C<\+V9O;G0^("`@("`-"B`@("`@ M("`@("`\+W1D/B`@#0H@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V M86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4+4%,24=. M.B!L969T)SX@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-0 M3$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U!!1$1)3D6QE/3-$)U1%6%0M24Y$ M14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,3AP=#L@ M34%21TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$;&5F=#X@#0H@("`@("`@("`@ M("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SY&:7AE9"!I M;F-O;64@;75T=6%L(&9U;F1S/"]F;VYT/B`-"B`@("`@("`@("`@(#PO9&EV M/B`@("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@("`@(#QT9"!A;&EG M;CTS1')I9VAT('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/B`@#0H@("`@ M("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M M04Q)1TXZ(&QE9G0G/B`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@ M("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@("`@ M#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[ M($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`-"B`@ M("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF M(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@ M("`\=&0@86QI9VX],T1R:6=H="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q M)3X@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@ M(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$ M8F]T=&]M('=I9'1H/3-$-R4@6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXY.2PW-3<\+V9O;G0^("`@("`-"B`@("`@("`@("`\+W1D/B`@ M#0H@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T M;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L969T)SX@("`@ M#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[ M($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)V)A8VMG#L@4$%$1$E.1RU,1494.B`P<'0[($U!4D=) M3BU,1494.B`Y<'0G/B`@#0H@("`@("`@("`@("`\9&EV('-T>6QE/3-$)U1% M6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@ M,3AP=#L@34%21TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$;&5F=#X@#0H@("`@ M("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SY% M<75I='D@86YD(&]T:&5R(&UU='5A;"!F=6YD"<^("`@("`-"B`@ M("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF M(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@ M("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4 M+4%,24=..B!R:6=H="<^("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U!!1$1)3D6QE/3-$)T)/4D1%4BU" M3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T)SX@ M(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN M92<^,2PR,S6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K M(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T)SX@("`-"B`@("`@("`@ M("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\ M+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@ M86QI9VX],T1R:6=H="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL M93TS1"=0041$24Y'+4)/5%1/33H@,G!X)SX@("`@(`T*("`@("`@("`@("`@ M/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF M(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@ M("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4@6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SX\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4G/C$P M-BPS,3@\+V9O;G0^/"]F;VYT/B`@("`@#0H@("`@("`@("`@/"]T9#X@(`T* M("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M M('=I9'1H/3-$,24@"<^("`@("`-"B`@("`@("`@("`@("8C,38P.R`@(`T* M("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@86QI9VX],T1R:6=H M="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=0041$24Y' M+4)/5%1/33H@-'!X)SX@("`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#(N-S5P M="!D;W5B;&4[(%1%6%0M04Q)1TXZ(&QE9G0G/B`@("`@#0H@("`@("`@("`@ M("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9 M.B!T:6UE"<^("`@("`-"B`@("`@("`@("`@(#QF M;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^ M("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N M/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T)/4D1% M4BU"3U143TTZ(&)L86-K(#(N-S5P="!D;W5B;&4[(%1%6%0M04Q)1TXZ(')I M9VAT)SX@("`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)U!!1$1)3D6QE/3-$)T)/4D1% M4BU"3U143TTZ(&)L86-K(#(N-S5P="!D;W5B;&4[(%1%6%0M04Q)1TXZ(&QE M9G0G/B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXD/"]F;VYT/B`@("`@#0H@("`@("`@("`@/"]T9#X@(`T* M("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0W)2!S='EL M93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`R+C6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXR,#(L,C`X/"]F;VYT/B`-"B`@("`@ M("`@("`\+W1D/B`@#0H@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V M86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"="3U)$15(M0D]4 M5$]-.B!B;&%C:R`R+C2!O9B!U;G)E86QI>F5D(&%N9"!R96%L:7IE9"!G86EN3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\V835D M9F,S-E\T,6,W7S1A-C!?.#=F-5\Y,65A9C$Y96-C96$-"D-O;G1E;G0M3&]C M871I;VXZ(&9I;&4Z+R\O0SHO-F$U9&9C,S9?-#%C-U\T838P7S@W9C5?.3%E M868Q.65C8V5A+U=O'0O:'1M;#L@8VAA2!$:7-C;&]S=7)E(%M!8G-T'0@0FQO8VM=/"]T9#X-"B`@("`@("`@/'1D(&-L87-S M/3-$=&5X=#X\9&EV('-T>6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!, M05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P M="<@86QI9VX],T1L969T/B`@(`T*("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U325I%.B`Q,'!T)SY);G9E;G1O"<^("`@#0H@("`@("`@("`@("`F(S$V,#L@("`- M"B`@("`@("`@("`\+W1D/B`@#0H@("`@("`@("`@/'1D('9A;&EG;CTS1&)O M='1O;2!S='EL93TS1"=415A4+4%,24=..B!C96YT97([(%!!1$1)3D6QE M/3-$)T1)4U!,05DZ(&EN;&EN92<^1&5C96UB97(@,S$L/"]F;VYT/CPO9F]N M=#X@(`T*("`@("`@("`@("`@/"]D:78^("`@("`-"B`@("`@("`@("`\+W1D M/B`@#0H@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B M;W1T;VT@6QE/3-$)U1%6%0M04Q) M1TXZ(&-E;G1E"<^("`@("`-"B`@("`@ M("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V M,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\ M=&0@8V]L6QE M/3-$)U1%6%0M04Q)1TXZ(&-E;G1E6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF M(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@ M("`\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&-E M;G1E"<^("`@("`-"B`@("`@("`@("`@ M(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O M;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@8V]L M6QE/3-$)U1% M6%0M04Q)1TXZ(&-E;G1E6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\ M+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@/"]T6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF M(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@ M("`\=&0@=F%L:6=N/3-$8F]T=&]M/B`@#0H@("`@("`@("`@("`\9F]N="!S M='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T* M("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@/"]T6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@(`T*("`@("`@ M("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ M(')I9VAT)SX@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-0 M3$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@(`T*("`@("`@("`@ M("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(')I M9VAT)SX@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9 M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE"<^("`@("`-"B`@("`@("`@ M("`@(#QD:78@"<^ M("`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`- M"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O M;&ED.R!415A4+4%,24=..B!R:6=H="<^("`@#0H@("`@("`@("`@("`\9F]N M="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE M6QE/3-$)T)/4D1% M4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T M)SX@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`- M"B`@("`@("`@("`\=&0@86QI9VX],T1R:6=H="!V86QI9VX],T1B;W1T;VT@ M=VED=&@],T0Q)2!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,G!X)SX@("`@ M(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO M=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$ M-R4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX\9F]N="!S='EL93TS1"=$25-0 M3$%9.B!I;FQI;F4G/C$L,3(Q+#DY,#PO9F]N=#X\+V9O;G0^("`-"B`@("`@ M("`@("`\+W1D/B`@#0H@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V M86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"="3U)$15(M0D]4 M5$]-.B!B;&%C:R`Q+C%P="!S;VQI9#L@5$585"U!3$E'3CH@;&5F="<^("`@ M#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[ M($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)V)A8VMG"<^("`@("`-"B`@("`@("`@("`@("8C,38P M.R`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@86QI9VX] M,T1R:6=H="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=0 M041$24Y'+4)/5%1/33H@-'!X)SX@("`@(`T*("`@("`@("`@("`@/&9O;G0@ M6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K M(#(N-S5P="!D;W5B;&4[(%1%6%0M04Q)1TXZ(&QE9G0G/B`@("`@#0H@("`@ M("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M M1D%-24Q9.B!T:6UE"<^("`@("`-"B`@("`@("`@ M("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\ M+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@ M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$ M)T)/4D1%4BU"3U143TTZ(&)L86-K(#(N-S5P="!D;W5B;&4[(%1%6%0M04Q) M1TXZ(')I9VAT)SX@("`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SY&:6YI7!E.B!T97AT+VAT M;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@ M("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$ M)W1E>'0O:'1M;#L@8VAA"!$:7-C;&]S=7)E(%M!8G-T"!$:7-C;&]S=7)E M(%M497AT($)L;V-K73PO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/&1I=B!S='EL93TS1"=415A4+4E.1$5.5#H@,'!T.R!$25-03$%9.B!B;&]C M:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G(&%L:6=N M/3-$:G5S=&EF>3X@#0H@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I M;FQI;F4[($9/3E0M1D%-24Q9.B!4:6UE3L@5$585"U)3D1%3E0Z(#,V<'0[ M($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE' M2%0Z(#!P="<^("`@(`T*("`@("`@/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U!!1$1)3D"<^("`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^ M("`-"B`@("`@("`@("`\=&0@8V]L6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SX\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4G/EEE87)S(&5N9&5D M($1E8V5M8F5R(#,Q+#PO9F]N=#X\+V9O;G0^("`@(`T*("`@("`@("`@("`@ M/"]D:78^("`@("`-"B`@("`@("`@("`\+W1D/B`@#0H@("`@("`@("`@/'1D M(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@ M(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$ M8F]T=&]M('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E"<^("`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@ M("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@8V]L6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E M6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@ M("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M M('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E"<^("`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO M=&0^("`-"B`@("`@("`@("`\=&0@8V]L6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@ M(#PO=&0^("`-"B`@("`@("`@/"]T6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`- M"B`@("`@("`@("`\=&0@86QI9VX],T1R:6=H="!C;VQS<&%N/3-$,B!N;W=R M87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M/B`@("`-"B`@("`@("`@("`@ M(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O M;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@;F]W M6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@ M(#PO=&0^("`-"B`@("`@("`@/"]T6QE/3-$)U!!1$1)3D6QE/3-$)U1% M6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@ M,3AP=#L@34%21TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$;&5F=#X@#0H@("`@ M("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SY& M961E6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^ M("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N M/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXQ+#6QE/3-$)U1%6%0M04Q)1TXZ(&QE M9G0G/B`@(`T*("`@("`@("`@("`@/&9O;G0@6QE M/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@("`@#0H@("`@("`@("`@("`\9F]N M="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE M6QE/3-$ M)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T M>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T* M("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@/"]T6QE/3-$)U!!1$1)3D6QE/3-$)T)/4D1%4BU" M3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T)SX@ M(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T)/4D1%4BU"3U143TTZ M(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T)SX@("`-"B`@ M("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXI M/"]F;VYT/B`@("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@("`@(#QT M9"!A;&EG;CTS1')I9VAT('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T M>6QE/3-$)U!!1$1)3D6QE/3-$)T)/4D1%4BU"3U14 M3TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T)SX@(`T* M("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN92<^ M,3DL-C0V/"]F;VYT/CPO9F]N=#X@("`@#0H@("`@("`@("`@/"]T9#X@(`T* M("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M M('=I9'1H/3-$,24@"<^("`@("`-"B`@("`@("`@("`@("8C,38P.R`@(`T* M("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@86QI9VX],T1R:6=H M="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=0041$24Y' M+4)/5%1/33H@,G!X)SX@("`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^ M("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N M/3-$8F]T=&]M('=I9'1H/3-$-R4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX\ M9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4G/C$L-S`T+#@P.#PO9F]N M=#X\+V9O;G0^("`-"B`@("`@("`@("`\+W1D/B`@#0H@("`@("`@("`@/'1D M(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S M='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`Q+C%P="!S;VQI9#L@5$58 M5"U!3$E'3CH@;&5F="<^("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE"<^("`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@ M(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H M/3-$,24@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K M(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!R:6=H="<^("`@#0H@("`@("`@ M("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%- M24Q9.B!T:6UE6QE/3-$)U1%6%0M24Y$14Y4 M.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)' M24XM4DE'2%0Z(#!P="<@86QI9VX],T1L969T/B`@("`@#0H@("`@("`@("`@ M("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SY$969E6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@ M("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@ M(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@;F]W6QE/3-$)U1% M6%0M04Q)1TXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@ M("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@86QI9VX],T1R:6=H="!V M86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X@(`T*("`@("`@("`@("`@/&9O M;G0@6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`- M"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^ M("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@;F]W6QE/3-$ M)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T M>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T* M("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@/"]T6QE/3-$)U!!1$1)3D6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)' M24XM3$5&5#H@,3AP=#L@34%21TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$;&5F M=#X@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SY&961E6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V M,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\ M=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@("`@#0H@("`@ M("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V M,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\ M=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@("`@#0H@("`@ M("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M M1D%-24Q9.B!T:6UE6QE/3-$)V)A8VMG#L@4$%$1$E.1RU,1494.B`P<'0[($U!4D=)3BU,1494.B`Y<'0G/B`@#0H@ M("`@("`@("`@("`\9&EV('-T>6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1) M4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,3AP=#L@34%21TE.+5))1TA4 M.B`P<'0G(&%L:6=N/3-$;&5F=#X@#0H@("`@("`@("`@("`@(#QF;VYT('-T M>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SY3=&%T93PO9F]N=#X@#0H@("`@ M("`@("`@("`\+V1I=CX@("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@ M("`@("`\=&0@86QI9VX],T1R:6=H="!V86QI9VX],T1B;W1T;VT@=VED=&@] M,T0Q)2!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,G!X)SX@("`@(`T*("`@ M("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`- M"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4@6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SX\9F]N="!S='EL93TS1"=$25-03$%9.B!I M;FQI;F4G/C,L-S0Y/"]F;VYT/CPO9F]N=#X@("`-"B`@("`@("`@("`\+W1D M/B`@#0H@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B M;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C M:R`Q+C%P="!S;VQI9#L@5$585"U!3$E'3CH@;&5F="<^("`@#0H@("`@("`@ M("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%- M24Q9.B!T:6UE"<^("`@("`-"B`@("`@("`@("`@ M(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O M;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L M:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T)/ M4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!R M:6=H="<^("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9 M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO M=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$ M-R4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXH,C4T/"]F;VYT/B`@(`T*("`@ M("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@;F]W6QE/3-$)T)/4D1%4BU" M3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T)SX@ M("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXI/"]F;VYT/B`@("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@ M("`@(#QT9"!A;&EG;CTS1')I9VAT('9A;&EG;CTS1&)O='1O;2!W:61T:#TS M1#$E('-T>6QE/3-$)U!!1$1)3D6QE/3-$)T)/4D1% M4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T M)SX@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T)/4D1%4BU"3U143TTZ M(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T)SX@("`-"B`@ M("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXI M/"]F;VYT/B`@("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@("`\+W1R M/B`@("`@#0H@("`@("`@(#QT6QE/3-$)U!!1$1)3D6QE/3-$)T)/4D1%4BU"3U14 M3TTZ(&)L86-K(#(N-S5P="!D;W5B;&4[(%1%6%0M04Q)1TXZ(&QE9G0G/B`@ M("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI M;F4[($9/3E0M1D%-24Q9.B!T:6UE"<^("`@("`- M"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@ M("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#(N-S5P="!D;W5B;&4[ M(%1%6%0M04Q)1TXZ(')I9VAT)SX@("`@(`T*("`@("`@("`@("`@/&9O;G0@ M6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M(%1I;65S($YE=R!2;VUA;B<^)B,Q-C`[/"]F;VYT/CPO9F]N=#X@#0H@("`@ M/"]D:78^/&)R+SX\=&%B;&4@8V5L;'!A9&1I;F<],T0P(&-E;&QS<&%C:6YG M/3-$,"!W:61T:#TS1#$P,"4@"<^("`@("`-"B`@("`@("`@("`@("8C,38P.R`@(`T*("`@("`@("`@(#PO M=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$ M,24@6QE/3-$)T)/4D1% M4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!C96YT M97(G/B`@("`-"B`@("`@("`@("`@(#QD:78@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX\ M9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4G/EEE87)S(&5N9&5D($1E M8V5M8F5R(#,Q+#PO9F]N=#X\+V9O;G0^("`@(`T*("`@("`@("`@("`@/"]D M:78^("`@("`-"B`@("`@("`@("`\+W1D/B`@#0H@("`@("`@("`@/'1D(&YO M=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL M93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`Q+C%P="!S;VQI9#L@5$585"U! M3$E'3CH@;&5F="<^("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$ M25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`- M"B`@("`@("`@("`\=&0@8V]L6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX\9F]N="!S M='EL93TS1"=$25-03$%9.B!I;FQI;F4G/C(P,30\+V9O;G0^/"]F;VYT/B`@ M("`-"B`@("`@("`@("`@(#PO9&EV/B`@("`@#0H@("`@("`@("`@/"]T9#X@ M(`T*("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T M=&]M('=I9'1H/3-$,24@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O M;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@8V]L M6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SX\9F]N="!S='EL93TS1"=$25-03$%9.B!I M;FQI;F4G/C(P,3,\+V9O;G0^/"]F;VYT/B`@("`-"B`@("`@("`@("`@(#PO M9&EV/B`@("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@("`@(#QT9"!N M;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@"<^ M("`@("`-"B`@("`@("`@("`@("8C,38P.R`@(`T*("`@("`@("`@(#PO=&0^ M("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@ M6QE/3-$)T1)4U!,05DZ(&EN;&EN92<^*"0I/"]F;VYT/CPO9F]N=#X@("`- M"B`@("`@("`@("`@(#PO9&EV/B`@("`@#0H@("`@("`@("`@/"]T9#X@(`T* M("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M M('=I9'1H/3-$,24@"<^("`@(`T*("`@("`@("`@("`@/&9O;G0@ M6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SX\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4G/E1A M>"!R871E/"]F;VYT/CPO9F]N=#X@("`-"B`@("`@("`@("`@(#PO9&EV/B`@ M("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@("`@(#QT9"!N;W=R87`] M,T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^ M("`-"B`@("`@("`@("`\=&0@8V]L6QE/3-$)T)/4D1%4BU" M3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!C96YT97(G M/B`@#0H@("`@("`@("`@("`\9&EV('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&-E M;G1E6QE/3-$)U1%6%0M04Q)1TXZ M(&-E;G1E"<^(`T*("`@("`@("`@("`@ M/&9O;G0@6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SX\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI M;F4G/E1A>"!R871E/"]F;VYT/CPO9F]N=#X@("`-"B`@("`@("`@("`@(#PO M9&EV/B`@("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@("`@(#QT9"!N M;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U1%6%0M24Y$ M14Y4.B`M,3AP=#L@1$E34$Q!63H@8FQO8VL[($U!4D=)3BU,1494.B`Q.'!T M.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1L969T/B`@(`T*("`@("`@ M("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G M/B`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$ M)U1%6%0M04Q)1TXZ(')I9VAT)SX@("`@#0H@("`@("`@("`@("`\9F]N="!S M='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1% M6%0M04Q)1TXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@ M("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@86QI9VX],T1R:6=H="!V M86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X@(`T*("`@("`@("`@("`@/&9O M;G0@6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`- M"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXS-"XP/"]F;VYT/B`@ M(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@;F]W6QE/3-$)U1% M6%0M04Q)1TXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXE/"]F;VYT/B`@("`@#0H@("`@("`@ M("`@/"]T9#X@(`T*("`@("`@("`@(#QT9"!A;&EG;CTS1')I9VAT('9A;&EG M;CTS1&)O='1O;2!W:61T:#TS1#(E/B`@#0H@("`@("`@("`@("`\9F]N="!S M='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@ M(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1% M6%0M04Q)1TXZ(')I9VAT)SX@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL M93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M M04Q)1TXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@ M("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@86QI9VX],T1R:6=H="!V86QI M9VX],T1B;W1T;VT@=VED=&@],T0Q)3X@(`T*("`@("`@("`@("`@/&9O;G0@ M6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@ M("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXS-"XP/"]F;VYT/B`@(`T* M("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@;F]W6QE/3-$)U1%6%0M M04Q)1TXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXE/"]F;VYT/B`@("`@#0H@("`@("`@("`@ M/"]T9#X@(`T*("`@("`@("`\+W1R/B`@("`@#0H@("`@("`@(#QT6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@(`T* M("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M M04Q)1TXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXI/"]F;VYT/B`@("`@#0H@("`@("`@("`@ M/"]T9#X@(`T*("`@("`@("`@(#QT9"!A;&EG;CTS1')I9VAT('9A;&EG;CTS M1&)O='1O;2!W:61T:#TS1#$E/B`@#0H@("`@("`@("`@("`\9F]N="!S='EL M93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@(`T* M("`@("`@("`@("`@/&9O;G0@6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@ M("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I M9'1H/3-$,24@6QE/3-$)U1%6%0M M04Q)1TXZ(')I9VAT)SX@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@(`T* M("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ M(&QE9G0G/B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO M=&0^("`-"B`@("`@("`@/"]T6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO M=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$ M,24@6QE/3-$)U1%6%0M04Q)1TXZ M(')I9VAT)SX@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-0 M3$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O M;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L M:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4@6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXH,BXY/"]F;VYT/B`@(`T*("`@("`@("`@(#PO=&0^ M("`-"B`@("`@("`@("`\=&0@;F]W6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@ M("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXI/"]F;VYT/B`@("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@ M("`@(#QT9"!A;&EG;CTS1')I9VAT('9A;&EG;CTS1&)O='1O;2!W:61T:#TS M1#(E/B`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I M;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@(`T*("`@("`@("`@("`@/&9O M;G0@6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`- M"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT M)SX@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I M;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!, M05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P M="<@86QI9VX],T1L969T/B`@("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T M>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SY.;VYD961U8W1I8FQE(&5X<&5N M6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@ M(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$ M8F]T=&]M('=I9'1H/3-$,24@6QE M/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@("`@#0H@("`@("`@("`@("`\9F]N M="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE M6QE/3-$)U1% M6%0M04Q)1TXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@ M("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@86QI9VX],T1R:6=H="!V M86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X@(`T*("`@("`@("`@("`@/&9O M;G0@6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`- M"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXM+2T\+V9O;G0^("`- M"B`@("`@("`@("`\+W1D/B`@#0H@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO M=W)A<"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4 M+4%,24=..B!L969T)SX@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@ M(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$ M8F]T=&]M('=I9'1H/3-$,24@6QE M/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@("`@#0H@("`@("`@("`@("`\9F]N M="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE M6QE/3-$)U1% M6%0M04Q)1TXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@ M("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@86QI9VX],T1R:6=H="!V M86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X@(`T*("`@("`@("`@("`@/&9O M;G0@6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`- M"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXM+2T\+V9O;G0^("`- M"B`@("`@("`@("`\+W1D/B`@#0H@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO M=W)A<"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4 M+4%,24=..B!L969T)SX@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)V)A8VMG6QE/3-$ M)U1%6%0M04Q)1TXZ(&QE9G0G/B`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`-"B`@("`@ M("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXI/"]F M;VYT/B`@("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@("`@(#QT9"!A M;&EG;CTS1')I9VAT('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/B`@#0H@ M("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/ M3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1% M6%0M04Q)1TXZ(&QE9G0G/B`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V M,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\ M=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@("`@#0H@("`@ M("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\ M+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@ M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@("`@#0H@("`@("`@ M("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%- M24Q9.B!T:6UE6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)' M24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1L969T M/B`@("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SY2)F%M<#M$(&-R961I=',\+V9O;G0^("`@("`-"B`@("`@ M("`@("`@(#PO9&EV/B`@("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@ M("`@(#QT9"!A;&EG;CTS1')I9VAT('9A;&EG;CTS1&)O='1O;2!W:61T:#TS M1#$E/B`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I M;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@(`T*("`@("`@("`@("`@/&9O M;G0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`- M"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXI/"]F;VYT/B`@("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@("`@ M(#QT9"!A;&EG;CTS1')I9VAT('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E M/B`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI M;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE M/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@(`T*("`@("`@("`@("`@/&9O;G0@ M6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@ M("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@("`@ M#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[ M($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF M(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@ M("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@("`@#0H@ M("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/ M3E0M1D%-24Q9.B!T:6UE"<^("`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@ M("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M M('=I9'1H/3-$,24@6QE/3-$)T)/4D1%4BU"3U143TTZ M(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!R:6=H="<^("`@#0H@ M("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/ M3E0M1D%-24Q9.B!T:6UE"<^("`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^ M("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@ M6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T M('-O;&ED.R!415A4+4%,24=..B!R:6=H="<^("`@#0H@("`@("`@("`@("`\ M9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T M:6UE"<^("`@("`-"B`@ M("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF M(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@ M("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4 M+4%,24=..B!R:6=H="<^("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE"<^("`@("`-"B`@("`@ M("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V M,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\ M=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE M/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%, M24=..B!R:6=H="<^("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$ M25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@ M("`@("`@("`\=&0@86QI9VX],T1R:6=H="!V86QI9VX],T1B;W1T;VT@=VED M=&@],T0Q)2!S='EL93TS1"=0041$24Y'+4)/5%1/33H@-'!X)SX@("`@(`T* M("`@("`@("`@("`@/&9O;G0@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#(N-S5P="!D;W5B M;&4[(%1%6%0M04Q)1TXZ(')I9VAT)SX@("`@(`T*("`@("`@("`@("`@/&9O M;G0@6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXE/"]F;VYT/B`@("`@#0H@("`@("`@("`@/"]T9#X@ M(`T*("`@("`@("`@(#QT9"!A;&EG;CTS1')I9VAT('9A;&EG;CTS1&)O='1O M;2!W:61T:#TS1#(E('-T>6QE/3-$)U!!1$1)3D6QE M/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#(N-S5P="!D;W5B;&4[(%1%6%0M M04Q)1TXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXD/"]F;VYT/B`@("`@#0H@("`@("`@("`@ M/"]T9#X@(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@] M,T0W)2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`R+C6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX\9F]N="!S='EL93TS M1"=$25-03$%9.B!I;FQI;F4G/C(L-S(Y+#`P,#PO9F]N=#X\+V9O;G0^("`- M"B`@("`@("`@("`\+W1D/B`@#0H@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO M=W)A<"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"="3U)$ M15(M0D]45$]-.B!B;&%C:R`R+C6QE/3-$)U!!1$1)3D6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#(N-S5P="!D;W5B;&4[(%1% M6%0M04Q)1TXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@ M("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M M('=I9'1H/3-$-R4@6QE/3-$)U1%6%0M24Y$14Y4.B`S-G!T.R!$25-03$%9 M.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G M(&%L:6=N/3-$:G5S=&EF>3X@("`-"B`@("`@(#QF;VYT('-T>6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SY$=7)I;F<@,C`Q-"!A;F0@,C`Q,RP@=&AE($-O M;7!A;GD@"!B96YE9FET2`Y)2!O9B!N970@:6YC;VUE(&9R;VT@ M9&]M97-T:6,@<')O9'5C=&EO;B!A8W1I=FET:65S(&EN(&5A8V@@>65A6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T)SY4:&4@ M=&%X(&5F9F5C=',@;V8@=&5M<&]R87)Y(&1I9F9E6QE/3-$)T9/3E0M1D%-24Q9.B!T:6UE"<^("`@("`-"B`@("`@("`@("`@("8C,38P.R`@(`T*("`@ M("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M M('-T>6QE/3-$)U!!1$1)3D6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K M(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T)SX@(`T*("`@("`@("`@ M("`@/&9O;G0@"<^("`@#0H@("`@("`@("`@("`F(S$V,#L@("`-"B`@("`@("`@("`\ M+W1D/B`@#0H@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS M1"=415A4+4%,24=..B!C96YT97([(%!!1$1)3D6QE/3-$)T1)4U!,05DZ M(&EN;&EN92<^,C`Q-#PO9F]N=#X\+V9O;G0^("`@(`T*("`@("`@("`@("`@ M/"]D:78^("`@("`-"B`@("`@("`@("`\+W1D/B`@#0H@("`@("`@("`@/'1D M(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@6QE/3-$)T1)4U!,05DZ(&EN;&EN M92<^,C`Q,SPO9F]N=#X\+V9O;G0^("`@(`T*("`@("`@("`@("`@/"]D:78^ M("`@("`-"B`@("`@("`@("`\+W1D/B`@#0H@("`@("`@("`@/'1D(&YO=W)A M<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@6QE/3-$)V)A8VMG"!A6QE/3-$)U1%6%0M M04Q)1TXZ(&QE9G0G/B`@(`T*("`@("`@("`@("`@/&9O;G0@6QE M/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@(`T*("`@("`@("`@("`@/&9O;G0@ M6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO M=&0^("`-"B`@("`@("`@("`\=&0@86QI9VX],T1L969T('9A;&EG;CTS1&)O M='1O;3X@("`@(`T*("`@("`@("`@("`@/&9O;G0@6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@ M("`@("`@(#PO=&0^("`-"B`@("`@("`@/"]T6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF M(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@ M("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXQ,"PQ M-C0\+V9O;G0^("`@("`-"B`@("`@("`@("`\+W1D/B`@#0H@("`@("`@("`@ M/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q M)2!S='EL93TS1"=415A4+4%,24=..B!L969T)SX@("`@#0H@("`@("`@("`@ M("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9 M.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF M(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@ M("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXV+#`X M.3PO9F]N=#X@("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@("`@(#QT M9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@ M6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@ M(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$ M8F]T=&]M('=I9'1H/3-$-R4@6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXQ-"PP,S<\+V9O;G0^("`@("`-"B`@("`@("`@("`\+W1D/B`@ M#0H@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T M;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L969T)SX@("`@ M#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[ M($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^ M("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@ M6QE/3-$)U1%6%0M04Q)1TXZ(')I M9VAT)SX@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9 M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE M/3-$)U!!1$1)3D'!E;G-E"<^("`@("`-"B`@("`@("`@("`@(#QF M;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^ M("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N M/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T)/4D1% M4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!R:6=H M="<^("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I M;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T M('-O;&ED.R!415A4+4%,24=..B!L969T)SX@("`-"B`@("`@("`@("`@(#QF M;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^ M("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@86QI9VX] M,T1R:6=H="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=0 M041$24Y'+4)/5%1/33H@,G!X)SX@("`@(`T*("`@("`@("`@("`@/&9O;G0@ M6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\ M+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@ M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4@6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SX\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4G/C(P-BPU,#`\ M+V9O;G0^/"]F;VYT/B`@("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@ M("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H M/3-$,24@"<^("`@("`-"B`@("`@("`@("`@("8C,38P.R`@(`T*("`@("`@ M("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@86QI9VX],T1R:6=H="!V86QI M9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=0041$24Y'+4)/5%1/ M33H@,G!X)SX@("`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T* M("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T M=&]M('=I9'1H/3-$-R4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX\9F]N="!S M='EL93TS1"=$25-03$%9.B!I;FQI;F4G/C(R,RPT,SD\+V9O;G0^/"]F;VYT M/B`@("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@("`@(#QT9"!N;W=R M87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U!!1$1)3D6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!4 M15A4+4%,24=..B!L969T)SX@(`T*("`@("`@("`@("`@/&9O;G0@6QE M/3-$)T1)4U!,05DZ(&EN;&EN92<^,C(Y+#0U,3PO9F]N=#X\+V9O;G0^("`@ M("`-"B`@("`@("`@("`\+W1D/B`@#0H@("`@("`@("`@/'1D(&YO=W)A<#TS M1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=" M3U)$15(M0D]45$]-.B!B;&%C:R`Q+C%P="!S;VQI9#L@5$585"U!3$E'3CH@ M;&5F="<^("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9 M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$ M)V)A8VMG"!L:6%B:6QI=&EE6QE/3-$)U1%6%0M04Q) M1TXZ(&QE9G0G/B`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@ M(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H M/3-$-R4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V M,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\ M=&0@;F]W6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`@ M(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O M;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@/"]T6QE/3-$)U!!1$1) M3D6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L M;V-K.R!-05)'24XM3$5&5#H@,3AP=#L@34%21TE.+5))1TA4.B`P<'0G(&%L M:6=N/3-$;&5F=#X@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T.R!415A4+41%0T]2051)3TXZ('5N9&5R;&EN92<^ M/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G M/B`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`- M"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^ M("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@;F]W6QE/3-$ M)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T M>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T* M("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@/"]T6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\ M+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@ M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@("`@#0H@("`@("`@ M("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%- M24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O M;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L M:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@("`@#0H@("`@("`@("`@ M("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9 M.B!T:6UE"<^("`@("`-"B`@("`@("`@("`@ M(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O M;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L M:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T)/ M4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!R M:6=H="<^("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9 M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V M,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\ M=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4@6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXH-S`L,#@U/"]F;VYT/B`-"B`@("`@("`@("`\+W1D/B`@#0H@ M("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@ M=VED=&@],T0Q)2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`Q+C%P M="!S;VQI9#L@5$585"U!3$E'3CH@;&5F="<^("`@#0H@("`@("`@("`@("`\ M9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T M:6UE6QE/3-$)U!!1$1)3D"<^("`@("`-"B`@("`@("`@ M("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\ M+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@ M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$ M)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=. M.B!R:6=H="<^("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-0 M3$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF M(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@ M("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4@6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXH,38Y+#4X-SPO9F]N=#X@(`T*("`@("`@("`@(#PO=&0^ M("`-"B`@("`@("`@("`\=&0@;F]W6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K M(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T)SX@("`-"B`@("`@("`@ M("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXI/"]F;VYT M/B`@("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@("`\+W1R/B`@("`@ M#0H@("`@("`@(#QT#L@4$%$1$E.1RU,1494.B`P<'0[($U!4D=)3BU,1494 M.B`Y<'0G/B`@#0H@("`@("`@("`@("`\9&EV('-T>6QE/3-$)U1%6%0M24Y$ M14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@-31P=#L@ M34%21TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$;&5F=#X@#0H@("`@("`@("`@ M("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SY.970@9&5F M97)R960@=&%X("AL:6%B:6QI='DI(&%S6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXI/"]F;VYT/B`@("`@#0H@("`@("`@("`@/"]T9#X@(`T* M("`@("`@("`@(#QT9"!A;&EG;CTS1')I9VAT('9A;&EG;CTS1&)O='1O;2!W M:61T:#TS1#$E('-T>6QE/3-$)U!!1$1)3D6QE/3-$ M)T)/4D1%4BU"3U143TTZ(&)L86-K(#(N-S5P="!D;W5B;&4[(%1%6%0M04Q) M1TXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXD/"]F;VYT/B`@("`@#0H@("`@("`@("`@/"]T M9#X@(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0W M)2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`R+C6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX\9F]N="!S='EL93TS1"=$ M25-03$%9.B!I;FQI;F4G/C4Y+#@V-#PO9F]N=#X\+V9O;G0^("`@(`T*("`@ M("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@;F]W6QE/3-$)T)/4D1%4BU" M3U143TTZ(&)L86-K(#(N-S5P="!D;W5B;&4[(%1%6%0M04Q)1TXZ(&QE9G0G M/B`@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I M;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE'1087)T7S9A-61F8S,V M7S0Q8S=?-&$V,%\X-V8U7SDQ96%F,3EE8V-E80T*0V]N=&5N="U,;V-A=&EO M;CH@9FEL93HO+R]#.B\V835D9F,S-E\T,6,W7S1A-C!?.#=F-5\Y,65A9C$Y M96-C96$O5V]R:W-H965T'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0@0FQO8VM=/"]T9#X-"B`@("`@("`@/'1D(&-L M87-S/3-$=&5X=#X\9&EV('-T>6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1) M4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z M(#!P="<@86QI9VX],T1J=7-T:69Y/B`@("`-"B`@("`@(#QF;VYT('-T>6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2 M;VUA;CL@1D].5"U325I%.B`Q,G!T.R!&3TY4+5=%24=(5#H@8F]L9"<^/&9O M;G0@6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K M.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX] M,T1J=7-T:69Y/B`@(`T*("`@("`@/&9O;G0@6QE/3-$)U1%6%0M24Y$14Y4.B`S-G!T M.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5)) M1TA4.B`P<'0G(&%L:6=N/3-$:G5S=&EF>3X@("`@#0H@("`@("`\9F]N="!S M='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!4:6UE65R(&UA=&-H:6YG(&-O;G1R:6)U=&EO;B!O9B!T:&4@9FER2X@16UP;&]Y965S(&)E8V]M92!F=6QL M>2!V97-T960@:6X@96UP;&]Y97(@;6%T8VAI;F<@8V]N=')I8G5T:6]N65A2`D,3`S M+#`P,"!A;F0@)#$P,2PP,#`@9F]R(&5A8V@@;V8@=&AE('EE87)S(&5N9&5D M($1E8V5M8F5R(#,Q+"`R,#$T(&%N9"`R,#$S+B8C,38P.R8C,38P.TEN(#(P M,30@86YD(#(P,3,@96UP;&]Y965S('=E65A2!A65E65A6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ(%1I M;65S($YE=R!2;VUA;B<^+CPO9F]N=#X\+V9O;G0^("`-"B`@("`\+V1I=CX\ M8G(O/CQD:78@3L@5$585"U) M3D1%3E0Z(#,V<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T M.R!-05)'24XM4DE'2%0Z(#!P="<^("`@(`T*("`@("`@/&9O;G0@2!C;VYT2UT;RUP87DB('-A9F4M:&%R8F]R M(&9O2!C;VYT6UE;G0L(&%N9"`R,"4@9F]R(&5A8V@@>65A65E(&)E8V]M97,@9G5L;'D@ M=F5S=&5D(&%F=&5R('-I>"!Y96%R3X@("`-"B`@("`@(#QF;VYT M('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ(%1I;65S M($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L M9"<^/&9O;G0@2!A M<'!R;W9E9"!T:&4@861O<'1I;VX@;V8@=&AE(#(P,#0@4W1O8VL@3W!T:6]N M(%!L86XL('=H:6-H(&%U=&AO'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/&1I=B!S='EL93TS1"=415A4+4E.1$5.5#H@,'!T.R!$25-0 M3$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P M<'0G(&%L:6=N/3-$:G5S=&EF>3X@("`-"B`@("`@(#QF;VYT('-T>6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA M;CL@1D].5"U325I%.B`Q,G!T.R!&3TY4+5=%24=(5#H@8F]L9"<^3D]4128C M,38P.R8C,38P.T8@+28C,38P.R8C,38P.T=%3T=205!(24,@86YD($]42$52 M($E.1D]234%424]./"]F;VYT/B`-"B`@("`\+V1I=CX\8G(O/CQD:78@6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q M,'!T)SY4:')O=6=H(&ET28C.#(Q-SMS(%(F86UP.T0@9&5P87)T M;65N="!N;W0@;VYL>2!D979E;&]P2!O9B!T:&4@ M8V]S;65T:6,@:6YG2!I=',@3%5"4D%*14P@;&EN92!O9B!W M871E2!M86YY(&]F('1H92!M86IO6QE/3-$)U1%6%0M24Y$ M14Y4.B`S-G!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@ M34%21TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$:G5S=&EF>3X@("`@#0H@("`@ M("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9 M.B!4:6UE2!D;V5S(&YO="!M86ME(&%N>2!S M86QE6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SY.;R!P6QE/3-$ M)U1%6%0M24Y$14Y4.B`S-G!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q% M1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$:G5S=&EF>3X@ M("`@#0H@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/ M3E0M1D%-24Q9.B!4:6UE2!T:&4@<')O9'5C="!T;R!T:&4@96YD('5S97)S M+"!S=6-H(&%S(&AO2!C;VYS:7-T('!R:6UA2!O9B!M M961I8V%L(&QU8G)I8V%N=',L('=H:6-H(&%R92!M87)K971E9"!B>2!T:&4@ M0V]M<&%N>2!D:7)E8W1L>2!T;R!M86YU9F%C='5R97)S('1H870@:6YC;W)P M;W)A=&4@=&AE;2!I;G1O('5R;VQO9VEC(&-A=&AE=&5R2!I2!O8G1A:6X@2!A M<'!R;W9A;"X@2&]W979E2!H879E('1O(&]B=&%I;B!S=6-H(')E9W5L M871O6QE/3-$ M)U1%6%0M24Y$14Y4.B`S-G!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q% M1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$:G5S=&EF>3X@ M("`@#0H@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/ M3E0M1D%-24Q9.B!4:6UE2!B87-E9"!O;B!S86QE2!B>2!#=7-T;VUE6QE/3-$ M)T9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($U!4D=)3BU,1494 M.B`P<'0[($U!4D=)3BU224=(5#H@,'!T)R!A;&EG;CTS1&IU6QE/3-$)T9/3E0M1D%-24Q9.B!T:6UE M6QE/3-$)T)/4D1% M4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!C96YT M97(G/B`-"B`@("`@("`@("`@(#QD:78@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX\9F]N M="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4G/EEE87)S(&5N9&5D($1E8V5M M8F5R(#,Q+#PO9F]N=#X\+V9O;G0^("`@(`T*("`@("`@("`@("`@/"]D:78^ M("`@("`-"B`@("`@("`@("`\+W1D/B`@#0H@("`@("`@("`@/'1D(&YO=W)A M<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@6QE/3-$)U!!1$1)3D6QE/3-$)T1)4U!,05DZ M(&EN;&EN92<^,C`Q-#PO9F]N=#X\+V9O;G0^("`@(`T*("`@("`@("`@("`@ M/"]D:78^("`@("`-"B`@("`@("`@("`\+W1D/B`@#0H@("`@("`@("`@/'1D M(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@ M("`@("`@/"]T6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^ M("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M/B`@#0H@("`@("`@ M("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%- M24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\ M+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@/"]T6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXD/"]F;VYT/B`@("`@ M#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B M;W1T;VT@=VED=&@],T0W)2!S='EL93TS1"=415A4+4%,24=..B!R:6=H="<^ M("`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^ M("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@ M6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXQ,2PT-3DL-#@R/"]F;VYT/B`@("`-"B`@("`@("`@("`\+W1D M/B`@#0H@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B M;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L969T)SX@ M("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI M;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@(`T* M("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@ M(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$ M8F]T=&]M('=I9'1H/3-$,24@6QE M/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@("`@#0H@("`@("`@("`@("`\9F]N M="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE M6QE/3-$ M)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T M>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T* M("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@/"]T6QE/3-$)U1% M6%0M04Q)1TXZ(&QE9G0G/B`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@ M("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@ M("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI M;F4[($9/3E0M1D%-24Q9.B!T:6UE"<^("`@("`-"B`@("`@("`@("`@(#QD M:78@6QE/3-$)U!!1$1)3D6QE/3-$ M)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=. M.B!L969T)SX@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!, M05DZ(&EN;&EN92<^,38Y+#0X-CPO9F]N=#X\+V9O;G0^("`@("`-"B`@("`@ M("`@("`\+W1D/B`@#0H@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V M86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"="3U)$15(M0D]4 M5$]-.B!B;&%C:R`Q+C%P="!S;VQI9#L@5$585"U!3$E'3CH@;&5F="<^("`@ M#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[ M($9/3E0M1D%-24Q9.B!T:6UE"<^("`@("`-"B`@ M("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF M(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@ M("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4 M+4%,24=..B!R:6=H="<^("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ M(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T)SX@("`-"B`@ M("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF M(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@ M/"]T6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO M=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$ M-R4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXQ,RPW-S$L M,CDU/"]F;VYT/B`@("`-"B`@("`@("`@("`\+W1D/B`@#0H@("`@("`@("`@ M/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q M)2!S='EL93TS1"=415A4+4%,24=..B!L969T)SX@("`@#0H@("`@("`@("`@ M("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9 M.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF M(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@ M("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@("`@#0H@ M("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/ M3E0M1D%-24Q9.B!T:6UE"<^("`@("`-"B`@("`@("`@("`@(#QD M:78@6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@ M("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M M('=I9'1H/3-$-R4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXH,S(Q+#8Q-CPO M9F]N=#X@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@;F]W M6QE M/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%, M24=..B!L969T)SX@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXI/"]F;VYT/B`@("`@#0H@("`@("`@("`@/"]T M9#X@(`T*("`@("`@("`@(#QT9"!A;&EG;CTS1')I9VAT('9A;&EG;CTS1&)O M='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)U!!1$1)3D6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4 M+4%,24=..B!L969T)SX@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)V)A M8VMG6QE/3-$)U!!1$1)3D6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#(N-S5P="!D M;W5B;&4[(%1%6%0M04Q)1TXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`@(#QF M;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXD/"]F;VYT/B`@("`@ M#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B M;W1T;VT@=VED=&@],T0W)2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C M:R`R+C6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX\ M9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4G/C$S+#0T.2PV-SD\+V9O M;G0^/"]F;VYT/B`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\ M=&0@;F]W6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#(N-S5P="!D;W5B;&4[ M(%1%6%0M04Q)1TXZ(&QE9G0G/B`@("`@#0H@("`@("`@("`@("`\9F]N="!S M='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE"<^("`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@ M("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M M('=I9'1H/3-$,24@6QE/3-$)T)/4D1%4BU"3U143TTZ M(&)L86-K(#(N-S5P="!D;W5B;&4[(%1%6%0M04Q)1TXZ(')I9VAT)SX@("`@ M(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN92<^,34L-#$V+#@Y M,SPO9F]N=#X\+V9O;G0^("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@ M("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H M/3-$,24@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^ M("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@/"]T6QE M/3-$)U1%6%0M24Y$14Y4.B`P<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=) M3BU224=(5#H@,'!T)R!A;&EG;CTS1&IU6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF M(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@ M("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K M(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!C96YT97(G/B`@("`-"B`@("`@ M("`@("`@(#QD:78@6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^ M("`-"B`@("`@("`@("`\=&0@8V]L6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXR,#$T/"]F;VYT/B`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@ M("`@("`@("`\=&0@;F]W6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T M('-O;&ED.R!415A4+4%,24=..B!L969T)SX@("`-"B`@("`@("`@("`@(#QF M;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^ M("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N M/3-$8F]T=&]M('=I9'1H/3-$,B4@6QE/3-$)U!! M1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@ M("`@("`\=&0@8V]L6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L M86-K(#$N,7!T('-O;&ED)SX@(`T*("`@("`@("`@("`@/&1I=B!S='EL93TS M1"=415A4+4E.1$5.5#H@,'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q% M1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$8V5N=&5R/B`@ M#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SX\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%- M24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@ M("`@("`\=&0@8V]L6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L M86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!C96YT97(G/B`@#0H@("`@ M("`@("`@("`\9&EV('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX\ M9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4G/D%S6QE/3-$)T)/4D1%4BU" M3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T)SX@ M("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@ M("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,B4@"<^(`T*("`@("`@("`@("`@/&9O;G0@ M6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[ M($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE' M2%0Z(#!P="<@86QI9VX],T1C96YT97(^("`-"B`@("`@("`@("`@("`@/&9O M;G0@6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SX\9F]N="!S='EL93TS1"=$25-03$%9.B!I M;FQI;F4G/E)E=F5N=65S/"]F;VYT/CPO9F]N=#X\+V9O;G0^("`@(`T*("`@ M("`@("`@("`@/"]D:78^("`@("`-"B`@("`@("`@("`\+W1D/B`@#0H@("`@ M("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@=VED M=&@],T0Q)2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`Q+C%P="!S M;VQI9#L@5$585"U!3$E'3CH@;&5F="<^("`@#0H@("`@("`@("`@("`\9F]N M="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE M6QE/3-$)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`- M"B`@("`@("`@("`\=&0@8V]L6QE/3-$)T)/4D1%4BU"3U14 M3TTZ(&)L86-K(#$N,7!T('-O;&ED)SX@(`T*("`@("`@("`@("`@/&1I=B!S M='EL93TS1"=415A4+4E.1$5.5#H@,'!T.R!$25-03$%9.B!B;&]C:SL@34%2 M1TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$8V5N M=&5R/B`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SX\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/ M3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M24Y$14Y4 M.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)' M24XM4DE'2%0Z(#!P="<@86QI9VX],T1C96YT97(^("`-"B`@("`@("`@("`@ M("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX\9F]N="!S='EL93TS1"=$25-0 M3$%9.B!I;FQI;F4G/D%S6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T M('-O;&ED.R!415A4+4%,24=..B!L969T)SX@("`-"B`@("`@("`@("`@(#QF M;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^ M("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@/"]T6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@ M(#PO=&0^("`-"B`@("`@("`@("`\=&0@8V]L6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\ M+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@ M;F]W6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`@(#QF M;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^ M("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N M/3-$8F]T=&]M('=I9'1H/3-$,24^("`@#0H@("`@("`@("`@("`\9F]N="!S M='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@ M("`@("`\=&0@8V]L6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@ M("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@;F]W6QE/3-$)U1%6%0M04Q) M1TXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@ M(#PO=&0^("`-"B`@("`@("`@/"]T6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXD/"]F;VYT/B`@("`@#0H@("`@("`@("`@/"]T M9#X@(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0W M)2!S='EL93TS1"=415A4+4%,24=..B!R:6=H="<^("`@(`T*("`@("`@("`@ M("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V M,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\ M=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXQ+#(P-RPY M,#,\+V9O;G0^("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@("`@(#QT M9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@ M6QE/3-$)U1%6%0M M04Q)1TXZ(&QE9G0G/B`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@("`@#0H@("`@("`@ M("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%- M24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`@ M(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O M;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@86QI M9VX],T1R:6=H="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X@(`T*("`@ M("`@("`@("`@/&9O;G0@6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXD/"]F;VYT/B`@("`@#0H@("`@("`@("`@ M/"]T9#X@(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@] M,T0W)2!S='EL93TS1"=415A4+4%,24=..B!R:6=H="<^("`@(`T*("`@("`@ M("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@ M("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@ M("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI M;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`- M"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@ M("`@("`\=&0@86QI9VX],T1R:6=H="!V86QI9VX],T1B;W1T;VT@=VED=&@] M,T0Q)3X@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^ M("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N M/3-$8F]T=&]M('=I9'1H/3-$-R4@6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXM+2T\+V9O;G0^("`-"B`@("`@("`@("`\+W1D/B`@#0H@ M("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@ M=VED=&@],T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L969T)SX@("`@#0H@ M("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/ M3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`- M"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT M)SX@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I M;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@ M("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@ M("`@("`@("`\=&0@86QI9VX],T1R:6=H="!V86QI9VX],T1B;W1T;VT@=VED M=&@],T0Q)3X@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O M;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L M:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4@6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXM+2T\+V9O;G0^("`-"B`@("`@("`@("`\+W1D/B`@ M#0H@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T M;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L969T)SX@("`@ M#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[ M($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)V)A8VMG6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^ M("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@ M6QE/3-$)U1%6%0M04Q)1TXZ(')I M9VAT)SX@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9 M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G M/B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`- M"B`@("`@("`@("`\=&0@86QI9VX],T1R:6=H="!V86QI9VX],T1B;W1T;VT@ M=VED=&@],T0Q)3X@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\ M+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@ M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4@6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXM+2T\+V9O;G0^("`-"B`@("`@("`@("`\+W1D M/B`@#0H@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B M;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L969T)SX@ M("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI M;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO M=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$ M,24@6QE/3-$)U1%6%0M04Q)1TXZ M(')I9VAT)SX@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-0 M3$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE M9G0G/B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^ M("`-"B`@("`@("`@("`\=&0@86QI9VX],T1R:6=H="!V86QI9VX],T1B;W1T M;VT@=VED=&@],T0Q)3X@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V M,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\ M=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4@6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXM+2T\+V9O;G0^("`-"B`@("`@("`@("`\ M+W1D/B`@#0H@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX] M,T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L969T M)SX@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I M;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ M(&QE9G0G/B`@(`T*("`@("`@("`@("`@/&9O;G0@6QE M/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`@(#QF;VYT M('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@ M(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@86QI9VX],T1R M:6=H="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X@(`T*("`@("`@("`@ M("`@/&9O;G0@6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO M=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$ M-R4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXM+2T\+V9O M;G0^("`-"B`@("`@("`@("`\+W1D/B`@#0H@("`@("`@("`@/'1D(&YO=W)A M<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS M1"=415A4+4%,24=..B!L969T)SX@("`@#0H@("`@("`@("`@("`\9F]N="!S M='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O M;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L M:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@("`@#0H@("`@("`@("`@ M("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9 M.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ M(&QE9G0G/B`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$ M)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T M>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T* M("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@/"]T6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^ M("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N M/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@("`@#0H@("`@("`@("`@("`\ M9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T M:6UE6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@ M("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I M9'1H/3-$,24@6QE/3-$)U1%6%0M M04Q)1TXZ(')I9VAT)SX@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@ M("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M M('=I9'1H/3-$,24@6QE/3-$)U1% M6%0M04Q)1TXZ(')I9VAT)SX@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL M93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^ M("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@ M6QE/3-$)U1%6%0M04Q)1TXZ(')I M9VAT)SX@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9 M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@ M("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXU.#(L-#6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@ M(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$ M8F]T=&]M('=I9'1H/3-$,24@6QE M/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@("`@#0H@("`@("`@("`@("`\9F]N M="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE M6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@ M(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M M04Q)1TXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@ M("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@86QI9VX],T1R:6=H="!V86QI M9VX],T1B;W1T;VT@=VED=&@],T0Q)3X@(`T*("`@("`@("`@("`@/&9O;G0@ M6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@ M("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXM+2T\+V9O;G0^("`-"B`@ M("`@("`@("`\+W1D/B`@#0H@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A M<"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4+4%, M24=..B!L969T)SX@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$ M25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)V)A8VMG"<^("`@("`-"B`@ M("`@("`@("`@(#QD:78@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T* M("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T M=&]M('=I9'1H/3-$-R4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX\9F]N="!S M='EL93TS1"=$25-03$%9.B!I;FQI;F4G/C@X-BPX,SD\+V9O;G0^/"]F;VYT M/B`@("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@("`@(#QT9"!N;W=R M87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U!!1$1)3D6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!4 M15A4+4%,24=..B!L969T)SX@(`T*("`@("`@("`@("`@/&9O;G0@6QE M/3-$)T1)4U!,05DZ(&EN;&EN92<^+2TM/"]F;VYT/CPO9F]N=#X@#0H@("`@ M("`@("`@/"]T9#X@(`T*("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@ M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U!!1$1)3D6QE/3-$)T)/ M4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L M969T)SX@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ M(&EN;&EN92<^,2PW.3(L,S8U/"]F;VYT/CPO9F]N=#X@(`T*("`@("`@("`@ M(#PO=&0^("`-"B`@("`@("`@("`\=&0@;F]W6QE/3-$)T)/4D1%4BU"3U143TTZ M(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T)SX@("`-"B`@ M("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF M(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@ M("`\=&0@86QI9VX],T1R:6=H="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q M)2!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,G!X)SX@("`@(`T*("`@("`@ M("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@ M("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4@6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SX\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI M;F4G/BTM+3PO9F]N=#X\+V9O;G0^(`T*("`@("`@("`@(#PO=&0^("`-"B`@ M("`@("`@("`\=&0@;F]W6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T M('-O;&ED.R!415A4+4%,24=..B!L969T)SX@("`-"B`@("`@("`@("`@(#QF M;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^ M("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@/"]T6QE/3-$)U!!1$1)3D"<^("`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@ M(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H M/3-$,24@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K M(#(N-S5P="!D;W5B;&4[(%1%6%0M04Q)1TXZ(')I9VAT)SX@("`@(`T*("`@ M("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN92<^,3,L-#0Y+#8W.3PO9F]N M=#X\+V9O;G0^("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@("`@(#QT M9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@ M6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T* M("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@86QI9VX],T1R:6=H M="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=0041$24Y' M+4)/5%1/33H@-'!X)SX@("`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@ M(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@86QI9VX],T1R M:6=H="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0R)2!S='EL93TS1"=0041$ M24Y'+4)/5%1/33H@-'!X)SX@("`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$ M)U!!1$1)3D6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L M86-K(#(N-S5P="!D;W5B;&4[(%1%6%0M04Q)1TXZ(&QE9G0G/B`@("`-"B`@ M("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXD M/"]F;VYT/B`@("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@("`@(#QT M9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0W)2!S='EL93TS1"="3U)$15(M M0D]45$]-.B!B;&%C:R`R+C6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SX\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4G/C$L M,S,T+#4P,3PO9F]N=#X\+V9O;G0^("`-"B`@("`@("`@("`\+W1D/B`@#0H@ M("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@ M=VED=&@],T0Q)2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`R+C6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[(%=) M1%1(.B`S-G!T)SX@("`@#0H@("`@("`@("`@("`\9&EV('-T>6QE/3-$)U1% M6%0M04Q)1TXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T.R!& M3TY4+5=%24=(5#H@8F]L9"<^/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V M,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\ M=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E M"<^("`@("`-"B`@("`@("`@("`@(#QF M;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^ M("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@8V]L6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@ M("`@/"]T"<^("`@("`-"B`@("`@("`@("`@("8C,38P.R`@(`T*("`@("`@("`@(#PO M=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$ M)U1%6%0M04Q)1TXZ(&-E;G1E"<^("`@ M("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@ M("`@("`@("`\=&0@8V]L6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`- M"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)U1%6%0M M04Q)1TXZ(&-E;G1E"<^("`@("`-"B`@ M("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF M(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@ M("`\=&0@8V]L6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@ M("`@/"]T6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`- M"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M/B`@#0H@("`@("`@("`@ M("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9 M.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O M;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@/"]T6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SY#=7-T;VUE6QE/3-$)U1%6%0M04Q)1TXZ M(&QE9G0G/B`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@("`@#0H@("`@("`@("`@("`\ M9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T M:6UE6QE M/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`@(#QF;VYT M('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@ M(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@86QI9VX],T1R M:6=H="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X@(`T*("`@("`@("`@ M("`@/&9O;G0@6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXD/"]F;VYT/B`@("`@#0H@("`@("`@("`@/"]T9#X@ M(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0W)2!S M='EL93TS1"=415A4+4%,24=..B!R:6=H="<^("`@(`T*("`@("`@("`@("`@ M/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SY#=7-T;VUE6QE/3-$)U1%6%0M04Q) M1TXZ(&QE9G0G/B`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`@(#QF M;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^ M("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@86QI9VX] M,T1R:6=H="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X@(`T*("`@("`@ M("`@("`@/&9O;G0@6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@ M(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H M/3-$-R4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXX-38L M,C@U/"]F;VYT/B`-"B`@("`@("`@("`\+W1D/B`@#0H@("`@("`@("`@/'1D M(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S M='EL93TS1"=415A4+4%,24=..B!L969T)SX@("`@#0H@("`@("`@("`@("`\ M9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T M:6UE6QE/3-$)V)A8VMG6QE/3-$)U1%6%0M M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T M.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1J=7-T:69Y/B`@(`T*("`@ M("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/ M3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^ M("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4@ M6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXV,34L.#DP/"]F M;VYT/B`-"B`@("`@("`@("`\+W1D/B`@#0H@("`@("`@("`@/'1D(&YO=W)A M<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS M1"=415A4+4%,24=..B!L969T)SX@("`@#0H@("`@("`@("`@("`\9F]N="!S M='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O M;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L M:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@("`@#0H@("`@("`@("`@ M("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9 M.B!T:6UE3X@("`-"B`@("`@("`@("`@("`@/&9O M;G0@6QE/3-$)U!!1$1)3D6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T M('-O;&ED.R!415A4+4%,24=..B!L969T)SX@(`T*("`@("`@("`@("`@/&9O M;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN92<^-"PS,C(L,3`S/"]F;VYT M/CPO9F]N=#X@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@ M;F]W6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4 M+4%,24=..B!L969T)SX@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@ M("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@86QI9VX],T1R:6=H="!V86QI M9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=0041$24Y'+4)/5%1/ M33H@,G!X)SX@("`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T* M("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T M=&]M('=I9'1H/3-$-R4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX\9F]N="!S M='EL93TS1"=$25-03$%9.B!I;FQI;F4G/C0L-#$W+#(Q,3PO9F]N=#X\+V9O M;G0^("`-"B`@("`@("`@("`\+W1D/B`@#0H@("`@("`@("`@/'1D(&YO=W)A M<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS M1"="3U)$15(M0D]45$]-.B!B;&%C:R`Q+C%P="!S;VQI9#L@5$585"U!3$E' M3CH@;&5F="<^("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-0 M3$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE M/3-$)V)A8VMG6QE/3-$)U!!1$1) M3D6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#(N M-S5P="!D;W5B;&4[(%1%6%0M04Q)1TXZ(&QE9G0G/B`@("`-"B`@("`@("`@ M("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXD/"]F;VYT M/B`@("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@("`@(#QT9"!V86QI M9VX],T1B;W1T;VT@=VED=&@],T0W)2!S='EL93TS1"="3U)$15(M0D]45$]- M.B!B;&%C:R`R+C6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SX\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4G/C$S+#0T.2PV M-SD\+V9O;G0^/"]F;VYT/B`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@ M("`@("`\=&0@;F]W6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#(N-S5P="!D M;W5B;&4[(%1%6%0M04Q)1TXZ(&QE9G0G/B`@("`@#0H@("`@("`@("`@("`\ M9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T M:6UE"<^("`@("`-"B`@("`@("`@("`@(#QF;VYT M('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@ M(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$ M8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T)/4D1%4BU" M3U143TTZ(&)L86-K(#(N-S5P="!D;W5B;&4[(%1%6%0M04Q)1TXZ(')I9VAT M)SX@("`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN92<^,34L M-#$V+#@Y,SPO9F]N=#X\+V9O;G0^("`@#0H@("`@("`@("`@/"]T9#X@(`T* M("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M M('=I9'1H/3-$,24@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\ M+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@/"]T3L@5$585"U)3D1%3E0Z(#0U<'0[($1)4U!,05DZ(&)L M;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<^("`@ M#0H@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M M1D%-24Q9.B!4:6UE'0O M:F%V87-C3X-"B`@("`\ M=&%B;&4@8VQA'0@0FQO8VM=/"]T9#X-"B`@("`@("`@ M/'1D(&-L87-S/3-$=&5X=#X\9&EV('-T>6QE/3-$)U1%6%0M24Y$14Y4.B`P M<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM M4DE'2%0Z(#!P="<@86QI9VX],T1J=7-T:69Y/B`@("`@#0H@("`@("`\9F]N M="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!4:6UE M6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ(%1I M;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T)SY!8V-U;75L871E9"!O M=&AE6QE M/3-$)U1%6%0M04Q)1TXZ(&-E;G1E6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SX\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4G/D-O;7!R M96AE;G-I=F4@26YC;VUE/"]F;VYT/CPO9F]N=#X\+V9O;G0^(`T*("`@("`@ M("`@("`@/"]D:78^("`@("`-"B`@("`@("`@("`\+W1D/B`@#0H@("`@("`@ M("`@/'1D(&%L:6=N/3-$6QE/3-$)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\ M+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@ M86QI9VX],T1R:6=H="!C;VQS<&%N/3-$,B!N;W=R87`],T1N;W=R87`@=F%L M:6=N/3-$8F]T=&]M('=I9'1H/3-$,3$E('-T>6QE/3-$)T)/4D1%4BU"3U14 M3TTZ(&)L86-K(#$N,7!T('-O;&ED)SX@(`T*("`@("`@("`@("`@/&1I=B!S M='EL93TS1"=415A4+4%,24=..B!C96YT97([(%1%6%0M24Y$14Y4.B`P<'0[ M($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE' M2%0Z(#!P="<^("`-"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SX\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4G/D1E8V5M8F5R M(#,Q+"`R,#$T/"]F;VYT/CPO9F]N=#X\+V9O;G0^("`@#0H@("`@("`@("`@ M("`\+V1I=CX@("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\ M=&0@;F]W6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!4 M15A4+4%,24=..B!L969T)SX@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@ M("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@86QI9VX],T1R:6=H="!V M86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=0041$24Y'+4)/ M5%1/33H@,G!X)SX@("`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ M(&-E;G1E6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!, M05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P M="<@86QI9VX],T1L969T/B`@("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T M>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SY"96=I;FYI;F<@8F%L86YC92`M M(&YE="!O9B!T87@\+V9O;G0^(`T*("`@("`@("`@("`@/"]D:78^("`@("`- M"B`@("`@("`@("`\+W1D/B`@#0H@("`@("`@("`@/'1D(&%L:6=N/3-$6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXD/"]F;VYT/B`@("`@#0H@("`@("`@("`@/"]T9#X@ M(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q,"4@ M6QE/3-$)U1%6%0M04Q)1TXZ M(&QE9G0G/B`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXQ-S@L.36QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[(%1%6%0M24Y$ M14Y4.B`P<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T M)SX@("`@#0H@("`@("`@("`@("`\9&EV('-T>6QE/3-$)U1%6%0M04Q)1TXZ M(&QE9G0[(%1%6%0M24Y$14Y4.B`M,3AP=#L@1$E34$Q!63H@8FQO8VL[($U! M4D=)3BU,1494.B`Q.'!T.R!-05)'24XM4DE'2%0Z(#!P="<^("`@#0H@("`@ M("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SY5 M;G)E86QI>F5D(&=A:6XO*&QO6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SYR96-L87-S:69I8V%T:6]N6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@ M(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H M/3-$,24@6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXQ-3(L.#6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@ M("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I M9'1H/3-$,24@6QE/3-$)V)A8VMGF5D("AL;W-S*2]G86EN(&]N('-A;&4@;V8@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O M;&ED.R!415A4+4%,24=..B!L969T)SX@(`T*("`@("`@("`@("`@/&9O;G0@ M6QE/3-$)T1)4U!,05DZ(&EN;&EN92<^*#(U+#$R M-SPO9F]N=#X\+V9O;G0^("`@("`-"B`@("`@("`@("`\+W1D/B`@#0H@("`@ M("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@=VED M=&@],T0Q)2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`Q+C%P="!S M;VQI9#L@5$585"U!3$E'3CH@;&5F="<^("`@#0H@("`@("`@("`@("`\9F]N M="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE M6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^ M("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N M/3-$8F]T=&]M('=I9'1H/3-$,3`E('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ M(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!R:6=H="<^("`@(`T* M("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN92<^,3@L-C"<^("`@("`-"B`@("`@("`@("`@(#QD:78@#PO9F]N=#X@("`-"B`@("`@("`@("`@ M(#PO9&EV/B`@("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@("`@(#QT M9"!A;&EG;CTS1')I9VAT('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$P)2!S M='EL93TS1"=0041$24Y'+4)/5%1/33H@-'!X)SX@#0H@("`@("`@("`@("`\ M9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T M:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ M(&)L86-K(#(N-S5P="!D;W5B;&4[(%1%6%0M04Q)1TXZ(&QE9G0G/B`@("`- M"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXD/"]F;VYT/B`@("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@("`@ M(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q,"4@6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SX\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4G/C(U M.2PX-CD\+V9O;G0^/"]F;VYT/B`@("`@#0H@("`@("`@("`@/"]T9#X@(`T* M("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M M('=I9'1H/3-$,24@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\ M+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@ M86QI9VX],T1R:6=H="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL M93TS1"=0041$24Y'+4)/5%1/33H@-'!X)SX@("`@(`T*("`@("`@("`@("`@ M/&9O;G0@6QE/3-$)T)/ M4D1%4BU"3U143TTZ(&)L86-K(#(N-S5P="!D;W5B;&4[(%1%6%0M04Q)1TXZ M(')I9VAT)SX@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9 M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#(N M-S5P="!D;W5B;&4[(%1%6%0M04Q)1TXZ(&QE9G0G/B`@("`@#0H@("`@("`@ M("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%- M24Q9.B!T:6UE'1087)T7S9A-61F8S,V7S0Q8S=?-&$V,%\X-V8U M7SDQ96%F,3EE8V-E80T*0V]N=&5N="U,;V-A=&EO;CH@9FEL93HO+R]#.B\V M835D9F,S-E\T,6,W7S1A-C!?.#=F-5\Y,65A9C$Y96-C96$O5V]R:W-H965T M'0O:F%V87-C M3X-"B`@("`\=&%B;&4@ M8VQA2`R,#$R M('1H92!S=7!P;&EE2!A;F0@:71S('-U<'!L:65R(&5N=&5R M960@:6YT;R!A('-E='1L96UE;G0@86=R965M96YT('=H97)E8GD@=&AE('-U M<'!L:65R(&%G2`Q+"`R,#$S(&9O2`D.36UE;G1S(&AA9"!B965N(&UA9&4N($%S(&$@2!R96-E:79E9"!O;FQY("0R-"PT,#,@:6X@9&%M86=E M('-E='1L96UE;G0@<&%Y;65N=',@9F]R('1H92!Y96%R(&5N9&5D($1E8V5M M8F5R("`@("`-"B`@("`@(#,Q+"`R,#$T+"!A3X-"CPO M:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\V835D9F,S-E\T,6,W7S1A-C!? M.#=F-5\Y,65A9C$Y96-C96$-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O M0SHO-F$U9&9C,S9?-#%C-U\T838P7S@W9C5?.3%E868Q.65C8V5A+U=O'0O:'1M;#L@ M8VAA2!2961E;7!T:6]N(%M!8G-T6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ(%1I;65S($YE M=R!2;VUA;CL@1D].5"U325I%.B`Q,G!T.R!&3TY4+5=%24=(5#H@8F]L9"<^ M3D]412!)("T@04-#4E5%1"!%6%!%3E-%4SPO9F]N=#X@(`T*("`@(#PO9&EV M/CQB'!E;G-E6QE/3-$ M)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=. M.B!C96YT97(G/B`-"B`@("`@("`@("`@(#QD:78@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SX\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4G/C(P,30\+V9O;G0^ M/"]F;VYT/B`@("`-"B`@("`@("`@("`@(#PO9&EV/B`@("`@#0H@("`@("`@ M("`@/"]T9#X@(`T*("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L M:6=N/3-$8F]T=&]M('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N M,7!T('-O;&ED.R!415A4+4%,24=..B!L969T)SX@(`T*("`@("`@("`@("`@ M/&9O;G0@6QE/3-$)T)/4D1% M4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!C96YT M97(G/B`-"B`@("`@("`@("`@(#QD:78@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX\9F]N M="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4G/C(P,3,\+V9O;G0^/"]F;VYT M/B`@("`-"B`@("`@("`@("`@(#PO9&EV/B`@("`@#0H@("`@("`@("`@/"]T M9#X@(`T*("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$ M8F]T=&]M('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O M;&ED.R!415A4+4%,24=..B!L969T)SX@(`T*("`@("`@("`@("`@/&9O;G0@ M6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O M;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@8V]L M6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@(`T*("`@("`@("`@("`@ M/&9O;G0@6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@ M(#PO=&0^("`-"B`@("`@("`@("`\=&0@8V]L6QE/3-$)U1%6%0M04Q) M1TXZ(&QE9G0G/B`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M24Y$14Y4 M.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)' M24XM4DE'2%0Z(#!P="<@86QI9VX],T1L969T/B`@("`@#0H@("`@("`@("`@ M("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SY";VYU6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T* M("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T M=&]M('=I9'1H/3-$,24@6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXR,C4L,#`P/"]F;VYT/B`-"B`@("`@ M("`@("`\+W1D/B`@#0H@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V M86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4+4%,24=. M.B!L969T)SX@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-0 M3$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@ M("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M M('=I9'1H/3-$,24@6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXR-3`L,#`P/"]F;VYT/B`-"B`@("`@("`@ M("`\+W1D/B`@#0H@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI M9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L M969T)SX@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9 M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@ M(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H M/3-$-R4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXR,#,L M-#@S/"]F;VYT/B`-"B`@("`@("`@("`\+W1D/B`@#0H@("`@("`@("`@/'1D M(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S M='EL93TS1"=415A4+4%,24=..B!L969T)SX@("`@#0H@("`@("`@("`@("`\ M9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T M:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V M,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\ M=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@("`@#0H@("`@ M("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)' M24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1L969T M/B`@("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SY087ER;VQL(&%N9"!R96QA=&5D(&5X<&5N6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@(`T*("`@ M("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ M(&QE9G0G/B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO M=&0^("`-"B`@("`@("`@("`\=&0@86QI9VX],T1R:6=H="!V86QI9VX],T1B M;W1T;VT@=VED=&@],T0Q)3X@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF M(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@ M("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4@6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXQ,#0L,SDT/"]F;VYT/B`-"B`@("`@ M("`@("`\+W1D/B`@#0H@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V M86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4+4%,24=. M.B!L969T)SX@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-0 M3$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE'!E;G-E6QE/3-$ M)U1%6%0M04Q)1TXZ(&QE9G0G/B`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`-"B`@ M("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF M(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@ M("`\=&0@86QI9VX],T1R:6=H="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q M)3X@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@ M(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$ M8F]T=&]M('=I9'1H/3-$-R4@6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXV-BPP,#`\+V9O;G0^("`@("`-"B`@("`@("`@("`\+W1D/B`@ M#0H@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T M;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L969T)SX@("`@ M#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[ M($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)V)A8VMG6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@ M(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H M/3-$,24@6QE/3-$)U1%6%0M04Q) M1TXZ(')I9VAT)SX@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$ M25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@(`T*("`@ M("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q) M1TXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@ M(#PO=&0^("`-"B`@("`@("`@/"]T6QE/3-$)U1% M6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@ M,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1L969T/B`@("`@#0H@ M("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SY386QE6QE/3-$)U1%6%0M M04Q)1TXZ(&QE9G0G/B`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`-"B`@("`@("`@ M("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\ M+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@ M86QI9VX],T1R:6=H="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X@(`T* M("`@("`@("`@("`@/&9O;G0@6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@ M("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M M('=I9'1H/3-$-R4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXM+2T\+V9O;G0^("`-"B`@("`@("`@("`\+W1D/B`@#0H@("`@("`@("`@ M/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q M)2!S='EL93TS1"=415A4+4%,24=..B!L969T)SX@("`@#0H@("`@("`@("`@ M("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9 M.B!T:6UE6QE/3-$)V)A8VMG"<^("`@("`-"B`@("`@("`@("`@(#QD:78@6QE/3-$)U!!1$1)3D6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O M;&ED.R!415A4+4%,24=..B!L969T)SX@(`T*("`@("`@("`@("`@/&9O;G0@ M6QE/3-$)T1)4U!,05DZ(&EN;&EN92<^,S@L-SDQ/"]F;VYT/CPO9F]N M=#X@("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@("`@(#QT9"!N;W=R M87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U!!1$1)3D6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!4 M15A4+4%,24=..B!L969T)SX@(`T*("`@("`@("`@("`@/&9O;G0@6QE M/3-$)T1)4U!,05DZ(&EN;&EN92<^,S6QE/3-$)U!! M1$1)3D6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K M(#(N-S5P="!D;W5B;&4[(%1%6%0M04Q)1TXZ(&QE9G0G/B`@("`-"B`@("`@ M("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXD/"]F M;VYT/B`@("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@("`@(#QT9"!V M86QI9VX],T1B;W1T;VT@=VED=&@],T0W)2!S='EL93TS1"="3U)$15(M0D]4 M5$]-.B!B;&%C:R`R+C6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SX\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4G/C@S,RPX M-3D\+V9O;G0^/"]F;VYT/B`@("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@ M("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I M9'1H/3-$,24@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O M;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@86QI M9VX],T1R:6=H="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS M1"=0041$24Y'+4)/5%1/33H@-'!X)SX@("`@(`T*("`@("`@("`@("`@/&9O M;G0@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#(N M-S5P="!D;W5B;&4[(%1%6%0M04Q)1TXZ(&QE9G0G/B`@("`@#0H@("`@("`@ M("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%- M24Q9.B!T:6UE'1087)T7S9A-61F8S,V7S0Q8S=?-&$V,%\X-V8U M7SDQ96%F,3EE8V-E80T*0V]N=&5N="U,;V-A=&EO;CH@9FEL93HO+R]#.B\V M835D9F,S-E\T,6,W7S1A-C!?.#=F-5\Y,65A9C$Y96-C96$O5V]R:W-H965T M'0O:F%V87-C M3X-"B`@("`\=&%B;&4@ M8VQA2!4'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/&1I=B!S='EL93TS1"=415A4 M+4E.1$5.5#H@,'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P M=#L@34%21TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$:G5S=&EF>3X@#0H@("`@ M("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9 M.B!4:6UE6QE/3-$)U1%6%0M M04Q)1TXZ(&IU6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T)SY$ M=7)I;F<@96%C:"!O9B!T:&4@>65A'1087)T7S9A-61F8S,V M7S0Q8S=?-&$V,%\X-V8U7SDQ96%F,3EE8V-E80T*0V]N=&5N="U,;V-A=&EO M;CH@9FEL93HO+R]#.B\V835D9F,S-E\T,6,W7S1A-C!?.#=F-5\Y,65A9C$Y M96-C96$O5V]R:W-H965T'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA2!0;VQI8WD@*%!O;&EC:65S*3QB2!;4&]L:6-Y(%1E>'0@0FQO8VM=/"]T M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\9&EV('-T>6QE/3-$)U1% M6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@ M,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1J=7-T:69Y/CQF;VYT M('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ(%1I;65S M($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L M9"<^06-C;W5N=',@4F5C96EV86)L92!A;F0@4F5S97)V97,\+V9O;G0^("`- M"B`@("`\+V1I=CX\8G(O/CQD:78@3L@5$585"U)3D1%3E0Z(#,V<'0[($1)4U!,05DZ(&)L;V-K.R!-05)' M24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<^("`@(`T*("`@("`@ M/&9O;G0@6EN M9R!A;6]U;G0@;V8@86-C;W5N=',@2!O9B!T:&5S92!O2!497AT($)L;V-K73PO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/&1I=B!S='EL93TS1"=415A4+4E.1$5. M5#H@,'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%2 M1TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$:G5S=&EF>3X\9F]N="!S='EL93TS M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SY4:&4@0V]M<&%N>2!R96-O9VYI>F5S(')E=F5N=64@=VAE M;B!P2!A;F0@:71S(&-U M28C.#(Q-SMS('!L M86YT+B!3:&EP;65N=',@87)E(&]N;'D@;6%D92!A9G1E2!A2!T;R!R97!U6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T)SY! M;GD@86QL;W=A;F-E(&9O2X\+V9O M;G0^("`@("`-"B`@("`\+V1I=CX\8G(O/CQD:78@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T)SY&2!O9F9E6QE M/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM M3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1J=7-T:69Y M/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=( M5#H@8F]L9"<^0V%S:"!A;F0@0V%S:"!%<75I=F%L96YT2!C;VYS:61E&-E2!T:&4@1F5D97)A;"!$97!O&EM=6T@;V8@)#(U,"PP,#`N/"]F;VYT/CPO9&EV M/CQS<&%N/CPO6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)' M24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1J=7-T M:69Y/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=% M24=(5#H@8F]L9"<^1&EV:61E;F1S/"]F;VYT/B`@("`@#0H@("`@/"]D:78^ M/&)R+SX\9&EV('-T>6QE/3-$)U1%6%0M24Y$14Y4.B`S-G!T.R!$25-03$%9 M.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G M(&%L:6=N/3-$:G5S=&EF>3X@("`@#0H@("`@("`\9F]N="!S='EL93TS1"=$ M25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!4:6UE28C.#(Q-SMS($)O87)D(&]F($1I2`S,"P@,C`Q-"X@3VX@3F]V96UB97(@ M,C`L(#(P,30L('1H92!#;VUP86YY)B,X,C$W.W,@0F]A6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2 M;VUA;CL@1D].5"U325I%.B`Q,'!T)SY/;B!-87D@,34L(#(P,3,L('1H92!# M;VUP86YY)B,X,C$W.W,@0F]A&5S('=E2!497AT($)L;V-K73PO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/&1I=B!S='EL93TS1"=4 M15A4+4E.1$5.5#H@,'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z M(#!P=#L@34%21TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$:G5S=&EF>3X\9F]N M="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!4:6UE M2!A;F0@9FEX960@:6YC;VUE M(&UU='5A;"!F=6YD2!E=F%L M=6%T97,@:71S(&EN=F5S=&UE;G1S('!E2!F;W(@<&]S'1E;G0@=&\@=VAI8V@@9F%I2P@4&]L:6-Y(%M0 M;VQI8WD@5&5X="!";&]C:UT\+W1D/@T*("`@("`@("`\=&0@8VQA3L@5$585"U)3D1%3E0Z(#,V<'0[($1)4U!,05DZ(&)L;V-K.R!-05)' M24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<^("`@(`T*("`@("`@ M/&9O;G0@2!T:&4@9FER2!C;W-T2!O=F5R:&5A9"X\+V9O;G0^/"]D M:78^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R M(&-L87-S/3-$2P@4&QA;G0@86YD($5Q=6EP;65N="P@4&]L:6-Y(%M0 M;VQI8WD@5&5X="!";&]C:UT\+W1D/@T*("`@("`@("`\=&0@8VQA2P@4&QA;G0@86YD($5Q M=6EP;65N=#PO9F]N=#X@(`T*("`@(#PO9&EV/CQB&5D(&%S3X@("`-"B`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q M,'!T)SY%6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@ M("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI M;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXT,#PO9F]N=#X@ M("`-"B`@("`@("`@("`@(#PO9&EV/B`@("`@#0H@("`@("`@("`@/"]T9#X@ M(`T*("`@("`@("`@(#QT9"!A;&EG;CTS1&QE9G0@=F%L:6=N/3-$8F]T=&]M M('=I9'1H/3-$-B4^(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M24Y$14Y4 M.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)' M24XM4DE'2%0Z(#!P="<@86QI9VX],T1L969T/B`@("`@#0H@("`@("`@("`@ M("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SY"=6EL9&EN M9R!I;7!R;W9E;65N=',F(S$V,#L\+V9O;G0^("`-"B`@("`@("`@("`@(#PO M9&EV/B`@("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@("`@(#QT9"!A M;&EG;CTS1&QE9G0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-B4^(`T*("`@ M("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L M;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<^("`- M"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M24Y$ M14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!- M05)'24XM4DE'2%0Z(#!P="<^("`-"B`@("`@("`@("`@("`@/&9O;G0@65A65A6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@ M("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I M9'1H/3-$,R4@6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I% M.B`Q,'!T)SY,;VYG+6QI=F5D(&%S2!N;W0@8F4@2!T:&4@86UO=6YT(&)Y('=H:6-H('1H92!C M87)R>6EN9R!A;6]U;G0@;V8@=&AE(&%S&-E961S('1H92!F86ER M('9A;'5E(&]F('1H92!A6EN9R!A M;6]U;G0@;W(@9F%I3X@("`-"B`@("`@(#QF M;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ(%1I M;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T)SX\9F]N="!I9#TS1%1! M0C$M,3$@2!497AT($)L;V-K73PO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/&1I=B!S='EL93TS1"=415A4+4E. M1$5.5#H@,'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@ M34%21TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$:G5S=&EF>3X\9F]N="!S='EL M93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)U1%6%0M24Y$14Y4.B`S M-G!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE. M+5))1TA4.B`P<'0G(&%L:6=N/3-$:G5S=&EF>3X@("`@#0H@("`@("`\9F]N M="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!4:6UE M2!B96QI979E'!E;G-E6UE M;G0@=&5R;7,@86YD(&QI<75I9"!N871U2!T;R!C;VYC96YT6UE;G1S+B!4:&4@0V]M<&%N>2!S;VUE=&EM97,@2!C6UE;G0@2!B M96QI979E6QE/3-$)U1%6%0M24Y$14Y4.B`S-G!T.R!$25-03$%9.B!B M;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G(&%L M:6=N/3-$:G5S=&EF>3X@("`@#0H@("`@("`\9F]N="!S='EL93TS1"=$25-0 M3$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!4:6UE65A65A28C.#(Q-SMS M(')E=F5N=65S(&1U65A6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)' M24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1J=7-T M:69Y/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=% M24=(5#H@8F]L9"<^5F5N9&]R($-O;F-E;G1R871I;VX\+V9O;G0^("`-"B`@ M("`\+V1I=CX\8G(O/CQD:78@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ(%1I;65S($YE M=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T)SY4:&4@<')I;F-I<&%L(')A=R!M M871E2!T:&4@0V]M<&%N>2!C;VYS:7-T(&]F(&-O;6UO M;B!I;F1U2X\+V9O;G0^/"]D M:78^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R M(&-L87-S/3-$2!497AT($)L;V-K73PO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/&1I=B!S='EL93TS1"=4 M15A4+4E.1$5.5#H@,'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z M(#!P=#L@34%21TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$:G5S=&EF>3X\9F]N M="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!4:6UE M6QE/3-$)U1%6%0M24Y$14Y4.B`S-G!T.R!$25-03$%9.B!B;&]C M:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G(&%L:6=N M/3-$:G5S=&EF>3X@("`@#0H@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9 M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!4:6UE"!B87-E"!C"!A"!R871E'!E8W1E9"!T;R!A<'!L>2!I M;B!T:&4@>65A'!E8W1E9"!T;R!B92!R96-O=F5R960@;W(@"!A3L@5$585"U)3D1%3E0Z(#,V M<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM M4DE'2%0Z(#!P="<^("`@(`T*("`@("`@("`\9F]N="!S='EL93TS1"=$25-0 M3$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!4:6UE"!P;W-I=&EO;B!T86ME M;B!O'!E8W1E9"!T;R!B92!T86ME;B!I;B!A('1A>"!R971U2!D M:60@;F]T(&AA=F4@86YY('5N2!I;G1E2!T:&4@4W1A=&4@;V8@3F5W(%EO&%T:6]N(&%N9"!&:6YA;F-E("@F(S@R,C`[1%1&)B,X M,C(Q.RD@8V]M;65N8V5D(&$@&%M:6YA M=&EO;B!O9B!T:&4@0V]M<&%N>28C.#(Q-SMS(&EN8V]M92!T87@@65A2!497AT($)L;V-K73PO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/&1I=B!S='EL93TS1"=415A4+4E.1$5.5#H@,'!T.R!$ M25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4 M.B`P<'0G(&%L:6=N/3-$:G5S=&EF>3X\9F]N="!S='EL93TS1"=$25-03$%9 M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!4:6UE65A2`D-S,P M+#`P,"!A;F0@)#2!497AT($)L;V-K73PO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/&1I=B!S='EL93TS1"=415A4+4E.1$5.5#H@,'!T.R!$25-03$%9.B!B;&]C M:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G(&%L:6=N M/3-$:G5S=&EF>3X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/ M3E0M1D%-24Q9.B!4:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T)SY3:&EP M<&EN9R!A;F0@:&%N9&QI;F<@8V]S=',@87)E(&-L87-S:69I960@:6X@;W!E M&EM871E;'D@)#@V+#`P,"!A;F0@)#0U+#`P,"!F;W(@=&AE('EE M87)S(&5N9&5D($1E8V5M8F5R(#,Q+"`R,#$T(&%N9"`R,#$S+"!R97-P96-T M:79E;'DN/"]F;VYT/CPO9&EV/CQS<&%N/CPO6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!, M05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P M="<@86QI9VX],T1J=7-T:69Y/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I% M.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9"<^061V97)T:7-I;F<@0V]S=',\ M+V9O;G0^(`T*("`@(#PO9&EV/CQB'!E;G-E9"!A2!;4&]L:6-Y(%1E>'0@0FQO M8VM=/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\9&EV('-T>6QE M/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM M3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1J=7-T:69Y M/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=( M5#H@8F]L9"<^4W1O8VLM0F%S960@0V]M<&5N2!E;7!L;WEE97,@86YD($1I2!;4&]L:6-Y(%1E>'0@0FQO M8VM=/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\9&EV('-T>6QE M/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM M3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1J=7-T:69Y M/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=( M5#H@8F]L9"<^16%R;FEN9W,@4&5R(%-H87)E($EN9F]R;6%T:6]N/"]F;VYT M/B`@("`-"B`@("`\+V1I=CX\8G(O/CQD:78@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T)SY"87-I8R!E87)N M:6YG2!497AT($)L;V-K M73PO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/&1I=B!S='EL93TS M1"=415A4+4E.1$5.5#H@,'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q% M1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$:G5S=&EF>3X\ M9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!4 M:6UE6QE/3-$)U1%6%0M24Y$14Y4.B`S-G!T.R!$25-03$%9 M.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G M(&%L:6=N/3-$:G5S=&EF>3X@("`@#0H@("`@("`\9F]N="!S='EL93TS1"=$ M25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!4:6UE'!E;G-E6QE M/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM M3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1J=7-T:69Y M/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=( M5#H@8F]L9"<^3F5W($%C8V]U;G1I;F<@4W1A;F1A6QE/3-$)U1%6%0M04Q)1TXZ(&IU M6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T)SY);B!$96-E;6)E M"!,;W-S+"!O"!#F5D('1A>"!B96YE M9FET+"!OF5D('1A>"!B96YE M9FET+"!S:&]U;&0@8F4@<')E"!A69O&-E<'1I;VYS+B8C,38P.R8C,38P.U1H:7,@86UE;F1M96YT(&]N M;'D@87!P;&EEF5D('1A>"!B96YE9FET('=H96X@82!N970@;W!E3L@5$585"U) M3D1%3E0Z(#,V<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T M.R!-05)'24XM4DE'2%0Z(#!P="<^("`@(`T*("`@("`@/&9O;G0@2`R,#$T+"!&05-"(&ES2!T:&%T('5S97,@=&AE(&=U:61A;F-E(&]F($=!05`@ M9F]R(&5N=&5R:6YG(&EN=&\@8V]N=')A8W1S('=I=&@@8W5S=&]M97)S('1O M('1R86YS9F5R(&=O;V1S(&]R('-EF4@3L@5$585"U)3D1%3E0Z(#,V<'0[($1) M4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z M(#!P="<^("`@(`T*("`@("`@/&9O;G0@2!47!I8V%L(')E<'5R8VAA6QE/3-$)U1%6%0M04Q)1TXZ(&IU6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SY);B!!=6=U2!M:71I9V%T:6YG(&5F9F5C M=',@:6UP;&5M96YT960@8GD@;6%N86=E;65N="P@86YD('1H92!D:7-C;&]S M=7)E2!A<'!L:6-A=&EO;B!B M96EN9R!P97)M:71T960N(%1H92!U<&1A=&4@=VEL;"`@#0H@("`@("!B92!A M9&]P=&5D(&9O3X-"CPO:'1M;#X-"@T* M+2TM+2TM/5].97AT4&%R=%\V835D9F,S-E\T,6,W7S1A-C!?.#=F-5\Y,65A M9C$Y96-C96$-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO-F$U9&9C M,S9?-#%C-U\T838P7S@W9C5?.3%E868Q.65C8V5A+U=O'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C M:&%R2!O9B!3 M:6=N:69I8V%N="!!8V-O=6YT:6YG(%!O;&EC:65S("A486)L97,I/&)R/CPO M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$2P@4&QA;G0L($%N M9"!%<75I<&UE;G0@57-E9G5L($QI=F5S(%M486)L92!497AT($)L;V-K73PO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'1A8FQE(&-E;&QP861D M:6YG/3-$,"!C96QL6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L M;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI M9VX],T1L969T/B`@("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SY&86-T;W)Y(&5Q=6EP;65N="!A;F0@9FEX M='5R97,@*'EE87)S*3PO9F]N=#X@("`@#0H@("`@("`@("`@("`\+V1I=CX@ M("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N M/3-$8F]T=&]M('=I9'1H/3-$-B4@6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXU/"]F;VYT/B`@("`@#0H@("`@("`@("`@/"]T9#X@(`T* M("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0S)2!S='EL M93TS1"=415A4+4%,24=..B!C96YT97(G/B`@("`@#0H@("`@("`@("`@("`\ M9&EV('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!, M05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P M="<@86QI9VX],T1L969T/B`@("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T M>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SY"=6EL9&EN9R8C,38P.R`H>65A M6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T* M("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T M=&]M('=I9'1H/3-$,R4@6QE/3-$)V)A8VMG6QE/3-$)U1%6%0M04Q)1TXZ(&-E M;G1E3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\V835D M9F,S-E\T,6,W7S1A-C!?.#=F-5\Y,65A9C$Y96-C96$-"D-O;G1E;G0M3&]C M871I;VXZ(&9I;&4Z+R\O0SHO-F$U9&9C,S9?-#%C-U\T838P7S@W9C5?.3%E M868Q.65C8V5A+U=O'0O:'1M;#L@8VAA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$6QE/3-$ M)U!!1$1)3D6QE/3-$ M)T1)4U!,05DZ(&EN;&EN92<^/&9O;G0@6QE/3-$)T1)4U!, M05DZ(&EN;&EN92<^0V]S=#PO9F]N=#X\+V9O;G0^("`@(`T*("`@("`@("`@ M("`@/"]D:78^("`@("`-"B`@("`@("`@("`\+W1D/B`@#0H@("`@("`@("`@ M/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@6QE/3-$)T1)4U!,05DZ(&EN M;&EN92<^1F%I6QE/3-$ M)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=. M.B!L969T)SX@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T M('-O;&ED.R!415A4+4%,24=..B!C96YT97(G/B`-"B`@("`@("`@("`@(#QD M:78@6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SY5;G)E86QI>F5D/"]F;VYT/B`-"B`@("`@ M("`@("`@(#PO9&EV/B`@("`@#0H@("`@("`@("`@("`\9&EV('-T>6QE/3-$ M)U1%6%0M04Q)1TXZ(&-E;G1E6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF M(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@ M("`\=&0@86QI9VX],T1R:6=H="!C;VQS<&%N/3-$,B!N;W=R87`],T1N;W=R M87`@=F%L:6=N/3-$8F]T=&]M/B`@("`-"B`@("`@("`@("`@("8C,38P.R`@ M(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@;F]W6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^ M("`-"B`@("`@("`@("`\=&0@86QI9VX],T1R:6=H="!V86QI9VX],T1B;W1T M;VT^(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M M04Q)1TXZ(&QE9G0G/B`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[ M($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE' M2%0Z(#!P="<@86QI9VX],T1L969T/B`@("`@#0H@("`@("`@("`@("`@(#QF M;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SY!=F%I;&%B;&4@9F]R M('-A;&4Z/"]F;VYT/B`@("`@#0H@("`@("`@("`@("`\+V1I=CX@("`@(`T* M("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@86QI9VX],T1R:6=H M="!V86QI9VX],T1B;W1T;VT^(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@(`T*("`@("`@("`@("`@ M/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\ M+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@ M86QI9VX],T1R:6=H="!C;VQS<&%N/3-$,B!N;W=R87`],T1N;W=R87`@=F%L M:6=N/3-$8F]T=&]M/B`@("`-"B`@("`@("`@("`@("8C,38P.R`@(`T*("`@ M("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@;F]W6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@ M("`@("`@/"]T6QE/3-$)U!!1$1)3D6QE/3-$)U1%6%0M24Y$14Y4.B`P M<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,3AP=#L@34%21TE. M+5))1TA4.B`P<'0G(&%L:6=N/3-$;&5F=#X@#0H@("`@("`@("`@("`@(#QF M;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SY&:7AE9"!I;F-O;64@ M;75T=6%L(&9U;F1S/"]F;VYT/B`-"B`@("`@("`@("`@(#PO9&EV/B`@("`@ M#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@("`@(#QT9"!A;&EG;CTS1')I M9VAT('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/B`@#0H@("`@("`@("`@ M("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9 M.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ M(&QE9G0G/B`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@("`@#0H@("`@("`@("`@("`\ M9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T M:6UE6QE M/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`@(#QF;VYT M('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@ M(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@86QI9VX],T1R M:6=H="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X@(`T*("`@("`@("`@ M("`@/&9O;G0@6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXD/"]F;VYT/B`@("`@#0H@("`@("`@("`@/"]T9#X@ M(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0W)2!S M='EL93TS1"=415A4+4%,24=..B!R:6=H="<^("`@(`T*("`@("`@("`@("`@ M/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\ M+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@ M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXR,#$L-C$Q/"]F M;VYT/B`-"B`@("`@("`@("`\+W1D/B`@#0H@("`@("`@("`@/'1D(&YO=W)A M<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS M1"=415A4+4%,24=..B!L969T)SX@("`@#0H@("`@("`@("`@("`\9F]N="!S M='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)V)A8VMG#L@ M4$%$1$E.1RU,1494.B`P<'0[($U!4D=)3BU,1494.B`Y<'0G/B`@#0H@("`@ M("`@("`@("`\9&EV('-T>6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!, M05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,3AP=#L@34%21TE.+5))1TA4.B`P M<'0G(&%L:6=N/3-$;&5F=#X@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SY%<75I='D@86YD(&]T:&5R(&UU='5A M;"!F=6YD"<^("`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@ M("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M M('=I9'1H/3-$,24@6QE/3-$)T)/4D1%4BU"3U143TTZ M(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!R:6=H="<^("`@#0H@ M("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/ M3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!4 M15A4+4%,24=..B!L969T)SX@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@ M("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@86QI9VX],T1R:6=H="!V M86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=0041$24Y'+4)/ M5%1/33H@,G!X)SX@("`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@ M(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$ M8F]T=&]M('=I9'1H/3-$-R4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX\9F]N M="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4G/C@Q-"PR,38\+V9O;G0^/"]F M;VYT/B`@("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@("`@(#QT9"!N M;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U!!1$1)3D6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED M.R!415A4+4%,24=..B!L969T)SX@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN92<^,3DR+#$S,#PO9F]N=#X\+V9O;G0^ M("`@("`-"B`@("`@("`@("`\+W1D/B`@#0H@("`@("`@("`@/'1D(&YO=W)A M<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS M1"="3U)$15(M0D]45$]-.B!B;&%C:R`Q+C%P="!S;VQI9#L@5$585"U!3$E' M3CH@;&5F="<^("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-0 M3$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U!!1$1)3D6QE/3-$ M)T)/4D1%4BU"3U143TTZ(&)L86-K(#(N-S5P="!D;W5B;&4[(%1%6%0M04Q) M1TXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXD/"]F;VYT/B`@("`@#0H@("`@("`@("`@/"]T M9#X@(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0W M)2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`R+C6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXX+#DY-2PW-C`\+V9O;G0^ M("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@("`@(#QT9"!N;W=R87`] M,T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@ M(#PO=&0^("`-"B`@("`@("`@("`\=&0@86QI9VX],T1R:6=H="!V86QI9VX] M,T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=0041$24Y'+4)/5%1/33H@ M-'!X)SX@("`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#(N-S5P="!D;W5B;&4[ M(%1%6%0M04Q)1TXZ(&QE9G0G/B`@("`@#0H@("`@("`@("`@("`\9F]N="!S M='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE"<^("`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@ M("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M M('=I9'1H/3-$,24@6QE/3-$)T)/4D1%4BU"3U143TTZ M(&)L86-K(#(N-S5P="!D;W5B;&4[(%1%6%0M04Q)1TXZ(')I9VAT)SX@("`@ M(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#(N-S5P="!D M;W5B;&4[(%1%6%0M04Q)1TXZ(&QE9G0G/B`@("`@#0H@("`@("`@("`@("`\ M9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T M:6UE6QE/3-$)V)A8VMG6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O M;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L M:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4@6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO M=&0^("`-"B`@("`@("`@("`\=&0@;F]W6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G M/B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`- M"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^("`@ M#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[ M($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$ M)U1%6%0M04Q)1TXZ(&QE9G0G/B`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\ M+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@ M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@("`@#0H@("`@("`@ M("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%- M24Q9.B!T:6UE6QE/3-$)U1% M6%0M04Q)1TXZ(')I9VAT.R!0041$24Y'+4)/5%1/33H@,G!X)SX@("`@(`T* M("`@("`@("`@("`@/&9O;G0@"<^("`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@ M(#PO=&0^("`-"B`@("`@("`@("`\=&0@86QI9VX],T1R:6=H="!V86QI9VX] M,T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=0041$24Y'+4)/5%1/33H@ M,G!X)SX@("`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!0041$24Y'+4)/5%1/33H@ M,G!X)SX@("`@(`T*("`@("`@("`@("`@/&9O;G0@"<^("`@("`-"B`@("`@("`@("`@(#QF;VYT M('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@ M(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@86QI9VX],T1R M:6=H="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=0041$ M24Y'+4)/5%1/33H@,G!X)SX@("`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!0041$ M24Y'+4)/5%1/33H@,G!X)SX@("`@(`T*("`@("`@("`@("`@/&9O;G0@"<^("`@("`-"B`@("`@ M("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V M,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@/"]T M6QE/3-$)U1% M6%0M04Q)1TXZ(&QE9G0G/B`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$ M)U1%6%0M04Q)1TXZ(&QE9G0G/B`@(`T*("`@("`@("`@("`@/&9O;G0@6QE M/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@(`T*("`@("`@("`@("`@/&9O;G0@ M6QE/3-$)U1%6%0M04Q)1TXZ(&QE M9G0G/B`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ M(&QE9G0G/B`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q) M1TXZ(&QE9G0G/B`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)U!!1$1)3D6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)' M24XM3$5&5#H@,3AP=#L@34%21TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$;&5F M=#X@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SY#;W)P;W)A=&4@8F]N9',@*&UA='5R:6YG('=I=&AI;B`Q('EE M87(I/"]F;VYT/B`-"B`@("`@("`@("`@(#PO9&EV/B`@("`@#0H@("`@("`@ M("`@/"]T9#X@(`T*("`@("`@("`@(#QT9"!A;&EG;CTS1')I9VAT('9A;&EG M;CTS1&)O='1O;2!W:61T:#TS1#$E/B`@#0H@("`@("`@("`@("`\9F]N="!S M='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@ M(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1% M6%0M04Q)1TXZ(')I9VAT)SX@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL M93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@(`T* M("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M M04Q)1TXZ(')I9VAT)SX@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@(`T*("`@ M("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q) M1TXZ(')I9VAT)SX@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$ M25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@ M(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H M/3-$-R4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXW+#,R M-2PY,S`\+V9O;G0^("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@("`@ M(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$ M,24@6QE/3-$)U1% M6%0M04Q)1TXZ(&QE9G0G/B`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@ M("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@ M("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI M;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U!! M1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)T)/4D1% M4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T M)SX@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN M;&EN92<^,2PQ,S$L,30W/"]F;VYT/CPO9F]N=#X@(`T*("`@("`@("`@(#PO M=&0^("`-"B`@("`@("`@("`\=&0@;F]W6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L M86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T)SX@("`-"B`@("`@ M("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V M,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\ M=&0@86QI9VX],T1R:6=H="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S M='EL93TS1"=0041$24Y'+4)/5%1/33H@,G!X)SX@("`@(`T*("`@("`@("`@ M("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@ M("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4@6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SX\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4G M/C$L,C,W+#0V-3PO9F]N=#X\+V9O;G0^("`-"B`@("`@("`@("`\+W1D/B`@ M#0H@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T M;VT@=VED=&@],T0Q)2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`Q M+C%P="!S;VQI9#L@5$585"U!3$E'3CH@;&5F="<^("`@#0H@("`@("`@("`@ M("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9 M.B!T:6UE"<^("`@("`-"B`@("`@("`@("`@(#QF M;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^ M("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N M/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T)/4D1% M4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!R:6=H M="<^("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I M;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T M('-O;&ED.R!415A4+4%,24=..B!L969T)SX@("`-"B`@("`@("`@("`@(#QF M;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^ M("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@/"]T6QE/3-$)U!!1$1)3D"<^("`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@ M("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I M9'1H/3-$,24@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L M86-K(#(N-S5P="!D;W5B;&4[(%1%6%0M04Q)1TXZ(')I9VAT)SX@("`@(`T* M("`@("`@("`@("`@/&9O;G0@6QE/3-$ M)U!!1$1)3D6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L M86-K(#(N-S5P="!D;W5B;&4[(%1%6%0M04Q)1TXZ(&QE9G0G/B`@("`-"B`@ M("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXD M/"]F;VYT/B`@("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@("`@(#QT M9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0W)2!S='EL93TS1"="3U)$15(M M0D]45$]-.B!B;&%C:R`R+C6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXX+#@V,RPR,#4\+V9O;G0^("`@#0H@("`@("`@("`@/"]T M9#X@(`T*("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$ M8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF M(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@ M("`\=&0@86QI9VX],T1R:6=H="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q M)2!S='EL93TS1"=0041$24Y'+4)/5%1/33H@-'!X)SX@("`@(`T*("`@("`@ M("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@ M("`@("`@/"]T'0O M:F%V87-C3X-"B`@("`\ M=&%B;&4@8VQA'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0@0FQO8VM=/"]T9#X-"B`@("`@ M("`@/'1D(&-L87-S/3-$=&5X=#X\=&%B;&4@8V5L;'!A9&1I;F<],T0P(&-E M;&QS<&%C:6YG/3-$,"!W:61T:#TS1#$P,"4@"<^ M("`@#0H@("`@("`@("`@("`F(S$V,#L@("`-"B`@("`@("`@("`\+W1D/B`@ M#0H@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!S='EL93TS1"=415A4 M+4%,24=..B!C96YT97([(%!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN M92<^1&5C96UB97(@,S$L/"]F;VYT/CPO9F]N=#X@(`T*("`@("`@("`@("`@ M/"]D:78^("`@("`-"B`@("`@("`@("`\+W1D/B`@#0H@("`@("`@("`@/'1D M(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E"<^("`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@ M("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@8V]L6QE/3-$)U1%6%0M04Q)1TXZ(&-E M;G1E6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T* M("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T M=&]M('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E"<^("`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@ M(#PO=&0^("`-"B`@("`@("`@("`\=&0@8V]L6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@ M("`@(#PO=&0^("`-"B`@("`@("`@/"]T6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T* M("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T M=&]M/B`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I M;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`- M"B`@("`@("`@/"]T6QE/3-$)U1% M6%0M04Q)1TXZ(&QE9G0G/B`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@("`@#0H@("`@ M("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M M04Q)1TXZ(&QE9G0G/B`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@("`@#0H@("`@("`@ M("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%- M24Q9.B!T:6UE"<^("`@("`-"B`@("`@("`@("`@(#QD:78@"<^("`@("`-"B`@("`@("`@("`@ M(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O M;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L M:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T)/ M4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!R M:6=H="<^("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9 M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N M,7!T('-O;&ED.R!415A4+4%,24=..B!L969T)SX@("`-"B`@("`@("`@("`@ M(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O M;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@86QI M9VX],T1R:6=H="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS M1"=0041$24Y'+4)/5%1/33H@,G!X)SX@("`@(`T*("`@("`@("`@("`@/&9O M;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V M,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\ M=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4@6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SX\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4G/C$L,3(Q M+#DY,#PO9F]N=#X\+V9O;G0^("`-"B`@("`@("`@("`\+W1D/B`@#0H@("`@ M("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@=VED M=&@],T0Q)2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`Q+C%P="!S M;VQI9#L@5$585"U!3$E'3CH@;&5F="<^("`@#0H@("`@("`@("`@("`\9F]N M="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE M6QE/3-$)V)A8VMG"<^("`@("`-"B`@("`@("`@("`@("8C,38P.R`@(`T*("`@("`@("`@(#PO M=&0^("`-"B`@("`@("`@("`\=&0@86QI9VX],T1R:6=H="!V86QI9VX],T1B M;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=0041$24Y'+4)/5%1/33H@-'!X M)SX@("`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#(N-S5P="!D;W5B;&4[(%1% M6%0M04Q)1TXZ(&QE9G0G/B`@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL M93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE"<^("`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@ M("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I M9'1H/3-$,24@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L M86-K(#(N-S5P="!D;W5B;&4[(%1%6%0M04Q)1TXZ(')I9VAT)SX@("`@(`T* M("`@("`@("`@("`@/&9O;G0@7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S M8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I M=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA7!E/3-$=&5X="]J879A"!$:7-C M;&]S=7)E(%M!8G-T'0^/'1A8FQE(&-E;&QP861D M:6YG/3-$,"!C96QL6QE/3-$ M)T9/3E0M1D%-24Q9.B!T:6UE"<^("`@#0H@("`@("`@("`@("`F(S$V,#L@("`-"B`@("`@("`@ M("`\+W1D/B`@#0H@("`@("`@("`@/'1D('9A;&EG;CTS1&)O='1O;2!S='EL M93TS1"=0041$24Y'+4)/5%1/33H@,G!X)SX@("`@(`T*("`@("`@("`@("`@ M/&9O;G0@6QE M/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED)SX@#0H@("`@ M("`@("`@("`\9&EV('-T>6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!, M05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P M="<@86QI9VX],T1C96YT97(^("`-"B`@("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!, M05DZ(&EN;&EN92<^665A6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^ M("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@/"]T6QE/3-$)U!!1$1)3D6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED M.R!415A4+4%,24=..B!C96YT97(G/B`-"B`@("`@("`@("`@(#QD:78@6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SX\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4G M/C(P,30\+V9O;G0^/"]F;VYT/B`@("`-"B`@("`@("`@("`@(#PO9&EV/B`@ M("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@("`@(#QT9"!N;W=R87`] M,T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)T)/4D1%4BU"3U14 M3TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T)SX@(`T* M("`@("`@("`@("`@/&9O;G0@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4 M+4%,24=..B!C96YT97(G/B`-"B`@("`@("`@("`@(#QD:78@6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SX\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4G/C(P,3,\ M+V9O;G0^/"]F;VYT/B`@("`-"B`@("`@("`@("`@(#PO9&EV/B`@("`@#0H@ M("`@("`@("`@/"]T9#X@(`T*("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R M87`@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L M86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T)SX@(`T*("`@("`@ M("`@("`@/&9O;G0@6QE/3-$)U!!1$1)3D6QE M/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM M3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1L969T/B`@ M("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SX\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T* M("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@86QI9VX],T1R:6=H M="!C;VQS<&%N/3-$,B!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M M/B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`- M"B`@("`@("`@("`\=&0@;F]W6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O M;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@86QI M9VX],T1R:6=H="!V86QI9VX],T1B;W1T;VT^(`T*("`@("`@("`@("`@/&9O M;G0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@(`T*("`@("`@ M("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXD/"]F;VYT/B`@("`@ M#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B M;W1T;VT@=VED=&@],T0W)2!S='EL93TS1"=415A4+4%,24=..B!R:6=H="<^ M("`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^ M("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@ M6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXR+#6QE/3-$ M)U!!1$1)3D"<^("`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@ M(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H M/3-$,24@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K M(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!R:6=H="<^("`@#0H@("`@("`@ M("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%- M24Q9.B!T:6UE"<^("`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO M=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$ M,24@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N M,7!T('-O;&ED.R!415A4+4%,24=..B!R:6=H="<^("`@#0H@("`@("`@("`@ M("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9 M.B!T:6UE6QE/3-$)U!!1$1)3D6QE/3-$)T)/ M4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L M969T)SX@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ M(&EN;&EN92<^,2PW,#0L.#`X/"]F;VYT/CPO9F]N=#X@(`T*("`@("`@("`@ M(#PO=&0^("`-"B`@("`@("`@("`\=&0@;F]W6QE/3-$)T)/4D1%4BU"3U143TTZ M(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T)SX@("`-"B`@ M("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF M(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@ M("`\=&0@86QI9VX],T1R:6=H="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q M)2!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,G!X)SX@("`@(`T*("`@("`@ M("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@ M("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4@6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SX\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI M;F4G/C(L-S0P+#6QE/3-$)V)A8VMG6QE M/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@(`T*("`@("`@("`@("`@/&9O;G0@ M6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@(`T*("`@("`@("`@("`@/&9O M;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V M,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\ M=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4@6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXH-"PP,#,\+V9O;G0^("`@("`-"B`@("`@ M("`@("`\+W1D/B`@#0H@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V M86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4+4%,24=. M.B!L969T)SX@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-0 M3$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V M,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\ M=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4@6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXH,3$L.#$P/"]F;VYT/B`-"B`@("`@("`@ M("`\+W1D/B`@#0H@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI M9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L M969T)SX@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9 M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U!!1$1)3D6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T M('-O;&ED.R!415A4+4%,24=..B!L969T)SX@(`T*("`@("`@("`@("`@/&9O M;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN92<^,RPW-#D\+V9O;G0^/"]F M;VYT/B`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@;F]W M6QE M/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%, M24=..B!L969T)SX@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@ M(#PO=&0^("`-"B`@("`@("`@("`\=&0@86QI9VX],T1R:6=H="!V86QI9VX] M,T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=0041$24Y'+4)/5%1/33H@ M,G!X)SX@("`@(`T*("`@("`@("`@("`@/&9O;G0@6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@ M("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M M('=I9'1H/3-$-R4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXH,S4Q/"]F;VYT M/B`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@;F]W6QE/3-$ M)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=. M.B!L969T)SX@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXI/"]F;VYT/B`@("`@#0H@("`@("`@("`@/"]T9#X@ M(`T*("`@("`@("`\+W1R/B`@("`@#0H@("`@("`@(#QT6QE/3-$)U!! M1$1)3D6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K M(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T)SX@(`T*("`@("`@("`@ M("`@/&9O;G0@"<^("`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@ M("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I M9'1H/3-$,24@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L M86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!R:6=H="<^("`@#0H@("`@ M("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M M1D%-24Q9.B!T:6UE6QE/3-$)V)A8VMG#L@4$%$1$E.1RU, M1494.B`P<'0[($U!4D=)3BU,1494.B`Y<'0G/B`@#0H@("`@("`@("`@("`\ M9&EV('-T>6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K M.R!-05)'24XM3$5&5#H@,S9P=#L@34%21TE.+5))1TA4.B`P<'0G(&%L:6=N M/3-$;&5F=#X@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SY4;W1A;"!P6QE/3-$)U!!1$1)3D6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#(N-S5P="!D;W5B M;&4[(%1%6%0M04Q)1TXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`@(#QF;VYT M('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXD/"]F;VYT/B`@("`@#0H@ M("`@("`@("`@/"]T9#X@(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T M;VT@=VED=&@],T0W)2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`R M+C6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXQ+#

6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@ M(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@86QI9VX],T1R M:6=H="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=0041$ M24Y'+4)/5%1/33H@-'!X)SX@("`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#(N M-S5P="!D;W5B;&4[(%1%6%0M04Q)1TXZ(&QE9G0G/B`@("`@#0H@("`@("`@ M("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%- M24Q9.B!T:6UE"!2871E(%)E8V]N8VEL:6%T:6]N(%M486)L92!497AT($)L M;V-K73PO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'1A8FQE(&-E M;&QP861D:6YG/3-$,"!C96QL6QE/3-$)T9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U!!1$1)3D6QE/3-$)U1%6%0M04Q) M1TXZ(&-E;G1E"<^(`T*("`@("`@("`@ M("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E"<^("`@("`-"B`@("`@("`@("`@("8C M,38P.R`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L M:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E6QE M/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%, M24=..B!L969T)SX@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@ M(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H M/3-$,B4@6QE/3-$)U1%6%0M04Q) M1TXZ(&-E;G1E6QE/3-$)T)/4D1%4BU"3U143TTZ M(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T)SX@("`-"B`@ M("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF M(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@ M/"]T6QE M/3-$)U!!1$1)3D6QE/3-$)U1%6%0M04Q)1TXZ M(&-E;G1E"<^(`T*("`@("`@("`@("`@ M/&9O;G0@6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SX\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI M;F4G/B@D*3PO9F]N=#X\+V9O;G0^("`@#0H@("`@("`@("`@("`\+V1I=CX@ M("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@;F]W6QE/3-$ M)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=. M.B!L969T)SX@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO M=&0^("`-"B`@("`@("`@("`\=&0@86QI9VX],T1L969T('9A;&EG;CTS1&)O M='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`- M"B`@("`@("`@("`\=&0@8V]L6QE/3-$)T)/4D1%4BU"3U14 M3TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!C96YT97(G/B`@ M#0H@("`@("`@("`@("`\9&EV('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E M6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K M(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T)SX@("`-"B`@("`@("`@ M("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\ M+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@ M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,B4@6QE/3-$)T1)4U!,05DZ(&EN M;&EN92<^*"0I/"]F;VYT/CPO9F]N=#X@("`-"B`@("`@("`@("`@(#PO9&EV M/B`@("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@("`@(#QT9"!N;W=R M87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO M=&0^("`-"B`@("`@("`@("`\=&0@8V]L6QE/3-$)T)/4D1% M4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!C96YT M97(G/B`@#0H@("`@("`@("`@("`\9&EV('-T>6QE/3-$)U1%6%0M04Q)1TXZ M(&-E;G1E6QE/3-$)T)/4D1%4BU"3U143TTZ M(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T)SX@("`-"B`@ M("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF M(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@ M/"]T6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXD/"]F;VYT/B`@("`@ M#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B M;W1T;VT@=VED=&@],T0W)2!S='EL93TS1"=415A4+4%,24=..B!R:6=H="<^ M("`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^ M("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@ M6QE/3-$)U1%6%0M04Q)1TXZ(')I M9VAT)SX@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9 M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXD/"]F;VYT/B`@("`@#0H@ M("`@("`@("`@/"]T9#X@(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T M;VT@=VED=&@],T0W)2!S='EL93TS1"=415A4+4%,24=..B!R:6=H="<^("`@ M(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`- M"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT M)SX@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I M;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!, M05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P M="<@86QI9VX],T1L969T/B`@("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T M>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SY3=&%T92!I;F-O;64@=&%X97,L M(&YE="!O9B!&961E6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T* M("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T M=&]M('=I9'1H/3-$-R4@6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXH-"PP,#`\+V9O;G0^("`@("`-"B`@("`@("`@("`\+W1D/B`@#0H@ M("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@ M=VED=&@],T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L969T)SX@("`@#0H@ M("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/ M3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T* M("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T M=&]M('=I9'1H/3-$-R4@6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXH,"XQ/"]F;VYT/B`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@ M("`@("`\=&0@;F]W6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`-"B`@("`@ M("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXI/"]F M;VYT/B`@("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@("`@(#QT9"!A M;&EG;CTS1')I9VAT('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#(E/B`@#0H@ M("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/ M3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1% M6%0M04Q)1TXZ(&QE9G0G/B`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`-"B`@("`@ M("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V M,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\ M=&0@86QI9VX],T1R:6=H="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X@ M(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T* M("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T M=&]M('=I9'1H/3-$-R4@6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXP+C(\+V9O;G0^("`-"B`@("`@("`@("`\+W1D/B`@#0H@("`@("`@ M("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@=VED=&@] M,T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L969T)SX@("`@#0H@("`@("`@ M("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%- M24Q9.B!T:6UE6QE/3-$)V)A8VMG6QE/3-$)U1%6%0M04Q) M1TXZ(&QE9G0G/B`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\ M+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@ M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@("`@#0H@("`@("`@ M("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%- M24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^ M("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4@ M6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXH,3@P+#`P,#PO M9F]N=#X@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@;F]W M6QE M/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`@(#QF;VYT M('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXI/"]F;VYT/B`@("`@#0H@ M("`@("`@("`@/"]T9#X@(`T*("`@("`@("`@(#QT9"!A;&EG;CTS1')I9VAT M('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/B`@#0H@("`@("`@("`@("`\ M9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T M:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE M9G0G/B`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@(`T*("`@("`@("`@("`@/&9O M;G0@6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^ M("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@ M6QE/3-$)U1%6%0M04Q)1TXZ(')I M9VAT)SX@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9 M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@(`T*("`@("`@("`@("`@/&9O M;G0@6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^ M("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@ M6QE/3-$)U1%6%0M04Q)1TXZ(')I M9VAT)SX@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9 M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ M(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@ M86QI9VX],T1L969T/B`@("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SY06QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@ M("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXH-38L,#`P/"]F;VYT/B`- M"B`@("`@("`@("`\+W1D/B`@#0H@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO M=W)A<"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4 M+4%,24=..B!L969T)SX@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@ M("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXH,2XP/"]F;VYT/B`@(`T*("`@ M("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@;F]W6QE/3-$)U1%6%0M04Q) M1TXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXI/"]F;VYT/B`@("`@#0H@("`@("`@("`@/"]T M9#X@(`T*("`@("`@("`@(#QT9"!A;&EG;CTS1')I9VAT('9A;&EG;CTS1&)O M='1O;2!W:61T:#TS1#(E/B`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@(`T*("`@ M("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ M(&QE9G0G/B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXI/"]F;VYT/B`@("`@#0H@("`@("`@("`@/"]T9#X@ M(`T*("`@("`@("`@(#QT9"!A;&EG;CTS1')I9VAT('9A;&EG;CTS1&)O='1O M;2!W:61T:#TS1#$E/B`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$ M25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@(`T*("`@("`@ M("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^ M("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4@ M6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXH,C4L,#`P/"]F M;VYT/B`-"B`@("`@("`@("`\+W1D/B`@#0H@("`@("`@("`@/'1D(&YO=W)A M<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS M1"=415A4+4%,24=..B!L969T)SX@("`@#0H@("`@("`@("`@("`\9F]N="!S M='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`- M"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXH,"XT/"]F;VYT/B`@ M(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@;F]W6QE/3-$)U1% M6%0M04Q)1TXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXI/"]F;VYT/B`@("`@#0H@("`@("`@ M("`@/"]T9#X@(`T*("`@("`@("`@(#QT9"!A;&EG;CTS1')I9VAT('9A;&EG M;CTS1&)O='1O;2!W:61T:#TS1#(E/B`@#0H@("`@("`@("`@("`\9F]N="!S M='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@ M(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M M04Q)1TXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXI/"]F;VYT/B`@("`@#0H@("`@("`@("`@ M/"]T9#X@(`T*("`@("`@("`@(#QT9"!A;&EG;CTS1')I9VAT('9A;&EG;CTS M1&)O='1O;2!W:61T:#TS1#$E/B`@#0H@("`@("`@("`@("`\9F]N="!S='EL M93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@(`T* M("`@("`@("`@("`@/&9O;G0@6QE/3-$ M)V)A8VMG"<^("`@("`-"B`@("`@("`@ M("`@(#QD:78@6QE/3-$)U!!1$1)3D6QE/3-$ M)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=. M.B!L969T)SX@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!, M05DZ(&EN;&EN92<^+2TM/"]F;VYT/CPO9F]N=#X@#0H@("`@("`@("`@/"]T M9#X@(`T*("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$ M8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U!!1$1)3D6QE/3-$)T)/4D1%4BU"3U14 M3TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T)SX@(`T* M("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN92<^ M+2TM/"]F;VYT/CPO9F]N=#X@#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@ M("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H M/3-$,24@6QE/3-$)U!!1$1) M3D6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N M,7!T('-O;&ED.R!415A4+4%,24=..B!L969T)SX@(`T*("`@("`@("`@("`@ M/&9O;G0@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O M;&ED.R!415A4+4%,24=..B!L969T)SX@("`-"B`@("`@("`@("`@(#QF;VYT M('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXI/"]F;VYT/B`@("`@#0H@ M("`@("`@("`@/"]T9#X@(`T*("`@("`@("`@(#QT9"!A;&EG;CTS1')I9VAT M('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)U!!1$1)3D6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T M('-O;&ED.R!415A4+4%,24=..B!L969T)SX@(`T*("`@("`@("`@("`@/&9O M;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN92<^+2TM/"]F;VYT/CPO9F]N M=#X@#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@("`@(#QT9"!N;W=R87`] M,T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@"<^("`@("`- M"B`@("`@("`@("`@(#QD:78@"<^("`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@ M("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M M('=I9'1H/3-$,24@6QE/3-$)T)/4D1%4BU"3U143TTZ M(&)L86-K(#(N-S5P="!D;W5B;&4[(%1%6%0M04Q)1TXZ(')I9VAT)SX@("`@ M(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN92<^,2PW,#4L,#`P M/"]F;VYT/CPO9F]N=#X@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@ M("`\=&0@;F]W6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#(N-S5P="!D;W5B M;&4[(%1%6%0M04Q)1TXZ(&QE9G0G/B`@("`@#0H@("`@("`@("`@("`\9F]N M="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE M"<^("`@("`-"B`@("`@("`@("`@(#QF;VYT('-T M>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T* M("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T M=&]M('=I9'1H/3-$,24@6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXR.2XV/"]F;VYT/B`@(`T*("`@("`@("`@(#PO=&0^("`- M"B`@("`@("`@("`\=&0@;F]W6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#(N M-S5P="!D;W5B;&4[(%1%6%0M04Q)1TXZ(&QE9G0G/B`@("`@#0H@("`@("`@ M("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%- M24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\ M+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@ M86QI9VX],T1R:6=H="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL M93TS1"=0041$24Y'+4)/5%1/33H@-'!X)SX@("`@(`T*("`@("`@("`@("`@ M/&9O;G0@6QE/3-$ M)T)/4D1%4BU"3U143TTZ(&)L86-K(#(N-S5P="!D;W5B;&4[(%1%6%0M04Q) M1TXZ(')I9VAT)SX@("`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXE/"]F;VYT/B`@("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@("`\ M+W1R/B`@("`@#0H@("`@("`\+W1A8FQE/CQS<&%N/CPO'0@0FQO M8VM=/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\=&%B;&4@8V5L M;'!A9&1I;F<],T0P(&-E;&QS<&%C:6YG/3-$,"!W:61T:#TS1#$P,"4@"<^("`@("`-"B`@("`@("`@("`@(#QF;VYT M('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@ M(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@8V]L6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SX\9F]N="!S='EL93TS1"=$25-03$%9.B!I M;FQI;F4G/EEE87)S(&5N9&5D($1E8V5M8F5R(#,Q+#PO9F]N=#X\+V9O;G0^ M("`@(`T*("`@("`@("`@("`@/"]D:78^("`@("`-"B`@("`@("`@("`\+W1D M/B`@#0H@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B M;W1T;VT@6QE/3-$)U1%6%0M04Q) M1TXZ(&-E;G1E"<^("`@("`-"B`@("`@ M("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V M,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\ M=&0@8V]L6QE M/3-$)U1%6%0M04Q)1TXZ(&-E;G1E6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF M(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@ M("`\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&-E M;G1E"<^("`@("`-"B`@("`@("`@("`@ M(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O M;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@8V]L M6QE/3-$)U1% M6%0M04Q)1TXZ(&-E;G1E6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\ M+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@/"]T6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF M(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@ M("`\=&0@86QI9VX],T1L969T(&-O;'-P86X],T0R(&YO=W)A<#TS1&YO=W)A M<"!V86QI9VX],T1B;W1T;VT^("`@#0H@("`@("`@("`@("`F(S$V,#L@("`- M"B`@("`@("`@("`\+W1D/B`@#0H@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO M=W)A<"!V86QI9VX],T1B;W1T;VT@6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`- M"B`@("`@("`@("`\=&0@86QI9VX],T1L969T(&-O;'-P86X],T0R(&YO=W)A M<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT^("`@#0H@("`@("`@("`@("`F M(S$V,#L@("`-"B`@("`@("`@("`\+W1D/B`@#0H@("`@("`@("`@/'1D(&YO M=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@6QE/3-$)T1)4U!,05DZ(&EN M;&EN92<^0W5R6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@ M(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ M(&QE9G0G/B`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)U!!1$1)3D6QE/3-$)U1%6%0M24Y$14Y4.B`P M<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,S9P=#L@34%21TE. M+5))1TA4.B`P<'0G(&%L:6=N/3-$;&5F=#X@#0H@("`@("`@("`@("`@(#QF M;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SY!8V-O=6YT6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXD/"]F;VYT/B`@("`@#0H@("`@("`@("`@/"]T9#X@(`T* M("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0W)2!S='EL M93TS1"=415A4+4%,24=..B!R:6=H="<^("`@(`T*("`@("`@("`@("`@/&9O M;G0@6QE/3-$ M)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T M>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T* M("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@86QI9VX],T1R:6=H M="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X@(`T*("`@("`@("`@("`@ M/&9O;G0@6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXD/"]F;VYT/B`@("`@#0H@("`@("`@("`@/"]T9#X@(`T* M("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0W)2!S='EL M93TS1"=415A4+4%,24=..B!R:6=H="<^("`@(`T*("`@("`@("`@("`@/&9O M;G0@6QE/3-$)U1%6%0M M04Q)1TXZ(&QE9G0G/B`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`-"B`@("`@("`@ M("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\ M+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@ M86QI9VX],T1R:6=H="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X@(`T* M("`@("`@("`@("`@/&9O;G0@6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@ M("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M M('=I9'1H/3-$-R4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXQ-BPX-C(\+V9O;G0^("`@("`-"B`@("`@("`@("`\+W1D/B`@#0H@("`@ M("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@=VED M=&@],T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L969T)SX@("`@#0H@("`@ M("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M M1D%-24Q9.B!T:6UE6QE/3-$)V)A8VMG#L@4$%$1$E.1RU,1494.B`P<'0[($U!4D=)3BU,1494 M.B`Y<'0G/B`@#0H@("`@("`@("`@("`\9&EV('-T>6QE/3-$)U1%6%0M24Y$ M14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,S9P=#L@ M34%21TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$;&5F=#X@#0H@("`@("`@("`@ M("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SY!8V-R=65D M(&5X<&5N6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^ M("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N M/3-$8F]T=&]M('=I9'1H/3-$-R4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX\ M9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4G/C$Y.2PR,S@\+V9O;G0^ M/"]F;VYT/B`@("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@("`@(#QT M9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@ M6QE/3-$)U!!1$1)3D6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O M;&ED.R!415A4+4%,24=..B!L969T)SX@(`T*("`@("`@("`@("`@/&9O;G0@ M6QE/3-$)T1)4U!,05DZ(&EN;&EN92<^,C`V+#4P,#PO9F]N=#X\+V9O M;G0^("`@("`-"B`@("`@("`@("`\+W1D/B`@#0H@("`@("`@("`@/'1D(&YO M=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL M93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`Q+C%P="!S;VQI9#L@5$585"U! M3$E'3CH@;&5F="<^("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$ M25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U!!1$1)3D6QE M/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%, M24=..B!L969T)SX@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1) M4U!,05DZ(&EN;&EN92<^,C(S+#0S.3PO9F]N=#X\+V9O;G0^("`@("`-"B`@ M("`@("`@("`\+W1D/B`@#0H@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A M<"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"="3U)$15(M M0D]45$]-.B!B;&%C:R`Q+C%P="!S;VQI9#L@5$585"U!3$E'3CH@;&5F="<^ M("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI M;F4[($9/3E0M1D%-24Q9.B!T:6UE"<^("`@("`- M"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@ M("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!4 M15A4+4%,24=..B!R:6=H="<^("`@#0H@("`@("`@("`@("`\9F]N="!S='EL M93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U14 M3TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T)SX@("`- M"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@ M("`@/"]T6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@ M(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$ M8F]T=&]M('=I9'1H/3-$,24@6QE M/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@("`@#0H@("`@("`@("`@("`\9F]N M="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE M6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G M/B`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@ M("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I M9'1H/3-$,24@6QE/3-$)U1%6%0M M04Q)1TXZ(')I9VAT)SX@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@(`T*("`@ M("`@("`@("`@/&9O;G0@6QE/3-$)U!!1$1)3D6QE/3-$)U1%6%0M24Y$14Y4 M.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,S9P=#L@34%2 M1TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$;&5F=#X@#0H@("`@("`@("`@("`@ M(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SY$97!R96-I871I M;VX\+V9O;G0^("`@#0H@("`@("`@("`@("`\+V1I=CX@("`@(`T*("`@("`@ M("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@86QI9VX],T1R:6=H="!V86QI M9VX],T1B;W1T;VT@=VED=&@],T0Q)3X@(`T*("`@("`@("`@("`@/&9O;G0@ M6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@ M("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXH.3,L,C,V/"]F;VYT/B`- M"B`@("`@("`@("`\+W1D/B`@#0H@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO M=W)A<"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4 M+4%,24=..B!L969T)SX@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@ M("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXH.3DL-3`R/"]F;VYT/B`-"B`@ M("`@("`@("`\+W1D/B`@#0H@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A M<"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4+4%, M24=..B!L969T)SX@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$ M25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O M;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L M:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXH,3,S+#@W,CPO9F]N=#X@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@ M("`@("`\=&0@;F]W6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O M;&ED.R!415A4+4%,24=..B!L969T)SX@("`-"B`@("`@("`@("`@(#QF;VYT M('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXI/"]F;VYT/B`@("`@#0H@ M("`@("`@("`@/"]T9#X@(`T*("`@("`@("`@(#QT9"!A;&EG;CTS1')I9VAT M('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)U!!1$1)3D6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T M('-O;&ED.R!415A4+4%,24=..B!L969T)SX@(`T*("`@("`@("`@("`@/&9O M;G0@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!4 M15A4+4%,24=..B!L969T)SX@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXI/"]F;VYT/B`@("`@#0H@("`@("`@ M("`@/"]T9#X@(`T*("`@("`@("`\+W1R/B`@("`@#0H@("`@("`@(#QT6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\ M+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@ M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4@6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXH,C(W+#$P.#PO9F]N=#X@(`T*("`@("`@("`@(#PO=&0^("`-"B`@ M("`@("`@("`\=&0@;F]W6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T M('-O;&ED.R!415A4+4%,24=..B!L969T)SX@("`-"B`@("`@("`@("`@(#QF M;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXI/"]F;VYT/B`@("`@ M#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@("`@(#QT9"!A;&EG;CTS1')I M9VAT('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)U!!1$1) M3D6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N M,7!T('-O;&ED.R!415A4+4%,24=..B!L969T)SX@(`T*("`@("`@("`@("`@ M/&9O;G0@2D@87-S970\+V9O;G0^("`@("`-"B`@("`@("`@("`@(#PO M9&EV/B`@("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@("`@(#QT9"!A M;&EG;CTS1')I9VAT('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE M/3-$)U!!1$1)3D6QE/3-$)T)/4D1%4BU"3U143TTZ M(&)L86-K(#(N-S5P="!D;W5B;&4[(%1%6%0M04Q)1TXZ(&QE9G0G/B`@("`- M"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXD/"]F;VYT/B`@("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@("`@ M(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0W)2!S='EL93TS1"="3U)$ M15(M0D]45$]-.B!B;&%C:R`R+C6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXH,RPV-CD\+V9O;G0^("`@("`-"B`@("`@("`@("`\ M+W1D/B`@#0H@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX] M,T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B M;&%C:R`R+C"<^("`@("`-"B`@("`@("`@ M("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\ M+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@ M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$ M)T)/4D1%4BU"3U143TTZ(&)L86-K(#(N-S5P="!D;W5B;&4[(%1%6%0M04Q) M1TXZ(')I9VAT)SX@("`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN M;&EN92<^-3DL.#8T/"]F;VYT/CPO9F]N=#X@("`@#0H@("`@("`@("`@/"]T M9#X@(`T*("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$ M8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF M(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@ M/"]T'0O:F%V87-C M3X-"B`@("`\=&%B;&4@ M8VQA'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$ M6QE/3-$ M)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN92<^665A6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@ M("`@/"]T"<^("`@("`-"B`@("`@("`@("`@("8C,38P.R`@(`T*("`@("`@("`@(#PO M=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$ M)U1%6%0M04Q)1TXZ(&-E;G1E"<^("`@ M("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@ M("`@("`@("`\=&0@8V]L6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`- M"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)U1%6%0M M04Q)1TXZ(&-E;G1E"<^("`@("`-"B`@ M("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF M(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@ M("`\=&0@8V]L6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SX\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI M;F4G/C(P,3,\+V9O;G0^/"]F;VYT/B`@("`-"B`@("`@("`@("`@(#PO9&EV M/B`@("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@("`@(#QT9"!N;W=R M87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)T)/4D1%4BU" M3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T)SX@ M(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^ M("`-"B`@("`@("`@("`\=&0@8V]L6QE/3-$)U1%6%0M04Q)1TXZ(&QE M9G0G/B`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\ M+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@ M8V]L6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@(`T*("`@("`@("`@ M("`@/&9O;G0@6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!- M05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1L M969T/B`@("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SY097)S;VYA;"!#87)E/"]F;VYT/B`@("`-"B`@("`@ M("`@("`@(#PO9&EV/B`@("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@ M("`@(#QT9"!A;&EG;CTS1')I9VAT('9A;&EG;CTS1&)O='1O;2!W:61T:#TS M1#$E/B`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I M;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@(`T*("`@("`@("`@("`@/&9O M;G0@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@ M("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI M;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`- M"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@ M("`@("`\=&0@86QI9VX],T1R:6=H="!V86QI9VX],T1B;W1T;VT@=VED=&@] M,T0Q)3X@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXD/"]F;VYT/B`@("`@ M#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B M;W1T;VT@=VED=&@],T0W)2!S='EL93TS1"=415A4+4%,24=..B!R:6=H="<^ M("`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@ M("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@ M("`@("`@/"]T6QE/3-$)U1%6%0M24Y$14Y4.B`P M<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM M4DE'2%0Z(#!P="<@86QI9VX],T1L969T/B`@("`@#0H@("`@("`@("`@("`@ M(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SY-961I8V%L/"]F M;VYT/B`@(`T*("`@("`@("`@("`@/"]D:78^("`@("`-"B`@("`@("`@("`\ M+W1D/B`@#0H@("`@("`@("`@/'1D(&%L:6=N/3-$6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@ M("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M M('=I9'1H/3-$,24@6QE/3-$)U1% M6%0M04Q)1TXZ(')I9VAT)SX@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL M93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M M04Q)1TXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@ M("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@86QI9VX],T1R:6=H="!V86QI M9VX],T1B;W1T;VT@=VED=&@],T0Q)3X@(`T*("`@("`@("`@("`@/&9O;G0@ M6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@ M("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXS+#`R."PV-3D\+V9O;G0^ M("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@("`@(#QT9"!N;W=R87`] M,T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U1% M6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@ M,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1L969T/B`@("`@#0H@ M("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SY0:&%R;6%C975T:6-A;#PO9F]N=#X@("`@(`T*("`@("`@("`@("`@/"]D M:78^("`@("`-"B`@("`@("`@("`\+W1D/B`@#0H@("`@("`@("`@/'1D(&%L M:6=N/3-$6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF M(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@ M("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@("`@#0H@ M("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/ M3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`-"B`@("`@ M("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V M,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\ M=&0@86QI9VX],T1R:6=H="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X@ M(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T* M("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T M=&]M('=I9'1H/3-$-R4@6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXY,38L.3(W/"]F;VYT/B`-"B`@("`@("`@("`\+W1D/B`@#0H@("`@ M("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@=VED M=&@],T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L969T)SX@("`@#0H@("`@ M("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M M1D%-24Q9.B!T:6UE"<^("`@("`- M"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@ M("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!4 M15A4+4%,24=..B!R:6=H="<^("`@#0H@("`@("`@("`@("`\9F]N="!S='EL M93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U14 M3TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T)SX@("`- M"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@ M("`@("`\=&0@86QI9VX],T1R:6=H="!V86QI9VX],T1B;W1T;VT@=VED=&@] M,T0Q)2!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,G!X)SX@("`@(`T*("`@ M("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`- M"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4@6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SX\9F]N="!S='EL93TS1"=$25-03$%9.B!I M;FQI;F4G/C$V-"PP,30\+V9O;G0^/"]F;VYT/B`@("`@#0H@("`@("`@("`@ M/"]T9#X@(`T*("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N M/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U1%6%0M04Q)1TXZ M(&QE9G0G/B`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`@ M(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O M;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@86QI M9VX],T1R:6=H="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X@(`T*("`@ M("`@("`@("`@/&9O;G0@6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@ M("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I M9'1H/3-$-R4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXQ M-2PU-CDL,#@R/"]F;VYT/B`@("`-"B`@("`@("`@("`\+W1D/B`@#0H@("`@ M("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@=VED M=&@],T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L969T)SX@("`@#0H@("`@ M("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M M1D%-24Q9.B!T:6UE6QE/3-$)U!!1$1)3D6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!4 M15A4+4%,24=..B!L969T)SX@(`T*("`@("`@("`@("`@/&9O;G0@"<^ M("`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`- M"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O M;&ED.R!415A4+4%,24=..B!R:6=H="<^("`@#0H@("`@("`@("`@("`\9F]N M="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE M6QE/3-$)U!!1$1)3D"<^("`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@ M(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H M/3-$,24@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K M(#(N-S5P="!D;W5B;&4[(%1%6%0M04Q)1TXZ(')I9VAT)SX@("`@(`T*("`@ M("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN92<^,3,L-#0Y+#8W.3PO9F]N M=#X\+V9O;G0^("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@("`@(#QT M9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@ M6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T* M("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@86QI9VX],T1R:6=H M="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=0041$24Y' M+4)/5%1/33H@-'!X)SX@("`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)U!!1$1)3D6QE/3-$ M)U1%6%0M04Q)1TXZ(&-E;G1E"<^(`T* M("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1) M4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z M(#!P="<@86QI9VX],T1C96YT97(^("`-"B`@("`@("`@("`@("`@/&9O;G0@ M6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SX\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI M;F4G/EEE87)S(&5N9&5D($1E8V5M8F5R(#,Q/"]F;VYT/BP\+V9O;G0^/"]F M;VYT/B`@("`@#0H@("`@("`@("`@("`\+V1I=CX@("`@(`T*("`@("`@("`@ M(#PO=&0^("`-"B`@("`@("`@("`\=&0@;F]W6QE/3-$)T)/4D1%4BU"3U143TTZ M(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T)SX@("`-"B`@ M("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF M(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@ M/"]T"<^("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@ M(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H M/3-$,24@6QE/3-$)U1%6%0M04Q)1TXZ M(&-E;G1E"<^(`T*("`@("`@("`@("`@ M/&9O;G0@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O M;&ED.R!415A4+4%,24=..B!C96YT97(G/B`@(`T*("`@("`@("`@("`@/&9O M;G0@6QE/3-$)T)/4D1% M4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T M)SX@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`- M"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SX\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[ M($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^ M("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@8V]L6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED M)SX@(`T*("`@("`@("`@("`@/&1I=B!S='EL93TS1"=415A4+4E.1$5.5#H@ M,'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE. M+5))1TA4.B`P<'0G(&%L:6=N/3-$8V5N=&5R/B`@#0H@("`@("`@("`@("`@ M(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX\9F]N="!S='EL M93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX\9F]N M="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE M6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T* M("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T M=&]M('=I9'1H/3-$,24^("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V M,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\ M=&0@8V]L6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@ M(#PO=&0^("`-"B`@("`@("`@("`\=&0@;F]W6QE/3-$)U1%6%0M04Q)1TXZ(&QE M9G0G/B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^ M("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^ M("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI M;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)V)A8VMG6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF M(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@ M("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXT+#6QE/3-$)U1% M6%0M04Q)1TXZ(&QE9G0G/B`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@("`@#0H@("`@ M("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`-"B`@("`@("`@ M("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\ M+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@ M86QI9VX],T1R:6=H="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0R)3X@(`T* M("`@("`@("`@("`@/&9O;G0@6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXD/"]F;VYT/B`@("`@#0H@("`@("`@ M("`@/"]T9#X@(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED M=&@],T0W)2!S='EL93TS1"=415A4+4%,24=..B!R:6=H="<^("`@(`T*("`@ M("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@ M("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXQ M+#,S-"PU,#$\+V9O;G0^("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@ M("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H M/3-$,24@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@(`T*("`@("`@("`@("`@/&9O M;G0@6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO M=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$ M,24@6QE/3-$)U1%6%0M04Q)1TXZ M(')I9VAT)SX@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-0 M3$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@(`T*("`@("`@("`@("`@ M/&9O;G0@6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@ M(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H M/3-$,24@6QE/3-$)U1%6%0M04Q) M1TXZ(')I9VAT)SX@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$ M25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1) M4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z M(#!P="<@86QI9VX],T1L969T/B`@("`@#0H@("`@("`@("`@("`@(#QF;VYT M('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SY#86YA9&$\+V9O;G0^("`- M"B`@("`@("`@("`@(#PO9&EV/B`@("`@#0H@("`@("`@("`@/"]T9#X@(`T* M("`@("`@("`@(#QT9"!A;&EG;CTS1')I9VAT('9A;&EG;CTS1&)O='1O;2!W M:61T:#TS1#$E/B`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-0 M3$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@(`T*("`@("`@("`@ M("`@/&9O;G0@6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@ M("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I M9'1H/3-$,24@6QE/3-$)U1%6%0M M04Q)1TXZ(')I9VAT)SX@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@(`T*("`@("`@ M("`@("`@/&9O;G0@6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@ M("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M M('=I9'1H/3-$,24@6QE/3-$)U1% M6%0M04Q)1TXZ(')I9VAT)SX@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL M93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@ M(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H M/3-$-R4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXW,#,L M,30R/"]F;VYT/B`-"B`@("`@("`@("`\+W1D/B`@#0H@("`@("`@("`@/'1D M(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S M='EL93TS1"=415A4+4%,24=..B!L969T)SX@("`@#0H@("`@("`@("`@("`\ M9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T M:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V M,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\ M=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@("`@#0H@("`@ M("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q) M1TXZ(&QE9G0G/B`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`@(#QF M;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^ M("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@86QI9VX] M,T1R:6=H="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X@(`T*("`@("`@ M("`@("`@/&9O;G0@6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@ M(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H M/3-$-R4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXM+2T\ M+V9O;G0^("`-"B`@("`@("`@("`\+W1D/B`@#0H@("`@("`@("`@/'1D(&YO M=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL M93TS1"=415A4+4%,24=..B!L969T)SX@("`@#0H@("`@("`@("`@("`\9F]N M="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE M6QE/3-$)V)A8VMG6QE/3-$)U1%6%0M04Q)1TXZ M(&QE9G0G/B`@(`T*("`@("`@("`@("`@/&9O;G0@6QE M/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`@(#QF;VYT M('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@ M(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$ M8F]T=&]M('=I9'1H/3-$,24^("`@#0H@("`@("`@("`@("`\9F]N="!S='EL M93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@(`T* M("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@ M(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M M04Q)1TXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@ M("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I M9'1H/3-$,24^("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-0 M3$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@(`T*("`@("`@("`@ M("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^ M("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N M/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@("`@#0H@("`@("`@("`@("`\ M9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T M:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE M9G0G/B`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1% M6%0M04Q)1TXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@ M("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@86QI9VX],T1R:6=H="!V M86QI9VX],T1B;W1T;VT@=VED=&@],T0R)3X@(`T*("`@("`@("`@("`@/&9O M;G0@6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`- M"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXX-38L,C@U/"]F;VYT M/B`-"B`@("`@("`@("`\+W1D/B`@#0H@("`@("`@("`@/'1D(&YO=W)A<#TS M1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=4 M15A4+4%,24=..B!L969T)SX@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL M93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^ M("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N M/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@("`@#0H@("`@("`@("`@("`\ M9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T M:6UE6QE/3-$)U!!1$1)3D6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[ M($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE' M2%0Z(#!P="<@86QI9VX],T1L969T/B`@("`@#0H@("`@("`@("`@("`@(#QF M;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SY/=&AE"<^("`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@ M("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I M9'1H/3-$,24@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L M86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!R:6=H="<^("`@#0H@("`@ M("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4 M+4%,24=..B!L969T)SX@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@ M("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@86QI9VX],T1R:6=H="!V86QI M9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=0041$24Y'+4)/5%1/ M33H@,G!X)SX@("`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T* M("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T M=&]M('=I9'1H/3-$-R4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX\9F]N="!S M='EL93TS1"=$25-03$%9.B!I;FQI;F4G/BTM+3PO9F]N=#X\+V9O;G0^(`T* M("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@;F]W6QE/3-$)T)/4D1% M4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T M)SX@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`- M"B`@("`@("`@("`\=&0@86QI9VX],T1R:6=H="!V86QI9VX],T1B;W1T;VT@ M=VED=&@],T0R)2!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,G!X)SX@("`@ M(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO M=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$ M-R4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX\9F]N="!S='EL93TS1"=$25-0 M3$%9.B!I;FQI;F4G/C$L-SDR+#,V-3PO9F]N=#X\+V9O;G0^("`-"B`@("`@ M("`@("`\+W1D/B`@#0H@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V M86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"="3U)$15(M0D]4 M5$]-.B!B;&%C:R`Q+C%P="!S;VQI9#L@5$585"U!3$E'3CH@;&5F="<^("`@ M#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[ M($9/3E0M1D%-24Q9.B!T:6UE"<^("`@("`-"B`@ M("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF M(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@ M("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4 M+4%,24=..B!R:6=H="<^("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U!!1$1)3D6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#(N-S5P M="!D;W5B;&4[(%1%6%0M04Q)1TXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`@ M(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXD/"]F;VYT/B`@ M("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@("`@(#QT9"!V86QI9VX] M,T1B;W1T;VT@=VED=&@],T0W)2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B M;&%C:R`R+C6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SX\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4G/C$S+#0T.2PV-SD\ M+V9O;G0^/"]F;VYT/B`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@ M("`\=&0@;F]W6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#(N-S5P="!D;W5B M;&4[(%1%6%0M04Q)1TXZ(&QE9G0G/B`@("`@#0H@("`@("`@("`@("`\9F]N M="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE M"<^("`@("`-"B`@("`@("`@("`@(#QF;VYT('-T M>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T* M("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T M=&]M('=I9'1H/3-$,24@6QE/3-$)T)/4D1%4BU"3U14 M3TTZ(&)L86-K(#(N-S5P="!D;W5B;&4[(%1%6%0M04Q)1TXZ(')I9VAT)SX@ M("`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN92<^,2PR,#6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#(N-S5P="!D M;W5B;&4[(%1%6%0M04Q)1TXZ(&QE9G0G/B`@("`@#0H@("`@("`@("`@("`\ M9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T M:6UE"<^("`@("`-"B`@("`@("`@("`@(#QF;VYT M('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@ M(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$ M8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T)/4D1%4BU" M3U143TTZ(&)L86-K(#(N-S5P="!D;W5B;&4[(%1%6%0M04Q)1TXZ(')I9VAT M)SX@("`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN92<^,34L M-#$V+#@Y,SPO9F]N=#X\+V9O;G0^("`@#0H@("`@("`@("`@/"]T9#X@(`T* M("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M M('=I9'1H/3-$,24@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\ M+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@ M86QI9VX],T1R:6=H="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL M93TS1"=0041$24Y'+4)/5%1/33H@-'!X)SX@("`@(`T*("`@("`@("`@("`@ M/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V M,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@/"]T M'0^/'1A8FQE(&-E;&QP861D:6YG/3-$ M,"!C96QL6QE/3-$)T9/3E0M M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@ M("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)U1%6%0M04Q)1TXZ M(&-E;G1E"<^("`@("`-"B`@("`@("`@ M("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\ M+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@ M8V]L6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`- M"B`@("`@("`@/"]T"<^("`@("`-"B`@("`@("`@("`@("8C,38P.R`@(`T*("`@("`@ M("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('-T M>6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E"<^("`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^ M("`-"B`@("`@("`@("`\=&0@8V]L6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO M=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$ M)U1%6%0M04Q)1TXZ(&-E;G1E"<^("`@ M("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@ M("`@("`@("`\=&0@8V]L6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`- M"B`@("`@("`@/"]T6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO M=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M/B`@#0H@("`@ M("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V M,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@/"]T M6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SY#=7-T;VUE6QE/3-$)U1%6%0M M04Q)1TXZ(&QE9G0G/B`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@("`@#0H@("`@("`@ M("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%- M24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`@ M(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O M;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@86QI M9VX],T1R:6=H="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X@(`T*("`@ M("`@("`@("`@/&9O;G0@6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXD/"]F;VYT/B`@("`@#0H@("`@("`@("`@ M/"]T9#X@(`T*("`@("`@("`@(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@] M,T0W)2!S='EL93TS1"=415A4+4%,24=..B!R:6=H="<^("`@(`T*("`@("`@ M("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SY#=7-T;VUE6QE/3-$)U1% M6%0M04Q)1TXZ(&QE9G0G/B`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`-"B`@("`@("`@ M("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\ M+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@ M86QI9VX],T1R:6=H="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X@(`T* M("`@("`@("`@("`@/&9O;G0@6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@ M("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M M('=I9'1H/3-$-R4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXX-38L,C@U/"]F;VYT/B`-"B`@("`@("`@("`\+W1D/B`@#0H@("`@("`@ M("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@=VED=&@] M,T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L969T)SX@("`@#0H@("`@("`@ M("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%- M24Q9.B!T:6UE6QE/3-$)V)A8VMG6QE/3-$ M)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5& M5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1J=7-T:69Y/B`@ M(`T*("`@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI M;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@ M(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H M/3-$-R4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXV,34L M.#DP/"]F;VYT/B`-"B`@("`@("`@("`\+W1D/B`@#0H@("`@("`@("`@/'1D M(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S M='EL93TS1"=415A4+4%,24=..B!L969T)SX@("`@#0H@("`@("`@("`@("`\ M9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T M:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V M,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\ M=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@("`@#0H@("`@ M("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M M1D%-24Q9.B!T:6UE3X@("`-"B`@("`@("`@("`@ M("`@/&9O;G0@6QE/3-$)U!! M1$1)3D6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K M(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T)SX@(`T*("`@("`@("`@ M("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN92<^-"PS,C(L,3`S M/"]F;VYT/CPO9F]N=#X@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@ M("`\=&0@;F]W6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED M.R!415A4+4%,24=..B!L969T)SX@("`-"B`@("`@("`@("`@(#QF;VYT('-T M>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T* M("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@86QI9VX],T1R:6=H M="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=0041$24Y' M+4)/5%1/33H@,G!X)SX@("`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^ M("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N M/3-$8F]T=&]M('=I9'1H/3-$-R4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX\ M9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4G/C0L-#$W+#(Q,3PO9F]N M=#X\+V9O;G0^("`-"B`@("`@("`@("`\+W1D/B`@#0H@("`@("`@("`@/'1D M(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S M='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`Q+C%P="!S;VQI9#L@5$58 M5"U!3$E'3CH@;&5F="<^("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)V)A8VMG6QE/3-$ M)U!!1$1)3D6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L M86-K(#(N-S5P="!D;W5B;&4[(%1%6%0M04Q)1TXZ(&QE9G0G/B`@("`-"B`@ M("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXD M/"]F;VYT/B`@("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@("`@(#QT M9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0W)2!S='EL93TS1"="3U)$15(M M0D]45$]-.B!B;&%C:R`R+C6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SX\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4G/C$S M+#0T.2PV-SD\+V9O;G0^/"]F;VYT/B`@(`T*("`@("`@("`@(#PO=&0^("`- M"B`@("`@("`@("`\=&0@;F]W6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#(N M-S5P="!D;W5B;&4[(%1%6%0M04Q)1TXZ(&QE9G0G/B`@("`@#0H@("`@("`@ M("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%- M24Q9.B!T:6UE"<^("`@("`-"B`@("`@("`@("`@ M(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O M;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L M:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T)/ M4D1%4BU"3U143TTZ(&)L86-K(#(N-S5P="!D;W5B;&4[(%1%6%0M04Q)1TXZ M(')I9VAT)SX@("`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN M92<^,34L-#$V+#@Y,SPO9F]N=#X\+V9O;G0^("`@#0H@("`@("`@("`@/"]T M9#X@(`T*("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$ M8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF M(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@ M/"]T'0O:F%V87-C M3X-"B`@("`\=&%B;&4@ M8VQA'0^/'1A8FQE(&-E;&QP861D:6YG/3-$,"!C96QL6QE/3-$)T9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K M(#$N,7!T('-O;&ED)SX@("`-"B`@("`@("`@("`@(#QD:78@6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SX\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E"<^(`T*("`@("`@("`@("`@ M/&9O;G0@6QE M/3-$)U1%6%0M04Q)1TXZ(&-E;G1E6QE/3-$)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX\9F]N="!S M='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)V)A8VMG#PO9F]N=#X@#0H@("`@("`@("`@("`\+V1I=CX@("`@(`T*("`@ M("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@86QI9VX],T1R:6=H="!V M86QI9VX],T1B;W1T;VT@=VED=&@],T0Q,"4^("`@#0H@("`@("`@("`@("`\ M9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T M:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE M9G0G/B`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXQ,S(L,3(S/"]F;VYT M/B`-"B`@("`@("`@("`\+W1D/B`@#0H@("`@("`@("`@/'1D(&YO=W)A<#TS M1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=4 M15A4+4%,24=..B!L969T)SX@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL M93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^ M("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N M/3-$8F]T=&]M('=I9'1H/3-$,24@6QE M/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@("`@(`T*("`@("`@("`@("`@/&9O M;G0@6QE/3-$)U1% M6%0M04Q)1TXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@ M("`@("`@(#PO=&0^("`-"B`@("`@("`@/"]T#PO9F]N=#X@(`T*("`@ M("`@("`@("`@/"]D:78^("`@("`-"B`@("`@("`@("`\+W1D/B`@#0H@("`@ M("`@("`@/'1D(&%L:6=N/3-$6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O M;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L M:6=N/3-$8F]T=&]M('=I9'1H/3-$,3`E('-T>6QE/3-$)U1%6%0M04Q)1TXZ M(')I9VAT)SX@("`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G M/B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`- M"B`@("`@("`@("`\=&0@86QI9VX],T1R:6=H="!V86QI9VX],T1B;W1T;VT@ M=VED=&@],T0Q)3X@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\ M+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@ M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,3`E('-T>6QE/3-$)U1%6%0M04Q) M1TXZ(')I9VAT.R!415A4+4E.1$5.5#H@,'!T.R!-05)'24XM3$5&5#H@,'!T M.R!-05)'24XM4DE'2%0Z(#!P="<^("`@("`-"B`@("`@("`@("`@(#QF;VYT M('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXH-C4L-3,Q/"]F;VYT/B`- M"B`@("`@("`@("`\+W1D/B`@#0H@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO M=W)A<"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4 M+4%,24=..B!L969T)SX@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$ M)U1%6%0M04Q)1TXZ(&QE9G0[(%!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO M=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$ M,24@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED M.R!415A4+4%,24=..B!L969T)SX@("`-"B`@("`@("`@("`@(#QF;VYT('-T M>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXI/"]F;VYT/B`@("`@#0H@("`@ M("`@("`@/"]T9#X@(`T*("`@("`@("`@(#QT9"!A;&EG;CTS1')I9VAT('9A M;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E('-T>6QE/3-$)U!!1$1)3D6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O M;&ED.R!415A4+4%,24=..B!L969T)SX@(`T*("`@("`@("`@("`@/&9O;G0@ M6QE M/3-$)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@ M(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$ M8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T1)4U!,05DZ(&EN;&EN92<^,C4Y+#@V M.3PO9F]N=#X\+V9O;G0^("`@("`-"B`@("`@("`@("`\+W1D/B`@#0H@("`@ M("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@=VED M=&@],T0Q)2!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`R+C6QE/3-$ M)U!!1$1)3D6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L M86-K(#(N-S5P="!D;W5B;&4[(%1%6%0M04Q)1TXZ(&QE9G0G/B`@("`-"B`@ M("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXD M/"]F;VYT/B`@("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@("`@(#QT M9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q,"4@6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SX\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4G/C$S,BPQ M,C,\+V9O;G0^/"]F;VYT/B`@("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@ M("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I M9'1H/3-$,24@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O M;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@/"]T'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'!E;G-E'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'1A8FQE(&-E;&QP861D:6YG/3-$,"!C M96QL6QE/3-$)T9/3E0M1D%- M24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4 M+4%,24=..B!C96YT97(G/B`-"B`@("`@("`@("`@(#QD:78@6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SX\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4G/C(P,30\ M+V9O;G0^/"]F;VYT/B`@("`-"B`@("`@("`@("`@(#PO9&EV/B`@("`@#0H@ M("`@("`@("`@/"]T9#X@(`T*("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R M87`@=F%L:6=N/3-$8F]T=&]M('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L M86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=..B!L969T)SX@(`T*("`@("`@ M("`@("`@/&9O;G0@6QE/3-$ M)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O;&ED.R!415A4+4%,24=. M.B!C96YT97(G/B`-"B`@("`@("`@("`@(#QD:78@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SX\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4G/C(P,3,\+V9O;G0^ M/"]F;VYT/B`@("`-"B`@("`@("`@("`@(#PO9&EV/B`@("`@#0H@("`@("`@ M("`@/"]T9#X@(`T*("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L M:6=N/3-$8F]T=&]M('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N M,7!T('-O;&ED.R!415A4+4%,24=..B!L969T)SX@(`T*("`@("`@("`@("`@ M/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V M,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\ M=&0@8V]L6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@(`T*("`@("`@ M("`@("`@/&9O;G0@6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@ M("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@8V]L6QE/3-$)U1% M6%0M04Q)1TXZ(&QE9G0G/B`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T M.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1L969T/B`@("`@#0H@("`@ M("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SY" M;VYU6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^ M("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N M/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXR,C4L,#`P/"]F;VYT/B`- M"B`@("`@("`@("`\+W1D/B`@#0H@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO M=W)A<"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4 M+4%,24=..B!L969T)SX@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@ M(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$ M8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXR-3`L,#`P/"]F;VYT/B`-"B`@ M("`@("`@("`\+W1D/B`@#0H@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A M<"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4+4%, M24=..B!L969T)SX@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$ M25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@ M("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M M('=I9'1H/3-$-R4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXR,#,L-#@S/"]F;VYT/B`-"B`@("`@("`@("`\+W1D/B`@#0H@("`@("`@ M("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@=VED=&@] M,T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L969T)SX@("`@#0H@("`@("`@ M("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%- M24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@ M("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)SX@("`@ M#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[ M($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K M.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX] M,T1L969T/B`@("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SY087ER;VQL(&%N9"!R96QA=&5D(&5X<&5N6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@ M(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M M04Q)1TXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@ M("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@86QI9VX],T1R:6=H="!V86QI M9VX],T1B;W1T;VT@=VED=&@],T0Q)3X@(`T*("`@("`@("`@("`@/&9O;G0@ M6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@ M("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXQ,#0L,SDT/"]F;VYT/B`- M"B`@("`@("`@("`\+W1D/B`@#0H@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO M=W)A<"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4 M+4%,24=..B!L969T)SX@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE'!E;G-E6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@(`T*("`@("`@("`@("`@/&9O M;G0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@ M("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@ M("`@("`@("`\=&0@86QI9VX],T1R:6=H="!V86QI9VX],T1B;W1T;VT@=VED M=&@],T0Q)3X@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O M;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L M:6=N/3-$8F]T=&]M('=I9'1H/3-$-R4@6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SXV-BPP,#`\+V9O;G0^("`@("`-"B`@("`@("`@("`\ M+W1D/B`@#0H@("`@("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX] M,T1B;W1T;VT@=VED=&@],T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L969T M)SX@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I M;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)V)A M8VMG6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@ M("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$8F]T=&]M M('=I9'1H/3-$,24@6QE/3-$)U1% M6%0M04Q)1TXZ(')I9VAT)SX@("`@#0H@("`@("`@("`@("`\9F]N="!S='EL M93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@ M(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1% M6%0M04Q)1TXZ(&QE9G0G/B`@("`-"B`@("`@("`@("`@(#QF;VYT('-T>6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@(`T*("`@ M("`@("`@(#PO=&0^("`-"B`@("`@("`@/"]T6QE M/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM M3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1L969T/B`@ M("`@#0H@("`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SY386QE6QE/3-$ M)U1%6%0M04Q)1TXZ(&QE9G0G/B`@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/B`@("`-"B`@ M("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF M(S$V,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@ M("`\=&0@86QI9VX],T1R:6=H="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q M)3X@(`T*("`@("`@("`@("`@/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^("`@ M(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\=&0@=F%L:6=N/3-$ M8F]T=&]M('=I9'1H/3-$-R4@6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SXM+2T\+V9O;G0^("`-"B`@("`@("`@("`\+W1D/B`@#0H@("`@ M("`@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!V86QI9VX],T1B;W1T;VT@=VED M=&@],T0Q)2!S='EL93TS1"=415A4+4%,24=..B!L969T)SX@("`@#0H@("`@ M("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M M1D%-24Q9.B!T:6UE6QE/3-$)V)A8VMG"<^("`@("`-"B`@("`@("`@("`@(#QD:78@6QE/3-$)U!!1$1) M3D6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N M,7!T('-O;&ED.R!415A4+4%,24=..B!L969T)SX@(`T*("`@("`@("`@("`@ M/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN92<^,S@L-SDQ/"]F;VYT M/CPO9F]N=#X@("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@("`@(#QT M9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@ M6QE/3-$)U!!1$1)3D6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#$N,7!T('-O M;&ED.R!415A4+4%,24=..B!L969T)SX@(`T*("`@("`@("`@("`@/&9O;G0@ M6QE/3-$)T1)4U!,05DZ(&EN;&EN92<^,S6QE M/3-$)U!!1$1)3D6QE/3-$)T)/4D1%4BU"3U143TTZ M(&)L86-K(#(N-S5P="!D;W5B;&4[(%1%6%0M04Q)1TXZ(&QE9G0G/B`@("`- M"B`@("`@("`@("`@(#QF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SXD/"]F;VYT/B`@("`@#0H@("`@("`@("`@/"]T9#X@(`T*("`@("`@("`@ M(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0W)2!S='EL93TS1"="3U)$ M15(M0D]45$]-.B!B;&%C:R`R+C6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SX\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4G M/C@S,RPX-3D\+V9O;G0^/"]F;VYT/B`@("`@#0H@("`@("`@("`@/"]T9#X@ M(`T*("`@("`@("`@(#QT9"!N;W=R87`],T1N;W=R87`@=F%L:6=N/3-$8F]T M=&]M('=I9'1H/3-$,24@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V M,#L\+V9O;G0^("`@(`T*("`@("`@("`@(#PO=&0^("`-"B`@("`@("`@("`\ M=&0@86QI9VX],T1R:6=H="!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!S M='EL93TS1"=0041$24Y'+4)/5%1/33H@-'!X)SX@("`@(`T*("`@("`@("`@ M("`@/&9O;G0@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L M86-K(#(N-S5P="!D;W5B;&4[(%1%6%0M04Q)1TXZ(&QE9G0G/B`@("`@#0H@ M("`@("`@("`@("`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/ M3E0M1D%-24Q9.B!T:6UE3X-"CPO:'1M M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\V835D9F,S-E\T,6,W7S1A-C!?.#=F M-5\Y,65A9C$Y96-C96$-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO M-F$U9&9C,S9?-#%C-U\T838P7S@W9C5?.3%E868Q.65C8V5A+U=O'0O:'1M;#L@8VAA M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S&5S(%!A:60\+W1D/@T*("`@ M("`@("`\=&0@8VQA'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@ M("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$F5D(%1A>"!"96YE9FET"!096YA;'1I M97,@86YD($EN=&5R97-T($%C8W)U960\+W1D/@T*("`@("`@("`\=&0@8VQA M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T* M("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R M(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$2!O9B!3:6=N M:69I8V%N="!!8V-O=6YT:6YG(%!O;&EC:65S("A$971A:6QS*2!;3&EN92!) M=&5M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R M/@T*("`@("`@/'1R(&-L87-S/3-$'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L M87-S/3-$2!O9B!3:6=N:69I8V%N="!!8V-O=6YT:6YG(%!O;&EC:65S("A$971A M:6QS*2!;3&EN92!)=&5M'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S M/3-$'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L M87-S/3-$2!O9B!3:6=N:69I8V%N="!!8V-O=6YT:6YG(%!O;&EC:65S("A$971A M:6QS*2!;3&EN92!)=&5MF5D M(%1R861E;6%R:R!296=I'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L M87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@ M("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@ M/'1R(&-L87-S/3-$2!O9B!3:6=N:69I8V%N="!!8V-O=6YT:6YG(%!O;&EC:65S M("A$971A:6QS*2!;3&EN92!)=&5M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$7!E.B!T97AT+VAT;6P[(&-H87)S M970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@ M:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M M;#L@8VAA2!O9B!3:6=N:69I8V%N="!!8V-O=6YT:6YG(%!O;&EC:65S("A$971A:6QS M*2`M(%!R;W!E2P@4&QA;G0L(&%N9"!%<75I<&UE;G0@57-E9G5L($QI M=F5S(%M,:6YE($ET96US73PO'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T* M("`@("`@/'1R(&-L87-S/3-$2P@<&QA;G0@86YD(&5Q=6EP;65N="!U M65A&EM=6T@6TUE;6)E2P@4&QA;G0L(&%N9"!%<75I<&UE;G0@ M57-E9G5L($QI=F5S(%M,:6YE($ET96US73PO'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$2P@<&QA;G0@86YD(&5Q M=6EP;65N="!U65A'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$2!O9B!3:6=N:69I8V%N="!!8V-O M=6YT:6YG(%!O;&EC:65S("A$971A:6QS*2`M(%!R;W!E'0^,C`@>65A'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R M(&-L87-S/3-$2!O9B!3:6=N:69I8V%N="!!8V-O=6YT:6YG(%!O;&EC:65S("A$ M971A:6QS*2`M(%!R;W!E'0^-R!Y96%R7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T* M#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O M;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAAF5D($=A:6X@*$QO7!E.B!T97AT+VAT;6P[(&-H M87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U% M5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O M:'1M;#L@8VAA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T* M("`@("`@/'1R(&-L87-S/3-$F5D($=A:6XO*$QO7!E.B!T97AT M+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^ M#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT M/3-$)W1E>'0O:'1M;#L@8VAA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@ M/'1R(&-L87-S/3-$3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\V835D9F,S-E\T M,6,W7S1A-C!?.#=F-5\Y,65A9C$Y96-C96$-"D-O;G1E;G0M3&]C871I;VXZ M(&9I;&4Z+R\O0SHO-F$U9&9C,S9?-#%C-U\T838P7S@W9C5?.3%E868Q.65C M8V5A+U=O'0O:'1M;#L@8VAA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R M/@T*("`@("`@/'1R(&-L87-S/3-$3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT M4&%R=%\V835D9F,S-E\T,6,W7S1A-C!?.#=F-5\Y,65A9C$Y96-C96$-"D-O M;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO-F$U9&9C,S9?-#%C-U\T838P M7S@W9C5?.3%E868Q.65C8V5A+U=O'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@ M("`@/'1R(&-L87-S/3-$'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R M(&-L87-S/3-$7!E.B!T97AT+VAT;6P[(&-H87)S M970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@ M:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M M;#L@8VAA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$"!R871E(&]F(#,T)3PO=&0^#0H@("`@ M("`@(#QT9"!C;&%S&5S(&%T('-T871U=&]R>2!F961E&5S+"!N970@;V8@1F5D97)A M;"!B96YE9FET/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B@T+#`P M,"D\"!B M96YE9FET/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B@R+CDP)2D\ M65A'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X- M"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP M92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA'!E;G-E'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$F5D(&=A:6X@;VX@;6%R:V5T86)L92!S96-U3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R M=%\V835D9F,S-E\T,6,W7S1A-C!?.#=F-5\Y,65A9C$Y96-C96$-"D-O;G1E M;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO-F$U9&9C,S9?-#%C-U\T838P7S@W M9C5?.3%E868Q.65C8V5A+U=O'0O:'1M;#L@8VAA65R($UA M=&-H:6YG($-O;G1R:6)U=&EO;BP@4&5R8V5N="!O9B!%;7!L;WEE97,G($=R M;W-S(%!A>3PO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S2!#;VYT65A65A2!#;VYT'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S65R($1I2!# M;VYT'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S65E&EM=6T@06YN=6%L($-O;G1R:6)U=&EO;G,@4&5R($5M<&QO>65E+"!! M;6]U;G0\+W1D/@T*("`@("`@("`\=&0@8VQA'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S M/3-$'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L M87-S/3-$'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L M87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@ M/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^,B!Y96%R'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R M/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$3X-"CPO:'1M;#X-"@T*+2TM+2TM M/5].97AT4&%R=%\V835D9F,S-E\T,6,W7S1A-C!?.#=F-5\Y,65A9C$Y96-C M96$-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO-F$U9&9C,S9?-#%C M-U\T838P7S@W9C5?.3%E868Q.65C8V5A+U=O'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S M/3-$7!E.B!T97AT+VAT;6P[(&-H M87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U% M5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O M:'1M;#L@8VAA'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$7!E.B!T97AT+VAT M;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@ M("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$ M)W1E>'0O:'1M;#L@8VAA'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L M87-S/3-$'1E'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@ M/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$3X-"CPO M:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\V835D9F,S-E\T,6,W7S1A-C!? M.#=F-5\Y,65A9C$Y96-C96$-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O M0SHO-F$U9&9C,S9?-#%C-U\T838P7S@W9C5?.3%E868Q.65C8V5A+U=O'0O:'1M;#L@ M8VAA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T* M("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$ M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T* M("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$ M'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T* M("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R M(&-L87-S/3-$#PO=&0^#0H@("`@("`@(#QT9"!C;&%SF5D("AL;W-S*2]G86EN(&]N('-A;&4@;V8@'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L M87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R M/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@ M("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@ M("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@(#PO M=&%B;&4^#0H@(#PO8F]D>3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R M=%\V835D9F,S-E\T,6,W7S1A-C!?.#=F-5\Y,65A9C$Y96-C96$-"D-O;G1E M;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO-F$U9&9C,S9?-#%C-U\T838P7S@W M9C5?.3%E868Q.65C8V5A+U=O'0O:'1M;#L@8VAA'!E;G-E'!E;G-E7)O;&P@86YD(')E;&%T M960@97AP96YS97,\+W1D/@T*("`@("`@("`\=&0@8VQA'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA"!3 M97)V:6-E'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R M(&-L87-S/3-$2!43X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT M4&%R=%\V835D9F,S-E\T,6,W7S1A-C!?.#=F-5\Y,65A9C$Y96-C96$-"D-O M;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO-F$U9&9C,S9?-#%C-U\T838P M7S@W9C5?.3%E868Q.65C8V5A+U=O&UL#0I# M;VYT96YT+51R86YS9F5R+45N8V]D:6YG.B!Q=6]T960M<')I;G1A8FQE#0I# M;VYT96YT+51Y<&4Z('1E>'0O:'1M;#L@8VAA&UL;G,Z;STS1")U'1087)T7S9A-61F8S,V @7S0Q8S=?-&$V,%\X-V8U7SDQ96%F,3EE8V-E82TM#0H` ` end XML 20 R43.htm IDEA: XBRL DOCUMENT v2.4.1.9
Note H - Income From Damage Settlement (Details) (USD $)
 12 Months Ended
Dec. 31, 2014
Dec. 31, 2013
Dec. 31, 2012
Mar. 31, 2013
Note H - Income From Damage Settlement (Details) [Line Items]        
Other Receivables, Net, Current   $ 48,805us-gaap_OtherReceivablesNetCurrent    
Damage Settlement [Member]        
Note H - Income From Damage Settlement (Details) [Line Items]        
Other Receivables, Net, Current     518,050us-gaap_OtherReceivablesNetCurrent
/ us-gaap_GainContingenciesByNatureAxis
= ug_DamageSettlementMember		  
Proceeds from Legal Settlements 24,403us-gaap_ProceedsFromLegalSettlements
/ us-gaap_GainContingenciesByNatureAxis
= ug_DamageSettlementMember		 1,070,561us-gaap_ProceedsFromLegalSettlements
/ us-gaap_GainContingenciesByNatureAxis
= ug_DamageSettlementMember		    
Damage Settlement Monthly [Member]        
Note H - Income From Damage Settlement (Details) [Line Items]        
Other Receivables, Net, Current       97,610us-gaap_OtherReceivablesNetCurrent
/ us-gaap_GainContingenciesByNatureAxis
= ug_DamageSettlementMonthlyMember
Damage Settlement Two Months [Member]        
Note H - Income From Damage Settlement (Details) [Line Items]        
Other Receivables, Net, Current   48,805us-gaap_OtherReceivablesNetCurrent
/ us-gaap_GainContingenciesByNatureAxis
= ug_DamageSettlementTwoMonthsMember		    
Damage Settlement Third Month [Member]        
Note H - Income From Damage Settlement (Details) [Line Items]        
Other Receivables, Net, Current   $ 24,403us-gaap_OtherReceivablesNetCurrent
/ us-gaap_GainContingenciesByNatureAxis
= ug_DamageSettlementThirdMonthMember		    

XML 21 R29.htm IDEA: XBRL DOCUMENT v2.4.1.9
Note B - Marketable Securities (Details) (USD $)
 12 Months Ended
Dec. 31, 2014
Dec. 31, 2013
Investments, Debt and Equity Securities [Abstract]    
Proceeds from Sale and Maturity of Marketable Securities $ 3,077,588us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities $ 4,139,018us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities
Marketable Securities, Realized Gain (Loss) $ (25,127)us-gaap_MarketableSecuritiesRealizedGainLoss $ 18,675us-gaap_MarketableSecuritiesRealizedGainLoss
XML 22 R28.htm IDEA: XBRL DOCUMENT v2.4.1.9
Note A - Nature of Business and Summary of Significant Accounting Policies (Details) - Property, Plant, and Equipment Useful Lives
 12 Months Ended
Dec. 31, 2014
Factory Equipment and Fixtures [Member] | Minimum [Member]  
Note A - Nature of Business and Summary of Significant Accounting Policies (Details) - Property, Plant, and Equipment Useful Lives [Line Items]  
Property, plant and equipment useful lives 5 years
Factory Equipment and Fixtures [Member] | Maximum [Member]  
Note A - Nature of Business and Summary of Significant Accounting Policies (Details) - Property, Plant, and Equipment Useful Lives [Line Items]  
Property, plant and equipment useful lives 7 years
Building [Member]  
Note A - Nature of Business and Summary of Significant Accounting Policies (Details) - Property, Plant, and Equipment Useful Lives [Line Items]  
Property, plant and equipment useful lives 40 years
Building Improvements [Member] | Maximum [Member]  
Note A - Nature of Business and Summary of Significant Accounting Policies (Details) - Property, Plant, and Equipment Useful Lives [Line Items]  
Property, plant and equipment useful lives 20 years
Waste Disposal System [Member]  
Note A - Nature of Business and Summary of Significant Accounting Policies (Details) - Property, Plant, and Equipment Useful Lives [Line Items]  
Property, plant and equipment useful lives 7 years
XML 23 R44.htm IDEA: XBRL DOCUMENT v2.4.1.9
Note I - Accrued Expenses (Details) - Accrued Expenses (USD $)
Dec. 31, 2014
Dec. 31, 2013
Note I - Accrued Expenses (Details) - Accrued Expenses [Line Items]    
Bonuses $ 225,000us-gaap_AccruedBonusesCurrent $ 250,000us-gaap_AccruedBonusesCurrent
Distribution fees 203,483ug_AccruedDistributionFeesCurrent 196,558ug_AccruedDistributionFeesCurrent
Payroll and related expenses 127,585us-gaap_AccruedSalariesCurrent 104,394us-gaap_AccruedSalariesCurrent
Sales rebates 96,000us-gaap_AccruedMarketingCostsCurrent  
Other 38,791us-gaap_OtherAccruedLiabilitiesCurrent 37,794us-gaap_OtherAccruedLiabilitiesCurrent
833,859us-gaap_AccruedLiabilitiesCurrent 728,015us-gaap_AccruedLiabilitiesCurrent
Accrued Annual Report [Member]    
Note I - Accrued Expenses (Details) - Accrued Expenses [Line Items]    
Accrued professional fees 61,000us-gaap_AccruedProfessionalFeesCurrentAndNoncurrent
/ us-gaap_FairValueByLiabilityClassAxis
= ug_AccruedAnnualReportMember		 66,000us-gaap_AccruedProfessionalFeesCurrentAndNoncurrent
/ us-gaap_FairValueByLiabilityClassAxis
= ug_AccruedAnnualReportMember
Accrued Audit Fee [Member]    
Note I - Accrued Expenses (Details) - Accrued Expenses [Line Items]    
Accrued professional fees $ 82,000us-gaap_AccruedProfessionalFeesCurrentAndNoncurrent
/ us-gaap_FairValueByLiabilityClassAxis
= ug_AccruedAuditFeeMember		 $ 73,269us-gaap_AccruedProfessionalFeesCurrentAndNoncurrent
/ us-gaap_FairValueByLiabilityClassAxis
= ug_AccruedAuditFeeMember
XML 24 R30.htm IDEA: XBRL DOCUMENT v2.4.1.9
Note B - Marketable Securities (Details) - Available-For-Sale Securities (USD $)
 12 Months Ended
Dec. 31, 2014
Dec. 31, 2013
Available for sale:    
Cost $ 8,995,760us-gaap_AvailableForSaleSecuritiesAmortizedCost $ 8,660,997us-gaap_AvailableForSaleSecuritiesAmortizedCost
Fair Value 9,389,501us-gaap_AvailableForSaleSecuritiesCurrent 8,863,205us-gaap_AvailableForSaleSecuritiesCurrent
Unrealized Gain/(Loss) 393,741us-gaap_AvailableforsaleSecuritiesGrossUnrealizedGainLoss1 202,208us-gaap_AvailableforsaleSecuritiesGrossUnrealizedGainLoss1
Fixed Income Mutual Funds [Member]    
Available for sale:    
Cost 8,373,674us-gaap_AvailableForSaleSecuritiesAmortizedCost
/ us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis
= ug_FixedIncomeMutualFundsMember		 7,325,930us-gaap_AvailableForSaleSecuritiesAmortizedCost
/ us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis
= ug_FixedIncomeMutualFundsMember
Fair Value 8,575,285us-gaap_AvailableForSaleSecuritiesCurrent
/ us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis
= ug_FixedIncomeMutualFundsMember		 7,425,687us-gaap_AvailableForSaleSecuritiesCurrent
/ us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis
= ug_FixedIncomeMutualFundsMember
Unrealized Gain/(Loss) 201,611us-gaap_AvailableforsaleSecuritiesGrossUnrealizedGainLoss1
/ us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis
= ug_FixedIncomeMutualFundsMember		 99,757us-gaap_AvailableforsaleSecuritiesGrossUnrealizedGainLoss1
/ us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis
= ug_FixedIncomeMutualFundsMember
Equity And Other Mutual Funds [Member]    
Available for sale:    
Cost 622,086us-gaap_AvailableForSaleSecuritiesAmortizedCost
/ us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis
= ug_EquityAndOtherMutualFundsMember		 1,131,147us-gaap_AvailableForSaleSecuritiesAmortizedCost
/ us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis
= ug_EquityAndOtherMutualFundsMember
Fair Value 814,216us-gaap_AvailableForSaleSecuritiesCurrent
/ us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis
= ug_EquityAndOtherMutualFundsMember		 1,237,465us-gaap_AvailableForSaleSecuritiesCurrent
/ us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis
= ug_EquityAndOtherMutualFundsMember
Unrealized Gain/(Loss) 192,130us-gaap_AvailableforsaleSecuritiesGrossUnrealizedGainLoss1
/ us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis
= ug_EquityAndOtherMutualFundsMember		 106,318us-gaap_AvailableforsaleSecuritiesGrossUnrealizedGainLoss1
/ us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis
= ug_EquityAndOtherMutualFundsMember
Corporate Debt Securities [Member]    
Available for sale:    
Cost   203,920us-gaap_AvailableForSaleSecuritiesAmortizedCost
/ us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis
= us-gaap_CorporateDebtSecuritiesMember
Fair Value   200,053us-gaap_AvailableForSaleSecuritiesCurrent
/ us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis
= us-gaap_CorporateDebtSecuritiesMember
Unrealized Gain/(Loss)   $ (3,867)us-gaap_AvailableforsaleSecuritiesGrossUnrealizedGainLoss1
/ us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis
= us-gaap_CorporateDebtSecuritiesMember
XML 25 R31.htm IDEA: XBRL DOCUMENT v2.4.1.9
Note C - Inventories (Details) (USD $)
Dec. 31, 2014
Dec. 31, 2013
Inventory Disclosure [Abstract]    
Inventory Valuation Reserves $ 20,000us-gaap_InventoryValuationReserves $ 20,000us-gaap_InventoryValuationReserves
XML 26 R8.htm IDEA: XBRL DOCUMENT v2.4.1.9
Statements of Cash Flows (USD $)
 12 Months Ended
Dec. 31, 2014
Dec. 31, 2013
Cash flows from operating activities:    
Net income $ 4,050,416us-gaap_NetIncomeLoss $ 5,903,309us-gaap_NetIncomeLoss
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization 181,188us-gaap_DepreciationDepletionAndAmortization 189,729us-gaap_DepreciationDepletionAndAmortization
Realized loss (gain) on sales of marketable securities 25,127us-gaap_MarketableSecuritiesRealizedGainLoss (18,675)us-gaap_MarketableSecuritiesRealizedGainLoss
Increase (decrease) in allowance for bad debts 12,325us-gaap_ProvisionForDoubtfulAccounts (11,089)us-gaap_ProvisionForDoubtfulAccounts
Deferred income taxes (254)us-gaap_DeferredIncomeTaxExpenseBenefit (12,161)us-gaap_DeferredIncomeTaxExpenseBenefit
Increase (decrease) in cash resulting from changes in operating assets and liabilities:    
Accounts receivable 185,162us-gaap_IncreaseDecreaseInAccountsReceivable (762,031)us-gaap_IncreaseDecreaseInAccountsReceivable
Receivable from damage settlement 48,805us-gaap_IncreaseDecreaseInOtherReceivables 469,245us-gaap_IncreaseDecreaseInOtherReceivables
Inventories 373,593us-gaap_IncreaseDecreaseInInventories (367,997)us-gaap_IncreaseDecreaseInInventories
Prepaid expenses and other current and non-current assets (94,585)us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets (6,690)us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
Prepaid income taxes (30,643)us-gaap_IncreaseDecreaseInPrepaidTaxes 3,602us-gaap_IncreaseDecreaseInPrepaidTaxes
Accounts payable (244,588)us-gaap_IncreaseDecreaseInAccountsPayable 234,314us-gaap_IncreaseDecreaseInAccountsPayable
Accrued expenses and taxes payable (25,794)us-gaap_IncreaseDecreaseInAccruedLiabilities 183,530us-gaap_IncreaseDecreaseInAccruedLiabilities
Net cash provided by operating activities 4,480,752us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations 5,805,086us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
Cash flows from investing activities:    
Acquisitions of plant and equipment (54,590)us-gaap_PaymentsToAcquirePropertyPlantAndEquipment (288,367)us-gaap_PaymentsToAcquirePropertyPlantAndEquipment
Purchases of marketable securities (3,437,478)us-gaap_PaymentsToAcquireMarketableSecurities (5,311,313)us-gaap_PaymentsToAcquireMarketableSecurities
Proceeds from sales of marketable securities 3,077,588us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities 4,139,018us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities
Net cash used in investing activities (414,480)us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations (1,460,662)us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
Cash flows from financing activities:    
Dividends paid (3,677,151)us-gaap_PaymentsOfDividends (4,458,544)us-gaap_PaymentsOfDividends
Net cash used in financing activities (3,677,151)us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations (4,458,544)us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
Net increase (decrease) in cash and cash equivalents 389,121us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease (114,120)us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease
Cash and cash equivalents, beginning of year 1,634,262us-gaap_CashAndCashEquivalentsAtCarryingValue 1,748,382us-gaap_CashAndCashEquivalentsAtCarryingValue
Cash and cash equivalents, end of year $ 2,023,383us-gaap_CashAndCashEquivalentsAtCarryingValue $ 1,634,262us-gaap_CashAndCashEquivalentsAtCarryingValue
XML 27 R32.htm IDEA: XBRL DOCUMENT v2.4.1.9
Note C - Inventories (Details) - Inventories (USD $)
Dec. 31, 2014
Dec. 31, 2013
Inventories [Abstract]    
Raw materials and work-in-process $ 395,092us-gaap_InventoryWorkInProcessAndRawMaterialsNetOfReserves $ 488,757us-gaap_InventoryWorkInProcessAndRawMaterialsNetOfReserves
Finished products 842,062us-gaap_InventoryFinishedGoodsNetOfReserves 1,121,990us-gaap_InventoryFinishedGoodsNetOfReserves
$ 1,237,154us-gaap_InventoryNet $ 1,610,747us-gaap_InventoryNet
XML 28 R40.htm IDEA: XBRL DOCUMENT v2.4.1.9
Note F - Geographic and Other Information (Details) - Geographic Information (USD $)
 12 Months Ended
Dec. 31, 2014
Dec. 31, 2013
Revenues from External Customers and Long-Lived Assets [Line Items]    
Revenues $ 13,449,679us-gaap_SalesRevenueNet $ 15,416,893us-gaap_SalesRevenueNet
Long-Lived Assets 1,207,903us-gaap_PropertyPlantAndEquipmentNet 1,334,501us-gaap_PropertyPlantAndEquipmentNet
UNITED STATES    
Revenues from External Customers and Long-Lived Assets [Line Items]    
Revenues 4,723,779us-gaap_SalesRevenueNet
/ us-gaap_StatementGeographicalAxis
= country_US		 4,580,429us-gaap_SalesRevenueNet
/ us-gaap_StatementGeographicalAxis
= country_US
Long-Lived Assets 1,207,903us-gaap_PropertyPlantAndEquipmentNet
/ us-gaap_StatementGeographicalAxis
= country_US		 1,334,501us-gaap_PropertyPlantAndEquipmentNet
/ us-gaap_StatementGeographicalAxis
= country_US
CHINA    
Revenues from External Customers and Long-Lived Assets [Line Items]    
Revenues 3,500,955us-gaap_SalesRevenueNet
/ us-gaap_StatementGeographicalAxis
= country_CN		 3,519,450us-gaap_SalesRevenueNet
/ us-gaap_StatementGeographicalAxis
= country_CN
CANADA    
Revenues from External Customers and Long-Lived Assets [Line Items]    
Revenues 2,436,596us-gaap_SalesRevenueNet
/ us-gaap_StatementGeographicalAxis
= country_CA		 3,390,619us-gaap_SalesRevenueNet
/ us-gaap_StatementGeographicalAxis
= country_CA
UNITED KINGDOM    
Revenues from External Customers and Long-Lived Assets [Line Items]    
Revenues 703,142us-gaap_SalesRevenueNet
/ us-gaap_StatementGeographicalAxis
= country_GB		 846,730us-gaap_SalesRevenueNet
/ us-gaap_StatementGeographicalAxis
= country_GB
INDIA    
Revenues from External Customers and Long-Lived Assets [Line Items]    
Revenues 615,890us-gaap_SalesRevenueNet
/ us-gaap_StatementGeographicalAxis
= country_IN		 431,015us-gaap_SalesRevenueNet
/ us-gaap_StatementGeographicalAxis
= country_IN
FRANCE    
Revenues from External Customers and Long-Lived Assets [Line Items]    
Revenues 582,478us-gaap_SalesRevenueNet
/ us-gaap_StatementGeographicalAxis
= country_FR		 856,285us-gaap_SalesRevenueNet
/ us-gaap_StatementGeographicalAxis
= country_FR
Other Countries [Member]    
Revenues from External Customers and Long-Lived Assets [Line Items]    
Revenues $ 886,839us-gaap_SalesRevenueNet
/ us-gaap_StatementGeographicalAxis
= ug_OtherCountriesMember		 $ 1,792,365us-gaap_SalesRevenueNet
/ us-gaap_StatementGeographicalAxis
= ug_OtherCountriesMember
XML 29 R2.htm IDEA: XBRL DOCUMENT v2.4.1.9
Statements of Income (USD $)
 12 Months Ended
Dec. 31, 2014
Dec. 31, 2013
Net sales $ 13,449,679us-gaap_SalesRevenueNet $ 15,416,893us-gaap_SalesRevenueNet
Costs and expenses:    
Cost of sales 5,317,707us-gaap_CostOfRevenue 5,610,813us-gaap_CostOfRevenue
Operating expenses 2,640,997us-gaap_OperatingExpenses 2,504,526us-gaap_OperatingExpenses
Total costs and expenses 7,958,704us-gaap_CostsAndExpenses 8,115,339us-gaap_CostsAndExpenses
Income from operations 5,490,975us-gaap_OperatingIncomeLoss 7,301,554us-gaap_OperatingIncomeLoss
Other income:    
Investment income 239,592us-gaap_InvestmentIncomeNet 259,747us-gaap_InvestmentIncomeNet
Income from damage settlement 24,403us-gaap_OtherNonoperatingIncome 1,070,561us-gaap_OtherNonoperatingIncome
Total other income 263,995us-gaap_NonoperatingIncomeExpense 1,330,308us-gaap_NonoperatingIncomeExpense
Income from operations before income taxes 5,754,970us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments 8,631,862us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
Provision for income taxes 1,704,554us-gaap_IncomeTaxExpenseBenefit 2,728,553us-gaap_IncomeTaxExpenseBenefit
Net income $ 4,050,416us-gaap_NetIncomeLoss $ 5,903,309us-gaap_NetIncomeLoss
Earnings per common share (basic and diluted) (in Dollars per share) $ 0.88us-gaap_EarningsPerShareBasicAndDiluted $ 1.28us-gaap_EarningsPerShareBasicAndDiluted
Weighted average shares (basic and diluted) (in Shares) 4,596,439us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted 4,596,439us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted
XML 30 R45.htm IDEA: XBRL DOCUMENT v2.4.1.9
Note J - Related Party Transactions (Details) (Director [Member], Accounting and Tax Services [Member], USD $)
 12 Months Ended
Dec. 31, 2014
Dec. 31, 2013
Director [Member] | Accounting and Tax Services [Member]
    
Note J - Related Party Transactions (Details) [Line Items]    
Related Party Transaction, Expenses from Transactions with Related Party $ 17,000us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty
/ us-gaap_RelatedPartyTransactionAxis
= ug_AccountingAndTaxServicesMember
/ us-gaap_RelatedPartyTransactionsByRelatedPartyAxis
= us-gaap_DirectorMember		 $ 14,000us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty
/ us-gaap_RelatedPartyTransactionAxis
= ug_AccountingAndTaxServicesMember
/ us-gaap_RelatedPartyTransactionsByRelatedPartyAxis
= us-gaap_DirectorMember
XML 31 R6.htm IDEA: XBRL DOCUMENT v2.4.1.9
Statement Of Stockholders' Equity (USD $)
Common Stock [Member]
Accumulated Other Comprehensive Income (Loss) [Member]
Retained Earnings [Member]
Total
Balance at Dec. 31, 2012 $ 459,644us-gaap_StockholdersEquity
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_CommonStockMember		 $ 178,979us-gaap_StockholdersEquity
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_AccumulatedOtherComprehensiveIncomeMember		 $ 12,199,395us-gaap_StockholdersEquity
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_RetainedEarningsMember		 $ 12,838,018us-gaap_StockholdersEquity
Balance (Shares) (in Shares) at Dec. 31, 2012 4,596,439us-gaap_SharesOutstanding
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_CommonStockMember		      
Change in unrealized gains on marketable securities, net of deferred income tax   (46,856)us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_AccumulatedOtherComprehensiveIncomeMember		   (46,856)us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
Net income     5,903,309us-gaap_NetIncomeLoss
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_RetainedEarningsMember		 5,903,309us-gaap_NetIncomeLoss
Dividends declared     (4,458,544)us-gaap_Dividends
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_RetainedEarningsMember		 (4,458,544)us-gaap_Dividends
Balance at Dec. 31, 2013 459,644us-gaap_StockholdersEquity
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_CommonStockMember		 132,123us-gaap_StockholdersEquity
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_AccumulatedOtherComprehensiveIncomeMember		 13,644,160us-gaap_StockholdersEquity
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_RetainedEarningsMember		 14,235,927us-gaap_StockholdersEquity
Balance (Shares) (in Shares) at Dec. 31, 2013 4,596,439us-gaap_SharesOutstanding
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_CommonStockMember		      
Change in unrealized gains on marketable securities, net of deferred income tax   127,746us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_AccumulatedOtherComprehensiveIncomeMember		   127,746us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
Net income     4,050,416us-gaap_NetIncomeLoss
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_RetainedEarningsMember		 4,050,416us-gaap_NetIncomeLoss
Dividends declared     (3,677,151)us-gaap_Dividends
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_RetainedEarningsMember		 (3,677,151)us-gaap_Dividends
Balance at Dec. 31, 2014 $ 459,644us-gaap_StockholdersEquity
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_CommonStockMember		 $ 259,869us-gaap_StockholdersEquity
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_AccumulatedOtherComprehensiveIncomeMember		 $ 14,017,425us-gaap_StockholdersEquity
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_RetainedEarningsMember		 $ 14,736,938us-gaap_StockholdersEquity
Balance (Shares) (in Shares) at Dec. 31, 2014 4,596,439us-gaap_SharesOutstanding
/ us-gaap_StatementEquityComponentsAxis
= us-gaap_CommonStockMember		      
XML 32 R35.htm IDEA: XBRL DOCUMENT v2.4.1.9
Note D - Income Taxes (Details) - Reconciliation of the Effective Income Tax Rate (USD $)
 12 Months Ended
Dec. 31, 2014
Dec. 31, 2013
Reconciliation of the Effective Income Tax Rate [Abstract]    
Income taxes at statutory federal income tax rate of 34% $ 1,957,000us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate $ 2,935,000us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
Income taxes at statutory federal income tax rate of 34% 34.00%us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate 34.00%us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
State income taxes, net of Federal benefit (4,000)us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes 13,000us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes
State income taxes, net of Federal benefit (0.10%)us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes 0.20%us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
Domestic Production Activities tax benefit (168,000)us-gaap_IncomeTaxReconciliationDeductionsQualifiedProductionActivities (180,000)us-gaap_IncomeTaxReconciliationDeductionsQualifiedProductionActivities
Domestic Production Activities tax benefit (2.90%)us-gaap_EffectiveIncomeTaxRateReconciliationDeductionsQualifiedProductionActivities (2.10%)us-gaap_EffectiveIncomeTaxRateReconciliationDeductionsQualifiedProductionActivities
Nondeductible expenses 1,000us-gaap_IncomeTaxReconciliationNondeductibleExpense 1,000us-gaap_IncomeTaxReconciliationNondeductibleExpense
Prior year over-accrual (56,000)us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes (19,000)us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes
Prior year over-accrual (1.00%)us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes (0.20%)us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes
R&D credits (25,000)us-gaap_IncomeTaxReconciliationNondeductibleExpenseResearchAndDevelopment (20,000)us-gaap_IncomeTaxReconciliationNondeductibleExpenseResearchAndDevelopment
R&D credits (0.40%)us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopment (0.20%)us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopment
Other, misc.   (1,000)us-gaap_IncomeTaxReconciliationOtherAdjustments
Actual income tax expense $ 1,705,000ug_ActualIncomeTaxExpenseBenefit $ 2,729,000ug_ActualIncomeTaxExpenseBenefit
Actual income tax expense 29.60%us-gaap_EffectiveIncomeTaxRateContinuingOperations 31.70%us-gaap_EffectiveIncomeTaxRateContinuingOperations
XML 33 R22.htm IDEA: XBRL DOCUMENT v2.4.1.9
Note C - Inventories (Tables)
 12 Months Ended
Dec. 31, 2014
Inventory Disclosure [Abstract]  
Schedule of Inventory, Current [Table Text Block]
   
December 31,
 
   
2014
   
2013
 
             
Raw materials and work-in-process
  $ 395,092     $ 488,757  
Finished products
    842,062       1,121,990  
    $ 1,237,154     $ 1,610,747  
XML 34 R36.htm IDEA: XBRL DOCUMENT v2.4.1.9
Note D - Income Taxes (Details) - Deferred Tax Assets and Liabilities (USD $)
Dec. 31, 2014
Dec. 31, 2013
Current    
Accounts receivable $ 10,164us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts $ 6,089us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts
Inventories 14,037us-gaap_DeferredTaxAssetsInventory 16,862us-gaap_DeferredTaxAssetsInventory
Accrued expenses 199,238us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities 206,500us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
223,439us-gaap_DeferredTaxAssetsGross 229,451us-gaap_DeferredTaxAssetsGross
Non-current    
Depreciation (93,236)us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment (99,502)us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment
Unrealized gain on marketable securities (133,872)us-gaap_DeferredTaxLiabilitiesUnrealizedGainsOnTradingSecurities (70,085)us-gaap_DeferredTaxLiabilitiesUnrealizedGainsOnTradingSecurities
(227,108)us-gaap_DeferredIncomeTaxLiabilities (169,587)us-gaap_DeferredIncomeTaxLiabilities
Net deferred tax (liability) asset $ (3,669)us-gaap_DeferredTaxAssetsLiabilitiesNet $ 59,864us-gaap_DeferredTaxAssetsLiabilitiesNet
XML 35 R24.htm IDEA: XBRL DOCUMENT v2.4.1.9
Note F - Geographic and Other Information (Tables)
 12 Months Ended
Dec. 31, 2014
Segment Reporting [Abstract]  
Schedule of Segment Reporting Information, by Segment [Table Text Block]
   
Years ended December 31,
 
   
2014
   
2013
 
             
Personal Care
  $ 9,421,041     $ 11,459,482  
Medical
    2,494,205       3,028,659  
Pharmaceutical
    1,686,563       916,927  
Industrial and other
    169,486       164,014  
      13,771,295       15,569,082  
Less: Discounts and allowances
    (321,616 )     (152,189 )
    $ 13,449,679     $ 15,416,893  
Schedule of Revenue from External Customers and Long-Lived Assets, by Geographical Areas [Table Text Block]
   
Years ended December 31,
 
    2014     2013  
   
Revenues
   
Long-Lived
Assets
   
Revenues
   
Long-Lived
Assets
 
                         
United States 
  $ 4,723,779     $ 1,207,903     $ 4,580,429     $ 1,334,501  
China
    3,500,955       ---       3,519,450       ---  
Canada
    2,436,596       ---       3,390,619       ---  
United Kingdom
    703,142       ---       846,730       ---  
India
    615,890               431,015          
France 
    582,478       ---       856,285       ---  
Other countries 
    886,839       ---       1,792,365       ---  
    $ 13,449,679     $ 1,207,903     $ 15,416,893     $ 1,334,501  
Reconciliation of Other Significant Reconciling Items from Segments to Consolidated [Table Text Block]
    Years ended December 31,  
   
2014
   
2013
 
             
Customer A
  $ 7,929,208     $ 9,712,382  
Customer B
    582,478       856,285  
Customer C
    615,890       431,015  
All other customers
    4,322,103       4,417,211  
    $ 13,449,679     $ 15,416,893  
XML 36 Show.js IDEA: XBRL DOCUMENT /** * Rivet Software Inc. * * @copyright Copyright (c) 2006-2011 Rivet Software, Inc. All rights reserved. * Version 2.4.0.3 * */ var Show = {}; Show.LastAR = null, Show.hideAR = function(){ Show.LastAR.style.display = 'none'; }; Show.showAR = function ( link, id, win ){ if( Show.LastAR ){ Show.hideAR(); } var ref = link; do { ref = ref.nextSibling; } while (ref && ref.nodeName != 'TABLE'); if (!ref || ref.nodeName != 'TABLE') { var tmp = win ? win.document.getElementById(id) : document.getElementById(id); if( tmp ){ ref = tmp.cloneNode(true); ref.id = ''; link.parentNode.appendChild(ref); } } if( ref ){ ref.style.display = 'block'; Show.LastAR = ref; } }; Show.toggleNext = function( link ){ var ref = link; do{ ref = ref.nextSibling; }while( ref.nodeName != 'DIV' ); if( ref.style && ref.style.display && ref.style.display == 'none' ){ ref.style.display = 'block'; if( link.textContent ){ link.textContent = link.textContent.replace( '+', '-' ); }else{ link.innerText = link.innerText.replace( '+', '-' ); } }else{ ref.style.display = 'none'; if( link.textContent ){ link.textContent = link.textContent.replace( '-', '+' ); }else{ link.innerText = link.innerText.replace( '-', '+' ); } } }; XML 37 R7.htm IDEA: XBRL DOCUMENT v2.4.1.9
Statement Of Stockholders' Equity (Parentheticals) (USD $)
 12 Months Ended
Dec. 31, 2014
Dec. 31, 2013
Change in unrealized gains on marketable securities, deferred income tax benefit $ (63,787)us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax $ 24,855us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
XML 38 R3.htm IDEA: XBRL DOCUMENT v2.4.1.9
Statements of Comprehensive Income (USD $)
 12 Months Ended
Dec. 31, 2014
Dec. 31, 2013
Net income $ 4,050,416us-gaap_NetIncomeLoss $ 5,903,309us-gaap_NetIncomeLoss
Other comprehensive income (loss):    
Unrealized gain (loss) on marketable securities 191,533us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax (71,711)us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
Income tax (expense) benefit (63,787)us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax 24,855us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
Other comprehensive income (loss), net of tax 127,746us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax (46,856)us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
Comprehensive income $ 4,178,162us-gaap_ComprehensiveIncomeNetOfTax $ 5,856,453us-gaap_ComprehensiveIncomeNetOfTax
ZIP 39 0001171843-15-001673-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001171843-15-001673-xbrl.zip M4$L#!!0````(`&I\>D95PEOIP[4``$V$#0`/`!P`=6&UL M550)``-W7Q15=U\4575X"P`!!"4.```$.0$``.Q=67.CR)9^GXCY#QH_W)AY M<)E]<5Z; M[P!^9K\#%_X;?O_F^\OKJZL?/WY\TN&CGFZZP',"5P<>^J!W>=GOH3___5^? M$9&A"Q")Z][S6]"[U]P>)_58Z9IAKN%?OCT/>QS#BM&/X"\^7ERK][&P;._+ M18P0^OB3X\ZO.(;AKTS;\S5;!Q?1D]?H6[/D\\;N!_&'I:OHR\VC@7\FSVY_,MT\'EW,DDO`AEML]8H`4=0_HG^;.^Q7\ M(F-$R[3_S&$/??VB>3OVK)R'?[^#3\>X\U=+X&6R%WZ3@<;T'(%CY3QY1T]L M?J`[@>V[JVR.UU\B.GR2SMJXMC_+,K8=RVD1_>!#/*RJJE?AM]M'O:SG(&[V MZO?[NR?]#2RTRZW%]"-+[O4^HS&NO?#K&7CMA6->(QE]N?#,Q=)"X@\_>W/! MZY>+8'ZYT?JG#\^XN-J-I#O0LS[\GFE\N="9[V/76;`_:S9Z_-GAV1'0T5]W MI.%/@.V;_JJ__0!^9!KHPU<3^F2("B38VHAW./GEHL_`/RS#[WXT\`V=L^R'-0L(A-]MJ6[ MHQ+)YFHMG`W=I+#8N+#XG;#XCGMW\%$"?*11P;_M,;?)C> M17_SV!Z'GZ\R2>Q`0-?;X*JL+XZ2OL24O@:Z'BP""Z5)#_X;38U%3LIQ2`F^.@2J@[]EYS M44O!>1?NQ$N&#^>:PV^;?GS0+>#/P M#NP`3,':8K\_NHX1Z/[0L76(V=5\Z"0STUM/1-_OOMW,!C_?W@UL8W8['0PG MH\ET,IM-O@Z>)P_3F-,WQ>WW&+U9W0!;?UMH[I])S\^45T[@IH3F>;4$22#Y M*L(CJ@)H3>O!?0+NNZEOD,RO20RAQ6DIA^VPZ/RJ\ZMV^-5)>G&XP\Q7C4M' M._^IYS_%ZZH63$+\82:ASEDZ9SFHLYQD9L$7CRLYRW9VCB=GG;NTV5U2*F_Y M;@LGTIU=.H?I'*;5#6!<>N-C!E[@<%[S['VJ^8$+'EYO/Y;PJY@^XPP5V]`Y M%;TY.8IF_+K^^^QL_WJTALR*D5^Z9'G"R+]^MJXA1UVN'+-EAF,XI,;=,W.?L$*X.STCF^.S-[23@,/-]9 MH,:7S&5(D[3?P#5@@?0/:7PGKU[P^'+?0`_O4H`JTH'YKKU8@-Q:VV:K.%D4 M3D6=L=(TUK*EMBZN=G'U-$4N7LH[`=O%U2ZNGI.QRM@D`*7C#Z]?'&.Q3L(3"R#/8MMEKGCB(RO;4[;9`!^W.!_#7#'1VV]GM^<9;%1MOQYKN M.^X*':X(*V`#VQB;'VB;:;V=]/W>M,U%L&A(!S;$N(A;;8@LUA!O`A,R M;<_C2_966=KZX22?[>[(%?#MZQLQ3!9+UWD/3QKB`DZ+C6"?>ZHKXG]TJ,%O MSORF>3X8F=[2\33K:07_T4YCFU]C.6UYLZ8@I'9CX8P.C/41\\`/-&LWJO3 M':61A*"HPNLD,O7?/NT7,-VXNS,$?%6ZT^^Q]7MZ'U?V+I%TEPYZVPB2VTY< M#5PFDAO!ML":P_J1>J6HW36/OP^VT_#Q-7SRVKB8OBRV2^1.D:'3KT7;-=!G?"#)V:<^,O5NCT>](,_20^CF\E'@U10;)Q.X4C\(KN M,!Q"+EWS)4`="HB/J;;855+CK+6ZV4;$-]]VZFV!]TKX@P"&82+A:!:4&'!= ME,&\`\]'?-XNEI:S`C`ZO@-79-8[=7[#ML0/H/,RY+?W96_$ MF&J#S13NT>Q.+&%W(BV[4[%V5R_@ML!2NRC<>>3Q/5+"MP$G_&MD>CJR.6@Z M[BJN/N]7:#ZF/1_XSS^^%;+"9TKTMNS/3]IOI*:H7$GZW MZ1&X'II7AIH;>V-:4ZP0>TOL/EOMGB[Q^TV=@EOAP?@=IWM@F+IFM4BW"8[: M[;?X_91.K0WV5@4_W[YI[D+3`5SB05DTKL,''X^S^&KQR]HD?"MVI^)VO#=, MQE=Z)[81>+YK:M:V@:UYC?981>.X:_QG??=VI^]#WBI_`N_$5QF]/#2K$ M;"O+7X$S=[7E&PK.D6[#ZP+=U?6WIS;7X&0^=:"U4U\)]1W@+*HL8`-IIYJJ MGG62$"FF#J)TZJOF6;3.D,CX*M!PVB[5#*>MGK/P=9].D545>9(0B:_T#`TRFR41Z)K[1,6I;L3%J= MM2KX;J=.D8WR2'P_T'C6+D6.9ZWV2'S?3Z?(1GDDOK(3[L@,0RG$+_1JO&*# M^746:RT_D:'@*S^=H@^EZ)-X=$YE:/WZK$'#=!Q>[[,!'WM+;9*=5C?L*3EE MHDZK3?55%5\SVHCAIEU:O?D'^*J*+R!U6FVNK^*K2=O74K9+J\-_@J_B2TN= M5IOKJSDO3+>L:%&P$5#S#CI@%(SAK,6]\"J^"M6IN3W]\*J4:@<;Z'JP""PX MI#$%_C?;!9IE_AV_(>>K9MIWCM=`K6_K&=$]M>AN(,>&_TS=/5]6!,WJ-U/E MA,:Y3N/GJG&.EL;Q5:M.]^>D^]-/^OA*6&@.];H72:Y_I('^B"+M.>`ULW@7>SFFKH%=>[N[PR>3S< MDN``"0#+;-X^U$8P]/1(I]:JZ6Y>_[A MA`PV[_+)\II,\=JX5\>PC%"DS3?3-4(>_PEA-:Z?ZJ60&X6=V9VHMI MH:6-I7FQ@CB.R8/>(W&0M4OZ];F=_HZA/WHSK(KQO\`P_3$`C4MYR967X+!Q M;S%GV?0+;3O--62)PN)OFH<\CTP6Z[[A-BZ@S M$!;O'F%>L7IV-=O3].2;0W+9+B[G4<`"D['X-\D"9%+N;4[`62YOJZ*SS04A0J`&`5`BB!%>3+$\,X&&)_`F]]>4# MO8L,>#2DP$D"HZHQ*>Q1Z=>!02H+3F0$D9-*P$#"\M!+Q"D*0U9%16:$I$;B M1#)\M`P.4FDH+"ORO%H*QU9@$UMW%@!M#E/Q$D%E5%G,4,R.3K\6$E*AR#S# MBJ)0!LENOSQZA%(,Y7A55+D=D`PR&0HJ"8;<$8A@Y4V\(T;(E)1X3^`OUK[*4KKP:OC@N@YN+*`:PK3=ER8BD\@4IAF^3#$ M)4>)^F3N@?_FQ+I?Z$0V&<8VF8E[SM'PIU5Z)J(CGI\DGE4D[HQ$!X=TKKO1/%.'AC[#:_C+A\!'56,#CH:% M7UW`D^D8VI^H2D(\3:Z&YQA,$6GC@$RM+]E8+%WPAHIP[^M0O.LM_;=CH6$V MC:4/]A/0`QB@3>`-7-.#7XW@/^WY8UC#BL(Y##I4XJR*ECNI_.P08'&)\+$% M0QK?+F569M.):T,%0\E6)%Y6Y,-)))+%*05!;!N<`/.`0TOBL**`T_7#*ZT@ MPLFR(!U.'ANL9R$48B,1)$4\A5`R:-!4ML#*"AM?@.30VR\<5H)&G)-"@0LB M7PV:YKW!*1S]#ZU^WC4K/!OB#S7774&AA]T">2"Y9'-+>NG`<#ROQ*&1T*,. M,M5^GO9CB1>XA&JK@!R\:Z:EO5A@[+AH:V%GQ$`U:6H\HHJ,K%9N9#6 M_D*D%KQ\^2EP<JP-QD ME4G43\N!"@/J[E&/!B1!49CTQ)Y)(J,"]PX_=MQ506VY0$\<+[/)LL=NV/WR M"QG)(J=GF;TJ-H[DHPN6FKG9"]F\EVS@><"O[]VL)$IJS+D)B%'&5R`I'O6' MT,`75N&J"XIGX#)U#T`02#OH^PT0@H',:,R!DI%/U5L@J$]]1 MC4;,3!=KZ%J41$:1"LFL5\*/V@HM/"FDIRP;W\W('K\VB'S>>06N[]3R(-`Y MG,TI'1I5)(6'2)(XLDEDA-_R6`HF/TYA6+$ZEEA7!X7U+2OQRAZ6?1)I+#25 M`^?11&=0IB3JD"^0`2>(O,@5T<S\8ZP(DKXM79I8$55(]2O M6QG8T%DLS*BI"-67XP?52PGKP[NV3>O+A0\-]>(JJW&\$IT]WDGH./:3[^A_ MUMPH"'L0$FW0R9'KT2Y87!EC!S1!QVB+),YCR'HYD[ M[=8"FB-9ZD##)[Q!X+\Y+NHX*>B;RF&#('^B/`4R8@BGE@G[,&%%*-%%5E]<>4B*PLG>;$@]SU&;7WG M02'`;%1ULI%2H#*6$UDS;`TX(OX2?%QNG0F3E14U<2B;?AXGI:"F4]=L7!RK MPGQ*+$)6`U?J/0)[`!1>8=BR*>XIFC(57(=@9:LX9OMFU;,Z^*O>B0RL\`A/ MLI847NI@&X=$)`BB(L9#QI9H1M&-!`]IYV@>X5J!?._F+#J1O(;/ET-$&,9K M`6)3@"H'\E2QA?)\PW(IG&11?*]N@0FB)X^A+(_K`*^ND:,=#*AXV!'_(C2R M>%5X"K-"R*J)B9=DF4WTPB5B:`5$I"<#\BC7"Z+)5$\X@R!:"M$Q@JB4`E35 M9=.%=MI!-'T'+UD0W2M.DP11DGX4*L>?%)95$IMTQ73IHR6^90*N=CBU+MI[ MS?T3:NXE?J9AMH[AF^!-0[:7G,C&*]PD=.FC)9>M%.\?)06;[C%Z-]%5?1G% M4SJ']?BX(^61R^C)J@2-^,@Z_[@)=20&.,+Q'R">ZMGZKC(YBB!91613EY@4$LZ\UZD>7N+[KR2.X=D* M<`O0IL\749%MZ@Q3,54BP9:!6N*(K,H));$6X-R<7BKH\""6)B_SHLKG08Q1 MI(6.5(`PXTY<(%@`CD#-Z[-$F\B1>;:)AEQ55'#)`TX"A,3%ZC)$J@I)4AD: M_)"Q4WB`C'C-ECQ*ED^PT+Q)T1$'"%YB)4NA2_:9T,@)4.51(9H8UU3*3 M+@%0XJNK>(%GA9(XBV&F>E4I)5FR6H0T19=0J"70DF?\O,CG.CX)6G0Z4?/> MPGS7`,;-ZIN'LK;M+9L#W3??HQ[4C/O=J-SJ("B,'.][K0=I[][$@S%(?C<$ M@]I_#L4@])JPR_39&>A_!:8+*IV](;\95HS/-N3$,W(`.LB)XY"BP*2E&O1\ MV%F+;2HSI,#+@JSD0,ZB7&@?9>$2VSG/LGS\9NMJ<%U'!\`(+X-$%U=`1=RC MUX>9_NKA]6"29F0Y,9F61K%_OI,>%\1;B2SJ@:3(!2901?=R'F5RN!18-#\4 MQDY"2(23`P4&R0LG@L1(4O'T1\YAMOL_O!YVQR6##B9N$B*IO(%>C`0CXK%I M:[9^'+O>DU\]3'MJ/QR+Y"66M&(HLYA]152T/9M.AJF8O**R7$QC9>AGO4*` M$OP2)6Z!Y9BJ^.G>!E;0_B4+"J]4O0W,`.;U;?BNGQF8FY[OPG1NJBT`J=;[ MWZ:3Y]M1[^NWP6PT&4Q[D^GP\Q5NU)AFT2,C1P_"-Q*OEN0$6>;REXA"_.?] MQ,#KGO6QZ>F:]0?0W-OH/4/$1"XW+RC*&ZV?%F&-QE8V>FGF^K7Q(GZCG(Q: MO[>GW\?@Q3+UL>5H^2N$]=L?F9\#.\.O94%2X12LQ('$1HZ)9`!58R#UC"UM M3BSX5T@(1(,G!MBWUR'\QM6LB6V`CU_`BIA"_.UAV-$RY+>V@NC5GE#$J*D_ M\(C)_H%>D50T6LH_HD=_=:S`]C5W-38MX))3G#IQ@JE1,BF%7PVA9<\=EUR@ M3]`XX.]Z6UYZJ(E!LU=Q\HFA^QFT?P.6]8OM_+"?8`AU;#C7H;YVMR*WF-'Z M^[%GY]5C^`FY=-%_DV$H-1*65C1IE*,V_B.+5FRD?E9A4<8G.``X3\?7M(0O+/#E7W\% MCO_3\^WOSY>3Z>AV^GS=8Y;^3[W1Y.GQ;O#'=>\%#?Y3[WXP^SJ97M[=CC=/ MK#^93;[^._HH&JJG61#O>MS_!'#5\;J*_O&O.?QV8^GH#T+R"E$GH(P?IL^7 MX\']Y`X2?S87<'4[!3]ZL_]O[UV8VS:6-N&_@L^;?&770@HNO#J)JV1)]E%> M6_)*+#_ZXY#-\\!PK'>_Z MYOY2.I-.I.NS^Z^WE]+-!^G]U[NKZ\N[.^GL^D*Z^_J9,NA/^/SNZN/UU8>K M\[/K>Z#R)R"3\6+;-)^=G]]\O;Z_NOXH?;GY='5^=7F7(RA/7;I2[',J,O%O M'OR?XC]W*4BU8K0&&Y5%2\\:TDO>1'H?!?3=0=`VX_3!AK?@!EF7#O25&E7$ M.OD8&;YE&ZXLT7/!J?0Z?"(2_Y%0B_P?;R0[D`SI@CC&,^0@FIY/U2.39(>!%+]4^F0\>*QE)+C!X,@.<3>R1"F+)H;)"L])4-5ORAQ6 MH&""*0EMDT[NT2>6#6@K2_2<2+6BX4@F##WS/2LRV>?4CIP:)HGH$]00H^^E MC]"_)"=Z\!DBT\^>B.&$3\5'8=!@!A%J3OA"1[/H.OCT'\E/3J6KD*Y4X`%R MLT\D4`N&;SZQA\7OJ+GYC3@>\R53@GQJ>OJV\T)_RX(DI="3@*.97X%DNG1] M1#'#?TED3Z5[^IIX28SI[.?_,=+4X<\%JK+C6&1F^*Q*!9_'U+.@ M\RR=O$\FL#$X%\AW^DHK8&1&T.YNXOGT0YLYI#(<>[8I%^%'CQXECDYB$OFL MH)T8$WX-7_.E9&\)LR3/O(!2FYG/,R7)^)O^+&:EPXGZ]/7][=EOEY^6D'XN MWT/EQY^EWR]O[RF8?SHY^T2!_:T$2O7I^=7UU< M76]V='H*+@Q^=4MQXNS^ZN9:>AVOKZ;\G-(3?Z;2O1AZCX3QWN`6!Q4TX/>X M=SKXD4V#_M7[,0LE=+U\T>@R7ID7*C:!1`\M]&EJ?O"6OKHJ2V"(L+<4/]5! M=A#9=\I?39*D*=(SZIV-!APIT;&)P.;]<10I.1YP`#2C9R.2+6@65<9E- M$\=Q9B+GV+I1T/*_D7G5O!H7Q6X3,_]9:E-=;U4I`\B;PO$E&5/@'4BO$;/1 M3]EHP[\H;E(!?GBAJOF;X41<'QMQH02FF0'M'0+ZRXM\Z8$$H027#5,X8]%7 MPV;@`P7\Y\^VXTBN%]*?4L7DP*/$.A6P-5`8B3Y?/K:;RF@S(2W`!F7"7I_0 M`[^W1,AM^B#3Q=`MF+Z"F@1ND!GMBD['LFQN9WBPC6WR#,RQ"&4T59Z@W>8I MH.J*G2`#VZ([F/+\10)[PZ-[WG;C^<-K@"=B-C+]RG0BYOUZHNK/\YDM08^% MA@Q:DIXG"9V$+-'S:^A-Z7O#EYFP7TPP5BCO/*H2F<_R1*!6$6`OU_1K%A@0@SHHP@B*8S[K%G;*;G2M.>,:/"?#+<1\*F`C/C MJQC0Y?0ECZF%>*Y`M2G,$&,RH7_'2\K#1A#%&J%8W"*:@IA'#_NP*'F^X7F" M0YOX_,L-$NL8R*"][2XY+AR((0XC/EZWJ2]T!WGEA&E[T0 M3ER%EW.UE9DDUX?L)US?Q0]P7DFK\0^)9 MN5SG/;K\."KH+6%6%A5F(I(DQTB;O]ST1&W#4(IF8HZ)^GL@S$H!A4_G&!#* MW70:H''H/VVZ08`I;6N:P\#,,]BC.>M(6$#`_Y`N+%7PX'9AAEZ\?GRMX3AN MNV+!Z&:=,7>WD"H.N6P7"""FTG\7@9,@'HW+]X,!*$#?FS%X4E,G+W&P,4$F MTN^IV98ZOZ6)0VF,1)#!`PF?81/'IJ:5&YG*)7A_##`"65S`O'B@@,!`I6?T3DZ@'RG^V(0/HOTXE**\2J!1QY&5`!7FS M`%*VB!(0XL84A1=D5,6I1&US08:7_"X=/O1"^HDE_:"J8WD\Z,OL5&``C%T?2K= MB;,!&\!^!).*&B\\9)5O(3"KIW263P$@$#.#J.33G4'80;A@`!%*'$.R>*GG MB&'#`37Q^?S?5.7`:.EL;9=R/8S$V<`%-'%LJC^%,X09T=,$?,AW$X@""'6I M3U!XHA M28@I'O:+D$$/OY^-%PE4,5?(5?J/'Y%!_]K4%F5.*8N8#C,#Z+&=3.T3PW4C M=MU%]X8E6,[$53GMC<"NE5@(FBP]/]G4@GTV`J;MP6K]+:+:%SSSW`[Q&/P$ MF2(>7&6;5.$*,P"HUI78`J#3N(963F`7:,IFYZ)K]7-)#!1-6V(^R5.CQ*H! MNRL9/$LB7"X:#)'Y^Y_A)/N#+@^&0UGMJT580#E/Y;P?7P%M2,Z'3>2<;S9] M63G7"W*N;78N?:6IG"M+S"=Y:A#/J:FW*O/Y+[O5Z[[86)_)U:\TZ81\SM.(JHSN,/H MD6I&GWG,,Z^5F4JB8,<5&+LS,?A9TB*/<%"%*QAVPJ7#R/S$YAA!`"%63&EQ MNI->[6SW0J*F8&EN*/"'LGLI"$F'Q]E=APT7N?1_X&:?!*=26L]2>C1L<5Z% M:R#N^F\\8&&L`,Z=<54_<8%L9NOZQ:Q[#6.]87ZYC*KFD5V"W[+DDN0")(F! M,[Y+A-T^,Z=AO$SQ:W-N:GY/2`'.!9?U;=U\DYN<[,KS(#B3A9(!I8QW5'-8 MC_RVBQ[/^0SI\9X>N\D4#LP^I=N>P&%?SO,&?'7LUX)4YE`PO2`4=Q\6"8D_ MA4*#0)#!(PHG$+Y(;9*0.<;98?S!"&PZ]P_I:N:][[!")(Z"A"A"D^0C_B3" MPSM@4DR^TQESQS]X[IT7MN9T.0*;18C01VV?!P#"Q2&+G0B2X("`W0?P$`V' MN(]T:K!PX&3F<8$A/$EYQK=`*HKI%=T#@9LLSA"88G+CE")"F8$I@@^$WS,> M!N2)/9S.CD<^Q'<;,763@3IO@C8/74&0L#I MSV-HJ;;QC4?"7S$EX9-GQ4_L3BW@WV?>(#R$$]L/PA/;E<5?7A3F MHQ2N/MSDPA3X$!R<868O[,VI;H71(#I:EAP(Z.9:E<'(BP1;[(D8%AZK&FRJ MN`Z)++%*)(R122T2=#,6=UK*KEG"+I(4CF$VE^'[-M]\(+*RN#7(IA+M MJ?2919Q3!>\8)DE-A@<2PB9*HE=,8V:'W/9@&X]J4Y_N(CH7NA>8RF(.=ZY6 M0XD`RO'!?0`HR-37# M$X>-R'8G-0BR174A"-`71HVP3D2H0!`YS`3C<))]M7@1<\?PT!&^K:GA8-GL M_A@T,3.,6"0H]]UXD6/%KYW`?72*4V5TUTD1'B\^#-T(]8]**`M=@6XN/'$356,HU`&!0G3UX4$`Y5<=A#N@29 MI1768KHDS(CCEDQ\Z^N&:>9#,9QR`8X02`N)'A;X4%8S#]^(*1"[LP@4MA]%.0K@@?P33`SS/EOGFTK?!*? M#90?XW-25;9CR&8,J3M^'?#/?5#Q?&8AXF7@\PS]'`T/AOG/(P4?USHQ/&X*[,O0FF>T6,=F"S8H MD^"LY>T#5%<+S8;9V*^Z=6Z3!_HB'IB@B?Q:<5IT@.&O*)Q?UI/WLBVVX>4X M*3776Q'7M6!GD$6=+8KG<"7QY!_[)8]P)$=PWO"RO8]LUMHG-1\J`/G8Y;O* MOEIR[@C#[2Y+3REWKJ&@KB:HBP`93>LNHC=<5?@0H,(B=*L$`'=&*Q#N>L^^ M,1.T\7\L-?WEP7VK`KX#$/]$@H#[_+F'8W6Y/43N./:$I;UI"H]'$80$LH5F7@#9$R_TG].%IY'2;8]RCP>2G:-UT0^"8KH)>.:?P\U% MMVZ$=A9LDH8J42OJD^<^GGQBN?_\[K3=@)W#N!MG3')X@01QNPD99N*&-0Y` MXZ6"W-!P'^T')XG]@T@P42HK$R4&L7?D&[5D(8$\9$EXF5(SINV;T11*-IOL M`X@Y"TE:F:&L;I'+:6/!6J*FD(C*`L).6445]@\>$`:/\+GP4#V6'L<*Y<$M MJQU(4V(DN7"&2"BV@[2N01T-])6B>`3$*+(`]@E:JY-!!'RD3^'VYN'=F MCY]*5Y,X9"Z]2Q:YD,FSG)FLJ,E3+@"/?YV);D?)?$'G`1NJ?!DYI*8TS1\J73T;$0J#[7@@4*B_D-I&95K+\,( M$>3N$DBD-/P7&+8ZAAV3G1NA)VOV5P&51\NQC`J/7VY;\13/WJLGJEIB$^:F M!HHB_YJ$LYSE,124R7"N;,`/`T56>AH/$+)X9#']@2NJLB01)H4ZH08S42QZ MLGAD\=Q342PUKIXJ*G2RI&3`\J03+AIQ,NAOC_#,)]JS(J>"5&EQ6.1NK`S2L,.*Y)NO" M$==E.N^RLI%+HS(,02QZ#2L7:BVN&9HJGF5E&LX0?4_MT->A(K:S8;Y-%<(2([8/KYC% M*$SUWY/W+$U!FXDA>6HS_9`^2$]7W&B`(BK\:[HA(;@6#AVLGI#!*"RUHJ]8 MMD!ET3KH-\%I@;I%K,,6KU?(C6Z@`X9-*I<"EMF0`_0`!SJQ`#,#T@D`UES& MFCA3-<]DJ"+%_2<^8:T?DQ^R@J36-U[,#"*%TZI'SZQ&5/P[D=I-"?AW!!G$ MK%`?*2_"F`]J!K+$*@MH!99XF<9%@K6,[>*(RY8[IH45A'J&8G5&?'`RPQ3< M64GRI")-.;?C:I,D5YY2S#&@*SI].W@Z>P%*$P[=! MSV!@U^62GN0:G00\*:W"FVZ3;%5%5C,8BSV4UT&*\ZNKTJOI.CQ[=;)A0?\P M^R%B,)2V-F"6NN&'+BNZ6HYQ?$M=]B&KE1T!^2*@^*>SB"Q M'NI^O'#M[=*SC.]%5-]YD3^7D0P:90+9X;R)1W8>TCS8,4CC,O37.MPF*'(H+&E64OFA5!@]T[U[Q%+)[J$/2LI_E,';M M5;90"]L\.4GFR7R)UUT:+D@B96YOXEVEQAN2>`%XNKBW@ M(0`#`FT/6!W=D*O>N`0SJ]P=ES1(M"G\,B['R[.#YTL]%AS]0>8F9HX^KK)M M/[/)&&D/;&O"UQYO[$M?QXN4NWS"PAYE8\&\G@V?9S4V8TIR7<*/:<0US+BZ MA,\<(+EN!PS&1(%D7C"'_B.^5P$[O9Q1<19GYCY(7%B!>>Y+E+K0@51&@$)> MU`).2U:#.3!_+K]/8X0E=.<+8`B:DWK.O`(FI&'SXPJ;-V_P1)^N8!^3H07- M0>"V3XZ'@_Y-PH\Q35QA,AR9X:+*\Z'.Y3\`TBP]%*[R&&6LHC#KH^FYHK1Y M#-UE+,GV%HEKF;22+[G-V@+;NJW83-.W^((85H75#TVZ(A0`+:1R^Q\&";%T MBM+]=-NS4AW,V.=[DF?%"33B/OXRE,F^I_@TVQU9HD3]<]:,++=@L?`] MQ"JFPRUG:9GGC%&0-1DL\'=20>2%?2"IV,WMP1CLZ8`NF=AAL)93)GDU*W?B M0T%HWNK--1R&#=EV<5S#!.E/A;LWEU1>1LU%_LBSN$18*4?BLGO,KA(4@-LK MIK6Z$UVZ&J)=1O3P-^`CG13Y;DRI0/!B.-QXX_T')=95-9"N8"BH"!SW6KGC MESX\.Y\_P7[*"M")5AI,T/A4Z704*6Y!R`L$7D'M1FB,E]1*3Y[C;[I(&^31 MEU+3QT@DDU^;D%S5C(O[#[FB&6",\RKX1E(<((L2V3G7G%@SLA8SKWI:&N<^ M)879WQ``X1!6J8A%`Z0#PB2>>&DG,F.2]90?@UGO3A%^*X*_.FHL[[(C4*;I MXD5Z:=N&+CLLNSD'%KQN0F7'ROA>*^[$)2IP)=9D^GUL)/M6:C$Q=TU:=>-V MT2@\$B5_!/UAJ"N\>P!LTI+P'NZ5B5W"RC>X*2D4JKD6QAP=/[&:[<# M)ZDR8$<$**E&#SCL87A*8GR6;OBW4)^.?_=&,J+PR?.Y-X!U>/,--XYLRKZ2 MQ1DD%4OIT<1[(<(EF)22/Y6NO>3G3'NPB',["**D)EKX9/.N@K+H8`@[U!:! MB^F9#AW[#3;/I>&[=*D"Z0ME[!T4Y:<'8P@EQ>NYBIQT([!-5H&8L2WI92`" M_J>S2*0&L-8#L`L@G4"]PF.OS-]"%VZLJ0*R M'396"2UQ84[F:(6?L9:HPAT]R;TVMT%1Y33;-5\#YFB*2]=A`E*YLIE!\4LF MM27NWD`$N0/8P"48"W+_>GIW*C)L''X=S-U3POG,`]K9W;@#Y_ST+H+?DK!X M,^8F96U/X^Z2HJ5DIF4V[][%-P2O11ZGN32]X&*1=+SK!=^W22?4JN?X2%:F ML7HI5T0M;AZFPBMMBR-9!@$XO782!W8*336@<#T/A0/7'T0.\JLK?EW/K[42 MEHC*EVD#3IL2$.20(]]Z],$`/\D#Q"27E1!G-T,E!?CE7#=X.ZD@[#T$'EU# MD_=,CYD*0Z:=CRMJ!R,DE4`2/':6[I([P'>X0-VWZ[--8U+B5J#RQ9T)'\[N MWL<&YMG=5_;IB:K*4L:YGXU_D%[?>S-J`PQ[RINWTA=>OC:166HT?\W>%=%' MI/?\DDCZ`YH7&)32D)K1LB`F!E=S^LQ,DAK`IGC$FVG45E0K$A3S:KLM\>ZQ+>[)YXHYG_+Y) MC)/T'!?M4)+(+%`3/!"B.BZ3JRTJ;C$0"&YY;FM&Z2'!PXS&R)?#5.U'& M.?B*;TV9(7#N0?2E&3=`/4\Z-L_!1R"42%;\V=D=ML`+WP!1G)+Q&-D6,Q;H M&GX\._O"0^M=D4#(,O7,_,AI:#S<:_N&&X"QPOO#LU@:=L7+_F;O"8IOB=W& MR;-T:)=:E`GP"%,LB2H47*61=1@C2)K8*-@]=P+J>7G$!YR0=?GK71+XF#;D]`[^1QW:6:_ M-YAFI]HK_5':^T]TL\IT#*Q#'3"U@^0:2EBV$]Z@(0[V!0*2-M%AAH"X^T), M@P%MN;@10K[3XTG?1PYCG?DH\GHM'F')R*-E>N")%T"02!EW(QPW,&8`X]S#%@ M\B:3DP?#X5TR$G+FS!8/9'L#&,1O;&QNK63CQ]:R7!![ZK#G+'JDTZA%GWX. M?8HGJS17_2XY3YQ\]/B-)@0NNN5A;SD_31+AR'TR#]#[Z)+IS=RJGHG(;'9A M(=(E&5B4C<>QZSQNR"YS\\CAHW=$O20N%_2"$G MDUK,7C7PB1=4/(`770G8./!Y>Q(<\[I.>VVP1 MK@DW/46ZY-1H(FF`,7U'QFM'6`.VX@9F&SU'()<5<#W%1*5N0/;KV!KB<0AT M#$K7HPAIX+T%82_SEK7=0L89_G+E6%FMN M)@G2I$"3H@C]]1VU2UCW1C=,76Y?()R7@LH]^1Z^!RQ^QPC[)7I\>\VN=VXF MK+O4%]\#[\IW_HFI_/6!GA14REA`QWM/5^D" MPY^OH(6E/36@^#HN'D,YFE2FN;JE>NKL_NKFFO\H.U?]U3OE M=-P;I$M:-Y5W4GL35[,3U].)ZUN=>&_[$]*V:HC$;-I;2E*?;;7<.%4]2:2VE^BI\\>JRBF_X3@9/K M;9)-?A9?M'WP?/C-)];$^`O/#VFH$][M].)KZ^&,<4K^;28EG]H`7:,OR`S,^R*]R*=F(N0AB:ODI+ZDN$KGS2(SJ7TBXSN7 MIG3/[C#2B^+2@B70==R._(VIY M&C*SC7V;7X&GQ7>8[XA5`^/7/L_4YGX"4TYXS^B)P?6FMBF%],!I9>?U@5WT M0Z4\\*BSNC#/8,&#"#.BLC$0Q7[8F5JN,+.D*$#B^8KGFDNDY3$48DG%:;,D M:4ALNQ0X5\'".4`5T'Z;)@[R'R8V.*)G>7H2OZ/(\*WMP*_#B&'*7E0D5SQ) M%1E^MSOCUH3(:81<"%;?UPZ%2F+UE>AF8G>^,R/(W_+(<)(.(B-@$7K@VA#> M`R,I(^7#MA2I27#ERT$@+IL1I^?Z=!^Q.EDO;)-7)8&>0>?=$HJE#SXATHTK MO??`]9YK!W[S/I?8^"\CFLV,Z)&"2YPQ*8O:P&GH3F72*S1J/J6C0$73?66((%Y9)2Q_7LB@O>@FO*25Q?W+?H>I+WX##'&1`A2@T8 M_ES52Z8T,Y,49>QX)`)HV_@!SNOD`E;4;H6(#^;LRM\%)@$$+'I/S,KE&O?1 MS;OJYIF51056]19*7V<9*1Q2F5"]:";FF"A?[AJ+*V9`T>K,-%BT"E7%OL68 MTG;JT6%@YAGLT9QM%N<40RX\2\XO!`&!\YBM=?8R'B)6DB(7Z;5ZKAA&W+T[ M'HW+]P/+!*'OS9A;J:$U7Z4H=E+R[ZG1F'KWI(D305PEA]FX2DH:,YD=F15@ M93&8<)_V;L7C1RMBH_XE)U`.O:>OQ$B/% M6ITLIY$A+P,J5M&">=5-@-`86IBB8"$A20B,=.7&9'C)[]+A69DYR.A2U;$\ M'O1ET6.`B,@R^GE<4IM'1]UP^(E_#U\4WYD4N_M!T]EOG@R+*XN985NB4O=8 MY$SR"K^L1F59-0LNW/&O^1&/E00N#IJK/AYSDQ<9A=M9E]1I$\?P'^'`5\MN M7G%,\!L6YP'J\H`6$-7,C?0%3ZF'2=4M)*AEF?F$J7\QPQ=*D7TQ)?1>2__T(EK`V.:#IG2-G[BZ[,,RZ2 MG^,ZD"P;55R>UM&B_746W$RJ*!@/4X3C0TA MY(&H@D`/8LS4A4"MT$@271]8D=BI[0((B&+DYY44LE9&W/8-2,:)"6J?'=GD93UFY$Z[.,]"9Z MMQ'ZE*@[>.##Q=7Y%:?YC!]B5\9W2G$.0$M?/W_SR7*6H1P9%5,@/WQ!W&R` MFQ54Y[HS2E5Q;%*9^-@)T+X'S+HGDA@XF?6%@O`9[/*R2>&_>\7AO[ M!U"M*_%9@4[C&KIJPPE"4S8[%UVKGTMRE-&T)>:3/#5*SC^L$'@\>)9$5F.? MJ2'^?E9)]M9SWDV+OFY'S81,YYYM-7U;.]8*<:YN=2U]I M*N?*$O-)GAHD:5<-Y5P7_V1W._UFNC\A5JS)'@#RA:PYQ+=\87XK*`$ MJ.JY@R;]DMT\9Q7J>82"$QI;-^R`WR=IYZE%$Z6># M$IM*R>/;.V@CP,Z6P(HDYOIFT<579"\_`&K?M"6RUBE/*(L2M&C,,84,@Q]"N4=1DN*YR3E>+*^4W`_ M,J.<(<7$_IY6I)]&[`)Z$E'5RV\.'Z&&#@N=R-7D$8T8^/E$9.4P_ZA%(&63 MQ>(PKRT=1BX6C*5G$D[W6=(@")`-KGX$2W-#P<7X?"=Q.]LK/#AE15-XQP?I MT;"%#]9AP7]P;FH\8&$LEB\;32->/Y_',;(X4O)$7!9T)5CW&L9ZPRYH,ZD^X'(D<9NG`D'4QDR88J+B]RGC=P:`0`B'PWK"E):>$A6S;/(<)#&JK&>TZ.#H$/N)+9#IV9O$:CT0"&GB#($I)J%'*2*4^0_BC$M^`1X/PUIBP,/I[$21 MFWPC1T'/U(`NCG06DPDDE<4_SD3KBK8SK(F-8"VCO\GYOEJ-S2M^4:\+3>Y& M7;(XMTJ4W)';S1G.,'!@HAJK`@E:L8KJE[R;B+CRR@LVJUL-@)H!IK0E;UQ* MD[V"-]2*_6^Y-MCL^\P;Q%W:Q/:#\,1V9?$79%3G@F"O/MSDHF#CGEW)#A$% MHV.-'>>XRA)56&SO6E+<]K6\KEWY7JW:@?-W75]\R)`-7Z`T;TC-?/#!5 MW+L-]F[,/9F5-N9*)>$@W@W,[>B47[.$7R3F%[<8#=^W^2:'K2&+>_R,.681 M:H>9-J_R)7WFC2()?9^9J87Y0$+8K$D0MFG,[)!;3FR#4UL@;J\S-9C"Y?46 M>/47JM?KBKB?I0W1$F*2.M,L]!Q*D#J0>"Y\ZT'H&U"]]\1A(S(48%WJTJE` M)HTO3#)A6QGY-M4%A&)S;D?+QX\!P M*]M0E)E#)T]>%!`.B7'T;KH$F:45MFZZ),P$Y798'+SHAG$LX5P/F90"?C[B M@V`=T<(FODPBF>FJ0/:<8W^+^U>">PO"FX.WF3R2Y?C'C[-4R)T9I-NYCX)\ M1?``O@EFACG_S;-MA4_BLX'R8WS*R[`@-V/>;]ZE,_;KD'_N@XKG,PN1[^H7 M^CD:'@SSGT<*/JYU8GJ.Y[^5_L?Y^>7EAP\_EP-R\AHKM_P.F<12\2W[.<6? MT)N6<&34_S$[0/;U?(!M"6Y*><&7DR=G2?E=M)J9@+5ZL'K-'*UO*HHQ92F, M!7AN"NS+T)IGM%C'9@LV*)/@K(7O`U17"\V&V=BO\ M;.\CVP&EGYH/%8!\[/)=95\M.7>$X7:7I:>4._%04%<3U$6`C*9U%]$;+EJ@ M/QASP%0*`.Z,5B#<]9Y]8R9HX_]8:OK+@_M6!7P'(/Z)!`&_6^`>CM7E]A"Y MX]@35KU!4WA,$N[J+>H[5&$;7KX_C"!D-7UG7@#YC"_TG].%IY'2;8]RCP>2 MG:-UT0^"8KH)>.:?P\U%_B*^Z?7Z7`A-$JATXU\(++J9?/+#@"6.AN,5M\W+O,.[H&8L<7F\L;4HI&B`D87R\[J<;&NXC1-;% M$9003R?*OF=B[2""D75DAG(L(4O/S]2--&W?C*;0!L!D'T#D7DC20F=E14A= MT?(-0MY$@5`1VP:$G;(BA>P?/*PN;*6FP0Z4D'Y1U*,_??[/%3Z6H2!QZF=]JB2D+R M+&`1`Q802D@)6J0`*H;$@IS3*,?>C)`Z" MD\`M)EX;J"1R-PW7*AT]&]?+0SYX8)0HIU9:E?#:RS!"I%&X!$HL0$L!.FQU MED2C&*H5('@^OBKSEN*S_Z)"^,'SH2UP"ZD12BGEU6.^:YG.IND3J]+Y^/8& MXHY1\S76?(Q?&U!SAQ##DKSEI/,;,XJ'U]`>NJ$^9!"E95&DZWBRV8`QFY5H4C1Y90@-O]T)G M&T$0%J^)QPI9!CS5+"E,+XK"C>):MRN` MAE\6@6C;?&`^J]J=!,MRC0'!M#,?@K(`\OU0=%210!_&&6X!R3"/:40>>9\I M`3J+0M[.4;0?7)#?5HT8>ZZYN)"7KA8*>9VG<6BB5\!%NG(0A4SQ MK*9+`(7&@4+E(=-ZIHRD=^N2K563?1^OYRV3`E\TO6&45_>HH(2//ZFN)":7MP5(/IP9+^(35@Z6%]\4H<=!/A&! MY\`EYC,GT.*=8_EWP1.%USC;6`(0%EEBO)Z:"R73&N7[--JA936\BLU->.]Q M^`OW]`MO_1S;3$_>LS0%"T@,RM/).NXX`7.;;2](%F!F0+07(Z3+6Q*4/ M\DR&&LS<;9MT?(QY`I6`K6^\%#@D**0U@Y]9A>7X=Z+<$27@WQ$4*F!E[DEY M"X-\+@60)599H#>PQ(M"UD>8]9#DK&5L%QXMMMPQ+:R<\C.4>C=B/XD9IOIC M"GDI26G*TOG3R=O!$YPNP-=F M2(Z7-L<4F:)RC=H#GI1VT$FW2;8G`>OW@P70R@NBQ@4[JNIUT'5X]NIDPP(# MW'Z(&`SQ$YZH^LNZ"+BL@FJN&_2@=SK\L>Z5HAI^$%=.CVGD=D=_<*K_&&^- M[$8H$PDJ+?'L3J4&\]7;F*_,2HPG=?Z-3!7T.,F:IZ8GN4]RL6$VK\4.=`S& M:_!JJ*W$J09&5XWQE#6UTLZ=YPELM-\5-'EW:XT%=7W)QH(Q"15M]^;:[`WR M!;VVT4E0KVZ6&%LJ::.J%:?5'^A-I[6:@#0N?K-I`5FV+>,2G&1%T@;;;A:J M#RIGU(9XL$D-M>9"GT+([Q23O/P8Z%=O<%[C?)-RC$,SJ+0-FNBW#J7,C>=, M7B^[=BUD`0MG"J_H``4`X2HX`JL`-#9KPVV*A.#X7^83F4*9%WJR^.P%L51&UQ[W(GRLS`Q;O!$K^3'FF M>68>TCCVP>@]1W1SB1]OOXZV/*C57JU,;+&&R553W0[W5J-`0JRK!"A56Q+X=M\:ZRE;E M9(HCA^*\OD<2`".\ZG&(45S:YX+0LZ;[L11B;H),4-0V!J";Z&L$;>MIBWWW3YA(6OB(T%\WHV?%[HI!E3DL@E[D(EKF'&Y?)\ M=O^1ZR+,5+AH_<>KH])_Q"%.X$,K9U1#)M!K,@=W/\]`V1EA"=[ZBGZ`YZ53(V]1`!2CN2F3S9HMFT:W9'1=G;*6$RC;+FFTK^F03+__JQK&:L"JLR4_2[[<`:"&5V_\P M2(BE4S2EI=N>U1YDCCB^)WFA#(%&/&:C#&6R[RD^S79'EBC1V1-J13J#+FY/1B#/1W0)1,[#-:Z,$E> MS>HW^M#JD+GKZ5YVDM3^]6,,$Z4_%;6^NSE09-1=Y=^3B>M"E'(G;1+`S MA:``KJ1B6G,GH-Q\T]40C:"CA[\!'^FDR'=C2@6"5_?D!Y>O5!`H=7P[^+^0ZY>'QQ$>7]7(ZD7ED6)[)QK MO,D968N95STMC7.?DL+.GA"+[!!6>I4%YJ8#PB2>>*U:,F.2]90?@YU*(*MX]=W9;@08]1T--B.J:-*2,C+?6 MF6M=B2TGVCENDE=-QB\)X=C0;-;E^HJSN24!`9#(A.-!;SJZKZ@B\^^\24BM M5()'R`9'R)B5#'LR_,1XLRH/:*'$H)]E8#:R-P[WDN.3`"^UG9RRTN_CPZ-O MI2<)=L68%JB\730*3Y;(NR5_&.H*[Q<-8<)#=ZSL=$OUO`\+%'/L>HK9Q9,1"BTC2@$PACPXRC)HA2^3\Z?H?@!V MPJE4-U09`(X&*?[U^EN!OV8;KZ1%K7@N?H@^?^\;;@!^FB1LOY6^]:-\#_)F M`Q=OS]'JJ MG3E)YM8/6L9N4QF&Y8%(%@&U^;&;P-."C3"/2YD'6K2_M+SY-3](S09NT*XK!H]!<,Q\]E7LB2!I$?3=.9X+T3<&2:]D4^E:R_Y.;/$6'4(.PBB MI(]"^&0'C#P>;XQQ25-P412$.47870GKX0V[#TJ.B.L% M<87R3*`L/&QUT=S(9;%/F;@ZWG\X%[I>"'.GYH?ML+%*:(F;%;$;8/@91`?$ M]^23W&MSP-!DJR[8:"47$`&YF<0=*0+F=R@Y. MQ/]&1)OFN$V;]Q!X=`U-N`Q.TXU@2#.Y_5VF05L>MN:N$ZG$GB4R],7W7/JG M:&_%$1$-D`:X!X^E;(2(`->">+2V;JL.J-%BZM2D@LQ=F1_.[M[')OG9W5?V MZ8FJRE(F7B(;4BJ]OO=FU'H9]I0W;Z4OO$E8LCGH,2-[JPN/2.)>5_H#&MP: ME-*0'CQB?^\G""L\ASA"$49(MYUT9T]MQ_#9T_`#F06DL7^*I/GL$]+E=SM( MPGI82(=T#\<*@^XD2X0KB=1C#K%N/D8H$QPD1DKBX";U/TXSLI-N:;'CNAQ& M>7HR1%*SN"B/_G,^NDXD,;*&POGX2[/`J$`P"AYU4D850S1C1C%M!D7?8DNM M)/2HP#G/==BQT@%M`>$_=),QS<$X*6*N*CG$FQIO8BJ$K7FLOU+-PR,IV22B M&5-K#\2$/%)NN=H)Y$,6!B^J9+@N5U)Y[06AMH^VZ[*;A0G]>;IYU+XL(I/@ M[E>,8WDDR`2BI8D>H(]X;&EU&BK7CU3<8B`0W/+<8NHUPAB+!GL1*<$E\-4[ M4<8Y^(H#T9C%<>Y!WH')0ECI;DAR&^?A(Q"*)"O^S-L!6^"%;X`HKD#Q&-D6 MLTKH&GX\._O"*PFXHL86*V9EYD=.*P%`J"#<5H!5]`C)%CP\F47-L;_9>X+B M6^)+J^19.K1+3=<$>(3-%[FLTB(WM=+'X8P'A`B\"DPJ2A<7D) M?@H>"/Q+@R*%C^[W!-#O57NF/XMI=[F,@"P=I?$BK11VPL8/D$EQ8MQ/>!C?. M'00"IC$!88:`N,=M3(/QZ!-AA)#O]!P4\HLH(_N;24PG!ZC"J!P7PI<9I&*6 MOYK)-B1DO,QXED2.(I$R\`SF4B%Q,N!G,W!Z>;[O/0.O&/`0QV:!L"0IHU+% MBAPG6#/>B&X&"C3TH02RO0$,XC>--K=6LB'Y:UDN MB#UUV',6/=)IU*)//X<^Q9-56@#P+CE/G'ST^#4\Y(*XY9D$.8=0DC3"G3\/ MT,G^DNG-W*J>B60W=L4CJD,QL"@;CV/7.:__"+?0S/QQ#/.?S,;C0Z6>L:(0 MS4"=IZ,*;4B2*ECP/Z10@HI:W-%#*%Z=V"2Y-QOI*\W<1!X]?D'.)U)4_0!2 M<)%FY\#CX45\R%-IZ+G-%ADP<#=6I$M.C2:2YFS1=V3<@W`=]C*W@=E&SQ'( M905\7#%1J;^1_3JVAG@4%!V#TO4H`JH8?@2PEQTV*K]9R*:&S3L/,V[+V'@" M]`L"1G9::PHJ];"@5`XT0&9L!%>=@;>&<@-QW#7\^`0K?'@/1+R&!3HM_\)M!J?39H:0O;Q5>RQV/RWH6DY"&1^AE4=K* MXBOKD07%NX-[<*>NYI4\@+;?6;6!_0F[V-P)6W]CZ^_#:_&$K;^Q]?_L,P]CZ&UM_(WICZV]L_;W'((ZMO['U=T?U':HP;/U]B'*/!Q)L_;T' M8EH%S_SS3.OO%6Y*"NEFE5W#XQ=,2*&RTKBR"K%P>2>OH*_[(/S=HE[O9]NU MI]%45.=]]Z7_9X/^Y2DEZ]+>J[P8:D*[\3U'^W#+M*N5M,?GH82TGK(L;9*T M+GG:0O*N,J>U"IYJJQ"^+N75C4*8EHX;,M\Q';WZ\A<)O7+IWF3U`H,K]X(\ MP(.?DT01>$7XGMU?W5Y5ZK%CCM;[3[7H3*HJSU9FN;$8GR3 M=G,L-0'"S7P>S\+"(R!81^9_9GIA\A`)%N'"XP0S'?)8*-MSG/<@8FRMN(4[ M"]IE20RL^9UMY:*;C4PE;1[@"_7-($`C$XJ7E+CF"=\2O3QY8]8!L/5I>WCC)U,CP@__6<^>S\$J&%G..`E;S>>;;/,8O,]UD M;HQ*`UYOS\?GL);'F0'S&?R\6*\(*H<*O>2$KF0\T2?Z)^3$O["V=)!S8OKV M`X_H$2O)ZF*SWH-4!.(7V>XL"D4_#DH\YPZ+H4R9"&5$/=;P\.T**0>KQW4D MK;D=.PA/^B6&I*KL.-QCSC+V\R9PZ,VJ'TB,Z2SM?UQ=W/_KK:0-9^70G#R: M'DO+WYM8L`T&+3OZ-":DT5&J]A6;KK8=1R,.ZNW^HB"OP-5E>913ZAM00EOB M\">H,2BI5($+/!&-"M+P1MX=P7.\1][('1ZED`-@"7$WD6M8,!%BO>%Q?A;$ M;)II;'4&1&U>`\[@48$V=RIKW@8C`]]&X*\01R<=EYZU.6B"T: MI$(A)FI@?3>#YZVT[ZP5=FHZXM9[M$X"$B<'X) M$8$1@;N%P'J2&Z6J/S>V/R,W@Y@L*9#.S9Y0D],-XZ1S44OZEL7GH<2[`A\N>^29T_P%[\L& M/2\=4G>;#(+(SN?+V<7%U?7'D_W]R>W5_=4(W-JG[F'YPKM)[;`-7_:/.BNYGTE)DRBR1JJQD[+45HF!X@ M1LP.37!BE2C$["3?W]Q>7-XFC'J`%&%)/55GT'S0L2T1A[%F2.)!A78LMP.A M=G?-=BD5Q95WS':EH8B.^[>G$&$08?8>83Z`F?P[V,#U.(-`@T#3#6X@T'0$ M:*`L*&\3O;(1?RRL6@Z3/QJV^]-K*)/ZI@:4$9"[$DB\`1='U6[)NO%7#?O. ME*!80,#>K,S">;:F-"K.7:NNR[H[KVY?'=#RH9BBF.[!\J&8HICN?OD6F2F[ M*K^P[`G@8*YDTA'/XFM0'K%C.*0R,CNWFFUD^R%0(5#MV?*AF**8[L'RH9BB MF.Y^^;;HGG%- M(]99;T)-\=(.[+EUWII!F`\I6U!OIJ,[H\%%6MDL.XD1/]2?%]KAP+#;58Q' MLC[4Y<&P5^3%II7&>E*RAQL&X0+AX@#@HC_LR]IHKO@YP@7"!<(%PD6>!YJB MR@-5K3;!$2H.[VYBB1-M)I8N#;!K=LP]UG,N+[_%4JYXS\'JLVZY-._XO+M4 MPM$>[<8V5->1Q'ZUH>.68]6\%MPFLQJ\//WU0--D933(\74]2V(C.G0]4=U# M647T0_1#]-LT^HW4GJRIB'Y=DU5$/T0_1+]-HY\ZUF155Q#]NB&KW8P"B-G> M6X276\MO61[K%]+>7:'8&-9KI\,^W4'0'MTA"[;0[[B^6]M?K M+_XQE+N;,-T(@!K4#SY4_C138X=98'DKRNTP68<8A1B%&(48U676(48A1B%& M(49UD'7;NGW=H)]AMP',5:Z/CJXW>EE7Y`1Z68_=RXK`@<"!P('`@<"!P('` M@<"Q^\,9WNMN>/DZWSP$%00J"%001ZL@$#@0.!`X$#@0.!`X$#@0.'9_).W6 M?6%IR`3V1ZJ1CG//GWF^$1+IP7.M0'H]-<+(M]U'RN#PR78E57HAAO\F+SMX M!$:%%(^�V@H8$NCS6E>I.@"D+;%:$"H0*@0I&5OHY0@5"!4(%04<>#U[H\ M&@S78\1AH\6;E9BS\VM6/*9B&U_4((?$B8YKDJ&L:WUYK'>O!G%G5`D:G@@; M"!M%V.A1V!B,YFQ0A`V$#80-A(V*4N%C>=C'R58?=K'#+W;X/9",ZC:T M&'9YPRYOJJSJ]+^]O.(LL'GG*O18FKPA^"'X(?AM$?PT?2CW!GT$ORZ)*H(? M@A^"W\;!3QG(NCJJ@[XEN8SHM\]9V+5XB?U]]P'`L*/SO*`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`^6#\44Q73WR[=%[Q06)\;BQ'NT,QI*0X*(_[,O:J'L)B@@7"!<(%QV#"TU1 MY8&J5IO@"!6'=S>!%8@W*3-8@;B;N[$-U74DL5]MZ+B#K4,WT#19&0UR?%W/ MDL`Z=-VQQQ']$/T0_:K1;Z3V9$U%].N:K"+Z(?HA^FV\!O%8D]5"?TA$O\XZ M6';K,\$:Q/L`8%CU[FBJWHWD\;@O#P?=Z^][3)7O$,80QA#&UFD<*NNCL=Q7 M5(2Q+NQ/A#&$,82QY1FECW5YV.M:Z,$Q0=BVXA.6/%17;-I53\NKQ&/MSQH> M4D#6[AV7W0G,:HD7&)Z%"($(@0B!"($(@0B!"($(<6`WD%71!8==9$9\D*W[ M+X[E"XKU+W?=7RSMK]=?_&,H=S=ANA$`-:@??*C\::;&#K/`\E:4VV&R#C$* M,0HQ"C&JRZQ#C$*,0HQ"C.H@Z[9U^[I!/\-N`YBK7!\=76_TLJ[("?2R'KN7 M%8$#@0.!`X$#@0.!`X$#@6/WAS.\U]WP\G6^>0@J"%00J"".5D$@<"!P('`@ M<"!P('`@<"!P[/Y(VJW[PM*0">R/5",=YYX_\WPC)-*#YUJ!]'IJA)%ONX^4 MP>&3[4JJ]$(,_TU>=O`(C`HI'@T;&D!#`UT>:TKU)D$5A+8K0@5"!4"%(BM] M':$"H0*A`J&BC@>O=7DT&*['B,-&BS4/P0_!#\-LB M^&GZ4.X-^@A^71)5!#\$/P2_C8.?,I!U=50'?4MR&=%OG[.P:_$2^_ON`X!A M1[FCZ2@WD@<#11Z/NW=)=DQ=Y1#&$,80QM:"L=%`ES6ECS#6A?V),(8PAC"V M2GJ-1D$L?Y9&".O"\9E_#L6UX*M??HJ"DT?#F+V],Y^(%3GD9I)4W_K@^7>& M0^Z(&?EV:)/@EIB>:]J.;82VY][#;^[)]_`]7.:_8R/\$K^N^B5G4\\/[?\0 MZ]P+0BER[?"63'Y]%076*XF^/J0O9!^8O=Y?9\'-1%&$_SZ2GGU;J0/]<&PETZO(3V-9W$>^3YQ-T=_ M?]C71OTF]`M*WL6+/$_\Q/.#W",??2\(OKH^H5N)3ORC8;N?Z"=J[6SZ?WV@ M$JO^9K@PF7MOI7G1WP]4M61:C6E\5S7+-01M4%@H'N-QYEHW$.&Q:$X#C2+= M8`51:SR3)L*VWAQ&:D]3&\TA$;=-RMJP4M:6FY8ZUE1=65/[I$K&65G24UE:;EXG^F@P[)B@]97"0BVA&X>ZUA^7HM7V M!&TM^GM:?S`J6Y%="5I?K12T)>8U'@_[:\I9ZV*F%99I2;6HZJK::[12L%CV_7$6K93!0Z%;IEM52"0!S M.A*,^#:5R97[C4J$'DIV?EII;5NQ:BZE5=I5>$DYN-L(>_ M'_R?XC]K&:D/-L;)3?%QZ5"7FL=C::4"#L(9V!0)O(E$T4J:>([C/=ON8X[? M;\M<>S7,9QXGR22.,S,LB[Y-D*@(_L$WP?64TN",I1QL51]4/)_= M$IL,05DF.*^E4)-FQ&0=HB85$N(?5">^A!NF!P(8LV,@.+&*'WKU:"W.WQ+L M2"DM1;'"\K2H(LH"'#L5M4=U);.A)%V5FT8MKYF(M5V9V-M@TVT&\"%Z=@H] M-43/_4!/.&;4!SPC;G8PJ@(1!A%F?Q!&1X3IUIY:PS*KY&,I"UJWK?:,T>V# M5]OI)NONF,/(-4+!0\'K)!)WHH;0"/N2\A%OC6=I:E`3SC:<@)4`>O;\?TYL M]V3F>R8)YNO_M&C;8&VZ/:]-A[74PY_U<5]6QEK'XL([DU_0J:P5A`J$BAU" M16\TFJ]?B5"QOH>ZPQUQVI&]$/T0_2KK:^KJ?)XK-3A'X)? M1\X!W?(_8T6V[DG0QO0"U@!9ETT[K@'"BPFK_5Z18=U$]P.M`X(PAC"&,+86 MC`U411[VL+!D%PU5_GEXC[WGT0,\_)"22'9)I<%IV.Y-U06<6)$VNK4N-K4RC M_=UP(E9VZI83&JQ>7P4*8B@EY,P-,5>B9S5JZO.F5ZG8*/3&-:D_0$Q,U M.[RG$&$080X!83!1LV-[:@W+#!,U,5^NBZ'MF*B)@K>'@K=?@3)5F^!8@N8Q M4;-[P(S95_N4?86)FOL3DX-0@5"!B9J'"17;O)O!1$U,U#PH3S2F*K7,JN-* M5<)$S6[**J(?HA^B'R9J'A/X[9?_&1,UNR=!&],+F.&T+IMVGN&$B9H=VI\( M8PAC"&.8J+F?^[/*4.6?QXF::;Y;TR2VRL3`/SS_GROW"[_7/W.M6^/Y?_=O2^^]\/ M-^<75R\?[_]]_QO1?OIP_[_TJ\&$!%;OC]F-Z?[OR\'$_Z_;_X33[W^>V7], MO9_LNRO[O:;^ST^^IPT_.,//XTOG_F[Z;'_X;OWS[\='S]2FYMC]>O_;Q!C_ MUXB\_WO@_.?]BW+UY3\??Y^1V^ET\NG[UW_>_V/])]*\O\_^ISUQKBZ_?QH8 MUR^#?_>^VK-!^''ZQ9X]_'G^:?!?_6!D$.5__DDFLZ]]YP\C_/SQ?WW2U/_\ M\<=O'_R?[L]^_?7_2N=WMR2_N>^/[OO3+%0GD&9S.0EV;:=^-&N9> M%!KFGM]\OI3NS_[[\JY<'6;OG^#O#J3-;XR!N8'NGPA".PF<;H$(%.JM@76<_E`VXT- M6,[S_B+`AFI/UD?=BP/K3$QAIR)5$2X0+G8(%YH\ MU%19&8P0+H[,0[92O8/T0J"A,^U(C=4[Z"^2%Y?.&:H''_&#*<`MLVK?4X!? MC^7^<+R>UC_R/-XWZW$/D0N1"Y%KX\4+QO*@-VA^SX:8=W2NYL9HV>%R!(CT MB/3'CO3R4.G)(V54!_8(]?OI&D;P0_!#\*L)")6'/06NNQ#\.B"J^^7HWI!W M>F\"/2_(A/@^L6I7NA-NZL-&[$Y?D.Y>=W7GHG2'X7?'$X8_Z_*PEX_ZK3MVXB7A_KAX$?D0^8X+^5[K M?171JV.F?XTUO\%870S4[1Z\(!(?#Q)K^](R[("0&%$+40M1:RW7L":K@X() MB;"%ON,E^M?NWG?,.^YTW7=\[X6&4]-MI_/!#XL$`=4C=M$\M"Z:D$_7WQ?+ M_D"[:"*,(8PAC*U9U6U$86PN8@QAK`-AR?SSN!DP_&M1^\F6.DTNZ."9IW!) MIC9O0;G$RZLZ6"9M*24[D`S))Z;GFK9C&R'8V:)WY;DWG1GN2](8=/AS()') MA)BA_8UD#'')-T+ZA\<>$G')E#8CC*"M+?_VM45'-'S)F-)S61A(3P9]Q0,A MKL0.:L2*GW>)X9,@I'][46"XUIM\X\QD[K85K^_9>ZUDGWRZO+^G^^3NR]DY MU59TY6%9SV\^W=R*3;-02-=?PT9#%+T(V6-+0;2Q'^@2Z-D?[[1\2TMQ?LW: M2.T-HB?LR3<24'N"#>NJ3+UTT=?L+%6J,K&YU`%T'3T@O^I^)H`A2'=0&"I` M>IV.SSEVCC:"T0C1BR"Z\QU&$8Y7`R@-`0H!ZC``JML-2A&@[;[\(2'X'0LX(3FTQXAU"*/6R9U))^A4D@K"Q9Y:-H<%&WKO%!&CDCMS5L)$QV$##8OV#8M%3K5N^LD.J(LBJPZ>J^DB MT^="<%'%B:0/Q"43.T1W%:J)3G"BXVJ"-;J94Q2H*M+A.E$X$=$"T:(+:*&< M=J\:-B(%_`.]58@4'4(*54>[`IU6'=DKB!I[@AK*J59@`N)%.W*RR'5U`/%@ M!^3GNO#H+T/;E+[XGA69K,K:&=11LT.;O@**J*&?JPMXBIIE3S3+:W4P*K%( M4;UTXO"*8(%@T26PT$['=8H5D0+=7(@4B!1@5HP4-"NZ"A9H5B!8=`DL-+P] M:QLI%OFUT%6UX66[]J"&,_BHH-@\^3XC;K`'K;90):!*Z(!*4$MO25$IM"PK MB!F(&0>#&2H(\*\:)#>($VQAY@!MH8B!D=P@RT,3`0JPZ.CL6[ M]<6W/5]Z(88O>=^(?V*8IA\93NW"HW\+]0CJ$7'ET1_,6Y^H2N+A\'84H0*A M(@ZEP((5'44*=&@A4G0**<9H5'04*M"H0*CH$E3,9Q0B4JR)%(L\6.B4VO"R MW;(=#O^]D$R?6'8X%V^%'BG4"*@1RH-P2XJIHDI`XQ&A`J%BSGCLH?'82:1` MCQ0B19>00BO)`D2HZ`14H%&!4-$EJ$"/U-8]4MV*JGORY&%'?, M5CZ6OL"(>HAZB'J(>HAZ:W@=$?40]8X+]5Z7)Y$B@NV9$Q21"Y'KN)`+[;4] MM-<6.71WZZ/MH8\V&?',#"/#R;3DC$O`5>^<[KMKFRQP1W?.QA2A=CKL4YBQ MO.C!(0MP9IOLVEV+^&795'+OV%U%J,I#93Y0LL#K;NK#I21U#W_*2 M8VJ6PB69><^8>4V9>;NH7VODV^ZCI"EJ3S)<"_[092E\(M*Y-YT9[HOD$TKH M?XC%/LST;PTD;\(^6]#R5?38\%Q9>GZRS2?)F'J1&\(+/>;_@ODF733WWBFO1E?($HZV>^'1"VNA:AW_JP6O0%1A`0 M^CP(BF,;#[;#E\#P"?U*FGB.XST';RM40QB+G'54XW5:]UR)\IX2:6R(7+VP/`P/9"K M>.H#,>M5E.PREYT9MNWN_LTD%(3]<@'>Q@(N=2+\DX)[(!%HV"1=$)-,'X@O MZ:I<=T!L-=5BTR)Q("$:V[S^7@:;M@J4V97DN^QGZ?#!4]L2>.9WRAR*-034 MPO*T"+*=QU*P]1$W.[JG$&$080X!871$F&[MJ466V:XRS6O0Z5@B$2_F72SU M+LX6XQ#77**."ONBJ;:F5]H]7JP+98<10HURBG*Z#XNW:U_'O);CGXQG!6W6 MNF951RNJUBVH56&N75R>W]R>W5_=4!&C9@SQ\Q;J435,Y6-6I,6-30B MWY$@'\HIRND^+%Y7S[RY6^M1Z:7U'3T;:EE+.>YA^4\=Q>OW9TRGJHBJX.YZN`=B$(\M*!61`M$B[U'BX&LC,9K M"0)B1363MNE"0INSE06_4(F@ MP8FH@:A1B1H#>328ZS>!J+$MTW,/?*.92,B16J]GINE'Q(I+G77> MA#WX!"2L^MDRJXZKZJD+UA.H)K=KN;A:$ M#80-A(WLQ_OB7>V2";P?0<@79.83TS:@DT=1/CH7@7S8MVBH=O9$[;P>Z[*F M%[I_HL*)AWNSWF4H0@5"Q0%!Q5CN*QI"19M0T4U/*V;`+;W\7]VDH=VC8;N2 MYTI3P_^'\!9D`3$COR0XH'-F*0;,5;,#`^8.,6#NM:KK\FA83`G?N6+;GYBW M3AC)"%P(7$<&7$-%5D;]CMGCAPY;VW(B;S!%KO!_@C]_^2D*3AX-8_;VRC6]*;DWOE_8@>EX0>23>_(]?`_V\SOVHE^B MQ[=?B&\2-S0>RH%,>'/5]3Z->VIX02_OM)> MO5-.E3&E=D42WDD;G(*:G8*>3D'?S!3$@MV93\2*'/J*[W0Z$+->M]'H(I]0 MI0N@!6=$XP(V@!C$KW:,=,HR^),8?B`1UR*61-&$3!^(+^FJW-Q66--]L6F1 M.!"G]#:]A6L`97<9N"0F9X6&;^C4'7JX.+U&1^HU-N4<8#;$[L+RM(CGG8=M ML/H0HCNZIQ!A$&$.`6%T1)AN[:E%1N#.4MU73VHOE:-C*36ZT9>?[[#84Z.; MG`H@[NC>6SC/UO3<#JY==EBFY(#S@W%'X([`'2$MMEO:-$4Z7W6GRX4GT]$^ M$(OXAE-<[<[%K>V9!=]&0$=7,&%WL1K=J9ZARD.U)^MST=.[CZ;H3$A/ISH' M(5P@7.P0+C1YJ*FR,BAFB2%<;,G2W)F';$^K].R'L7H7&B')BTOG#-6#C_C! MQ,*66;7WB85CN3_7W";X0Z1'IRY%>'BH]>50H\E-@,T+]?KJ&$?P0_!#\:@)"Y6%/@>LN!+\. MB.I^.;HWY)W>FT#/N*=\[4IWPDU]V(C=Z0O2W>NN[ER48M^\?3.?$3@0.!`X MC@$XNNEBQ6A>C.;M.'2B$MD3)?*Z)RN*/L<'U"#)<)T(3$"T0+3H`EJHJCQ2 ME3PC$"K6@XK]\F]B("\&\N(](=X3XCUA^+,N#WOYJ-^Z8R=>$NZ/BQ>1#Y'O MN)#OM=Y7$;TZ9OK76//87A.1&)'X()%8Z_<0B??;7XNHA:AU9*BE:K(Z*)B0 M"%OH.]ZK-ISZ8!]\Q_=>:#C2S/>^V8'MN=+$\^DKH>#'Q8)`JI' M;&)W6$WL>#Y=?U\L^P/M18J4.UIX^&*?4+QGR7L*`-*AOU MS:14:D--50:C%JAD@2!GKO7),S?$T9-Q?SB>H[1^W$W0VY2WZGC0&[1&;X68 MMR.J2F^DS`M!Q9#OVJ.PN9CV%+J?5J8PSN848KU!7I[T%$5/Z6PV<+'_[/KD M-F7LB:J.5&4%>LL)S@GW!KFL#WOC>:*;C+XQTAMS7.^K+9&>ZL/+R81`-V.2 M/'I+WW=+*(6F[=@&M#L^\C[%RUQ*K^4F[(]W6E>JI0#D9OWM]L;43-B3[W"B M]@0;UK7E]=)%7[/E7:DMCUWO#J`=\@%=^.QG9BJ"=`>%H0*DUVE%GV/G:",8 MC1"]"*([W_H8X7@U@-(0H!"@#@.@NMTY&0$J]S':BV@O9MG37L/Z7+S7)M`8 MP7@1&+_^X4TM%B,4=VSWK06LJT6:[Q^3$*(."*+NC>^27ZQ[@#C5\2V(9UI$ MJ&-!*#2B]FSWX0D/P>E8P`G-ISU"J$4>MTZDYB7NN:6V8+S=3GBIM1-)[/VYPHV.1TCTO4KJ[ M!);N%"=5Y7%_*"N*4K=1=J+R.I/GU*GL.82+/;5L#@LV]-XI(D8E=^:LCFTB MA89(L6ND0,,"DE['>A\-"S0L$"XZQ8F.PP8:%NT;%HN<:MWTDQU0>U>6;YDK M-B73YT)P48G45^F!9UVBNPK51"2Z.H!X ML`/RA;4I??,^*3*@#)IU!I3`[M.DK0N,[^KDZ@:>H6?9$L[Q6!Z,2 MBQ352R<.KP@6"!9=`@OM=%RG6!$IT,V%2(%(`6;%2$&SHJM@@68%@D67P$+# MV[.VD6*17PM=51M>MFL/:CB#CPJ*S1->^K[[/0!1):!*Z(!*4$MO25$IM"PK MB!F(&0>#&2H(\*\:)#>($VQAY@!MH8B!D=P@RT,3`0JPZ.CL6[ M]<6W/5]Z(88O>=^(?V*8IA\93NW"HW\+]0CJ$7'ET1_,6Y^H2N+A\'84H0*A M(@ZEP((5'44*=&@A4G0**<9H5'04*M"H0*CH$E3,9Q0B4JR)%(L\6.B4VO"R MW;(=#O^]D$R?6'8X%V^%'BG4"*@1RH-P2XJIHDI`XQ&A`J%BSGCLH?'82:1` MCQ0B19>00BO)`D2HZ`14H%&!4-$EJ$"/U-8]4MV*JGORY&%'?, M5CZ6OL"(>HAZB'J(>HAZ:W@=$?40]8X+]5Z7)Y$B@NV9$Q21"Y'KN)`+[;4] MM-<6.71WZZ/MH8\V&?',#"/#R;3DC$O`5>^<[KMKFRQP1W?.QA2A=CKL4YBQ MO.C!(0MP9IOLVEV+^&795'+OV%U%J,I#93Y0LL#K;NK#I21U#W5D M0J"#*;EBKL)[X_NM$9);8GJN:3NV`3U.[^$%]^1[^!YDLFOKZ+`>B71%X9T7/:! MJ?SU@7)/_D%,^/.59!'3GAI.\.LKY=4[==P?4O6:SK95"HO3 M;\+`QI.>13Y99=;ZJW?*J=[+S+D%LM[M:)W5[(SU=,9Z89VUL=X_G'5N-.L= MKC,\2\YS8DUZ3=:RBX%T">4LMUN()K;$;3Y1315&76Z:Z M^6UJA9KN-57?EQ5JOH\416MM@9JLSP41/<.#_Q51+;]T2\]US;VFC9=;RL8SW]K2-MZ)L++[OK1--RE;VB5AM.6ES352 M$Q9$*UNTR2J6#=Y,72]+=F/QVRS9K+#WG\3PV[8P^H,FA)<-/R83M4\NR#?B M>+,I<<-6]H[6Z)C5G*A5CE:K3'E=^[VWW)HNQ8!M+G3C':DU,BWV8J$WN7DW ML-`LI_K,^CL*0GBN)8!MLIK%D3,D/[[E8805#I16K*"A(L!EP6"-#-5S2H+M M1K;[>#,C/IM>.UI7.=7&@T5"4C;ZN_59V=@=-M3&.V3E$OXK=;@.*^=>]UT_=^Q*PEX5#*)X\P,RZ+4"&>_(JX9 MX)M@9ICSW^1N)12E[%YBJ0N"J@\JGL_>7RP1I%U]R[)6?DIRC;;D=="&R-F# M*T/3`[F*ISX0LU[E>FR9-(4,VW87.6]2)43\<@'>Q@(N%+]:%LL,H?H!RBG*Z#XNW M:U_'O);CGXQG!6W6NF951RNJUBVH56&N75R>W]R>W5_=4!&C9@SQ\Q;J435,Y6-6I,6-30BWY$@'\HIRND^+%Y7S[RY6^M1Z:7U!_.%#2T=' MM$"TV'NT&,C*:+R6("!65#-IFRXDM#E;6?`K]QMQ0\^W2?&2!@U-5!T[X43' M58C:DQ5]KEP-*A$T.!$U$#4J46,@CP9SG6(1-;9E>NZ!;S03Z9B&/S:\%3U2 MZ_7,-/V(6'&3@LZ;L`>?@(3]>EIFU7'UZU''8UG31TM$)NQ$9QY+WQY$/T0_ M1+\MYAD,Y'Y]?6]$O^X<*79^2JC'RU5C;1#K&[$)L;YE5AT9UFNZW-/'B/4= MDU5$/T0_1+_-H]]8[O551+]NR.I^.<\WY/'>S_Q:)RU85K^!6O1_+[UTN;O8 MO=D5>!6[(BZ)V7H]U6=,'>4:@PHF'>[/>92A"!4+%`4'%6.XK&D)%FU#134\K9L`M MO?Q?79]06OY#+.G1L%W)`NR@)B17Q(30LIH3O7+'M3\Q;)XQD!"X$KB,#KJ$B*Z-^Q^SQ0X>M;3F1-YBB5N`Q MYJ=U`(P0MX\'MS5M**O*J,`J1&XT./=P-R)P'0]PJ8.QW!\52RXBXA[J/?FD$@['?8I%%E>]."0 M!5BT37;MK@S]LFPJN??6'Z(7HA>BUM8(0_;$\ M*G3Q64L<$?MR>A7O_P4!2>/AC%[>V<^$2MRR,TD+D]P;WP_8\V_ MSUSK4UJEX!Z>O2??P_=@3[_C;_XE?LW*VHEF_:4OO#75\JK=ZJB#GKI#-LG[5W"V1W-7\_-7R_,?Z",QAN? M?OWLX^XD+VNL8D_1AS732(9XUPXU]3Q5!Z.!U@XUS?C/"V1G]M\:G!R/-7VT MMD3,4?1N^Q.M7R1-&?059?L3_>A[P1KKHVEZ3Z_;L>S]:Q.Q@'?:N-=75RKTMY/5_'X[Y2 M#ARM4IZ&$WXT;#>X<>]]P[+=Q[LDD'`-_-#UT7#A'!934*LW6IM+_7(,%674 M;V9Y$Y:\/],RA_F:XP+E[+V7BNQ92GW M`*QPHKIG)ZIK>J*ZG3]1:4`5^^"/2T[4@^=8RYUREQPOX[>_N;^4+J43Z?WE M]>6'JWN)OO7ZKOZ0+#B1==C#WP_^3_&?NURG32V3TLHR-:EI0K<>_;%IR+LX?;).23NGPAEVW1FN"]2,//

.]$%^:&J'Y1'5O_OW>A+Z'2!/;#T*I]R/\FQCF4_P8^?^-F1?\ M'$@SX^54NA0?!M(#`24ET;.L\R)1JS^D=-ON@L'H7"04`)^4!5=5A1%,EP+_J&R?P!'V%S$'&'( M0")4HBV)XC:9/E!:=%66`,'9HZ!W3C->H^2O*S?_HX0],3F0:A)Z_(Y1BF;P M]P_J$'H9I&2P*?LDF!$SM+\!W:]G3A1(/_33WR6O];[1%P'5QB.!"?25-V(> MML_>1!^G:R(9($`SGYS`K:;MPE(P,YLN!CS-60E"),-'AFEZO@7>".G9#I\D MQYY2O2=1!2H]O+`'KF[O3J77]T]>0.)OGXQOA"XX<>D;3&K/!7"'"O,;,3;S M25`I-2S+AB4R'.F'0;H"M5."7\1K`YSMOUE_`Z;[[;0.DE8#).'8%!@B$+,E ME-H9%E$CRZ/;[1_ZJ$5M(+",Z#+Z+X6=1Q>]%!L,[LZ2'IAH4%`Q)#X.%="3 MT#NA_Q?[DHT).7DR_`>Z['3IIY%C@+V="JU'/N8!I)$62P03[J% M'NESC*13B>[,9"_GMVB83I!OY)&F#BFU[SW#MT#^+JCY9X8,@J/PR?-9"EG= M_,6>,J9LMO0-=(OWF:#3,R<381EX]$!_XM"E-P`4Z8\I@M%_2X2J(!MP(MD1 M;8JZG)?N>%_E6<(8RF#P5+J/O\VI@V<#H-YF8`[?RNQA\2:]]K=ZB7Y(-0.\ MHHZW!F@P<)4&;^G+?A2:(GSV!&SG5(4LIO1C`5QS/X(A*5JQ]]#ULAU&0\Q\ M06&05V'\UX']O6S4TU8`!.W,AG;F70CGKYM98E\&[:/Y89F7%`L_&S[=#)JB M])BTEV"=,(82Z`=#ZAOA>]RPO%G6*F3OF5L'67I^LNDH&=2$'S_Z!MUE%.SH MPP%[AK^,Z8T'+WS*F`*P?1.2.!8Q;`)(\2FT4TU@Q19)0/4%>:)"1H!ZF.*+ MI(YE1MRI=.TEPS!+C("1P4BA;^"Z(Q1OYZAAA]`KT_8Y+,7\4GN%W5TK3ZD? M8E6_0KD[$LS_[+$*N"TPU?\LK.'<]\0W^XR.J\XLM_IUJ'OI.^ MQ_:LU9;MW1?U3SJ)-<=._67M3J+ANK0]B69+6OGF,V[@U?@J5]A4[#I=5PJW M:FO0MSR$K#/AY7<8CQ_8R80_&]_M:30]5*[T6>+52"]H8B]+?=%V\$QI3V145MBS*5A/J7H#1S:ON@L`)_J.7P`?^_OS-U[3_QIV[X3 M4#IU2-.8L!)5?4<>03G>DIGG`T?V.5YE5^$J$%%2=L/[03HI^_CCY0W'@`IT,*7[Q:1T/5(;T:8; M()#APBU@-\VFX1,(@K`BDWW^9/A3PR1T2YET/\K2E#Y"_Y*][++S MEOT+_GM!AYD9/H\.<#TZDDLI$4/S?)KX=1)%)'$G[%G\5A;&]AFB!1+Y;C-` MSO".!1.P2P"/T@:W9M\I*1#IR;WO7DA'!5[&JQK?3Y;1G,[J,TB&N(LHD8.4 MX(STL'N#6/`HT^F4;3-R6,`$R.2GK^]OSWZ[_"2!E,/+G^E2^"?\[GKJT:E% MU+0#RF'.0FS8=!\)"!3P7=Q&TS=&`1]PFJ%T:OQ-9S>-'/J4(0(BRM>-3@JF M3QF\S.W#T0!)B@X0U$V7B5W!0_300Q2`*$+DRB./':K:``FK@>\![`"#WTC3 MO3?Q(A\NI>DZF8DP27!O_\B0ZFW5LKVF#SB1Q6.3YN'I30T.Y?&F#&4D,*^* MU%#9#<3F84$*$WIB9A+(9UY"Q4\5M,,_DA>%`JP-Z='Q'NAO71(^>_X_(,K\ M1VR?TSWDPNT;@S0[X#8+W-R5(2*E)R!E3U,#RWRBVRR9FQ>%+$53FE`K)7\K MF2@`@3PG`7'@`M\+,E,1\$D`*P-234[R6LN#S$&*?1#K(K$H/,,A[%:1XG=` MI;[]>_[#V(S7'J@OSX^#;T`B^=4Q%1JXM74)L=([VYCA=(78PL'?R;)Y<%,* M83\N`^3\5JG7MO?9Y08A92](M0!%"I_]'RPRD%1&+]U[5!42KIZ$&4+Q@`<& MFHYA3[FDTT'$=7E6ZHK2@:&M"5I7K"2#'(CDB7S/\1[SW['H+X;-U$QG$6;) M\J;V4@Q3"?:`]6A0I&/7[$%J?G#5:_G1H_3\Y-&M3;`0+ M]L+U1!!FA!-49".&M8*E[D M*3U$B`T$O(C/(F%&&CCG2G7/O[QG""Z:FTDRDD/8L29=RGE*RV*PX]#6CYYG MP8DG\_`7G_[)5I*].+^Z<]L:U1#?V25&-1,+$>6\Y&;DBN"14!/6@$A1R\O* M;K*KTJ-*I2"?2CD1RF_Y)`_#Y9LO9]2P"/QTDS#=4F;8S$%_<:.@[5(E-(_$ M>_2-V1,[0T%H.CNYL\P(^B^Z30'L6)H'?^[UPQLQAP?B>,\`!,S5P&0D"83G MQXOL"T6^3N+[B<6&BN,Y98`WI3!^)KT.GKQG=VY,,S?FFUC)D._T-!KPE)(L MJ"7G81ZF7W94A2'.#=>P#";FYT^V:W")9[L%-`4U>""4.Q\WFJ0%IU5^QPT M(R>+3'!!3/RT*NXA504W/1"UF!T#P8E5RKRM7L*9\[=4N&)*ZQ1'O#PM7C2W M!H:;JNOW9T764BPJ2%L[@=L0I020F1']Q0B M#"(,($ROO_A&I]L8HR/&=&M7;<(,*V5!Z];5GC&Z??AJVXY==\=TI??0II4N M"AX*W@Z0N*U^J^UTRJK:!-O*<5C8Z6##:_TECO8\-WRR23NFG6XP^XI9:_3. MZ`HJ[*Y_RX+>+%ODP5CN::JL]-2Z&\)-J(GUI&0/-PS"!<+%WL.%JLJ]/L6, MD;:6-"!@5#-IC7,_&I!M+-]G'EU:IQ#1].>:&B-L;,>.1*]EEXS.+[ELL?J3)EJ?J$90C0B' MA#P8#>3^0$P,98'94F MB">U$ZKW1"?LSK77MJ.;I@U-J*ZA[**Z(?HA^BW>?3KR0OSI1#]NG(2:,L'O9*S>8Z/JT9)HV<$ M/2,'XQE1=7DX5&5M/'>?OWO8/!#_"`('`LA8/7K'ZB<2 M!&\E:$L#W;("44?0\9ZA+&"^O!>Z6#N*M^AD.!HGPVM=4^6!.BBP:N=Z:W_\ M!&_6\[(@<"%P(7"M`%QJ7Y/543&(%H%KP\#54<=F+0#V\@#8*>?G,H1O5SXZ MBMS:Z;!/-Y/E10\.6;";MLFNW27)+LNF$F])A^^U=+G7&\N#81[IB\SN)NXO M):M[N+<1`A$"$0(W#H%]N:<.Y-&XOE(A0F`''-+\\]9;">3;EHS+5F3';4OF MS@'8M:11UY*'N6-8>U[Q"B<[=BA9H4/)Q[0YU%7:RZD6D%M8R2W#3'<`98D+ MOF8:JS]>P56Z-^JH[=""9K6Z]X\]^7JC:D^P85US2"\5KC7+=Y<"R+:ND>>I MV>HM\LY?GOZZHGE+3@P7=')I\Z+[R)W6W:LLCEH&M4R!/>VUZW+R%S=N]4B/'LGG1<-FYX7+8.+=.RZI<0,8JN[1> MIO#(N^TC[RWY1MRHKAGS!ER=J"BZ@G3'9^7M%/T6&7G+77$MZ`*XX=7YY+F/ M)Y_L;\3*K\X2\-#U*>[\Y>FOSX*`A,U1&C&Z8R"TQDD<\1BMT5T#$5JCB'2M M(AV>NQ'I#@OI*NSAU0TS7!HTM5$!==!O7FUZ=)0U*^KF?9.`+>G=/35&L.8, M;A#<(+A!MNG'P@V"&P0W"&H0W"!'OT$6'<_:*B:R5@W`PA%O=]Z879?V^^K: M(;&DN]`(2=!PX==T?F"=V#VO$[N[D@#=J0_;DX<:U);&AJ_[48\$X0+A8J>- M/35E*(^5[D7;(UQ4^S/V;_8(%P*50".^%$QY6!3A6!(H_[(&>*<2+#N'%J#^0M1%ZIKH,&6AB(&1T"#+0Q,"@JKD5^')V<7%U_?'D_X$[NLW:4$SO;VXO+F\3 M;CPX=#=*ZJDZHQ/V'-OZ6:K#I$-E5:GF6HY5\[IMF\QJ\/*,[3P:R",]7SMC MCLF[5X[KB>H>RBJB'Z(?HM^FT:]X#.B8"P%1;RD>:HAZB'J(>@M13Y6'8TW6 M!_T:[$/PVS/P0Y,/P0_!#TV^/9'116[BW7I^>P>`DUM0)X?`IK;WJG8Z[-/- M:GG1@T,6[-9MLFMW'9>795/)S6!WU8FJR[W>6!X,ZUVHW=0K2\GJ'NYMA$"$ M0(3`S;L3-&4HCQ5]_]P)"(!U?&SD3T4`1``\=@#LRSUU((_&M0B($+B'$(@V M($(@0F`3&U#7>W)?4=$&[,C.KG*P\L\-.M=XA1[\G^(_V>>221QG9EB6[3Z* M*2F"F?!-,#/,^6]L*_;(VD%XHBIE2Z(H98NR%'>J/JAXO@IFN(\Y+TJA-\O^ MO$0FZZ*U?Y;^N+JX_]=;21_,%J);:=!P0W1<2>CN&5NN*5MNZ]CZQR4/07[P M'"NEX;7YILZ462_,=^[6I6E8]6IAU']'06A/7JH6>A?L;38>8\#%Y?G-[=G] MU0V5D\BUB)\'X3O#H62$GO39^-OSI7,Z5V]*_*#A?==J"[EEG.D.H"QQ8U6M MLH[WLKX*_TSBAL3_63I$;I@>2'7,CH'@Q"JFSNI7QIR_I7*\<3;^20P_D`A% M+DNZ(":9/A!?TE5YVR?E(XP)6>.^?4/HE4QGR05'2,ER(P\I6EG MQ=2YUBR[39V7-47MU3H+6S2Q$2(181!ACA!AZJ\C$&$.P@@K94'KMM6>,;I] M\&K;BEUWQQQ&%#`*'@I>)Y&XK2HES2ZK1K$?<\DK@PW4&2EQD&_7RHF]UM)9 MVY[JED,"]A69#J"2U>XN\;M3P6HHC[6QK"FC(B]V?LO>F5B/3D40(5P@7.P0 M+L;R4-5D?:0A7.S/V1Z-Q$5&XGLT$A'U.\")CJ,_-F%`0[$;&P4A8T\@`XNJ MH_LQ?=?Q69;G:%FBFN@`)SJN)K#5/%J6W=@H"!E[`AG82/H@W)#+1'\?L4%Y MYCB2QYMGE.9C%58I64-LF]$!),4JHEA%M#2ZMB?KFB:K^UCSZ`"+B2+X(?@A M^&T1_'KJ4-;4/2SV<8#@UU%?\C(5DPJ\7C6T&4L]-6(3EGIJD4U'6.H)*QYW M=V\C!"($(@1BP<_C@\`J,YA_7E&'JBYI7'B."UGCO7X+:>,YXI;DYZ):8^DX M:2:5]&18DN>2Q`4MA4]&*)G>=.;;`;$D7?M1\B92)O>*K<5(4X<_!U+`ZHK1 M[\,G(IW3APSW)?>#F>]9D1D&E&()*EO(DN'2EP[82^TP?@/_5C\MN_G)^KPS MB_3+3U%P\F@8L[=WY'%*W/"6S#P_M-W'"SLP'2^(?')/OH?O81W>Q>O^2_S0 M=00EAFXF-S/B&_"4>$L@1:Y-WS7Y]=6,ON$5984;TM>P3TSEKP]45M7?#!VHXP:^OE%?OU)2ZRH'>M4.2FB5)3TG2VR#IW'.A0@+\ MRG-O[>"?+\2'#XQ'HM92-="J./47JT5W2[X1-R+7)/S,:CW]]84+RMR`_.OL M7+17[Y1374NG4T?DN[;FHU>QN:7Y#%::SYWY1*S((3>3XB:X>/V6O>/\B MODRV0U.A?L=4T`%4Y&OGLA.+6NW?6,9FMW% MB"!L=@PVL5+7GL`FU@+L\)Y"A$&$^9#X?9IY=;J),5@-L&.[:A-F6*OWZ5B4 M#8NR=4OIHN"AX.UQ"-5:G>L+6;H-K9X-I%0LO"7<\%I_(7[@N88CG1L^V:0= M@UEW>YYUAX6_H/!73U-EI:<6>;'SZ(3.1,ET*O8*X0+A8H=PH:IRKT\Q8[Y0 M(`+&[L_]:$"VL7R?B66;AE.G$-%R/&Y5L/OLL>ZH!$WNC7NRIO3K-@PJ!+0@ M$380-M+A=%G11O*@/T;80*\E&IU?G@Q_:I@D"LML3[0^48V@&BEU2,B#T4#N M#W14(VA][GRS(&SL"6R,U8$\UH9Y1B!D;,?RW+@QN7:%IF.Q.J]<*PI"WS8< MEI+)"A%6[XE.V)U8?:N:'4<2&=F&*CK8ZEOJ`*[G!CF^KG=QB>6WNF,^(_HA M^B'ZU:%?3UZ8+X7HUY63P(Z*#U:3A496T\=Y^_ M>]@\$/\(`@<"QP$"1U_NT[.G@J&AZ%@]>L?J)Q($;R4H0D?MV3!@WE7#<;QG MPS5)H<,+NEB[B;?H9#@:)\-K75/E@3HHL&KG>FM__`1OUO.R('`A<"%PK0!< M:E^3U5$QB!:!:\/`U5''9BT`8E>5SL,1MA3`E@+8567?]C9"($(@0B!V53D^ M"*PR@_GG<5>53)>.U5H5O.-O3CL>9+HM?/0\*_CH>T&F0T846,76#;W*5A1Q MO2@H%S7?F$%Y]6[Z@0CW"K;2[3/8_.H/*WOU-*>T M1^>U>4H;]SG2AT-5&S?9V>N2U+C/4;\_&"NKHF%R;7=+PLAW`[H:9\G='7NX M#;;IFCI0BP*W>.BJ?;T>TT(I&8E_?>//?FRQ&I/L&'=4Y->*EQK5ODO/35M*]IDGIJM!IOL_.7I MKRMZ/.7$<$'#IS;C88[\;JM[#0A0RZ"6*;"GO6Y^.7:.-J)DMLC>N;Y/2_(5 ML6][FU?#S8N;M[!YNU>1Z%@V+QHN.S=<#AOGUNELEXO;6F67ULL4'GFW?>2- MW9?5I]I:R<,3;@>V-Q[1]@7]%AEY#1&Q6;/032>)>>[C";O9R*_.$O#0]2GN M_.7IK_GM46.41HSN&`BM<1)'/$9K=-=`A-8H(EVK2(?G;D2ZPT*Z"GMX=<,, MEP9-;51`'?2;5YL>'67-BKIYWR1@2WIW3XT1+$V%&P0W"&Z0;?JQ<(/@!L$- M@AH$-\C1;Y!%Q[.V:@ZM52JT<,3;G3=FUQ5`O[IV2"SI+C1"$C1<^#6='UA. M>L_+2>^NBQ+_1^E"U"N$"XV&G_7TT9RF.E>]'V"!?5_HS] MFSW"Q4'`14_NCQ2YIZ%UT6VX0.L"X:(#<*'*NDXA0U$1+CH7-$AO-!E?:S(`Q6C MKKH-&VAF(&QT"#;0S,"PJP/U4HGLP/^RW4>+ MEF<$:@6T(A$R$#+0BMQ+O$!G%>)%A_!BU!O(0UU!$Z/#D($F!D)&AR`#30R, MO:J#HV/Q:EVYEHW)A*@RNL")CJN,@=J71V.T,KL@*GM?2A2QX:"P`6NI[LLY M%%U7"!P=`HZ>KLJ*VD>CH@.B@D8%8D.7L`&-BIT[J]#_M.'E^^`;KDDJ%Q%] M4:@:4#7,\Z(_TN3><(1F8X=/F@@9"!D=@@R\\>PX7J!G"O&B0W@QZ@]D;82> MJ2Y#!IH8"!D=@@PT,3"H:FX%OIQ=7%Q=?SQY?W-_?_/YK:3-ON?).&+OUTWX M1'S)I$L5^G9US\'.><'67N".;K,V%-/[F]N+R]N$&P\.W8V2>JK.Z(0]Q[9^ MENHPZ5!95:JYEF/5O&[;)K,:O#QC.X\&\DC/U\Z88_+NE>-ZHKJ'LHKHA^B' MZ+=I]"L>`SKF0D#46XJ'&J(>HAZBWD+44^7A6)/U0;\&^Q#\]@S\T.1#\$/P M0Y-O3V1TD9MXMY[?W@'@Y!;4R2&PJ>V]JIT.^W2S6E[TX)`%NW6;[-I=Q^5E MV51R,]A==:+JA=J-_7*4K*ZAWL;(1`A$"%P\^X$31G*8T7?/W<" M`F`='QOY4Q$`$0"/'0#[\: MSGD44#X3/SASK4^>^_C)_D:LLR`@8?#^Y2/Q'NGZ/-FFX9SYQ`CNX?7WY'OX M'D)>W_'!?TE&,AP2B$&N22A%KAW>DLFOKZ+`>B69=)KT2?:!.=3^`BK4WPQ7 M4]3>O:>K%\2$/__Z>O=*LHAI3PTG^/65\NI=;ZCIP^$X,Z/\.$4ROOC>C/CA MRQ?'<$,ZKA^AQ**6D;JAWTAKLZ679HZ?L MT4O8TQ\I/6T+[.GGV%-"B4JA@B+%%M@SJ)2>\^L"47I?4<;]?F/V+$/&L'*5 M2LA0QY0Y&R%C5,V-LP(96D\?],>#C9`QKN9&D0Q='RL#M;G,+D'&2*GDQL?W M!3*&BJ[VM!HJ5B9"K>3%'!&CWF"HUPG&RD148^Q543P':G\TW@@1>B4GYHCH MZ:JBUNW4E8GH57+BPVV!B/Y(ZPU'FR"B7\F).2)&_8$VV@@GJI&3)8* MU_AB7CK+KVN+U@H6_MOSPG^[BWGJ3L&_H3S6QK*FC(J\V'E04F="XSH5<(EP M@7"Q0[@8RT-5D_61AG"Q/V=[-!(7&8GOT4A$U.\`)SJ._MBS!@W%;FP4A(P] M@0SL08'NQ_1=QV=9GJ-EB6JB`YSHN)H8J'UY-%903:!EB9#1$4YT'#)ZNBHK M*EJ6>^Z&7";Z^X@-RC/'D3S>:RA..:^_CNB$=7G$B4E8='DE5AU7T>6>K&N: MK.YCB;@#K+V,X(?@A^"W1?#KJ4-94_>P-M(!@E]'?( M35@9KT4V'6%E/"P0W]V]C1"($(@0B/61CP\"J\Q@_OE\>=`-E,$J*;:U3"&P MFG*&PG-\5EH#;#C6QII25[IM+;)JRAO6DC4>JIH^JJLRN`Y9X^IRAS%9[TO) M6ECG;AVBJLL?UA.UL.[=.D15ET.,B3HO)6IA;<1UB*HNCUA/U,):B>L055TN M\#6^^`ZG@CA-4[-UV%9+6J?[N\[\LK@R7UUSW37]=4?]W.ZR\MJ1GXQR6GZL%SK'3PZYO[ M2^FC\&B,*/=_ELYO/G^YO?S7Y?7=U>^7TM4U_?=EV55X]A(0_G[P?XK_K.6E M/M@P,S?%R_RMJ6E&T\@!]1K?GF:ED;X>Q)%_:`?TI9'K$TKZ?^CO'PW;#23# MM23'"^`[SY6FAO\/X94G`V)&OAW:S"H))6\BT?=+/N&#A<9WB4PFQ`Q/JVSG MFI4YB-J62X0,K-6YKK2M8YJ-;;1=UW8?I0?#,5R32">)K\7XWO7#Q;[MC4/*D]K*A77Y M,;)#M]&JKLFJIE=OE)WHFLY$-73*V*["^J[/'L'B4,!B.)+'A6`\!(LMV9TU MIN0ZER!%[I4=!I<\_"U["BT9]D0=+;11^4_J*=FJ+?HU?S'XTVNX%'Q3?2?X M0":>GW>-;Y9`GYB.$00L[`A"D8(:8QFM952`.^-$YQ5A7Y-'0[2:T6K>^59! MT%@.-%JQ;[;)Q->#OMS75<2:EDMBTG;[N6>& M^D]@M(.U'AC43JR@?R15# M^FH\756'!UJ,8IL'`JS'@_!WS/!7%BR)\-?)$P'_/*[%`_\2N?-I48I%12?* MJL:83\2*''(SR:0L\X(8\R_[Y`7!/5"P6AF+@TCPEW9]1L,$B)"(D)CCCPBYZ_!/S/'''/]]VQN'E("`:;M5 M;NO=ZYK.W)1TRMBNPOJNSQ[!XE#``G/\.QF_ACG^G<@9PAQ_M)8/50%V((Z\ M2XH0<_S1:N[&5D'06`XT,,?_L+`&<_PQQQ]S_#''_UA"=C!IM6U688X_YOAC MCO]"J-RV=")<=I-5F.._%I>/'/4PQ_\XXG(PQ[]C6V=C&A&37-?FT]XDN6*. M?W?W->;X(_PA_&&._W'!7]6)@'\>Y_BGB?UK9NF7Y/TW?,\U"6\F]\9W*7)M MGN0?!=:K?-;_>/#767`SB9/]];\R[Z;/I_%%5^XW$H13XH8?#=N%UW]F:2>O M)(N8]M1P@E]?*:_>47FEXII.?DE2WVUNHL/<1+6U)SH^3XE_`OQ;<_:K;AH?54;INQIOA;`V7S4[V"W%,Z[IG+'^=/K%809UMNM;^C(+0G+^56_0IFTCTS MDZZIF70[;R9I236=/RXY40^>D\GVO;ZYOY3^)9U(5]?G-Y\OI0^W-Y^EB[// M9Q\OI;O+^_M/EY_I_*L,U*RC#?X6-9`63J/!) M032;.3;QP4?IN2S\`SX&D3;<%VZCCC1U^',@S9X,?VJ8)`HI`CC2S/>LR`P# M6;J]O#X[OZ(G9EDR(S\T;(=8\=<4*"0K(E+H292P:&*88>2#A]0.@H@$IQ(E MB`IW9/B,*#T[NF2XEF2'04HD2]NF+[==^CY#"D@8.@3VKV0\^H3_]4RW%'EX MR<^.?6T!%3/C)3?&#WUU)"M]1:+ZD'U!"9_88>XWCA?0$P2GFW'.""2Z@R,G MC/DEY@T$R-+,B0+IA_%0'J@*I7)*U_))>D@2-N/IBDQI-C`QS"?QP_#)"(OO M9)A@NQ&Q?I9^Z(WDD=)/'Q,D3&R?4AD^>_P]@61,*+.DX,F>P2LXQ5-X`[#5 MH+]W816-%S8`?Q M*!:?9@Y4R5_O7[(TI&SZ-UV!D$L]@"G=G`Y]R=1X)#%'`NG)L.BJ$OQ`#I-JB3R,+7"*!$TH MS(!ZO:T63D<7C(%W"?]*M3/=OW3[%JS>TL'GK8Y5"=4$H9\-GYE:I+[E8>61D)<(+F.CB*35Z=Y4'ET:$2S M2N&'HD]CJLN$XY-M/-@.BS6]L`.3*MK([[@I7.,UW(DA?$4-X;/S\]NOEQ?2 MY7]_N;R^N[PK#55=UO`57E)AJQ:B_-:TAK=J\]+SFD]-)XE\G]$S&GV(6@QS M);V85<3L,2IT@1V`2?2V+/F@AHT'49ZTE?S;M<+K$NNMF2M\27+*ZD`=8@1@ M>Y6Z5H^XXORMO>+",EV%4(/:\H+EHKC5@ED8*HH(@PBSWPBSX"H?$:8KU_GK M&&&E+&C=MMHS1KONF,.(>$?!0\'K)!)WH@SJ2%E0Y*,#SK"MK/5[ MSXV"8IYZEU(KL!C+KN%@*P'!PQ4*-VV1!YK6EQ5%*7-G-N/"8==2Z50F`D(% M0L4NH:*O(%1T\)B/]F(;RW=A!Z%O/T0LP&A"T')$==`13G1=+2BZW!MAY4^T M('>]41`R]@0RU/%`[O='"!GHICQVL_.+\>)[CL-BS'S"2UK&T6B;O'U%?8+Z MY'#TB3:4^Z,^ZA,T01$R.L*)KD.&TI/U<0\A`YV9!VA5GKEN9#C4H)QY?EAI M3Z(YB;H!=<,\+P;J_#W7LHQ`]8"H@:AQ5*@Q0-1`OR9:H,("C2P[A'OT^@V! M9B'GZ:WTD#\=JCJUK\1C[V7;' MKD;L0^Q#[*O!OB'%OB6JBB+V==/5W*9]7^AI6F#?JC7$L!EK(S9A,]86V=0< MRY?HQ;IMN5H*ST>Z+H_ZV(ZZBUL;$1`1$!%PTP@XU$:RHO81`;NSM:OL6OYY MW)$:_C778:Q!*Z"Y5DVYAM;0WB7S?+YW]5)=A`ZBA4M+AXJUO"K8Q*53Q:+7 M.&ICBX6EU1,V<>GPGD*$080Y!(3!)BX=VU.;\.RVZIW%7AK82Z-;*A<%#P7O MZ./PJC;!L83781.7SOK:NP('V)D!F[CLT_T=0@5"!39Q.4RH6..8C_8B-G'9 M`PD_)'6P^[#B#JD%;.*"%F0G-@I"QIY`!C9Q030=38%]3` MLJGHUT0+-+9`L8E+1V`3%*!!LXH)F9V?V"J+&GJ`&-G%!7^9!6Y+8Q*5# M8(AJ84_4`C9Q06.R,WL%46-/4`.;N*#W]@5YL9("-#+") MR]Y(*F(?8A]B'S9Q.2+L6\/5C$UGCWFI$?/&]"0D"RC7#R?#MS+6N/==<3)FJ#/,,^DN\ MF.O/9I3G=//9#+HXFW'%VD"$/GUC MZ4Q&VNHSV<@L5*5B3>IF,=2UP;B-6;!KOGEEM#9RZ*/A6"VT+*L\@LT7PP]?[GW##0P3L+BL]]I2#=2V=9W\=Q2$]N0E8VAE;94E MS:M[9EY=4_/J=MZ\TI+6:W]</,=*![Z^N;^4?I-.I-O+3V?WEQ?2E[/; M^S^E^]NSZ[NS\_NKF^N[TDB-['TS_"W:XE4R49B78N*%=C?ZH(5^-]+&>)BO MWQGYMOLH$<-\DKR)1*56>B&&'TC$M8@E47%B""'IJBR!8+&*2R#^[*?GWG1F MN"_2S+`M*?0D:EH94R,(#%GZ;-@D#.D?\,`YE6SB.+8L??KT199^4(<09L>_ M^T'M\7_X))@1*OC?B/,B2Q//EPS3]"(W!`+AEZ'Q70J(_\TV27`J?3*>Z58R M268D2HW^)[5RTL2H>O12E M"&"W9]_XAQT^91^IUP5J%5J`5A",IG!^;WR_$USFZN&O"\&?4FVA#G,Z;\T9 ME&CTC?)$R_)$3WFBK\>3WB9X\LM/WQ]\AW??_']02P,$%`````@`:GQZ1F6H MN>HW#0``^:\``!,`'`!U9RTR,#$T,3(S,5]C86PN>&UL550)``-W7Q15=U\4 M575X"P`!!"4.```$.0$``.U=;5/;.A;^OC/['[+LE]VYDX8$"H5IF0FOFS84 M;H"V],Z=CK'E1,6Q@FR3A%^_DE]('%NV;$M6H.V70G#\'#_/D71T="2__U>S MV3@#-L":"XS&W;P!C_[CCO_;:#:.T'ARI<-&SW;)7W47/@+RF?T(,/F=_'WD MNI/]5FLZG;[1R:6.#C%PD(=UX-`/&LWF08/^^^<_WE.0(PPHQ'[C>N0USC7< MZ.PTVCO[FYO[Y(>;ZZ-&9[/]-O@2^88%[?L[S0&-V=BRG0\;2V"S.VR]07C8 MZFQN;K6B"S>"*_=G](/8]=,M_^KVWMY>R__K\Z4.3+N0W+;=^G;>O])'8*PU MH>VXFJU3``?N._Z'?:1K+D0VAUT-YA7TMV9T69-^U&QWFEOM-S/'V#@(F< MWF-D@0$P&[[I^^Y\`CYL.'`\L:A%_FX$=_BW-_R!?Q"] M'&1!@S+?LXDJX,HE/X^![6XTZ)UO!KWGA_":0RIROIFZT"X<=39,!@! MVR%N%N`5,##MV\1(L28>:A;U@ZL1`$7(BWVM=2"<.,T9G5IH6H2MZ"LM05[6 M(YV"[2(,@7.MW5EYRB4N%R+5)4:/T"&-TD0X<(%K;<9G4.976U$O5M7``="1 MK4,+^ET',MT1.#%-X'>LSZ@#(A"/R05O)H3A8V`"C(%![MQU'.`ZFFWTH79' MK'`YI>>ZA1!C/P/W2K/XK(I?NRRXKEFZ9_D<]PE@S!0P%\: M=:4$S$)Z#,"BHPS"T?TM[0Y8Y&F=YE#3)J03<%RG:QLGLPGI]X`3YR0TPQ]Q M3,VY\X>=\*LMRE8+6*X3?>+SU]QL-R,&61BA-*6,O3`'@#1\#\BR=`&P)&%< MQ"Z.6ZUA/;*&_!A3,#E@AU>T'&\\]N_6A$3$Z/LF1N-\=5S$)`5A`^`/&^V- MQA3`X00N[(9(U'L(R)0*+,VISJ%- M)G[NW$\J$=\AO5#\+BSGX+H8.N1/Q^17>W@),$0&8??")-Q)"[EDV%HYY!1H5-!UO!`& M%\8J'HQENW$B9):C.',^M!:N^4*<,MFB?WMD":&S1[L2:?V$>3+'BBRXW[%P M@0QYKFJQ24FQ7RPBOEG$`:J$ M:[2@@4R^Z']TRO6H672:U76/-(SG1*><*Q8'0KE&9+B#3^2+;`<>0*DX&F=OS/E22+IU"0;5&K55%QVUSBDN'S M_==^9(FS$7+]5L0`$B+U1K1]!B88CI M9\XE*A/@,2THZY"!6:,A]S39D6.S?5W'*F4^G91<*V!!=\W(*9ZZ'@5.+ MJ[#!E(]DQ?7(8"XC/5-8H$,/^CDBBM,;3S!Z],NY'6DB90.^N&:3PQ]KFE0^ M^&`8Z`<^M?:_`>(+;%EY'#)F4F+UDC2KRL13GW3@H8-+JGCS2AFNRJ:(O#'E M!!C'8(*!'NQ*(C];P.?)-KICA%WXY'_.M$Y2.DF,;:J#V:(^($X4L<7A0:`M M;T%A+9)1J8*D3J_7;`,>MR( M#:8\Q.96A,66X.T:(=)2!;-\75+`7I8N:6RQ9Z?E]EVZ2+\?(8O8"C5?YF0EW.E@X.5,6Y13[I>-B3%B63V5`] M?7@NINIVQDM*;`6%'?D("4>7%OF6H.3.*G,Q7Z)0^43F9P%>RK.F7<7H/VK> M)Q8=WE6R-=`5;G(+_\@K`GXXOW%HD/N\0;=+CY`*&F/*'D@9;:6B1;\+_XOL MDA2@?>F]`46[[?RDM9RNFP/7?RC_6,N_OIY_V?[[KV_ZQ)O=VF_WC*?=Q^'M MW+XY]J9GNWAO]U/GY\WUW+%V'_6G3>NC^^[FJ']IW'ZWMM[:W^XNCHY[\[/K MA^N/H-,ZO?YSJ[=C`L?8_CJYT.WO)SLF_C1XSVR[\.D8M>-6#AYWV'WV, M.KNGUN[YWHEU?36>PM.9&]\>1UT,_N']"T>B>S_H[V>;[SL'T#)SONV?@23NYNC_H[ M)WN'HZ'W,-4O#[]\UX>;1N]H^W'ZX>_&T=4@/*CS%?DRG\,)SLD\'SUXBO`Q M\NY9-6[(SX-4FR^1T41S*&970-,9OE*_9 M3&FM@O0,-SI%D7OJEK-ZA.:RY!?P`#Y%(M=H2W<-:3L"0PIM&U*] M>QEF/<>K@DZ0YLHQ+I,C4K6#&E-/^`K.KUL-&J54\A;!5ZQP&:Y6:B(JA?5K M>"R^)$JX^_^<`\U>$27<_4C606)RJ]$2KV\L&R@K.RJKI)E?$;ZG,VHRO7!H M)>%`FY*)!5%:P*FG@Q5@5NQIVL\6D'8'G1$P MSA`R:A0S`_;EJ)?%7>9K2^3V4YEO=2V?QPQKU&NL\LE!K)"3#>]\"HA(FE7G MPS`A%1\ES25N;+M7'H5"#&2Z(W!BFH!F1!;OWQN0 M-E0R_S#\T=5=C[-G\X:^I[<[D9_G?;MR&XT_/@.F&X6C[-,"DHM#5^>M)?;I\/K6H6+4[@ M))N"=Y(Q<(\#KT*V\R=Y#FA"8%QB%'ZV6+ZM45Q>BUY!_,5-/GO/62E?2)^' MUE7O50!=]"/&Z5+>L]P4A`@C.F7,8U2=<]%*]BA/X+^`U18=;05-E'M/JFC>7MD5M18-\WR@XOY;G"6IGVX(M5+]< M)M]S!$S-Y2]&)=X1J-G+YY94*X%-W%S:^\,82-6+6)YO2'Y8V5,DL!$LDJ.7FV\;FLM!9W6*"I':8K MB+I$F.##"4OZ3RT':0FS[=4W9_916\)>KYBP;/E\:#F;._(@UZPYIQ.2J:Z< M=_4E*G]J:J>I>.J#W`I"I3.8M:U<;J!*S*7''53>X.#?9$!B;]L#DAKO*D25 ME^D;[WF=J.S(` M`$$H`P`3`!P`=6`L` M`00E#@``!#D!``#M?5F3X[:2[ON-F/]0T_-R;TR4JQ>[[7;8$Z&EU)9/;2-5 M>SD3$Q4L$I+HID@=D*PN^==?@(O$!2!`$$E(U3H/Q]62B$SFET@D$HG,G_[] M_/SL(_(1MB+DG#UNS]S1_XW6_^_L_&P4K#=SVSV;^A'YUH[<)T0^\Y\0)O\F MWZ^B://CQ<67+U^^L MW:_BLVL+G[U]?_;F_8^O7_](_OAT/SI[^_K-=^E#Y`G/]3\_6B$Z>UY[?OCS MJP*QYT?L?1/@Y<7;UZ_?7>0_?)7^\L=G^D'I]U_>);]^\^'#AXODV]U/0Y?U M0S+LFXL_KJ_F]@JMK7/7#R/+MRF!T/TQ3#Z\"FPK<@-?@J\S[B_HO\[SGYW3 MC\[?O#U_]^:;Y]#9L4A^XT0[,L4!OKM(OWR5".SL["<<>&B&%F?)._X8;3?H MYU>AN]YXE/7DLQ5&BY]?Q4M"[,VW;]ZFI/XC7C[@!P)L&'BN0R&:^@0^-(_( MWVOD1Z_.Z,B?9M,=&_'YDB)\03^_:'KRXK_.=#-'M1*C%?)#HH\IO18,LIXF M3.IE<6AY5&'F*X3:"*_TV(5V5(O#/]Q9F."S0I%K6UZHR&1U%#T\SU=DU%7@ M.0B'E_^*W6A[3P9X&^!W`C8;'M0",7_\=N*4'T>[9HZL<#7Q@B]M9DS^2#*7 M-?!S$T1H<&-%,4;!8AB'KH_"T/*=>;Q>6W@;+.;NTG<71`)^-+#M(/8CUU_> M$7YL%XEDVW%P3?:*H[),/J)@B:W-BBJF M_I"-.<+`>6VMK2:9.%'DR MWHOH:6VZ-B7F!L?(N7S>$"%(*7WM$9U6X-<9\JA])TL.68`P46CJX@=2\X#_ MK!Y(ZY9YN$W^V@J8:WA0&Y#JR\L]->JP*UA&XB+?>8&M9-+OTO2T-DR*:Y0T M9XR'-)KTXHHES1+CH=Y6&6DFI8;1::I8BX,\J&5JW.%@ M@XB)IOY*1+"BNXT-7=8^A6@1>U=$("D]`9_RXVAA>_!DN1X=;A+@N56S&Z(U M0/"T%A:KID/`4^WGNN!]FYB&8(%,167 MBP5*0HD[JC/B2HP7"&#EDY$$8HH@NQ%>N]4BXD%5'J2'T+(0H MHOHNQ57YM]H`WZ\,U15!P$_#@WIB-_1EH^#:^BO`HYC\M4982E`-#^JQ=;8= MK^/$FTY64MYJ)79\Y8;1M>:Q5BTQC_5'#B.J-"8.JBL,W.FAH6_7RW2MY5^E M\7&-;F?1SY;GCO64UFU-T=>69XOUE%:V2C$F>;Z8C^E3M6:?7YY-N7&T[0L; M(COR/$L,HE4#N-$5>9:%0W25\#@@ZPT1P(!L!HB5B[;RX]&KLXQ,D=_=&*X?79!'+K+?7-0?SP4) MS&RPMEQ?F=?TZ<)2"\'MB@R![?@1G>\HMV.8-0"X/B2B.5^C]2/"+>5;>G2_ M7D*P:7E>.^;H`WN6B+*ZODLGV!4A7F(+/4?(=Y"3,T:?;G_.GZTSA)07V*7Q M/9HI$>!\>+(Q1QXQ)^'YTK(V#[L1"%]H2OX,F0)*7G-AA8_)NV8/7U"#=(&\ M*,P_24S4^>LWY[E%Y5,IZ)4ZTYG3"\CPWD?..-TC.2'&V23'1%RQMD*!H`*EUCI#?2"4U^:&Y%A:68)(+[`Q"#IA>CA=>\@02.4 M>WHP$%&!92"]:9I)BCC1^-,,D:UPC&Y0!()-A03DM"F[6QV6GJI8A`@H27\4 MA%%(-RI9S&KP&$8T%18"!BXML.5?&QI\,66PO-4_,2C-VT6F`E!X[`F46>T= M!Y$B5M$H2$9FE5>#X'9#L\9=?[G/:=$/0YW(;E]SZ$`PY".S4&BQ5'U8*+BU M6XP#5_>:[)+$9.@V$=)]\540PDZ%`AF3BP-/YYASH"@:"9.DAD,:3Z:$(%=J M%IG#7Z29PLF0>*=_<:#'-V%$N4II`CFO+#(FL6A0P2(83.D`&2?*T4W@!^69 M"#8Q&*0,.T^2F'`%!;>[JU/+;"D$.GQB9G=\`@4M0M0@+YC)LU^UZ/'?**`G M^C$AGBUK@1\.T2+`J'`J?.WZ`4Z.M2*$R20G"V1YE/3.SS6*5H&SMP,@'D.? M[!MURX43J6Q\>P05;ONU8R][U2P#`$Z/ZJ0,&W8YQX=.B$1D32X M5Y:;)D*996A]I_DDXG?D+E>$P.")6-\ENHGIB]PN$AYNXXA>OG<(7SU`J,C) MX6_]5$6<(?Y>N';]=%%.,2A\HSWW@'634-&[.Z4?G-(/3ND'I_2#4_K!*?W@ ME'YPVLG(K3OL38S&([WE`^\.#Z7(/ME@9)-+#7+8$I>5A#C-0#UTSB#^RBE63AO%T#WL M!1(<*9D$`<6$I1JWD/K11,[HR95LAF6#M"3.,?H.TI5J67;8R9\"=*<`W2E` M=PK0G0)TIP#=*4#'P"FM*32*,2T<#)GTRB9T\*?:'/F(`5%S:JUP-?"3FLDT M(>C)\F@2T"`:61AOB7?]F^4!75:1(FS4T6W4U)*O*R=$F(0_?O6XC'.0N24D M:G@7*HV=A/B`IEY6<"F<(1L1G2$LD`T2)&9-](X&KD:A04;5]Q1#6)P:J!E< MO&2TM1;@X<@,R`/,ZV]M`6]N[,8WNS*U!*,L&0G?3DG^=QAM+#>_7#7(JF65 MIC8$+#)DS=X7:`N7E""%MJX+AEF7`S"P=FT1C@Z43#(2468E^=>*K\*N-4WD MC@J=1KE)AIN[;67!M["F?30)U>3N8^$.HDN5O@>%2M^0H04QT:,XA).0G4PY M#"7"PR,]'#)0AQR=FU@U30J9! MG@SN@]3FL7Z8(':N7%)`H4.&^F9CKUKGD12AD&N?$R7>'VV M1PU\&SA47R-T\$?,'/F(8UH=HB1PX1&C1=V:-*T>#8'#5 MOTE2X@6GTUGOG;6EL

3GDKE(PZ$6+59!WQ5F4%E#Z1]GBJLP@$#H>868^_ M-4`\D8%5"\UH%@H>/21^Z63V;UQ\HXU8XLBD0 MA?6)A32/X/**6&[BTD+*EXS6;EJ)C684)I7>ELBG[?@@P&HB=P0X-4I+HA:0 MXNV,P/Z\"CPR>I@6T8-TM!NH&72T)=2T?%V#+S(8RT<9#/R$+EP*K+2>Z*B=3F!DVHXT9?>3D5?A*8<2%:\/4 M]92@:K;`O!@_&<%!I6C6#7$_:Y9I_UQ>69N7K9X">,2$]X.4D*9A)Y`G`\YV MBB,WR7,&4]?-'^XLNJE8H<%7^C*.PGP.(@?HT7LU>\:0)XMM&+`['F#Y(7U=B*%ZGNYVW@1;^H6 M)ZP[R1XL+P\/'`+BDCT&#*7$!W/CK$`ZH1,.XF@58%H"#!BQ&KDCB7ASI05U M*:U&=!J&<4_P9*2.XCX-5TY@?5MJ%`O-$7J!ITCO.#$J24SB6*^74$'"6BF* M<4]&>!O@=Z?.$:?0@/G00*J3].0A\),S)^@0`9,@&%H0L0*VR("VHQ5B<-$" M-J$>-J$R88(F+2TUDF)+"^;!NU9MRV$\])$X])`ZKA\2I.UD= M1G9W,OVQTK'[Y#K(=T#DOA_<9/JAY.V&O2!DXIV&`Y[U[*A3_/,4_SS%/T_Q MSU/\\Q3_/,4_3_'/4_SS%/\\Q3]/\<_#B/<<2:CGJXWR%`,\PH6SSRM!M'W0 MQ`N^O-*Q83SM<#"/]W.*"G1LYPVV7FZ*5FY*A-$4[MDH8+ M4\A4@08Y0Y6A:R+8!#1+RA7G9&0.$V:\MO!G%%%?=[]QGF5[ZWQ3#8&W%%V# MP<4V\Z"(I9P\X0K))$I(/37&A5P('!OI&6]:IH9ALPR!.@+G92=W942S#I!# MY!.Y@5;KY)$\PNDGE")`"Z#E`Z&&D16B,4K_._7I>C!#(=DID56`N@JCE>4O M43CU]VM#4A6>O%.QAI&L+Z6?HCD/&6Y]!4$&9C]49[1>1@'"!DC1->-W@BI.O2R?DP($JK\+E!ZP+NX"BH8I%IN$OMW;7?P&! M[V=DK6[Z=>YRHN:\?L/>W4[JXEL0^O"N=,[I#?(JW:_-GZ_)7:(]A/HEK_)> M]5-(HQ&,'6M:IS\FGV5?!C[405@7CHP>8[:9196#LTXH:#]I*QT;42\TU''\ MW#30$1T_-\H#)O&3F/\LX#2P_Q6[&/7:'K@%=3,PME?84OR\A7`!3T*J7+". M9GI!ETGX10#+%BG7 MM#B>HM.C8KR/88]*EB.C*[/R#))PKZ0AT9\K6U'VB>M;OJW!PVH:Z(@\K$9Y M"$-;G9;?VP5H[046F4,PMQ(:R%I92]("RE;FS%X&QX8-JBQ'9@TJ7\\E3*:T MT,&N%U"N:-=`\A_JEC^1-8&&QY+K4M7M-P3VK>@??GV5=N*4"3?KA'5`E!#C M+=$MN,:84H0/>>UL)T')9L#0EPEO@@@-;J@GAX+%,`[)FX6AY3OS>+VV\#98 MS-VE[RY&[2)E1U+:D/!=D/MX&:\@U@O+3\+*%L?R$S33:[ MPR@DF"?_O%UDIMKR=NH3CMV0HDUD3IO/-0GXGB`Y))Q\AA!+[^]@=/:*5:YT M@[AW?*5BQWV8@R%S.]N`2=_"^I=CN-W1*9^1F8O MQAI!LCP@3`L6W&/+V9U6[=4&=-J#\6HX;;N]FI4/`*$0/)!.HG1JCXJ)3,H9 MI^D0VX*5`YZ^/'+=YFME5/`YQZ5W`/-&`&AUHO!%=T#*/MXE\W=1]FR(OI2= M3ZY3KEAU5&!E;Z!G7-F%@%;20AI$=T#*?IG=5*%'I>K;,EHR!_EA[NC.4.3B MQ*7M1_W;D.]T')@6)\",N:.5B;(OKPQ95X,WK)24)-2T%I9_'*1[3[F MV^0C"I;8VJSHQBY]CZF_"/`ZO6+6H6Q+6IYGAC;TQAIQ+`'G&Y>6>D63RH@] M32(9LH9;J@I@+54YD1'BX4R%CXQ":QTF`.-M(>=`$[E.W4^K(J&B`IT$0II& MPV\2L%;JI0H$>#@3X)>4/WI\.[;6UA+-412EY=94]QTO8A),_0AA%$:#W0*9 M.-.P6X]FDB:OIK>;`$+A'4R\>)KE5F/_Z%[.@^ MN";N%AU@.T,.6F\2``%G1C>&.M67+5#MR8V2(6O6C=*B'[5*L2))RR91]#'; M?IVAI"+UG86C[3TFNWWR9DFNA[K+Q1L2YI%;<@;CH;)`E^N MM-U"N@<2(:L?O`ZWR5];50?MZ!,8K@("';T?1S.*"D4K!IX7?+%\&TT"3']# M"T^A,!,6P*LI\7%$B01JU224D*&X\$;;FR+S>+-)HSJ6MW=V MPMO%39#<2-]?8_$=1GYV(\J,^R2:R9G=MTG"JU_(XDQI;>5/X7RD!FH&`UKM MIFR3Q*0[BJKG^?1@8[FT3-X^:`<27UP2E2]4;^:RKWCW`)@T[:.PG:T%FD'Z MO2BJU7[2K3>6BRG-6TQL^"8(+>]V<17XRROW"3EIJF0?$U*%CR-R8]7DG,'^ M@R:O=OE0J'?6UL=I>/0X_-'FM\]$_4'_NC8AP"<7B0KW#Z8^83!>[[9[>MV7:D>!;Q,ZZ7W-F1M^'F'DN!']"R9'@$_NB$!KE%H.E;;X MR_+A-^0[`2Y1;6OJ)(8X?%]>3A(Y`(W%TKME,O?BSG-H'9,[SQ-7#E%375+5 M&'.(R`NMQN@)>4'B>=)06[#>Q!'"\V`1?;$PZB7NK,+(<;@=W62=@]]T?5PM MM+ER-YLT-O.+Y3OD)\M1$/:QE9.D?%3HRDHSAU-TE;S]&:?S1':223-<2KB/ M+9N(Y.$OD;*RRU'C1U04IR"9\4.+#%1,TK_=9*GZTV3=)KO#Y)X(W#9!A8VC MP59)QCG>_'"+$MYYO_,[8N]7_2RL(I)'@Z-0=CEFNF(E&=U/(=EL7H:1N[8B MF%*#%0K'X[%619,CT!A"4:QF]:7`&@Y\\J>-"GO^'F92:QZ.RG]I+^'\P-UT MNEBWHCCW:2<8=;?K:%/+EO3T@7GX0.;U(O9H6#H5CWS-FCNQM_%&-,_NIS4@EHF\TK:%GW15ZB MTK7Y^ZX"TWEBO(!B,'L8:?`B\-,:M)R^MWW.E?;LF%U[6M61Z21UL!J^>ZXN M%PM$DRC1CJ49V8";\T84^#%M3!7U047R<(TR]GSE?0T)0ZQ>6GTJ0SM6CE0/ M6LI;NA^Y^6(XA7C(UUD39X=Q=>R"D(;;[,N>YE0[5HZH=HZJL(&:)NSYR2Z. M)5T>+LGTPK[EC>(P(N8")Y.]G+@A=_[M+G:N3U&%=(/&=#5P+*[ M<+M(3'`A2+W[GDP#6K<^Z>*3BB2\#_;UK))<-3KV5!ISEU/1I;J"5)H%]SP9FZD;3=377H&IC=@/HN99Z8:=U7!XVWH^+A^Z91Z, M462Y7BC#X%6UA1'W`-X`2PJ)![UQF2)[,$)+V8&S");G5>R`227-LB?Z!KMN M=@(_(@;C,JU4\/.K,/72M0?HN9=YA]M[\OC@V87J5"PD"[B?7Y$GL1T_HG/R M:5HKW)P.EN:[U$7K(C9@1S=]6,`EG(2$^N#^=.Z15KO8IE9XT4 MH$61PA3FDB#]\-H@GM!@HH45>U'?:%*1RAREJ87D+'\)9J#W@X.=@1^'$2Y( M60))=2"O2SLB[5!FP_7#A&S'R1Y]-]N2>EK/="J'+&5G[''$(Y@]\VGA(F7["@F9P*C^,'8]VD40 MSLQ4*)A,G6J+"T=&0$=I.9GI>H.#I_2Z"CPL#&H&KS%T1(@E.IECJK8F['^&B^)?]82YHN_I-&8ZOM+5:#",0%,!5+'Q*9K&.FI#55.RP1,%TAO>[] ME:H:EH4!E$1R;3T#B[Q$X,!%7A8&T#+`G8KYKF2!(("0(6O(JS(>]VV#C)Q6 M@+<=X%XLZG(^Q+Q]ETF73['=@4]7&BI%MM3IRI_)=!D?<-[Q3EDT05TX-NDD M8!WG(*HKX%\!IEY02#.EV7?]@&)MLJ2-1^(TS)WR.BLI>)F M0W8MIT5+>&'//*09@`D&MH+8;*BP#Y3EPXP__?OY^=G__'[]V[?_^S]_V)OX M^4__NP_.W]\_+?_<^I_&\9>/W^,/W__C[5^?[K>A]_V3_?=K[]?HAT^CJSOG MSW]Z[[[S_WB\'8VGVX_W_[K_%;V]F-S_][OI^P4*G6]_W]S:_C\OWR_P/V9_ M1^OG/P?N[^O@PIU/W>';-_]YA8.WWT^\[Z\_7'KW\_47=_+L?/[7]?+YZ;]ULW__KVT_NYGWT<7WG;A[_'%V]'__]]N[+Y+TU>;K]Y^0'Y\_% MY)WSQRRX>>^_O_K^GT]_?/GYY_\]&\UGY^=J@5?W&3EIEN%U',66-XE]1SKF MVO2PV7!K:X.=!UT;Y:%[1[U\2)G*VVJVAT#TO.'=LRH,0K'`73HK_D#2B4\EP8BR[3B/&;*&^A<[GECT`\!3F=?*'L=K0T>^(F42^!&OY7*+ M>SGFJ)8>4SC7*`PA/:M8SZ@NN[N25K\'^//4O\.!C4)ZMVEF?;DF'C5V+2^\ M01&]$QXB_`13ME>!"V/&NP$Q9D>Y%H(%.D7?L3(A0@I79*D(`J='4!O('@V* M3:(#.HG?T2;D0/&AXYM:"]KBD,A"-J>JAPN13RX-8Q/?K%IM3Z$,F40/:_DYB\?LDV$-!O5WYM2+DEQ9AY'[2W![C!EE":(C&]YM3)X()$_ M`4DSX2>.8I5B>R)90:,TC\AJG=2\L?O%2D#8U*22QTPD.<#`>LH`I\PD(&8\ MBL;\''FTN,("")_G-?]:!!(J#YB+R[5;5.IO"J?U.:W,5O:H_9*4S8'&4[CB M/)`5']`N+2=?LIH&,)2B;RB"UP9&.3E"79[,N3``8`-F!PY9ER6H:VES>'R. MTRJ*,&FX9M/'%KQ<6C!81"O$+BRM&J"MUBZ\YQ&0]F7:CZ@>W,U'*Y'D0#K( M-UG4F[?FS.34#WG)0+LE7,_.T>#0R3O+G@`*0]84LZ0_L]8)2GS,8==@/\)[*P M&=>32?YE`LZ6=`;X]_H!E[%"?:&OS(N9@&UOJT"C3OR@.R#?PA+1S"XBJQ5Q M@\?H"7G!9@UT_Z`[4\?M+&@`)=.7#YI=!!D%-JL[FCD\\G5'-UYY)$SS+2>. MPB=73P?.7W'6U;M'6U,C;>AH%]*>U,6;PZLM9W?Y0/8ML>2!/>N61N/3Q^@) M""628Z#MEDRC*1@%M"A7[/K+VPW"R1OUZ.TQJ1]UI*B-E'.DFTHR]G-<7&LV M:]6;S2H<$@MZV+9.0@/YB&Y6\2_$UO=H# MYM-"N*K"3IB7O)G7*9UJQQ)M-)U]5O#DZ'T>%WRQ?)O>(1P' M\6.TB+VL/B.([0?@\D"RO%^SE@`(4&"*"]0XW=TGZD4-]M0.XIJ%')@%$<&G M++=4H5J_O`.:S77>7N`<9@`@S"#0HR!)U8->X$XI'15XF7"$1_5=H1#ZMMHA MX7C!A^(@B?U/22'JODM,JU[X;>]O,AXQ6V)/3O5VU7[K+PSN5A38XM;I[F^* M\%DP9<[X6BB>'0T"E6Q-K0G9M[+T%6=!/N^\@UDAMOL2T8+ M"4WOJ,`&U&2IMYE04(#B1%&2BA]RV>DVV\:T,VSZ[3`=PWB-M# M=)\0E?X[##E*%Z-3Q8UN+C.*@(T?^,0@=WZR7:VY^LO`AR4OL.;5;()@+:OY M$)ELT]`9(*A6KW<(AX%O>2,+,QL9LRIHU1\Q&_H06H$LZL%Z5\UJOWRX1HYK M6YZD+,N_/@XQ5MY0J)6M57)ED07'1G%$R&:(PZ]9V8 M[&Y?'?]8?Y\]-&-7LF2\8Y&LO3=]2<7[T8?:);LX(@D.X"H MFIJ/_G&H5[)DO*.1+'UWF;VDFF2GFJW!](BLP71O#1H+2*E)=C+3*UDRWM%( MEKZ[N):20L`]"3>/$BJ[$Y,S=I>\N MB%FB7V27]_TEE1QH,%>9%]6`0+4R@8!@HF89D^%],`K\,/!**-]8: MW2Y*]."BOWQBQJ._?)4NXM(@+;!Z#ER:,)'?1HQ,1GX[(B07\FU?NR2E,9#< MSU5_;W0K)YS[N^(EE9?4?I5P3V/84I##8Q3D4#IG4EV0HY:"'!VC($M80HE?'5Q&YT["N6X#?16?V#;\3KVJ(N; MA0'7&XQ6=)7?%\'+;R,JND42-*Z"$#:#JS4/739=DL3`=O.MZ/>_55?5A^*$ M:B=B0W<4=QD0-,@7;2F/@4_WEN`96$R"8$A+[\=5)@8SXXHM4*`>MA5B<)MN M-J$>-G,RN59-.EPJHT%[F4(W!FZ@/T2+`M&F!9X5ALG=*"FA#*D(7=DRFO^C0B4Y0P+4D MKQ*E1RT2KYN55[M#V`T<2)71RI_!^[4Z5$@O5H?14CTK[II5?PW5@QJTZE^$ MII7QQBBRW%T)V?Q33DB#69RR_9B*V6WRI!@!BDZL]QYPZ(35KO!F2W&9NNLU ML5S\F^7%:+C-"YQM1W0>0T4;F@D:C#8HZWC1"`K$"5X4*;N&EEAC(GI M]6>T1B1V_>70"MWPDQ\\TCK6]"6F_B:.RAD/5=;A0A?P3/>RTVX(A$A-+Z8" MP>$(M)4#YQPF0M.3#IJ-]QR>&LK&CMH?ZZ:6>N#[L>6EQW"R![O<)XUN^7NS M[+M695P!`BQ?>WJQXT83)%N@OPE8&?VYY M%KTJ!3]SJI2.%3.!_&`REC)J=SA8H)!Z5I974).![]P0*PT.H11Y%];^#.B"5NC((QZF*-L>B\%48XTQ?=NU<^1ZGVX`$$44#36C4D3 MBB*!2MSR[309^P'QY>(GANY[$73@72O(FPYNK(ALC8+%,`[)ZX2T`_$\7J\M MO`T6A9S9K"4F,2=W@>?:[DXFKY0JXVHAW>Z01B,YM6K`6IB0/]G11*J_'AA0 M6E$X#M(E?D-IJ6/WR77(Y`8[&"H3,'L3%&+"E)H+E84)U)(O)P)W@%,E8?R: M)U-+F9('O]=9H01S>L$`P.0Y0UOQ0US:S"A]O:U^H(U78_,?[4F"I]8_8GT^ MM?XY`-MWH*U_ZB?`2;VAOG)\*L1>M&%LD#%4#X0=R;2(E/)AXY[?'K)]=//: M4X*%7)H/>W8QU40[9F"^+!3+P"D]$(IV(&D\YM0,T&>:&GX?; M(?+M%;'-GZ'6*B%-N--3\RN66.#ZR_OR:>>4X98@(4W3^:*R,Z`9Q*H@X=*. M1;1A#+P&\*%@,KU)- M$*YJ#IN0P>H&LI&&AMJ+TNBHICUF391MY":1.-":1FQ:)DN8J"#$%QJ@;Q=& MMXNDK75VBG=%O!HXK!KI&39N*I`URP^@QN\,/5J1=#.F\J_-UI%MLYG/%I3* MR^J^YKU\&%D;-TH+A67PC8F!](*D$PWE<1+@V>7-8#0=3V]DRU,KC'DHMSR! MSESS&M@JT@8%_1Y;#J(S?(:6]!9=\AX9)U>?AK/!KY=7[6%O,:K9*=D_[FT$ MKG_16S[D-`:^L].TZ6PV_3BXG][*SG"I00Q/:6&268:-G$#TN_![RBV%;M[Y M;BM:>7UN[0RT7)J8R\ZABY&W(FC//,H8JKF!<-ZP@*+9Q4$B,,A(`N1*#S`@ MEK?6Z`\X$#@.*],Q>]@<"54K08*56 MDJCMV`W3R&`2:`*+<%?(&`F?]@$E4Z8`:8'+"J4[RW6$!I/QB-'+^V"FDB4; M<1[1J2;*@0(J)6B9-`:U9=`*5Y/Q=#3UDPC68$U9!UG_F(3,E7(#7O388A57 M2U'T9=;KP)]'@?UY=]!,5MGYRL*(6"ZFVG*[N`K\Y97[1(Q_ZR'+$FN.H,]LPCT#MVB%+A^CV3[R\G3]3+KGX-49M]G1^ M(PMLT$+Z^>]?H'%C""47O:`;4FO[11O_V0%AE.8:6,]#Y!,11B`A,QZIE[R[ MYXHWQ[,Q^D^28H3#*HA`]PB[%SLNSJSHPRG6''Q52 M[+07(B*?%2%92#/++EM!:$8SP1>+O4#..;K\8)':NVSY(6WNL4LJ@SDJD:/\DI'GV#?6YE4,Z#M/"$;DEX)1F4'G)N+*$ MFF/(CPOEXNBCP/(P/5B@F:ASFJ.:E((NU$Y6C%'E/:+)4(^T2G_:=GI/8?!( MVW-A,D;/.VUHI(. MUU;@8/?D6.1F67_TO"LZ!-Y2=`VF775#6$ZJ4ED_?5C.$7U;GRA)I=B\LL6D M8VWI^3UY(;(D09M('CEUF[@;E5Z!2--Z$+WF`&/\&J@9G@("(,OG#WR125TD M[4/3QX53$@V:GHW5EZ;SR2F%@_=9:K>+&Q2EX]-%:4S^&T:NG24I4I4C___$ M6/P904NU44W?/Q0BF44K%64FL7[W-04NLPC,G4=V99U;B[!&J^TC&KMG-(^@ MW@"$-:Y\3P_^TWVWZ9"2<*'S1L-[&VJF,2<;_X3`G$P="[L!5'D@-B$HP&3+ M`@D5L10^8<;]31$D!\@0&U&N=2A"GI MTPB2R6(^W2$":L.=D1U3H2!G1&QJWG*53OD;:PU6#TU$\JA,GU!^8)5.&B@# M=A,2$C5?Z5U2I251A*]_)B0.U)=("DJCK8H`@(2LSTN((XPI]34]:[!2<6'+ M7R8KP.]NM)KZ#LU5C2WO+B!;-12Y./DN/V!.2[W=+IA#P=EC<+:-UP]N:]3A M@13?L%-/>&3SM.\K^5@:D1:,MQC6"-A%D,` MG32\T3PM^]EJQ!TWY$@\@'#!*8M)?CDO(Q*5EK_:SGG*C M"S/NR"8S:+2!QY>;3-V-]CB.Z+9'%IKBCTU*6SK`E4N]])90WBR'JVQ]P]=6 M9*^2,@&%[]/CUQZ#.#+!)V&OU8 MH.TL1:`8BD#7N!S"5>GHR)').WBZ9[I0^A*%CW1JQ;7U[*[C]<#W\ZU3OM@3 M+5@-60Y:VDRKM?X+*,/0.K22OVC!8GT;VVM`-&6#5*DQWA;R=M M*6?(N4=XK6HXY`D:BS_I)?)Q]1L,369D5OPCE)"'?J+P*\3D.Q MNVQ8E813J;%K<6SVE M?T^]Y=7T7*E_O.X,T%/S>$9,\]0\_M0\WDSS^%/38TB3NA>E[E,X'LUZ1X53 M5^-35^-35^-N5O+4@?=@._">NED=9S>KO%3B+5F:+1I"FZ=[1Q"W@T_,:)RR MP^9=+$6`#N]'7G.U6ZR$6U=59U(.;Q9_O=V.NL\1J8Y&_&/AOL*YOQ3J+UAK MPMP<15$:6%.O[I'*4#QTNU!NF_%4#D[E:,C'<&7'`EP,>/%;!6@*P5MI(76O MEJ!JRFB)*'JH0M8FXCFZ*!QNT]I^4"&&9H+&;YRUU.NB(1.($L:_+A/-",)% M&)K(F8XP2*DR'["*[(#BZPTT80(,0L3,!AAT@@94U M*>DL^YH@M#X;!:T37Z)F-N'3$KEF2$C&SO@(NO\Z0 M9T7(N;-PM$WJ^EM)KAMOB-U"QEA;4S6=WM-+S1D#[>J+A.""+PPJYLOHM-=P'G;2 MD1=-$,'$6S@@F8RQZ(9(-LZBTV+V;")?J$T$37;CT.S''M8)]C'KVMM%F5G& M$%X/ZU:-*KQ]9(-VD,92"3>P@/2^KQ;M>68]SQ%^M0L%D0(_OVI9N:%9$`I>8QM&/K%%<$M8H+I2T:%[Q MD1Y-FC1+9N-):GMO76@<1&.J<6#'=.]/6V\1DW=&66.:L*: MR6)"=9LO#MW5J8IFQ!5__@=JV("U-/*58#A-]O7A&/WP(O]B,+;R>N5[NBI0Y$==ACF@XUD62R_P`P'1(2 M(^+C+@.LS1:5!STJ#[,BCWP'IG6+FU+Z'7G>/_S@BS]'5ACXR)F&8=P4/FV' M`6_XHT*#*Z,<%VW718O\I75YM>V*V<,>AT'BB"07O\:[I$5J^PWXA'RB,4!8 M'?@HUF6N5'(4=&YXR\12V$%`*`Y]#-N$!L'D.#1NA9OB]C]=4%*/5H@20?Q_ M4$L#!!0````(`&I\>D9P:[=)&U@``$IP!``3`!P`=6`L``00E#@``!#D!``#M??USY#:.Z.^OZOT/ MO-U[J9FZ=L;.YR;9W:JV/9XXZ[%]MB>Y7&HK):O9MC)JJ2.I/>[\]8]?DBB) M7Z(D4K-W5U<;CRT"(`""(`@"?_VW@P/P!B8P"PJX`O=[$)V\*#8OP0$X23?; MVS`"YTF!_AH6T1-$OTN>8(;^C?[^6!3;;U^]^O#APZ!AGX["MP]-6WAX??HA_>W9V`SPZ/ MOJ2#T(@X2M[?!SD$SYLXR?_V)P[9\WT6?YIF#Z\^.SS\_%7YX9_HE]\^XU\T MOO_P.?GZZ)MOOGE%_EI]FD>B#Q'8HU?_]?;B-GR$F^`@2O(B2$*,((^^S1WCQE(H`:I\+F`R0JN2F(Q M"(6D"0:B5Q5@##H-&T!CK#)I5L(DF/_VIUU^\!`$VU_/$[1BX&V!J-S`I%C> MYP5>SK(+\G)#`(B)2C+U[!N,C+WQS@WQP<'C&-^K,.U:MRM5+R,7V- M"92+NQ=7J)3Z3/G7^#XF"Q1]GSP@820'[V[_]'?Z-:@^![^4`_[Y5XJF2_XR M:XH@R,*2%O2CAG[VQ:LP16M_6QPTIK+.THVQ\(K4;-)$`%;:=A<3^.PD]LG3=EY)&`G^^(C5=.C"3B+G,K[M#=O/Q/P]K:U M_C\>OGXV8`_=VQZ]*F0*(2=Q@."/''($A6\U$,F93:AJ(SQU?VQ\Q* MS^@YY"+-IS47'!KWOJV`"O7A$LL'I'14FOC=0Q22$AJ.UAQ;&W3/6,03S`M\ M/*5`)SI1BM",KB3J`$2'`*E^E%^"B'SJ5344\FF&&L33&Z(:5\4CS"[3)&VJ MW20V1(+*M>LIHD%\O%(X'!)Q0*>.:6,-3013K%>]=\>3H+B:G(#7[3L MA.S\2/@Y:#V]#K($;=7Y-.`LC!`4@4&V2H$5!O`0OH@22;,&J"*/\'HX1'!63XAM_$!7NXV]S"[6A-45[L"9\VM$'H'&FI)B=-H MHQV-$H4N@8&`0J,ZFDO5F6#)O>OP,(WA57L`-X?$/ZO$K:LUM>D(-DZ3S>`C M3A%_TP> MT)82I2L:)D"'ALDN`"8AUJG=GVP:DK53PP4/"")X$2.8+P'R>#9!]AX6P7V, M[R1*#'XO.:?6Q\ZEQF2"&'RK-B)E'\F"+)?B:/N3]&F",[:K(]-%\`Q>L/R3 ME^">1E@\AP,FU+TI%U]CV4VA/1X41Q3G.'E$_\*7%V#7M.NYU*(OP`JN89:A M#^M`9$?;_E?7^HMG2.+5R#1=0N0O?B1VOJ+52W!VJMG(,E#)G7W8.+.P94@] ML05((#G7H%7Y+V;[VTHYY:)LB,%Q,O*$4QEM#V!*)M@*_E?I1I+4@.U`0-.4 M%EV%SL,5JX(*7QIZCC5IA2T*,:MX,L6A!_H@CE^@_.!7H*8AQ M^L^R.`FR;(\,Z(]!/-'#-"/$;CT$(YIDI@X-(A MC&TNMF3/1LJ?%A'71Y=K)>82*5]Z=GZM=*&AI[W9 M9>U-D:AE#3.?UIXJL+F,W\C)D.A>_2VV>T@%$AB2<,V'J'A4O;WU%_56RK03 MMY8S8XH7K$;)$E*21)X3O0GCABP`&K0`;-B_D$`.!V7_X-=R"?KS?L(Z"Q5\ MMUXWCUI16@%_$N'L9>0&><]1%HFC75:A,2?GA6_:%"@+]GT<3#RTWRVO,[@- MHK)"SC)9D;6ZS)'IGS+Z8(+6L4=G0)+T'2D96=5&(J<*6GT@I`-!0,!X/5KT MD#2O:Z9L&:J!Y)WTA*I&X;LUX#QJC>Z(7Q][U).&/`0*44_*]O+UE"57($A4 MG:;UU%7H/-0Z59`C4973;C**]U*=!C+D=4L3 M;SJ>0@>Z#4:\E=CIP07:>:<0/X'K]-T+QB@1,OZ39Z'R?.9E65$]Y$1W%CT7 M.\1/7+CQ]UVTQ?&'-]E$]0_DR!R[GU)")%IP%H3X!$"N7,G'Q.M<,RC>+URU M0N351CUW:\_R>!>1]$0,]WR#BXR06%8^F3*I$3JU'TI2)"I5CB&:%'&#?`<5 MC`3)*Y1^]D,,U'6&ZV,5^VO$O8+767(TFN8,H\3H_*2LHD;VYC[("PA64;Y- M<^2CY'OTSXWG`[&)&)M''^W$!QR#);`GLU8:C#X*/:I)4CJ]6S9T`;9X,"U6 M70[WOAV:2==(UT;8&)=AN-OL8OQ0[Q1N,QA&I&X=^CF&)*LU62TW:59$?Y#? M2TF9*$%A'-H<9\B,1+;,YX=YCA,92AQ@Q2'QG;$PJBZULAO&8ZIM;$$*=:(+ M)R4^+Y$'%46*>FTMB[R0F>19V6/)C8N6!:X#RVIR1'=:%VGR<'`1/2'CL9S# M;<2X`AC^O)@%)!'I$V>+=!`Y3Q1I4Z!\C$NCB-_Z/@,J9=1)-A#.T%OBAX@: M>RG M3B458W)^1!`0H3#] M&A4@\[-&NX1H*YE!D67W9MO5HA,HD&3&UA%)-[9=:M0=.X#&-KV9SQ'7PWS? M_QL9&X5!'YPQQL&>]LBNQ>G6B=21\W'FCBFE*4D@DT_?OO'K9A/1QCNDBC!N M[/,`DS":J@>L')WC@AMR2N05A+P-\MP+]_>G2(_)X,/.$AWX$C\AJ7O+YE)?B#7?&8 M9KBVV'?@B\67WWRU^.+S;\H_1GF.3S@DO;ZN4@^"`IS"$.(:]N#SHT7]LA<_ MYUT`-'*+'[<]P7CO.XHI4XNV2G8X.ZQ:6@GO.LBN,E+/:$5`EZTM)M9.*5K' M[KH!249J7&FPKMF)9Q73B5NB=4K>6+OX'`+:3V-9+?6)U:^#SOWN*J'$2-LZ MEM%W)22]("6*)9S^"#LLA7M.=@6I'*0%J:(;E>.J^N-]$)-J M.`?BPN__@T3JJSZD!:FB2I&OZ6']?^59,\GZ+'4#BR!*X*IL4=E(E%U'X31= MO@VP.GWCI*='6OR(#@20C?1Z8#<7)J]PAI,?UJX1.4>/:;R"64X;U$^A50(L M7B[ENG0H+^5R[O-/_OR7SXZ^_HXD-Q=[[QZ'7&[-LN;"^8[O"1IZ#F)ZA,X! MW4+\9I`/87([6=G=7BZF1[1==YC\$2KST9"P.7>_N$Q6;FRA%J>'=B,ZFI16 MDDM9(#3-"R(B1>$"JCGNS66QYOJ`0HZGT5.T@LEJDE2E&OAX!WSSAK$5=EER6_EWL()A MC-BZ\AU0Z@BCD$O*H/C5]Y[D0_`+_=2W MOD@%)+G?Y"8XX`F6+KP]G:Z8(W>9`&E,E<'U)7WXVVS3R=Z*O,#7!B]%JC?; MNQ*Y4O;CV8#@33LZ/IUR2C"YM69B(G2W'^77<[%K:J&I+C]&L'#SN+ MTP^YHR!+%Y_KA"`5,29!%=(%D(P2MGOU'$:1RE,2/1&S8,BS)7WMHDE.;29X M76Z9)@1)'S#50TDD.>#&>-\4^TBX^9S)D"$#ML*Z,V+=O>Z&]6\O&[=/H7U& M>$?3/O-H@@E=TIV3?@9B]`UX\8"^?@EP5F000])>;J/N0NE#-?N(GU=-8S8Y M?L-A2I.=S>3__UEDVDVRK.IF;(\"??5<$! MUHCF&"9P/4V:FP[EZ/6B3%N%2`BR>_+M\\6W1IBB!]^JN?NH5&Q`E[JQV+\. M_X?V[Z/V\)39Q?.DVQ=TBE5NA->#>VI"EWD_6;_ZUD>VS?YVACP8<"SJXFAW MJ72C=1VL/FY8]63IV\ABT2L;Q\Y$!65B5BN@D!_CVCVNEZ<;U>,1SD/K.(KT M#4_G9ML$\E/K5'NVXZH3Z]-7;N#"!HYN],R(DGDHH`FI`[J`HM\D:7(PJP9M MPS1'K>'&[)Q$]2=K*:K!..9Y9`1E_KC:CYI)TTCM&BU*QSZ=L/JV;H\F)=(I M(EY/,+M/U8$(+6%]BQG/0\$D(C4[D?`SMP]S">&W*K4Z4[4V7I=7A"8$&19` M)MOMO$JM]A&S5OU$7!EP(,:M>(/\D<1R5W!UO'^7X[#/U19F`2Z*M\0EU&@Q M3U(E;X=^Q_Z8)I,HYT"*/+R5&D:QHI=.B!,LM@PLN-^#M`0)@@JF9T=R'`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`!:U993.WN3MZD#=F1V9X MO8MQPWF)5NT>B*8MD@CF`8$2;2( MC>.,&M:C7P85[$`N$MB6!20_:N$MSY!J=UD+<2$U:I46!SZ7O+R=`I"3]B7AHC%Z!( M>R0S'U+J"/%K,E>G!NZVLT.)5O;L"/^][99X*5G49GZC2E%C%D.,Q=O@.=KL M-M/9AR8"UP_J&]@E(F??"`NA^:G/(!!)LQ!#>U(6[L+#KS\%>0%/HWR;YD%\ MNT?_$*J!P+F4CYP@XJWP*:5T2"1-O@?E`$!'S*``GH$LF/>HGK'U8X2W43*Q M%6@@<&X%>.PR*T"_F8\5$(FD804ZDQKR2`!?`!/7X13>EZ?98E_G04P9ONV! MW6WQ0W/"%&]*&8`%P""J($BQY_)J9E/:KK\>--\2]&*7=<78IR"*<9;.69KA M'!XW2FJ`U:DCJZ='=NE0#CQ8I]D!3O#3::*G-1I-@,,DS51I)_['BGK)O>NWF;+)2SX=?SZ+G MLI[.VUVQ"^*S7;(RCABK!KL.%BMHD<6)\9"RM#4=!,BH&82(#<121H=U$Q_0 M.UIN&6E-4+@Z27/7>V<#]5PV4)XH:?7^O/"<_MY3H(:[9&?N@])`2CS(U<@; M>-YD:9Z_2[)6_]E8"HT=*C;FF#AK$F$II-U?FV:B@FMK.:,&'`7&E2*B%;WV MIU$>QFF^R^#4(3D9.OU`/F4'RF[D@VS$UU?1[!]$>?N6*PQFG M3XK&.,J2%*#65_#SGD:K9#/;DF0S&\5._)1F[W&]JC2$.6XA?!-\>(N,4Q8% M<7X)BZOU#5#CVN/M3*$T8^``VY0`2N?J`(!Y$R<&6PIR+O>FM M$$(SU(]=`ZJC,7QG41+EC\BK3].50[U5H/6EJ'*2I!$Q.@!7]UGMPL)[^3UC MD0HU3S/_(87X:/UQ5YZ5')UKSTI*B;S7!(ZNHB%:U\I7$32=*%NUSY0,L/"M M^'X5%?A^SU24XYUE3FA)D2?]TU&D[TBM,/-Y?V(BG_K)B98%0V(&M%CO&5S! M+(B=="#1H73>@41#D&QKHY_[#A&8R:\1)#"8[G"-(AT'D7-V@3YVJE<:Q"ZS M`_L0IFI$Z==IZB50@:(9S-OZB3K%X+!]D@:CCV8]:I(D>N6]QH>9Z`3JI.N5 M9*5(90UW9A0]]./28':=KFI&EO'6Z+U8-[#Y"8/:0"U9 M`O'K9RP^ MVZX:R?H5^VF3-;?I1<(L-A<9=2HGOM&^:P$26;K(%]]1$^O;T+17"8$]0 MLFQ*J^]2F0?1X_1AR`@$CZCLGO1AF9/9[:I#! M+M"'FU-N"A[7QICDS77+<+YH9KN##%A"8S-Z[/WE,DU6%/U]#-E)W^%F(D3O M^GZI!VVRXMG\IU5;3.]W3A8R-S#_4KX,:LHJPG2=16GV,PRRB3W^/NAGHIPB MVJ0I:.A3L$??@O0)9@-Q>CGB#FZ:<`J?8)Q.UI1U.%'.'R4,)%AVL?M) ML-E^=PK"#*ZBXJ-R*-3:8NEF*)AG[1B;K#R_RV%D"KWT:AQW#KV7RURWAV$K M9P*FCN[#D_("R]5O.U8)S^%^T4'M-&_,D"B)*I//%F`3Y>&G<_3496(U,.Q" M#E@FBRU#7+?"*$]1D!BF'CVZURQ-GM90(NV61.J/<%?M+/#@L0:)D3Q8"I=^ MSD/2M<2VT56CQ![8/31%-*?.7O7FL^.:MC?LR16+UY!E"BT"OHJ/F;D^W!EB M\#IXT`_E[SB_#S\01Q0L:0@E7\9Q^B%`LSY+L]-T=U^L=S'K7C>)89R`2K?) M1.-/0-T,,0<9#&'TA$N]>74$I],OT2N#D=EK>PW=(:`N;1Y2FL>B76YR\8>B"]Q9:/-` M+1K!SHHY.9IU):5+G2@]Q>3A["6F1/LR>A;ZUQ"/4IOJ28V@&YRZ29N,3JPT M1B1XR7CL2:3T$+9%;B:-S\W%R^PC=HDR&G-D7"UM%E_.KY*[+,`M">LJJ.[4 MU8"6T7S+H5JKIU5?YOL!C01I`C9!]AX6^-0$\FKX?#9T*VW1:[DA!T=P;:L@ MF2-W58AOU*O,IO;>F?JB(L+F6NC$1'@B)9/.<7C!B@W^%!#'V,FJQM8 M1!GI#>RFRF4?]*XS3'O0)BU>7T,@L?L:AJXPII]2]KUUH5G8OA^_[&WD+7S` M<&_@%C>A21ZFU%`I+J=)$S(J9,\4Z>>@^GXV.J83':]0RDE;)D8@DXD;&9G? M*78&."RMVL:MV/C(=S.H9B_C+[OT$\YHP/;%W@-=9;

XK"R;K0"_$X3J85 MT2"OKDLJ>9--AWW>;8SHQ0"H),8O?NEL;3HU7:-#2YH$\4F00_]2ADU=G[YS"S2B]["510&L>'";W[M>,TWD,LZX=)OYM!:3Y;J@GI$)FQ)O?SL.,JWA?6G+I'&W<.MSL M:+5#OF$4Q%4//C.12P>Z>^4G)T*:(%)^3CPUVC_1=V,[O0RJOE2*R0Y)V2/F M'T<-2*+2#2QV64*NV\MTIIQL"I/M[@:HQSO]FU\.&=(FT;4+F.??@FHX4;B@ M&NGU@B%/+$,&;V#ZD`7;QR@\3]8I,G8DP&4:/U"/=I2)K"1"HB_U M&,`-\A](,A0(LU'ZF0\R5+CD%8Y1U6B0,9PH!B%'YC@0(25$JTG8:VT'(?Q8 M')W@&C9&.=_>\0ABJK+]KX@U4BW)8?CI0_KTBGV+E>3S\A]8/S[G](.#YR0F M7>.391U_-7LBNK M[\\OEWXL>Y>WO,`8Q=8"6XXLL*5C@2UE`EM>+D^7GLX*7>XV1+8<)+(WQ^.* M#,%S*K(WQVK[^(_SRS>G5V^]>-Y='O."8Y3;"NY\9.-X[M@XGLN,X_GEZ;EG MXW@N-([GPXSCV7GRVK-QK+G+BXS1;!'.)I&6$P(F M@J8!4>$@EW<68A)451Y`]>T<0MTJKK.SIG2"-E>6)+!QE[X-?DNSDUU>I!O$ M6N.H@WJTHZB#D@C5-14H4D!&@6K8'+H'&PJ%:8-^]D,B#RVP$X4:0YR.7#1Q8DD[.Z*"O!+`UWA/;W;C>#%G:=3)=SV`(D'&;K730C M&\-?PCGN*<=CKW(\-I/C\9SD>*R4X_%(**4X\E` M.2[CF#IVI9DVE*=LG..,$@D9LI?><@L,;J$M MI%D5^.O')7OSQ6&ZA$7]"!87=*%5)O%SV(LT%VYJX]BTWC2X/F'V)=!`<_&+ M#.[M=0T)8%#@!0;VTO/&.E!%>%MIQ4%[K98M&HS@&*[3#)?ZC8,\C]912"L3 M(K*NUG?!\Q0*/H2F7 M-K)G"XRNK5=E,8\\B$D/86YUUJ[QG?O\I&^?T*"RB0%-AL?Q\)I6=->ROS[/2J0XZNV*HQVFR M0T"9)9[H@"I`Y-*L"2F0:`K[R//UIE(XK:.A9&J##,)IA!\>W>_(7@XEZB&W M"[+ACF*L.CKD$=;J:["&WI[SFDJA:1Y4<[5N4L5@WP9Q@'-NIK<2;4QNH_)B M(F0O2H,]`DA?%F:0^O^S:<&J%IS`@HCF;%N=\BR(LA^#>`>/]Z5/LS_!YX.I M\FC4")U6$E*2(GLZ6'X(R)?M#!L?^F,D0EZ-]/.V;K5$]'.9)+L@IK6*3&^( MI2/=WOU+Z=`XJW0`*S(UBP?K6EDTMR3)C(?N1M=9NH9Y'N$")]Q.A\Y,EXCZ MR;+EE,:=-HW98#T?*"?.YD?80NV-Z,&6.5&UCJ^VX5%0AZ3_O4'.6Z MB(:0"IUEPA\#]+7`*GDR24+6M\Q1=XH#PHP,Z%MR!Q,E#R=I7CAPD,7X/)D; M(3'*S/,,WB-'V6\Y!!/)"4R(?+(>:E/I:#I4K-YJ$""C%H"-^Y<2RN'@*X1N MTY$)5[<&H^,*!&IJ5(%^[P=?,]%U8N_JR5I[K#R-*)"Q@%^X(QR'DW%V[PJ->"';>2%6$'<941YH3-6;7$) M+J?Q%AD5TI+A.:O-5(;JOO5\OM&)K%D"7#'9(3DLQ`:J4F1'W.4$V;-N-S:C M1%EZ;4US-[Z=P6VS(N-5,S?+N)LJI#ETI$C1.7 M=(+#"LR+VZ--J2QZI*[C*5J*Y(7HR;@%V.*1"^K9E(._]>T?&TNW59G>@!?V MB2_=,]Z4NJ;`YM(ZR*O>_SEEY^S=J4RHG;)5F=!/GC M69Q^R'&:]!4R=@%IOQ,6T1/-_C1UKXT!.4N\,J5(9G70<+#&XVEN?5I"`$$% MPM=IK+_C-0Z?%!09ZM.ZA#`_?3*0FTB?=#RQOI*_RAZ")/J#/%,] M29,\C:-5V5/W&DD8N27DGU?KZHUBU:`@YUKM)JO;Z"$A+UZ38AF2NK.(W&L$ M+T3$5E5M)KE'!)P:_$ZS>M-35\'VK2++0F M"-04@9(D\$M=V\ECIK?GI=*XU?2A"Q;G"718$0:MW^5PO8LO(K0[WN%*'1*[ M(.JQUQNBH[K#O0G37EY(WE;E2^BD?7;JLH*^N,)(B>(DKLL6%4'5D'-P"D4=S):7=\J M3S41:>RF0H>#,A@A62(&_8'@!0PPHYI>\\R1QC'RLL:EUF5^8 MDXIP0#OP\!&N=C&\6B^?@BC&M)RE&7[B41-31G8CXI^IG)^1KDJ'TN0T$W$H MM;)[5P86GTO<,;AN^Y"YA='\PDTV MT)&_+\,ONP4K/P=([4@)-9_W6!JFEU=2JBE:ROL4AN2AX>='N(V3L;0EPUS= MDXK1RRJFL(_!YT<+@+_W6*U>S6XF9\7L;`I.2[3FT'I)'[HN32"CPVIMSV5Q M'QJN[L/A9YH$EV1S>"Z1XO-QMI`1HS@?D"%:O]Z75Z^39MLS5S)@#.^Z0L*2 M&%UZT1K:)4/E<1MCSK M/#AQE-W2YXF)OS05Q3,2\1QLDIA.X1HB2*L>`8#6`(=IGFW/O!W'%TYC@%/'J8;V0==(#6C5&!WO0FIJ M3*P`]\;*=\#43)B-%K3ZZ=N8A\LTZ7M0%PQQUTFGBUPB>?3A0=@Q$:YMA)R] MS$I(YF,?C;S&U9%(PCDIF72=(JBPB#*28\Z"/*YR$ZUI<5DMPI9(6>XM!4?< M6%J%JPD1E"!G>:\X5'L::;I#&#LD^@$?,`9:R3]*'APINPE:UP$57`#GV"R@^2I[.MG=/9+@OADEQ?I!AT# M<:@C31[P6Z(5/?,>[]_`]"$+MH]1&"!VP\!I+&YT:KVMI;%G8K#<&$KZT+O$ M"2JD-+J'T!X0O"SF1Y8ACQL0Y#->D5-IM'C13B+'`67B^=#\U9IX=]Q[U>KO MR+H4<$.H9I8EOTOK9['H+#OE@IZ"3->).Q/,05K!OG'[A%8R/;SP3\`Y;("@ MHZN\1(BK1?$H-7EJGFK@3Z:[K0[CD\B-A07^^F\'!^"7G][^^,4_?_FO<+M[ M_CGY\IO5'U\_/?R\3]Z=[CZ\^3K[YNM_?/;;N[M]'G_]%/YQ&/]0_.7=R<7U MZN?_CC__,OFO^ZN3T_/]F[O?[WZ`G[TZN_O/S\^_6L-\]<5/VZLP^>_77ZVS M?]S\46R>?UY&/VW25]'M>73\V=%_7&3I9U^?Q5^__>9U?'>[^1"=/:_>__[P MD(:?;<)ODG=W/ZR#;_[Q%WC\VU?Q'\?[P_/K/][\N(4WF\WZXOG=^^/WJS]V MGZ6_+?\C6L?GKY\OO@HN]U_]_L6[:/M5\69S'6WO?SZY^.K\CQ_>_.7+N_#[ MP\UA5GRY++*K_TZ.7G]]^^7^,"A6[_[S;W_[)SBYO3DXL#\F"HI)7Z;%M$Z& M%J?;TA4Z^P6NQ/T2X/$S2A,T%7*S;X$!5VQ[7G!ONL)PM]F1 M]AJJXN9.GR):D>1Z4QQ(K\E;Q!HNVP95*C_G=.Q!2B9YBVC-=/N@]GF"G%Z8 M%V4LD:6*3)O`K4;I,D2MH46:PDU'<:%HIKBRNCU^$KF-1-O,Y=:S8V@_->Z. MS5'\V`2MC\YJ:I*4_4?X-)XYQH][2+K3N\:`+2-$SKJ=WAS[`VKL;MU5<\+, M]GC27](PU=9;L9"&TSZ M#8[_:NL$SR4I,A*AN8GR]\?[8YB$CYL@>[]\CO)ICO\:G*Z/_VIRI,=_;AC` MXT`U#/R"!WH_])N)MGGH-^"%]:$?=Y-F0?Q+6(@ZKH^T=0L1.>V](J)`V62; M?;P`Z'-!AW8_&Z]*8(T]5CK=`0<0@2[>H6$.K5*%SKM!*BDQMT5XQ%S-4%N, M&@O4F+RM\;G.TM4N+#K@I[-"&HSNRV@JJ)%7T,2#@$"_!";*6_5,`\&V"F?J M6&&30WSQ[OAF^KW%5ZF$H?S:W[NM+M;"+CN05VO8MZLJY2^3HV@^UA') MRZ!`9^^K-2L6,94K*D+CM":)@`#9^Q+R)7G2S0J*M'U.+TZ!0E"\)R";I^U* MA_=!`7/3==[X>@)W4+G,>>32J!OY1K@KNU[C(LZ6*[PS%?MPV&F$N]RM8?M-=R7[>"(I$TG@2V)F4A?P??KW=0MR(I(1FN(C%HUP[ MZ$(J9.$F^BTH/_;NABD9S]:X?((#`DQG093]&,0[>+PG&<,G<9!/MO#ER!P' M`J2$R,K'XH\`^6H>>[M6;+QQ4,_6KL'=-BJ"./H#KE@@X10^P3@EK3=.TKPX M2[.^+K\-3.?U"/K3*&V$5T$"982)@P4P,%*K6'G*\-`ASUKP5;,\.Q;:=O:L ML.'.$A#?X=S`ARAG(2^&L&=TP0ZJ8^_6BD@#;:V``1Y:K;#RT(97=>TO_J[" M]N3C@!MI]J+'8:1>A]+ES:&&%FD5&#K*+%+OY1K(3*R-JR`#5@QP_UA#0=P[ M!$9/.!-H.@V3XG(:UI%1(?/\V.>@_GXFRJ03':]%RDD/:=&'C=_5^DV:KG*V MFU]$R80ZI,3G.I*@(D9Z28UVR70-R*!%Y?GAP:`U8,JZB&=':%H!=9=+_#P'%+R&<98@@I8/53 M5#R>)RLS?;W9QND>POSJ"69? M'AH:\_X07:8L]:9.=EBNX-0Z7T,"%2B`88$O#[U?NUD+NFS09\6X(0?NVR(H MR#JX16YPD$7I5)N'&)'3TX^(`NES/OI)VZIZ.=VH1-0XTT@G.*CA!X5UEF8P M#/(I7YB(,;E^""HB0J,E"U!^/IN@BUILS;>E,GS1#BX#1/P`P0"`J`0`$":Q:7M]:R M+L]35KRS[4*M0_8Z"!_K_1=C'4M!I9#=GL)MR>RML7FELA@DX+PX#-1WS'`$ M53#57R5';8,';X(HP<@0?)B$$40G%YIR.Y7GID;H],"N)$6BIW@,:`Q:`)9A M/8>G?$;BY/=K/0]L+62P"1[@+2R*F'B1IN9//,RM;1/2(#-&.W4`U-18JP";-0<54$D%YE&=.8^DBU`?AB! M;>RT:\:[3K34T&.L)M@!IP-GJ"D2(4ET1<0"RVNH-N3'*%L1V+;:T@;@=3-I M4V.N+'@@59=YG-<,Y213&!$?1B[M-)4/JT+G-L"DH*1OH::9/"8R$*5!'2;[ M8A0/93H:CA@DN(O9+HM#XT:!FN-NWPFIBU%F%)$J4T):GY3C_=R)&PBDO M0/2S']!<0%P`['C/_\6Q!1)AGX5!$A!F9)_F<*;N+VF30G$2AE@G@409#-&? MI[M0:6%PFUK1P"T-(=*//-LHI4":KV([D[(\7UWN,(2K]=O@MS3CLEQS[68E M'^FL7[*4!%D]`_(]SEPA(QI9RCX[)VN%4#;25,[7>C_JI)Y>PPS_`CG=1U.8 M`R4^][GNYF80! M_M1?8$[.YK+T@GA>`QYX!OGCV>GYR7F""QFOEAL,>))-1(C(Z6-.$072=\;Y MXP+@KP'['-#OO:Y]I;`:FX1TJH-*P&XV:7);I.'[JLH+VGQN'X,,8H1=JS!: M@RH]7J>*9$"0O$T5&@K(V$55]24G_@@@`!8`@R!V"+R($G":QC'.V]FB#W+\ MP4O?8;L^>M#J867&M@$Z>AWL2<.ZJW6%@D,[A79J,+HN+*ND1E98E@TB'1:S M543RS78;(,HPUIVM6[UO?T>QJNS-'N7PTF4PPBQV["P M$4TR/:K&8EO4Z4BR_=Q[098BU(F3?>4O@E3"V M)3]^-M9[PKLD@V'ZD)!R3<%S^5IPBEU`ALIU:%9"AT0K^*_)Q7/YO>>`K$9P MO#%73=@^)".!6GDLUS`)8MPP;9FLJK:3M)N:0^TR(L=I6'<`H7U5=`%JCQ=4 M<$D*1=7AE('VZPF/H$L&"F_,XB$/3F]@#M','Q%HKE`C*Q8^3>*%"J%3U5:2 M(LVNH&.(5O(5/=DPK_ZSD3";N14Z#@QZS/P8;;=1\O`]XE7,>S]@N7J" M61'E^#W8=%9.@,6ULG5)D)9UJ#[L6#$_I0^E(FH4/13/;TCK^2=D_-)LCXMI MTT0`9!ZSIW86T%@12"DVMPWG961(@Y)L`*A&@'*([S"V7H+-8*5RZG:/+^J\ MD:OU)2RH#W>&J#Q%_\V+*&0)2SC%&OWO$^G1K`U%V$%UEQA@19_LWJ2"A6,; MN%4H.Q5@68,2(*@A@AJDOQR#07)GD1)[+@[H!B.NAL>JVV1O@R)\1!:V\7=* MYA1&<0`USOO,6)/:M]SBHJRLE($2:N.C*NV.M*@JRQ)]$FS3_#OP)DMS?'FT M]U^);*">&=1P-&6^5?,<`4YIQ0%,#"LZ@/!&J3ZO:QAT9\H_D-#^JF]0B(6" M]IBX/(IFE*_\!K-W_#*YY;*2$C)=?MM`BMS>T0XC=L"VH%@D,\BO&T>K>IA_ M$T8/J!4K0OTV>(XVN\TR279!W*@]@U9FN2<[7R9]J)I!/>H>Y/9?+`PXH-!; M!9)PGF")8-%>,W-:-!9Z9K!P^C+>LB[!H%6+*,$5FY:[XC'-\$V)C4LU")^3 M%3(ZV;V+NYOO*F39D!IB-3I_5<2FT2ZY6S98*$.N5C3TY*(3$%W>M MW+9>Y#E.S1R1='N/+I>=]-GNQ1U]NN_M9K5A#='('BY?;['8M,64T""O.WBV MB^,]Q@]7=S#;V.Y8Y@C\;E'&=(X9!L@!`0XH=(#!+VA15H^5H$92%/7FTX_= M0W:;,H7O:@OQ"]GDX18^D.S_*?8..3+'.X&4$&U"9C4"E$,\1U^U`N1-K7K> MUJF;UUD:0KC*\87&!7P(XKJ4U21ZI,3G^K9`18SL'HP-H?=>9!!7S M-OB`@(/&4._.[4@:9E#6J!?'[9?,18I`+Y/5!0P0LKIOZ#*.TP\!X@=N>8R^ MN4AS]/?K-(["2=:)%1UNH_HV)$K6`P%%LO8H,*[K+#K:E?!HFVWT*:`@`84) M?F'_O8//!3A&\GWON[W4$"WBUX(UB^W+73[!9`=O:-HU<:@)4,Q:PMEI]@0= M4O=67T.1U*Z3<8`;N##34E_FVU#<30-MPIQA-4*0SN/_O/Y]AQ0^QJZ0`STT M0^S6R!K1I*@J0HPJ^8$;/FN=["7^=A42,U;96D?RA/\QC5ISXU@6%AUNI(]>4O9-!=YL;V;"'JM4*](-FAP-@QA'N>(4%]S) MK]:7:8+UGG;AHR\$SJ($>0CXYRHE4JFMHII:XZ)S6(]K5,)5_<89$L!A(=FY M:7)`K&Z%B1CB"A>7FJLSPJYK@DVB8F4]L?'E8N]GO`VR][#`[O0M#'<9AV$* M,Z[`YC+#1$Z&1,OK`:`>,6L'0B]7WEIK&#(@:;!Z1N'`29#B,Z1+?H5`AB_( M+6I!]N8*A)EQ\W2UT$L36M<,YAP;HS05SOU!/GX0=RH/N;"'-G1X*UQE3*)! M'2N2GD:`"6M:&>[S\&K-CB]!?)[D1;;;U+&H*>R=&6*W M!LZ()HF6X;'D'35YZUH-!]SX69]!>BD";[S,F68;Q.Q4]#_)X"HJ\$^3!-45 MZ!R'TN64].CD0`>5;1WF>6PQ$+&RQT.+,1;[(JUIUP#<=W\T`.$HJU-/B41_ MZ$#05*-YA?O,!<4V3T-F##GPUO6]7`1.)+@6&2$Q?V:DO?Q:W.B5\;/4$<)Y\P8&-#ADO%M*!/:C01I(-[ M#`KPL!:`0F-EC!D\(#JOPZR!*VJJ@N2`UNK0^E2 MI36T2-2W',6WS)KK7F\H8%X-39@R0.7>Y?!J_3HOHDU03%,NM(7!;0GX!FY9 M5?>65J,B>W?&@][/P@_+D#27Q`_1LS1!/X:0BW0[,%&]:7!] M9.E+H.P5+OP`:CB@"6C6)W!;+6F\W;5AHOVQAN;]XIT]31".TW031,DD&ZP0 MD=-M542!;#,EWX+J8_`+_=SO(44IK,9F*9WJD!Z2LL2<.S1X.L4Q03N7I*Z: M)+M\+CR^JVJ>K%D/>1OE;[688YVZ=8,8"M]"7.)@D@@X!]ZE>>+PRB+5^`NA M>OB)-W?ET(@BM^9C5W+N,BW@\C(H=AE,U\>[/$I@GJ-5<[O;;()LGZYOHXM=C+.M\CN<6:V]ZW5,CKN&=4[G M)7/\$!%@"0X`)00?1DI2B*%DQ.#?<^0T?$5&$'C!2'J)H+5L[J)I=`$E#A#J MP"^$/H^Y87[TO6STYUX+;*IX.2/S`D$^+^#&H-.D>Y(O#*WM']UCTQH\MF.43^E_\E[,T MNPWX#\P]UR'PW;V)'DBI:OLX1@9?^$ZTL254"`X0A@.,HJ'.AH]PM8OAU9H5?+V! MN/,J\K[/DW6:;4CFQO&>_5'@-XR4,F1!AM.4H?[TR5*&&"1RZ*2?@PH8X*`M MP/V^^J+C07C)#K+7E49VD"4OAR3&R1%)/(.1U-H$KU,]-B!(IK@J997L\W[4 MM(>P&WIIRIOABO@&I@]9L'V,PB">;M^6(W.\;TL)D:@:_^$\8@%:N0D423+= M$;9J5J62U`M^_5S`+`GBDUU>I!N8D9*JS7H`#G9M*XK+5G2V=K\[^Q#5$F_RUMP>6.?7%.&D#H`U+4[3""R)5!<*[KT. MYN-!#-4@045A.^8.\#0N@PU:?"0,7:*;SM.0(W/=OD5&B*P*`OM($!3PD@VJ M$UHC[5,Y5_M<*8@)C>*(/MI8DXHRW/U<]7?D(6-%Q8I=-HNY2T_2)$_C:(5[ M%DSF=XQ-HM/$^I&)EQIA'@OI3T2*&_'WW!PF:G>IQ2Z1@2(%/#K!-88O\SR) MAC:M]OA"&G(;W3Z;:NAQ&M0PIL5GH,.42-/@Q\)@/(9/M.KWP.]U2^E`F>W9=@V":W0`" M6%F6%QC.RWF$HVWTH?$8NR_7AAAP0V23&N[>-+A^#=:7P'%T662D9ZS/2MML MQ4'[IV!51;^+*+A'%A]?<+^%`2Y\O[I*;O"E=X:V@>,@C_)W27J?PXST>#I/ MMKNBZ6,=[TL8^Y,XR">\SIZ>:$^U**>:C[Z.Y?T>5`,!&3F?6W9G.BHL=3FI M3"R*%^+$E7-D);(=7)5M!\N9OS7,$^\!SF1K5@RY5&M0Y3G*B8^H.EHT, MJ/8?!0=E#QE/%F+FLIOZ,F]2792X18/TT8.;8T7>R*HY@RC[(,GW5M'1SI^G MT5.T@LEJ0M>DC<)Q]+R%7J)YU5>B/=['#B\1#+\?BV9F'2&O-G=Z96.]KY/A MKIS=L6EU?3:<:B*R,R3^3.[*>G5D)U([H?\Z!;<'M$]M5_,^ADGXN`FR]].M M("U.SY7>6^08EWL'U<#9E(\P%:^RP+N('[:I).=)`;-HE]7;D#\#_,^. MID];1$>%SK/)T];,$5B[6=7),1"ETL9UZ^)X*8C@L`"*PR.Z4$J%RA5\C5YB-8TU&Y,="/PZM5C*\J=T,1*KCA`;SO3 M`YSCU!1SRE3Z=8;TJP9$#N1TA^4+1B@-E`]]ZR]D3OEZ,LZ^WI\1HGXVK2=( MIP6F^]$VIE)*@D%S54R59;1@HO5)_`WRX;"S%R4/,`GW--(TW>E&A<[M)96" M$EF5$_0GP`U9E-',V81V#(3)GP1T++"\IOJ>OEO`3RQ/@TWP`&]A4<3DH-%[ MZS6%Y=:3,Z1*9=Z^1^:-O6O!8`"%`VI`LSL1]!0K9\_ZL,O:Y],CZ;?+]H'G M,DF^!UVCZ=]LSA@60NZEAYU-U;(B`WG0=1UDQ7ZZK52`Q7V/]C8)TNH&]'4? M^7(^^Z5<4,W:`L)9V@>A>8!W&3K]!N&T,64U0L?5-!2D&&D/-VHNF;Y&`I6I ME)@+`Z)F/TB@]P^PFD%R'/,P(DJU]?V`MCZI2LTO$MM+G-QN9\XG^^B&#D<_ ME\LW%V&N75+?,9 MA/G)+LO0($S2H4".Y=L\?AC`XQ:`C?0G+_6,6@(RF?[X*TPKDV(7Q-1#OPN> MV6M`=D<@%PD>!")ZD"F"9P#I./#BGHY\^:E'\ZV<4T*)CP)8,PM?S*QX%"#D< M.=@$*PAVR0IF9/"*I<'P'X$M0O>II\R7@3QK:<0(_)_"->NO-9@X*>7YV2Z. M]YAVN+J#V<90<0KT*5KWX,-C%#XJE>8>$N.PQFB(OL'5IS[OKH8R2*\E%OSV M;UHPT:\WVSC=PTQ*_'*#$UR1AO\,@VRY*Q[3+/H#FAH;J;T`D"%6*!(("&X0 M5%BQT0)[1,BLS,T0/IJIUC`I.=:TRQWN3GRUKDKXRG3E#BE(0C[&NU!8%S]> MKV%(]BBL)TD1%?M/@FV:?Y>#L/%J*8OR]Y]Z>\S1GF;;)Q>SP;7C79)!BN"R M#CGX*&`HE0UI2+BEXT",!^)?5X+QSO[.O"1BD,S?N=-=TO,C3%:IZ=IXHA_; MK@Q?LF%SE$BDP0'G)#!AR!;X5^D)&LB(,"].C[R2;9DHN.&!Z\6K=6JE>U2T?!:*S>^`04]]!`3 M5D3(14V?D*"H0UNM*/13$871-B@@*?"IT79.'@[UK3> MTFHIH*6T';LVN$]ACNT`7OKY=1"9^,$Y'D3<7#(*;-$PL-KA"B&<:OBSUMU) MM60CF_4$&2`Z_N^V6WI[',2U..7HC4C_*19IU%SR7S4#?0NQX*NX: M2@&A80"-X_JATJ'^VO.JI]2];-#.W]EU'KOY6";)+HAI07RM',B=#QW!V@ET M)>#GMJ<[#?%%CVRZSMF^6T7%&82&+,=?X_LU@<+[8GAC`A)F"R;I,$-BN4+H M<4@N+M_LT9T-;RHL<(=V/>3O?WFH$4,%J'XQ68,"%2R`@8$O#V=@EOI.O2U` M.]8Y]OJMJ#S2!\>#6MZK4MY1+>\U<@E@)?.4RMR;J^A%U$?.7(8XILT`RF"M M9J7&<=DVH8I:^U^,XCFTY:":J5U:TG&:OB>5,)L(I8E'[>^=;8HMQ)+D(?P5 M*]HOV`9=2U7"7"9-T8QWP/1.+JY_")QBG)&Z#"_R=I=G-Z\OE MR?GI^:5Z/7&@`(,%.&"D(")`X$`%S[M#:#'[ENRL^>_%ZCZMY$?^32K>5HO,N"%<3U8F_@`\Y@(\)C9%Z\ M.[Y9_O#ZPGR!5]``#ZY>XR5$H?7U*&MS+LBEW9>3[N-=UL0:K_760B\J=>85+S7(N>P(OY[%(FU2W&2^:DS.?L\1^;,C1 MXUEQ]%C)T6.O'#TQY.C)K#AZHN3HR;0KI M";[05NOIZ0FM(SB#LR9/;HN/W9FX3F1K4Z#13,96OWG'YOP\:#S9,'GD%R*]U'U,FSFXZVI3(_&ZF:E$8>8";YW"1%59BNE7B&@(%(B2V<^.\<(XO&WF]Q]2`DM MFCM"P8+YD-+E(KHL]"^3YK1T(A$QP?,*@_"1+IN M4V^+THYUKIT]&RIU:U3QV+A*KEX7^)$Z$O>>B#M=L^P9_XZB#[F[$I4_V:BZ;#AL`^?K_ MGZ@3[KQE_'*KV"]9$>6W.UQBY6R7K#2[.1U&,N]I8AT="H/GP5AD6;[ZL$C>0SUC,M":U8,&PBJD40Z MY=@9;(;:F;4D8\@)=\D0"#O.4L:U;(SM&!E3EOG5V3#7`E',IRT+[=3=9R;I M:!+9+;DX6C;KHY:&RPRA\V2UPT7L@KBRHQ!W=_"510&L9J-[*-9'`T:!+?X*)B,.V--7_K@%((LTOF3[#U3^?$L M&"NBO\5?^12=97E=PRS'1^Z3(-,\M"V_!/A3[Y>F7;I;O)5-S)T"7S\&V28( MX:[`BTBCP:V/_?-71'R;Q?().MRY#)]I*5Y?N;<-ZA)Z2-'R3!783@Q>EFW!_0Q>+<%['.`OI^%^5>SOI2T?*:.;[[DE,@J M_-%+Y4]^WZ7%=QD:?;#;TG^`;="]M_JXN-^\AK!:;?BNVF*UU<.\K+8*O>%J MPS?4LUMM'=:+Y-V#&U')XVW`OBPB_&?\&W-CT$A)J?NUNQ37P2E87^V8. MYUDA4ZL"B^VI.%L@/P5Y`4^C?)OF07R[1__8J!<)&0#*$8`.\1Z+D4ZCQ6G- M=*TB"*=L\\=UC4FA9ZXLPO(>O_\/"^TJ,@+B,H_7@![)HBN'DGJX='"CQ?PO MY7B?F7P]9%8F:)ERQ&4Y!])?K,1^*'\KW_S.']_;E+1X+)Z0RV*/3T$4XT+D M9VF&ZV)K62L=X*V0GXR@%JLU,W58R533I4UT5E(.^E=I3^R69,?.#`+0`&! M$A+NJDI_>NFY072?>8ODV9]O+A39%YE,VVE@T#',JS=>T(=D3K-R4FZ"`^'5*E.R0@ETA M2FD["^G#CQ)"F:6+&R]@(.`&7]>$41P1`&2K"1O"]"%+\PF+9-F774YE>1$% M][C#5:1MR\U].9O=I4N]2`"R.3K>9\1ZT%3X97$&5T@=XMLB*'8X8-[X>/AZ M"G"K!X(!5"C:@P2KSI-\1V"9^8JTD(33I=IV0,\3D@9Y0SK5X2.'U-P*''7< MTYDF?W+CO6:?'&1 MYOG+!4"#\>-6-'P!E@5]!DI.T<@?N@X:MMC+P4L^7>$Y2\<=IPNK[$V!L-/3 M"*)%LQE6K5JPS2R/7$Q&N#0_C6DOXSC]$"#FS6;#5$Q5)"ZU@]"L- ME",=V*3);9&&[Z7G&'HQPB9.)IW#\-.'].D5@O,*WY;@'\BUR<'AT0&[.#'$ MX2J`;$:.Y-J$W930D8`,70`Z6'P.=:M7_<2)5:L'-YP:`?:DH&.7L/T]ANLT MP_Y!'.1YM(Y"ZJ[K#'KYN$)AUN\)9-`!S1M\KX9]`%M$!F4PE]W'V]2!-L]1 M!DJ$/*YFG_%1K].?8!S_(TD_)+?(N4H3N#K/\UT[!<3>1LO`NS?/$DK4EAD/ M.GB/1X%R&*#C/*F&L>":UE@U>5_>&'=P[QTP;'AHC=A%*VPXJZAAS\EK?#9S M_OGUM]]DR/SWPMD:>725`;1)%UZN&5ZL-SXEA]XM[4E(4+SVIR&2PZRRYODH3['2(^# MY:?-0Z!GCT,P`>'!339/CMD]+1?1^9.@@`]IMA_+;C6!NC]#-/"KC1;Y%)3? M>CGE:X31-%;=J0UP7:YW]W$4GL5I4(PE>AZD"Q,@Q*P6.?T0D"_]7&DK)="4 M=WM6CI(_>]S176=1FN&:E]4W\CNP'BD'&"HM+EM_"O/NK>A<;T1%;+&]!I6S MV#:H5&;,GT5Y&,0TM^X,_6X$UU4.VMDA1DJ"[ED$'5"F5I(A/H/Z6BF5MD(] M8RSG6Y#NZNMF7WO.AVJ2+I".>GK/7<=(]$3"(.6AQ@H86H#QLK\#G.52(0<,.Z#HF7>\:&1%^%J;$W"U3\;$8.$Y MSG[&F6-!_H@V!1RK71WOW^6XO'455ZSWB#X/"7"6#'F?5L(%]WOP`H-&=N0E MJ$.N-?@%J!&`&H-?,S.,.R*]&8/?GM.;SY,GY%JEF<*EDVP@W$C?%Q?*:9GM M'QT^V,3AR,D%_9!.=F/^O@E9R7JV\`_LCC"5G(\_)8W)V):Y]- M8B*PNN63F>0*^D=JD@VYT\,D]^*W4Y,L(?@L2@)T\IM(02KH'ZF"&'*GAX+T MXK?G/7L9AK@L>UX_ONFY=9<`N'=)\]O"N[,TV\EEW'%M^7%IEQSWEF/4%+LL MP3&$ZL%*_B9-Y5DA9#BHQB\`@T"")S6,!2!0O-Z7&3+)QR[^.K<:_BZ^!(*I7WIU9VATS>&[&*%OE,55@M2U/VJ MW@'C*#@;"5ZPL2]]VUS-W(2!4!-VN+:TG)/WG(HY MC%T2#W2P`&9RH$`*/>0TP8;[E[!Z>OV.$0V>.([GEY:]4C'.LO=_D]5YS^-U M@Q/-2;6[R7G@6"C2N\>24N82E6TMU2]<-;>SI<\85!T^.T]BY[+*3+C0ZR[7 M@)_VB?$G:./.&E MJ'KN;JTLN1.Z@4\PV4%R^Z-\.4#OR=CG[#9L+F==\4RD]V"2.5N]`&T^&<(O M0B9Y_U4#=F%Z=N.J)E:L:"&10*;\:B\:Z*XR<7R%S4?4_&B/X3 MR$2J!+;F,:\O40_AD4@-AO-\?N^^D`NPHE<6]W&Y^]_`'%F<$+?K.$5[4YPJ MJX&9:TT#5WD4PADN%!W1)P[A1_0"S)R+MGK55T[NH^.L=`D.O8A2Z&@)2FY% MO(V2-"-=W0J(R,%/)9M0J&U]"XM'W"$&)W*2:U=%2+U^"T,C9\+,QK(P*`4/ M*'S`(5BTS-GKYR(+TFP5);@*TGD!-SG1922>`C$FIN<`.@FO]]<.A2"_$76H M`V[[/M$C:\.^]X[3M?=-74C(8\1./5%%X,Z$0WYK(J(?6I=,V))F3\2[6X9A MM@OBG/P7KOI>O98)1?CGZ@^-K0[CH=F<#-,",%S\O>U\BF4.XIE1XM(@>5@= MDZL'(J1'^'A#@_567D4$7;M*Q[N6W]%DU32Z#SI:<_.L@Q*><*^ M0]^-%QTAT%P5R.*1ZJ(@^!OO>;\\K]N1CFH2CH..PK/\9Z*`(_?E)\$VS;\K M/4A-SQ`_(4BCN(9L]I[RG9I9/O4K;/S\.K]*[K(`/\;6-T>5YT)Q#^0)4/PD MGH$5]4R=3YEJ/3,T.ZT%8VVN\&K-0DX@6==\ZEW7P*Z#_)ZPB0VD5A;&15[^ MIFUN)1B<>I1-W!+;6WT$?B&?_=/O8QVA0)K&H#.I433@(DH@.31/J@4U%ND:<$(UG`L``00E#@``!#D!``#M?5MSV[B3[_NI.M_!F_-R M3FUYG,M,,IF:F2I=K(PROJUDSVUK*T63D,2$(C0@:5OY]`?@1>(%(`$0($1' M^[#_C&VB&[]N-!J-1O?/_W%Z>O(!^`!9(7!.[K^1]!]'R[/7+EV_.LC]\D?SE3T_D!X6_ M?WP3__6K]^_?G\6_W?UIX-+^$`_[ZNRORXNYO0)KZ]3U@]#R;4(@<'\*XA]> M0-L*7>AS\'7"_`OR7Z?9GYV2'YV^>GWZYM5W3X'SXM<$N9.3GQ'TP`PL3F+6 M?PJW&_#+B\!=;SS"4?RS%0*+7UY$2SS&J^]?O4Y&^#_1\A/ZA.450,]U"/)3 M'TL%S$/\[S7PPQAT201W1GY^5O?EV:_*F2/*AL`*^`%6LX2> M`(.TKS&3:ED<6A[1@_D*`!'P"I^=_:H:N/SPGVXLA.6S`J%K6UX@R61Y%#4\ MSU=XU!7T'(""\W\C-]S>X@%>0_2F@?!19 M,=DG9XHLS14,P>#*"B,$X&(8!:X/@L#RG7FT7EMH"Q=S=^F["XR`'PYL&T9^ MZ/K+&\R/[8(F;%L.KLA>$2Z&>.?Z`D+KW@-S8$?(#?FXIW^G$OS1%&_-?@@1 M'T.%/U>BD634<6)\;ZTG+B8*?ZZ,B?,A]F<6;GB#;1H/%\6_5Z@LDP\`+I&U M61'%=*ZQ!4!3?P'1.G8>.#AK&$"-92:$/HCOO\S/U''U6S+B!,'UV%I;2[QT MPM#C\5Z:OE:F:U-L;E`$G/.G#0:!2^DKGZBT`A]GP"/V'6\Y>`-"6*&)YPZY MU@'[6S4BK5KFX3;^U[:!N9H/E0E2?GNY)49=[PZ6DCC+#E3:=C+NN=1]K4PF M^3V*FS/*1PI->G['XF:)\E%GNPPWDUS#J#15M,V#F]N:CU7R6+;5W/PQ/E2R M-&X0W`!LHHF_$F)9D=/&AFQK=P%81-X%!B2AU\`G_SA*V!X\6*Y'AIM`-+XQ`S;T;==S8\L` M%]A4G"\6((X0[JC.L"?!P[+@8$H0'H,%0`@X>.1!$("0;,07KG6/N>!51ZXA MU&R$("3ZSL55\6^5"7R_,Y1WA`9^:CY4$[LADPWAI?49HE&$_[4&B`NHF@_5 MV#K;CM91[$W'.REKMVIV?/F&4;7GT7:M9AZKGQQ&5&F,'52W,7"GAH:Z4R_5 MM>:?2NWG"MW.O)_-SQWM*Z7'FKROS<\6[2NE;!5B3/Q\43]3IVKU/C\_FWSC M*#L7UD1V^'GF&$2I!C"C*_PL-P[1%N$QQ/L-!F"`#P/8RH5;_G!E[:=Y(/$& M%N"_BW]Q@5DI,`F>0N`[P,G8)$.+WT_N-A],SH-V@8)'KFXAR@C@(P7P,!#! MZ=*R-I]*(PWN@Y!CI1NW>JY+%#)3),\I5@$PQ?\,M'*[IU*$-Z^,`U2<@(7LC"?\ MSX(F5B_ST[\XV\17?:?VRO5V2KS`)H9;Q4+(%B=$#D"_O'CUW>P+&G9(F52U+*X>-@N4E):+K#_"#)IU-YDJ6F?\VJRH$(:6=]%NU]HQ MG1Q4+F"@=V7ER)C=JUCZ25U2>7"4R4M68DF\C3"DT\6@D>F#=T&%)^>#=[IK MD?!W$!*>$XXTN>XT,F9E5:.D>6%1\3'FP<=,7T$?%I>]MM5%(67<->04'!,J M4RY\E9?4L.N0'IN8Z4-S@PKG15B#F%F79+_9DMN:$207L!%F,MV-H1\,P0(B MD+O$NW1]B.);B!!@T,FU1'&4Y(G&)0A7T-D;'2VN3I?L&SZ>-"ZZHJWO4*RJ M-+B%`N,9I&BDM[KZE*U*RO@^PN>L,9%*Y??&Q,D5.R%Z#T-%`L9%U:"NA3VC M"(W"HY"J3$NB?P%VN,`^#![PI+,%5M+X'Z'H1LWD=A>1MMH-9[T#.DISTX8@L M"W*J%C^T].U_/BLGA?RJ+UF$]F2M_67Z]2(](ODT`CK#,J(L*,@<.&:7'&QV MB:1""F2=')-.CDDGQZ230YA,]TDGW]I!B,][4G8&DC^ILEZ'$([HS@0?.XO#.1\#RW*_`^0UZQ-7^@&T.8?O:WS_B&"`WP+\:X__T ME_BHYD(G"9#AD[JV*PDMS)I1(I%%4KG:T",T8\DSBJ?4$PW,=,_\C8Q.&Z!3 M=V6U]GVBM3Y8DC/X+4`!N&@9&5(]-;R-7R]ZHL@[7HUKLT`.AA99R2=R*(HX M4V:E4Y/JR!F^_.--]JW!2_Z6AYI*U6E@L5#H4?:\O@_?3%P?#^=:W@T,W%B* MW001V72E@Q#'N&&?XH:-BL21W:A".+(2VV/?^P_(TO8;B M(FS8O:U5Z(*'RP>CL:QF=BFU='):5FDC4>,^$+>`.0"4#S*'*F(C:9VB8`9L M@!40LXK/6#JE6T>O1X*MA4W!FY$VH:X]4X%>8=90,[JK\BAU)>C$0,W<)IL5 MP-IJ?/JS&]_TEBDHL2(V:B[JI(1T@\#&BBY%!LU"?A20JH46]6[_]61ZYD(:Y&33^HN^Z@* M(@3:(P/FW5`.-6:&!\R_,B]4"Q_DJH7KC.TT$S4N5;Y8#P=Z)O.2+BQ?RYN) M>%RS(5!NO+4MW`:*!RO>@KYSR;:XF9'_JV MYJN;"J$>Y$(P$#)WY9;PHB\J9;@R99U"5H-0ALOGY!IK=9!/5$.M!PNI#BLE M(?Q6^0@WUI8$K3O(1"A1,NP"-6LP+0VAC):YC*&DQU=U%IHDR"!F^O@C+$46 M:"9#O2E;N:)J^F5)(=9+6=)`4^*BR(;M.UF0S)5H]BQ1K\7U>Z+IBI:YJ\`< M_%\K!DY@^?]$5ROW:3B9%QW)^X4"7S2)U)+VG0-N5X(LQ8O!<7% M9.4X#Z']904]S$"05!35^_B.2S!LUY#/V9-W^N%,HT^ M2:T*D+%K4HYNQ^1IN,[7U:(L&.\&0]=N1B"=#U5C:W5&NICZP,FJD1;BQ0O7 MUE,PF8.JZ;XDS4+F@'"/I M<)4DTGZ_NP2D2YOF32XE#4M^6$@NP4H1,2A@E'O3%6NF$^K5.&&#E3E^',9_NXZS?;GH! MWX%/[:WS)N[`@2FCL%U202<'=L8I_>!%QCR82X0Z:1*3]D"/;7>.;7?,OGHY M=J&DR9K>A=)(4';L/K@.\!TMPMD/?B`!@5JIY*"0"*P6NZ;E;+^5/EQO%R MXWBY<;S<.%YN'"\W#E=6Q\N-@Q;/\7+C0`1QO-SH*M[:DU#K-QQEE7V%S8H6 M=?XJD'0^G'CP\45KY_QZD8T5='0ZK=)K$PD]'DM[=2QE*IO`:?3XXN_XXN_X MXN\@)M.=L[8S'!/,R?4&((M4W1G8H?N0[/+4S2M:QIKRZG6F)\M/W`,=CMFD M^D;\@"CIQ'F\2*X3F:AV-E\K=RFM@?,Y"I*"5K=P!FSHVV[<]RXM_@A)&S4\ MPQL$R5VK,]RV68!JJ9FRZS(25XRSR1JW/.T%M.0F\-`UXFMI643%NIP\D!LT M]I<6^@)"XA'L#]^S]'R>'5<).FTT/00^6.BI&-A$LI>+N1%'^8S/8K=@ M(2EC;A"P`C`&R?].?;))S4`0>61K(M[-:&7Y2Q!,_?V&%?J'4IJTQ._0>,&D2:*OW7$_RFU*&`M(13HEL3 M;A#86*Z3^5.I&X5GG.NYUHV*<''R3>D.GVPDGLYTI%1QHYM.E2>A:"J,:59- M4K15OMM1[:>F'>*Z=5(SHL9B&8:]U!WH\F^#'@"ZA[E#L4*]*/6@;3@RG%4LLLQ*5Z>M MY&"F15WAZI`XVX&*5(:Z@8S'Q`52&6H!,=AA!>])::QO8/\;N0@T=D]7>N7! M3]W06A;5ZL+5AP"V!Q"UJK!+NZ?K1`NHA)^#`M`151F6DK_KM`%PXDG.+8\< M;2^MD'"XO5YTI@?"3)@)0K12"7&@#9=,H;DBE$D;=@EY.3+L$DJO,P[_D%LH M"AM'M7`1TUXY[5W$NH'ZY"+6`F*PTGVVBUTOM-;GH9$Y`/O.H::T+;\`EN(W M6:JL.&5JAJTX+T>FK3A[17#8:6[8C=GI;`*$>](+&/\/.:H\X`V+A#'CQX;E MX(8.+1&B?R!O1ZAV7@Y0^5)L"CIWTED=8(U&:(L555]7;"["AU(P0$+<%0SE M.V(F(",G\F4E==(BX#1OM[[2L8@L$5.;,`N!A&`48B""S?F4?K MM86V<#%WE[Z[<&T2XDHNOL@#=>BY<2=Y>3>T.IC.E]TUU&0MZC5:6GZ:2;M_ M]9YDV=[DA)-K([I3N&#L!K8'`XPZZ09$V5R)#HWT0H-XFGV='9.JG9/88 M5@CB/0<@4I?H%EG.[GYZKU=:+8,V7HWO^N**5KSTUR5#=6_B.EG]HWP"9JLE M00;9YLREYF7.(M=N79=&U;XVF?0.8GTUB+2\H-C@]6Q1C'?/IMHMBG20KA8% MFURKY-7RJ)H710V]`U@4C2(MI9;5@->S17&>OATD:1)M3HRDM!KP@\P#GX'0 M1;&OWU(Z+2<39Z#<0C[FCE4+9E1K\YZ?2Q:\N7O M2B-VM,YXR!JO#=8@V$)A+1X8^[5:/E`J>\JN$0H<.I=)'3EY!X^"!\%)ZSII MI&DXOL@AV%(%]P8(^[5&?DOF0/(LQM;:6H(Y"$,OWC?E3T//8K%,_1!@G,/! M;J.-'7R]!Z)ZDF;+DX@ME$;X>A4XGZ;O1M)WI_(Q\QB+_&LEWTG:(,VC^\_` M#F_A)?;LR`#;&7#`>A-+6./B:<>0]$UZ>,5 M?;']B`"^/8K^5>^ZA]OX7UMY=[#W>2,7$`N8O#(F68&Y4D<#SX./EF^#"43D M;TC91!"D<&F8FA0?OK6Y.+%6\M)%LY5'N;=F!G)N)]FPY+*Q@7&MD_W?,=RO.06CV@/(]33,YHX(=/^JH!ED_);__F MEI8EJ<^KJZ'6`[GS8":?9M^V2FR:J-2!&6?2,OLJ2DR(;,"4U$22KHQ`K]G1 M@52Y:9N.&HK)F1_25.[O3)CAZ7ICN2CN[X;PEK*!@>5=+RZ@O[QP'X"3).9V ML;1E^.B58RZ'=*H;/W;FI^=J?8HZ9#6?]L%`U\T\%/XF1M\&6'*;DC^I2=Q MA$VN5Y*MQ2V39X>1K3^`[T!4X$K4FG(,T0L1\4"12:C[<-0NI;R3XPN#5A]V MQV;`,B&VBSA)WQ($`$]Y-08/P(.QGTVBH'"]B4*`YG`1/F(@.KDYD&&D9^%' M2;0S#6D9<)*+.Z_/',9-XF,"5]*>X\ MX!.X&Z2\=7&.;2+9HVAC(WJ9:%L%K"07,Y[KT`J`DW_43CF9%"4S'G':SV)I(]$G8C>IE@NPM% M9:S=!?C`?AZ$[MH*]=3D+5'HDS]>!B<34[M0E70)QL<<]PCZ^)\VR`57.EB3 MPCSTS/$2QSC+]>A#;F2[PENW20N\%AK+-SCDR[DE+M!=*W]S;YVE'YG>S;+2&UUX'=^*,($;WK_D24PK6SC.H-+67,XG>0!_$I=QWM-)7MFGAEBZ7DS@[ MIK+G34F.R MGM&875J_T"Z518R5WNJ)(.(*WOL<2`6N_>[^+1;BVLF_/'8.H>$V_65'*TZ, M%=,K3JA@ERS*`I";&]0;"V*J0/2 MG:5+LZVQ)<_%[W>_Q\N)M!F)VP4FJ`6W<-]:`&]R M>C.VU+-I_$Y)1/NTR*E/#@>MB&%+-^-9E&?+A6!M.UI'<3F66#LH@)%R$9V& MQ*58,KXP!4N\M19!C^KBT(K`M;VY.M:"JZH1P=?0X;R1NN$K9.6%X42`[TVU MQL+35JOF#EU\W3)?S>:&YFZ@+#28^#;9+E=E#$++]0)^+)MFVS$[,J'FSEB\ M*+W^//!DZNGOS<'65.1"3/VBJLF M0EXH9?D+B7^"E1=OSKN!XTHX3V3*P258WP/4:!":1S":U2V@UP1Y#CQ:-.`& M*``7;5_I#",\6:QH-/FH690E"F:ODP4%R$*I8B7;@3_%ATGXD*01ZQ<$A5J? M%A4/>+GXE_!MSY]6$(*L1LA\B_]CS6F\V%\:#WP(8ER#08N.\06#I=:O(),8 MP[7E^IWZ%3FRIF\\)%<1%Z*Y4G6RDIM9_E*;W[4VY073 MIR1$]_^S^\=[Z^>UC^O?7OQM'CAW?H_;O?7W^^N]T&WKL'^^M+ M[V/XX]WHXL;Y^Q_OS0_^7_?7H_%T^^'VW]N/X/79Y/:_WDS?+D#@?/_GYMKV M_SE_NT"_S[Z&ZZ>_!^Z?:WCFSJ?N\/6K_[Q`\/6[B??N\OVY=SM?/[J3)^?+ MO\LEM%^O[??^W>W'A?7^]Q_!\/-;[^MP^W)Z\_7#'QLP6Z\7%T]W7X9?G*_1 M:_AY\)_NPIN>/UV\M:ZV;__]_L[=O`T_K&_/7C`+F; MSQ_^>OSG_==;Y_;C/Q__^F<2WCX.?OGE?TY&\]GIJ;C9E9>`V)5'6QJFSYK\ M:SK;?ENM&T71MDOK,T3D6!N0!&[ZDTA-!U1>TN:.KPH,6]&EY\2ZI6PG[A-P MDOR;RRB,+&\2^0[W94/=QT:]>D%5C>\::I%0=\T@))Z$Z:Q#IKB$FKXW>YD@ M(:5&0.03AA6$5T<0;2"R0D!FLY^$OF-T/<'>29<3QU*$3M]VIB\BSD^\;W94 M`M[B6;_7^[<2#[BBWV(*7J;!G7'&_-!0SH_"XP21#1L7=6G&*H_W:_+XX2NI M7QAT?<8OD#:SC31I<:'8)R^(!RGHM(!%MR+.B!J[V5`CWQUVYAZ*[9A;0!04 MF/N`8!#<^0A8'E'!#WBS(X\<7FF5-#\7IJ(@4I(7`%=%=TA191@#.W9.W[S" M\GG#O>,R/C-Y-Z!PPV6!HF*M*O&(7DJ[1&7/K$,AU:M:G:/S4FFZ9#?W*N6J M8N(7*;D1N-AT*/@:LGV1=!UR2ES` MMJ+%/&F5(1G?T'%<5%8Q%/+.6`A#R[LH;/A=O`U\<`,\!G8WRS7Y9`HS[\:; M%,83>0-8^[VP)Y2>E[@9*/^],:^'$TFBB)4Y&CSUI[Q,`.;`\BH5]+3<"320 M-!)B9>A=(>C?!)4RW[6-).<8+A"7LK&[E6<#84-[`K][Y@!":A(Q![*7U@)LXML+%5IVC2Y"Z38@9R[Z9E:OB*CY8#15#C?CTH!\:T1ZV!+5O@.V M+0&O7X:]-+Y-@ULR>%ZNKGC+&I_;[1(?4<$Z M*!)EB'^0G3V)H8Y(!*O`C];5HX1!0V=`:1VA+DDUHE)5C4Q8Y7@JX!M0-!5L M]5F]E(A%68A"I3&C>Y6Z;I+$6.BSQ@C#K2+M1)O)Z5)+6O%C*NS5F95I5*#6 ME6%:7&)257X,G,@F_PC^*[(\=^$"YP;!]&<#,M\X!:A#@\/+T3.T/]S"R-6< MX=6F]XDV^6!)ZC3G]4F;73*H6RK9>_962U3M?C@T(W8%R8&:\(O/P>EAHD.+ M125O+$:BTT#1@4[5XFWWZ=D,-F^0"]'?P$)F7&8J^6>I#W2@4WUXU[T^\%B[ MKI1#FA`6-'$A(QF"OLXX_!`_!@7-?&\%[#8*K7?HL" MF:0Z]=[$[2K/2C"K7XHY[/?VIEI<63#16.5JQO*)"RL,G,]1$,8E@3LT7!72 M9N[T=1JG*KJ9'G2:PX-/;!%G*@?M453MUWT,NC3@DVK=+Y=FR3 M+NWISW*>*7DYA_4H;N]F><'`\^"CY=ODY?`81O?A(O+2(K!:]A8-7![&0XB7 MM"U&ATP,OFVJ3&?W\J\35=E3.X0737P"SR%DKF")I!I6.D`>D$&H\O;\S``% M_Q9IQGHVF;@H2R=ZD5#JDY13;!2F&+>56:.SKEQV3+?^(!R[1G^:%T,3S[*N MH"_ZN)ORB=%JDWRJF919K$[V,#RA'./,'@?=+3(V"\9*.K*TM'E]U>`I(7MF MLI-"#2B6)PNN_5MDD99[^[I9W:D"!R\]6?SM,9>PSRQU4?/6KB.OFDK/>&\K M>8U%0EJ(ED?Q/=?#7)."?/(%A;(!^'V\\@?2 M1FMNKX`3>>!Z,0=+LNW.P(84U_674U(N:1UC,]RFOZ2T[%&CXS)LR&;]U%"X MH#>L431''KIF2J4S]"^_;*4415&/FC0I^1K-`7IP;6T=4ZET3+<5:K%"2[W9 M*!B6!"16!@UOJ-"WO!&>`F?G$LHG1G>O.L4BX-&F:.H.Z!(XKFUYG$@7__J@ M02Y-3%W)*$%U7EEX,=D@"@DWO+UXZ%^9[='2J-7TF2J+.PL6\G4BO.NXEK?K M_\.'//-#0T$07O39$S;^5#!EG<1,4^8U-LMA$S.]XS9)D`,N:F_X_CH/?"YS MN<.-G'=.'-$9>`!^!.)ZP-INGQB4#)L/D=-)040,W,S6UXRY&KM!DM@P`V&$ M_/C^,TM_"&)>M8F7@[39O;J5N'F`51<5;;V<-<7'RB1,;Q\J5K#:*MM=!<(^ M`+A$UF;EVKDY2^:A4L?B#I#5?]UB=]KMIZF@@@F6_3E&")%C(G;LX!J;S;@2 MA+\D'=.=+!M$>^1,BB-Y*`3):0VM2?-BQ#GC4FUZ[$U.ZRIA.#G=)S5.B&7; M\X_/,)I"<6QBQLV[$A-0$"\;V++DA`07^P9H^^ENSI90`.SOEO#A+/U;(J`W MV7\0V;S)R28WGF&GJ4D3";KYV>><8'D81U=J8<3C]0A&,GLEVC@:*(9QT"L8 M!RW/R=E`'X9J8<3C]0A&,OMB@V%)&*>*%_6T5XMZ>E4.54G".)FIA1&/UR,8 MR>QS)9+$88S#P*-X-$9G>RL=X(\1-3XAM@TU\$39E#5/E;EUHV=`:Y)N M+3WC^X=*6=Z^V!V1M`/H.XUQ1_I5`Y@*U!BY'("YP&;JNH5S;6 M@/-05_Y[XZ"SU2TID5&:GJGLR(R1H2#.PW[A/#2=)9DQ,A+$>=0OG$?*DR)% M:[EY7A(DR3CEQ)OUG=%#>#WFS*DJRX>4VF>OK#6X7A18UQ<08A,S??:NEQT' M6.7X\O-V(.2=\V)TZ!@:DDNV$CT,:0H-/0!T#\LF2'N<8&#;T3KRB(*F$?8U M'GD%_"!7`3&-&@A6%FT0?=D*4B,NJ0Y-"E@0/FD.O?(UR<>#\4,9EYXS5B,GS*U2P#*R)?;TG0?H MA,S>I(K*B`$6-03:0W,BOOLJ>1_%21:OBNO%K?5D<,_?L6#X196LFR0A[#WJ M\D>'#4`N=/!J0V'[N^4Z9H=@`1'I=>%901`?E^)"Z#HUIPT[O7`^:I6HE3!4 M!7QEKV<+?)'`"`J54O[ZL"O5ZIE::;4NO-7>B@E:WT\O#V;7 MZ[O)DD!>/FJ?['SG?E5CNHBQ+&9GP0CBM6*[6)4RDA(JDYADIJX@C)5%'F:6"[ZP_(B M,-QF]?FV([*KZ(H\U1,T(Q_)!94WH`TXM@LZI4P,?#^RO.0*A/>:F/FE\6V+ M2_.2]E[,V1O+ZLFCTK\P>>(3%4)JRT?/*COE<;=%+8`41YN': MGY&BP.U4'8,ZPNSETF8?L'$E!$3$S69ZM]D4R6]9JBV MQU+IBH%/6!=WP]G@X_G%P'=FYU>#T70\O9K.9M,/@]OI]16G9>(:Y+!;UO#A M8*;70<:;H#3ZT:VF/#F%=0?$4-Z)G1/F\M\;SVMH0KHR056E!]KL#L=60*I: M`;UI\:X[=W$>5SWK*A&K1.QY;MHUX)8J#(L52K$V;I@\2DN58PP>@`?C^G,D M#CV!2-2FR8QY,%E$=,V-BZ[(0&5FK\^Q2CJ0`ZQ_7V9@26Z+8UA3;@5=`KE1 MC89;1`4K@I:IVD:5N24E)J4SCO;`=)`TIII7X_X2EX;I%YF:HKTC3`7/-U'[ MF1M\&6Z'P+=79$7HVL@;:1K,Y]"WG3!&Z]NK=45Z+3,>EHR,F'#UJ8O^)ZC(+Q>Q&T(4[>.7!7I$TPM M/>/;F8Q\ZA%44#"LRE3&DCZ/I9&FX8B8G*":<"PWJY$N2DBVS>M%FC2ARW6@ MD3&7'J_/6:#"6>SD(A:D!/=6R-W`I?C71G?T&KV*8Y/%>:F[)I1:!%,?#^.N MDX?J<4H?UA+2^-8FWUQB M7/MKX@HE?7Y<`T735P(<.DVY&6#BIZ0NV:YL=7=2:B)Y:`?4.ADUPJ>H@6ZT MV7ANIU)J(MDG*37"IRE41WCJ\#B4(W=X)Z':550''//\T_N]6'7.;K%SGF#^ M<$160EJ(/1CJ1]G#@S69'Y:=EXJ MH6>VP!M05?$:5_Y\MUY#?QY"^\ON905V`N8K#!-AMVJB57E<''2?JQIP82[_ MDK>]5MQ8V[C-T_5BQV".:2UASGJ*O4ZVK56&)JAS!^"N'8&L1](3H'AJJBZ1 MBB2>KYPK8*:"_=&$8-<;RT5$[:X7I0[BOP'/F4!T%VCI!,5'N,^74_4ZP(=[ MJAGONXZZ)%5#8G;TEEJB$WJFNST#U2RXTCIM0"HDNFMAR1T*W7_Q_&PT!95, M/%V6MLO8^`,[`5!`--G?/\.S<@623"ZM8E92UI&TU;(AG@=YOV$]#8$/%FZH M)3#)(O4,!=R(;B;P=I$PE1+?>7(WP+<\4GUIX#MQ$A$(PC2HTZ%6<+'S7,/: MK424J5;+DG>2/80"@`%<8;YRS_O23#4=VE-/\+GJ1P/,F0:T#+W)77*MW,T& M3^`^JY]^*C_(QW&U[L,_UH%X23NX5Q'@`*73SY MI4:K0*'RC,5.PS03<;L`6V?5$H?)=1%)NYF3QYQQ]<=](43Y4%_6*18/=D\J M`"?]2OM%*=M7%'+C-==H;,W2?LI9%V4=FL%%UVB":CM=X,-55/BLV;)Z.>D]BT\P MB2!]9P9"%P&R.7>S5D3(R[AC++CXRY:SOY:K1$X;KW+:%.9H/X+AQT?"VI2] M]JB1DJ+NJW,,11\Z)<-/OVH5L"`$!E#MZOJ0-8@`F:^%MB/H[WJQ!7^0C=%?#L+;1_@WL!!O MK07Q$0]=`A(8&>G)VLCGN66O!H[CQG_B$895R90YLNDWY.V%RP9-5=G@MJ;S MS@](DX&%"QQ]KV?9Q`Y>Q!QXM:D_FPT_QONI#YR\#I'=]&XAI#E+V/C^J<;KJ:^0]X11)9W`_&!;7>0RU)CDJH%UPOJ4/I,H':V MS66PB-I1_1)L461_[T5EP^^O?<[7&P]N`0BN'P#ZX26GN18?T?!9H\-%%O?8 M%D?<]-X1I[339[Y')C:'EAT&;"CT;32*.3R$7:E+G=0E:$8TZA`--D?(MU0Z M6Z4;EBY\=&F%>!+D;7CN]\E%28?^&0\W1M/&N&+S'"X;%^RJ;F3Y3T=59ID1 M$3*+-"B2%+1L/DZU&OVPW"ZJS%O"9ZP*3H..,N>@KUA#2XX.S.2W,1"-X"LH MK:-2:2ZM)W<=K0>^GVW86005JWGF97:N.")<'5283$9UA$2@IOQ/ZVU&0.7Q M)$CJ_WV+3E!\#NY40 M>R;?/*O>N\3DHJ8XD0I#Q+X%G$2>MR6\`^<6H+6LY>$GT&-3(X"BP@I$G:37 M33X`N$369D6>"#EQ[&+J+R!:)S&(7#ZJW%4N6)(`R`R05V(DHT!C>AV3EG@1 M7%Y@^#/K!(;3QVY%Y]NSO!_2>+RO2=>R")6(9)6D@AU;]Q7-L?C2DFK/UZ;M MR+$WWP'UYCOV&%,C).X>8VVOW(]->[28N3V&"AKW';OR]*$KS[&3B)QT>#J) M5*U<+PR$C+??(KDE0S2K*G:]`015?YFZVWJZ1S*)F0PJR9VQ"MTBV2!VW3:D M[U4-Y8514[G03#7Q8]\65>N+JS=+N]8=W87F?LL]Y[76>`IS$(9>\L*P_3OQ M_2/%6\S6$/_Q%YW!N3IR$6 MIY*0'*F>0@+Y>`O&9V`7!,-M4D5+UQFUGJ"YC"#!590WM@T8MHPEE+GA?>A" M_\ST0N#2M_@&BC%M9>G+[82`I[#RMK*R*'QM^$`I+Y$B!JI>Q+9='[>/,.:, M^SESP_=F:ZA)2Z<"@ZK'K.V$LW*1$_,E*YWR`+TU:%4HY/.V5'3M*DXDG82^ M$%L=N;Y81"[HZ(G^A^_="+OLE9[1+=X'S8`-W`?"4G`%0HW]`VNH&4L:E3@H M5=[=,``T_?@K7]3S`BPM;S\U[253*_2,QGA:"KD>2`5AO,ZB.Q]GP+-"X-Q8 M*-S&A;2MN$Y;T#KGBC6PSO!.(TVY&$\32/P1'KZ1I%*OFH86"^_PCV8\X8I7 MT;)ME5.:"M)W6(2&V_QO=,5Z!*@;3$\06EO%_A#\X"J0Y=A%P,:_UI>84*)@ M]N0KKKJ%-/826*4LA-:+2=_!B$+E8`TV[:Y#& M*-;3'*`'UP:\X;B&SP]U*50*@HI60, M[8C$24@/$FRAPVTNMT8FD:1N/'JH@7;/P3.(L.?J`/=3,MP,+%TRBA^2RG+L MQ1,`^[LE?#C#7R;K!O^CO%R8HYJQ=R+X$YUG@]+RIIX,G#%#TFS;HUP8S4@\ M6@;<(@:E:P%A1-/8]<0-[*0Z[[GOC+'E:8\NZX]\:!5$\P6 M$T1^R-Y8'`H:N=(#4F9G@'EP"!\3SU*@Y<7A#,4+9*`MX9![UB]^^BR,-P:! MC=Q-['6I@S<_:G_<$3HH*=;O6K@CJ3$")!7*T ML-)E8%+(?Y0XU^9&37;DW?M[4K\^JHE)"J).'[U')J4>I50$[Z4M3#+\']"+ M,`1H.W&]RJ,>>?3+P_9/YRO`9*<>J;N1_;CQ<"/L>"XA4F9BBH/VT`\LH9)A MW>:(F0S\)_"\WWWXZ,^!%4`?.-,@B.JN!<6`9PW?0Q$PD`LCIU(50OR M^:'[X\'7P).!_\/>J63$N'\^(V/>6P&(__/_`U!+`P04````"`!J?'I&MT^D M5[@/``"RJP``#P`<`'5G+3(P,30Q,C,Q+GAS9%54"0`#=U\457=?%%5U>`L` M`00E#@``!#D!``#M75ESVS@2?M^J_0]($#9BH/=85Y"D4#C:WPXNAN'W_VKT3#.H`XCI;_I]3HA_U&P^/#R\ M-6G2P+0Q#%"(31BP%T:C<6*P?__\QSM62`]#5L21,9Z'Q@7`1GO?:.T?;6\? MT8?;<<]H;[?VHDPTQV-P%)ASZ`+CT76\X.AQ@AW[>"M5)GOS%N%9L[V]O=.T MO8``SX1;<7HO=,6I+8*;9.'#)DT!L6UN&03@&227P(6!#TRXS!8V9DP/*K^U MVVKOM!+1X4R9Y#'(%/ZPDP!M-3]=G-]PQ99(D5N$-Q;#8.0#ST,$$!MYR=OXO>_; MWA2=)._H6X;D*($S@E.#JW'$JN!X*[!=WV&M@K^;8S@]W@IGC82P+PZ8O*4( MDP0`FQ@Y4%Y#31\CG_8"FU;QJAHB`87T)?`A8;9?+T]?,YRL*#0-H77DG_#G?9N/\<1)YWFS3R.<4:)/. MG&,@EWO)0#-#0;J*GDL.F\\QG$,OH#-Y5&DE!(E2GL@I:DLIR@@L)ZSF*\U" M%SC,HKF90UC6DS))!)60H6@G1U&"Y@YJ.->CX<@TPU7X.B4WQ!!78R>=0 MD;4K)=H([Z0HDR12#'I[98.> M<36E/Y!Y%XO]MQ$)%M)4$R4CJKRK5<^CH'%_71HK=;^:U(Q)`8+YP$$/919' M\OE$I$&&K0.YI4$%&4Q2/:&)*+E$!'8N`0DQ1--N&-@>#`+@63>AZP*\0-,; M>^91Q]T$'NF8)@H]8GNS:TJ323V.%'DO%*0T^7^ES/;MP'100(N@/UB!1H<] M\$(9UTFQ!BW7B`MF[U-%&ZNRC:3PNK.6M8SN!A1P.2:>DAY)K+?5+-.JRTD MXY3Y7Y$<@PNJS7@)'8,SB&88^',V`5M7U$C&0V^*L,LQY/A1)%9XR:T=(5\# M@RUI)7*Y=<`E&RG1=8CZ##`A#7`)/%&-/)G>UT0`5#HCR= M:M0[$-+TGC[$(@TNTT@+K0D3$E8,)'07_&F18DN22#'D%6(.@N#!+VR+3"3. M>).\%(??:\)>&&X:LYC`YH).L3AQ%64:@CA6L9'@D_$F@B%J,G5[*0TP"9N" M+*6\J[?%P8_2:)2,M9JV0E1*R)8@@NI"QDH2 M*!G`:.N=T@(SZ<*I15,^CZ/;B$-"&>:?2$L"_\&4J\@N7 MM41M1+`-CKN>M==S0,5#AC2ITH`6[W&1.*&R+EZ3U^SQX]L M_OGQXL/N7W]^,OWP\;.W=V@]'=S//B^\VW[X<':`#P]^;W^]'2\"Y^#>?-IV MWI-?;WOGU];G/YR=/>_3Y*K7'R[.QM_&[V&[.1C_9V>X/X6!M?O1OS*]/T[W MI_CWT1-Q'S]W[(\N:MHW0[O;;OU\CE'[8.`<7!R>.N,;]\$>/%IWWV8S9+9= M\]"[';^?@L/??X7=K_O.4W>Q/;Q^.OO@PY'K3L\?;^^Z=]93V$9?.S_;4V=X M^GB^#RX7^]]V;VU_GYRYU[8_^=P[W__MYT]7P\/0,N_W+')I#@^_DO9BN__1 M?VIUT6.W/3L^_LOHW8SB4ZS/:;3Y@%>JM18^R4>$(5)E$$SG;$@;/"OES5?%JS5&&Y24Q; MM3R*[BB.@U5;;:HM)06QD+!@0F$8S;ZO8`N)HU+KD<1R06+P@NMU)@%;JZK, MK]JFJ),D4G0T<8!J;0Y3B>NM\^HSS*RU$W0!OB+<"^F3"W&A.TH2R3G=%4>I MUN:4`S`(,C@$8XFA[J;B#:>A&_)=NKQ6RY;IL]M/JV51+NSOBH,^Y0O[Z2CS M"D7<'JH>L:A95YVQ$!M(%3*H)]]=<=Q(>>I":A[5A(KV:F2[;/&SNGN*@T;B MS1S9KJD\G%%3)CUS(>Z!RN2*"58<&9(?U/B;K0JMSV,?T8F(JMGQK%./V&11 M.`LJ3:$>,K<+=E$BT.BPW0]X M"55VW6IT2^LY,KD\21;VJY'D:[!7C5:[L=-Z^QA8_/[!9\!@BDU9+@'`0Z9PS`'R>L0D=$BQE-5:REHC6K)GB#;=5*B>?BU7-(:N:UO[+ M@:1OKUT/#/(N)7@J(!+>-%NUN2096.%[Q6J(;[[EI1YO9;:+=<3;Q3J3@+"[ ME+>,Z(I0?JWQ$7UG>[,A@2[KP%L&B%,=;Q%J*FP942HJW$;6F.>S0AP/H9[M M\.TD2=H@I)EM$K*O9QB%?E*(3<4O9\RUL.:J.JMU:IU9%^5$D*0Z+-?R!IGE M0UWT4<%KGI2KEEV[NIJ.RQ;/=%%V?%*=4U"?7JHE0! MCZRA"H.=NF@B!R84J]RYF<`=ZMJ;*.,M[5T;$P/8`;9#:JRK# M*1E(A.X%XI]7>;NWHHDL)JM*!JDSW[1^M2#DP25\*,;LX M6Q#`AX9$Y?(TZP+"!!)/(>; MT/>C%\!9+;H$5U,FALX_JQG6LP134'1QUA@^DJZ#S+M$]^A/H!V1Y+U(_REP M@N_C`V]6)97;%;5S'2M"`D_6I#]`ST+44_-,^BY"H*-V%6"J8L2J@#G?.*"7 MUNNCED<8-W%-PAI'\5]Y:+3(T9SFQ&8X@I=/?J\&Y)Q*9E40_/CY MZ=4U5G8!V;%_Y2%TG=KT2Q213'3/%ZU5LWNI"N4NG4E"X"Q7L^+0;7R4):NY MBSQ:(%X\<]:(ODVB/QY&/\`)*^"Y@689:F6GR=^8E%2D<&^>3IUD'>"EE%<7 MI%476!>RS%",,U$;FZHRX84/(`QB[V,#S3[:7$0*K=ZD'N9+FKT4]G>>JS7L M#QO2Z?L;FEKUI`UJ(YMY0Q9:O)KR%5UJ]5BA25C&7!78'H$SB%_5%2F')ALT M^`HU<\M9I037P+:^Y_SXLI%"@%4:"XHK9+GPK@]'*T@5VEKD66N$/@$DJ_QK M.KBQD,\,7DV7:XO\\`;]GY9EQBV4[?-8QGJ6+CWUY_U(P.MZ\\\"K3#410>R M-9QURF$J)Q)15JWF!CE`"7]]MKN<_;UN;VF;L/$'0_9$1\7T!R;\0Q3)O.;X MLYHG>KQJ@WX9?NEJ35XNRW[J^@Y:0%Q:1L=E0S<5_QD"W`G)'&'["7[7*>=% M+MFF]51MI1055EI(,`@=9\$H@]888O?'3Q`OUD!N[%>Z(T'#H74-W/*UK8JB MM!I[UT0L;P'J0Z`:TE\5M,*.4(O1BO=UX$JC.JICAQHR7@VRJJ^KI&A%=W6P MDMU12]>\X[$M"S<0W]LF#"[X?I[<>I^%7&"_KC6EP%AT($S@NPLE49: ME4"KHE!(_?D!A+HIDX55OE!@6?SL*'"2G3+1;@26)#;R8'!U#_'>MC8:K@U9 MTN$<)]H&GH0CM%&R!)C4?NXB=/.HBO MHO900`8(CTXO.[UA?WBIBX+/`5W:%U/"Z/QA01?@NQ& MGYYK6`=KP)8VY*35=[31,0=(VI#CM%W=P'?7`-_3#7RO`OA^CSG;NB#/H)&% MV'+.@3;XQ;C6T01Y9.XLM%4H`T\2Z\OE&\]M;/',NFI60+@&:>,'Q'-J8PJI M`);.I^51MSC*VV&R6(!2'UW7ABQIMBI9I\"1IPX485FD?UBZ*)(@0E5^W!%S_UK\&"_;NRM.F*97@DMAC MF1S,J-=1DQ4NF29P`H@^0U,6CK1#C^",75M#+3,Z'7X`CFWQDC\B?*>/-BJ( M\MN1?&C:[-PEN\K#LW312@RK=,CZ`.>VZ6C3V;-PI/7_$00$4G_.1P%P;A;T MAZN+%N70I$%&R6VRNARYKH0Q49)?V!I=5QD-`Q0````(`&I\>D9EJ+GJ M-PT``/FO```3`!@```````$```"D@0RV``!U9RTR,#$T,3(S,5]C86PN>&UL M550%``-W7Q15=7@+``$$)0X```0Y`0``4$L!`AX#%`````@`:GQZ1OO>9VH[ M,@``02@#`!,`&````````0```*2!D,,``'5G+3(P,30Q,C,Q7V1E9BYX;6Q5 M5`4``W=?%%5U>`L``00E#@``!#D!``!02P$"'@,4````"`!J?'I&<&NW21M8 M``!*<`0`$P`8```````!````I($8]@``=6`Q0````(`&I\>D:<$(UG&UL550% M``-W7Q15=7@+``$$)0X```0Y`0``4$L!`AX#%`````@`:GQZ1K=/I%>X#P`` MLJL```\`&````````0```*2!/X$!`'5G+3(P,30Q,C,Q+GAS9%54!0`#=U\4 F575X"P`!!"4.```$.0$``%!+!08`````!@`&``X"``!`D0$````` ` end XML 40 R17.htm IDEA: XBRL DOCUMENT v2.4.1.9
Note I - Accrued Expenses
 12 Months Ended
Dec. 31, 2014
Other Liabilities and Financial Instruments Subject to Mandatory Redemption [Abstract]  
Other Liabilities Disclosure [Text Block]
NOTE I - ACCRUED EXPENSES

Accrued expenses at December 31, 2014 and 2013 consist of:

   
2014
   
2013
 
             
Bonuses
  $ 225,000     $ 250,000  
Distribution fees
    203,483       196,558  
Payroll and related expenses
    127,585       104,394  
Annual report expenses
    61,000       66,000  
Audit fee
    82,000       73,269  
Sales rebates
    96,000       ---  
Other
    38,791       37,794  
    $ 833,859     $ 728,015  

XML 41 R1.htm IDEA: XBRL DOCUMENT v2.4.1.9
Document And Entity Information (USD $)
 12 Months Ended
Dec. 31, 2014
Mar. 01, 2015
Jun. 30, 2014
Document and Entity Information [Abstract]      
Entity Registrant Name UNITED GUARDIAN INC    
Document Type 10-K    
Current Fiscal Year End Date --12-31    
Entity Common Stock, Shares Outstanding   4,596,439dei_EntityCommonStockSharesOutstanding  
Entity Public Float     $ 74,690,668dei_EntityPublicFloat
Amendment Flag false    
Entity Central Index Key 0000101295    
Entity Current Reporting Status Yes    
Entity Voluntary Filers No    
Entity Filer Category Smaller Reporting Company    
Entity Well-known Seasoned Issuer No    
Document Period End Date Dec. 31, 2014    
Document Fiscal Year Focus 2014    
Document Fiscal Period Focus FY    
XML 42 R18.htm IDEA: XBRL DOCUMENT v2.4.1.9
Note J - Related Party Transactions
 12 Months Ended
Dec. 31, 2014
Related Party Transactions [Abstract]  
Related Party Transactions Disclosure [Text Block]
NOTE J - RELATED PARTY TRANSACTIONS

During each of the years ended December 31, 2014 and 2013 the Company paid to Bonamassa, Maietta, and Cartelli, LLP, $17,000, and $14,000, respectively, for accounting and tax services. Lawrence Maietta, a partner in Bonamassa, Maietta, and Cartelli, LLP, is a director of the Company.

XML 43 R4.htm IDEA: XBRL DOCUMENT v2.4.1.9
Balance Sheets (USD $)
Dec. 31, 2014
Dec. 31, 2013
Current assets:    
Cash and cash equivalents $ 2,023,383us-gaap_CashAndCashEquivalentsAtCarryingValue $ 1,634,262us-gaap_CashAndCashEquivalentsAtCarryingValue
Marketable securities 9,389,501us-gaap_AvailableForSaleSecuritiesCurrent 8,863,205us-gaap_AvailableForSaleSecuritiesCurrent
Accounts receivable, net of allowance for doubtful accounts of $30,000 in 2014 and $18,000 in 2013 1,593,260us-gaap_AccountsReceivableNetCurrent 1,790,747us-gaap_AccountsReceivableNetCurrent
Receivable in connection with damage settlement   48,805us-gaap_OtherReceivablesNetCurrent
Inventories (net) 1,237,154us-gaap_InventoryNet 1,610,747us-gaap_InventoryNet
Prepaid expenses and other current assets 165,691us-gaap_PrepaidExpenseAndOtherAssetsCurrent 130,001us-gaap_PrepaidExpenseAndOtherAssetsCurrent
Prepaid income taxes 30,643us-gaap_PrepaidTaxes  
Deferred income taxes 223,439us-gaap_DeferredTaxAssetsNetCurrent 229,451us-gaap_DeferredTaxAssetsNetCurrent
Total current assets 14,663,071us-gaap_AssetsCurrent 14,307,218us-gaap_AssetsCurrent
Property, plant, and equipment:    
Land 69,000us-gaap_Land 69,000us-gaap_Land
Factory equipment and fixtures 4,138,875us-gaap_FixturesAndEquipmentGross 4,090,968us-gaap_FixturesAndEquipmentGross
Building and improvements 2,773,002us-gaap_BuildingsAndImprovementsGross 2,766,319us-gaap_BuildingsAndImprovementsGross
Waste disposal system   133,532us-gaap_PropertyPlantAndEquipmentOther
Total property, plant and equipment 6,980,877us-gaap_PropertyPlantAndEquipmentGross 7,059,819us-gaap_PropertyPlantAndEquipmentGross
Less accumulated depreciation 5,772,974us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment 5,725,318us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
Net property, plant, and equipment 1,207,903us-gaap_PropertyPlantAndEquipmentNet 1,334,501us-gaap_PropertyPlantAndEquipmentNet
Other assets: 68,042us-gaap_OtherAssetsNoncurrent 9,147us-gaap_OtherAssetsNoncurrent
Total assets 15,939,016us-gaap_Assets 15,650,866us-gaap_Assets
Current liabilities:    
Accounts payable 141,111us-gaap_AccountsPayableCurrent 385,699us-gaap_AccountsPayableCurrent
Accrued expenses 833,859us-gaap_AccruedLiabilitiesCurrent 728,015us-gaap_AccruedLiabilitiesCurrent
Income taxes payable   131,638us-gaap_AccruedIncomeTaxesCurrent
Total current liabilities 974,970us-gaap_LiabilitiesCurrent 1,245,352us-gaap_LiabilitiesCurrent
Deferred income taxes 227,108us-gaap_DeferredTaxLiabilitiesNoncurrent 169,587us-gaap_DeferredTaxLiabilitiesNoncurrent
Commitments and contingencies      
Common stock, $.10 par value; 10,000,000 shares authorized; 4,596,439 shares issued and outstanding at December 31, 2014 and 2013, respectively 459,644us-gaap_CommonStockValue 459,644us-gaap_CommonStockValue
Accumulated other comprehensive income 259,869us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax 132,123us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax
Retained earnings 14,017,425us-gaap_RetainedEarningsAccumulatedDeficit 13,644,160us-gaap_RetainedEarningsAccumulatedDeficit
Total stockholders’ equity 14,736,938us-gaap_StockholdersEquity 14,235,927us-gaap_StockholdersEquity
Total liabilities and stockholders’ equity $ 15,939,016us-gaap_LiabilitiesAndStockholdersEquity $ 15,650,866us-gaap_LiabilitiesAndStockholdersEquity
XML 44 R12.htm IDEA: XBRL DOCUMENT v2.4.1.9
Note D - Income Taxes
 12 Months Ended
Dec. 31, 2014
Income Tax Disclosure [Abstract]  
Income Tax Disclosure [Text Block]
NOTE D – INCOME TAXES

The provision for income taxes consists of the following:

   
Years ended December 31,
 
   
2014
   
2013
 
Current
           
Federal
  $ 1,714,387     $ 2,721,068  
State
    (9,579 )     19,646  
      1,704,808       2,740,714  
Deferred
               
Federal
    (4,003 )     (11,810 )
State
    3,749       (351 )
      (254 )     (12,161 )
Total provision for income taxes
  $ 1,704,554     $ 2,728,553  

The following is a reconciliation of the Company’s effective income tax rate to the Federal statutory rate (dollar amounts have been rounded to the nearest thousand):  

   
Years ended December 31,
 
   
2014
   
2013
 
   
($)
   
Tax rate
   
($)
   
Tax rate
 
Income taxes at statutory federal income tax rate of 34%
  $ 1,957,000       34.0 %   $ 2,935,000       34.0 %
State income taxes, net of Federal benefit
    (4,000 )     (0.1 )     13,000       0.2  
Domestic Production Activities tax benefit
    (168,000 )     (2.9 )     (180,000 )     (2.1 )
Nondeductible expenses
    1,000       ---       1,000       ---  
Prior year over-accrual
    (56,000 )     (1.0 )     (19,000 )     (0.2 )
R&D credits
    (25,000 )     (0.4 )     (20,000 )     (0.2 )
Other, misc.
    ---       ---       (1,000 )     ---  
Actual income tax expense
  $ 1,705,000       29.6 %   $ 2,729,000       31.7 %

During 2014 and 2013, the Company realized the tax benefits of the Domestic Production Activities deduction, which amounted to approximately 9% of net income from domestic production activities in each year.

The tax effects of temporary differences which comprise the deferred tax assets and liabilities are as follows:

   
Years ended December 31,
 
   
2014
   
2013
 
Deferred tax assets
           
Current
           
Accounts receivable
  $ 10,164     $ 6,089  
Inventories
    14,037       16,862  
Accrued expenses
    199,238       206,500  
      223,439       229,451  
Deferred tax liabilities
               
Non-current
               
Depreciation
    (93,236 )     (99,502 )
Unrealized gain on marketable securities
    (133,872 )     (70,085 )
      (227,108 )     (169,587 )
Net deferred tax (liability) asset
  $ (3,669 )   $ 59,864  

XML 45 R11.htm IDEA: XBRL DOCUMENT v2.4.1.9
Note C - Inventories
 12 Months Ended
Dec. 31, 2014
Inventory Disclosure [Abstract]  
Inventory Disclosure [Text Block]
NOTE C – INVENTORIES 

Inventories consist of the following:

   
December 31,
 
   
2014
   
2013
 
             
Raw materials and work-in-process
  $ 395,092     $ 488,757  
Finished products
    842,062       1,121,990  
    $ 1,237,154     $ 1,610,747  

Finished product inventories at December 31, 2014 and 2013 are stated net of a reserve of $20,000 for slow moving and obsolete items.

XML 46 R23.htm IDEA: XBRL DOCUMENT v2.4.1.9
Note D - Income Taxes (Tables)
 12 Months Ended
Dec. 31, 2014
Income Tax Disclosure [Abstract]  
Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]
   
Years ended December 31,
 
   
2014
   
2013
 
Current
           
Federal
  $ 1,714,387     $ 2,721,068  
State
    (9,579 )     19,646  
      1,704,808       2,740,714  
Deferred
               
Federal
    (4,003 )     (11,810 )
State
    3,749       (351 )
      (254 )     (12,161 )
Total provision for income taxes
  $ 1,704,554     $ 2,728,553  
Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]
   
Years ended December 31,
 
   
2014
   
2013
 
   
($)
   
Tax rate
   
($)
   
Tax rate
 
Income taxes at statutory federal income tax rate of 34%
  $ 1,957,000       34.0 %   $ 2,935,000       34.0 %
State income taxes, net of Federal benefit
    (4,000 )     (0.1 )     13,000       0.2  
Domestic Production Activities tax benefit
    (168,000 )     (2.9 )     (180,000 )     (2.1 )
Nondeductible expenses
    1,000       ---       1,000       ---  
Prior year over-accrual
    (56,000 )     (1.0 )     (19,000 )     (0.2 )
R&D credits
    (25,000 )     (0.4 )     (20,000 )     (0.2 )
Other, misc.
    ---       ---       (1,000 )     ---  
Actual income tax expense
  $ 1,705,000       29.6 %   $ 2,729,000       31.7 %
Schedule of Deferred Tax Assets and Liabilities [Table Text Block]
   
Years ended December 31,
 
   
2014
   
2013
 
Deferred tax assets
           
Current
           
Accounts receivable
  $ 10,164     $ 6,089  
Inventories
    14,037       16,862  
Accrued expenses
    199,238       206,500  
      223,439       229,451  
Deferred tax liabilities
               
Non-current
               
Depreciation
    (93,236 )     (99,502 )
Unrealized gain on marketable securities
    (133,872 )     (70,085 )
      (227,108 )     (169,587 )
Net deferred tax (liability) asset
  $ (3,669 )   $ 59,864  
XML 47 R19.htm IDEA: XBRL DOCUMENT v2.4.1.9
Accounting Policies, by Policy (Policies)
 12 Months Ended
Dec. 31, 2014
Accounting Policies [Abstract]  
Loans and Leases Receivable, Allowance for Loan Losses Policy [Policy Text Block]
Accounts Receivable and Reserves

The carrying amount of accounts receivable is reduced by a valuation allowance that reflects our best estimate of the amounts that will not be collected. The reserve for accounts receivable comprises the allowance for doubtful accounts and sales returns. In addition to reviewing delinquent accounts receivable, we consider many factors in estimating our reserve, including historical data, experience, customer types and credit worthiness, and economic trends. From time to time, we adjust our assumptions for anticipated changes in any of these or other factors expected to affect collectability.
Revenue Recognition, Policy [Policy Text Block]
Revenue Recognition

The Company recognizes revenue when products are shipped, title and risk of loss pass to customers, persuasive evidence of a sales arrangement exists, and collections are reasonably assured.  All products are shipped Free On Board (“FOB”) Hauppauge, New York, the location of the Company’s plant. Both title and risk of loss are deemed by both the Company and its customers to have passed to the customers at the time the goods leave the Company’s plant. Shipments are only made after confirmation that a valid purchase order has been received and that the future collection of the sale amount is reasonably assured. All sales of the Company’s products are deemed final, and there is no obligation on the part of the Company to repurchase or allow the return of the goods unless they are defective. The Company does not make sales on consignment, and the collection of the proceeds of the sale is not contingent upon the customer being able to sell the goods to a third party.

Any allowance for returns is taken as a reduction of sales within the same period the revenue is recognized. Such allowances are based on historical experience. The Company has not experienced significant fluctuations between estimated allowances and actual activity.

From time to time during 2014 the Company offered discounts and/or rebates to some of its customers in order to retain or increase sales to those customers. In 2014 those sales discounts totaled $119,965, compared with $11,000 in 2013. Of the $119,965 in sales discounts in 2014, $23,965 had been paid, and $96,000 accrued, as of December 31, 2014. The $96,000 of accrued sales discounts consisted of rebates given to one of the Company’s largest customers in order to retain and increase its business with that customer.
Cash and Cash Equivalents, Policy [Policy Text Block]
Cash and Cash Equivalents

For financial statement purposes, the Company considers as cash equivalents all highly liquid investments with an original maturity of three months or less at inception. The Company deposits cash and cash equivalents with high credit quality financial institutions and believes that any amounts in excess of insurance limitations to be at minimal risk. Cash and cash equivalents held in these accounts are currently insured by the Federal Deposit Insurance Corporation up to a maximum of $250,000.
Stockholders' Equity, Policy [Policy Text Block]
Dividends

On May 14, 2014, the Company’s Board of Directors declared a semi-annual cash dividend of $0.48 per share, which was paid on June 13, 2014 to all stockholders of record as of May 30, 2014. On November 20, 2014, the Company’s Board of Directors declared a semi-annual cash dividend of $0.32 per share, which was paid on December 22, 2014 to all stockholders of record as of December 8, 2014. Total dividends declared and paid in 2014 were $3,677,151.

On May 15, 2013, the Company’s Board of Directors declared a semi-annual cash dividend of $0.47 per share, which was paid on June 14, 2013 to all stockholders of record as of May 30, 2013. On November 22, 2013, the Company’s Board of Directors declared a semi-annual cash dividend of $0.50 per share, which was paid on December 20, 2013 to all stockholders of record as of December 6, 2013. Total dividends declared and paid in 2013 were $4,458,544.
Supplemental Disclosures of Non-Cash Investing and Financing Activities [Policy Text Block]
Supplemental Disclosures of Non-cash Investing and Financing Activities

Cash payments for income taxes were $1,867,089 and $2,605,474 for the years ended December 31, 2014 and 2013, respectively.
Marketable Securities, Policy [Policy Text Block]
Marketable Securities

Marketable securities include investments in equity and fixed income mutual funds, and government securities, all of which have a high degree of liquidity, are classified as "Available for Sale" securities, and are reported at their fair values. Unrealized gains and losses on "Available for Sale" securities are reported as accumulated other comprehensive income (loss) in stockholders' equity, net of the related tax effects. Investment income is recognized when earned. Realized gains and losses on sales of investments and declines in value judged to be other than temporary, if any, are reported in other income with cost being determined on a specific identification basis. Fair values are based on quoted market prices. The Company evaluates its investments periodically for possible impairment and reviews factors such as the length of time and extent to which fair value has been below cost basis and the Company’s ability and intent to hold the investment for a period of time which may be sufficient for anticipated recovery in market value.
Inventory, Policy [Policy Text Block]
Inventories

Inventories are valued at the lower of cost or current market value. Cost is determined using the average cost method, which approximates cost determined by the first-in, first-out (“FIFO”) method. Inventory costs include material, labor and factory overhead.
Property, Plant and Equipment, Policy [Policy Text Block]
Property, Plant and Equipment

Property, plant and equipment are carried at cost, less accumulated depreciation. Major replacements and betterments are capitalized, while routine maintenance and repairs are expensed as incurred. Assets are depreciated under both accelerated and straight-line methods. Depreciation charged to income as a result of using accelerated methods was not materially different than that which would result from using the straight-line method for all periods presented. Certain factory equipment and fixtures are constructed by the Company using purchased materials and in-house labor. Such assets are capitalized and depreciated on a basis consistent with the Company's purchased fixed assets.

Estimated useful lives are as follows: 

Factory equipment and fixtures (years)
5
-
7
Building  (years)
 
40
 
Building improvements 
 
Lesser of useful
life or 20 years
 
Waste disposal system  (years)
 
7
 
Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block]
Impairment of Long-Lived Assets

Long-lived assets and certain identifiable intangibles are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset to future net cash flows expected to be generated by the asset. If such assets are considered to be impaired, the impairment to be recognized is measured by the amount by which the carrying amount of the assets exceeds the fair value of the assets. Assets to be disposed of are reported at the lower of the carrying amount or fair value less costs to sell.  No impairments were necessary at December 31, 2014 and 2013.
Other Assets [Policy Text Block]
Other Assets

Other assets at December 31, 2014 consisted of $60,042 expended in connection with the development of a new dosage form and manufacturing process for RENACIDIN, and $8,000 in costs incurred in re-registering the Company’s LUBRAJEL trademark. The Company will determine the appropriate amortization rate for these assets at such time as they are put into service.
Fair Value of Financial Instruments, Policy [Policy Text Block]
Fair Value of Financial Instruments

Management of the Company believes that the fair value of financial instruments, consisting of cash and cash equivalents, accounts receivable, accounts payable, and accrued expenses approximates their carrying value due to their short payment terms and liquid nature.
Concentration Risk, Credit Risk, Policy [Policy Text Block]
Concentration of Credit Risk

Accounts receivable potentially exposes the Company to concentrations of credit risk. The Company monitors the amount of credit it allows each of its customers, using the customer’s prior payment history to determine how much credit to allow or whether any credit should be given at all.  It is the Company’s policy to discontinue shipments to any customer that is substantially past due on its payments. The Company sometimes requires payment in advance from customers whose payment record is questionable.  As a result of its monitoring of the outstanding credit allowed for each customer, as well as the fact that the majority of the Company’s sales are to customers whose satisfactory credit and payment record has been established over a long period of time, the Company believes that its accounts receivable credit risk has been reduced.

For the year ended December 31, 2014, two of the Company’s distributors and marketing partners accounted for 64.7% of the Company’s revenues during the year, and 56.3% of its outstanding accounts receivable at year end. For the year ended December 31, 2013, two of the Company’s distributors and marketing partners, one the same as in 2014, and the other different, accounted for a total of 69% of the Company’s revenues during the year, and 72% of its outstanding accounts receivable at year end.
Vendor Concentration [Policy Text Block]
Vendor Concentration

The principal raw materials used by the Company consist of common industrial organic and inorganic chemicals. Most of these materials are available in ample supply from numerous sources. The Company has five major raw material vendors that collectively accounted for approximately 84% and 67% of the raw material purchases by the Company in 2014 and 2013, respectively.
Income Tax, Policy [Policy Text Block]
Income Taxes

Income taxes are accounted for under the asset and liability method. Deferred tax assets and liabilities are recognized for future tax consequences attributable to the temporary differences between the financial statement carrying amounts of assets and liabilities and their respective tax bases and operating loss and tax credit carry forwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in the period that includes the enactment date. Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion or all of the deferred tax assets will not be realized.

Uncertain tax positions are accounted for utilizing a recognition threshold and measurement attribute for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. As of December 31, 2014 and 2013, the Company did not have any unrecognized income tax benefits.  It is the Company’s policy to recognize interest and penalties related to taxes as interest expense as incurred.  During the years ended December 31, 2014 and 2013 the Company did not record any interest or penalties. The Company’s tax returns are subject to examination by the United States Internal Revenue Service and by the State of New York for years 2010 through 2013. In March 2014 the New York State Department of Taxation and Finance (“DTF”) commenced a routine examination of the Company’s income tax returns for years 2010 through 2012. The DTF has completed its examination and has accepted the tax returns as filed.
Research, Development, and Computer Software, Policy [Policy Text Block]
Research and Development

The Company's research and development expenses, included in operating expenses, are recorded in the year incurred. Research and development expenses were approximately $730,000 and $717,000 for the years ended December 31, 2014 and 2013, respectively.
Shipping and Handling Cost, Policy [Policy Text Block]
Shipping and Handling Costs

Shipping and handling costs are classified in operating expenses in the accompanying statements of income. Shipping and handling costs were approximately $86,000 and $45,000 for the years ended December 31, 2014 and 2013, respectively.
Advertising Costs, Policy [Policy Text Block]
Advertising Costs

Advertising costs are expensed as incurred. During 2014 and 2013 the Company incurred $20,000 and $16,000, respectively, in advertising costs.
Share-based Compensation, Option and Incentive Plans Policy [Policy Text Block]
Stock-Based Compensation

In 2004, the Company approved a stock option plan ("2004 Stock Option Plan") authorizing the granting of stock options to Company employees and Directors. No options were ever issued under this plan, and it expired in March 2014.
Earnings Per Share, Policy [Policy Text Block]
Earnings Per Share Information

Basic earnings per share are computed by dividing net income by the weighted average number of common shares outstanding during the year. Diluted earnings per share include the dilutive effect of outstanding stock options.
Use of Estimates, Policy [Policy Text Block]
Use of Estimates

In preparing financial statements in conformity with U.S. generally accepted accounting principles, management is required to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and revenues and expenses during the reporting period. Actual results could differ from those estimates. Such estimated items include the allowance for bad debts, possible impairment of marketable securities, reserve for inventory obsolescence, and the allocation of overhead.
New Accounting Pronouncements, Policy [Policy Text Block]
New Accounting Standards

In December of 2013, FASB issued ASU 2013-11, “Income Taxes (Topic 740): Presentation of an Unrecognized Tax Benefit When a Net Operating Loss Carryforward, a Similar Tax Loss, or a Tax Credit Carryforward Exists.” This amendment requires that an unrecognized tax benefit, or a portion of an unrecognized tax benefit, should be presented in the financial statements as a reduction to a deferred tax asset for a net operating loss carryforward, a similar tax loss, or a tax credit carryforward with exceptions.  This amendment only applies to entities that have an unrecognized tax benefit when a net operating loss carryforward, a similar tax loss, or a tax credit carryforward exists at the reporting date. This update became effective for interim and annual reporting periods beginning after December 15, 2013. The update does not have a material impact on the Company’s results of operation.

In May 2014, FASB issued ASU 2014-09, “Revenue from Contracts with Customers.” This standard applies to any entity that uses the guidance of GAAP for entering into contracts with customers to transfer goods or services or enters into contracts for the transfer of nonfinancial assets unless those contracts are within the scope of other standards. It requires that an entity should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration the entity expects to receive for the exchange of goods or services. This amendment is effective for interim and annual reporting periods beginning after December 15, 2016. The Company is still evaluating the potential impact on the Company’s results of operations.

In June 2014, FASB issued ASU 2014-11, “Transfers and Servicing: Repurchase-to-Maturity Transactions, Repurchase Financings, and Disclosures.” This standard aligns the accounting for repurchases-to-maturity transactions and repurchase agreements executed as a repurchase financing with accounting for other typical repurchase agreements. These types of transactions will now be accounted for as secured borrowings. It eliminates sales accounting for repurchase-to-maturity and supersedes guidance for accounting transactions involving transfers of financial assets with contemporaneous repurchase financing agreements that leads to off-balance accounting. This update becomes effective for interim and annual reporting periods beginning after December 15, 2014 and is not expected to have a material impact on the Company’s results of operations.

In August 2014, FASB issued ASU 2014-15, “Presentation of Financial Statements-Going Concern.  Disclosure of Uncertainties about Entity’s Ability to Continue as a Going Concern.” Currently, GAAP lacks guidance about management’s responsibility to evaluate whether there is substantial doubt about an entity’s ability to continue as a going concern. This amendment now provides guidance by providing a definition of substantial doubt, requires evaluation by management every reporting period for going concern issues, provides principles for considering any mitigating effects implemented by management, and the disclosures required for the assessment period of one year after issuance of the financial statements. This update becomes effective for interim and annual reporting periods beginning after December 15, 2016 with early application being permitted. The update will be adopted for reporting periods starting January 2015, and is not expected to have a material impact on the Company’s results of operations.
XML 48 R15.htm IDEA: XBRL DOCUMENT v2.4.1.9
Note G - Comprehensive Income
 12 Months Ended
Dec. 31, 2014
Disclosure Text Block [Abstract]  
Comprehensive Income (Loss) Note [Text Block]
NOTE G – COMPREHENSIVE INCOME

Accumulated other comprehensive income comprises unrealized gains and losses on marketable securities net of the related tax effect.

Changes in Accumulated Other
Comprehensive Income
 
December 31, 2014
   
December 31, 2013
 
Beginning balance - net of tax
  $ 132,123     $ 178,979  
Unrealized gain/(loss) on marketable securities before reclassifications - net of tax
    152,873       (65,531 )
Realized (loss)/gain on sale of securities reclassified from accumulated other comprehensive income
    (25,127 )     18,675  
Ending balance - net of tax
  $ 259,869     $ 132,123  

XML 49 R13.htm IDEA: XBRL DOCUMENT v2.4.1.9
Note E - Benefit Plans
 12 Months Ended
Dec. 31, 2014
Compensation and Retirement Disclosure [Abstract]  
Pension and Other Postretirement Benefits Disclosure [Text Block]
NOTE E - BENEFIT PLANS

Defined Contribution Plan

The Company sponsors a 401(k) defined contribution plan ("DC Plan") that provides for a dollar-for-dollar employer matching contribution of the first 4% of each employee's pay. Employees become fully vested in employer matching contributions after one year of employment. Company 401(k) matching contributions were approximately $103,000 and $101,000 for each of the years ended December 31, 2014 and 2013.  In 2014 and 2013 employees were able to defer up to $17,500 for each year respectively (plus $5,500 for employees over the age of 50) of their yearly pay as a pre-tax investment in the 401(k)plan, in accordance with limits set by the IRS. (Those limits have been increased to $18,000 (plus an additional $6,000 for employees over the age of 50) for the year 2015).

The Company also makes discretionary contributions to each employee's account based on a "pay-to-pay" safe-harbor formula that qualifies the 401(k) plan under current IRS regulations. In December 2014 and 2013 the Company’s Board of Directors authorized discretionary contributions in the amount of $175,000 per year, to be allocated among all eligible employees, for the 2014 and 2013 plan years. The 2014 contribution was paid in 2014, and the 2013 contribution was paid in 2013. Employees become vested in the discretionary contributions as follows: 20% after two years of employment, and 20% for each year of employment thereafter until the employee becomes fully vested after six years of employment.

Stock Option Plans

In March 2004 the Board of Directors of the Company approved the adoption of the 2004 Stock Option Plan, which authorized the granting of stock options to both employees and Directors. The plan was ratified by the shareholders on May 19, 2004. No options were ever granted under the plan, and it expired in March 2014.

XML 50 R14.htm IDEA: XBRL DOCUMENT v2.4.1.9
Note F - Geographic and Other Information
 12 Months Ended
Dec. 31, 2014
Segment Reporting [Abstract]  
Segment Reporting Disclosure [Text Block]
NOTE  F -  GEOGRAPHIC and OTHER INFORMATION

Through its Guardian Laboratories division the Company manufactures and markets cosmetic ingredients, personal care products, pharmaceuticals, medical lubricants, health care products, and specialty industrial products.  It also conducts research and development, primarily related to the development of new and unique cosmetic and personal care products. The Company’s R&D department not only develops new products but also modifies and refines existing products, with the goal of expanding the potential markets for the Company’s products. Many of the cosmetic ingredient products manufactured by Guardian, particularly its LUBRAJEL line of water-based moisturizing and lubricating gels, are currently used by many of the major multinational personal care products companies.

The Company operates in one business segment. The Company’s products are separated into four distinct product categories: personal care products (including cosmetic ingredients), pharmaceuticals, medical products, and industrial products. Each product category is marketed differently. The cosmetic ingredient/personal care products are marketed through a global network of marketing partners and distributors.  These marketing partners purchase product outright from the Company and market and re-sell those products to the end users.  The Company does not make any sales on consignment.

No prior regulatory approval was needed by the Company to sell any products other than its pharmaceutical products.  The end users of its products may or may not need regulatory approvals, depending on the intended claims and uses of those products.

The pharmaceutical products are two urological products that are sold to end users primarily through distribution agreements with the major drug wholesalers. For these products, the Company does the marketing, and the drug wholesalers supply the product to the end users, such as hospitals and pharmacies. These products are drug products that required the Company to obtain regulatory approval before marketing.

The medical products are not pharmaceutical products. They consist primarily of medical lubricants, which are marketed by the Company directly to manufacturers that incorporate them into urologic catheters and other medical devices and products that they sell. These products are distinguished from the pharmaceutical products in that, unlike the pharmaceutical products, the Company is not required to obtain regulatory approval prior to marketing these products. Approvals are the responsibility of the company that markets the medical device.  However, the Company is responsible for manufacturing these products in accordance with current Good Manufacturing Practices for medical devices.

The industrial products are also marketed by the Company directly to manufacturers, and generally do not require that the Company obtain regulatory approval. However, the manufacturers of the finished products may have to obtain such regulatory approvals before marketing these products.

The geographic information set forth in table "(b)" below is partially based on sales information provided to the Company by Customer A (shown in table "(c)" below), which exclusively markets the Company's cosmetic ingredients in Canada and China, and also sells some of the Company's products into France on a non-exclusive basis along with Customer B.

(a)  
Net Sales

   
Years ended December 31,
 
   
2014
   
2013
 
             
Personal Care
  $ 9,421,041     $ 11,459,482  
Medical
    2,494,205       3,028,659  
Pharmaceutical
    1,686,563       916,927  
Industrial and other
    169,486       164,014  
      13,771,295       15,569,082  
Less: Discounts and allowances
    (321,616 )     (152,189 )
    $ 13,449,679     $ 15,416,893  

(b)
Geographic Information

   
Years ended December 31,
 
    2014     2013  
   
Revenues
   
Long-Lived
Assets
   
Revenues
   
Long-Lived
Assets
 
                         
United States 
  $ 4,723,779     $ 1,207,903     $ 4,580,429     $ 1,334,501  
China
    3,500,955       ---       3,519,450       ---  
Canada
    2,436,596       ---       3,390,619       ---  
United Kingdom
    703,142       ---       846,730       ---  
India
    615,890               431,015          
France 
    582,478       ---       856,285       ---  
Other countries 
    886,839       ---       1,792,365       ---  
    $ 13,449,679     $ 1,207,903     $ 15,416,893     $ 1,334,501  

(c)
Sales to Major Customers

    Years ended December 31,  
   
2014
   
2013
 
             
Customer A
  $ 7,929,208     $ 9,712,382  
Customer B
    582,478       856,285  
Customer C
    615,890       431,015  
All other customers
    4,322,103       4,417,211  
    $ 13,449,679     $ 15,416,893  

Customer A had one customer that comprised 32% of Customer A’s sales of the Company’s products in 2014, and 36% of its sales in 2013.

XML 51 R16.htm IDEA: XBRL DOCUMENT v2.4.1.9
Note H - Income From Damage Settlement
 12 Months Ended
Dec. 31, 2014
Disclosure Text Block [Abstract]  
Interest and Other Income [Text Block]
NOTE H - INCOME FROM DAMAGE SETTLEMENT

In May 2012 the supplier of one of the Company’s pharmaceutical products, RENACIDIN, curtailed production due to manufacturing issues. In January 2013 the Company and its supplier entered into a settlement agreement whereby the supplier agreed to pay the Company $518,050 for the profit the Company lost during 2012 as result of the curtailment, plus $97,610 a month beginning January 1, 2013 for each month that the curtailment continued; $48,805 for each of the first two months after shipments resumed; and a final payment of $24,403 for the third month after shipments resumed. Because deliveries resumed at the end of October 2013, the supplier’s obligation to pay $97,610 per month ceased as of that date.  By the end of the first quarter of 2014 all damage payments had been made. As a result, the Company received only $24,403 in damage settlement payments for the year ended December 31, 2014, as compared with $1,070,561 for the year ended December 31, 2013.

XML 52 R34.htm IDEA: XBRL DOCUMENT v2.4.1.9
Note D - Income Taxes (Details) - Provision for Income Taxes (USD $)
 12 Months Ended
Dec. 31, 2014
Dec. 31, 2013
Current    
Federal $ 1,714,387us-gaap_CurrentFederalTaxExpenseBenefit $ 2,721,068us-gaap_CurrentFederalTaxExpenseBenefit
State (9,579)us-gaap_CurrentStateAndLocalTaxExpenseBenefit 19,646us-gaap_CurrentStateAndLocalTaxExpenseBenefit
1,704,808us-gaap_CurrentIncomeTaxExpenseBenefit 2,740,714us-gaap_CurrentIncomeTaxExpenseBenefit
Deferred    
Federal (4,003)us-gaap_DeferredFederalIncomeTaxExpenseBenefit (11,810)us-gaap_DeferredFederalIncomeTaxExpenseBenefit
State 3,749us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit (351)us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit
(254)us-gaap_DeferredIncomeTaxExpenseBenefit (12,161)us-gaap_DeferredIncomeTaxExpenseBenefit
Total provision for income taxes $ 1,704,554us-gaap_IncomeTaxExpenseBenefit $ 2,728,553us-gaap_IncomeTaxExpenseBenefit
XML 53 R21.htm IDEA: XBRL DOCUMENT v2.4.1.9
Note B - Marketable Securities (Tables)
 12 Months Ended
Dec. 31, 2014
Investments, Debt and Equity Securities [Abstract]  
Schedule of Available-for-sale Securities Reconciliation [Table Text Block]
December 31, 2014
 
Cost
   
Fair Value
   
Unrealized
Gain/(Loss)
 
                   
Available for sale:
                 
Fixed income mutual funds
  $ 8,373,674     $ 8,575,285     $ 201,611  
Equity and other mutual funds
    622,086       814,216       192,130  
    $ 8,995,760     $ 9,389,501     $ 393,741  
                         
December 31, 2013
                       
                         
Available for sale:
                       
Corporate bonds (maturing within 1 year)
  $ 203,920     $ 200,053     $ (3,867 )
Fixed income mutual funds
    7,325,930       7,425,687       99,757  
Equity and other mutual funds
    1,131,147       1,237,465       106,318  
    $ 8,660,997     $ 8,863,205     $ 202,208  
XML 54 R26.htm IDEA: XBRL DOCUMENT v2.4.1.9
Note I - Accrued Expenses (Tables)
 12 Months Ended
Dec. 31, 2014
Other Liabilities and Financial Instruments Subject to Mandatory Redemption [Abstract]  
Schedule of Accrued Liabilities [Table Text Block]
   
2014
   
2013
 
             
Bonuses
  $ 225,000     $ 250,000  
Distribution fees
    203,483       196,558  
Payroll and related expenses
    127,585       104,394  
Annual report expenses
    61,000       66,000  
Audit fee
    82,000       73,269  
Sales rebates
    96,000       ---  
Other
    38,791       37,794  
    $ 833,859     $ 728,015  
XML 55 R41.htm IDEA: XBRL DOCUMENT v2.4.1.9
Note F - Geographic and Other Information (Details) - Sales to Major Customers (USD $)
 12 Months Ended
Dec. 31, 2014
Dec. 31, 2013
Segment Reporting, Other Significant Reconciling Item [Line Items]    
Sales $ 13,449,679us-gaap_SalesRevenueNet $ 15,416,893us-gaap_SalesRevenueNet
Customer A [Member]    
Segment Reporting, Other Significant Reconciling Item [Line Items]    
Sales 7,929,208us-gaap_SalesRevenueNet
/ us-gaap_MajorCustomersAxis
= ug_CustomerAMember		 9,712,382us-gaap_SalesRevenueNet
/ us-gaap_MajorCustomersAxis
= ug_CustomerAMember
Customer B [Member]    
Segment Reporting, Other Significant Reconciling Item [Line Items]    
Sales 582,478us-gaap_SalesRevenueNet
/ us-gaap_MajorCustomersAxis
= ug_CustomerBMember		 856,285us-gaap_SalesRevenueNet
/ us-gaap_MajorCustomersAxis
= ug_CustomerBMember
Customer C [Member]    
Segment Reporting, Other Significant Reconciling Item [Line Items]    
Sales 615,890us-gaap_SalesRevenueNet
/ us-gaap_MajorCustomersAxis
= ug_CustomerCMember		 431,015us-gaap_SalesRevenueNet
/ us-gaap_MajorCustomersAxis
= ug_CustomerCMember
All Other Customers [Member]    
Segment Reporting, Other Significant Reconciling Item [Line Items]    
Sales $ 4,322,103us-gaap_SalesRevenueNet
/ us-gaap_MajorCustomersAxis
= ug_AllOtherCustomersMember		 $ 4,417,211us-gaap_SalesRevenueNet
/ us-gaap_MajorCustomersAxis
= ug_AllOtherCustomersMember
XML 56 R5.htm IDEA: XBRL DOCUMENT v2.4.1.9
Balance Sheets (Parentheticals) (USD $)
Dec. 31, 2014
Dec. 31, 2013
Accounts receivable, allowance (in Dollars) $ 30,000us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent $ 18,000us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent
Common stock, par value (in Dollars per share) $ 0.10us-gaap_CommonStockParOrStatedValuePerShare $ 0.10us-gaap_CommonStockParOrStatedValuePerShare
Common stock, shares authorized 10,000,000us-gaap_CommonStockSharesAuthorized 10,000,000us-gaap_CommonStockSharesAuthorized
Common stock, shares issued 4,596,439us-gaap_CommonStockSharesIssued 4,596,439us-gaap_CommonStockSharesIssued
Common stock, shares outstanding 4,596,439us-gaap_CommonStockSharesOutstanding 4,596,439us-gaap_CommonStockSharesOutstanding
XML 57 R10.htm IDEA: XBRL DOCUMENT v2.4.1.9
Note B - Marketable Securities
 12 Months Ended
Dec. 31, 2014
Investments, Debt and Equity Securities [Abstract]  
Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block]
NOTE B - MARKETABLE SECURITIES

The fair values of the Company’s marketable securities are determined in accordance with GAAP, with fair value being defined as the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants. As such, fair value is a market-based measurement that should be determined based on assumptions that market participants would use in pricing an asset or liability. As a basis for considering such assumptions, the Company utilizes the three-tier value hierarchy, as prescribed by GAAP, which prioritizes the inputs used in measuring fair value as follows:

 
•
Level 1 - inputs to the valuation methodology are quoted prices (unadjusted) for identical assets or liabilities in active markets.

 
•
Level 2 - inputs to the valuation methodology include quoted prices for similar assets and liabilities in active markets, and inputs that are observable for the asset or liability, either directly or indirectly, for substantially the full term of the financial instrument.

 
•
Level 3 – inputs to the valuation methodology are unobservable and significant to the fair value measurement.

The following available-for-sale securities, which comprise all of the Company's marketable securities, are re-measured to fair value on a recurring basis and are valued using Level 1 inputs using quoted prices (unadjusted) for identical assets in active markets:

December 31, 2014
 
Cost
   
Fair Value
   
Unrealized
Gain/(Loss)
 
                   
Available for sale:
                 
Fixed income mutual funds
  $ 8,373,674     $ 8,575,285     $ 201,611  
Equity and other mutual funds
    622,086       814,216       192,130  
    $ 8,995,760     $ 9,389,501     $ 393,741  
                         
December 31, 2013
                       
                         
Available for sale:
                       
Corporate bonds (maturing within 1 year)
  $ 203,920     $ 200,053     $ (3,867 )
Fixed income mutual funds
    7,325,930       7,425,687       99,757  
Equity and other mutual funds
    1,131,147       1,237,465       106,318  
    $ 8,660,997     $ 8,863,205     $ 202,208  

Proceeds from the sale and redemption of marketable securities amounted to $3,077,588 and $4,139,018 for the years ended December 31, 2014 and 2013, respectively. Losses of $25,127 and gains of $18,675 were realized for the years ended December 31, 2014 and 2013, respectively.

Investment income consisted principally of unrealized and realized gains and losses, interest income from bonds and money market funds, and dividend income from bond funds and mutual funds.

XML 58 R27.htm IDEA: XBRL DOCUMENT v2.4.1.9
Note A - Nature of Business and Summary of Significant Accounting Policies (Details) (USD $)
 0 Months Ended 12 Months Ended 0 Months Ended
Dec. 22, 2014
Jun. 13, 2014
Jun. 14, 2013
Dec. 31, 2014
Dec. 31, 2013
Dec. 20, 2013
Note A - Nature of Business and Summary of Significant Accounting Policies (Details) [Line Items]            
Number of Major Product Lines       2ug_NumberOfMajorProductLines    
Sales Discounts, Goods       $ 119,965us-gaap_SalesDiscountsGoods $ 11,000us-gaap_SalesDiscountsGoods  
Sales Discounts Paid       23,965ug_SalesDiscountsPaid    
Accrued Marketing Costs, Current       96,000us-gaap_AccruedMarketingCostsCurrent    
Cash, FDIC Insured Amount       250,000us-gaap_CashFDICInsuredAmount    
Common Stock, Dividends, Per Share, Cash Paid (in Dollars per share) $ 0.32us-gaap_CommonStockDividendsPerShareCashPaid $ 0.48us-gaap_CommonStockDividendsPerShareCashPaid $ 0.47us-gaap_CommonStockDividendsPerShareCashPaid      
Payments of Ordinary Dividends, Common Stock       3,677,151us-gaap_PaymentsOfDividendsCommonStock 4,458,544us-gaap_PaymentsOfDividendsCommonStock  
Income Taxes Paid       1,867,089us-gaap_IncomeTaxesPaid 2,605,474us-gaap_IncomeTaxesPaid  
Impairment of Long-Lived Assets Held-for-use       0us-gaap_ImpairmentOfLongLivedAssetsHeldForUse 0us-gaap_ImpairmentOfLongLivedAssetsHeldForUse  
Other Assets, Noncurrent       68,042us-gaap_OtherAssetsNoncurrent 9,147us-gaap_OtherAssetsNoncurrent  
Number of Customers       2ug_NumberOfCustomers 2ug_NumberOfCustomers  
Number of Vendors       5ug_NumberOfVendors 5ug_NumberOfVendors  
Unrecognized Tax Benefits       0us-gaap_UnrecognizedTaxBenefits 0us-gaap_UnrecognizedTaxBenefits  
Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued       0us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued 0us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued  
Research and Development Expense       730,000us-gaap_ResearchAndDevelopmentExpense 717,000us-gaap_ResearchAndDevelopmentExpense  
Shipping, Handling and Transportation Costs       86,000us-gaap_ShippingHandlingAndTransportationCosts 45,000us-gaap_ShippingHandlingAndTransportationCosts  
Advertising Expense       20,000us-gaap_AdvertisingExpense 16,000us-gaap_AdvertisingExpense  
Special Dividend [Member]            
Note A - Nature of Business and Summary of Significant Accounting Policies (Details) [Line Items]            
Common Stock, Dividends, Per Share, Cash Paid (in Dollars per share)           $ 0.50us-gaap_CommonStockDividendsPerShareCashPaid
/ us-gaap_DividendsAxis
= ug_SpecialDividendMember
LUBRAJEL® And RENACIDIN IRRIGATION® [Member] | Sales Revenue, Net [Member] | Product Concentration Risk [Member]            
Note A - Nature of Business and Summary of Significant Accounting Policies (Details) [Line Items]            
Concentration Risk, Percentage       94.60%us-gaap_ConcentrationRiskPercentage1
/ us-gaap_ConcentrationRiskByBenchmarkAxis
= us-gaap_SalesRevenueNetMember
/ us-gaap_ConcentrationRiskByTypeAxis
= us-gaap_ProductConcentrationRiskMember
/ us-gaap_ProductOrServiceAxis
= ug_LUBRAJELAndRENACIDINIRRIGATIONMember		 94.40%us-gaap_ConcentrationRiskPercentage1
/ us-gaap_ConcentrationRiskByBenchmarkAxis
= us-gaap_SalesRevenueNetMember
/ us-gaap_ConcentrationRiskByTypeAxis
= us-gaap_ProductConcentrationRiskMember
/ us-gaap_ProductOrServiceAxis
= ug_LUBRAJELAndRENACIDINIRRIGATIONMember		  
LUBRAJEL [Member] | Sales Revenue, Net [Member] | Product Concentration Risk [Member]            
Note A - Nature of Business and Summary of Significant Accounting Policies (Details) [Line Items]            
Concentration Risk, Percentage       85.90%us-gaap_ConcentrationRiskPercentage1
/ us-gaap_ConcentrationRiskByBenchmarkAxis
= us-gaap_SalesRevenueNetMember
/ us-gaap_ConcentrationRiskByTypeAxis
= us-gaap_ProductConcentrationRiskMember
/ us-gaap_ProductOrServiceAxis
= ug_LUBRAJELMember		 91.40%us-gaap_ConcentrationRiskPercentage1
/ us-gaap_ConcentrationRiskByBenchmarkAxis
= us-gaap_SalesRevenueNetMember
/ us-gaap_ConcentrationRiskByTypeAxis
= us-gaap_ProductConcentrationRiskMember
/ us-gaap_ProductOrServiceAxis
= ug_LUBRAJELMember		  
RENACIDIN [Member] | Sales Revenue, Net [Member] | Product Concentration Risk [Member]            
Note A - Nature of Business and Summary of Significant Accounting Policies (Details) [Line Items]            
Concentration Risk, Percentage       8.80%us-gaap_ConcentrationRiskPercentage1
/ us-gaap_ConcentrationRiskByBenchmarkAxis
= us-gaap_SalesRevenueNetMember
/ us-gaap_ConcentrationRiskByTypeAxis
= us-gaap_ProductConcentrationRiskMember
/ us-gaap_ProductOrServiceAxis
= ug_RENACIDINMember		 2.90%us-gaap_ConcentrationRiskPercentage1
/ us-gaap_ConcentrationRiskByBenchmarkAxis
= us-gaap_SalesRevenueNetMember
/ us-gaap_ConcentrationRiskByTypeAxis
= us-gaap_ProductConcentrationRiskMember
/ us-gaap_ProductOrServiceAxis
= ug_RENACIDINMember		  
Capitalized Product Development Cost for RENACIDIN [Member]            
Note A - Nature of Business and Summary of Significant Accounting Policies (Details) [Line Items]            
Other Assets, Noncurrent       60,042us-gaap_OtherAssetsNoncurrent
/ us-gaap_FairValueByAssetClassAxis
= ug_CapitalizedProductDevelopmentCostForRENACIDINMember		    
Capitalized Trademark Registration Cost for LUBRAJEL [Member]            
Note A - Nature of Business and Summary of Significant Accounting Policies (Details) [Line Items]            
Other Assets, Noncurrent       8,000us-gaap_OtherAssetsNoncurrent
/ us-gaap_FairValueByAssetClassAxis
= ug_CapitalizedTrademarkRegistrationCostForLUBRAJELMember		    
Sales Revenue, Net [Member] | Product Concentration Risk [Member]            
Note A - Nature of Business and Summary of Significant Accounting Policies (Details) [Line Items]            
Concentration Risk, Percentage       32.00%us-gaap_ConcentrationRiskPercentage1
/ us-gaap_ConcentrationRiskByBenchmarkAxis
= us-gaap_SalesRevenueNetMember
/ us-gaap_ConcentrationRiskByTypeAxis
= us-gaap_ProductConcentrationRiskMember		 36.00%us-gaap_ConcentrationRiskPercentage1
/ us-gaap_ConcentrationRiskByBenchmarkAxis
= us-gaap_SalesRevenueNetMember
/ us-gaap_ConcentrationRiskByTypeAxis
= us-gaap_ProductConcentrationRiskMember		  
Sales Revenue, Net [Member] | Customer Concentration Risk [Member]            
Note A - Nature of Business and Summary of Significant Accounting Policies (Details) [Line Items]            
Concentration Risk, Percentage       64.70%us-gaap_ConcentrationRiskPercentage1
/ us-gaap_ConcentrationRiskByBenchmarkAxis
= us-gaap_SalesRevenueNetMember
/ us-gaap_ConcentrationRiskByTypeAxis
= us-gaap_CustomerConcentrationRiskMember		 69.00%us-gaap_ConcentrationRiskPercentage1
/ us-gaap_ConcentrationRiskByBenchmarkAxis
= us-gaap_SalesRevenueNetMember
/ us-gaap_ConcentrationRiskByTypeAxis
= us-gaap_CustomerConcentrationRiskMember		  
Accounts Receivable [Member] | Customer Concentration Risk [Member]            
Note A - Nature of Business and Summary of Significant Accounting Policies (Details) [Line Items]            
Concentration Risk, Percentage       56.30%us-gaap_ConcentrationRiskPercentage1
/ us-gaap_ConcentrationRiskByBenchmarkAxis
= us-gaap_AccountsReceivableMember
/ us-gaap_ConcentrationRiskByTypeAxis
= us-gaap_CustomerConcentrationRiskMember		 72.00%us-gaap_ConcentrationRiskPercentage1
/ us-gaap_ConcentrationRiskByBenchmarkAxis
= us-gaap_AccountsReceivableMember
/ us-gaap_ConcentrationRiskByTypeAxis
= us-gaap_CustomerConcentrationRiskMember		  
Cost of Goods, Product Line [Member] | Supplier Concentration Risk [Member]            
Note A - Nature of Business and Summary of Significant Accounting Policies (Details) [Line Items]            
Concentration Risk, Percentage       84.00%us-gaap_ConcentrationRiskPercentage1
/ us-gaap_ConcentrationRiskByBenchmarkAxis
= us-gaap_CostOfGoodsProductLineMember
/ us-gaap_ConcentrationRiskByTypeAxis
= us-gaap_SupplierConcentrationRiskMember		 67.00%us-gaap_ConcentrationRiskPercentage1
/ us-gaap_ConcentrationRiskByBenchmarkAxis
= us-gaap_CostOfGoodsProductLineMember
/ us-gaap_ConcentrationRiskByTypeAxis
= us-gaap_SupplierConcentrationRiskMember		  
Rebates [Member]            
Note A - Nature of Business and Summary of Significant Accounting Policies (Details) [Line Items]            
Accrued Marketing Costs, Current       $ 96,000us-gaap_AccruedMarketingCostsCurrent
/ us-gaap_NatureOfExpenseAxis
= ug_RebatesMember		    
XML 59 FilingSummary.xml IDEA: XBRL DOCUMENT 2.4.1.9 Html 113 198 1 false 54 0 false 4 false false R1.htm 000 - Disclosure - Document And Entity Information Sheet http://u-g.com/role/DocumentAndEntityInformation Document And Entity Information false false R2.htm 001 - Statement - Statements of Income Sheet http://u-g.com/role/ConsolidatedIncomeStatement Statements of Income false false R3.htm 002 - Statement - Statements of Comprehensive Income Sheet http://u-g.com/role/ConsolidatedComprehensiveIncome Statements of Comprehensive Income true false R4.htm 003 - Statement - Balance Sheets Sheet http://u-g.com/role/ConsolidatedBalanceSheet Balance Sheets false false R5.htm 004 - Statement - Balance Sheets (Parentheticals) Sheet http://u-g.com/role/ConsolidatedBalanceSheet_Parentheticals Balance Sheets (Parentheticals) false false R6.htm 005 - Statement - Statement Of Stockholders' Equity Sheet http://u-g.com/role/ShareholdersEquityType2or3 Statement Of Stockholders' Equity false false R7.htm 006 - Statement - Statement Of Stockholders' Equity (Parentheticals) Sheet http://u-g.com/role/ShareholdersEquityType2or3_Parentheticals Statement Of Stockholders' Equity (Parentheticals) false false R8.htm 007 - Statement - Statements of Cash Flows Sheet http://u-g.com/role/ConsolidatedCashFlow Statements of Cash Flows false false R9.htm 008 - Disclosure - Note A - Nature of Business and Summary of Significant Accounting Policies Sheet http://u-g.com/role/NoteANatureofBusinessandSummaryofSignificantAccountingPolicies Note A - Nature of Business and Summary of Significant Accounting Policies false false R10.htm 009 - Disclosure - Note B - Marketable Securities Sheet http://u-g.com/role/NoteBMarketableSecurities Note B - Marketable Securities false false R11.htm 010 - Disclosure - Note C - Inventories Sheet http://u-g.com/role/NoteCInventories Note C - Inventories false false R12.htm 011 - Disclosure - Note D - Income Taxes Sheet http://u-g.com/role/NoteDIncomeTaxes Note D - Income Taxes false false R13.htm 012 - Disclosure - Note E - Benefit Plans Sheet http://u-g.com/role/NoteEBenefitPlans Note E - Benefit Plans false false R14.htm 013 - Disclosure - Note F - Geographic and Other Information Sheet http://u-g.com/role/NoteFGeographicandOtherInformation Note F - Geographic and Other Information false false R15.htm 014 - Disclosure - Note G - Comprehensive Income Sheet http://u-g.com/role/NoteGComprehensiveIncome Note G - Comprehensive Income false false R16.htm 015 - Disclosure - Note H - Income From Damage Settlement Sheet http://u-g.com/role/NoteHIncomeFromDamageSettlement Note H - Income From Damage Settlement false false R17.htm 016 - Disclosure - Note I - Accrued Expenses Sheet http://u-g.com/role/NoteIAccruedExpenses Note I - Accrued Expenses false false R18.htm 017 - Disclosure - Note J - Related Party Transactions Sheet http://u-g.com/role/NoteJRelatedPartyTransactions Note J - Related Party Transactions false false R19.htm 018 - Disclosure - Accounting Policies, by Policy (Policies) Sheet http://u-g.com/role/AccountingPoliciesByPolicy Accounting Policies, by Policy (Policies) false false R20.htm 019 - Disclosure - Note A - Nature of Business and Summary of Significant Accounting Policies (Tables) Sheet http://u-g.com/role/NoteANatureofBusinessandSummaryofSignificantAccountingPoliciesTables Note A - Nature of Business and Summary of Significant Accounting Policies (Tables) false false R21.htm 020 - Disclosure - Note B - Marketable Securities (Tables) Sheet http://u-g.com/role/NoteBMarketableSecuritiesTables Note B - Marketable Securities (Tables) false false R22.htm 021 - Disclosure - Note C - Inventories (Tables) Sheet http://u-g.com/role/NoteCInventoriesTables Note C - Inventories (Tables) false false R23.htm 022 - Disclosure - Note D - Income Taxes (Tables) Sheet http://u-g.com/role/NoteDIncomeTaxesTables Note D - Income Taxes (Tables) false false R24.htm 023 - Disclosure - Note F - Geographic and Other Information (Tables) Sheet http://u-g.com/role/NoteFGeographicandOtherInformationTables Note F - Geographic and Other Information (Tables) false false R25.htm 024 - Disclosure - Note G - Comprehensive Income (Tables) Sheet http://u-g.com/role/NoteGComprehensiveIncomeTables Note G - Comprehensive Income (Tables) false false R26.htm 025 - Disclosure - Note I - Accrued Expenses (Tables) Sheet http://u-g.com/role/NoteIAccruedExpensesTables Note I - Accrued Expenses (Tables) false false R27.htm 026 - Disclosure - Note A - Nature of Business and Summary of Significant Accounting Policies (Details) Sheet http://u-g.com/role/NoteANatureofBusinessandSummaryofSignificantAccountingPoliciesDetails Note A - Nature of Business and Summary of Significant Accounting Policies (Details) false false R28.htm 027 - Disclosure - Note A - Nature of Business and Summary of Significant Accounting Policies (Details) - Property, Plant, and Equipment Useful Lives Sheet http://u-g.com/role/PropertyPlantandEquipmentUsefulLivesTable Note A - Nature of Business and Summary of Significant Accounting Policies (Details) - Property, Plant, and Equipment Useful Lives false false R29.htm 028 - Disclosure - Note B - Marketable Securities (Details) Sheet http://u-g.com/role/NoteBMarketableSecuritiesDetails Note B - Marketable Securities (Details) false false R30.htm 029 - Disclosure - Note B - Marketable Securities (Details) - Available-For-Sale Securities Sheet http://u-g.com/role/AvailableForSaleSecuritiesTable Note B - Marketable Securities (Details) - Available-For-Sale Securities false false R31.htm 030 - Disclosure - Note C - Inventories (Details) Sheet http://u-g.com/role/NoteCInventoriesDetails Note C - Inventories (Details) false false R32.htm 031 - Disclosure - Note C - Inventories (Details) - Inventories Sheet http://u-g.com/role/InventoriesTable Note C - Inventories (Details) - Inventories false false R33.htm 032 - Disclosure - Note D - Income Taxes (Details) Sheet http://u-g.com/role/NoteDIncomeTaxesDetails Note D - Income Taxes (Details) false false R34.htm 033 - Disclosure - Note D - Income Taxes (Details) - Provision for Income Taxes Sheet http://u-g.com/role/ProvisionforIncomeTaxesTable Note D - Income Taxes (Details) - Provision for Income Taxes false false R35.htm 034 - Disclosure - Note D - Income Taxes (Details) - Reconciliation of the Effective Income Tax Rate Sheet http://u-g.com/role/ReconciliationoftheEffectiveIncomeTaxRateTable Note D - Income Taxes (Details) - Reconciliation of the Effective Income Tax Rate false false R36.htm 035 - Disclosure - Note D - Income Taxes (Details) - Deferred Tax Assets and Liabilities Sheet http://u-g.com/role/DeferredTaxAssetsandLiabilitiesTable Note D - Income Taxes (Details) - Deferred Tax Assets and Liabilities false false R37.htm 036 - Disclosure - Note E - Benefit Plans (Details) Sheet http://u-g.com/role/NoteEBenefitPlansDetails Note E - Benefit Plans (Details) false false R38.htm 037 - Disclosure - Note F - Geographic and Other Information (Details) Sheet http://u-g.com/role/NoteFGeographicandOtherInformationDetails Note F - Geographic and Other Information (Details) false false R39.htm 038 - Disclosure - Note F - Geographic and Other Information (Details) - Net Sales Sheet http://u-g.com/role/NetSalesTable Note F - Geographic and Other Information (Details) - Net Sales false false R40.htm 039 - Disclosure - Note F - Geographic and Other Information (Details) - Geographic Information Sheet http://u-g.com/role/GeographicInformationTable Note F - Geographic and Other Information (Details) - Geographic Information false false R41.htm 040 - Disclosure - Note F - Geographic and Other Information (Details) - Sales to Major Customers Sheet http://u-g.com/role/SalestoMajorCustomersTable Note F - Geographic and Other Information (Details) - Sales to Major Customers false false R42.htm 041 - Disclosure - Note G - Comprehensive Income (Details) - Accumulated Other Comprehensive Income Sheet http://u-g.com/role/AccumulatedOtherComprehensiveIncomeTable Note G - Comprehensive Income (Details) - Accumulated Other Comprehensive Income false false R43.htm 042 - Disclosure - Note H - Income From Damage Settlement (Details) Sheet http://u-g.com/role/NoteHIncomeFromDamageSettlementDetails Note H - Income From Damage Settlement (Details) false false R44.htm 043 - Disclosure - Note I - Accrued Expenses (Details) - Accrued Expenses Sheet http://u-g.com/role/AccruedExpensesTable Note I - Accrued Expenses (Details) - Accrued Expenses false false R45.htm 044 - Disclosure - Note J - Related Party Transactions (Details) Sheet http://u-g.com/role/NoteJRelatedPartyTransactionsDetails Note J - Related Party Transactions (Details) false false All Reports Book All Reports Element us-gaap_ConcentrationRiskPercentage1 had a mix of decimals attribute values: 2 3. Process Flow-Through: 001 - Statement - Statements of Income Process Flow-Through: 002 - Statement - Statements of Comprehensive Income Process Flow-Through: 003 - Statement - Balance Sheets Process Flow-Through: Removing column 'Dec. 31, 2012' Process Flow-Through: 004 - Statement - Balance Sheets (Parentheticals) Process Flow-Through: 006 - Statement - Statement Of Stockholders' Equity (Parentheticals) Process Flow-Through: 007 - Statement - Statements of Cash Flows ug-20141231.xml ug-20141231.xsd ug-20141231_cal.xml ug-20141231_def.xml ug-20141231_lab.xml ug-20141231_pre.xml true true XML 60 R38.htm IDEA: XBRL DOCUMENT v2.4.1.9
Note F - Geographic and Other Information (Details)
 12 Months Ended
Dec. 31, 2014
Dec. 31, 2013
Note F - Geographic and Other Information (Details) [Line Items]    
Number of Operating Segments 1us-gaap_NumberOfOperatingSegments 1us-gaap_NumberOfOperatingSegments
Number of Customers 2ug_NumberOfCustomers 2ug_NumberOfCustomers
Sales Revenue, Net [Member] | Product Concentration Risk [Member]    
Note F - Geographic and Other Information (Details) [Line Items]    
Concentration Risk, Percentage 32.00%us-gaap_ConcentrationRiskPercentage1
/ us-gaap_ConcentrationRiskByBenchmarkAxis
= us-gaap_SalesRevenueNetMember
/ us-gaap_ConcentrationRiskByTypeAxis
= us-gaap_ProductConcentrationRiskMember		 36.00%us-gaap_ConcentrationRiskPercentage1
/ us-gaap_ConcentrationRiskByBenchmarkAxis
= us-gaap_SalesRevenueNetMember
/ us-gaap_ConcentrationRiskByTypeAxis
= us-gaap_ProductConcentrationRiskMember
XML 61 R20.htm IDEA: XBRL DOCUMENT v2.4.1.9
Note A - Nature of Business and Summary of Significant Accounting Policies (Tables)
 12 Months Ended
Dec. 31, 2014
Accounting Policies [Abstract]  
Property, Plant, And Equipment Useful Lives [Table Text Block]
Factory equipment and fixtures (years)
5
-
7
Building  (years)
 
40
 
Building improvements 
 
Lesser of useful
life or 20 years
 
Waste disposal system  (years)
 
7